Citrus Sinensis ID: 014722
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | 2.2.26 [Sep-21-2011] | |||||||
| Q38873 | 535 | Calcium-dependent protein | yes | no | 0.976 | 0.764 | 0.809 | 0.0 | |
| Q42438 | 533 | Calcium-dependent protein | no | no | 0.973 | 0.765 | 0.807 | 0.0 | |
| Q6NLQ6 | 538 | Calcium-dependent protein | no | no | 0.973 | 0.758 | 0.742 | 0.0 | |
| P93759 | 530 | Calcium-dependent protein | no | no | 0.952 | 0.752 | 0.713 | 1e-176 | |
| Q8W4I7 | 528 | Calcium-dependent protein | no | no | 0.961 | 0.763 | 0.668 | 1e-160 | |
| Q9SSF8 | 541 | Calcium-dependent protein | no | no | 0.968 | 0.750 | 0.658 | 1e-157 | |
| Q9M9V8 | 545 | Calcium-dependent protein | no | no | 0.971 | 0.746 | 0.661 | 1e-156 | |
| Q9SIQ7 | 582 | Calcium-dependent protein | no | no | 0.971 | 0.699 | 0.607 | 1e-152 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.863 | 0.685 | 0.633 | 1e-137 | |
| Q3E9C0 | 523 | Calcium-dependent protein | no | no | 0.949 | 0.760 | 0.553 | 1e-135 |
| >sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/410 (80%), Positives = 369/410 (90%), Gaps = 1/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCC P S++ + +GK K K NPFY +EY + S +L VLK+P+G DIS+ YD
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRE+GRGEFG+TYLCTD GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I + DLQILMEA +
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDV 410
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/410 (80%), Positives = 366/410 (89%), Gaps = 2/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P S +G + K K NPFY + Y NGS +L VLK+P+G DIS+ YDL
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
GRE+GRGEFG+TYLCTD+ GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNIV
Sbjct: 60 GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAVSI 409
VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEA +
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADV 409
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/415 (74%), Positives = 358/415 (86%), Gaps = 7/415 (1%)
Query: 1 MGNCCARPDS---SSGKRAKGKKEKPNPFYGDEYVVANGSTVVHR---LCVLKEPSGQDI 54
MGNCC S + K KG+K K NPF D + G R L VL +P+G++I
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRK-KQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREI 59
Query: 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
Y LGRELGRGEFGVTYLCTD + FACKSI KKKLRTAVDIEDVRREV+IM+H+P
Sbjct: 60 ESKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMP 119
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+HPN+V+LK+TYED+ AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQVCH
Sbjct: 120 EHPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCH 179
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
+ GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRN
Sbjct: 180 KHGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRN 239
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YGPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDL++
Sbjct: 240 YGPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIR 299
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
KML+PD K+RLTA++VL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V+AE
Sbjct: 300 KMLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAE 359
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
LS EE +G++E F++MDT++RGKIN++EL++GL K G IP+ DLQILM+A I
Sbjct: 360 HLSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDAGDI 414
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1597), Expect = e-176, Method: Compositional matrix adjust.
Identities = 292/409 (71%), Positives = 352/409 (86%), Gaps = 10/409 (2%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPF---YGDEYVVANGSTVVHRLCVLKEPSGQDISID 57
MGNCC S + K + PNPF YG+ + +G +L VLKEP+G +I
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHH---DGL----KLIVLKEPTGHEIKQK 53
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LGRELGRGEFGVTYLCT++ GE FACKSI KKKL+T++DIEDV+REV+IM+ +P+HP
Sbjct: 54 YKLGRELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHP 113
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV+LK+TYEDD AVH+VMELCEGGELFDRIVARGHYTERAAA+V+KTI+EVVQ+CH+ G
Sbjct: 114 NIVTLKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHG 173
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
VMHRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVL+R+YG
Sbjct: 174 VMHRDLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQ 233
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
E+D+WSAGVILYILLCGVPPFWAETE GVA+AI++SVIDFKRDPWPKVS+NAKDL+KKML
Sbjct: 234 EIDIWSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKML 293
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLS 357
+PDP++RLTA++VL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V+AE LS
Sbjct: 294 HPDPRRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLS 353
Query: 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
VEE + +KE F++MDT+ RGKI + EL +GL K G +P+ D+QILM+A
Sbjct: 354 VEETSCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDA 402
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 272/407 (66%), Positives = 331/407 (81%), Gaps = 4/407 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCC P + + + K + D A G + VL + ++I Y L
Sbjct: 1 MGNCCRSPAAVAREDVKSNYSGHDHARKD----AAGGKKSAPIRVLSDVPKENIEDRYLL 56
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
RELGRGEFGVTYLC + ++ + ACKSISK+KLRTAVDIEDV+REV IMKHLPK +IV
Sbjct: 57 DRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSSIV 116
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
+LK+ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAA V KTIVEVVQ+CH+ GV+H
Sbjct: 117 TLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGVIH 176
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLFANKKE+SPLKAIDFGLS+FF+PGE+F+EIVGSPYYMAPEVLKRNYGPE+D
Sbjct: 177 RDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEID 236
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R VIDFKR+PWP +SE AK+LV++ML PD
Sbjct: 237 IWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLEPD 296
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RLTA++VLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V+AEFLS EE
Sbjct: 297 PKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLSTEE 356
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
V +K F MDT+ G +++EEL+ GL + E+++Q+L+EAV
Sbjct: 357 VEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAV 403
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 554 bits (1427), Expect = e-157, Method: Compositional matrix adjust.
Identities = 272/413 (65%), Positives = 323/413 (78%), Gaps = 7/413 (1%)
Query: 1 MGNCCA----RPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISI 56
MGNC A PD+S + KK+ P + Y +G L V+ IS
Sbjct: 1 MGNCIACVKFDPDNS---KPNQKKKPPRGRQRNPYDDPDGLRTHAPLRVIPMSHQSQISD 57
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y LGRELGRGEFG+TYLCTD E ACKSISK+KLRTAVD+EDVRREV IM LP+H
Sbjct: 58 KYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEH 117
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PN+V LK TYED+ VH+VMELCEGGELFDRIVARGHYTERAAA V +TI EVV++CH
Sbjct: 118 PNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVN 177
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYG 236
GVMHRDLKPENFLFANKKE+S LKAIDFGLSV F+PGE+F EIVGSPYYMAPEVLKRNYG
Sbjct: 178 GVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYG 237
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
PEVDVWSAGVILYILLCGVPPFWAETEQGVA AI+R V+DFKRDPW ++SE+AK LVK+M
Sbjct: 238 PEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQM 297
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL 356
L PD +RLTA++VL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V+AE L
Sbjct: 298 LEPDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEHL 357
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
S++EV ++ F +MD + GKI+ ELR GL K G + E ++++LME +
Sbjct: 358 SIQEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLMEVADV 410
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 551 bits (1420), Expect = e-156, Method: Compositional matrix adjust.
Identities = 275/416 (66%), Positives = 327/416 (78%), Gaps = 9/416 (2%)
Query: 1 MGNC--CARPDSSSGKRAK-----GKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQD 53
MGNC C RPDS K + + K NPF GD + + V + + Q
Sbjct: 1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGD-FTRSPAPIRVLKDVIPMSNQTQ- 58
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
IS Y LGRELGRGEFG+TYLCTD E ACKSISK+KLRTAVDIEDVRREV IM L
Sbjct: 59 ISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTL 118
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
P+HPN+V LK +YED+ VH+VMELCEGGELFDRIVARGHYTERAAAAV +TI EVV +C
Sbjct: 119 PEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMC 178
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
H GVMHRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PG++F EIVGSPYYMAPEVLKR
Sbjct: 179 HSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKR 238
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R V+DFKRDPWP++SE+AK LV
Sbjct: 239 DYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLV 298
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353
K+ML+PDP +RLTA++VL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+V+A
Sbjct: 299 KQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVIA 358
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
E LS++EV +K F +MD +K GKI EL+ GL K G + E ++++LME +
Sbjct: 359 EHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVADV 414
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 539 bits (1388), Expect = e-152, Method: Compositional matrix adjust.
Identities = 252/415 (60%), Positives = 326/415 (78%), Gaps = 8/415 (1%)
Query: 1 MGNCCARPDSSS--GKRAKGKKEKPNPFYGDEYVVANGSTVVHRLC------VLKEPSGQ 52
MG+C + P S GKR ++ N + + + RL VL EP G
Sbjct: 1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
I + YDLG+ELGRGEFGVT+ C +++ E+FACK ISK+KLRT +D+EDVRREV+IM+
Sbjct: 61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
LPKHPNIVS K+ +ED AV++VME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV+V
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
CHE GV+HRDLKPENFLF+N E++ LKAIDFGLS+FF+P ++FNEIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R IDF+RDPWPKVS AK+L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
VK ML+ +P RLT +EVLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L++V
Sbjct: 301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
A+ L EE+A + + F+ MDT+K G + EELR GL K GQ +P+ D+++LM+A
Sbjct: 361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDAA 415
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1257), Expect = e-137, Method: Compositional matrix adjust.
Identities = 230/363 (63%), Positives = 277/363 (76%), Gaps = 1/363 (0%)
Query: 45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
VL P +D+ Y LG+ELGRG+FGVT+LCT G +FACK+I+K+KL DIEDVR
Sbjct: 61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
REVQIM HL PNIV LK YED +VH+VMELC GGELFDRI+A+GHY+ERAAA++++
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
TIV++V CH GV+HRDLKPENFL NK E+SPLKA DFGLSVF++PGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239
Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+R +DF DPWP
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
+S AKDLVKKMLN DPKQRLTA +VL HPW++ +AP+V L V +RLKQF MN
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359
Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
KK AL+V+A LS EE+ GLKE F+ MDT+ G I LEELR GL K G + E ++Q LM
Sbjct: 360 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLM 419
Query: 405 EAV 407
EA
Sbjct: 420 EAA 422
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9C0|CDPKY_ARATH Calcium-dependent protein kinase 34 OS=Arabidopsis thaliana GN=CPK34 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-135, Method: Compositional matrix adjust.
Identities = 236/426 (55%), Positives = 291/426 (68%), Gaps = 28/426 (6%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSG--------- 51
MGNCC S G+ + KE+P P E + K P
Sbjct: 1 MGNCC-----SHGRDSDDNKEEPRP----ENGGGGVGAAEASVRASKHPPASPPPATKQG 51
Query: 52 ----------QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE 101
+D+ Y LG+ELGRG+FGVT+LCT G +FACK+I+K+KL DIE
Sbjct: 52 PIGPVLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIE 111
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA 161
DVRREVQIM HL PNIV LK YED +VH+VMELC GGELFDRI+A+GHY+ERAAA+
Sbjct: 112 DVRREVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAAS 171
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
+++TIV+++ CH GV+HRDLKPENFL +K E+SPLKA DFGLSVF++PGE F +IVG
Sbjct: 172 LLRTIVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVG 231
Query: 222 SPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
S YY+APEVL+R YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+ +DF DP
Sbjct: 232 SAYYIAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDP 291
Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 341
WP +S AKDLV+KMLN DPKQRLTA +VL HPW++ +AP+V L V +RLKQF M
Sbjct: 292 WPVISPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAM 351
Query: 342 NKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
N KK AL+V+A LS EE+ GLKE F+ MDT+ G I LEELR GL K G + E ++Q
Sbjct: 352 NNFKKVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQ 411
Query: 402 ILMEAV 407
LMEA
Sbjct: 412 QLMEAA 417
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| 297811393 | 535 | calmodulin-domain protein kinase 7 [Arab | 0.976 | 0.764 | 0.812 | 0.0 | |
| 18416872 | 535 | calmodulin-domain protein kinase 7 [Arab | 0.976 | 0.764 | 0.809 | 0.0 | |
| 449442535 | 531 | PREDICTED: calcium-dependent protein kin | 0.968 | 0.764 | 0.836 | 0.0 | |
| 224104161 | 533 | predicted protein [Populus trichocarpa] | 0.976 | 0.767 | 0.832 | 0.0 | |
| 255544870 | 536 | calcium-dependent protein kinase, putati | 0.976 | 0.763 | 0.833 | 0.0 | |
| 297812129 | 533 | calcium-dependent protein kinase 19 [Ara | 0.973 | 0.765 | 0.809 | 0.0 | |
| 449476073 | 530 | PREDICTED: LOW QUALITY PROTEIN: calcium- | 0.966 | 0.764 | 0.836 | 0.0 | |
| 15239742 | 533 | calcium-dependent protein kinase 19 [Ara | 0.973 | 0.765 | 0.807 | 0.0 | |
| 224059554 | 534 | calcium dependent protein kinase 14 [Pop | 0.976 | 0.765 | 0.820 | 0.0 | |
| 255577483 | 529 | calcium-dependent protein kinase, putati | 0.959 | 0.759 | 0.822 | 0.0 |
| >gi|297811393|ref|XP_002873580.1| calmodulin-domain protein kinase 7 [Arabidopsis lyrata subsp. lyrata] gi|297319417|gb|EFH49839.1| calmodulin-domain protein kinase 7 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1836), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 333/410 (81%), Positives = 370/410 (90%), Gaps = 1/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCC P S++ + +GK + K NPFY +EY + S +L VLK+P+G DIS+ YD
Sbjct: 1 MGNCCGSPGSATNESKQGKPRNKNNPFYSNEYTATDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRE+GRGEFG+TYLCTD GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
VSLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSPLKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I +ADLQILMEA +
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADADLQILMEATDV 410
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18416872|ref|NP_568281.1| calmodulin-domain protein kinase 7 [Arabidopsis thaliana] gi|75319419|sp|Q38873.1|CDPK7_ARATH RecName: Full=Calcium-dependent protein kinase 7; AltName: Full=Calmodulin-domain protein kinase CDPK isoform 7 gi|13605617|gb|AAK32802.1|AF361634_1 AT5g19450/F7K24_200 [Arabidopsis thaliana] gi|1399277|gb|AAB03247.1| calmodulin-domain protein kinase CDPK isoform 7 [Arabidopsis thaliana] gi|14586378|emb|CAC42909.1| calcium-dependent protein kinase-like protein [Arabidopsis thaliana] gi|332004432|gb|AED91815.1| calmodulin-domain protein kinase 7 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1833), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/410 (80%), Positives = 369/410 (90%), Gaps = 1/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCC P S++ + +GK K K NPFY +EY + S +L VLK+P+G DIS+ YD
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRE+GRGEFG+TYLCTD GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
E AG+KEAFEMMD NKRGKINLEEL+ GL K GQ I + DLQILMEA +
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDV 410
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449442535|ref|XP_004139037.1| PREDICTED: calcium-dependent protein kinase 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/409 (83%), Positives = 375/409 (91%), Gaps = 3/409 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P + SGK+ KGK +K NPF D YVV+NG+ + VLK+P+G+DIS YDL
Sbjct: 1 MGNCCATPATPSGKQHKGKNKKQNPFAAD-YVVSNGNGGGN--WVLKDPTGRDISALYDL 57
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
G ELGRGEFGVTYLCTD N GEK ACKSISKKKLRTAVDI+DVRREV+IMK+LPKHPNIV
Sbjct: 58 GSELGRGEFGVTYLCTDRNTGEKLACKSISKKKLRTAVDIDDVRREVEIMKNLPKHPNIV 117
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SL+DTYED+ AVHIVMELCEGGELFDRIVARGHYTERAAA VM+TIVEVVQ+CH+ GVMH
Sbjct: 118 SLRDTYEDEQAVHIVMELCEGGELFDRIVARGHYTERAAAVVMRTIVEVVQMCHKNGVMH 177
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 178 RDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 237
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP VS+NAKDLVKKML+PD
Sbjct: 238 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPIVSDNAKDLVKKMLDPD 297
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RLTA+EVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 298 PKKRLTAQEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 357
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
VAG+KEAFEMMDT KRGKINL+ELR+GL K GQ IP+ DLQIL+EA +
Sbjct: 358 VAGIKEAFEMMDTGKRGKINLDELRVGLQKLGQQIPDPDLQILVEAADL 406
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224104161|ref|XP_002313342.1| predicted protein [Populus trichocarpa] gi|222849750|gb|EEE87297.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/411 (83%), Positives = 378/411 (91%), Gaps = 2/411 (0%)
Query: 1 MGNCCARPD--SSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDY 58
MGNCC P SSS K+ KGKK+K NPF+GD Y V NGS V +L VLKEP+G+DI Y
Sbjct: 1 MGNCCFTPSGASSSEKKVKGKKKKQNPFFGDSYAVTNGSGDVDKLWVLKEPTGRDILAHY 60
Query: 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
DLGRELGRGEFG+TYLCTDVN+G+KFACKSISKKKLRTAVDI+DVRREV+IMKHLP HPN
Sbjct: 61 DLGRELGRGEFGITYLCTDVNSGDKFACKSISKKKLRTAVDIDDVRREVEIMKHLPAHPN 120
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
IV+LK +YEDD+AVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+ GV
Sbjct: 121 IVTLKASYEDDTAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHKHGV 180
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
MHRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPE+LKRNYGPE
Sbjct: 181 MHRDLKPENFLFANKKETAVLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEILKRNYGPE 240
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS IDFKRDPWP+VS+NAKDLVKKMLN
Sbjct: 241 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSFIDFKRDPWPRVSDNAKDLVKKMLN 300
Query: 299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
PDPK RLTA++VLEHPW+QNAKKAPNV LGETV+ARLKQFSVMNKLKKRAL+V+AE LSV
Sbjct: 301 PDPKLRLTAQQVLEHPWIQNAKKAPNVPLGETVRARLKQFSVMNKLKKRALRVIAEHLSV 360
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
EEVAG+KEAF+MMDT KRG INLEELR+GL K GQNI +ADL+ILMEA +
Sbjct: 361 EEVAGIKEAFDMMDTGKRGSINLEELRVGLQKLGQNIADADLRILMEAADV 411
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544870|ref|XP_002513496.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223547404|gb|EEF48899.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/414 (83%), Positives = 374/414 (90%), Gaps = 5/414 (1%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPN----PFYGDEYVVANGSTVV-HRLCVLKEPSGQDIS 55
MGNCC P SSS K K PF+G++YVV +GS + H+L VLKEP+G+DIS
Sbjct: 1 MGNCCTIPSSSSSSEKKKAKGNNKNKQNPFFGNDYVVNSGSGYIDHKLVVLKEPTGRDIS 60
Query: 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
YDLGRELGRGEFG+TYLCTDVN EK ACKSISKKKLRTAVDIEDVRREV+IMKHLP
Sbjct: 61 AHYDLGRELGRGEFGITYLCTDVNTDEKLACKSISKKKLRTAVDIEDVRREVEIMKHLPH 120
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
HPNIVSL+ TYEDD+AVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+
Sbjct: 121 HPNIVSLRATYEDDNAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHK 180
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS+NAKDLVKK
Sbjct: 241 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKK 300
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEF 355
MLNPDPK RLTA++VL HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+VVAE
Sbjct: 301 MLNPDPKLRLTAQQVLGHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVVAEH 360
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
LSVEEVAG+KEAF+MMDT +RGKINLEELR+GL K GQ IP+ADLQILMEA +
Sbjct: 361 LSVEEVAGIKEAFDMMDTTRRGKINLEELRIGLQKIGQQIPDADLQILMEAADV 414
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297812129|ref|XP_002873948.1| calcium-dependent protein kinase 19 [Arabidopsis lyrata subsp. lyrata] gi|297319785|gb|EFH50207.1| calcium-dependent protein kinase 19 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1813), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/410 (80%), Positives = 367/410 (89%), Gaps = 2/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P S +G + K K NPFY + Y NGS +L VLK+P+G DIS+ YDL
Sbjct: 1 MGNCCASPGSETGSKNGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
GRE+GRGEFG+TYLCTD+N G+K+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPNIV
Sbjct: 60 GREVGRGEFGITYLCTDINTGDKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNIV 119
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAVSI 409
VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEA +
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADV 409
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476073|ref|XP_004154632.1| PREDICTED: LOW QUALITY PROTEIN: calcium-dependent protein kinase 8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/409 (83%), Positives = 374/409 (91%), Gaps = 4/409 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P + SGK+ KG K K NPF D YVV+NG+ + VLK+P+G+DIS YDL
Sbjct: 1 MGNCCATPATPSGKQHKGNK-KQNPFAAD-YVVSNGNGGGN--WVLKDPTGRDISALYDL 56
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
G ELGRGEFGVTYLCTD N GEK ACKSISKKKLRTAVDI+DVRREV+IMK+LPKHPNIV
Sbjct: 57 GSELGRGEFGVTYLCTDRNTGEKLACKSISKKKLRTAVDIDDVRREVEIMKNLPKHPNIV 116
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SL+DTYED+ AVHIVMELCEGGELFDRIVARGHYTERAAA VM+TIVEVVQ+CH+ GVMH
Sbjct: 117 SLRDTYEDEQAVHIVMELCEGGELFDRIVARGHYTERAAAVVMRTIVEVVQMCHKNGVMH 176
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP VS+NAKDLVKKML+PD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPIVSDNAKDLVKKMLDPD 296
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RLTA+EVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 297 PKKRLTAQEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 356
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
VAG+KEAFEMMDT KRGKINL+ELR+GL K GQ IP+ DLQIL+EA +
Sbjct: 357 VAGIKEAFEMMDTGKRGKINLDELRVGLQKLGQQIPDPDLQILVEAADL 405
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15239742|ref|NP_197446.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|30687323|ref|NP_850853.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|75319668|sp|Q42438.1|CDPK8_ARATH RecName: Full=Calcium-dependent protein kinase 8; AltName: Full=Calcium-dependent protein kinase isoform CDPK19; Short=AtCDPK19 gi|836942|gb|AAA67655.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|836948|gb|AAA67658.1| calcium-dependent protein kinase [Arabidopsis thaliana] gi|332005325|gb|AED92708.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] gi|332005326|gb|AED92709.1| calcium-dependent protein kinase 19 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 700 bits (1807), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/410 (80%), Positives = 366/410 (89%), Gaps = 2/410 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P S +G + K K NPFY + Y NGS +L VLK+P+G DIS+ YDL
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYDL 59
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
GRE+GRGEFG+TYLCTD+ GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNIV
Sbjct: 60 GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 300 PKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 359
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAVSI 409
VAG+KEAFEMMD+ K GKINLEEL+ GL K G Q IP+ DLQILMEA +
Sbjct: 360 VAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADV 409
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059554|ref|XP_002299904.1| calcium dependent protein kinase 14 [Populus trichocarpa] gi|222847162|gb|EEE84709.1| calcium dependent protein kinase 14 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 693 bits (1789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/412 (82%), Positives = 368/412 (89%), Gaps = 3/412 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKP---NPFYGDEYVVANGSTVVHRLCVLKEPSGQDISID 57
MGNCC P +S K K +K NPF+GD Y V N S V +L VLKEP+G+DI
Sbjct: 1 MGNCCVTPTGASSSEKKVKGKKKEKKNPFFGDNYAVINESGNVDKLGVLKEPTGRDILAH 60
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
YDLGRELGRGEFGVTYLCTD+N GEKFACKSISKKKLRTAVDIEDVRREV+IMKHLP HP
Sbjct: 61 YDLGRELGRGEFGVTYLCTDINTGEKFACKSISKKKLRTAVDIEDVRREVEIMKHLPAHP 120
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIVSLK +YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM+TIVEVVQ+CH+ G
Sbjct: 121 NIVSLKASYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMRTIVEVVQMCHKHG 180
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
V+HRDLKPENFLFANKKE+S LK IDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGP
Sbjct: 181 VIHRDLKPENFLFANKKETSALKTIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGP 240
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS+NAK LV KML
Sbjct: 241 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDNAKGLVMKML 300
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLS 357
NPDPK RLTA++VLEHPW+QNAKKAPNV LGETVKARLKQFSVMNKLKKRAL+V+AE LS
Sbjct: 301 NPDPKLRLTAQQVLEHPWIQNAKKAPNVPLGETVKARLKQFSVMNKLKKRALRVIAEHLS 360
Query: 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
VEEVAG+K+AF+ MDT K+G INLEELR+GL K GQ+I +ADLQILMEA I
Sbjct: 361 VEEVAGIKDAFDSMDTGKKGSINLEELRVGLQKLGQHIADADLQILMEAADI 412
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577483|ref|XP_002529620.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530905|gb|EEF32765.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/406 (82%), Positives = 369/406 (90%), Gaps = 4/406 (0%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDL 60
MGNCCA P S + K K+KPNPF D Y + NG V HRL VLK+P+G++I Y+L
Sbjct: 1 MGNCCATPPSDPHENKK-YKKKPNPFSID-YGLNNG--VSHRLTVLKDPTGREIEQRYEL 56
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
G ELGRGEFGVTYLCTD +GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV
Sbjct: 57 GGELGRGEFGVTYLCTDKESGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 116
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
SLKDTYEDD+AVH+VMELCEGGELFDRIV+RGHYTERAAAAV KTIVEVVQ+CH+ GVMH
Sbjct: 117 SLKDTYEDDNAVHLVMELCEGGELFDRIVSRGHYTERAAAAVTKTIVEVVQMCHKHGVMH 176
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVD 240
RDLKPENFLFANKKES+ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFANKKESAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DFKRDPWPKVS+NAKDLVKKML+PD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 296
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
PK+RLTA++VL+HPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVEE
Sbjct: 297 PKRRLTAQQVLDHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVEE 356
Query: 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
VAG+KE F +MDT+ +GKINL+ELR+GL K G I + D+Q+LMEA
Sbjct: 357 VAGIKEGFRLMDTSNKGKINLDELRIGLQKLGHQITDTDVQMLMEA 402
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| TAIR|locus:505006616 | 535 | CPK7 "calmodulin-domain protei | 0.976 | 0.764 | 0.790 | 3.1e-177 | |
| TAIR|locus:2150230 | 533 | CDPK19 "calcium-dependent prot | 0.971 | 0.763 | 0.793 | 2.5e-175 | |
| TAIR|locus:2103498 | 538 | CPK32 "calcium-dependent prote | 0.973 | 0.758 | 0.727 | 7.3e-162 | |
| TAIR|locus:2054386 | 530 | CPK14 "calcium-dependent prote | 0.957 | 0.756 | 0.710 | 6.9e-158 | |
| TAIR|locus:2011201 | 545 | CDPK1 "calcium-dependent prote | 0.968 | 0.744 | 0.654 | 1.8e-142 | |
| TAIR|locus:2074338 | 528 | CPK13 "calcium-dependent prote | 0.957 | 0.759 | 0.652 | 4.8e-142 | |
| TAIR|locus:2027227 | 541 | CPK30 "calcium-dependent prote | 0.973 | 0.754 | 0.642 | 7.1e-141 | |
| TAIR|locus:2061290 | 582 | CPK24 "AT2G31500" [Arabidopsis | 0.968 | 0.697 | 0.589 | 1.4e-133 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.861 | 0.683 | 0.610 | 2.9e-119 | |
| TAIR|locus:2150225 | 523 | CPK34 "AT5G19360" [Arabidopsis | 0.957 | 0.766 | 0.551 | 8.8e-118 |
| TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1721 (610.9 bits), Expect = 3.1e-177, P = 3.1e-177
Identities = 324/410 (79%), Positives = 360/410 (87%)
Query: 1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCC P S++ + +GK K K NPFY +EY + S +L VLK+P+G DIS+ YD
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRE+GRGEFG+TYLCTD GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+PKHPN+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
VSLKD++EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ+CH+QGVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGEQFNEIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VS++AKDLV+KML P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DPK+RLTA +VLEH W+ NAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 301 DPKKRLTAAQVLEHTWILNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 360
Query: 360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAVSI 409
E AG+KEAFEMMD NKRGKIN Q I + DLQILMEA +
Sbjct: 361 EAAGIKEAFEMMDVNKRGKINLEELKYGLQKAGQQIADTDLQILMEATDV 410
|
|
| TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1703 (604.5 bits), Expect = 2.5e-175, P = 2.5e-175
Identities = 326/411 (79%), Positives = 360/411 (87%)
Query: 1 MGNCCARPDSSSGKRAKGK-KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCCA P S +G + KGK K K NPFY + Y NGS +L VLK+P+G DIS+ YD
Sbjct: 1 MGNCCASPGSETGSK-KGKPKIKSNPFYSEAYTT-NGSGTGFKLSVLKDPTGHDISLMYD 58
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRE+GRGEFG+TYLCTD+ GEK+ACKSISKKKLRTAVDIEDVRREV+IMKH+P+HPNI
Sbjct: 59 LGREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNI 118
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
VSLKD +EDD AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI+EVVQ+CH+ GVM
Sbjct: 119 VSLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVM 178
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE+S LKAIDFGLSVFF+PGE FNEIVGSPYYMAPEVL+RNYGPEV
Sbjct: 179 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEV 238
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP+VSE AKDLV+KML P
Sbjct: 239 DIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEP 298
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DPK+RL+A +VLEH W+QNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 299 DPKKRLSAAQVLEHSWIQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALRVIAEHLSVE 358
Query: 360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQN-IPEADLQILMEAVSI 409
EVAG+KEAFEMMD+ K GKIN Q IP+ DLQILMEA +
Sbjct: 359 EVAGIKEAFEMMDSKKTGKINLEELKFGLHKLGQQQIPDTDLQILMEAADV 409
|
|
| TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1576 (559.8 bits), Expect = 7.3e-162, P = 7.3e-162
Identities = 302/415 (72%), Positives = 350/415 (84%)
Query: 1 MGNCCARPDS---SSGKRAKGKKEKPNPF---YGDEYVVANGSTVVHRLCVLKEPSGQDI 54
MGNCC S + K KG+K K NPF YG + +G +L VL +P+G++I
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRK-KQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREI 59
Query: 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
Y LGRELGRGEFGVTYLCTD + FACKSI KKKLRTAVDIEDVRREV+IM+H+P
Sbjct: 60 ESKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMP 119
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+HPN+V+LK+TYED+ AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQVCH
Sbjct: 120 EHPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCH 179
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
+ GVMHRDLKPENFLF NKKE++PLKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVLKRN
Sbjct: 180 KHGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRN 239
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YGPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDL++
Sbjct: 240 YGPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIR 299
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
KML+PD K+RLTA++VL+HPWLQNAK APNVSLGETV+ARLKQF+VMNKLKKRAL+V+AE
Sbjct: 300 KMLDPDQKRRLTAQQVLDHPWLQNAKTAPNVSLGETVRARLKQFTVMNKLKKRALRVIAE 359
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAVSI 409
LS EE +G++E F++MDT++RGKIN IP+ DLQILM+A I
Sbjct: 360 HLSDEEASGIREGFQIMDTSQRGKINIDELKIGLQKLGHAIPQDDLQILMDAGDI 414
|
|
| TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 6.9e-158, Sum P(2) = 6.9e-158
Identities = 289/407 (71%), Positives = 345/407 (84%)
Query: 1 MGNCCARPDSS-SGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYD 59
MGNCC S K+ KG K PNPF +EY N + +L VLKEP+G +I Y
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFK-LPNPF-SNEY--GNHHDGL-KLIVLKEPTGHEIKQKYK 55
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LGRELGRGEFGVTYLCT++ GE FACKSI KKKL+T++DIEDV+REV+IM+ +P+HPNI
Sbjct: 56 LGRELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNI 115
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
V+LK+TYEDD AVH+VMELCEGGELFDRIVARGHYTERAAA+V+KTI+EVVQ+CH+ GVM
Sbjct: 116 VTLKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVM 175
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEV 239
HRDLKPENFLFANKKE++ LKAIDFGLSVFF+PGE+FNEIVGSPYYMAPEVL+R+YG E+
Sbjct: 176 HRDLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEI 235
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D+WSAGVILYILLCGVPPFWAETE GVA+AI++SVIDFKRDPWPKVS+NAKDL+KKML+P
Sbjct: 236 DIWSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHP 295
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVE 359
DP++RLTA++VL+HPW+QN K A NVSLGETV+ARLKQFSVMNKLKKRAL+V+AE LSVE
Sbjct: 296 DPRRRLTAQQVLDHPWIQNGKNASNVSLGETVRARLKQFSVMNKLKKRALRVIAEHLSVE 355
Query: 360 EVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEA 406
E + +KE F++MDT+ RGKI +P+ D+QILM+A
Sbjct: 356 ETSCIKERFQVMDTSNRGKITITELGIGLQKLGIVVPQDDIQILMDA 402
|
|
| TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1393 (495.4 bits), Expect = 1.8e-142, P = 1.8e-142
Identities = 273/417 (65%), Positives = 321/417 (76%)
Query: 1 MGNC--CARPDSSSGK-RAKGKK----EKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQ- 52
MGNC C RPDS K +K KK K NPF GD + L + S Q
Sbjct: 1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGD---FTRSPAPIRVLKDVIPMSNQT 57
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
IS Y LGRELGRGEFG+TYLCTD E ACKSISK+KLRTAVDIEDVRREV IM
Sbjct: 58 QISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMST 117
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
LP+HPN+V LK +YED+ VH+VMELCEGGELFDRIVARGHYTERAAAAV +TI EVV +
Sbjct: 118 LPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMM 177
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
CH GVMHRDLKPENFLFANKKE+SPLKAIDFGLSVFF+PG++F EIVGSPYYMAPEVLK
Sbjct: 178 CHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLK 237
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
R+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R V+DFKRDPWP++SE+AK L
Sbjct: 238 RDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSL 297
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
VK+ML+PDP +RLTA++VL HPW+QNAKKAPNV LG+ V++RLKQFS+MN+ KK+ L+V+
Sbjct: 298 VKQMLDPDPTKRLTAQQVLAHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRFKKKVLRVI 357
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAVSI 409
AE LS++EV +K F +MD +K GKI + E ++++LME +
Sbjct: 358 AEHLSIQEVEVIKNMFSLMDDDKDGKITYPELKAGLQKVGSQLGEPEIKMLMEVADV 414
|
|
| TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1389 (494.0 bits), Expect = 4.8e-142, P = 4.8e-142
Identities = 267/409 (65%), Positives = 327/409 (79%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVV--ANGSTVVHRLCVLKEPSGQDISIDY 58
MGNCC P A +++ + + G ++ A G + VL + ++I Y
Sbjct: 1 MGNCCRSP------AAVAREDVKSNYSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
L RELGRGEFGVTYLC + ++ + ACKSISK+KLRTAVDIEDV+REV IMKHLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
IV+LK+ EDD+AVH+VMELCEGGELFDRIVARGHYTERAAA V KTIVEVVQ+CH+ GV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
+HRDLKPENFLFANKKE+SPLKAIDFGLS+FF+PGE+F+EIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R VIDFKR+PWP +SE AK+LV++ML
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
PDPK+RLTA++VLEHPW+QNAKKAPNV LG+ VK+RLKQFSVMN+ K++AL+V+AEFLS
Sbjct: 295 PDPKRRLTAKQVLEHPWIQNAKKAPNVPLGDVVKSRLKQFSVMNRFKRKALRVIAEFLST 354
Query: 359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAV 407
EEV +K F MDT+ G ++ + E+++Q+L+EAV
Sbjct: 355 EEVEDIKVMFNKMDTDNDGIVSIEELKAGLRDFSTQLAESEVQMLIEAV 403
|
|
| TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1362 (484.5 bits), Expect = 7.1e-141, Sum P(2) = 7.1e-141
Identities = 264/411 (64%), Positives = 316/411 (76%)
Query: 1 MGNC--CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDY 58
MGNC C + D + K + KK+ P + Y +G L V+ IS Y
Sbjct: 1 MGNCIACVKFDPDNSKPNQ-KKKPPRGRQRNPYDDPDGLRTHAPLRVIPMSHQSQISDKY 59
Query: 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
LGRELGRGEFG+TYLCTD E ACKSISK+KLRTAVD+EDVRREV IM LP+HPN
Sbjct: 60 ILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPN 119
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
+V LK TYED+ VH+VMELCEGGELFDRIVARGHYTERAAA V +TI EVV++CH GV
Sbjct: 120 VVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGV 179
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE 238
MHRDLKPENFLFANKKE+S LKAIDFGLSV F+PGE+F EIVGSPYYMAPEVLKRNYGPE
Sbjct: 180 MHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPE 239
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
VDVWSAGVILYILLCGVPPFWAETEQGVA AI+R V+DFKRDPW ++SE+AK LVK+ML
Sbjct: 240 VDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLE 299
Query: 299 PDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSV 358
PD +RLTA++VL+HPW+QNAKKAPNV LG+ V++RLKQFS+MN+LKK+AL+V+AE LS+
Sbjct: 300 PDSTKRLTAQQVLDHPWIQNAKKAPNVPLGDIVRSRLKQFSMMNRLKKKALRVIAEHLSI 359
Query: 359 EEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEAVSI 409
+EV ++ F +MD + GKI+ + E ++++LME +
Sbjct: 360 QEVEVIRNMFTLMDDDNDGKISYLELRAGLRKVGSQLGEPEIKLLMEVADV 410
|
|
| TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1309 (465.8 bits), Expect = 1.4e-133, P = 1.4e-133
Identities = 244/414 (58%), Positives = 318/414 (76%)
Query: 1 MGNCCARPDSSS--GKRAKGKKEKPNPFYGDEYVVANGSTVVHRLC------VLKEPSGQ 52
MG+C + P S GKR ++ N + + + RL VL EP G
Sbjct: 1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
I + YDLG+ELGRGEFGVT+ C +++ E+FACK ISK+KLRT +D+EDVRREV+IM+
Sbjct: 61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
LPKHPNIVS K+ +ED AV++VME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV+V
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
CHE GV+HRDLKPENFLF+N E++ LKAIDFGLS+FF+P ++FNEIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R IDF+RDPWPKVS AK+L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
VK ML+ +P RLT +EVLEHPW++NA++APNV+LG+ V+ +++QF +MN+ KK+ L++V
Sbjct: 301 VKNMLDANPYSRLTVQEVLEHPWIRNAERAPNVNLGDNVRTKIQQFLLMNRFKKKVLRIV 360
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILMEA 406
A+ L EE+A + + F+ MDT+K G + Q +P+ D+++LM+A
Sbjct: 361 ADNLPNEEIAAIVQMFQTMDTDKNGHLTFEELRDGLKKIGQVVPDGDVKMLMDA 414
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1174 (418.3 bits), Expect = 2.9e-119, P = 2.9e-119
Identities = 221/362 (61%), Positives = 268/362 (74%)
Query: 45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
VL P +D+ Y LG+ELGRG+FGVT+LCT G +FACK+I+K+KL DIEDVR
Sbjct: 61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
REVQIM HL PNIV LK YED +VH+VMELC GGELFDRI+A+GHY+ERAAA++++
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
TIV++V CH GV+HRDLKPENFL NK E+SPLKA DFGLSVF++PGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239
Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+R +DF DPWP
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
+S AKDLVKKMLN DPKQRLTA +VL HPW++ +AP+V L V +RLKQF MN
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNF 359
Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILM 404
KK AL+V+A LS EE+ GLKE F+ MDT+ G I + E ++Q LM
Sbjct: 360 KKVALRVIAGCLSEEEIMGLKEMFKGMDTDSSGTITLEELRQGLAKQGTRLSEYEVQQLM 419
Query: 405 EA 406
EA
Sbjct: 420 EA 421
|
|
| TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
Identities = 232/421 (55%), Positives = 289/421 (68%)
Query: 1 MGNCCARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTV---VHRLC----VLKE-PSG- 51
MGNCC S G+ + KE+P P G V A ++V H K+ P G
Sbjct: 1 MGNCC-----SHGRDSDDNKEEPRPENGGGGVGAAEASVRASKHPPASPPPATKQGPIGP 55
Query: 52 ------QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
+D+ Y LG+ELGRG+FGVT+LCT G +FACK+I+K+KL DIEDVRR
Sbjct: 56 VLGRPMEDVKSSYTLGKELGRGQFGVTHLCTQKATGLQFACKTIAKRKLVNKEDIEDVRR 115
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
EVQIM HL PNIV LK YED +VH+VMELC GGELFDRI+A+GHY+ERAAA++++T
Sbjct: 116 EVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRT 175
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
IV+++ CH GV+HRDLKPENFL +K E+SPLKA DFGLSVF++PGE F +IVGS YY
Sbjct: 176 IVQIIHTCHSMGVIHRDLKPENFLLLSKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYY 235
Query: 226 MAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
+APEVL+R YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+ +DF DPWP +
Sbjct: 236 IAPEVLRRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILSGQVDFSSDPWPVI 295
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLK 345
S AKDLV+KMLN DPKQRLTA +VL HPW++ +AP+V L V +RLKQF MN K
Sbjct: 296 SPQAKDLVRKMLNSDPKQRLTAAQVLNHPWIKEDGEAPDVPLDNAVMSRLKQFKAMNNFK 355
Query: 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINXXXXXXXXXXXXQNIPEADLQILME 405
K AL+V+A LS EE+ GLKE F+ MDT+ G I + E ++Q LME
Sbjct: 356 KVALRVIAGCLSEEEIMGLKEMFKGMDTDNSGTITLEELRQGLAKQGTRLSEYEVQQLME 415
Query: 406 A 406
A
Sbjct: 416 A 416
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q38873 | CDPK7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8097 | 0.9761 | 0.7644 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.6__1231__AT5G12480.1 | annotation not avaliable (535 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 419 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-109 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-99 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-71 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-66 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-65 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-62 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-60 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-57 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-53 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-52 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-51 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-51 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-49 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-48 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-48 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-47 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-45 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-45 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-44 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-44 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-43 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-42 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-41 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-40 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-39 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-39 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-38 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-38 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-37 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-36 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-36 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-36 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-36 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-35 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-35 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-35 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-34 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-34 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-33 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-33 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-33 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-33 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-33 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-32 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-32 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-31 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-31 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-31 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-31 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-31 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-30 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-29 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-29 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-28 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-27 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-27 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-27 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-27 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-27 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-27 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-27 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-26 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-26 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-26 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-25 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-25 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-25 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-25 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-25 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-24 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-24 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-24 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-23 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-23 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-22 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-22 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-22 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-20 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-19 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-18 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-17 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-12 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| cd00051 | 63 | cd00051, EFh, EF-hand, calcium binding motif; A di | 5e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| pfam13405 | 30 | pfam13405, EF_hand_4, EF-hand domain | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-04 | |
| smart00054 | 29 | smart00054, EFh, EF-hand, calcium binding motif | 8e-04 | |
| pfam00036 | 29 | pfam00036, efhand, EF hand | 9e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| PTZ00184 | 149 | PTZ00184, PTZ00184, calmodulin; Provisional | 0.003 | |
| pfam13202 | 25 | pfam13202, EF_hand_3, EF hand | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 | |
| COG5126 | 160 | COG5126, FRQ1, Ca2+-binding protein (EF-Hand super | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-109
Identities = 115/260 (44%), Positives = 156/260 (60%), Gaps = 7/260 (2%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y++ +LG G FG YL D G+ A K I KKK++ D E + RE++I+K L KHP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV L D +ED+ +++VME CEGG+LFD + RG +E A ++ I+ ++ H +G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YG 236
++HRDLKPEN L E +K DFGL+ PGE+ VG+P YMAPEVL YG
Sbjct: 118 IVHRDLKPENILL---DEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
VD+WS GVILY LL G PPF + + I P +S AKDL++K+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 297 LNPDPKQRLTAEEVLEHPWL 316
L DP++RLTAEE L+HP+
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 296 bits (761), Expect = 2e-99
Identities = 113/266 (42%), Positives = 151/266 (56%), Gaps = 13/266 (4%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y+L R+LG G FG Y G+ A K + K+ ++ D RRE++I++ L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV L D +ED +++VME CEGG+LFD + G +E A + I+ ++ H G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLK--RN 234
++HRDLKPEN L +K DFGL+ + VG+P+YMAPEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----DFKRDPWPKVSENAK 290
YGP+VDVWS GVILY LL G PPF E +IR ++ +F W SE AK
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
DL+KK LN DP +R TAEE+L+HPW
Sbjct: 235 DLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 2e-71
Identities = 90/257 (35%), Positives = 136/257 (52%), Gaps = 13/257 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L + G+ +A K + KKK+ ++E E I+ + HP IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
++ + +++V+E GGELF + G ++E A IV ++ H G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 184 KPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
KPEN L +K DFGL+ G + N G+P Y+APEVL YG VD
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
WS GV+LY +L G PPF+AE + + + I++ + F +S A+DL+ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDP 232
Query: 302 KQRLT---AEEVLEHPW 315
+RL AEE+ HP+
Sbjct: 233 TKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 1e-66
Identities = 93/255 (36%), Positives = 130/255 (50%), Gaps = 44/255 (17%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG G FG YL D G+K A K I K+ + + E++ RE++I+K L HPNIV L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKL-NHPNIVKLY 57
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
+ED++ +++VME CEGG L D + G +E ++ I+E ++ H G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLKRN--YGPEV 239
LKPEN L ++ +K DFGLS IVG+P YMAPEVL Y +
Sbjct: 118 LKPENILL--DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D+WS GVILY L KDL++KML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 300 DPKQRLTAEEVLEHP 314
DP++R +A+E+LEH
Sbjct: 201 DPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 208 bits (533), Expect = 3e-65
Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y++ +++G+G FG YL ++G+ + K I + + ED EV+I+K L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQV 172
PNI+ +++E+ + IVME +GG+L +I + + E + ++
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 173 CHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEV 230
H + ++HRD+KP+N FL +N +K DFG+S +VG+PYY++PE+
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+ Y + D+WS G +LY L PF E +A I++ + P + S
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP-SQYSSEL 231
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHP 314
++LV +L DP++R + ++L+ P
Sbjct: 232 RNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 1e-62
Identities = 88/267 (32%), Positives = 135/267 (50%), Gaps = 14/267 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ G LGRG FG YL D + GE A KS+ + + ++E + RE++I+ L +H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QH 58
Query: 117 PNIVSLKDTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
PNIV + D+ I +E GG L + G E + I+E + H
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---RPGEQFNEIVGSPYYMAPEVL 231
G++HRD+K N L + +K DFG + GE + G+PY+MAPEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
+ YG D+WS G + + G PP W+E A+ + + P+ +SE A
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316
KD ++K L DPK+R TA+E+L+HP+L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 6e-62
Identities = 90/263 (34%), Positives = 139/263 (52%), Gaps = 14/263 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+++ ++G+G FG Y G++ A K I KL + E + E+QI+K KH
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KH 56
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
PNIV +Y + IVME C GG L D + + TE A V K +++ ++ H
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-N 234
G++HRD+K N L + E +K IDFGLS + N +VG+PY+MAPEV+
Sbjct: 117 NGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVIDFKRDPWP-KVSENAKDL 292
Y + D+WS G+ L G PP+ +E +A+ + + P K S+ KD
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 293 VKKMLNPDPKQRLTAEEVLEHPW 315
+KK L +P++R TAE++L+HP+
Sbjct: 231 LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 90/268 (33%), Positives = 138/268 (51%), Gaps = 19/268 (7%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+ +G +G +L + G+ +A K I K + ++ V E I+ + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ +++VME GG+L + G E A + IV ++ H G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN---------EIVGSPYYMAPEV-LKR 233
KP+N L + + LK DFGLS Q N IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
+ VD WS G ILY L G+PPF ET + + Q I+ I++ D +VS+ A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 294 KKMLNPDPKQRLTA---EEVLEHPWLQN 318
K+L PDP++RL A EE+ HP+ +
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 193 bits (489), Expect = 2e-57
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 28/294 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + R+LG G FG YL D + A K ++KK + ++E RE+QI+ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVC 173
PNIV L D ++D+ ++++VME +GG L D + G +E A ++ I+ ++
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-------FNEIVGSPYYM 226
H +G++HRD+KPEN L ++ +K IDFGL+ + VG+P YM
Sbjct: 118 HSKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 227 APEVLK----RNYGPEVDVWSAGVILYILLCGVPPF----WAETEQGVAQAIIRSVIDFK 278
APEVL D+WS G+ LY LL G+PPF + + I+
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 279 RDPWPK-----VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
P +S+ A DL+KK+L DPK RL++ L H L + K +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
|
Length = 384 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 8e-57
Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 33/285 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ G+ +G G F L + +++A K + K++L ++ V+ E +++ L H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P I+ L T++D+ ++ V+E GEL I G E+ I+ ++ H +
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------------------RPGEQ 215
G++HRDLKPEN L +K DFG + + +
Sbjct: 122 GIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 216 FNEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
F VG+ Y++PE+L G D+W+ G I+Y +L G PPF E Q I++
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA----EEVLEHPW 315
F P P +AKDL++K+L DP+ RL +E+ HP+
Sbjct: 239 YSF---P-PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 4e-53
Identities = 88/264 (33%), Positives = 142/264 (53%), Gaps = 14/264 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+Y LG +GRG FGV Y ++ G+ A K IS +K++ ++ + +E+ ++K+L KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PNIV + E +++I++E E G L I G + E A + +++ + HEQ
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAPEVLKRNY 235
GV+HRD+K N L K+ +K DFG++ + +VG+PY+MAPEV+
Sbjct: 119 GVIHRDIKAANILTT--KDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174
Query: 236 GPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDL 292
G D+WS G + LL G PP++ + A+ R V D P P+ +S KD
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
+ + DP R TA+++L+HPW+
Sbjct: 231 LMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 6e-52
Identities = 82/265 (30%), Positives = 137/265 (51%), Gaps = 18/265 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG G FG L + FA K + K+ + E + E +I++ HP IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
T++D ++++ME C GGEL+ + RG + E A + +V + H +G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVW 242
KPEN L + +K +DFG + + G++ G+P Y+APE+ L + Y VD W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 243 SAGVILYILLCGVPPFWAETE--QGVAQAIIRSV--IDFKRDPWPKVSENAKDLVKKMLN 298
S G++LY LL G PPF + E + I++ ++F + + AKDL+K++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
+P++RL +++ +H W
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-51
Identities = 93/281 (33%), Positives = 145/281 (51%), Gaps = 28/281 (9%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLRTAVDIEDVRREV 107
S D Y ++G G G Y TD G++ A K + K+ + E+
Sbjct: 13 SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII------NEI 66
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY---TERAAAAVMK 164
IMK KHPNIV D+Y + +VME +GG L D + ++ E A V +
Sbjct: 67 LIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCR 123
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSP 223
+++ ++ H Q V+HRD+K +N L + +K DFG + + + N +VG+P
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTP 180
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI--IRS--VIDFK 278
Y+MAPEV+KR YGP+VD+WS G++ + G PP+ E +A+ I + + K
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLK 237
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
+P K S KD + K L DP++R +AEE+L+HP+L+ A
Sbjct: 238 -NP-EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 84/268 (31%), Positives = 141/268 (52%), Gaps = 22/268 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + LG G FG L +G+ +A K +SK K+ +E V E +I++ + +H
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RH 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
P +V+L +++DDS +++VME GGELF + G + E A AA +V ++
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA---QVVLALEYL 117
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LK 232
H +++RDLKPEN L + +K DFG + + + G+P Y+APE+ L
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILS 172
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
+ YG VD W+ G+++Y +L G PPF+ + + + I+ + F S +AKDL
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS----FFSPDAKDL 228
Query: 293 VKKMLNPDPKQRL-----TAEEVLEHPW 315
++ +L D +RL ++ HPW
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-49
Identities = 86/293 (29%), Positives = 131/293 (44%), Gaps = 41/293 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + +G G G+ + D GE A K ++ ++L + RE++ ++ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
P +V L D + S +VME +L + + E + M+ +++ V H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVL-- 231
G+MHRDLKP N L + LK DFGL+ F E ++ V + +Y APE+L
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ--AIIRSV--------------- 274
R Y P VD+W+ G I LL G P F E + + Q + R++
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 275 ----IDF---KRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
I F K P P S A DL+K +L DP +RL+A E L HP+
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 84/288 (29%), Positives = 136/288 (47%), Gaps = 47/288 (16%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
LG G +GV Y D GE A K K+R + E + RE+ ++K L KHPNI
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL-KHPNI 60
Query: 120 VSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
V L D + +++V E C+ + D+ G + ++M ++ + CH
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQF-NEIVGSPYYMAPEVL--KR 233
++HRDLKP+N + N+ LK DFGL+ F P + +E+V + +Y APE+L +
Sbjct: 119 ILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSK 174
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SVIDFKR 279
+Y VD+WS G I ++ G P F ++E I + + D+K
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234
Query: 280 DP--WPK---------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+P + DL+ KML +P +R++A+E L+HP+
Sbjct: 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 8e-48
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 37/294 (12%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG FG +L D + G+ +A K + K + I VR E I+
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-ADS 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV L +++D+ +++VME GG+L + ++ + + E A + +V + H+
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------------------VFF 210
G +HRD+KP+N L +K DFGL V
Sbjct: 121 GFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 211 RPGEQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG 265
R +Q N VG+P Y+APEVL+ YG E D WS GVILY +L G PPF+++T Q
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQN 318
II + P P VS A DL+ ++L DP+ RL EE+ HP+ +
Sbjct: 238 TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 9e-47
Identities = 85/288 (29%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPKHPNI 119
++G G +GV Y D GE A K I KLR + RE++++K L HPNI
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-NHPNI 60
Query: 120 VSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+ L D + +++V E + +L + E + + +++ + CH G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
++HRDLKPEN L LK DFGL+ F P + V + +Y APE+L +
Sbjct: 119 ILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQAIIRSVI 275
Y VD+WS G I LL P F ++E
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235
Query: 276 DFK---RDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
F P PK+ S A DL+ +ML+ DP +R+TAE+ L HP+
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 75/262 (28%), Positives = 128/262 (48%), Gaps = 8/262 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
++L R +G+G FG + + + FA K ++K+K + +V E +I++ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+V+L +++D+ +++V++L GG+L + + ++E + IV ++ H +G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYG 236
++HRD+KP+N L E + DF ++ P G+P YMAPEVL R Y
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
VD WS GV Y L G P+ + Q I S A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236
Query: 297 LNPDPKQRL--TAEEVLEHPWL 316
L DP++RL +++ HP+
Sbjct: 237 LERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 10/263 (3%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ + +G FG YL + G+ FA K + K + + +V+ E IM + P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L +++ +++VME GG+ I G E A + +V V+ H++G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPE-VD 240
D+KPEN L ++ LK DFGLS R G + + VG+P Y+APE + + D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
WS G +++ L G PPF AET V I+ I++ + S A DL+ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 301 PKQRLTA---EEVLEHPWLQNAK 320
P +RL A +E+ HP+ ++
Sbjct: 236 PAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-45
Identities = 91/268 (33%), Positives = 133/268 (49%), Gaps = 13/268 (4%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ + ++G+G +G +L + GE A K + K L ++ V E I+ K
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
+V L ++DD +++ ME GG+ + G +E A M + E V HE
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
G +HRDLKPENFL S +K DFGLS N +VGSP YMAPEVL+ + Y
Sbjct: 121 GYIHRDLKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGY 175
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----DPWPKVSENAKD 291
VD WS G +LY LCG PPF T + + +R DP +S+ A D
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235
Query: 292 LVKKMLNPDPKQRLTA-EEVLEHPWLQN 318
L+ K++N DP +R + E++ HP+ +
Sbjct: 236 LITKLIN-DPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 20/269 (7%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
G ++G G FG Y +++ GE A K I + I+++ E+++++ L KHPN+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KHPNL 61
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
V V+I ME C GG L + + E ++E + H G++
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFF-----RPGEQFNEIVGSPYYMAPEVLKRN 234
HRD+KP N + +K DFG +V GE+ + G+P YMAPEV+
Sbjct: 122 HRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 235 ----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---KVSE 287
+G D+WS G ++ + G P W+E + I+ V + P P ++S
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN--EFQIMFHVGAGHKPPIPDSLQLSP 235
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
KD + + L DPK+R TA E+L+HP++
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-44
Identities = 91/277 (32%), Positives = 148/277 (53%), Gaps = 23/277 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISK----KKLRTAVDIEDVRREVQI 109
+++L R LG G +G +L V + G+ +A K + K +K +TA E R E Q+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA---EHTRTERQV 57
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
++ + + P +V+L ++ D+ +H++++ GGELF + R H+TE + IV
Sbjct: 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMA 227
+ H+ G+++RD+K EN L + DFGLS F E+ G+ YMA
Sbjct: 118 LDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 228 PEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
PEV++ + VD WS GV+ + LL G PF + EQ +Q+ I I + P+PK
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKSKPPFPK 233
Query: 285 -VSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQ 317
+S A+D ++K+L DPK+RL A+E+ HP+ Q
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 91/299 (30%), Positives = 141/299 (47%), Gaps = 56/299 (18%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
Y + ++LG G FG YL + GE A K + KKK + E+ REV+ ++ L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRKLNE 56
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVC 173
HPNIV LK+ + ++ ++ V E E G L+ + R ++E +++ I++ +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
H+ G HRDLKPEN L + +K DFGL+ R + + V + +Y APE+L R
Sbjct: 116 HKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 234 --NYGPEVDVWSAGVI---LYIL---------------LCGV-----PPFWAETEQGVAQ 268
+Y VD+W+ G I LY L +C V W E + +A
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LAS 231
Query: 269 AI-----------IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ + +I P S A DL+K ML DPK+R TA + L+HP+
Sbjct: 232 KLGFRFPQFAPTSLHQLI-------PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 3e-43
Identities = 86/297 (28%), Positives = 141/297 (47%), Gaps = 45/297 (15%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLP 114
Y+ G++LG G + V Y D G A K I +K+ + ++ RE+++++ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALREIKLLQEL- 59
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
KHPNI+ L D + S +++V E E + D+ + T + M + ++
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGLE 116
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEV 230
H ++HRDLKP N L A+ LK DFGL+ F P + V + +Y APE+
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQA 269
L R+YG VD+WS G I LL VP +++ GV
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS- 232
Query: 270 IIRSVIDFK-------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
+ ++FK + +P S++A DL++++L +P +R+TA + LEHP+ N
Sbjct: 233 -LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-42
Identities = 91/273 (33%), Positives = 131/273 (47%), Gaps = 25/273 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ +G+G FG ++G+ K I + T + + + EV I++ L KH
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KH 58
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRI----VARGHYTERAAAAVMKTIVEVV 170
PNIV D D S ++IVME CEGG+L I R + E ++ ++ +
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 171 QVCH-----EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
CH V+HRDLKP N FL AN +K DFGL+ F VG+P
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTP 174
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
YYM+PE L Y + D+WS G ++Y L PPF A + +A I K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----KFRRI 230
Query: 283 PKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
P S +++K MLN DP +R + EE+L+ P
Sbjct: 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 80/269 (29%), Positives = 138/269 (51%), Gaps = 20/269 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D + + +G G FG +L D + +A K ++ ++ + V E +++K + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SH 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P I+ L T D ++++ME GGELF + G ++ IV ++ H +
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-Y 235
+++RDLKPEN L KE +K DFG + R ++ + G+P Y+APEV++ +
Sbjct: 121 EIVYRDLKPENILL--DKEGH-IKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGH 175
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--DPWPKVSENAKDLV 293
VD W+ G+++Y +L G PPF+ + G+ + I+ ++F R D + AKDL+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDLI 229
Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQ 317
KK+L D +RL A++V H W +
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 88/283 (31%), Positives = 143/283 (50%), Gaps = 33/283 (11%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKH 116
+ L +G+G FG Y D + A K I L A D IED+++E+Q + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC-RS 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P I ++ S + I+ME C GG D ++ G E A +++ ++ ++ HE+
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE------QFNEIVGSPYYMAPEV 230
G +HRD+K N L + + + +K DFG+S G+ + N VG+P++MAPEV
Sbjct: 118 GKIHRDIKAANILLSEEGD---VKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV---- 285
+K++ Y + D+WS G+ L G PP V I K +P P +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNP-PSLEGNK 222
Query: 286 -SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
S+ KD V LN DPK+R +A+E+L+H +++ AKK ++L
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 76/275 (27%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK----- 111
D + + LG+G GV Y G+ +A K I E+ R+ Q+++
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRK--QLLRELKTL 53
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
+ P +V + + + IV+E +GG L D + G E A + + I++ +
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLD 113
Query: 172 VCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPE 229
H + ++HRD+KP N L +K E +K DFG+S V +Q N VG+ YM+PE
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--VS 286
++ +Y D+WS G+ L G PF Q +++++ D P S
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFS 229
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
+D + L DPK+R +A E+L+HP+++ A
Sbjct: 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-39
Identities = 90/272 (33%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 58 YDLGR--ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
L ++G G G+ + TD + G + A K K LR E + EV IM+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ- 74
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
HPNIV + +Y + +VME EGG L D IV E A V +++ + H
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHA 133
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-------IVGSPYYMAP 228
QGV+HRD+K ++ L +K DFG Q ++ +VG+PY+MAP
Sbjct: 134 QGVIHRDIKSDSILL---TSDGRVKLSDFGFCA------QVSKEVPRRKSLVGTPYWMAP 184
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
EV+ R YG EVD+WS G+++ ++ G PP++ E + I ++ ++ KVS
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL-HKVSP 243
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
+ + +ML DP QR TA E+L HP+L A
Sbjct: 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 93/303 (30%), Positives = 139/303 (45%), Gaps = 54/303 (17%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLP 114
Y+L + +G G +GV D G K A K IS D+ D + RE+++++HL
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL- 56
Query: 115 KHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
+H NI+ L D + ED + V+IV EL E +L I + T+ + I+
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG 115
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----VFFRPGEQFNEIVGSPYY 225
++ H V+HRDLKP N + N + LK DFGL+ E V + +Y
Sbjct: 116 LKYLHSANVIHRDLKPSN-ILVN--SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 226 MAPEVL--KRNYGPEVDVWSAGVIL--------------YI----LLC---GVPPFWAET 262
APE+L Y +D+WS G I YI L+ G P E
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS--EED 230
Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ + A+ ++S+ + P P S A DL++KML DPK+R+TA+E L HP
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290
Query: 315 WLQ 317
+L
Sbjct: 291 YLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 2e-38
Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 16/269 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++G LG G FG + GE +A K + K+++ ++ V +E I+ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SH 77
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV++ +++D++ V+ ++E GGELF + G + A +V + H +
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
+++RDLKPEN L NK +K DFG + + ++ + G+P Y+APEV++ + +
Sbjct: 138 DIIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGH 192
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
G VD W+ GV+LY + G PPF+ +T + + I+ + F W A+DLVK
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKG 248
Query: 296 MLNPDPKQRLTA-----EEVLEHPWLQNA 319
+L D +RL +V HP+ A
Sbjct: 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA 277
|
Length = 329 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 82/277 (29%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY+L +G G V Y + N EK A K I +K +T ++++R+EVQ M H
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMS-QCNH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD---RIVARGHYTERAAAAVMKTIVEVVQVC 173
PN+V ++ + +VM GG L D RG E A V+K +++ ++
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-----RPGEQFNEIVGSPYYMAP 228
H G +HRD+K N L E +K DFG+S R + VG+P +MAP
Sbjct: 119 HSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 229 EVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
EV++ Y + D+WS G+ L G P+ V +++ DP P +
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN------DP-PSLE 228
Query: 287 ENA---------KDLVKKMLNPDPKQRLTAEEVLEHP 314
A + ++ L DP +R TAEE+L+H
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 9e-38
Identities = 87/289 (30%), Positives = 153/289 (52%), Gaps = 26/289 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
+++L + LG G +G +L V ++G+ +A K + K + + A E R E Q+++H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+ + P +V+L ++ D+ +H++++ GGELF + R + E+ IV ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPEV 230
H+ G+++RD+K EN L + + DFGLS F E+ G+ YMAP++
Sbjct: 121 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 231 LK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VS 286
++ + VD WS GV++Y LL G PF + E+ I R ++ P+P+ +S
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMS 236
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN-------AKKAP 323
AKD+++++L DPK+RL A+E+ +HP+ Q AKK P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-37
Identities = 87/298 (29%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y+ ++G G +G Y + GE A K I + + I +R E+++++ L +HP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58
Query: 118 NIVSLKD--TYEDDSAVHIVMELCEGGELFD--RIVARG--HYTERAAAAVMKTIVEVVQ 171
NIV LK+ T + ++++V E + D ++ +TE MK ++E +Q
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPE 229
H G++HRD+K N L N LK DFGL+ + R + V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVIDFKRDPWPK 284
+L YGPEVD+WS G IL L G P F TE + I S D + WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD---ENWPG 228
Query: 285 V---------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
V +A DL+ K+L DPK+R++A++ L+H +
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 18/264 (6%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
G LG G FG Y ++++G+ FA K S++ ++ + +E+ ++ L +HPN
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN 63
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
IV T ++ ++I +EL GG L + G + E + I+ ++ H++
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
+HRD+K N L +K DFG++ V F + F GSPY+MAPEV+ +
Sbjct: 124 VHRDIKGANILVDTNGV---VKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQG 177
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDL 292
YG D+WS G + + G PP W++ E A+ + + P P +S+ AKD
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
+ K L DP R TA E+LEHP++
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 92/298 (30%), Positives = 135/298 (45%), Gaps = 61/298 (20%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
+G G +GV C + GE A K K + + D EDV+ REV++++ L +H N
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-----AAAAVMKTIVEVVQV- 172
IV+LK+ + +++V E E L E AV I +++Q
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 173 --CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAP 228
CH ++HRD+KPEN L ES LK DFG + RP + V + +Y AP
Sbjct: 114 AYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE--------QGVAQAIIRSVIDFK 278
E+L NYG VDVW+ G I+ LL G P F +++ + + F
Sbjct: 171 ELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 279 RDP------WP--------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+P +P KVS A D +K L DPK+RLT +E+L+HP+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 25/269 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+D+ +LG G +G Y G+ A K + ++ D++++ +E+ I+K
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DS 57
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
P IV +Y ++ + IVME C G + D + TE AA++ ++ ++ H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKR- 233
+HRD+K N L + ++ K DFG+S + N ++G+P++MAPEV++
Sbjct: 118 NKKIHRDIKAGNILLNEEGQA---KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI 174
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP------KVSE 287
Y + D+WS G+ + G PP+ ++ +R++ P P K S
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPY-SDIHP------MRAIFMIPNKPPPTLSDPEKWSP 227
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
D VKK L DP++R +A ++L+HP++
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 43/301 (14%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ + LG+G+ G +L G+ FA K + KK++ ++ V E +I+ L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DH 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHY-TERAAAAVMKTIVEVVQVCH 174
P + +L +++ ++ + +VM+ C GGELF G +E A ++ ++ H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------------------- 207
G+++RDLKPEN L ES + DF LS
Sbjct: 121 LLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 208 ---VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE 263
P + N VG+ Y+APEV+ + +G VD W+ G++LY +L G PF
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL----TAEEVLEHPWLQNA 319
I++ + F P VS +A+DL++K+L DP +RL A E+ +HP+ +
Sbjct: 238 DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295
Query: 320 K 320
Sbjct: 296 N 296
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 17/268 (6%)
Query: 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHL 113
++ G+ LG+G FG YLC DV+ G + A K + T ++ + E+Q++K+L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
+H IV DD + I ME GG + D++ A G TE + I+E V+
Sbjct: 62 -QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYL 120
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYMAPE 229
H ++HRD+K N L + + +K DFG L G + G+PY+M+PE
Sbjct: 121 HSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--PKVS 286
V+ YG + DVWS G + +L PP WAE E A A I + +P VS
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVS 233
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+A++ +++ + K+R +AEE+L H
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 86/269 (31%), Positives = 138/269 (51%), Gaps = 23/269 (8%)
Query: 62 RELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHP 117
+ LG+G +G + T + G+ FA K + K + R D + E I++ + KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
IV L ++ +++++E GGELF + G + E A + I ++ H+QG
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGL---SVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
+++RDLKPEN L + +K DFGL S+ G + G+ YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
+G VD WS G ++Y +L G PPF AE + I++ ++ P ++ A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231
Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQ 317
KK+L +P RL A EV HP+ +
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-36
Identities = 90/270 (33%), Positives = 131/270 (48%), Gaps = 24/270 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY+L + +G G +G Y D+ GE A K I KL D E +++E+ ++K +H
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC-RH 59
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
PNIV+ +Y + IVME C GG L D V RG +E A V + ++ + HE
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--- 231
G +HRD+K N L E +K DFG+S + +G+PY+MAPEV
Sbjct: 120 TGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE 176
Query: 232 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
K Y + D+W+ G+ L PP + I +S P PK+ + K
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS----NFPP-PKLKDKEK 231
Query: 291 ------DLVKKMLNPDPKQRLTAEEVLEHP 314
D +KK L DPK+R TA ++L+HP
Sbjct: 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 6e-36
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 11/259 (4%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
++G G G+ + T ++G+ A K K LR E + EV IM+ +H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
++Y + +VME EGG L D IV E AAV +++ + V H QGV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
+K ++ L + +K DFG + + +VG+PY+MAPE++ R YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WS G+++ ++ G PP++ E A +IR + K KVS + K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 301 PKQRLTAEEVLEHPWLQNA 319
P QR TA E+L+HP+L A
Sbjct: 258 PAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 80/264 (30%), Positives = 136/264 (51%), Gaps = 15/264 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV--RREVQIMKHLPKHPNIVS 121
+G+G FG Y + +A K +SKK++ ++ R + + L + P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
LK +++ DS +++V + GGELF + G ++E A + +V ++ H+ +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPE 238
DLKPEN L + + DFGLS + N G+ Y+APEVL ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKH 177
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
VD WS GV+++ + CG PF+AE Q + + I + F ++ +S+ + VK +LN
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKGLLN 234
Query: 299 PDPKQRL----TAEEVLEHPWLQN 318
+P+ RL A E+ EHP+ +
Sbjct: 235 RNPQHRLGAHRDAVELKEHPFFAD 258
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 17/273 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKH--PNIV 120
+GRG +G Y V G A K I+ L T D + D++REV ++ L + PNI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
+Y + I+ME EGG + R + + G E+ + +++ ++ ++ H+ GV+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK--RNYG 236
HRD+K N L N + +K DFG++ + + VG+PY+MAPEV+ + Y
Sbjct: 124 HRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
+ D+WS G+ +Y + G PP+ I +S R S+ ++ V
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAAC 238
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE 329
L+ +PK+RL+AEE+L+ W++ K P L E
Sbjct: 239 LDEEPKERLSAEELLKSKWIKAHSKTPVSILKE 271
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 79/275 (28%), Positives = 144/275 (52%), Gaps = 16/275 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
+++L + LG G +G +L V + G+ +A K + K L + A +E R E +++H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+ + P +V+L ++ ++ +H++++ GGE+F + R +++E I+ ++
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--RPGEQFNEIVGSPYYMAPEV 230
H+ G+++RD+K EN L ++ + DFGLS F E+ G+ YMAPE+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
+ K +G VD WS G++++ LL G PF E E+ + R ++ +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237
Query: 289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
A+DL+ K+L DPK+RL A E+ EHP+ +
Sbjct: 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 28/274 (10%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
ELG G FG Y G A K I ++ + ++ED E+ I+ KHPNIV L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC-KHPNIVGL 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ Y ++ + I++E C+GG L ++ TE V + ++E + H V+HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVL------KRN 234
DLK N L + +K DFG+S + Q + +G+PY+MAPEV+
Sbjct: 128 DLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV------SEN 288
Y + D+WS G+ L L PP E +R ++ + P + S +
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPH-HELN------PMRVLLKILKSEPPTLDQPSKWSSS 237
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
D +K L DP R TA E+L+HP++ +
Sbjct: 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 82/294 (27%), Positives = 133/294 (45%), Gaps = 49/294 (16%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
Y + ++G G F G+ +A K + KK + +E V RE+Q ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFK---SLEQVNNLREIQALRRLSP 56
Query: 116 HPNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQV 172
HPNI+ L + D + +V EL + L++ I R E+ + M +++ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEV 230
H G+ HRD+KPEN L K + LK DFG ++ +P + E + + +Y APE
Sbjct: 116 MHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169
Query: 231 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSV-------IDFKRD 280
L + YGP++D+W+ G + + +L P F E + Q A I V + K
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFR 227
Query: 281 PW-------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
P S DL+KK+L DP +R+TA++ L HP+
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 81/267 (30%), Positives = 134/267 (50%), Gaps = 22/267 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLP 114
D+ + ++LG+G +G Y +++ + +A K + L + E D E++I+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIRILASV- 56
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVV 170
HPNI+S K+ + D + + IVME G+L I R E+ + ++ +
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 171 QVCHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
Q HEQ ++HRDLK N L AN +K D G+S + +I G+P+YMAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNMAKTQI-GTPHYMAPE 171
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-SE 287
V K R Y + D+WS G +LY + PPF A + Q + + R K P P + S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ ++ ++ ML PK R +++L P
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 85/260 (32%), Positives = 133/260 (51%), Gaps = 17/260 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
LG+G FG L + G+ +A K I KK++ A D + E +++++ +HP + +L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTAL 60
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
K +++ + VME GGELF + ++E A IV + H V++RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 183 LKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
LK EN + + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 121 LKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
W GV++Y ++CG PF+ + + + + I+ I F R +S AK L+ +L D
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKD 233
Query: 301 PKQRL-----TAEEVLEHPW 315
PKQRL A+E++EH +
Sbjct: 234 PKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 80/264 (30%), Positives = 131/264 (49%), Gaps = 14/264 (5%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ LG+G FG L E +A K + K + D+E E +++ KHP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ + VME GG+L I G + E A IV +Q HE+G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
DLK +N L ++ +K DFG+ G + G+P Y+APE+L + YGP V
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAV 177
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D W+ GV+LY +L G PF + E + Q+I+ + + R W +S+ AK ++K L
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSFLTK 233
Query: 300 DPKQRLTA-----EEVLEHPWLQN 318
+P++RL +++ HP+ +
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 80/259 (30%), Positives = 125/259 (48%), Gaps = 12/259 (4%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG L + K ++ +L D E+ I+ L +HPNI++
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QHPNIIA 63
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVM 179
+ + DD+ + I ME GG L+D+IV + + E + IV V H+ G++
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVLK-RNYGP 237
HRD+K N +F K + +K DFG+S E +VG+PYYM+PE+ + Y
Sbjct: 124 HRDIKTLN-IFLTK--AGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
+ D+W+ G +LY LL F A + I++ + S LV +L
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELISLVHSLL 237
Query: 298 NPDPKQRLTAEEVLEHPWL 316
DP++R TA+EVL+ P L
Sbjct: 238 QQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 90/261 (34%), Positives = 137/261 (52%), Gaps = 17/261 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y++ R +G G FG L VN+ +K+A K I K ++ +ED R+E ++ + KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KH 57
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGH-YTERAAAAVMKTIVEVVQVCH 174
PNIV+ K+++E D ++IVME C+GG+L +I + RG + E + VQ H
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK 232
E+ V+HRD+K +N FL N K +K DFG + + PG VG+PYY+ PE+ +
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 233 R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAK 290
Y + D+WS G ILY L PF A + +I V P P S +
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQA----NSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 291 DLVKKMLNPDPKQRLTAEEVL 311
L+K+M +P+ R +A +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-33
Identities = 85/265 (32%), Positives = 141/265 (53%), Gaps = 11/265 (4%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y ++G+G G + DV G++ A K I+ +K E + E+ +MK L K+P
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL-KNP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV+ D++ + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
V+HRD+K +N L +K DFG P + + + +VG+PY+MAPEV+ R Y
Sbjct: 136 VIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GP+VD+WS G++ ++ G PP+ E I + ++P K+S +D + +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDFLNR 251
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
L D ++R +A+E+L+HP+L+ AK
Sbjct: 252 CLEMDVEKRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSIS--KKKLRTAVDIEDVRREVQIMKHL 113
I++ G+ LG+G FG YLC DV+ G + A K + + T+ ++ + E+Q++K+L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 114 PKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
+H IV D + + I ME GG + D++ A G TE + I+E +
Sbjct: 62 -QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS 120
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYMA 227
H ++HRD+K N L + + +K DFG L G + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
PEV+ YG + DVWS G + +L PP WAE E AI + P +
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHI 234
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
SE+A+D + + + + R +AEE+L HP+ Q
Sbjct: 235 SEHARDFLGCIF-VEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
L +P+G ++L +G G +G Y G+ A K + + E+++
Sbjct: 1 LPDPTG-----IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKE 51
Query: 106 EVQIMKHLPKHPNIVS------LKDTYEDDSAVHIVMELCEGG---ELFDRIVARGH-YT 155
E I++ HPNI + K+ +D + +VMELC GG +L + +G
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGE 214
E A +++ + + HE V+HRD+K +N L E +K +DFG+S
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDFGVSAQLDSTLG 168
Query: 215 QFNEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQ 268
+ N +G+PY+MAPEV+ + P+ DVWS G+ L G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDM 221
Query: 269 AIIRSVIDFKRDPWPKVSENAK------DLVKKMLNPDPKQRLTAEEVLEHPWL 316
+R++ R+P P + D + + L + +QR EE+LEHP++
Sbjct: 222 HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 83/272 (30%), Positives = 128/272 (47%), Gaps = 21/272 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+D+ +GRG FG + + G+ +A K + K L + E I+ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNS 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH 174
P I L+ ++D +++VME GG+L ++ R + E A + +V + H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--VGSPYYMAPEVL- 231
+ G +HRD+KPEN L + +K DFG + + N VG+P Y+APEVL
Sbjct: 120 QMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 232 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWP 283
K YG E D WS GVI Y ++ G PF T I+ + + F D P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED--P 234
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
KVS + DL++ +L K+RL E + HP+
Sbjct: 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 24/270 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHLP 114
++ LG+ LG+G FG YLC D + G + A K + + T+ ++ + E+Q++K+L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL- 61
Query: 115 KHPNIVS----LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
H IV L+D E + I ME GG + D++ + G TE + I+E V
Sbjct: 62 LHERIVQYYGCLRDPME--RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG----LSVFFRPGEQFNEIVGSPYYM 226
H ++HRD+K N L + +K DFG L G + G+PY+M
Sbjct: 120 SYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--P 283
+PEV+ YG + D+WS G + +L PP WAE E A A I + +P P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPP 232
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
VS++ +D +K++ + K R +A+E+L H
Sbjct: 233 HVSDHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 10/260 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y+ R +GRG FG+ +LC + + K I +++ T + + E Q++K L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SHP 59
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHE 175
NI+ + + +D A+ IVME GG L + I R + E I+ + H
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
+ ++HRDLK +N L K +K DFG+S + +VG+P Y++PE+ + +
Sbjct: 120 KLILHRDLKTQNILLDKHK--MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP 177
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
Y + D+W+ G +LY L F A + I+ D + S + + L+
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLIL 234
Query: 295 KMLNPDPKQRLTAEEVLEHP 314
MLN DP +R +++ P
Sbjct: 235 SMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-33
Identities = 84/260 (32%), Positives = 139/260 (53%), Gaps = 11/260 (4%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
++G+G G Y DV G++ A K ++ L+ E + E+ +M+ KHPNIV+
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN-KHPNIVNY 81
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
D+Y + +VME GG L D +V E AAV + ++ ++ H V+HRD
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 140
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
+K +N L +K DFG P + + + +VG+PY+MAPEV+ R YGP+VD
Sbjct: 141 IKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WS G++ ++ G PP+ E I + ++P K+S +D + + L D
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNRCLEMD 256
Query: 301 PKQRLTAEEVLEHPWLQNAK 320
++R +A+E+L+HP+L+ AK
Sbjct: 257 VEKRGSAKELLQHPFLKIAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 82/262 (31%), Positives = 131/262 (50%), Gaps = 15/262 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L + G +A K + K+ + ++ E +++++ +HP + +LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
++ + VME GGELF + +TE A IV ++ H + V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
K EN + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W GV++Y ++CG PF+ + + + + I+ I F R +S AK L+ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234
Query: 302 KQRL-----TAEEVLEHPWLQN 318
KQRL A+EV+EH + +
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 81/262 (30%), Positives = 144/262 (54%), Gaps = 23/262 (8%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
++G G G+ + + ++G + A K + LR E + EV IM+ +H N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY-QHQNVVEM 83
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
+Y + ++ME +GG L D IV++ E A V +++++ + H QGV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
+K ++ L +K DFG + + +VG+PY+MAPEV+ R YG EVD
Sbjct: 143 IKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP------KVSENAKDLVK 294
+WS G+++ ++ G PP+++++ QA+ R + P P K+S +D ++
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 295 KMLNPDPKQRLTAEEVLEHPWL 316
+ML +P++R TA+E+L+HP+L
Sbjct: 253 RMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 22/268 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ + +++G+G+F V Y + +G A K + ++ A +D +E+ ++K L H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
PN++ ++ +++ ++IV+EL + G+L I H+ ++ +TI + VQ+C
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 174 ----HEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMA 227
H + +MHRD+KP N F+ A +K D GL FF + +VG+PYYM+
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVIDFKRDPWPK 284
PE + N Y + D+WS G +LY + PF+ + + + I + D+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
SE +DLV + +NPDP++R VL+
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 89/307 (28%), Positives = 130/307 (42%), Gaps = 61/307 (19%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+D+ ++G G +G Y D + GE A K + + I +R E++I++ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-NHR 66
Query: 118 NIVSLKDTYEDDSAV------------------HIVMELCEGGELFDRIVARGHYTERAA 159
NIV+LK+ D H +M L E G + H++E
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--------HFSEDHI 118
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FN 217
+ MK ++E + CH++ +HRD+K N L NK + +K DFGL+ + E +
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYT 175
Query: 218 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
V + +Y PE+L + YGP +DVWS G IL L P F A E + I R
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235
Query: 276 DFKRDPWPKVSE--------------------------NAKDLVKKMLNPDPKQRLTAEE 309
WP V + A DL+ ML DP +R TAEE
Sbjct: 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 310 VLEHPWL 316
L PWL
Sbjct: 296 ALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 86/259 (33%), Positives = 136/259 (52%), Gaps = 11/259 (4%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
++G G G+ + T+ + G++ A K K LR E + EV IM+ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHENVVDM 84
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
++Y + +VME EGG L D IV E A V +++ + H QGV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 183 LKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
+K ++ L + +K DFG + + +VG+PY+MAPEV+ R YG EVD
Sbjct: 144 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
+WS G+++ ++ G PP++ E A IR + + KVS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 301 PKQRLTAEEVLEHPWLQNA 319
P QR TA+E+L+HP+L+ A
Sbjct: 260 PSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 48/297 (16%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
Y+ E+G G +G Y D+N G + ++ KK+R + E + RE+ ++K L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 114 PK--HPNIVSLKD---TYEDDSA--VHIVMELCEG--GELFDRIVARGHYTERAAAAVMK 164
HPNIV L D D + +V E + + G +M+
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
++ V H ++HRDLKP+N L + + +K DFGL+ + +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------ 271
Y APEVL ++ Y VD+WS G I L P F +E I
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231
Query: 272 ------------RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ FK P++ E DL+KKML +P +R++A E L+HP+
Sbjct: 232 RNVSLPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-32
Identities = 83/286 (29%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + + G +G YL ++FA K I+K+ L I+ V E I+ ++
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAEN 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +VS+ ++E + +VME EGG+ + G A V ++ H
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF--------------RPGEQF--NEIV 220
G++HRDLKP+N L + +K DFGLS + +F ++
Sbjct: 121 GIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 221 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFK 278
G+P Y+APEV L++ YG VD W+ G+ILY L G PF+ +T E+ Q I +
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE--- 234
Query: 279 RDPWPK----VSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQ 317
WP+ + +A+DL+ ++L +P +RL A EV +H +
Sbjct: 235 ---WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 9e-32
Identities = 83/265 (31%), Positives = 139/265 (52%), Gaps = 11/265 (4%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y ++G+G G Y DV G++ A I + L+ E + E+ +M+ K+P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV+ D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
V+HRD+K +N L +K DFG P + + + +VG+PY+MAPEV+ R Y
Sbjct: 137 VIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GP+VD+WS G++ ++ G PP+ E I + ++P K+S +D + +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDFLNR 252
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
L+ D ++R +A+E+L+H +L+ AK
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAK 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
D++ R LG G FG L T N + A K K K+ ++ V E +I+ ++
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-N 89
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
HP V+L +++D+S +++V+E GGE F + + IV + +
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRN 234
+++RDLKPEN L + +K DFG + + + G+P Y+APE+L
Sbjct: 150 LNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVG 204
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLV 293
+G D W+ G+ +Y +L G PPF+A + Q I+ +I F PK + N K L+
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF-----PKFLDNNCKHLM 259
Query: 294 KKMLNPDPKQRL-----TAEEVLEHPWLQN 318
KK+L+ D +R A+ V EHPW N
Sbjct: 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 82/289 (28%), Positives = 125/289 (43%), Gaps = 48/289 (16%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMKHLPKHP 117
+LG G + Y + GE A K I +D E+ RE+ +MK L KH
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIH-------LDAEEGTPSTAIREISLMKEL-KHE 58
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV---MKTIVEVVQVCH 174
NIV L D ++ + +V E + +L + G V +++ + CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL-- 231
E V+HRDLKP+N L + E LK DFGL+ F P F+ V + +Y AP+VL
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------------- 274
R Y +D+WS G I+ ++ G P F + I R +
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 275 -IDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
F R P +P DL+ ++L +P+ R++A + L+HPW
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 88/292 (30%), Positives = 139/292 (47%), Gaps = 33/292 (11%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIV 120
LG G G C N G FA K+I+ D++ + RE++I K K P IV
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSC-KSPYIV 62
Query: 121 SLKDTY--EDDSAVHIVMELCEGGEL---FDRIVARGHYT-ERAAAAVMKTIVEVVQVCH 174
+ E S++ I ME CEGG L + ++ RG E+ + +++++ + H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPEV 230
+ ++HRD+KP N L K + +K DFG+S GE N + G+ +YMAPE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMAPER 174
Query: 231 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIR-SVIDFKRDPWP 283
++ + Y DVWS G+ L + PF E E + I+ + K +P
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 284 KV--SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
+ SE KD +K+ L DP +R T ++LEHPW++ K V++ + V
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK-VNMAKFVAQ 285
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 82/304 (26%), Positives = 141/304 (46%), Gaps = 52/304 (17%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + +GRG FG L + G +A K + K ++ + VR E I+ +
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADN 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L +++D++ ++++ME GG++ ++ + +TE + + + H+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL---------SVFFR------PGEQFNEI-- 219
G +HRD+KP+N L K +K DFGL + F+R P + I
Sbjct: 121 GYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 220 ----------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVP 256
VG+P Y+APEV L+ Y E D WS GVI+Y +L G P
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 257 PFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVL 311
PF ++ Q + II + + F + +S AKDL+K++ + ++RL E+
Sbjct: 238 PFCSDNPQETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294
Query: 312 EHPW 315
HP+
Sbjct: 295 SHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 82/265 (30%), Positives = 138/265 (52%), Gaps = 11/265 (4%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y ++G+G G Y D+ G++ A K ++ L+ E + E+ +M+ K+P
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-NKNP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV+ D+Y + +VME GG L D +V E AAV + ++ + H
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-Y 235
V+HRD+K +N L +K DFG P + + + +VG+PY+MAPEV+ R Y
Sbjct: 136 VIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GP+VD+WS G++ ++ G PP+ E I + ++P ++S +D + +
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDFLNR 251
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAK 320
L D +R +A+E+L+HP+L+ AK
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLKLAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L R +G G +G+ Y D +GE A K + R + I +R E+ ++ +L +HPNI
Sbjct: 12 LNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNL-RHPNI 68
Query: 120 VSLKDTYEDDSA--VHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
V LK+ + +VME CE L D + ++E +M ++ +Q HE
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHE 126
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
++HRDLK N L +K LK DFGL+ + P + V + +Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------------S 273
Y +D+W+ G IL LL P ++E II+
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 274 VIDFKRDPW-------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ P+ P +SE L+ +L DPK+R TAEE LE + +
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-31
Identities = 92/298 (30%), Positives = 141/298 (47%), Gaps = 47/298 (15%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+I+ Y + +G G FG+ D G+ A K I K T V + RE++++KH
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65
Query: 113 LPKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
L +H NI+SL D + ED ++ V EL G R++ ++ + I+
Sbjct: 66 L-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMA 227
++ H GV+HRDLKP N L E+ LK DFGL+ R + Q V + YY A
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLA---RIQDPQMTGYVSTRYYRA 173
Query: 228 PEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TE------QGVAQAI 270
PE++ + Y EVD+WSAG I +L G P F + T+ V I
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 271 --------IRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
++S+ + P + +A DL++KML DP++R++A E L HP+L
Sbjct: 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-31
Identities = 84/265 (31%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG C G+ +ACK + KK+++ E QI++ + +V+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVN 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
L YE A+ +V+ + GG+L I G+ + E A I+ ++ H + +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEVL + Y
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
D W G ++Y ++ G PF E+ + + R V++ + K SE AK + K +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
DPKQRL A EV HP+ +N
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 9e-31
Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 16/258 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L + G +A K + K+ + ++ E +++++ +HP + +LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRD 182
+++ + VME GGELF + ++E A IV + H E+ V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 183 LKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
LK EN + + +K DFGL + G G+P Y+APEVL+ N YG VD
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
W GV++Y ++CG PF+ + + + + I+ I F R P+ AK L+ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLLKKD 234
Query: 301 PKQRL-----TAEEVLEH 313
PKQRL A+E+++H
Sbjct: 235 PKQRLGGGPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 87/308 (28%), Positives = 134/308 (43%), Gaps = 56/308 (18%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK-----LRTAVDIEDVRREV 107
D+ Y +G G +G+ T G K A K IS + RT RE+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------REI 54
Query: 108 QIMKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
+I++ KH NI+ + D ++E + V+IV EL E +L+ +++ H +
Sbjct: 55 KILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYF 111
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNE 218
+ I+ ++ H V+HRDLKP N L + LK DFGL+ P E
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 219 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------------ 258
V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 259 -WAETEQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEE 309
E + A+ I+S+ + PW P A DL+ KML +P +R+T EE
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288
Query: 310 VLEHPWLQ 317
L HP+L+
Sbjct: 289 ALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
LG++LG G FG Y + A K++ K+ + IE+ RE +IM+ L
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKL-D 59
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
HPN+V L ++ ++IVME EGG+L + + ++ +Q+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLS------LSDLLSFALQIAR 113
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG-SPY-YM 226
+ +HRDL N L +K DFGLS + + + G P +M
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLPIRWM 170
Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
APE LK + + DVWS GV+L+ I G P+ + + ++ + + R P P
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEYLKNGYRLPQPP 226
Query: 285 V-SENAKDLVKKMLNPDPKQRLTAEEVLE 312
DL+ + DP+ R T E++E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 76/268 (28%), Positives = 143/268 (53%), Gaps = 30/268 (11%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+++G G FG L +G+++ K I+ K+ + E+ R+EV ++ ++ KHPNIV
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KHPNIVQ 63
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC------H 174
++++E++ ++IVM+ CEGG+L+ +I A+ R I++ VQ+C H
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLALKHVH 118
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK- 232
++ ++HRD+K +N +F K +K DFG++ V E +G+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQN-IFLTK--DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SEN 288
R Y + D+W+ G +LY + F A + + IIR +P V S +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSSHYSYD 228
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
++LV ++ +P+ R + +LE ++
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHP 117
G LG+G +G Y C N G+ A K + + L + E ++ EV ++K L KH
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHV 62
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV T DD+ + I ME GG + + G E K I++ V H
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFG-------LSVFFRPGEQFNEIVGSPYYMAPEV 230
V+HRD+K N + + +K IDFG + + + G+PY+MAPEV
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV---- 285
+ + YG + D+WS G ++ + G PP A ++ A I + R P++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFYIGA----HRGLMPRLPDSF 234
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
S A D V L D +R +A ++L H +L
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 87/274 (31%), Positives = 137/274 (50%), Gaps = 20/274 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+D+ + +GRG FG L ++ + +A K +SK ++ D E IM H
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANS 102
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
IV L ++DD +++VME GG+L + +++ E+ A +V + H
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
G +HRD+KP+N L +S LK DFG + + VG+P Y++PEVLK
Sbjct: 162 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
YG E D WS GV LY +L G PF+A++ G I+ ++ + F D ++S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEISK 276
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
AKDL+ L D + RL +E+ HP+ +N
Sbjct: 277 QAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 82/259 (31%), Positives = 131/259 (50%), Gaps = 12/259 (4%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG C G+ +ACK + KK+L+ + E +I++ + IVSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT--IVEVVQVCHEQGVMHR 181
+E + +VM L GG+L I G A A+ I+ ++ H++ +++R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVD 240
DLKPEN L + ++ D GL+V + G++ G+P YMAPEVL+ Y VD
Sbjct: 120 DLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300
++ G LY ++ G PF E+ + + R ++ + K S AKDL + +L D
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 301 PKQRL-----TAEEVLEHP 314
P++RL +A+EV EHP
Sbjct: 237 PEKRLGCRGGSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 80/264 (30%), Positives = 129/264 (48%), Gaps = 15/264 (5%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG L +G +A K + K + D+E E +I+ HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ + VME GG+L I + E A I + H++G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEV 239
DLK +N L ++ K DFG+ G+ + G+P Y+APE+L+ YGP V
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D W+ GV+LY +LCG PF AE E + +AI+ + + W +S++A D++K +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP--TW--LSQDAVDILKAFMTK 233
Query: 300 DPKQRLTA------EEVLEHPWLQ 317
+P RL + E +L HP+ +
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 81/262 (30%), Positives = 127/262 (48%), Gaps = 21/262 (8%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKF-ACKSIS-------KKKLRTAVDIEDVRREVQI 109
Y + LG G FG Y NNG+ A K I+ K K I D+ EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARG-HYTERAAAAVMKT 165
+K +HPNIV T+ ++ ++IVM+L EG GE F+ + + +TE +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 166 IVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
+V ++ H E+ ++HRDL P N + E + DFGL+ +P + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPW 282
Y PE++K YG + DVW+ G ILY + PPF++ +A I+ +V + +
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238
Query: 283 PKVSENAKDLVKKMLNPDPKQR 304
SE+ D++ L PD + R
Sbjct: 239 ---SEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-30
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 40/283 (14%)
Query: 67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-- 124
G +GV Y D GE A K + +K + I +R E+ I+ L +HPNIV++K+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVV 73
Query: 125 TYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+ +++VME E +L + + + + +M ++ V H+ ++HRDL
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDL 132
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVL--KRNYGPEVD 240
K N L N+ LK DFGL+ + P + + ++V + +Y APE+L + Y +D
Sbjct: 133 KTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAID 189
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP----------------- 283
+WS G I LL P F ++E I + + WP
Sbjct: 190 MWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYP 249
Query: 284 -----------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+S+N DL+ ++L DP +R++AE+ L+HP+
Sbjct: 250 YNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 73/257 (28%), Positives = 130/257 (50%), Gaps = 16/257 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ + +++GRG+F Y T + + + A K + ++ A +D +E+ ++K L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
PN++ D++ +D+ ++IV+EL + G+L I ++ ++ +T+ + VQ+C
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSA 118
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAP 228
H + VMHRD+KP N + +K D GL FF + +VG+PYYM+P
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
E + N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 288 NAKDLVKKMLNPDPKQR 304
++LV + PDP QR
Sbjct: 236 KLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 80/275 (29%), Positives = 132/275 (48%), Gaps = 31/275 (11%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSI------SKKKLRTAVDIEDVRREVQIMKHLP 114
G +G G FG YL + ++GE A K + + K R ++ + RE+ ++K L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL- 63
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+H NIV + D ++I +E GG + + G + E ++ I++ + H
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------------RPGEQFNEIVGS 222
+G++HRD+K N L NK +K DFG+S RP Q GS
Sbjct: 124 NRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQ-----GS 175
Query: 223 PYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
++MAPEV+K+ Y + D+WS G ++ +L G P + + Q QAI + + +
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEI 232
Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+S A D ++K D +R TA E+L+HP+L
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 77/260 (29%), Positives = 129/260 (49%), Gaps = 15/260 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L + +G+ +A K + K+ + ++ E +++K+ +HP + SLK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ + VME GGELF + ++E IV + H +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
K EN + + +K DFGL G+P Y+APEVL+ N YG VD
Sbjct: 122 KLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W GV++Y ++CG PF+ + + + + I+ I F R +S +AK L+ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLIKDP 234
Query: 302 KQRL-----TAEEVLEHPWL 316
+RL A+E++ H +
Sbjct: 235 NKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 77/271 (28%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
LG++LG G FG Y T + A K++ K+ + IE+ RE +IM+ L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKL-D 59
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
HPNIV L ++ + IVME GG+L D + + ++ +Q+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELS-----LSDLLSFALQIAR 114
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG-SPY-YM 226
+ +HRDL N L +K DFGLS + + G P +M
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLPIRWM 171
Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
APE LK + + DVWS GV+L+ I G P+ + ++ + R P P
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS----NAEVLEYLKKGYRLPKPP 227
Query: 285 VSENAKDLVKKML---NPDPKQRLTAEEVLE 312
+L K ML DP+ R T E++E
Sbjct: 228 NCP--PELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 83/269 (30%), Positives = 132/269 (49%), Gaps = 18/269 (6%)
Query: 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI--SKKKLRTAVDIEDVRREVQIMKHL 113
+++ LG+ LGRG FG YLC D + G + A K + T+ ++ + E+Q++K+L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 114 PKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
+H IV D + + I +E GG + D++ A G TE + I++ V
Sbjct: 62 -RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----VFFRPGEQFNEIVGSPYYMA 227
H ++HRD+K N L + + +K DFG S G + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
PEV+ YG + DVWS + +L PP WAE E AI + + P V
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPDGV 234
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
S+ +D +K++ + K+R TAE +L HP
Sbjct: 235 SDACRDFLKQIFVEE-KRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 46/291 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+G G +G D G K A K +S+ ++A+ + RE++++KH+ H N++
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKHM-DHENVIG 78
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
L D + ED V++V L G +L + IV ++ ++ I+ ++ H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVL--K 232
G++HRDLKP N + N E LK +DFGL+ R + + V + +Y APE++
Sbjct: 137 AGIIHRDLKPSN-IAVN--EDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNW 190
Query: 233 RNYGPEVDVWSAGVILYILL---------------------CGVPP--FWAETEQGVAQA 269
+Y VD+WS G I+ LL G P + A+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250
Query: 270 IIRSVIDFKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
I+S+ + + + + A DL++KML DP +R+TA E L HP+L
Sbjct: 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 81/280 (28%), Positives = 130/280 (46%), Gaps = 29/280 (10%)
Query: 54 ISIDYDLGRE-----LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
+ +Y+ LG+G +G+ Y D++ + A K I ++ R ++ + E+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIA 57
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKT 165
+ +L KH NIV + ++ I ME GG L + ++ E+ K
Sbjct: 58 LHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRP-GEQFNEIVG 221
I+E ++ H+ ++HRD+K +N L S +K DFG S P E F G
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTETFT---G 171
Query: 222 SPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
+ YMAPEV+ R YG D+WS G + + G PPF E G QA + V FK
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFK 228
Query: 279 RDPW--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
P +S AK+ + + PDP +R +A ++L+ P+L
Sbjct: 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 8e-29
Identities = 95/337 (28%), Positives = 142/337 (42%), Gaps = 73/337 (21%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y++ ++LG+G +G+ + D E A K I R A D + RE+ ++ L HP
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHP 67
Query: 118 NIVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
NIV L + E+D +++V E E +L H A + I+E V
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMET-DL--------H------AVIRANILEDVHKRYI 112
Query: 174 -----------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--- 219
H V+HRDLKP N L + +K DFGL+ E+ E
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPENPVL 169
Query: 220 ---VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------------- 258
V + +Y APE+L Y VD+WS G IL +L G P F
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229
Query: 259 WAETEQGVAQ-------AIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTA 307
+ + + ++ S+ R P PK S++A DL+KK+L +P +RLTA
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289
Query: 308 EEVLEHPWLQNAKK-APNVSLGETVKARL---KQFSV 340
EE LEHP++ + L + L + SV
Sbjct: 290 EEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSV 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
ELG G GV G+ A K+I + ++ + RE+ I+ P
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGHYTERAAAAVMKTIVEVVQVCHEQ 176
IV + ++ + I ME +GG L D+I +G ER + +++ + HE+
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPEVL 231
++HRD+KP N L ++ + +K DFG+S G+ N + VG+ YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIRSVIDFKRDPWPKV 285
+ N Y + D+WS G+ L L G P+ E + Q I+ R P K
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKF 229
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
S + +D V L DP++R + +E+LEHP+++
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 85/294 (28%), Positives = 134/294 (45%), Gaps = 43/294 (14%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
DY ++G G +GV Y + G+ A K K+R + E V RE+ ++K
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKE 55
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMEL--CEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
L +HPNIV L+D +S ++++ E + + D + + + + I++ +
Sbjct: 56 L-QHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPE 229
CH + V+HRDLKP+N L NK +K DFGL+ F P + V + +Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE 171
Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS- 286
VL Y VD+WS G I + P F ++E I R + D WP V+
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 287 ------------------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
E+ DL++KML DP +R++A++ L HP+
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 14/265 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ ++G+G FGV + + +A K I K+ + E+ E +++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DS 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGH-YTERAAAAVMKTIVEVVQVCH 174
I+ +++ D ++IVME E G+L + RG E I+ + H
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLK- 232
+ ++HRD+K N LF + ++ +K D G++ F N IVG+PYY++PE+ +
Sbjct: 119 SKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAKD 291
+ Y + DVW+ GV+LY G PF A QG A+I +I P S+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANN-QG---ALILKIIRGVFPPVSQMYSQQLAQ 231
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316
L+ + L D +QR ++L +P L
Sbjct: 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++L + +G G +G Y +VN GE A K I KL D V++E+ +MK KH
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDC-KH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
NIV+ +Y + I ME C GG L D G +E A V + ++ + H +
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPEVL---- 231
G MHRD+K N L ++ +K DFG+S + +G+PY+MAPEV
Sbjct: 126 GKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK- 290
K Y D+W+ G+ L PP + + +S +F+ PK+ + K
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP---PKLKDKMKW 237
Query: 291 -----DLVKKMLNPDPKQRLTAEEVLEHPW 315
VK L +PK+R TAE++L+HP+
Sbjct: 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 51/290 (17%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VR----REVQIMKHLPKH 116
+G G +GV + C + G+ A K V+ ED ++ RE++++K L KH
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIRMLKQL-KH 59
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
PN+V+L + + +H+V E C+ + + + E ++ ++ V CH+
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--K 232
+HRD+KPEN L + +K DFG + + PG+ + + V + +Y APE+L
Sbjct: 119 HNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 233 RNYGPEVDVWSAGVILYILLCGVP--PFWAETEQ------GVAQAIIRSVIDFK------ 278
YGP VDVW+ G + LL G P P ++ +Q + I R F
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 279 ---------RDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
R+P +P +S A +K L DP +RL+ EE+LEHP+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 83/266 (31%), Positives = 129/266 (48%), Gaps = 12/266 (4%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG C G+ +ACK + KK+++ E QI++ + +VS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
L YE A+ +V+ L GG+L I G+ + E A I ++ H + ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
D W G ++Y ++ G PF E+ + + R V + + + K SE A+ + +++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 299 PDPKQRL-----TAEEVLEHPWLQNA 319
DP RL AEEV HP+ + A
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 86/295 (29%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+GRG +G+ + EK A K I+ +D + RE+++++HL H N++++K
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRHL-DHENVIAIK 70
Query: 124 D--------TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
D + D V+IV EL + +L I + ++ + ++ ++ H
Sbjct: 71 DIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS 126
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP----GEQFNEIVGSPYYMAPEVL 231
V+HRDLKP N L + LK DFGL+ R G+ E V + +Y APE+L
Sbjct: 127 ANVLHRDLKPSNLLL---NANCDLKICDFGLA---RTTSEKGDFMTEYVVTRWYRAPELL 180
Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ETEQGV----- 266
Y +DVWS G I LL P F E + G
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 267 AQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
A+ IRS+ R +P + A DL++KML DP +R+T EE L HP+L
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 76/257 (29%), Positives = 128/257 (49%), Gaps = 16/257 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ + +++GRG+F Y T + +G A K + L A D +E+ ++K L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
PN++ ++ +D+ ++IV+EL + G+L I H+ ++ KT+ + VQ+C
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNEIVGSPYYMAP 228
H + VMHRD+KP N + +K D GL FF + +VG+PYYM+P
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
E + N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 235
Query: 288 NAKDLVKKMLNPDPKQR 304
+ LV +NPDP++R
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-27
Identities = 76/267 (28%), Positives = 137/267 (51%), Gaps = 19/267 (7%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED--VRREVQIMKHLPK 115
Y R +G+G +G L +G+++ I K LR A E +E Q++ L K
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQL-K 57
Query: 116 HPNIVSLKDTYE-DDSAVHIVMELCEGGELFDRIV-ARGHY-TERAAAAVMKTIVEVVQV 172
HPNIV+ ++++E +D ++IVM CEGG+L+ ++ +G E I +Q
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
HE+ ++HRDLK +N ++ +K D G++ V + + ++G+PYYM+PE+
Sbjct: 118 LHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 232 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
+ Y + DVW+ G +Y + F A+ +++ +I+ K P PK S
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIEGKLPPMPKDYSPEL 230
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+L+ ML+ P++R + + +L P++
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-27
Identities = 73/258 (28%), Positives = 127/258 (49%), Gaps = 13/258 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G+G FG + +A K+I K + + ++ E ++ + P IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ +++V+ GGELF + G + A ++ ++ H+ V++RDL
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
KPEN L + DFGL + + ++ N G+P Y+APE+L Y VD
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W+ GV+LY +L G+PPF+ E + + I++ + F +AKDL+ +L+ DP
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDP 232
Query: 302 KQRL---TAEEVLEHPWL 316
+RL A+E+ HP+
Sbjct: 233 TRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 83/261 (31%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG C G+ +ACK + KK+++ E QI++ + +VS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVS 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
L YE A+ +V+ L GG+L I G + E A I ++ H++ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
+RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
D W+ G +LY ++ G PF ++ + + R V + + + K S +A+ L K +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 299 PDPKQRL-----TAEEVLEHP 314
DPK+RL A EV EHP
Sbjct: 242 KDPKERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 81/306 (26%), Positives = 130/306 (42%), Gaps = 57/306 (18%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ +G G FG L V+ +A K++ K + V+ E I+ + +V
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEWVVK 65
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L +++D ++ VM+ GG++ ++ G + E A + + ++ H+ G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR--------------------PGEQFNEI-- 219
D+KP+N L +K DFGL FR P E+++EI
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 220 ----------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVP 256
VG+P Y+APEVL R Y D WS GVILY +L G P
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 257 PFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVL 311
PF A+T +I + + K+S A DL+ + L + RL A+E+
Sbjct: 243 PFLADTPAETQLKVINWETTLHIP--SQAKLSREASDLILR-LCCGAEDRLGKNGADEIK 299
Query: 312 EHPWLQ 317
HP+ +
Sbjct: 300 AHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 84/293 (28%), Positives = 128/293 (43%), Gaps = 46/293 (15%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
Y+ ++G G +G + + E A K ++R D E V RE+ ++K L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKEL 56
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
KH NIV L D D + +V E C+ + FD G + M +++ +
Sbjct: 57 -KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
CH V+HRDLKP+N L E LK DFGL+ F P ++ V + +Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 231 L--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
L + Y +D+WSAG I L G P F + I R + + WP VS+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 288 -------------------------NAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+DL++ +L +P QR++AEE L+HP+
Sbjct: 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 85/274 (31%), Positives = 140/274 (51%), Gaps = 20/274 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DYD+ + +GRG FG L ++ + +A K +SK ++ D E IM
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 102
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L ++DD +++VME GG+L + +++ E+ A +V + H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
G++HRD+KP+N L + LK DFG + + VG+P Y++PEVLK
Sbjct: 162 GLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
YG E D WS GV L+ +L G PF+A++ G I+ ++ ++F D ++S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISK 276
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
+AK+L+ L D + RL EE+ +HP+ +N
Sbjct: 277 HAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 89/302 (29%), Positives = 139/302 (46%), Gaps = 51/302 (16%)
Query: 58 YDLGRELGRGEFGVTYLCTDV--NNGEKFACKSISK---KKLRTAVDIEDVRREVQIMKH 112
Y+L +ELG+G +G+ + + E A K I+ KK+ + RE+++++H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKLLRH 57
Query: 113 LPKHPNIVSLKD----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
H NI L D + + +++ EL E +L I + T+ + + I+
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN-----EIVGSP 223
++ H V+HRDLKP N L E LK DFGL+ F N E V +
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA-------------------ET 262
+Y APE++ ++Y +DVWS G IL LL P F ET
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233
Query: 263 EQGV----AQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ AQ IRS+ + + P +P + A DL++K+L DP +R++ EE LEHP
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293
Query: 315 WL 316
+L
Sbjct: 294 YL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 71/265 (26%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV----RREVQIMKHLPKH 116
G++LG G F Y DV G A K ++ + T+ + E+V R+E+++M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P+I+ + +DS ++ +E GG + + G + E + ++ + HE
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV-----FFRPGEQFNEIVGSPYYMAPEVL 231
++HRD+K N L + + L+ DFG + GE +++G+ +MAPEVL
Sbjct: 123 QIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 232 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
+ YG DVWS G ++ + PP+ AE I + P+ +S
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHP 314
+D+ + L P+ R + E+L+HP
Sbjct: 241 RDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 30/301 (9%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
RE+G G FG Y DV E A K +S ++ +D+ +EV+ ++ L +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIE 79
Query: 122 LKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
K Y + +VME C G ++ + V + E AA+ ++ + H +
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNY 235
HRD+K N L E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 138 HRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVILAMDEGQY 191
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA-----K 290
+VDVWS G+ L PP + I ++ D P +S N +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------DS-PTLSSNDWSDYFR 244
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV--SLGETVKARLKQFSVMNKLKKRA 348
+ V L P+ R ++EE+L+H ++ ++ P V L + K +++ + K +
Sbjct: 245 NFVDSCLQKIPQDRPSSEELLKHRFVLR-ERPPTVIIDLIQRTKDAVRELDNLQYRKMKK 303
Query: 349 L 349
+
Sbjct: 304 I 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 80/313 (25%), Positives = 137/313 (43%), Gaps = 61/313 (19%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ + +G+G FG L + G+ +A K++ K ++ + V+ E ++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDS 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +VSL +++D ++++ME GG+L ++ ++E M V ++ H+
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------------------------RP 212
G +HRD+KP+N L +K DFGLS F R
Sbjct: 121 GFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 213 GEQFNEI------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVI 247
+ I VG+P Y+APE+ L++ YG E D WS G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 248 LYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305
++ L G PPF +E + II R + F D +S A+DL+++++ + + RL
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRL 294
Query: 306 ---TAEEVLEHPW 315
A E+ HP+
Sbjct: 295 GRGGAHEIKSHPF 307
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R +GRG + L +A K + K+ + DI+ V+ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ +S + V+E GG+L + + E A I + HE+G+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
DLK +N L ++ +K D+G+ RPG+ + G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 240 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
D W+ GV+++ ++ G PF TE + Q I+ I R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233
Query: 291 DLVKKMLNPDPKQRLTA------EEVLEHPWLQN 318
++K LN DPK+RL ++ HP+ +N
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 31/276 (11%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACK-------SISKKKLRTAVDIEDVRREVQIMKHL 113
G +G+G +G YL +V GE A K + R ++ +R E++ +K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
H NIV + + I +E GG + + G + E+ + ++E +
Sbjct: 66 -DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE------QFNEIVGSPYYMA 227
H +G++HRDLK +N L K DFG+S + + Q + GS ++MA
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGIS---KKSDDIYDNDQNMSMQGSVFWMA 178
Query: 228 PEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP- 283
PEV+ + Y +VD+WS G ++ + G P W++ E A+ + P P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAPPIPP 235
Query: 284 ----KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+S A D + +P R TA E+L+HP+
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 78/271 (28%), Positives = 128/271 (47%), Gaps = 20/271 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG L E +A K + K + D+E E +++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ ++ VME GG+L I G + E A I + H +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL---SVFFRPGEQFNEIVGSPYYMAPE-VLK 232
G+++RDLK +N + +K DFG+ ++F G+ G+P Y+APE +
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAY 175
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKD 291
+ YG VD W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVS 230
Query: 292 LVKKMLNPDPKQRL----TAE-EVLEHPWLQ 317
+ K +L P +RL T E ++ EH + +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 72/265 (27%), Positives = 132/265 (49%), Gaps = 15/265 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y++ +++G G FG YL ++ E K I K+ + E ++EV ++ + KHP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KHP 59
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCH 174
NIV+ +++++ + IVME C+GG+L RI R + ++ V++ ++ H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-VGSPYYMAPEVLK 232
++ ++HRD+K +N FL N + K DFG++ + VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVA---KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175
Query: 233 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
R Y + D+WS G +LY L PF + I + P S + +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRS 232
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316
L+ ++ P+ R + +L+ P+L
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 77/264 (29%), Positives = 133/264 (50%), Gaps = 17/264 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK--HPNIVS 121
LGRG FG L GE +A K++ K + ++E + E +I + HP +V+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ + V VME GG+L I ++E A +V +Q HE +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVL-KRNYGPEV 239
DLK +N L + +K DFGL G++ + G+P ++APEVL + +Y V
Sbjct: 126 DLKLDNLLLDTEGF---VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182
Query: 240 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299
D W GV++Y +L G PF + E+ V +I+ + + R +S A +++++L
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRR 238
Query: 300 DPKQRL-----TAEEVLEHPWLQN 318
+P++RL AE+V + P+ ++
Sbjct: 239 NPERRLGSGEKDAEDVKKQPFFRD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R LG+G FG C G+ +ACK + KK+++ E +I++ + +VS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVM 179
L YE A+ +V+ + GG+L I G+ + E+ A + ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPE 238
+RDLKPEN L ++ ++ D GL+V GE VG+ YMAPEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
D W G ++Y ++ G PF E+ + + R V + + + K SE+AK + + +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 299 PDPKQRL-----TAEEVLEHPWLQN 318
+PK+RL A V +HP +N
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFKN 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 85/274 (31%), Positives = 134/274 (48%), Gaps = 20/274 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ + +GRG FG L + + +A K +SK ++ D E IM
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANS 102
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L ++DD +++VME GG+L + +++ E+ A +V + H
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKRN 234
G +HRD+KP+N L +S LK DFG + + VG+P Y++PEVLK
Sbjct: 162 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 235 -----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKVSE 287
YG E D WS GV LY +L G PF+A++ G I+ ++ + F D +S+
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDISK 276
Query: 288 NAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQN 318
AK+L+ L D + RL EE+ H + +N
Sbjct: 277 EAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 72/263 (27%), Positives = 121/263 (46%), Gaps = 16/263 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L E +A K + K + D++ E +I+ KHP + +L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
++ + VME GG+L +I + E + + + H GV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDV 241
K +N L K DFG+ G G+P Y+APE+L+ YGP VD
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W+ GV++Y ++ G PPF A+ E + ++I+ D W +S+ A ++K + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 302 KQRL-------TAEEVLEHPWLQ 317
+RL + + +HP+ +
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 85/302 (28%), Positives = 133/302 (44%), Gaps = 52/302 (17%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
Y +G G +GV D +G+K A K I A D+ + RE++I++H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-----AFDVPTLAKRTLRELKILRHF 61
Query: 114 PKHPNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
KH NI++++D D V++VM+L E +L I + TE + ++
Sbjct: 62 -KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL--SVFFRPGEQ---FNEIVGSPY 224
++ H V+HRDLKP N L E L+ DFG+ + P E E V + +
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 225 YMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPP--FW 259
Y APE+L Y +D+WS G I L + + G P
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236
Query: 260 AETEQGVAQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+ I+++ + PW PK S A DL+ +ML DP++R+T E+ L+HP+
Sbjct: 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296
Query: 316 LQ 317
L
Sbjct: 297 LA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 19/261 (7%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G+G FG L +G+ +A K + KK + + + + E ++ KHP +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV----GSPYYMAPEVL-KRNYGPE 238
KPEN L ++ + DFGL + G + ++ G+P Y+APEVL K+ Y
Sbjct: 123 KPENILLDSQGH---VVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
VD W G +LY +L G+PPF++ + I+ + K P +S +A+ L++ +L
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQ 232
Query: 299 PDPKQRLTA----EEVLEHPW 315
D +RL A E+ H +
Sbjct: 233 KDRTKRLGAKDDFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 86/287 (29%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
+G G +GV Y D GE A K K+R + E V RE+ ++K L HPNI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL-NHPNI 60
Query: 120 VSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
V L D ++ +++V E + + D G + + +++ + CH
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
V+HRDLKP+N L +++ + LK DFGL+ F P + V + +Y APE+L R
Sbjct: 120 VLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SVIDFK-- 278
Y VD+WS G I ++ P F ++E I R S+ D+K
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236
Query: 279 -----RDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
R KV E+ DL+ KML DP +R++A+ L+HP+
Sbjct: 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 72/253 (28%), Positives = 120/253 (47%), Gaps = 16/253 (6%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R +GRG + L N + +A K + K+ + DI+ V+ E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ S + +V+E GG+L + + E A I + HE+G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
DLK +N L +K D+G+ PG+ + G+P Y+APE+L+ YG V
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 240 DVWSAGVILYILLCGVPPF-------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
D W+ GV+++ ++ G PF TE + Q I+ I R +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 293 VKKMLNPDPKQRL 305
+K LN DPK+RL
Sbjct: 234 LKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-26
Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 17/296 (5%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
RE+G G FG Y DV N E A K +S ++ +D+ +EV+ ++ L +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ Y + +VME C G V + E AAV ++ + H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
D+K N L + E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPWPKVSENAKDLVKKM 296
+VDVWS G+ L PP + I ++ + W SE ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVV 352
L P+ R T+E +L+H ++ ++ P + + ++ ++ L+ R ++ +
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-26
Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 10/257 (3%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L E FA K++ K + D+E E +++ +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
T++ + VME GG+L I + G + E A I+ +Q H++G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
K +N L + +K DFG+ GE + + G+P Y+APE+LK + Y VD
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
WS GV+LY +L G PF E E + +I+ F R W +S+ AKD + K+ DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235
Query: 302 KQRL-TAEEVLEHPWLQ 317
+RL ++ +HP+ +
Sbjct: 236 TKRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 14/259 (5%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG +L + FA K++ K + D+E E +++ +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
T++ + VME GG+L I + + A I+ +Q H +G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEV-LKRNYGPEVDV 241
K +N L +K DFG+ G+ + G+P Y+APE+ L + Y VD
Sbjct: 123 KLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-WPK-VSENAKDLVKKMLNP 299
WS GV+LY +L G PF E+ + Q+I +P +P+ ++ AKD++ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------NPCYPRWLTREAKDILVKLFVR 233
Query: 300 DPKQRLTAE-EVLEHPWLQ 317
+P++RL + ++ +HP+ +
Sbjct: 234 EPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-25
Identities = 68/248 (27%), Positives = 118/248 (47%), Gaps = 9/248 (3%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G+G FG L + +A K + KK + + + + E ++ KHP +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVL-KRNYGPEVDV 241
KPEN L ++ + DFGL + G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W G +LY +L G+PPF++ + I+ + K P ++ +A+ L++ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 302 KQRLTAEE 309
+RL A++
Sbjct: 236 TKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 15/257 (5%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
RE+G G FG Y DV E A K +S ++ +D+ +EV+ ++ + KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIE 89
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
K Y + +VME C G V + E AA+ ++ + H ++HR
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGP 237
D+K N L E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 150 DIKAGNILLT---EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDG 203
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKM 296
+VDVWS G+ L PP + I ++ + + W S+ ++ V
Sbjct: 204 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVDSC 260
Query: 297 LNPDPKQRLTAEEVLEH 313
L P+ R T+EE+L+H
Sbjct: 261 LQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 83/311 (26%), Positives = 130/311 (41%), Gaps = 57/311 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACK-------SISKKKLRTAVDIEDVR----REVQ 108
G LG G +G D G+ A K S K R V + + RE++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
IM + KH NI+ L D Y + +++VM++ +L + + TE ++ I+
Sbjct: 73 IMNEI-KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF---------------RPG 213
+ V H+ MHRDL P N +F N K K DFGL+ + +
Sbjct: 131 GLNVLHKWYFMHRDLSPAN-IFINSK--GICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 214 EQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
E+ V + +Y APE+L Y VD+WS G I LL G P F E E I
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247
Query: 272 RSVIDFKRDPWPKV------------------------SENAKDLVKKMLNPDPKQRLTA 307
+ D WP+ S++A DL++ +L +P +R++A
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307
Query: 308 EEVLEHPWLQN 318
+E L+H + ++
Sbjct: 308 KEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 18/268 (6%)
Query: 58 YDLGRELGRGEFGVTYLCTD--VNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
Y L + LG+G FG YL D E+ K I +L ++ +E Q++ L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ-ANQEAQLLSKL- 59
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER-AAAAVMKTIVEV---V 170
HP IV ++ + A I+ E CEG +L ++ H + + V + +++ V
Sbjct: 60 DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPE 229
H++ ++HRDLK +N N + LK DFG+S + G+PYYM+PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
LK + Y + D+WS G ILY + C F + V I+ + + + N
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSR-QLN 234
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ +++ MLN DP R +A E+L +P++
Sbjct: 235 S--IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 56/305 (18%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y+ ++G+G FG + + A K + + + I +R E++I++ L KH
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL-KHE 71
Query: 118 NIVSLKD--------TYEDDSAVHIVMELCE---GGELFDRIVARGHYTERAAAAVMKTI 166
N+V+L + + ++V E CE G L ++ V +T VMK +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKML 128
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF------RPGEQFNEIV 220
+ + H ++HRD+K N L + LK DFGL+ F +P N +V
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
+ +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 279 RDPWPKV----------------------------SENAKDLVKKMLNPDPKQRLTAEEV 310
+ WP V +A DL+ K+L DP +R+ A+
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 311 LEHPW 315
L H +
Sbjct: 305 LNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 86/301 (28%), Positives = 139/301 (46%), Gaps = 45/301 (14%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
Y+ ++G G +GV Y D + ++I+ KK+R + E V RE+ ++K +
Sbjct: 4 YEKVEKIGEGTYGVVYKARD-----RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM 58
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTE--RAAAAVMKTIVEVVQ 171
+H NIV L+D + +++V E + +L + + + + R + I+ +
Sbjct: 59 -QHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
CH V+HRDLKP+N L + + LK DFGL+ F P F V + +Y APE+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174
Query: 231 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR--------------SV 274
L R+Y VD+WS G I ++ P F ++E I R S+
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234
Query: 275 IDFKRDPWPK------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
D+K +PK + DL+ KML DP +R+TA LEH + ++ A
Sbjct: 235 PDYK-SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293
Query: 323 P 323
P
Sbjct: 294 P 294
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPN 118
++G G +GV Y + GE A K K+R + E V RE+ ++K L HPN
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 119 IVSLKDTYEDDSAVHIVME-LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
IV L D ++ +++V E L + + F + + +++ + CH
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL--KRN 234
V+HRDLKP+N L +K DFGL+ F P + V + +Y APE+L +
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS-------- 286
Y VD+WS G I ++ F ++E I R++ WP V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237
Query: 287 -----------------ENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
E+ +DL+ +ML+ DP +R++A+ L HP+
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 21/292 (7%)
Query: 42 RLCVLKEPSGQDISIDYDLGR------ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
R V+K+P D+ D E+G G FG Y T+ + E A K +S +
Sbjct: 1 RKGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ 60
Query: 96 TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT 155
T +D+ +EV+ ++ L KHPN + K Y + +VME C G V +
Sbjct: 61 TNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ 119
Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
E AA+ ++ + H ++HRD+K N L E +K DFG + P
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPANS 176
Query: 216 FNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
F VG+PY+MAPEV+ + Y +VDVWS G+ L PP + I
Sbjct: 177 F---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233
Query: 272 RS-VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
++ + + W +++ + V L P++R + E+L H +++ + A
Sbjct: 234 QNDSPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 58 YDLG------RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+DLG R LG G G+ + D + ++ A K I L ++ RE++I++
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIR 57
Query: 112 HLPKHPNIVSLKDTYEDDS--------------AVHIVMELCEGGELFDRIVARGHYTER 157
L H NIV + + +V+IV E E ++ +G +E
Sbjct: 58 RL-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEE 114
Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-- 215
A M ++ ++ H V+HRDLKP N +F N E LK DFGL+ P
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHK 172
Query: 216 --FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271
+E + + +Y +P +L NY +D+W+AG I +L G P F E Q I+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
Query: 272 RSV----------------IDFKRDPW----------PKVSENAKDLVKKMLNPDPKQRL 305
SV + D P V+ A D ++++L +P RL
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
Query: 306 TAEEVLEHPWLQ 317
TAEE L HP++
Sbjct: 293 TAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 82/309 (26%), Positives = 131/309 (42%), Gaps = 57/309 (18%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ LG G FG L V+ +A K++ KK + + V+ E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L +++D ++ VM+ GG++ ++ G + E A + + V+ H+ G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 182 DLKPENFLFANKKESSPLKAIDFGL---------SVFFRPGEQFNE-------------- 218
D+KP+N L +K DFGL S +++ G+ +
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 219 -------------------------IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL 252
+VG+P Y+APEVL R Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEE 309
G PPF A+T +I P K+S A DL+ K+ P+ RL A+E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADE 301
Query: 310 VLEHPWLQN 318
+ HP+ +
Sbjct: 302 IKAHPFFKT 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 87/280 (31%), Positives = 128/280 (45%), Gaps = 18/280 (6%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
ELG G FG Y + G A K I K + ++ED E+ I+ HPNIV L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKL 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMH 180
D + ++ + I++E C GG + D ++ TE V K +E + HE ++H
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL------KR 233
RDLK N LF + +K DFG+S R ++ + +G+PY+MAPEV+ R
Sbjct: 127 RDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
Y + DVWS G+ L + PP V I +S P + S KD +
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDFL 242
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
KK L + R T ++L+HP++ P L KA
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 82/305 (26%), Positives = 135/305 (44%), Gaps = 53/305 (17%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + +GRG FG L + G +A K + K + + +R E I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-ADG 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
+V + +++D ++++ME GG++ ++ + +E A + V + H+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV---------FFR-----PGEQFN----- 217
G +HRD+KP+N L K +K DFGL F+R P F+
Sbjct: 121 GFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 218 -----------------EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFW 259
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 260 AETEQGVAQAIIRSVIDFKRD----PWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLE 312
+ET Q R V+++K P +SE AKDL+ + D + R+ EE+
Sbjct: 238 SET----PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292
Query: 313 HPWLQ 317
HP+ +
Sbjct: 293 HPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 24/274 (8%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
R +GRG + L +A K I K+ + DI+ V+ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L ++ +S + V+E GG+L + + E A I + HE+G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 182 DLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEV 239
DLK +N L + +K D+G+ RPG+ + G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 240 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
D W+ GV+++ ++ G PF TE + Q I+ I R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 291 DLVKKMLNPDPKQRLTAE------EVLEHPWLQN 318
++K LN DPK+RL ++ HP+ +N
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 75/257 (29%), Positives = 127/257 (49%), Gaps = 10/257 (3%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG L GE FA K++ K + D+E E +++ ++P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
T++ + VME GG+L I +G + A IV +Q H +G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDV 241
K +N + +K DFG+ G+ + + G+P Y+APE+L+ Y VD
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
WS GV+LY +L G PF + E + ++I + R W +++ +KD+++K+ DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235
Query: 302 KQRL-TAEEVLEHPWLQ 317
+RL + HP+ +
Sbjct: 236 TRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 70/261 (26%), Positives = 125/261 (47%), Gaps = 13/261 (4%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G+G FG L +G+ +A K + KK + + + + E ++ KHP +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
KPEN L ++ + DFGL + G+P Y+APEV+++ Y VD
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W G +LY +L G+PPF+ + I+ + + P S A +++++L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDR 235
Query: 302 KQRLTAE----EVLEHPWLQN 318
++RL A+ E+ EHP+ ++
Sbjct: 236 QRRLGAKEDFLEIQEHPFFES 256
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 85/313 (27%), Positives = 127/313 (40%), Gaps = 65/313 (20%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ +LG G FG Y + G A K I + I +R E++I+K L KH
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-KH 66
Query: 117 PNIVSLKD-TYE--DDSA-----VHIVM-----ELCEGGELFDRIVARGHYTERAAAAVM 163
PN+V L D E D S V++V +L G L + V TE M
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCYM 121
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNE---- 218
++E + HE ++HRD+K N L N+ LK DFGL+ + P
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLARPYDGPPPNPKGGGGG 178
Query: 219 -------IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
+V + +Y PE+L +R Y VD+W G + + P +++
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238
Query: 270 IIR--------------------SVIDFKRDPWPKVSENAK-------DLVKKMLNPDPK 302
I + V F P + E DL+ K+L+ DP
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 303 QRLTAEEVLEHPW 315
+RLTA + LEHP+
Sbjct: 298 KRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 68/246 (27%), Positives = 116/246 (47%), Gaps = 9/246 (3%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G+G FG L ++G +A K + KK + + + E ++ KHP +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+++ ++ V++ GGELF + + E A + + H +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 184 KPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
KPEN L ++ + DFGL P E + G+P Y+APEVL++ Y VD
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
W G +LY +L G+PPF++ + I+ + + A DL+ +L+ D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 302 KQRLTA 307
++RL A
Sbjct: 236 RRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 49/293 (16%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
+G G +G Y D N G K ++ KK R +D E + RE+ +++ L + I
Sbjct: 9 IGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 120 VSLKD---TYEDD--SAVHIVMELCEGG-----ELFDRIVARGHYTERAAAAVMKTIVEV 169
V L D E + ++++V E + + R R + + M +++
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQLLKG 122
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAP 228
V CH+ GVMHRDLKP+N L K+ LK D GL F P + + + + +Y AP
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAP 180
Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV- 285
EVL +Y VD+WS G I + P F ++E I + + WP V
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 286 -----------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
S DL++KML DP +R++A+ L HP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 88/298 (29%), Positives = 129/298 (43%), Gaps = 43/298 (14%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSI----SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
ELG+G +G Y G A K I + K + E+ I+ H P
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDIL-HKAVSPY 60
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV-----QVC 173
IV + + AV++ ME + G L D++ A G TE V++ I V +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE 229
E ++HRD+KP N L + +K DFG+S G + +G YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171
Query: 230 VLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVIDFKR 279
+K Y + DVWS G+ + + G P+ ET + AI+ D
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229
Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
P S++A+D V K LN P +R T ++LEHPWL K +V + E V LK+
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNADVDMAEWVTGALKR 285
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 1e-23
Identities = 77/271 (28%), Positives = 134/271 (49%), Gaps = 23/271 (8%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
+G+G FG + D + A K I L A D IED+++E+ ++ P +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYVTKY 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
+Y + + I+ME GG D + A G + E A ++K I++ + H + +HRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
+K N L + E +K DFG++ + + N VG+P++MAPEV++++ Y + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKM 296
+WS G+ L G PP +R + ++ P + S+ K+ +
Sbjct: 184 IWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236
Query: 297 LNPDPKQRLTAEEVLEHPWL-QNAKKAPNVS 326
LN DP R TA+E+L+H ++ +NAKK ++
Sbjct: 237 LNKDPSFRPTAKELLKHKFIVKNAKKTSYLT 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 77/280 (27%), Positives = 117/280 (41%), Gaps = 51/280 (18%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
LG++LG G FG Y T K A K++ K+ + + E+ E IMK L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKL-S 59
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC- 173
HPNIV L ++IV E GG+L D + G +K ++++ +Q+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE------KLTLKDLLQMALQIAK 113
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
+ +HRDL N L +K DFGLS +I YY
Sbjct: 114 GMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYYRKR 161
Query: 226 ---------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 274
MAPE LK + + DVWS GV+L+ I G P+ + + V + +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG- 220
Query: 275 IDFKRDPWPKV-SENAKDLVKKMLNPDPKQRLTAEEVLEH 313
R P P+ + +L+ + DP+ R T E++E
Sbjct: 221 ---YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-23
Identities = 74/269 (27%), Positives = 128/269 (47%), Gaps = 29/269 (10%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSL 122
LG+G FG C G+ +ACK ++KK+L+ E E +I+ + H IVSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGH----------YTERAAAAVMKTIVEVVQV 172
++ + + +VM + GG+L R H + E A I+ ++
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDL------RYHIYNVDEENPGFPEPRACFYTAQIISGLEH 112
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-IVGSPYYMAPEVL 231
H++ +++RDLKPEN L N ++ D GL+V + G+ + G+P +MAPE+L
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
Query: 232 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
+ Y VD ++ GV LY ++ PF A E+ + + + +++ K S +K
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
Query: 291 DLVKKMLNPDPKQRL-----TAEEVLEHP 314
+ +L DP++RL + + HP
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHP 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-23
Identities = 80/268 (29%), Positives = 129/268 (48%), Gaps = 23/268 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY+L + +G G +G Y +++ GE A K I KL D +++E+ ++K KH
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKEC-KH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
NIV+ +Y + I ME C GG L D G +E A V + ++ + H +
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGSPYYMAPEV--LKR 233
G MHRD+K N L + + +K DFG++ + +G+PY+MAPEV +++
Sbjct: 126 GKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK 182
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK- 290
N Y D+W+ G+ L PP + + + S +F+ PK+ + K
Sbjct: 183 NGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMSKSNFQP---PKLKDKTKW 237
Query: 291 -----DLVKKMLNPDPKQRLTAEEVLEH 313
+ VK L +PK+R TAE +L H
Sbjct: 238 SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 3e-23
Identities = 84/295 (28%), Positives = 138/295 (46%), Gaps = 41/295 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+Y++ +++G G FG +L E F K+IS + L+ + V EV +M+ L KH
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMREL-KH 71
Query: 117 PNIVSLKDTY--EDDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
NIV D + + + ++I+ME C+ G+L I G E A + + ++ +
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 171 QVCHE-------QGVMHRDLKPENFLF-------------ANKKESSPLKAI-DFGLSVF 209
CH + V+HRDLKP+N AN P+ I DFGLS
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 210 FRPGEQFNEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
+ VG+PYY +PE+L ++Y + D+W+ G I+Y L G PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------ 245
Query: 267 AQAIIRSVIDFKRDPWPKVSENAKD---LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
A + + + KR P + +K+ L+K +LN K+R +A + L + ++N
Sbjct: 246 ANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 70/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG L E +A K + K + D+E E +++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ ++ VME GG+L I G + E A I + H +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
G+++RDLK +N + ++ +K DFG+ G G+P Y+APE++ +
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YG VD W+ GV+LY +L G PPF E E + Q+I+ + + + +S+ A + K
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICK 233
Query: 295 KMLNPDPKQRL 305
++ P +RL
Sbjct: 234 GLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 6e-23
Identities = 83/288 (28%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-EDVRREVQIMK 111
D S +++ +G+G +G + + NG K A K L DI E++ E I+K
Sbjct: 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILK 69
Query: 112 HLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRI---VARG-HYTERAAAA 161
L HPN+V KD D + +V+ELC GG + D + + RG E A
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIV 220
++ + +Q H +HRD+K N L + +K +DFG+S + N V
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 221 GSPYYMAPEV------LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
G+P++MAPEV L Y DVWS G+ L G PP A+ +R++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRAL 238
Query: 275 IDFKRDPWPKV------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
R+P P + S D ++K L D ++R T ++L+H ++
Sbjct: 239 FKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-23
Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 40/290 (13%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSI---SKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
+LG G G + G A K + +K +R + + RE+QIM H + P
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-----KQILRELQIM-HECRSPY 64
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVC 173
IVS + +++ + + ME + G L DRI +G + A AV++ + + V
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE 229
+MHRD+KP N L ++ + +K DFG+S GE N I VG+ YM+PE
Sbjct: 124 R---IMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPE 172
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----DPWPK 284
++ Y + DVWS G+ + L G PF Q ++D + +P P+
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR 232
Query: 285 V-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE 329
+ E+ +D V L DP +R T +++ P A +A NV L
Sbjct: 233 LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQA 282
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 7e-23
Identities = 84/279 (30%), Positives = 130/279 (46%), Gaps = 22/279 (7%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
ELG G FG Y + G A K I K + ++ED E++I+ HP IV L
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKL 74
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
+ D + I++E C GG + D I+ RG TE + + ++E +Q H ++
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQYLHSMKII 132
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVL------K 232
HRDLK N L + +K DFG+S + ++ + +G+PY+MAPEV+
Sbjct: 133 HRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
Y + D+WS G+ L + PP V I +S P K S +D
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKWSMEFRDF 248
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETV 331
+K L+ P+ R +A ++LEHP++ + N L E V
Sbjct: 249 LKTALDKHPETRPSAAQLLEHPFV--SSVTSNRPLRELV 285
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 7e-23
Identities = 81/319 (25%), Positives = 136/319 (42%), Gaps = 66/319 (20%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNN--GEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLP 114
Y++ +GRG +G Y N G+++A K K+ T + R E+ +++ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL- 59
Query: 115 KHPNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAA-------AVMKT 165
KH N+VSL + + + + V+++ + E +L+ I + H + + +++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLWQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFR-PGEQF---NEIV 220
I+ V H V+HRDLKP N + E +K D GL+ F P + + +V
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------QA 269
+ +Y APE+L R+Y +D+W+ G I LL P F + +
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236
Query: 270 II---------------------RSVIDFKRDPWP------------KVSENAKDLVKKM 296
I + DFK +P K DL++K+
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296
Query: 297 LNPDPKQRLTAEEVLEHPW 315
L DP +R+TAEE LEHP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 8e-23
Identities = 76/266 (28%), Positives = 132/266 (49%), Gaps = 21/266 (7%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
++G+G FG + D + A K I ++ +IED+++E+ ++ P +
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC-DSPYVTKY 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
+Y D+ + I+ME GG D ++ G E A +++ I++ + H + +HRD
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
+K N L + E +K DFG++ + + N VG+P++MAPEV+K++ Y + D
Sbjct: 127 IKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN----AKDLVKKM 296
+WS G+ L G PP V I K +P P + N K+ V+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIP------KNNP-PTLEGNYSKPLKEFVEAC 236
Query: 297 LNPDPKQRLTAEEVLEHPW-LQNAKK 321
LN +P R TA+E+L+H + ++ AKK
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVRFAKK 262
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 77/265 (29%), Positives = 129/265 (48%), Gaps = 22/265 (8%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSL 122
+G+G FG Y D E A K I L A D IED+++E+ ++ P I
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC-DSPYITRY 67
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
+Y + + I+ME GG D ++ G E A +++ I++ + H + +HRD
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN-YGPEVD 240
+K N L + E +K DFG++ + + N VG+P++MAPEV+K++ Y + D
Sbjct: 127 IKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 241 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV----SENAKDLVKKM 296
+WS G+ L G PP +R + ++ P + S+ K+ V+
Sbjct: 184 IWSLGITAIELAKGEPPN-------SDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKK 321
LN DP+ R TA+E+L+H ++ K
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTK 261
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 74/286 (25%), Positives = 133/286 (46%), Gaps = 43/286 (15%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHLPKHPNI 119
+G G +G+ C G+ A K K + D + V+ RE++++K L +H N+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQL-RHENL 62
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
V+L + + +++V E + L D E + I+ ++ CH ++
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLKRN--YG 236
HRD+KPEN L + +S +K DFG + PGE + + V + +Y APE+L + YG
Sbjct: 123 HRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 237 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------FKRDP------- 281
VD+W+ G ++ +L G P F +++ II+ + + F+++P
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 282 ------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+PK+S DL K+ L DP R ++ ++L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 77/273 (28%), Positives = 137/273 (50%), Gaps = 20/273 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG FG + N G+ +A K ++K ++ + R E ++ + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRR 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
I +L ++D++ +++VM+ GG+L + E A + +V + H+
Sbjct: 62 W-ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVL-- 231
G +HRD+KP+N L ++ ++ DFG + Q N VG+P Y++PE+L
Sbjct: 121 LGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQA 177
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVIDFKRDPWPKV 285
K YGPE D WS GV +Y +L G PF+AE+ I+ + F D V
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDV 236
Query: 286 SENAKDLVKKMLNPDPKQRL---TAEEVLEHPW 315
SE AKDL+++++ P+ RL ++ +HP+
Sbjct: 237 SEEAKDLIRRLICS-PETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 45/276 (16%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + +GRG FG L + G +A K + K + + +R E I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-ADS 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
+V + +++D ++++ME GG++ ++ + TE + V + H+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSV---------FFR------PGE-QFNEI- 219
G +HRD+KP+N L +K +K DFGL F+R P + F +
Sbjct: 121 GFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 220 -------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFW 259
VG+P Y+APEV + Y D WS GVI+Y +L G PPF
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 260 AETEQGVAQAII--RSVIDFKRDPWPKVSENAKDLV 293
+ET Q + ++ + + F P +SE AKDL+
Sbjct: 238 SETPQETYKKVMNWKETLIFP--PEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 76/291 (26%), Positives = 138/291 (47%), Gaps = 39/291 (13%)
Query: 46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
L++P+G ++L +G G +G Y V G+ A K + T + E++++
Sbjct: 1 LRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQ 51
Query: 106 EVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYT--ER 157
E+ ++K H NI + K+ D + +VME C G + D I T E
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQF 216
A + + I+ + H+ V+HRD+K +N L E++ +K +DFG+S R +
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 217 NEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
N +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHP 221
Query: 271 IRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+R++ R+P P++ S+ + ++ L + QR T E++++HP++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 89/309 (28%), Positives = 132/309 (42%), Gaps = 51/309 (16%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y + +G+G +GV D + GEK A K I D + RE+++++ L +HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL-RHP 59
Query: 118 NIVSLKD--------TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
+IV +K ++D +++V EL E +L I A T + ++
Sbjct: 60 DIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRA 115
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFR--PGEQF-NEIVGSPYY 225
++ H V HRDLKP+N L AN LK DFGL+ V F P F + V + +Y
Sbjct: 116 LKYIHTANVFHRDLKPKNIL-ANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 226 MAPEV---LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 263
APE+ Y P +D+WS G I +L G P F ET
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232
Query: 264 QGVAQAIIRSVIDF--KRDP------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
V R + K+ P +P A L++++L DPK R TAEE L P+
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 316 LQNAKKAPN 324
+ K
Sbjct: 293 FKGLAKVER 301
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-22
Identities = 71/254 (27%), Positives = 127/254 (50%), Gaps = 20/254 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG FG + N + FA K ++K ++ + R E ++ + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDN 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
I +L ++D++ +++VM+ GG+L + E A + +V + H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVL-- 231
+HRD+KP+N L + ++ DFG L + Q + VG+P Y++PE+L
Sbjct: 121 LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---- 283
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQVT 234
Query: 284 KVSENAKDLVKKML 297
VSE+AKDL+++++
Sbjct: 235 DVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 76/315 (24%), Positives = 130/315 (41%), Gaps = 55/315 (17%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ LG G FG L V+ +A K++ KK + + V+ E I+ + +V
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L +++D ++ VM+ GG++ ++ + E A + + ++ H+ G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR--------------------PGEQFNEI-- 219
D+KP+N L +K DFGL FR P + ++++
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 220 --------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILL 252
VG+P Y+APEV L++ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML--NPDPKQRLTAEEV 310
G PPF A T +I P K+S A DL+ K+ + R A+++
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302
Query: 311 LEHPWLQNAKKAPNV 325
HP+ + ++
Sbjct: 303 KAHPFFSEVDFSSDI 317
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 21/263 (7%)
Query: 64 LGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 120
LG+G FG +L + + G+ +A K + K L+ D + E I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPFIV 61
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
L ++ + ++++++ GG+LF R+ +TE + + + H G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN-EIVGSPYYMAPEVL-KRNYGPE 238
RDLKPEN L E +K DFGLS E+ G+ YMAPEV+ +R +
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAKDLVKKML 297
D WS GV+++ +L G PF + + I+++ + P+ +S A+ L++ +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----PQFLSPEAQSLLRALF 233
Query: 298 NPDPKQRLTA-----EEVLEHPW 315
+P RL A EE+ HP+
Sbjct: 234 KRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 7e-22
Identities = 71/266 (26%), Positives = 123/266 (46%), Gaps = 30/266 (11%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG N G+ +ACK + KK+L+ + E +I++ + P IV+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLA 59
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVC 173
+E + + +VM L GG+L I G HY+ + ++
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL-------- 111
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
H +++RD+KPEN L ++ + D GL+V + G+ + G+ YMAPE+LK
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----FKRDPWPKVSEN 288
Y VD ++ G +Y ++ G PF E+ + + R ++ F+ +E
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEE 225
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHP 314
+KD+ + L P+ RL + E + P
Sbjct: 226 SKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 77/294 (26%), Positives = 133/294 (45%), Gaps = 41/294 (13%)
Query: 46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
L +P+ +++ +G+G +G Y T+ +G A K + VD E++
Sbjct: 17 LGDPTD-----TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVD-EEIEA 67
Query: 106 EVQIMKHLPKHPNIVSLKDT-YEDDSAVH----IVMELCEGG---ELFDRIVARGHYTER 157
E I++ LP HPN+V Y+ D V +V+ELC GG EL ++ G +
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 158 AAAA-VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215
A + ++ + +Q H ++HRD+K N L + +K +DFG+S +
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLR 184
Query: 216 FNEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
N VG+P++MAPEV+ +Y DVWS G+ L G PP +
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------ 238
Query: 270 IIRSVIDFKRDPWP------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
++++ R+P P K + + + L D + R + +LEHP+++
Sbjct: 239 -VKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 38/292 (13%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-- 115
Y+ E+G G +G Y D ++G A KS+ + + + VR EV ++K L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFD 60
Query: 116 HPNIVSLKDT-----YEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVE 168
HPNIV L D + ++ V +V E + D++ G E +M+ +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFLR 119
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
+ H ++HRDLKPEN L + + +K DFGL+ + +V + +Y AP
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRAP 176
Query: 229 EV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW----- 282
EV L+ Y VD+WS G I + P F +E I + D W
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236
Query: 283 ------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
P++ E+ L+ +ML +P +R++A L+HP+
Sbjct: 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 69/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG L E +A K + K + D+E E +++ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ ++ VME GG+L +I G + E A I + H +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGL-SVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
G+++RDLK +N + ++ +K DFG+ G G+P Y+APE++ +
Sbjct: 121 GIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP 177
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YG VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + K
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAVAICK 233
Query: 295 KMLNPDPKQRL 305
++ P +RL
Sbjct: 234 GLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-21
Identities = 68/281 (24%), Positives = 119/281 (42%), Gaps = 50/281 (17%)
Query: 62 RELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
++LG G FG Y + A K++ K+ + + +D +E ++MK L HPN
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKL-GHPN 57
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV----QVC- 173
+V L ++ +++V+E EGG+L D + + + ++ +++ Q+
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAK 116
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
+ +HRDL N L +K DFGLS ++ YY
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSR---------DVYDDDYYRKK 164
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV-AQAIIRS 273
MAPE LK + + DVWS GV+L+ I G P+ G+ + ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-----GLSNEEVLEY 219
Query: 274 VIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ R P P+ + +L+ DP+ R T E++E
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 57/305 (18%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D + R +G G FGV + TD +G++ A K + + V + V RE++++ KH
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFF-KH 58
Query: 117 PNIVSLKDT--------YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
N++S D +E+ +++V EL + +L IV+ + + I+
Sbjct: 59 DNVLSALDILQPPHIDPFEE---IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN---EIVGSPYY 225
++ H G++HRD+KP N L + + LK DFGL+ P E + E+V + YY
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170
Query: 226 MAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPPFWAET 262
APE+L R+Y VD+WS G I L L G P A
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230
Query: 263 E--QGVAQAIIRSVIDFKRDPWPKV--------SENAKDLVKKMLNPDPKQRLTAEEVLE 312
+G I+R + P V + A L+ +ML DP +R++A + L
Sbjct: 231 SACEGARAHILRGP---HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
Query: 313 HPWLQ 317
HP+L
Sbjct: 288 HPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 85/296 (28%), Positives = 137/296 (46%), Gaps = 49/296 (16%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G +G D GEK A K +S+ ++ + + RE+ ++KH+ +H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKHM-QHENVIGLL 80
Query: 124 DTYEDDSAVH------IVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQ 176
D + + +VM + D GH +E ++ ++ ++ H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKR-- 233
G++HRDLKP N L N E LK +DFGL+ R + + V + +Y APEV+
Sbjct: 137 GIIHRDLKPGN-LAVN--EDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWM 190
Query: 234 NYGPEVDVWSAGVILYILLCGV-----------------------PPFWAETEQGVAQAI 270
+Y VD+WS G I+ +L G P F + E A++
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250
Query: 271 IRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
I+S+ + R +PK S A DL++KML D +RLTA E LEHP+ + + A
Sbjct: 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 7e-21
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 31/262 (11%)
Query: 67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPNIVSLKDT 125
G+FG + + F K I K IE V Q+MK +PN + L +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVH---QLMKD---NPNFIKLYYS 77
Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185
++M+ + G+LFD + G +E +++ +VE + H+ ++H D+K
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 186 ENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-------YMAPE-VLKRNYGP 237
EN L+ K+ + D+GL +I+G+P Y +PE + NY
Sbjct: 138 ENVLYDRAKDR--IYLCDYGLC----------KIIGTPSCYDGTLDYFSPEKIKGHNYDV 185
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
D W+ GV+ Y LL G PF + ++ + + K VS+NA D V+ ML
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSML 245
Query: 298 NPDPKQRLTA-EEVLEHPWLQN 318
+ RLT E+++HP+L+
Sbjct: 246 KYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 77/294 (26%), Positives = 137/294 (46%), Gaps = 39/294 (13%)
Query: 43 LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
L L++P+G ++L +G G +G Y V G+ A K + T + E+
Sbjct: 8 LSALRDPAGI-----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEE 58
Query: 103 VRREVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIV-ARGH-Y 154
++ E+ ++K H NI + K D + +VME C G + D + +G+
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118
Query: 155 TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG 213
E A + + I+ + H V+HRD+K +N L E++ +K +DFG+S R
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 175
Query: 214 EQFNEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 267
+ N +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CD 228
Query: 268 QAIIRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+R++ R+P PK+ S+ D ++ L + R + E++L+HP++
Sbjct: 229 MHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 76/267 (28%), Positives = 111/267 (41%), Gaps = 82/267 (30%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIV-----------MELCEGG------ELFDR 147
RE ++K L KH NIV+L D + +V M+ C GG LF
Sbjct: 52 REASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF 110
Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL- 206
+ RG + CH++ V+HRDLKP+N L + + E LK DFGL
Sbjct: 111 QLLRG-----------------LAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLA 150
Query: 207 ---SVFFRPGEQF-NEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA 260
SV P + + NE+V + +Y P+VL Y +D+W G I Y + G P F
Sbjct: 151 RAKSV---PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206
Query: 261 ET---EQGVAQAIIRSVIDFKRDPWPKVSENAK--------------------------- 290
T +Q I R + + WP VS N +
Sbjct: 207 STDVEDQ--LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHG 264
Query: 291 -DLVKKMLNPDPKQRLTAEEVLEHPWL 316
+L K L +PK+R++A E ++HP+
Sbjct: 265 EELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 104 RREVQIMKHLPKHPNIVSLKDTYE-DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
RRE + L HPNIV+L D+ E + V E G L + + A G +
Sbjct: 26 RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--------- 213
M +++ + H QG++HRDLKP+N + + K +DFG+ PG
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143
Query: 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
+ E++G+P Y APE L+ P D+++ G+I L G + VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200
Query: 273 --SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR-LTAEEVLE 312
S +D PW +++K LN DP+QR +A + E
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPALAE 242
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 6e-20
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVV 170
H IV D ++ D + ++ME GG+L +I R + E + IV +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV---------G 221
H + +MHRDLK N + +K DFG S +Q+++ V G
Sbjct: 183 DEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFS------KQYSDSVSLDVASSFCG 233
Query: 222 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
+PYY+APE+ +R Y + D+WS GVILY LL PF +++ + Q ++ K D
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG----KYD 289
Query: 281 PWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
P+P VS K L+ +L+ +P R T +++L +L+
Sbjct: 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 68/245 (27%), Positives = 109/245 (44%), Gaps = 41/245 (16%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
REV ++K+L KH NIV+L D + + +V E + +L + G+ + M
Sbjct: 52 REVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL----SVFFRPGEQFNEI 219
++ + CH++ ++HRDLKP+N L K E LK DFGL SV P + ++
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---PTKTYSNE 163
Query: 220 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
V + +Y P+VL Y +D+W G ILY + G P F T + I R +
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223
Query: 278 KRDPWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVL 311
+ WP ++ N + DL+ +L + K R++AE L
Sbjct: 224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283
Query: 312 EHPWL 316
H +
Sbjct: 284 RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-19
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+G G +G D +K A K +S+ ++ + RE++++KH+ KH N++
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHM-KHENVIG 78
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
L D + E+ + V++V L G + IV ++ ++ ++ ++ H
Sbjct: 79 LLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
G++HRDLKP N E L+ +DFGL+ + ++ V + +Y APE++
Sbjct: 137 AGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYRAPEIMLNWM 191
Query: 234 NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAETEQGVAQAI 270
+Y VD+WS G I+ LL G P + A+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKY 251
Query: 271 IRSVIDFKRDPWPKVSENAK----DLVKKMLNPDPKQRLTAEEVLEHPWL 316
I+S+ + K+ A DL++KML D +R++A E L HP+
Sbjct: 252 IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 44/288 (15%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G +G D G + A K +S+ ++ + + RE++++KH+ KH N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHM-KHENVIGLL 82
Query: 124 DTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
D + E+ + V++V L G + IV T+ ++ I+ ++ H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NY 235
++HRDLKP N E LK +DFGL+ ++ V + +Y APE++ +Y
Sbjct: 141 IIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHY 195
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN------- 288
VD+WS G I+ LL G F + I+R V + K+S
Sbjct: 196 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255
Query: 289 --------------------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
A DL++KML D +R+TA + L H +
Sbjct: 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG FG + + +A K ++K ++ + R E ++ +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GDC 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE 175
I +L ++D++ +++VM+ GG+L + E A + +V + H+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFG--LSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
+HRD+KP+N L + ++ DFG L + Q + VG+P Y++PE+L+
Sbjct: 121 LHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 234 ------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHIT 234
Query: 285 -VSENAKDLVKKML 297
VSE AKDL+++++
Sbjct: 235 DVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 83/296 (28%), Positives = 119/296 (40%), Gaps = 56/296 (18%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIEDVRREVQIMKHLPKHP 117
+LG G + Y NG+ A K IS K TA+ RE ++K L KH
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL-KHA 63
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV L D + V E I G M ++ + H Q
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL--KRN 234
++HRDLKP+N L + E LK DFGL+ P + ++ V + +Y P+VL +
Sbjct: 124 ILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-----IRSVIDF-KRDPWPKVSE- 287
Y +D+W AG I +L G P F GV+ I +V+ D WP VS+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 288 ---------------------------NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
A+DL +ML PK R++A++ L HP+
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-19
Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 44/286 (15%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G +GV C E A K + V E RE+++++ L K NIV LK
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQENIVELK 66
Query: 124 DTYEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ + +++V E E EL + + G E+ + + + +++ + CH+ ++HR
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN--EIVGSPYYMAPE-VLKRNYGPE 238
D+KPEN L ++ + LK DFG + G N E V + +Y +PE +L YG
Sbjct: 125 DIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVID---------FKRDP------W 282
VD+WS G IL L G P F E+E + Q I+ V+ F +P +
Sbjct: 182 VDMWSVGCILGELSDGQPLFPGESE--IDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239
Query: 283 PKVSENAK--------------DLVKKMLNPDPKQRLTAEEVLEHP 314
P V+ DL+K +L +P R E+ L HP
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 35/243 (14%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
REV ++K L KH NIV+L D + ++ +V E + +L + G+ + +
Sbjct: 53 REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL 110
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGS 222
++ + CH + V+HRDLKP+N L + E LK DFGL+ P + ++ V +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYSNEVVT 167
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
+Y P++L +Y ++D+W G I Y + G P F T + I R + +
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE 227
Query: 281 PWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVLEHP 314
WP + N + +L+ K+L + ++R++AEE ++HP
Sbjct: 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 WLQ 317
+
Sbjct: 288 YFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 54/314 (17%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
ELG G GV +G A K I +++ A+ + RE++++ H P IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVE-VVQVCHEQGVMH 180
+ D + I ME +GG L D+++ + G E + ++ + + + +MH
Sbjct: 65 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVLKRN-Y 235
RD+KP N L ++ E +K DFG+S G+ N VG+ YM+PE L+ Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------------------------- 267
+ D+WS G+ L + G P + +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235
Query: 268 -QAIIRSVIDFKRDPWPKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
AI + +P PK+ S+ +D V K L +PK+R +E+ +HP+++ A +
Sbjct: 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA-E 294
Query: 322 APNVSLGETVKARL 335
V V + +
Sbjct: 295 LEEVDFAGWVCSTM 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 35/244 (14%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-M 163
REV ++K L KH NIV+L D D ++ +V E + +L + G+ + +
Sbjct: 53 REVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL 110
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGS 222
I+ + CH + V+HRDLKP+N L + E LK DFGL+ P + ++ V +
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVVT 167
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
+Y P+VL Y ++D+W G I + + G P F T + I R + +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEE 227
Query: 281 PWPKVSENAK--------------------------DLVKKMLNPDPKQRLTAEEVLEHP 314
WP +S N + +L+ K L + K+R++AEE ++H
Sbjct: 228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 WLQN 318
+ ++
Sbjct: 288 YFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 29/273 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
+ + +G G G Y G +A K I + VR RE++I++
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRD 128
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+ HPN+V D ++ + + +++E +GG L +A E+ A V + I+ +
Sbjct: 129 V-NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAY 183
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
H + ++HRD+KP N L + K +K DFG+S + + + N VG+ YM+PE +
Sbjct: 184 LHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERI 240
Query: 232 KRNY------GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-- 283
+ G D+WS GV + G PF QG A + I + P
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQG-DWASLMCAICMSQPPEAPA 298
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
S + + L +P +R +A ++L+HP++
Sbjct: 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 73/266 (27%), Positives = 123/266 (46%), Gaps = 18/266 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH---PNIV 120
+GRG FG Y C + G+ +A K + KK+++ E + +IM L P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
+ + + +++L GG+L + G ++E I+ ++ H + V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN--YGPE 238
RDLKP N L E ++ D GL+ F ++ + VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAKDLVKKML 297
D +S G +L+ LL G PF + + I + P S + L++ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234
Query: 298 NPDPKQRL-----TAEEVLEHPWLQN 318
D +RL A+EV EHP+ ++
Sbjct: 235 QRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 70/291 (24%), Positives = 134/291 (46%), Gaps = 44/291 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+++G G +G D G K A K + + ++ + + RE++++KH+ KH N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHM-KHENVIG 78
Query: 122 LKDTYEDDSAV------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
L D + D ++ ++VM G +++ +E ++ +++ ++ H
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-- 233
G++HRDLKP N E LK +DFGL+ + + V + +Y APEV+
Sbjct: 137 AGIIHRDLKPGNLAV---NEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNWM 191
Query: 234 NYGPEVDVWSAGVILYILLCGVP-----------------------PFWAETEQGVAQAI 270
+Y VD+WS G I+ +L G P F + + A+
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251
Query: 271 IRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
++ + F++ + P + A ++++KML D + R+TA E L HP+ +
Sbjct: 252 VKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 8e-18
Identities = 75/275 (27%), Positives = 109/275 (39%), Gaps = 39/275 (14%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR--REVQIMKHLPKHPNIV 120
E+G G G Y G A K + RT E+ R ++ ++ P IV
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH---- 174
+ DS V I MEL D+++ R G E K V +V+ H
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG---KMTVAIVKALHYLKE 132
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--- 231
+ GV+HRD+KP N L S +K DFG+S + G YMAPE +
Sbjct: 133 KHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPP 189
Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
Y DVWS G+ L L G P+ +TE V I+ ++ P + N
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-------QEEPPSLPPN 242
Query: 289 A------KDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
V L D ++R E+L+HP+++
Sbjct: 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 96/384 (25%), Positives = 160/384 (41%), Gaps = 80/384 (20%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LG +G G FGV Y ++ EK A K + + D + RE+ IMK+L H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-------DPQYKNRELLIMKNL-NHI 119
Query: 118 NIVSLKDTY--------EDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTI- 166
NI+ LKD Y E + +++VM E + V + HY A + +
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVM------EFIPQTVHKYMKHYARNNHALPLFLVK 173
Query: 167 VEVVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
+ Q+C H + + HRDLKP+N L + LK DFG + G++ +
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYI 231
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------ 272
S +Y APE++ NY +D+WS G I+ ++ G P F ++ II+
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291
Query: 273 ---------SVIDFK---------RDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ D K + +PK ++A + + + L +P +RL E L
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351
Query: 314 PWLQNAKKAPNVSLGETV----------KARLKQFSVMNKLK---KRALQVVAEFLSVEE 360
P+ + + P + L + + A +K+ S + K K + EFL +E
Sbjct: 352 PFFDDLRD-PCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYEAYKEFLMSDE 410
Query: 361 VAGLKEAFEMMDT--NKRGKINLE 382
+A + D G+ N++
Sbjct: 411 ----NDANIIADKISKDFGESNID 430
|
Length = 440 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-17
Identities = 73/264 (27%), Positives = 122/264 (46%), Gaps = 16/264 (6%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH---PNIV 120
+GRG FG Y C + G+ +A K + KK+++ E + +IM L P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
+ + + +++L GG+L + G ++E+ I+ ++ H + V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN--YGPE 238
RDLKP N L E ++ D GL+ F ++ + VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298
D +S G +L+ LL G PF + I R + + S K L++ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 299 PDPKQRL-----TAEEVLEHPWLQ 317
D +RL A+EV EH + +
Sbjct: 236 RDVSKRLGCLGRGAQEVKEHVFFK 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 28/208 (13%)
Query: 62 RELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
++LG G FG LC N GE+ A KS+ D RE++I++ L H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTL-DHE 66
Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
NIV K E ++ ++ME G L R + H + ++ Q+C
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLF---SSQICKG 121
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSP-YY 225
Q +HRDL N L ++ +K DFGL+ + + E SP ++
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 226 MAPEVLK-RNYGPEVDVWSAGVILYILL 252
APE L+ + DVWS GV LY L
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 45/295 (15%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKHL 113
Y+ E+G G +G + D+ NG +F ++ K++R E + REV +++HL
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 114 P--KHPNIVSLKDT-----YEDDSAVHIVMELCEGG--ELFDRIVARGHYTERAAAAVMK 164
+HPN+V L D + ++ + +V E + D++ G TE +M
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMF 117
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
++ + H V+HRDLKP+N L + S +K DFGL+ + +V + +
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQMALTSVVVTLW 174
Query: 225 YMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
Y APEV L+ +Y VD+WS G I + P F ++ I+ + + WP
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 284 K-----------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+ + E KDL+ K L +P +R++A L HP+
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 43/102 (42%), Positives = 63/102 (61%), Gaps = 12/102 (11%)
Query: 219 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
I+G+P Y+APE+L + +GP VD W+ GV L+ L G+PPF ET Q V Q I+
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNIL------ 593
Query: 278 KRD-PWP----KVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
RD PWP K+S NA++ ++ +L DP +R +E+ +HP
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 65/264 (24%)
Query: 105 REVQIMKHLPKHPNIVSL------KDTYEDDSAVHIVME-----LCEGGELFDRIVARGH 153
RE+ +MK L H NI+ L + + E+ V++VME LC+ ++
Sbjct: 64 RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-------VIQMDL 115
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
ER + + + + + + H G++HRDLKP N + K LK +DFGL+
Sbjct: 116 DHERMSYLLYQMLCGIKHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTS 171
Query: 214 EQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---------------------YIL 251
V + YY APEV L Y VD+WS G I+ I
Sbjct: 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE 231
Query: 252 LCGVPP--FWAETEQGVA---------QAIIRSVIDFKRDPWPKVSEN--------AKDL 292
G P F + + V + F +P SE+ A+DL
Sbjct: 232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKLKASQARDL 290
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWL 316
+ KML DP++R++ ++ L+HP++
Sbjct: 291 LSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 72/283 (25%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
YD+ R +G+G G YL D + A K I + + + RE +I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHP 62
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMK---TI 166
IV + D V+ M EG L +++ + + A + I
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------PG 213
++ H +GV+HRDLKP+N L E L D+G ++F +
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVDERN 179
Query: 214 EQFNE------IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQGV 266
++ IVG+P YMAPE L E D+++ GVILY +L P+ + + +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 267 AQAIIRSVIDFKRD--PWPKVSENAKDLVKKMLNPDPKQRLTA 307
+ R VI + P+ ++ + K L DP +R ++
Sbjct: 240 S---YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 9e-16
Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 15/192 (7%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
E+G G+FG+ +L + K A K+I + A+ ED E Q+M L HP +V L
Sbjct: 11 EIGSGQFGLVWLGYWLEK-RKVAIKTIREG----AMSEEDFIEEAQVMMKL-SHPKLVQL 64
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ S + +V E E G L D + A RG +++ + + E + V+HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLK-RNYGP 237
DL N L E+ +K DFG++ F +Q+ G+ + + +PEV Y
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 238 EVDVWSAGVILY 249
+ DVWS GV+++
Sbjct: 181 KSDVWSFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 53/304 (17%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y + +G G G+ D G A K +S+ + + RE+ ++K + H
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-NHK 80
Query: 118 NIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
NI+SL + + E+ V++VMEL + +++ ER + + + + +
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGIKH 138
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV- 230
+ H G++HRDLKP N + K LK +DFGL+ V + YY APEV
Sbjct: 139 L-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 231 LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIR 272
L Y VD+WS G I+ L+ G F W + + + Q +R
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 273 SVID-------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLE 312
+ ++ F +P SE A+DL+ KML DP +R++ +E L
Sbjct: 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314
Query: 313 HPWL 316
HP++
Sbjct: 315 HPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 58/199 (29%), Positives = 83/199 (41%), Gaps = 21/199 (10%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+LG G FGV +G K A K + KL +D D +E IM L H N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL-DHENL 58
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+ L + +V EL G L DR+ A GH+ I ++ +
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPY-YMAPEVL 231
+HRDL N L A+ + +K DFGL E + + V P+ + APE L
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 232 K-RNYGPEVDVWSAGVILY 249
+ R + DVW GV L+
Sbjct: 173 RTRTFSHASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ +G G G+ D A K +S+ + + RE+ +MK + H NI+S
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIS 80
Query: 122 L------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
L + + E+ V++VMEL + +++ ER + + + + + + H
Sbjct: 81 LLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 137
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
G++HRDLKP N + K LK +DFGL+ V + YY APEV L
Sbjct: 138 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 235 YGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGVAQAIIR 272
Y VD+WS G I+ I G P P + + Q + +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 273 SVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ + +PK+ + A+DL+ KML DP +R++ +E L+HP++
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 32/277 (11%)
Query: 58 YDLGRELGRGEFGVTYLCTD-VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH---- 112
Y + R LG G G T LC V++GE FA K + + + + D + EV + +
Sbjct: 34 YWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFF 91
Query: 113 --LPKHPNIV-SLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKT 165
+ H + E+ + +V++ G+L I +R + E A +
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP------GEQFNEI 219
++ V H + ++HRD+K N L + + +K DFG S + G F
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTF--- 205
Query: 220 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
G+PYY+APE+ +R Y + D++S GV+LY LL PF E + V + +
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG----R 261
Query: 279 RDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
DP P +S +++V +L+ DPK+R ++ ++L P
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 77/277 (27%), Positives = 114/277 (41%), Gaps = 54/277 (19%)
Query: 64 LGRGEFGVTYLCT-----DVNNGE-KFACKSISKKKLRTAVDIEDVR--REVQIMKHLPK 115
LG G FG Y T +G + A K++ K A D E +E +M +
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNF-N 57
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
HPNIV L + +I+MEL EGG+L + R ER ++ T+ E++ +C +
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLL-TLKELLDICLD 114
Query: 176 --QGV--------MHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQFNEIVGSP 223
+G +HRDL N L + K + +K DFGL+ +I S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 224 YY------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
YY MAPE L + + DVWS GV+++ IL G P+ A Q V Q
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT 306
+ + + L+ DP +R T
Sbjct: 226 VTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 62/261 (23%), Positives = 110/261 (42%), Gaps = 23/261 (8%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPN 118
+ELG G+FGV V+ G+ ++ K +R A+ +D E ++M L HPN
Sbjct: 8 FLKELGSGQFGV------VHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPN 60
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-KTIVEVVQVCHEQG 177
+V L + IV E G L + + R M + E ++ G
Sbjct: 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
+HRDL N L E + +K DFGL+ + +Q+ G+ + + PEV +
Sbjct: 121 FIHRDLAARNCLVG---EDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYS 176
Query: 235 -YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV-SENAKD 291
+ + DVWS GV+++ + G P+ + V +++ R PK+
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----RLYRPKLAPTEVYT 232
Query: 292 LVKKMLNPDPKQRLTAEEVLE 312
++ + P+ R +++L
Sbjct: 233 IMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 6e-15
Identities = 81/280 (28%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 62 RELGRGEFG-VTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
R LG G FG V+ C D N GE A K++ K+ + ++E+ I+K L H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL-YHE 66
Query: 118 NIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
NIV K + + ++ME G L D Y + + + ++ Q+C
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSP-YY 225
H Q +HRDL N L N + +K DFGL+ G ++ E SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGV-----PPFWAETEQGVAQAIIRSV--IDF 277
A E LK N + DVWS GV LY LL PP E G Q + V I+
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236
Query: 278 ----KRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
R P PK + L+K + K R T ++
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 76/300 (25%), Positives = 129/300 (43%), Gaps = 53/300 (17%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
+ +G G G+ D A K +S+ + + RE+ +MK + H NI+
Sbjct: 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIIG 87
Query: 122 LKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
L + + E+ V+IVMEL + +++ ER + + + + + + H
Sbjct: 88 LLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGIKHL-HS 144
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRN 234
G++HRDLKP N + K LK +DFGL+ V + YY APEV L
Sbjct: 145 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 235 YGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA----------QAIIRSVID 276
Y VD+WS G I+ ++ G F W + + + Q +R+ ++
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 261
Query: 277 -------------FKRDPWPKVSEN-------AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
F +P SE+ A+DL+ KML D +R++ +E L+HP++
Sbjct: 262 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 74/323 (22%), Positives = 137/323 (42%), Gaps = 78/323 (24%)
Query: 61 GRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
G ++GRG +G Y D + +A K I + + RE+ +++ L KHPN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLREL-KHPN 59
Query: 119 IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERA-----------AAAVMKT 165
++SL+ + D V ++ + E +L+ + + H +A +++
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFF----RPGEQFNEIV 220
I++ + H V+HRDLKP N L + E +K D G + F +P + +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------- 258
+ +Y APE+L R+Y +D+W+ G I LL P F
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236
Query: 259 ------------WAETEQGVAQAIIRSVIDFKRDPWP-----------KVSENAK--DLV 293
W + ++ + + DF+R+ + KV ++K L+
Sbjct: 237 IFNVMGFPADKDWEDIKKMPEHSTLMK--DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 294
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
+K+L DP +R+T+E+ ++ P+
Sbjct: 295 QKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 80/302 (26%), Positives = 126/302 (41%), Gaps = 56/302 (18%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIEDVRREVQIMKHL 113
Y+ +LG G + Y NG+ A K I ++ TA+ RE ++K L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLKGL 60
Query: 114 PKHPNIVSLKDTYEDDSAVHIVME-----LCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
KH NIV L D + +V E LC+ D+ G + ++
Sbjct: 61 -KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDK--HPGGLHPENVKLFLFQLLR 114
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMA 227
+ H++ ++HRDLKP+N L ++ E LK DFGL+ P ++ V + +Y
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPSHTYSNEVVTLWYRP 171
Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI-------------- 270
P+VL Y +D+W G I ++ GV F + Q + I
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231
Query: 271 IRSVIDFK------------RDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ S+ FK R W K+S +A+DL K+L PK RL+A+ L H +
Sbjct: 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
Query: 317 QN 318
+
Sbjct: 292 SD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 4/151 (2%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ + + + RG FG YL NN + +A K + K + + V+ E + L K
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV L + + + V++VME GG++ + G++ E A + + + H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
G++HRDLKP+N L +N+ +K DFGLS
Sbjct: 124 GIIHRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 75/323 (23%), Positives = 136/323 (42%), Gaps = 78/323 (24%)
Query: 61 GRELGRGEFGVTYLC--TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
G ++GRG +G Y D + +++A K I + + RE+ +++ L KHPN
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLREL-KHPN 59
Query: 119 IVSLKDTY--EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK-----------T 165
+++L+ + D V ++ + E +L+ + + H +A M+
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFF----RPGEQFNEIV 220
I++ + H V+HRDLKP N L + E +K D G + F +P + +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------- 258
+ +Y APE+L R+Y +D+W+ G I LL P F
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
Query: 259 ------------WAETEQGVAQAIIRSVIDFKRDPWP-----------KVSENAKD--LV 293
W + + ++ DF+R + KV ++K L+
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQK--DFRRTTYANSSLIKYMEKHKVKPDSKVFLLL 294
Query: 294 KKMLNPDPKQRLTAEEVLEHPWL 316
+K+L DP +R+T+E+ L+ P+
Sbjct: 295 QKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 67/329 (20%), Positives = 126/329 (38%), Gaps = 65/329 (19%)
Query: 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMK 111
+ +G+ N ++ K L + ED++ E+ +
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNT-----LVAVKKINLDSCSK-EDLKLLQQEIITSR 54
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT----ERAAAAVMKTIV 167
L +HPNI+ ++ DS +++V L G D + + H+ E A A ++K ++
Sbjct: 55 QL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVL 111
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV---FFRPGEQFNEIVGSP- 223
+ H +G +HR +K + L S K + GL + G++ + P
Sbjct: 112 NALDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 224 ------YYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF---------------- 258
+++PEVL++N Y + D++S G+ L G PF
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 259 ---------WAETEQGVAQAIIRSVIDFKRDPWP-----KVSENAKDLVKKMLNPDPKQR 304
+ E ++Q+ + RD SE+ V+ L DP+ R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 305 LTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
+A ++L H + + K+ N SL + +K
Sbjct: 287 PSASQLLNHSFFKQCKRR-NTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 45/283 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPKHPN 118
ELGRG +GV V G A K ++R V+ ++ +R ++ I P
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 119 IVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
V+ + V I ME+ + + + ++ +G E + +IV+ ++ H
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 176 Q-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV-----GSPYYMAPE 229
+ V+HRD+KP N L N+ +K DFG+S G + + G YMAPE
Sbjct: 122 KLSVIHRDVKPSNVL-INRN--GQVKLCDFGIS-----GYLVDSVAKTIDAGCKPYMAPE 173
Query: 230 VL-----KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKRDPW 282
+ ++ Y + DVWS G+ + L G P+ W Q + Q + +P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPS 225
Query: 283 PKV-----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
P++ S +D V K L + K+R E+L+HP+ +
Sbjct: 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 72/270 (26%), Positives = 116/270 (42%), Gaps = 39/270 (14%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPN 118
LG G G Y + A K I +DI V + QIM L P
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI-------PLDIT-VELQKQIMSELEILYKCDSPY 60
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
I+ + ++ + I E +GG L + +I H R A AV+K + + +
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL---- 114
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VGSPYYMAPE-VL 231
++HRD+KP N L + + +K DFG+S + N I VG+ YMAPE +
Sbjct: 115 KILHRDVKPSNMLVNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERIS 166
Query: 232 KRNYGPEVDVWSAGVILYILLCGVPPF-WAETEQG--VAQAIIRSVIDFK--RDPWPKVS 286
YG DVWS G+ L G P+ + QG + +++ ++D P + S
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
E + + + PK+R E +++HP++
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 75/267 (28%), Positives = 115/267 (43%), Gaps = 42/267 (15%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPN 118
L R+LG G+FG +V G ++ K L+ +D +D E QIMK L +HP
Sbjct: 10 LLRKLGAGQFG------EVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK 62
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK--TIVEV-VQVC-- 173
++ L + ++IV EL + G L + Y + A +K ++++ QV
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALKLPQLIDMAAQVASG 115
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YM 226
Q +HRDL N L E++ K DFGL+ + + G+ + +
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDI-YEAREGAKFPIKWT 171
Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
APE N + + DVWS G++L I+ G P+ T V Q + + R P P
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY----RMPCPP 227
Query: 285 VSENAKDLVKKML---NPDPKQRLTAE 308
K+L ML DP R T E
Sbjct: 228 GCP--KELYDIMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 65/217 (29%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
D LGR +G G+FG Y ++ EK A + K + E +E IM+
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-D 65
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEVVQVC 173
HP+IV L ++ V IVMEL GEL Y + + + I+ Q+
Sbjct: 66 HPHIVKLIGVITENP-VWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQLS 117
Query: 174 ------HEQGVMHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQFNEIVGS-PY 224
+ +HRD+ N L + SP +K DFGLS + + G P
Sbjct: 118 TALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 258
+MAPE + R + DVW GV ++ IL+ GV PF
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 21/238 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ ELG G GV + + +G A K I +++ A+ + RE+Q++ H
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV + D + I ME +GG L + G E+ V +++ + E+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
+MHRD+KP N L ++ E +K DFG+S G+ N VG+ YM+PE L
Sbjct: 123 HKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 174
Query: 232 K-RNYGPEVDVWSAGVILYILLCG----VPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
+ +Y + D+WS G+ L + G PP E E + + + P P+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 61/284 (21%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ LG +G+GEFG L G+K A K + K TA E +M L +H
Sbjct: 7 ELKLGATIGKGEFGDVMLGD--YRGQKVAVKCL--KDDSTAAQ--AFLAEASVMTTL-RH 59
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC--- 173
PN+V L + ++IV E G L D + +RG RA + + + + VC
Sbjct: 60 PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGM 115
Query: 174 ---HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPE 229
E+ +HRDL N L + E K DFGL+ + Q + P + APE
Sbjct: 116 EYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPE 169
Query: 230 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
L+ + + DVWS G++L+ + F R P+P++
Sbjct: 170 ALREKKFSTKSDVWSFGILLW-----------------------EIYSFGRVPYPRIP-- 204
Query: 289 AKDLVK------KMLNPD--PKQRLTAEEVLEHPWLQNAKKAPN 324
KD+V +M P+ P + +V++ W + K P
Sbjct: 205 LKDVVPHVEKGYRMEAPEGCPPE---VYKVMKDCWELDPAKRPT 245
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 31/204 (15%)
Query: 62 RELGRGEFGVT---YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
+ELG G FG + A K++ ++ + ++ RE +M L HP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV 178
IV L + + + +VMEL G L + R + + + +
Sbjct: 58 IVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNY 235
+HRDL N L N+ ++ K DFG+S GS YY A + + Y
Sbjct: 117 VHRDLAARNVLLVNRHQA---KISDFGMSRALGA--------GSDYYRATTAGRWPLKWY 165
Query: 236 GPEV----------DVWSAGVILY 249
PE DVWS GV L+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 62 RELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
R+LG G FG LC N GE+ A KS+ K I D+++E++I+++L H
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 66
Query: 118 NIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGHYTERAAAAV-MKTIVE-VVQVC 173
NIV K +D + + ++ME G L + Y R + +K ++ VQ+C
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI---VGSP- 223
+ +HRDL N L ++ + +K DFGL+ +++ + + SP
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 224 YYMAPEVL-KRNYGPEVDVWSAGVILYILL 252
++ APE L + + DVWS GV LY LL
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 48/242 (19%)
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
HP+++ +KDT + +V+ +L+ + R A + K I+E ++ H
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
Q ++HRD+K EN +F N + + D G + F F + G+ APEVL R+
Sbjct: 175 AQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-------VI--------DFK 278
Y + D+WSAG++L+ +L P E + ++S +I +F
Sbjct: 232 KYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290
Query: 279 RDP---------------------WPKVS-----ENAKDLVKKMLNPDPKQRLTAEEVLE 312
RDP +P + + LV KML D R +AEE+L
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350
Query: 313 HP 314
+P
Sbjct: 351 YP 352
|
Length = 357 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 47/244 (19%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKHPNI 119
ELG G FG Y E+ + S++ K L+ + ++ R+E ++M L +HPNI
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNI 70
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT-------------- 165
V L + ++ E G+L + +V +++ A + +T
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 166 --IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
I ++ +HRDL N L +K DFGLS +I +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS---------RDIYSAD 178
Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
YY M PE +L + E D+WS GV+L+ I G+ P++ + Q V +
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE- 237
Query: 270 IIRS 273
+IRS
Sbjct: 238 MIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPNIV 120
+ELG G+FGV +L G+ A ++ K + A+ ED E ++M L HP +V
Sbjct: 10 KELGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLV 62
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
L ++IV E E G L + + R G ++ ++ + + E ++ +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN-Y 235
HRDL N L + + +K DFG++ + +++ G+ + + PEV + Y
Sbjct: 123 HRDLAARNCLVS---STGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 236 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
+ DVWS GV+++ + G PF ++ V + I R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 27/228 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ L R+LG G FG + N + A K + L +D ++EVQ +K L +H
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRL-RH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT---------IV 167
+++SL V+I+ EL E G L + V+ +
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVASLIDMACQVA 114
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YM 226
E + EQ +HRDL N L E K DFGL+ + + PY +
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT 171
Query: 227 APEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + + DVWS G++LY + G P+ V I
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 67/237 (28%), Positives = 98/237 (41%), Gaps = 39/237 (16%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQI 109
++I+ + +G GEFG G+K ++ K L+ + D E I
Sbjct: 5 YVTIE----KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASI 58
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTE-------RAAA 160
M HPNI+ L+ V I+ E E G L F R G +T R A
Sbjct: 59 MGQF-DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIA 116
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQFNE 218
+ MK + E+ V HRDL N L +S L K DFGLS E
Sbjct: 117 SGMKYLSEMNYV-------HRDLAARNILV-----NSNLVCKVSDFGLSRRLEDSEATYT 164
Query: 219 IVG--SPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
G P + APE + R + DVWS G++++ ++ G P+W + Q V +A+
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 67/299 (22%)
Query: 67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126
G G + C D E K+ + T E I++ + HP+I+ LK T+
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRGGTAT---------EAHILRAI-NHPSIIQLKGTF 152
Query: 127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE 186
+ +++ + +L+ + A+ + A+ ++++ +Q HE ++HRD+K E
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAE 211
Query: 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--------MAPEVLKRN-YGP 237
N +F N L DFG + F P +I + YY APE+L R+ YGP
Sbjct: 212 N-IFINHPGDVCLG--DFGAACF--P----VDINANKYYGWAGTIATNAPELLARDPYGP 262
Query: 238 EVDVWSAGVILY----------------------------ILLCGVPP--FWAETEQGVA 267
VD+WSAG++L+ I G P F + + +
Sbjct: 263 AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322
Query: 268 QAIIRSVIDFKRDP-----WPKVSENAKD---LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ I R P W + E D L+ KML D R +AE +L+ Q+
Sbjct: 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ ELG G GV +G A K I +++ A+ + RE+Q++ H
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HECNS 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV + D + I ME +GG L + E V ++ + E+
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAPEVL 231
+MHRD+KP N L ++ E +K DFG+S G+ N VG+ YM+PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL 174
Query: 232 K-RNYGPEVDVWSAGVILYILLCG---VPP 257
+ +Y + D+WS G+ L L G +PP
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 67/250 (26%), Positives = 106/250 (42%), Gaps = 49/250 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LG +G GEFG V GE + + ++ K ++ V + E +M L H N+
Sbjct: 10 LGEIIGEGEFG------AVLQGE-YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNL 61
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH----- 174
V L + ++IVMEL G L + + RG RA +V++ + + V
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116
Query: 175 -EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
+ ++HRDL N L + E K DFGL+ G +++ + APE LK
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKH 171
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN-AKD 291
+ + DVWS GV+L+ V + R P+PK+S K+
Sbjct: 172 KKFSSKSDVWSYGVLLW-----------------------EVFSYGRAPYPKMSLKEVKE 208
Query: 292 LVKKMLNPDP 301
V+K +P
Sbjct: 209 CVEKGYRMEP 218
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 67/278 (24%), Positives = 101/278 (36%), Gaps = 37/278 (13%)
Query: 60 LGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
L R LG G FG Y + + + + + D D E IM H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV----EVVQV 172
NIV L + I++EL GG+L + ER ++ MK ++ +V +
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 173 CH---EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
C E +HRD+ N L K K DFG++ +I + YY
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKGG 179
Query: 226 --------MAPEV-LKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI 275
M PE L + + DVWS GV+L+ I G P+ T Q V + +
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG- 238
Query: 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ DP ++ P+ R +LE
Sbjct: 239 --RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 67/215 (31%), Positives = 93/215 (43%), Gaps = 49/215 (22%)
Query: 64 LGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LG+G FG LC N GE A K K + TA + D RE++I+K L +H NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSL-QHDNI 67
Query: 120 VSLKDT-YEDDSA----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
V K Y SA + +VME G L D + + K ++ Q+C
Sbjct: 68 VKYKGVCY---SAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-----KLLLYASQICK 119
Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS----------VFFRPGEQFNE 218
+ +HRDL N L ++ + +K DFGL+ PGE
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVLPQDKEYYKVREPGE---- 172
Query: 219 IVGSP-YYMAPEVLKRN-YGPEVDVWSAGVILYIL 251
SP ++ APE L + + DVWS GV+LY L
Sbjct: 173 ---SPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 73/312 (23%), Positives = 137/312 (43%), Gaps = 58/312 (18%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+ + Y++ L G G ++CT +K K+++ K RE+ I+K
Sbjct: 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILK 141
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
+ H I++L Y S V +VM + +LF + G A + + ++E +
Sbjct: 142 TI-SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALA 199
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE-----IVGSPYYM 226
H +G++HRD+K EN +F ++ E++ L DFG + + + G+
Sbjct: 200 YLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLDAHPDTPQCYGWSGTLETN 254
Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ--AIIRSV----IDF- 277
+PE+L + Y + D+WSAG++L+ + + V F + + +Q +IIR + ++F
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314
Query: 278 -----------------KRDPW--PKV------SENAKDLVKKMLNPDPKQRLTAEEVLE 312
R P+ P V + + L+ KML D + R +A+++L
Sbjct: 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374
Query: 313 HPWLQNAKKAPN 324
P K+ N
Sbjct: 375 LPLF--TKEPIN 384
|
Length = 392 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 16/209 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D + +LG G++G Y A K++ + + +E+ +E +MK + KH
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KH 61
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV-MKT-IVEVVQVCH 174
PN+V L + +I+ E G L D + A + M T I ++
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVL 231
++ +HRDL N L E+ +K DFGLS G+ + G+ + + APE L
Sbjct: 122 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 177
Query: 232 KRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
N + + DVW+ GV+L+ I G+ P+
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 51/286 (17%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDI--EDVRREVQIMKHLPKH 116
L RELG G FG +L + + + ++ K L+ TA + +D RE +++ + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVEVV 170
NIV + +V E E G+L R H + A T+ +++
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNK--FLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 171 QVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
Q+ + Q +HRDL N L +K DFG+S ++
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---------RDVY 173
Query: 221 GSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 266
+ YY M PE ++ R + E DVWS GV+L+ I G P++ + + V
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
+ I + + + P D++ DP+QR+ +++ E
Sbjct: 234 IECITQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 58/213 (27%), Positives = 85/213 (39%), Gaps = 33/213 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
++G+G FG Y + + A K+ + +E +I+K HPNIV
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTC--RSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC------HE 175
L ++IVMEL GG L + ++ V K + +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY------YMAPE 229
+ +HRDL N L E++ LK DFG+S R E V + APE
Sbjct: 112 KNCIHRDLAARNCLVG---ENNVLKISDFGMS---REEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 230 VLKRNYG---PEVDVWSAGVILY-ILLCGVPPF 258
L NYG E DVWS G++L+ G P+
Sbjct: 166 AL--NYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 33/278 (11%)
Query: 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR---EVQIMKHLPK 115
DLG E+GRG FG +G A K I R+ VD ++ +R ++ ++
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGG-ELFDRIV---ARGHYTERAAAAVMKTIVEVVQ 171
P IV + I MEL + + F + V + E + V+ +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 172 VCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----VGSPYY 225
E+ ++HRD+KP N L + +K DFG+S G+ + I G Y
Sbjct: 122 YLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPY 173
Query: 226 MAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVIDFKR 279
MAPE + + Y DVWS G+ LY + G P+ W + Q +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSN 233
Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ S + + + L D +R +E+LEHP+++
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 77/266 (28%), Positives = 114/266 (42%), Gaps = 29/266 (10%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L R+LG G+FG ++ T N K A K++ + E +E QIMK L +H +
Sbjct: 10 LERKLGAGQFGEVWMGT-WNGTTKVAVKTLKP----GTMSPEAFLQEAQIMKKL-RHDKL 63
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT-IVEVVQVCHEQG 177
V L ++ ++IV E G L D + G M I E + +
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
+HRDL N L E+ K DFGL+ E + G+ + + APE N
Sbjct: 124 YIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAA--N 177
Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
YG + DVWS G++L I+ G P+ T + V + + R R P P E
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY----RMPRPPNCPEEL 233
Query: 290 KDLVKKMLNPDPKQRLTAE---EVLE 312
DL+ + + DP++R T E LE
Sbjct: 234 YDLMLQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVM 163
+E +I+K HPNIV L ++IVMEL +GG+ + G + ++
Sbjct: 42 QEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
+ ++ + +HRDL N L E + LK DFG+S E+ + + S
Sbjct: 101 ENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMS-----REEEDGVYAST 152
Query: 224 --------YYMAPEVLKRNYG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
+ APE L NYG E DVWS G++L+ G P+ + Q +AI
Sbjct: 153 GGMKQIPVKWTAPEAL--NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE 210
Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNP----DPKQR 304
+ V R P P E D V +++ DP QR
Sbjct: 211 QGV----RLPCP---ELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----------EDVRREVQIMK 111
+ +G GEFG +V +G K K+++ A+ D E IM
Sbjct: 10 KVIGAGEFG------EVCSGR---LKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEV 169
HPNI+ L+ V IV E E G L D + + G +T +++ I
Sbjct: 61 QF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASG 118
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFR--PGEQFNEIVGS-PY 224
++ + G +HRDL N L +S L K DFGLS P + G P
Sbjct: 119 MKYLSDMGYVHRDLAARNILV-----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
+ APE + R + DVWS G++++ ++ G P+W + Q V +AI
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 36/271 (13%)
Query: 58 YDLGRELGRGEFGV---TYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
+ LGR LG+GEFG L ++ + +K A K + K + ++ DIE+ RE MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58
Query: 115 KHPNI-----VSLKDTYEDDSAVHIV-MELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
HPN+ VSL+ + + +V + + G+L ++ E ++T+V
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM-SRIGEEPFTLPLQTLVR 117
Query: 169 -VVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
++ + + +HRDL N + E+ + DFGLS G+ + +
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 222 SPY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVI- 275
S ++A E L N Y DVW+ GV ++ I+ G P+ GV + I + +
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLI 229
Query: 276 --DFKRDPWPKVSENAKDLVKKMLNPDPKQR 304
+ + P P E+ +L+ + +P+PK R
Sbjct: 230 KGNRLKQP-PDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 60 LGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
LG+ LG G FG + + N K A K + K T D+ D+ E+++MK
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKM 79
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG------HYTERAAAAVMKTI 166
+ KH NI++L D +++++E G L + + AR Y +
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 167 VEVVQVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
++V ++ + +HRDL N L E + +K DFGL+ + +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDYY 196
Query: 217 NEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
+ +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR----EVQIMKHLPKHPNI 119
+G GEFG G++ +I K L++ E RR E IM HPNI
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAI--KTLKSGYT-EKQRRDFLSEASIMGQF-DHPNI 67
Query: 120 VSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+ L+ V I+ E E G L F R G +T +++ I ++ E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 178 VMHRDLKPENFLFANKKESSPL--KAIDFGLSVFFRPGEQ---FNEIVGSPY---YMAPE 229
+HRDL N L +S L K DFGLS F + +G + APE
Sbjct: 127 YVHRDLAARNILV-----NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 230 VLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
+ R + DVWS G++++ ++ G P+W + Q V AI
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACK--SISKKKLR---TAVDIEDVRREVQIMKHLP 114
LG+ LG G FG + + + K +++ K L+ T D+ D+ E+++MK +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
KH NI++L D +++++E G L + + AR T +
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
+ + ++ Q +HRDL N L E + +K DFGL+ + + +
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVHNIDYYKK 192
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
+MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 60 LGRELGRGEFG--VTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
LG+ LG G FG V ++ + +++ K L+ T D+ D+ E+++MK +
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
KH NI++L D +++++E G L + + AR T +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
+ + ++ Q +HRDL N L E++ +K DFGL+ + + +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNNIDYYKK 195
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
+MAPE L R Y + DVWS GV+++ I G P+
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 45/232 (19%)
Query: 60 LGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LG+ LG G FG V N E K T D+ D+ E+++MK + KH
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR---GHYTERAAAAVMK---TIVEVV 170
NI++L + +++V+E G L D + AR G Y + T ++V
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 171 QVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
++ + +HRDL N L E +K DFGL+ +I
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA---------RDIH 183
Query: 221 GSPYY------------MAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
YY MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 81/305 (26%), Positives = 113/305 (37%), Gaps = 63/305 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVN-----------NGEKFACKSISKKKLRTAVDI---EDVRR 105
+LG G+FG +LC N A ++ K LR ED +
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV--- 162
EV+I+ L PNI L D + ++ME E G+L + T A
Sbjct: 69 EVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 163 -------MKT-IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
M T I ++ +HRDL N L + +K DFG+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMS------- 177
Query: 215 QFNEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-IL-LCGVPPFW 259
+ S YY MA E VL + + DVW+ GV L+ IL LC P+
Sbjct: 178 --RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 260 AETEQGVAQAIIRSVIDFKRD---PWPKVSENAKDLVKKMLN---PDPKQRLTAEEVLEH 313
T+Q V + D R P P KD+ + ML D + R T E+ H
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNC--PKDIYELMLECWRRDEEDRPTFREI--H 291
Query: 314 PWLQN 318
+LQ
Sbjct: 292 LFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 27/269 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ L + +G+GEFG DV G+ + ++ K ++ + E +M L +H
Sbjct: 7 ELKLLQTIGKGEFG------DVMLGD-YRGNKVAVKCIKNDATAQAFLAEASVMTQL-RH 58
Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK---TIVEVVQV 172
N+V L E+ ++IV E G L D + +RG + ++K + E ++
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEY 117
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-YMAPEVL 231
+HRDL N L + E + K DFGL+ + + P + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 171
Query: 232 K-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+ + + + DVWS G++L+ I G P+ + + R +K D
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY---PRIPLKDVVPRVEKGYKMDAPDGCPPVV 228
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
D++K+ + D R + ++ E L++
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLRE--QLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 48/224 (21%)
Query: 62 RELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHP 117
R +G+G FG Y T + ++G+K C + K L D+E+V +E IMK HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHC---AVKSLNRITDLEEVEQFLKEGIIMKDF-SHP 56
Query: 118 NIVSLKD-TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-- 174
N++SL + + +V+ + G+L + I +E V I +QV
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGM 111
Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
+ +HRDL N + ES +K DFGL+ +I YY
Sbjct: 112 EYLASKKFVHRDLAARNCML---DESFTVKVADFGLA---------RDIYDKEYYSVHNH 159
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPF 258
MA E L+ + + + DVWS GV+L+ L+ G PP+
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 72/261 (27%), Positives = 112/261 (42%), Gaps = 47/261 (18%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG+G FG + T + + A K+ K+ L + I+ + E +I+K HPNIV L
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCHEQGVMH 180
++IVMEL GG+ + R E ++K ++ + + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLS------VFFRPGEQFNEIVGSPYYMAPEVLKRN 234
RDL N L E++ LK DFG+S ++ G + I + APE L N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167
Query: 235 YG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-------------------II 271
YG E DVWS G++L+ GV P+ T Q + ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 272 RSVIDFKRDPWPKVSENAKDL 292
+ D+K + PK SE K+L
Sbjct: 228 QRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 57/287 (19%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
L RELG+G FG+ Y L V GE A K++++ + + + E +MK
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF- 66
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC- 173
++V L +VMEL G+L + +R E T+ + +Q+
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 174 ---------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
+ +HRDL N + A E +K DFG++ +I + Y
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---------RDIYETDY 174
Query: 225 Y------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA-QA 269
Y MAPE LK + + DVWS GV+L+ + P+ QG++ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSNEE 229
Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNP----DPKQRLTAEEVLE 312
+++ VID P EN D + +++ +PK R T E++
Sbjct: 230 VLKFVIDGGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKH 116
G+ LG G FG T + A ++ K L+ E + E++IM HL H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT---------IV 167
NIV+L + ++ E C G+L + + R + + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLN-------FLRRKRESFLTLEDLLSFSYQVA 151
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL-------SVFFRPGEQFNEIV 220
+ + + +HRDL N L + K +K DFGL S + G +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSNYVVKGNARLPV- 207
Query: 221 GSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
+MAPE + Y E DVWS G++L+ I G P+
Sbjct: 208 ---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 35/291 (12%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHP 117
L RELG G FG +L N + ++ K L+ A D +D RE +++ +L +H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHE 67
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-------------HYTERAAAAVMK 164
+IV + + +V E + G+L + A G T+ + +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFRPGEQFNE 218
I + Q +HRDL N L E+ +K DFG+S ++R G
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYSTDYYRVG---GH 181
Query: 219 IVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
+ +M PE ++ R + E DVWS GV+L+ I G P++ + V + I + +
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL 241
Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
+ P + DL+ +P RL +E+ H LQN KA V L
Sbjct: 242 QRPRTCP---KEVYDLMLGCWQREPHMRLNIKEI--HSLLQNLAKASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 65/255 (25%), Positives = 107/255 (41%), Gaps = 42/255 (16%)
Query: 74 LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAV 132
L D + F K LR + + R + +P PN+V L + +V
Sbjct: 11 LVMDTRTQQTFILKG-----LRKSSEYSRERLTI-----IPHCVPNMVCLHKYIVSEDSV 60
Query: 133 HIVMELCEGGELFDRIVARGHYTE---RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189
+V++ EGG+L+ I + E + AA M ++ + H +G++ RDL P N L
Sbjct: 61 FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNIL 117
Query: 190 FANKKESSPLKAIDFGLSVFFRPGEQFNEIVG---SPYYMAPEVLKRNYGPEV-DVWSAG 245
++ L+ F R E + G Y APEV + E D WS G
Sbjct: 118 LDDRGH--------IQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLG 169
Query: 246 VILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305
IL+ LL G G+ ++ ++ VSE A+ L++++L +P +RL
Sbjct: 170 AILFELLTGKTLVECHP-SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERL 221
Query: 306 TA-----EEVLEHPW 315
A E++ HP+
Sbjct: 222 GAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---F 216
AV + ++ + H +G++HRD+K EN + N E L DFG + F R
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFH 319
Query: 217 NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 249
I G+ APEVL + Y P VD+WSAG++++
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 57/293 (19%)
Query: 62 RELGRGEFGVTY--LCTDVNNGE---KFACKSISKK-KLRTAVDIEDVRREVQIMKHLPK 115
RELG+G FG+ Y D+ GE + A K++++ LR ++ + E +MK
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASVMKGFTC 68
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
H ++V L +VMEL G+L + + E T+ E++Q+ E
Sbjct: 69 H-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 176 ----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
+ +HRDL N + A +K DFG++ +I + YY
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMT---------RDIYETDYY 175
Query: 226 ------------MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAII 271
MAPE LK + D+WS GV+L+ + + QG++ + ++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW----EITSLAEQPYQGLSNEQVL 231
Query: 272 RSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE------HPWLQ 317
+ V+D P E DL++ +PK R T E++ HP
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 62/269 (23%), Positives = 110/269 (40%), Gaps = 32/269 (11%)
Query: 64 LGRGEFGVTYLC----TDVNNGEKF-ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
LGRGEFG +L + GE K++ K K + RRE+ + + L H N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGEL--FDRIVARGHYTERAAAAVMKTIVEVV-QVCH- 174
+V L + ++++E + G+L F R + K V + Q+
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPYYMA 227
+HRDL N L ++++E +K LS V+ + + ++A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 228 PE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
PE V + ++ + DVWS GV+++ + G PF+ +++ V + + P
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----LQAGKLELPVP 241
Query: 286 SENAKDLVKKMLN---PDPKQRLTAEEVL 311
L K M +PK R + E++
Sbjct: 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 21/220 (9%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
++LG G+FG ++ NN K A K++ + +E E +MK L +H +V
Sbjct: 12 KKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-QHDKLVR 65
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVM 179
L + ++I+ E G L D + + G I E + + +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRNYG 236
HRDL+ N L + ES K DFGL+ E + G+ + + APE + N+G
Sbjct: 126 HRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--NFG 179
Query: 237 P---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
+ DVWS G++LY I+ G P+ + V A+ R
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 20/219 (9%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISK-KKLRTAVDIEDVRREVQIMKHLPKHPNIVSL 122
+G GEFG + G K +I K T +D E IM H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRL 71
Query: 123 KDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMH 180
+ I+ E E G L D+ + G ++ +++ I ++ + +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY-------YMAPEVLK- 232
RDL N L + E K DFGLS R E E + + APE +
Sbjct: 131 RDLAARNILVNSNLEC---KVSDFGLS---RVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 233 RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
R + DVWS G++++ ++ G P+W + V +AI
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 48/286 (16%)
Query: 57 DYDLGRELGRGEFGVTYL--CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
D L RELG G FG +L C +++ + ++ K T +D +RE +++ +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL- 64
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGEL--FDR--------------IVARGHYTERA 158
+H +IV D + +V E + G+L F R A+G
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
+ I + Q +HRDL N L + +K DFG+S +
Sbjct: 125 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDFGMS---------RD 172
Query: 219 IVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
+ + YY M PE ++ R + E DVWS GVIL+ I G P++ +
Sbjct: 173 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
V + I + + + PK D++ +P+QRL +E+
Sbjct: 233 EVIECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 53/241 (21%), Positives = 96/241 (39%), Gaps = 46/241 (19%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI---EDVRREVQIMKHLPKHPNI 119
ELG FG Y ++++ K L+ + E+ + E + L +HPNI
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNI 70
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA---AVMKTIVEVVQVCH-- 174
V L + + ++ C +L + +V R +++ + +K+ +E H
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 175 -----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
V+H+DL N L +K +K D GL F E+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYAAD 178
Query: 224 YY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
YY M+PE ++ + + D+WS GV+L+ + G+ P+ + Q V +
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
Query: 270 I 270
I
Sbjct: 239 I 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 60 LGRELGRGEFG--VTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
LG+ LG G FG V ++ +++ K L+ T D+ D+ E+++MK +
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERA 158
KH NI++L + +++++E G L + + AR + +
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
+ + ++ + +HRDL N L E + +K DFGL+ + + +
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDYYKK 192
Query: 219 IVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 258
+MAPE L R Y + DVWS G++++ I G P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 17/194 (8%)
Query: 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-VRREVQIMKHLPKHPNIV 120
+ELG G+FGV V G+ ++ K ++ ED E ++M L H +V
Sbjct: 10 KELGTGQFGV------VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLV 62
Query: 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-KTIVEVVQVCHEQGVM 179
L ++IV E G L + + G + + M K + E + + +
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKR-NY 235
HRDL N L + +K DFGLS + +++ VGS + + PEVL +
Sbjct: 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKF 178
Query: 236 GPEVDVWSAGVILY 249
+ DVW+ GV+++
Sbjct: 179 SSKSDVWAFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G FG +G K K+ + D D E++++ L HPNI++L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 124 DTYEDDSAVHIVMELCEGGELFD-----RIV------ARGHYTERAAAA--VMKTIVEV- 169
E+ ++I +E G L D R++ A+ H T + +++ +V
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 170 --VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGS-PY 224
+Q E+ +HRDL N L S K DFGLS GE+ + +G P
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGENLAS---KIADFGLS----RGEEVYVKKTMGRLPV 182
Query: 225 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
+MA E L + Y + DVWS GV+L+ + L G P
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 11/193 (5%)
Query: 63 ELGRGEFG-VTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121
ELG G FG V + EK I K +++ RE +M+ L +P IV
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVR 60
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ E +S + +VMEL E G L + H TE+ ++ + ++ E +HR
Sbjct: 61 MIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS---PY-YMAPEVLK-RNYG 236
DL N L + + K DFGLS E + + P + APE + +
Sbjct: 120 DLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 237 PEVDVWSAGVILY 249
+ DVWS GV+++
Sbjct: 177 SKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 72/259 (27%), Positives = 111/259 (42%), Gaps = 27/259 (10%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L ++LG G+FG ++ N K A KS+ + + E E +MK L +HP +
Sbjct: 10 LVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRL 63
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT-IVEVVQVCHEQG 177
V L + ++I+ E E G L D + G M I E + +
Sbjct: 64 VRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
+HRDL+ N L + E+ K DFGL+ E + G+ + + APE + N
Sbjct: 123 YIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAI--N 176
Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENA 289
YG + DVWS G++L I+ G P+ T V Q + R R P P E
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY----RMPRPDNCPEEL 232
Query: 290 KDLVKKMLNPDPKQRLTAE 308
+L++ P++R T E
Sbjct: 233 YELMRLCWKEKPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G FG +G + K+ + D D E++++ L HPNI++L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 124 DTYEDDSAVHIVMELCEGGELFD-----RIV------ARGHYT-----ERAAAAVMKTIV 167
E +++ +E G L D R++ A + T + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGS-PY 224
+ ++ +HRDL N L + K DFGLS G++ + +G P
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVGENYVA---KIADFGLS----RGQEVYVKKTMGRLPV 175
Query: 225 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
+MA E L + Y DVWS GV+L+ + L G P
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 52/275 (18%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+ RG+ G +Y + NG +F K I+ + +I D+ + +HPNIV L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKL--------QHPNIVKLI 749
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH---EQGVMH 180
+ +++ E EG L + V R ER + I + ++ H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 181 RDLKPENFLFANKKE-----SSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN 234
+L PE + K E S P L D + S Y+APE +
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFI-------------SSAYVAPETRETK 853
Query: 235 YGPE-VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVIDFKRDPW------P 283
E D++ G+IL LL G P A+ E GV +I+ D D W
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911
Query: 284 KVSENAKDLVKKM---LN---PDPKQRLTAEEVLE 312
VS N ++V+ M L+ DP R A +VL+
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 62/258 (24%), Positives = 111/258 (43%), Gaps = 25/258 (9%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L ++LG G+FG ++ T N K A K++ + + E +MK L +H +
Sbjct: 10 LEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTL-QHDKL 63
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV--MKTIVEVVQVCHEQG 177
V L + ++I+ E G L D + + + + I E + ++
Sbjct: 64 VKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPEVLKRN 234
+HRDL+ N L + S K DFGL+ E + G+ + + APE + N
Sbjct: 123 YIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAI--N 176
Query: 235 YGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
+G + DVWS G++L I+ G P+ + V +A+ R + + P E
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP---EELY 233
Query: 291 DLVKKMLNPDPKQRLTAE 308
+++ + P++R T E
Sbjct: 234 NIMMRCWKNRPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 40/204 (19%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKK-KLRTAVDI---EDVRREV--QIM 110
D+ LG++LG G FGV Y + VN K K + KK AV+I E VRR
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCA 192
Query: 111 KHLPKHPNIVSLKD--------TYEDDSAVHIVME------------LCEGGELFDRIVA 150
+ VS K YE +S + +M+ L + +L
Sbjct: 193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL-----P 247
Query: 151 RGHYTERAAA---AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
+G ER +M+ I+ + H G++HRD+KP+N +F+ S K ID G +
Sbjct: 248 KG--LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAA 303
Query: 208 VFFRPGEQF--NEIVGSPYYMAPE 229
R G + E + P Y APE
Sbjct: 304 ADLRVGINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 66/255 (25%), Positives = 112/255 (43%), Gaps = 32/255 (12%)
Query: 43 LCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI-- 100
L +LKE + I + LG G FG Y + GEK ++ K+LR A
Sbjct: 1 LRILKETEFKKIKV-------LGSGAFGTVYKGLWIPEGEKVKI-PVAIKELREATSPKA 52
Query: 101 -EDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA 159
+++ E +M + +P++ L S V ++ +L G L D + R H +
Sbjct: 53 NKEILDEAYVMASV-DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGS 108
Query: 160 AAVMKTIVEVVQ---VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
++ V++ + E+ ++HRDL N L + +K DFGL+ E+
Sbjct: 109 QYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKE 165
Query: 217 NEIVGSPY---YMAPE-VLKRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271
G +MA E +L R Y + DVWS GV ++ L+ G P+ G+ + I
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEI 220
Query: 272 RSVIDF-KRDPWPKV 285
S+++ +R P P +
Sbjct: 221 SSILEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 49/258 (18%)
Query: 63 ELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDI----------EDVRREVQ 108
+LG G+FG +LC VN + +F + L AV I D +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA--------A 160
I+ L K PNI+ L D+ + ++ E E G+L ++ ++ H ++ A
Sbjct: 72 ILSRL-KDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 161 AVMKTIVE------VVQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
+ I +Q+ +HRDL N L E+ +K DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTIKIADFGMSR 186
Query: 209 FFRPGEQF---NEIVGSPYYMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAET 262
G+ + V +MA E +L + DVW+ GV L+ ++LC P+ T
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246
Query: 263 EQGVAQAIIRSVIDFKRD 280
++ V I + +F RD
Sbjct: 247 DEQV----IENAGEFFRD 260
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 50/243 (20%)
Query: 63 ELGRGEFGVTY----LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118
ELG FG Y +++ + A K++ K + + ++E +M L HPN
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE---------- 168
IV L + V ++ E G+L + ++ R +++ ++ V+
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 169 -VVQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
+Q+ +H+DL N L E +K D GLS EI
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176
Query: 222 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
+ YY M PE ++ + + D+WS GV+L+ I G+ P++ + Q V
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236
Query: 268 QAI 270
+ +
Sbjct: 237 EMV 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LG+ LG GEFG L D + K A K++ K + T +IE+ E MK H
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDF-DH 60
Query: 117 PNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVAR------GHYTERAAAAVMK 164
PN++ L + + +++ + G+L ++ + M
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGS 222
I ++ + +HRDL N + E + DFGLS G+ + + I
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLR---EDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 223 PY-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
P ++A E L Y + DVW+ GV ++ I G P+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 64/252 (25%), Positives = 102/252 (40%), Gaps = 40/252 (15%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKS---------ISKKKLRTAVDI---EDVRREV 107
L +LG G+FG +LC E + ++ K LR V D +E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAA------A 161
+IM L K+PNI+ L D + ++ E E G+L + R + A +
Sbjct: 69 KIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 162 VMKTIVEVVQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
+ + VQ+ +HRDL N L N +K DFG+S G+
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLYSGDY 184
Query: 216 FNEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 268
+ I G +MA E +L + DVW+ GV L+ LC P+ +++ V
Sbjct: 185 Y-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV-- 241
Query: 269 AIIRSVIDFKRD 280
I + +F R+
Sbjct: 242 --IENTGEFFRN 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 74/290 (25%), Positives = 123/290 (42%), Gaps = 53/290 (18%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKS------------ISKKKLRTAVDI---EDVRREV 107
+LG G+FG +LC + EKF K ++ K LR + D +E+
Sbjct: 12 KLGEGQFGEVHLC-EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT-- 165
+IM L K PNI+ L + ++ E E G+L ++ ++R E A A + T
Sbjct: 71 KIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTIS 128
Query: 166 ----------IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
I ++ +HRDL N L ++ +K DFG+S G+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADFGMSRNLYSGDY 185
Query: 216 FNEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 268
+ I G +M+ E +L + DVW+ GV L+ + LC P+ +++ V
Sbjct: 186 Y-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-- 242
Query: 269 AIIRSVIDFKRDP-----WPKVSENAKDLVKKMLN---PDPKQRLTAEEV 310
I + +F RD PK + L K ML+ + K+R + +E+
Sbjct: 243 --IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 31/203 (15%)
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----------EDVRREVQIMKH 112
ELG G FG K + KK++ A+ + +++ RE +IM
Sbjct: 2 ELGSGNFGCV----------KKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQ 171
L +P IV + E + A+ +VME+ GG L + + T +M + ++
Sbjct: 52 L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMK 109
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS---PY-YMA 227
+ +HRDL N L N+ + K DFGLS + + + + P + A
Sbjct: 110 YLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKWPLKWYA 166
Query: 228 PE-VLKRNYGPEVDVWSAGVILY 249
PE + R + DVWS G+ ++
Sbjct: 167 PECINFRKFSSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 42/234 (17%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
LG+ LG GEFG T + +++ K L+ ++ ++ D+ E ++K + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGEL-----FDRIVARGHYTERAA------------ 159
P+++ L D + +++E + G L R V +
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 160 AAVMKTIVEVV-QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
A M ++ Q+ E ++HRDL N L A ++ +K DFGLS R
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLS---RD 176
Query: 213 GEQFNEIVGSPY------YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPF 258
+ + V +MA E L + Y + DVWS GV+L+ I+ G P+
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKHP 117
+ LG G FG Y + GEK ++ K LR +++ E +M + HP
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMASV-DHP 69
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV---VQVCH 174
++V L S V ++ +L G L D + R H + ++ V++ +
Sbjct: 70 HVVRLLGICLS-SQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLE 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY---YMAPE-V 230
E+ ++HRDL N L K +K DFGL+ E+ G +MA E +
Sbjct: 127 EKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 231 LKRNYGPEVDVWSAGVILYILL 252
L R Y + DVWS GV ++ L+
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 7e-06
Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 5/73 (6%)
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
VM+ ++ ++ H G++HRD+KPEN L + +K IDFG +V G FN +
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLY 369
Query: 221 G--SPYYMAPEVL 231
G P Y PE L
Sbjct: 370 GMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR------------EV 107
+ RELG+G FG+ Y E A K + K + T V I+ V E
Sbjct: 10 MSRELGQGSFGMVY--------EGIA-KGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
+MK H ++V L ++MEL G+L + + E ++
Sbjct: 61 SVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 168 EVVQVCHE----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSV------FFR 211
+++Q+ E +HRDL N + A E +K DFG++ ++R
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYYR 176
Query: 212 PGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
G + V +M+PE LK + DVWS GV+L+ I P+ + + V +
Sbjct: 177 KGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233
Query: 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
++ + K D P + +L++ +PK R + E++
Sbjct: 234 VMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNE- 218
A+MK ++ V+ H++ ++HRD+K EN +F N L DFG ++ F + E F+
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327
Query: 219 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVIL 248
VG+ +PE+L + Y D+WS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 57/244 (23%), Positives = 94/244 (38%), Gaps = 52/244 (21%)
Query: 62 RELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIE-DVRREVQIMKHLPKHPN 118
R++G+G FG + + E F ++ K + D++ D +RE +M HPN
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPN 69
Query: 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT----------IVE 168
IV L + ++ E G+L + + R + + + + +
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 169 VVQVCHEQGV------------MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
Q+C + V +HRDL N L E+ +K DFGLS
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS--------- 177
Query: 217 NEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAET 262
I + YY M PE + Y E DVW+ GV+L+ I G+ P++
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237
Query: 263 EQGV 266
+ V
Sbjct: 238 HEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 55/298 (18%)
Query: 52 QDISIDYDLGRELGRGEFGVTYL--CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+DI + + ELG G FG +L C ++ + ++ K + +D +RE ++
Sbjct: 5 RDIVLKW----ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMK-- 164
+ L +H +IV + + +V E G+L + + G
Sbjct: 61 LTVL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 165 TIVEVVQVCHEQG----------VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
T+ +++ + + +HRDL N L + +K DFG+S
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGDFGMS------- 169
Query: 215 QFNEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWA 260
+I + YY M PE +L R + E D+WS GV+L+ I G P W
Sbjct: 170 --RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WY 226
Query: 261 ETEQGVAQAIIRSVIDFKRDPWPKVSEN-AKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ A I + +R P+ +++ +P+QR+ +++ H LQ
Sbjct: 227 QLSNTEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDI--HSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 80/349 (22%), Positives = 132/349 (37%), Gaps = 91/349 (26%)
Query: 51 GQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
G+DI + + + LG G FG D E A K + T D + E+
Sbjct: 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYT----RDAKIEI 176
Query: 108 QIMKHL------PKHPNIVSLKDTYEDDSA-VHIVMELCEGGELFDRIVARGHYTERAAA 160
Q M+ + + P ++ ++ +++++ + IVM G L D I+ G ++ R A
Sbjct: 177 QFMEKVRQADPADRFP-LMKIQRYFQNETGHMCIVMPK-YGPCLLDWIMKHGPFSHRHLA 234
Query: 161 AVMKTIVEVVQVCH-EQGVMHRDLKPENFLF---------ANKKESSP----LKAIDFGL 206
++ + H E +MH DLKPEN L + P ++ D G
Sbjct: 235 QIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294
Query: 207 SVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYIL-------------- 251
R IV + +Y +PEV L + D+WS G I+Y L
Sbjct: 295 CCDERHSR--TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352
Query: 252 --------LCGVPPFWAE---TEQG---------------------VAQAIIRSVIDFKR 279
L +P WA TE+ +A+A R V + R
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA--RPVREVIR 410
Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN----AKKAPN 324
D DL+ +L+ D ++RL A ++ HP++ ++ PN
Sbjct: 411 DDL------LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPN 453
|
Length = 467 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+G G FG +G + K+ + D D E++++ L HPNI++L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 124 DTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKT--IVEVVQVCH------ 174
E +++ +E G L D + +R T+ A A T + Q+ H
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 175 -------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGS-PY- 224
++ +HRDL N L E+ K DFGLS R E + + +G P
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS---RGQEVYVKKTMGRLPVR 188
Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 256
+MA E L + Y DVWS GV+L+ + L G P
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 61 GRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ LG G FG + + G+ A K+I + R +++ + M L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT--FQEITDHMLAMGSL-DH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ---VC 173
IV L +++ +V +L G L D + R H ++ V++ +
Sbjct: 69 AYIVRLLGICPG-ASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPE- 229
E ++HR+L N L K S ++ DFG++ P ++ ++E +MA E
Sbjct: 126 EEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 230 VLKRNYGPEVDVWSAGVILYILLC-GVPPF 258
+L Y + DVWS GV ++ ++ G P+
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 40/169 (23%), Positives = 65/169 (38%), Gaps = 28/169 (16%)
Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
E AV + ++ H Q L + L G SV F+ EQ
Sbjct: 16 EEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL-----------DG-SVAFKTPEQ 63
Query: 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
PY+MAPEV++ +Y + D++S G+ LY L P E+ AI+ +
Sbjct: 64 SR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP---YNEERELSAILEIL 117
Query: 275 IDF-------KRDPWPKVSE--NAKDLVKKMLNPDPKQRLTAEEVLEHP 314
++ R VS + +D ++ + P++R A L H
Sbjct: 118 LNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHC 166
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 27/123 (21%), Positives = 46/123 (37%), Gaps = 20/123 (16%)
Query: 92 KKLRTAVDIEDVRREVQIMKHLPKH----PNIVSLKDTYEDDSAVHIVMELCEGGELFDR 147
K + D REV I++ L + P ++ + E D +++ME EG L +
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVL---ASGESDGWSYLLMEWIEGETLDEV 83
Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDF 204
A ++ + H+ + H DL P N L + K L ID+
Sbjct: 84 SEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILVDDGKI---LGIIDW 133
Query: 205 GLS 207
+
Sbjct: 134 EYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238008 cd00051, EFh, EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-05
Identities = 13/44 (29%), Positives = 25/44 (56%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L+EAF + D + G I+ +EL+ L G+ + E ++ ++ V
Sbjct: 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREV 45
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. Length = 63 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
LG+ LG GEFG ++ K A K++ K + T ++ED E MK HP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEF-DHP 60
Query: 118 NIVSLK----DTYEDDS--AVHIVMELCEGGEL-----FDRIVARGHY-TERAAAAVMKT 165
N++ L T E + + +++ + G+L + R+ Y + M
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSP 223
I ++ + +HRDL N + E+ + DFGLS G+ + + I P
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 224 Y-YMAPEVL-KRNYGPEVDVWSAGVILY 249
++A E L R Y + DVWS GV ++
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 23/169 (13%)
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT----ERAAAA 161
E+ + K L HPNIV + T+ D+ + +V G D I H+ E A A
Sbjct: 49 ELHVSK-LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAY 105
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFA--NKKESSPLKAIDFGLSVFFRPGEQFNEI 219
+++ +++ + H G +HR +K + L + K S L++ LS+ G++ +
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN---LSM-INHGQRLRVV 161
Query: 220 VGSPYY-------MAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 258
P Y ++PEVL++N Y + D++S G+ L G PF
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 16/143 (11%)
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPY-YMAPE-VLKRN 234
+HRDL N L + E++ +K DFGL+ ++ P P +MAPE + R
Sbjct: 201 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 257
Query: 235 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
Y + DVWS GV+L+ I G P+ + + R + + R P + ++
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASPY---PGVKIDEEFCRRLKEGTRMRAPDYT--TPEMY 312
Query: 294 KKMLN---PDPKQRLTAEEVLEH 313
+ ML+ +P QR T E++EH
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|205583 pfam13405, EF_hand_4, EF-hand domain | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 3e-04
Identities = 13/29 (44%), Positives = 18/29 (62%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGG 392
L+EAF++ D + G I+ EELR L G
Sbjct: 2 LREAFKLFDKDGDGYISAEELRKALRSLG 30
|
Length = 30 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 34/122 (27%), Positives = 48/122 (39%), Gaps = 24/122 (19%)
Query: 92 KKLRTAVDIEDVRREVQIMKHLPKH----PNIVSLKDTYEDDSAVHIVMELCEGGELFDR 147
++ RT RRE +IM K P V D IVME EG L D
Sbjct: 42 RRERT-------RREARIMSRARKAGVNVP-AVYFVDPENFI----IVMEYIEGEPLKD- 88
Query: 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
++ + + I +V H G++H DL N + + K + IDFGL+
Sbjct: 89 LINSN---GMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLA 141
Query: 208 VF 209
F
Sbjct: 142 EF 143
|
Length = 211 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV---DIEDVRREVQIMKHLPKH 116
LGR LG G FG T + ++ K L++ + + + E++IM HL H
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD 146
NIV+L ++I+ E C G+L D
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 11/76 (14%)
Query: 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193
IVME EG L D E A +++ + +V H+ G++H DL N + +
Sbjct: 76 IVMEYIEGELLKD-------ALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128
Query: 194 KESSPLKAIDFGLSVF 209
+ + IDFGL F
Sbjct: 129 R----IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHLPKH 116
G+ LG G FG T G++ ++ K L+ + E + E++I+ HL +H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD 146
NIV+L V ++ E C G+L +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLN 131
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 39/167 (23%), Positives = 71/167 (42%), Gaps = 22/167 (13%)
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVC 173
H NIV L+ + + IV E G L D + + G ++ + ++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ------FNEIVG-SP-YY 225
E G +H+ L L +S L G FR ++ + + G SP +
Sbjct: 124 SEMGYVHKGLAAHKVLV-----NSDLVCKISG----FRRLQEDKSEAIYTTMSGKSPVLW 174
Query: 226 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
APE ++ ++ DVWS G++++ ++ G P+W + Q V +A+
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|197492 smart00054, EFh, EF-hand, calcium binding motif | Back alignment and domain information |
|---|
Score = 36.2 bits (85), Expect = 8e-04
Identities = 11/22 (50%), Positives = 15/22 (68%)
Query: 364 LKEAFEMMDTNKRGKINLEELR 385
LKEAF + D + GKI+ EE +
Sbjct: 2 LKEAFRLFDKDGDGKIDFEEFK 23
|
EF-hands are calcium-binding motifs that occur at least in pairs. Links between disease states and genes encoding EF-hands, particularly the S100 subclass, are emerging. Each motif consists of a 12 residue loop flanked on either side by a 12 residue alpha-helix. EF-hands undergo a conformational change unpon binding calcium ions. Length = 29 |
| >gnl|CDD|200946 pfam00036, efhand, EF hand | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 9e-04
Identities = 12/25 (48%), Positives = 16/25 (64%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGL 388
LKEAF+ D + GKI+ EE + L
Sbjct: 2 LKEAFKEFDKDGDGKISFEEFKELL 26
|
The EF-hands can be divided into two classes: signaling proteins and buffering/transport proteins. The first group is the largest and includes the most well-known members of the family such as calmodulin, troponin C and S100B. These proteins typically undergo a calcium-dependent conformational change which opens a target binding site. The latter group is represented by calbindin D9k and do not undergo calcium dependent conformational changes. Length = 29 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 66/328 (20%), Positives = 130/328 (39%), Gaps = 65/328 (19%)
Query: 59 DLGRELGRGEFGVT--YLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+L E+GRG +T YL G + I+ + T ++ ++ EV ++ H +H
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEV-VLSHFFRH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI----VEVVQV 172
PNI++ + S + ++ G + + ++ E + A++ I + +
Sbjct: 59 PNIMTSWTVFTTGSWLWVISPFMAYGSA--NSLLKTYFPEGMSEALIGNILFGALRGLNY 116
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
H+ G +HR++K + L + S L + L R G++ + P +
Sbjct: 117 LHQNGYIHRNIKASHILISGDGLVS-LSGLS-HLYSLVRNGQKAKVVYDFPQFSTSVLPW 174
Query: 226 MAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF------------------------ 258
++PE+L+++ Y + D++S G+ L G PF
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234
Query: 259 --------WAETEQGVAQAIIRSVI----------DFKRDPWPKV-SENAKDLVKKMLNP 299
++ GV I SV+ + R P K S ++LV+ L
Sbjct: 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294
Query: 300 DPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
DP++R +A +L H + + K+ S+
Sbjct: 295 DPEKRPSASSLLSHAFFKQVKEQTQGSI 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 35/145 (24%), Positives = 56/145 (38%), Gaps = 31/145 (21%)
Query: 77 DVNNGEKFACKSISKK-------------KLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
+ G+ K++ K+ ++R E R E +++ K V+
Sbjct: 9 IIYLGDFLGLKAVIKERVPKSYRHPELDERIRR----ERTRNEARLLSRARKAG--VNTP 62
Query: 124 DTYE-DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
Y+ D IVME EG L D E +++ I +V H+ G++H D
Sbjct: 63 VVYDVDPDNKTIVMEYIEGKPLKD-------VIEEGNDELLREIGRLVGKLHKAGIVHGD 115
Query: 183 LKPENFLFANKKESSPLKAIDFGLS 207
L N + + K L IDFGL
Sbjct: 116 LTTSNIIVRDDK----LYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/94 (31%), Positives = 43/94 (45%), Gaps = 26/94 (27%)
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------------M 226
+HRDL N L + E++ +K DFGL+ +I P Y M
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWM 243
Query: 227 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|185504 PTZ00184, PTZ00184, calmodulin; Provisional | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 21/55 (38%), Positives = 32/55 (58%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
A+ L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++ V
Sbjct: 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
Length = 149 |
| >gnl|CDD|205383 pfam13202, EF_hand_3, EF hand | Back alignment and domain information |
|---|
Score = 34.6 bits (81), Expect = 0.003
Identities = 12/22 (54%), Positives = 15/22 (68%)
Query: 364 LKEAFEMMDTNKRGKINLEELR 385
LK+ F DTN GKI+ EEL+
Sbjct: 1 LKDLFRQFDTNGDGKISKEELK 22
|
Length = 25 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 26/94 (27%)
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------------M 226
+HRDL N L + + +K DFGL+ +I P Y M
Sbjct: 195 IHRDLAARNILLSEN---NVVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 227 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 258
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227455 COG5126, FRQ1, Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.004
Identities = 19/54 (35%), Positives = 29/54 (53%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI 409
L+ E++ LKEAF++ D + G I+ EL L G N EA++ L E +
Sbjct: 14 LTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDA 67
|
Length = 160 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.18 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.16 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.04 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.98 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.91 | |
| cd05022 | 89 | S-100A13 S-100A13: S-100A13 domain found in protei | 98.87 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.82 | |
| cd05027 | 88 | S-100B S-100B: S-100B domain found in proteins sim | 98.75 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.75 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.68 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 98.65 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.65 | |
| COG5126 | 160 | FRQ1 Ca2+-binding protein (EF-Hand superfamily) [S | 98.64 | |
| smart00027 | 96 | EH Eps15 homology domain. Pair of EF hand motifs t | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| KOG0027 | 151 | consensus Calmodulin and related proteins (EF-Hand | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| cd05029 | 88 | S-100A6 S-100A6: S-100A6 domain found in proteins | 98.54 | |
| cd05031 | 94 | S-100A10_like S-100A10_like: S-100A10 domain found | 98.54 | |
| KOG0031 | 171 | consensus Myosin regulatory light chain, EF-Hand p | 98.52 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.49 | |
| cd05025 | 92 | S-100A1 S-100A1: S-100A1 domain found in proteins | 98.48 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.48 | |
| cd05026 | 93 | S-100Z S-100Z: S-100Z domain found in proteins sim | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| cd00213 | 88 | S-100 S-100: S-100 domain, which represents the la | 98.43 | |
| cd00052 | 67 | EH Eps15 homology domain; found in proteins implic | 98.36 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 98.23 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.21 | |
| KOG0030 | 152 | consensus Myosin essential light chain, EF-Hand pr | 98.2 | |
| cd05023 | 89 | S-100A11 S-100A11: S-100A11 domain found in protei | 98.19 | |
| KOG0037 | 221 | consensus Ca2+-binding protein, EF-Hand protein su | 98.15 | |
| KOG0028 | 172 | consensus Ca2+-binding protein (centrin/caltractin | 98.14 | |
| cd00051 | 63 | EFh EF-hand, calcium binding motif; A diverse supe | 98.09 | |
| PF14658 | 66 | EF-hand_9: EF-hand domain | 98.09 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.08 | |
| KOG0041 | 244 | consensus Predicted Ca2+-binding protein, EF-Hand | 98.04 | |
| PTZ00183 | 158 | centrin; Provisional | 98.03 | |
| PTZ00184 | 149 | calmodulin; Provisional | 98.02 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 98.01 | |
| cd00252 | 116 | SPARC_EC SPARC_EC; extracellular Ca2+ binding doma | 97.97 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-67 Score=469.16 Aligned_cols=268 Identities=38% Similarity=0.684 Sum_probs=247.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA----VDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
.+++.|.+.+.||+|+||.|-+|..+.||+.||||++.+...... .....+.+|+++|++| +|||||+++++|+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeec
Confidence 477789999999999999999999999999999999987765432 2334578999999999 99999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
.+..|+||||++||+|++.+..++.+.+.....+++|++.||.|||+.||+||||||+|||+..+.++..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999988888999999999999
Q ss_pred eccCCCcccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCc
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 283 (419)
.......+.+.+|||.|.|||++.. .+..++|+||+||+||-+++|.+||.+..... ..++|.++.+.+....|.
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~ 407 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD 407 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence 9888888899999999999999873 24458999999999999999999998776655 889999999999999999
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.+++++.+||.+||..||++|||+.|+|+||||+....
T Consensus 408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 99999999999999999999999999999999997543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-63 Score=419.48 Aligned_cols=301 Identities=41% Similarity=0.759 Sum_probs=275.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+.++|++.+.||+|.|+.||++.+..||+.+|+|++....+... +.+.+.+|+++-+.| +||||+++.+.+.....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEESF 84 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccce
Confidence 4577889999999999999999999999999999999987776544 778999999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.|+|+|++.|++|..-|.++-.++|..+-.+++||++||.|+|.+||||||+||+|+++.+......+||+|||+|..+.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999999888887789999999999999999999999999999999999999988888889999999999998
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.+.-....+|||.|||||+++ .+|+..+|||+.|||||-|+.|.+||++.+...+.+.|+++.++++.+.|+.++++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 777777889999999999998 4799999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhhh
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 354 (419)
+||.+||..||.+|+|+.|+|+|||+.+........-.+.....|++|....+|+-.++..+..
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavLtav~s 308 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987543322223355678899999999999998876654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-61 Score=450.46 Aligned_cols=255 Identities=38% Similarity=0.642 Sum_probs=240.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+......+.+.+||++.++| +|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 4699999999999999999999999999999999998888888889999999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
.|+|+.++|..++++++.++|.+++.+++||+.||.|||+++|+|||||..|++++. +.+|||+|||+|..+... +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~---~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE---NMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC---cCcEEecccceeeeecCccc
Confidence 999999999999998899999999999999999999999999999999999999964 455999999999998744 7
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
...+.+|||.|.|||++. ..++..+||||+||++|.||+|+|||...+..++...|....+.++. .+|.++++||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 778999999999999987 47999999999999999999999999999999999999988777665 6899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+||+.||.+|||++++|.|+||+.
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999999999999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-59 Score=442.28 Aligned_cols=321 Identities=58% Similarity=1.001 Sum_probs=293.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+...|++.+.||.|.||.||+|+++.+|+.+|+|++.+.......+.+.+.+|+.+|++++.|||||.++++|++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 55677899999999999999999999999999999999988877666778999999999999559999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC-CCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~-~~~~kl~Dfg~a~~~ 210 (419)
+++|||+|.||.|++.+... .+++..+..++.|++.|+.|||+.||+||||||+|+|+..... +..+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999887 5999999999999999999999999999999999999987654 458999999999999
Q ss_pred cCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.++......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||++.+.......+..+.+.+..+.|+.++..+
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~a 269 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESA 269 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHH
Confidence 8877888999999999999998 689999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHh
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFE 369 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~ 369 (419)
++||.+||..||.+|+|+.++|+|||++.....+.......+..+.+++...+++++..+...+...+ ...++..|.
T Consensus 270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 346 (382)
T KOG0032|consen 270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQFLSMSKLKKLALRVLAESLS---ISGLKEMFK 346 (382)
T ss_pred HHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHHHHHHHHHHHHHHHHHhhhhh---HHHHHHHHH
Confidence 99999999999999999999999999998766666666666777788888888888776666666655 777888899
Q ss_pred hhCCCCC
Q 014722 370 MMDTNKR 376 (419)
Q Consensus 370 ~~D~~~~ 376 (419)
.+|.+++
T Consensus 347 ~~~~~~~ 353 (382)
T KOG0032|consen 347 LMDTDNN 353 (382)
T ss_pred hhccccc
Confidence 9988776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-59 Score=415.28 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=226.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-eEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AVHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~~~l 134 (419)
.+.+.++.||+|+.|+||+|+|+.|++.+|+|++... .+....+++.+|+++++.. +|||||++|+.|..+. .++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 4678889999999999999999999999999999433 2455678999999999999 9999999999999998 5999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+||+|.+++...+.++|.....|+.++++||.|||+ ++||||||||+|||++..++ |||||||.+..+..+
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence 99999999999999988899999999999999999999996 99999999999999976555 999999999887655
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHhcccccCCCCCc-cCC
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVAQAIIRSVIDFKRDPWP-KVS 286 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~-~~~ 286 (419)
..++.+||..|||||.+.+ .|+.++||||||+.++|+.+|+.||... ...+.+..|..+.. ..... .+|
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp---P~lP~~~fS 308 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP---PRLPEGEFS 308 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC---CCCCcccCC
Confidence 5688999999999999985 7999999999999999999999999764 44555555555332 22222 389
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
+++++||..||++||.+|||+.|+++|||+++....
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 999999999999999999999999999999976443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-59 Score=413.76 Aligned_cols=260 Identities=34% Similarity=0.645 Sum_probs=237.5
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++++.||+|+||+||.++.+.|++.+|+|++.++.+......+...+|..+|.++ +||.||+++..|++.+.+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 35799999999999999999999999999999999998887777788999999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec-cCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~-~~~ 213 (419)
|+||+.||.|+.+|.+.+.++|..++.++..|+.||.|||++|||||||||+|||++ ..++++|+|||+|+.. ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd---~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD---EQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec---CCCcEEEeccccchhcccCC
Confidence 999999999999999999999999999999999999999999999999999999996 4556999999999854 445
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
....+.+||+.|||||++. ..|+..+|+||||+++|+|++|.+||.+.+...+.++|.+....... ..++.+++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHH
Confidence 5667789999999999987 57999999999999999999999999999999999999887633322 2379999999
Q ss_pred HHHhcCCCCCCCC----CHHHHhcCCccccCcc
Q 014722 293 VKKMLNPDPKQRL----TAEEVLEHPWLQNAKK 321 (419)
Q Consensus 293 i~~~L~~dp~~R~----s~~~~l~~~~~~~~~~ 321 (419)
++++|..||++|. ++.++-+||||.....
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 9999999999995 7999999999987643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-58 Score=415.53 Aligned_cols=264 Identities=39% Similarity=0.680 Sum_probs=237.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..||.+|+.+ +|||||.+++++.+.+.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEE
Confidence 44579999999999999999999999999999999998876 455678889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC---CCeEEeecccceec
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES---SPLKAIDFGLSVFF 210 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~---~~~kl~Dfg~a~~~ 210 (419)
+|||||.||+|.+++...+.++|..++.++.||+.||++||+++||||||||+|||++..... ..+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999875233 67999999999999
Q ss_pred cCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.++.-..+.+|+|.|||||++. ++|+.|+|+||+|+|+|++++|++||...+..+....+.++.-..+..+ ..++...
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~ 244 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPL 244 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCch
Confidence 9888888999999999999985 7899999999999999999999999999999988886665543322221 2356667
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 7999999999999999999999999987643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-57 Score=418.45 Aligned_cols=258 Identities=33% Similarity=0.630 Sum_probs=238.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.||.+++.||+|+|++|++|+++.+++.||||++.++.+......+.+..|-.+|.+|.+||.|++|+--|+|...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 48999999999999999999999999999999999888777767778889999999999999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
+||+++|+|.++|.+.+.+++..++.++.||+.||+|||++|||||||||+|||++. ++++||+|||.|+.+.+...
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~---dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK---DGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC---CCcEEEeeccccccCChhhc
Confidence 999999999999999999999999999999999999999999999999999999964 55699999999987754321
Q ss_pred ------------c--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 216 ------------F--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 216 ------------~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
. .+++||-.|.+||+|. +..++.+|||+||||+|+|+.|.+||.+.++..+.++|+...+.++.
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~- 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE- 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC-
Confidence 1 4589999999999998 46789999999999999999999999999999999999998887765
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+++.+++||+++|..||.+|+|+.|+.+||||....
T Consensus 309 ---~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 309 ---GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred ---CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 5789999999999999999999999999999998654
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-58 Score=391.63 Aligned_cols=264 Identities=36% Similarity=0.692 Sum_probs=242.4
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.+-..|.-.+.||.|..++|.++.++.+|..+|+|++....-.. ..-.+.-..|+.+|+++..||||+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 45557888899999999999999999999999999986432211 1224566789999999999999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+..+++|+|.|+.|.|++++...-.++|+..+.||+|+++|+.|||.++||||||||+|||++. +.++||+|||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd---n~~i~isDFGFa 170 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD---NMNIKISDFGFA 170 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc---ccceEEecccee
Confidence 99999999999999999999999889999999999999999999999999999999999999964 445999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
+.+.+++.+...+|||+|+|||.+. ..|+..+|+||+|||+|.|+.|.+||+.....-++..|+.+.+.+..+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 9999999999999999999999875 258889999999999999999999999999999999999999999999
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.|.++|...++||.+||+.||.+|+|+.|+|.||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 999999999999999999999999999999999999653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=387.24 Aligned_cols=256 Identities=32% Similarity=0.618 Sum_probs=238.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|++++.||.|+||.|.+++++.+|..+|+|++.+...-.....+...+|..+|+.+ .||.++++++.+.+.+.+|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEE
Confidence 35799999999999999999999999999999999988877777788889999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||.+||.|++++.+.+++++..++.++.||+.||+|||+++|++|||||+|||++. ++.+||+|||+|+.+...
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~---~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ---NGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc---CCcEEEEeccceEEecCc-
Confidence 9999999999999999999999999999999999999999999999999999999965 455999999999987643
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
..+.+|||.|+|||++. ..|+.++|.|||||++|||+.|.+||...+...+.++|..+.+.++. .+++++++||
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 67889999999999987 68999999999999999999999999999999999999999988875 5799999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCCccccCc
Q 014722 294 KKMLNPDPKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 294 ~~~L~~dp~~R~-----s~~~~l~~~~~~~~~ 320 (419)
.++|+.|-.+|. ...++.+||||+...
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 999999999994 677999999999654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=415.52 Aligned_cols=260 Identities=41% Similarity=0.718 Sum_probs=232.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh--hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.....|++.+.||+|+||.|+.|.+..+|+.||+|++.++..... ...+.+.+|+.+++++..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345579999999999999999999999999999998877533211 234567789999999944999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+|||||.||+|++++...++++|.+++.+++|+++|++|||++||+||||||+|||++.+. +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEecccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999997652 56999999999988
Q ss_pred -cCCCcccccccCcccCchhhhcc-c-CC-CcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccC-
Q 014722 211 -RPGEQFNEIVGSPYYMAPEVLKR-N-YG-PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV- 285 (419)
Q Consensus 211 -~~~~~~~~~~gt~~y~aPE~~~~-~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 285 (419)
.......+.+||+.|+|||++.+ . |+ .++||||+||+||.|++|..||...+...+...|.++.+.++. .+
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YLL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----CcC
Confidence 46677889999999999999985 4 64 7899999999999999999999998888888888887766554 34
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=409.80 Aligned_cols=264 Identities=33% Similarity=0.558 Sum_probs=236.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.-.++|+++..||+|+||.||+|+.+.||..+|+|++++........++.++.|-.+|... ++|+||+++-.|++.+++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCee
Confidence 3456899999999999999999999999999999999998887777888999999999997 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||||++||++..+|...+.+++..++.++.+++.|+..||+.|+|||||||+|+||+ ..+++||+|||+|.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD---~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID---AKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec---CCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999996 456699999999853210
Q ss_pred ----------------------C--C-----c-------------------ccccccCcccCchhhhcc-cCCCcccHHH
Q 014722 213 ----------------------G--E-----Q-------------------FNEIVGSPYYMAPEVLKR-NYGPEVDVWS 243 (419)
Q Consensus 213 ----------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~~-~~~~~~Diws 243 (419)
. . . ..+.+|||-|||||++.+ .|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0 0 0 013579999999999874 7999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCccccCc
Q 014722 244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAK 320 (419)
Q Consensus 244 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~~l~~~~~~~~~ 320 (419)
||||+||||.|.+||.+.+..++..+|.+....+..+.-..++++++|||.+||. ||++|. +++||.+||||+...
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999999999999999999999999887555555555789999999999999 999998 599999999999765
Q ss_pred c
Q 014722 321 K 321 (419)
Q Consensus 321 ~ 321 (419)
.
T Consensus 453 W 453 (550)
T KOG0605|consen 453 W 453 (550)
T ss_pred c
Confidence 4
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=416.44 Aligned_cols=258 Identities=38% Similarity=0.682 Sum_probs=239.7
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
-|++++.||.|+-|.|.+|++..||+.+|||++.+...........+.+||-+|+.+ .|||++++|++|++..++|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence 499999999999999999999999999999999887444445567889999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||++||.|++++..++++++.+++++++||+.|+.|+|..+|+||||||+|+|++.+++ |||+|||+|..-.++.-+
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999975443 999999999988888888
Q ss_pred cccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.+.+|+|.|.|||++.+ .| +.++||||+|||||.||||++||.+.+...++.++.++.+..+ ..+|.++.+||.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHH
Confidence 99999999999999986 44 6799999999999999999999999999999999999998877 478999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
+||..||++|+|.+|+++|||+......
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCCC
Confidence 9999999999999999999999875443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-56 Score=409.14 Aligned_cols=264 Identities=32% Similarity=0.515 Sum_probs=229.4
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-e
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-A 131 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~ 131 (419)
.+.++|.++++||.|.||.||+|+.+.+|+.||||.++++.. ...+ -.-++|+..|++|..|||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456789999999999999999999999999999999987654 3322 234579999999944999999999999888 9
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+|+|||||+ .+|+++++.++ .+++..++.|+.||++||+|+|.+|+.|||+||+|||+.. ...|||+|||+|+.+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---NDVIKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc---cceeEeccccccccc
Confidence 999999996 49999998754 5999999999999999999999999999999999999964 445999999999999
Q ss_pred cCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-------
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP------- 281 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------- 281 (419)
.....+..++.|.+|+|||+|. +.|+.+.|+||+|||++|+.+-++.|.|.++.+++.+|..-........
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 9888899999999999999976 4699999999999999999999999999999888777754332222111
Q ss_pred -------------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 282 -------------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 282 -------------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.++.+.++.+||.+||..||++||||.|+|+||||+.....
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 23468899999999999999999999999999999875443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=386.89 Aligned_cols=257 Identities=28% Similarity=0.585 Sum_probs=222.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
+.|+.+.++|+|+||+||+|+++.||+.||||++..+. .++.-.+-.++||++|++| .|||+|.++++|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence 35899999999999999999999999999999986543 2344455678999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~ 213 (419)
+|||+. ++.+-+... ..++++.+..++.|++.|+.|+|+++++||||||+|||++.+ +.+||||||+|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~---gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN---GVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC---CcEEeccchhhHhhcCCc
Confidence 999986 555555543 458999999999999999999999999999999999999754 459999999999887 77
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-------------- 277 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 277 (419)
+.+..++.|.||+|||.+.+ +|+..+||||+||++.||++|.+-|++.++-+++-.|....-+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 88889999999999999875 79999999999999999999999999999888776665432111
Q ss_pred -----C--------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 278 -----K--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 278 -----~--------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+ ...+++++.-+.+|+++||..||.+|+|.+|+|.||||..
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1 1124567788999999999999999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=369.74 Aligned_cols=259 Identities=32% Similarity=0.572 Sum_probs=226.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|...+.||+|.||.||+|++..||+.||||.++.....+..+ ....+||+.|+.+ +||||+.++++|...+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~-~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN-RTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc-HHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence 36889999999999999999999999999999999876654433 3566799999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+||++. +|...++.+ ..++...+..++.+++.||+|||++.|+||||||.|+|++. ++.+||+|||+|+.+.+..
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~---~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS---DGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC---CCcEEeecccchhccCCCC
Confidence 999974 898888764 45899999999999999999999999999999999999964 4559999999999876443
Q ss_pred -cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc-------
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK------- 284 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------- 284 (419)
.....+-|.+|+|||.+.| .|+..+|+||+|||+.||+.|.+-|.+.++-+++..|.+..-......|+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3334478999999999874 799999999999999999999999999999999998887665555554543
Q ss_pred -----------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 -----------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 -----------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.++.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 456789999999999999999999999999999743
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=377.27 Aligned_cols=256 Identities=30% Similarity=0.559 Sum_probs=219.8
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeee-EEEeCC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-TYEDDS 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~-~~~~~~ 130 (419)
..-..+|++.+.||.|+||+||++.+..+|..+|.|.+.-... +....+++..|+.+|++| +|||||++++ .|.++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDN 92 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccc
Confidence 3344579999999999999999999999999999999985443 556678899999999999 9999999998 454444
Q ss_pred -eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CEeeCCCCCcEEeecCCCCCCeEE
Q 014722 131 -AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHE--QG--VMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 131 -~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~--~~--ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
-++||||||.+|+|.+.++. +..++|..++.++.|++.||..+|+ .. |+||||||.||+++. ++.|||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~---~gvvKL 169 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA---NGVVKL 169 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC---CCceee
Confidence 49999999999999988754 4569999999999999999999999 45 999999999999974 456999
Q ss_pred eecccceeccCCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 202 IDFGLSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
+|||+++.+..... ..+.+|||.||+||.+. ..|+.+|||||+||++|||+.-.+||.+.+-.+...+|.++... .
T Consensus 170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~ 247 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--P 247 (375)
T ss_pred ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--C
Confidence 99999998876554 46789999999999987 57999999999999999999999999999999999999887432 2
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
-+-...|.++..||..|+..||+.||+. +|++.+.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 2113578999999999999999999986 5555443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=396.86 Aligned_cols=258 Identities=30% Similarity=0.541 Sum_probs=226.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~ 133 (419)
+.|+.+++||+|.||.||+|++..+|+.||+|.+........ ...-..+||.+|++| +||||++|.+...+. ..+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 469999999999999999999999999999999987764333 345667899999999 999999999988766 7899
Q ss_pred EEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|+|||+. +|..++... -.|++.++..+|+||+.||.|||++||+|||||.+|||++++ +.+||+|||+|+++..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~---G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN---GVLKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC---CCEEeccccceeeccC
Confidence 99999975 887777653 369999999999999999999999999999999999999654 4599999999998765
Q ss_pred CC--cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc-----
Q 014722 213 GE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP----- 283 (419)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 283 (419)
.. .+...+-|++|+|||.|.+ .|+.++|+||+||||.||++|++.|.+.++.+++..|.+..-......|+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 54 4667788999999999875 69999999999999999999999999999999999998776655555454
Q ss_pred --------------------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 284 --------------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 284 --------------------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.++..+.+|+..||..||.+|.||.++|+|+||...
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 246678999999999999999999999999999543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-55 Score=404.20 Aligned_cols=254 Identities=31% Similarity=0.583 Sum_probs=230.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..- ...+++.+.+|+++++.| +||||+.++++|+...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence 479999999999999999999999999999999987653 455788999999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
+|||.| +|..++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+. ..+.+|+||||+|+.+..+..
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~---~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE---KGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec---CCCceeechhhhhhhcccCce
Confidence 999987 9999999999999999999999999999999999999999999999995 455699999999998776544
Q ss_pred -ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 216 -~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....|||.|||||... +.|+..+|+||+|||+||+++|++||......+....|......++ .+.+..+++|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHH
Confidence 35678999999999988 5799999999999999999999999998888888888876654333 37899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..+|.+||.+|+|+.+++.|||.+..
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-53 Score=381.45 Aligned_cols=263 Identities=32% Similarity=0.527 Sum_probs=228.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.-..+|++.+.||.|.-++||+|++..+++.||||++..+...+ +.+.+++|++.|+.+ +||||++++..|..+..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhc-CCCCcceEEEEEEeccee
Confidence 34457999999999999999999999999999999998877544 478999999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+||.||.+|++.+++... ..++|..++.|+++++.||.|||++|.||||||+.|||++. ++.|||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~---dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS---DGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC---CCcEEEcCceeeeee
Confidence 9999999999999999864 34999999999999999999999999999999999999965 455999999987655
Q ss_pred cC-CC----cccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------
Q 014722 211 RP-GE----QFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID------ 276 (419)
Q Consensus 211 ~~-~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 276 (419)
.. +. .+++.+||++|||||++. ..|+.|+||||||++..||.+|..||.......++-.-+++...
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~ 256 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG 256 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence 33 22 135679999999999965 36999999999999999999999999888877766665555442
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
...+.....+..++.+|..||++||.+|||++++|+|+||+..+.
T Consensus 257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 222333457889999999999999999999999999999997654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-53 Score=384.74 Aligned_cols=269 Identities=34% Similarity=0.650 Sum_probs=230.6
Q ss_pred ecCCCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-----------hhhHHHHHHHHHHHHhCC
Q 014722 46 LKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----------AVDIEDVRREVQIMKHLP 114 (419)
Q Consensus 46 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~ 114 (419)
.....+...-++|++++.||+|.||.|-+|++..+++.||||++.+..... ...++.+++||.+|++|
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl- 165 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL- 165 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-
Confidence 334455566678999999999999999999999999999999998754432 12357899999999999
Q ss_pred CCCCeeeeeeEEEeC--CeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEee
Q 014722 115 KHPNIVSLKDTYEDD--SAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA 191 (419)
Q Consensus 115 ~hpnIv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~ 191 (419)
.|||||+|+++..+. +.+|||+|||..|.+...- .... +++.+++.++++++.||+|||.+|||||||||+|+|++
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 999999999998764 5799999999999885432 2334 89999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEeecccceeccCC------CcccccccCcccCchhhhccc-----CCCcccHHHHHHHHHHHHhCCCCCCC
Q 014722 192 NKKESSPLKAIDFGLSVFFRPG------EQFNEIVGSPYYMAPEVLKRN-----YGPEVDVWSAGVILYILLCGVPPFWA 260 (419)
Q Consensus 192 ~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~ 260 (419)
. +++|||+|||.+.....+ ..+...+|||.|+|||.+.+. .+.+.||||+||+||.|+.|..||.+
T Consensus 245 ~---~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 245 S---DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred C---CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 4 466999999998876322 234557899999999988641 35689999999999999999999999
Q ss_pred CCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
....++..+|.+..+.++.. +.+.+.+++||.+||.+||++|++..++..|||......
T Consensus 322 ~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 322 DFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred chHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 99999999999988877765 367899999999999999999999999999999987543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=368.09 Aligned_cols=269 Identities=42% Similarity=0.737 Sum_probs=243.0
Q ss_pred Cccccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--
Q 014722 52 QDISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-- 128 (419)
Q Consensus 52 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-- 128 (419)
..+.++|.+. ++||-|-.|.|..+.++.||+.+|+|++... ...++|+++.-..+.|||||.++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3467788886 4699999999999999999999999987532 4567899888888899999999999863
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 129 --DSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
...+.+|||.++||.|++.+..++. ++|.++..|++||..|+.|||+.+|.||||||+|+|+.....+..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4678899999999999999998776 999999999999999999999999999999999999999888999999999
Q ss_pred ccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccccCC
Q 014722 205 GLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 279 (419)
|+|+.-.....+.+.+-||+|.|||++. ..|+..+|+||+||++|-|++|.+||+... ..++..+|..+.+.|+.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9999877667778888999999999998 579999999999999999999999997754 46678889999999999
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcc
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG 328 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~ 328 (419)
+.|..+|+.++++|+.+|..+|++|.|+.++++|||+......+...+.
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 9999999999999999999999999999999999999988777666554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=382.15 Aligned_cols=257 Identities=36% Similarity=0.685 Sum_probs=240.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|.||.|-+|.+...|+.||||.|.+..+.+..++-.+++||++|..| +||||+.+|++|+..+.+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceE
Confidence 4667899999999999999999999999999999999999999999999999999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
.|||||..+|.|++++.+++.+++.+++.+++||.+|+.|+|.++++|||||.+|||++.+ +++||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N---~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN---NNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC---CCeeeeccchhhhhcc
Confidence 9999999999999999999999999999999999999999999999999999999999654 4599999999999988
Q ss_pred CCcccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
...+.+++|+|.|.+||+.++ .| ++.+|-|||||+||.|+.|.+||.+.+...+..+|.++.+.-+. -+..+.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~ 280 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDAS 280 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHH
Confidence 888999999999999999986 44 68999999999999999999999999999999999888764433 366789
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
-||..||..||++|.|+.++..|=|++-
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhheeec
Confidence 9999999999999999999999988864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-53 Score=369.10 Aligned_cols=260 Identities=29% Similarity=0.481 Sum_probs=223.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE--eCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~~~~~ 133 (419)
++|+.+..|++|+||.||+|+++.|++.||+|.++.+.-.....+ .-.+||.+|.++ +|||||.+-++.. +-+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 479999999999999999999999999999999987654333333 345699999999 8999999999875 346799
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|||||+. +|.+.+..-+ ++...++..++.|++.||+|||.+.|+||||||+|+|++..+ .+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G---~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG---ILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC---cEEecccchhhhhcC
Confidence 99999975 8888887754 799999999999999999999999999999999999996544 499999999998764
Q ss_pred C-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc-----
Q 014722 213 G-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK----- 284 (419)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 284 (419)
. ..+...+-|.+|+|||.+.+ .|+.+.|+||+|||+.||+++++.|.+..+.+++..|.+..-......|+.
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 44667788999999999875 699999999999999999999999999999999998876554333333322
Q ss_pred -----------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 285 -----------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 285 -----------------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+++...+|+..+|.+||.+|.||.|+|+|+||.....
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 3467889999999999999999999999999998543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-53 Score=375.44 Aligned_cols=264 Identities=34% Similarity=0.539 Sum_probs=225.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----- 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----- 128 (419)
+...|..++.||.|+||.|+.|.++.+|+.||||.+... +......+...+|+.+|+++ +|+||+.+.+++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccc
Confidence 344677789999999999999999999999999998643 34556678889999999999 89999999999864
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
-+.+|+|+|+| +.+|...+..+..+++..+..+++|++.||.|+|+.+|+||||||.|++++. +..+||+|||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~---~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA---DCDLKICDFGLAR 173 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc---CCCEEecccccee
Confidence 45699999999 5699888888877999999999999999999999999999999999999964 4458999999999
Q ss_pred eccC---CCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-------
Q 014722 209 FFRP---GEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID------- 276 (419)
Q Consensus 209 ~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------- 276 (419)
...+ ...++.++.|.+|+|||++. ..|+.+.||||+|||+.||++|++-|.+.+...++..|+.-...
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8864 34457788999999999875 57999999999999999999999999998877776666533211
Q ss_pred ----------------cCCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCC
Q 014722 277 ----------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323 (419)
Q Consensus 277 ----------------~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~ 323 (419)
.+.. .+++.++.+.+|+.+||..||.+|+|++|+|.|||+.......
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 1111 2467899999999999999999999999999999998755443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-53 Score=400.72 Aligned_cols=259 Identities=30% Similarity=0.529 Sum_probs=236.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|.+++.||+|+||+|++|..+.+++.+|||++++..+-...+++..+.|.+++....+||.+++++.+|+..+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 35899999999999999999999999999999999999888888899999999999999789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~ 213 (419)
||||+.||++ .++...+.+++..++.++..|+.||.|||++||||||||.+|||++.+ +++||+|||+++..- .+
T Consensus 447 vmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e---Gh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE---GHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc---CcEEecccccccccCCCC
Confidence 9999999994 445555789999999999999999999999999999999999999654 559999999998654 55
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
....+.+|||.|||||++. ..|+.++|+|||||+|||||.|.+||.+.++.++...|+.....++. .+|.++.++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~----~ls~ea~~i 598 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSKEAIAI 598 (694)
T ss_pred CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----cccHHHHHH
Confidence 6778999999999999998 57999999999999999999999999999999999999987665543 589999999
Q ss_pred HHHhcCCCCCCCCC-----HHHHhcCCccccCcc
Q 014722 293 VKKMLNPDPKQRLT-----AEEVLEHPWLQNAKK 321 (419)
Q Consensus 293 i~~~L~~dp~~R~s-----~~~~l~~~~~~~~~~ 321 (419)
++++|.+||++|.. +.++..||||+....
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 99999999999994 689999999997653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-53 Score=392.78 Aligned_cols=256 Identities=32% Similarity=0.557 Sum_probs=222.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
...|....+||+|+.|.||.|+...+++.||||.+..... ...+-+.+|+.+|+.+ +|+|||++++.|...+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEE
Confidence 3468889999999999999999999999999999986643 3457889999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++||+|.+.+... .++|.+++.|++++++||+|||.+||+|||||.+|||++.++. +||+|||++..+....
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeecccccc
Confidence 99999999998877654 5999999999999999999999999999999999999976544 9999999999887654
Q ss_pred -cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.-.+.+|||+|||||+.. ..|++++||||||++++||+-|.+||...+...-+..|-. ........+..+|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcCCccccCHHHHHH
Confidence 456789999999999987 5799999999999999999999999986655443333322 2222333456799999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+||+.|+++|+||.++|+||||+.+
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999999999999654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=380.99 Aligned_cols=257 Identities=34% Similarity=0.556 Sum_probs=214.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--eEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--AVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--~~~ 133 (419)
.+|...+.||+|+||.||++.+..+|+..|+|.+.... ....+.+.+|+.+|++| +|||||++++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeE
Confidence 35888999999999999999999999999999997652 11267899999999999 6999999999855444 699
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|.|||+++|+|.+++...+ .+++..++.+.+|+++||.|||++||+||||||+|||++.. ++.+||+|||.+.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~--~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPS--NGDVKLADFGLAKKLES 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCC--CCeEEeccCcccccccc
Confidence 9999999999999999876 79999999999999999999999999999999999999762 34599999999887653
Q ss_pred ----CCcccccccCcccCchhhhcccC--CCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCccC
Q 014722 213 ----GEQFNEIVGSPYYMAPEVLKRNY--GPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 213 ----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
........||+.|||||++.... ..++|||||||++.||+||.+||... ......-.+..... .......+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~--~P~ip~~l 248 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS--LPEIPDSL 248 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC--CCCCCccc
Confidence 12234578999999999988433 34999999999999999999999763 33333333333321 11223458
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
|.++++||.+||..||++||||.++|+|||.+...
T Consensus 249 s~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 249 SDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999999999999998644
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=355.92 Aligned_cols=254 Identities=33% Similarity=0.625 Sum_probs=234.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||.|-||.||.|+.+.++-.||+|++.++.+.......++.+|+++...| +||||+++|++|-+....|++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccceeEEE
Confidence 4799999999999999999999999999999999988776666667899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIV--ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||...|+++..+. ...++++..++.++.|++.||.|+|.++++||||||+|+|++..+. +||+|||.+...+ .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAP-S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeecC-C
Confidence 99999999999998 4567999999999999999999999999999999999999965544 9999999998755 4
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
..-.+.+||..|.|||+..+ .++..+|+|++|++.||++.|.+||...+..+....|.+..+.++ ..++.++.||
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dl 252 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADL 252 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHH
Confidence 55578899999999999885 799999999999999999999999999999999999988877666 4789999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|.+||.++|.+|.+..|++.|||+..
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=382.39 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=223.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+...+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEE
Confidence 699999999999999999999999999999999765433333456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~---~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK---EGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC---CCCEEEEecCcchhccCC--c
Confidence 99999999999998888999999999999999999999999999999999999964 345999999998765432 2
Q ss_pred cccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..+++.+++||.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~ 231 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKK 231 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHHH
Confidence 34579999999999874 688999999999999999999999999888887777776654433 2468899999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 296 MLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 296 ~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
||+.||.+||+ +.++++||||+..
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 99999999995 9999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=387.40 Aligned_cols=254 Identities=32% Similarity=0.615 Sum_probs=224.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++++ +||||+++++++.+++.+|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEE
Confidence 5799999999999999999999999999999999765543444566788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||+.||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC---CCEEEeeccCceEcCCC--
Confidence 9999999999999988889999999999999999999999999999999999999654 45999999999876432
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..++..+++||.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 247 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVK 247 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHH
Confidence 23467999999999987 4688999999999999999999999998887777777766544332 247899999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||+.||.+||+ +.++++||||+..
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 999999999997 7999999999863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=378.02 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=218.4
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++.+.+.+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78889999999999999999999999999998765543333445678899999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~---~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD---RGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC---CCCEEEeeCCCcEEcCCCCe
Confidence 99999998877643 35899999999999999999999999999999999999964 34599999999987655555
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..............+++++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 55678999999999987 57899999999999999999999999876654333333332222222333468999999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||+.||++||+ ++++++||||...
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=389.67 Aligned_cols=259 Identities=27% Similarity=0.481 Sum_probs=220.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 3799999999999999999999999999999999765443444556788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~---~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS---KGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC---CCCEEEeeccCccccccccc
Confidence 999999999999998889999999999999999999999999999999999999964 4459999999987543211
Q ss_pred -----------------------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCC
Q 014722 215 -----------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 215 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 258 (419)
.....+||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012357999999999986 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCC---CCCCHHHHhcCCccccC
Q 014722 259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPK---QRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 259 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~---~R~s~~~~l~~~~~~~~ 319 (419)
.+.+..+....+.........+....+++++++||.+|+. +|. .||++.|+++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9888887777777543333333334578999999999875 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=384.72 Aligned_cols=250 Identities=32% Similarity=0.579 Sum_probs=219.0
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999865544444556788899999999 899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 220 (419)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEeeCCCCcccccCCCccccee
Confidence 9999999888889999999999999999999999999999999999999654 459999999987532 223344567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++||||+||++|+|++|..||...+.......+......++ ..+++++.+||.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999987 4689999999999999999999999988887777776665544332 35799999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccccC
Q 014722 300 DPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=368.15 Aligned_cols=262 Identities=32% Similarity=0.553 Sum_probs=234.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|++++.||.|.-|+||+|+...++..+|+|++.+..+........+..|-+||+.+ +||.++.||..|+.+...|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence 34799999999999999999999999999999999998877777778888999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-
Q 014722 135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR- 211 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~- 211 (419)
|||||+||+|....+++. .+++..++.++..++-||+|||-.|||+|||||+|||+. ++++|.|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr---edGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR---EDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe---cCCcEEeeeccccccCCC
Confidence 999999999999887753 599999999999999999999999999999999999995 56679999999864210
Q ss_pred ---------------------------------C-C----------------------CcccccccCcccCchhhhcc-c
Q 014722 212 ---------------------------------P-G----------------------EQFNEIVGSPYYMAPEVLKR-N 234 (419)
Q Consensus 212 ---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~-~ 234 (419)
. . ...++.+||-.|.|||++.+ .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 01234679999999999996 6
Q ss_pred CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC----HHHH
Q 014722 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT----AEEV 310 (419)
Q Consensus 235 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~~~ 310 (419)
.+.++|+|+|||++|||+.|..||.+.+..++..+|+.....++..+ .++..++|||+++|.+||.+|.. |+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 89999999999999999999999999999999999999888887764 78899999999999999999998 9999
Q ss_pred hcCCccccCccC
Q 014722 311 LEHPWLQNAKKA 322 (419)
Q Consensus 311 l~~~~~~~~~~~ 322 (419)
-+||||+..++.
T Consensus 390 K~HpFF~gVnWa 401 (459)
T KOG0610|consen 390 KRHPFFEGVNWA 401 (459)
T ss_pred hcCccccCCChh
Confidence 999999986653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=385.40 Aligned_cols=257 Identities=33% Similarity=0.552 Sum_probs=224.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEE
Confidence 699999999999999999999999999999999866543334556788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA---SGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCCEEEEeCcCCccccc--cc
Confidence 99999999999988888999999999999999999999999999999999999964 44599999999876543 33
Q ss_pred cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC----ccCCHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW----PKVSENAKD 291 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~~~~ 291 (419)
....||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+.........+.+ ..+++++.+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 4567999999999987 46899999999999999999999999988877776666554322222222 256899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
||.+||..+|.+|||+.++++||||...
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=390.09 Aligned_cols=259 Identities=29% Similarity=0.546 Sum_probs=222.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 3699999999999999999999999999999999865443344556788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~---~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA---KGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC---CCCEEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999999999999999964 44599999999875432110
Q ss_pred ---------------------------------------ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCC
Q 014722 216 ---------------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV 255 (419)
Q Consensus 216 ---------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~ 255 (419)
....+||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 01246999999999986 56899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCccccC
Q 014722 256 PPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA 319 (419)
Q Consensus 256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~~l~~~~~~~~ 319 (419)
+||.+.+.......+.........+....+++++.+||.+||. +|.+|++ +.++++||||+..
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999888777776666544333333334679999999999997 8999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=380.48 Aligned_cols=272 Identities=28% Similarity=0.470 Sum_probs=229.6
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|...+.||+|+||.||+|.+..+++.||||++...... ..++++.+|+.+|.++ ++|||.++|+.|..+..++++|
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHH
Confidence 488889999999999999999999999999999877643 3578999999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ- 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 215 (419)
|||.||++.+.+...+.+.+..+..++++++.||.|||..+.+|||||+.|||+... +.+||+|||.+........
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~---g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES---GDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc---CcEEEEecceeeeeechhhc
Confidence 999999999999888778999999999999999999999999999999999999755 4599999999988765433
Q ss_pred ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
..+++|||.|||||++++ .|+.|+||||||++++||++|.+|+........+..|.+...... -...++.+++||.
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L---~~~~S~~~kEFV~ 244 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL---DGDFSPPFKEFVE 244 (467)
T ss_pred cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc---ccccCHHHHHHHH
Confidence 378899999999999985 799999999999999999999999977766333322222221111 1257889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhh
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSV 340 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (419)
.||.+||+.||||.++|+|+|++...+ .+....+..+.++++.
T Consensus 245 ~CL~k~P~~RpsA~~LLKh~FIk~a~k---~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 245 ACLDKNPEFRPSAKELLKHKFIKRAKK---TSELKELIDRYKRWRV 287 (467)
T ss_pred HHhhcCcccCcCHHHHhhhHHHHhcCC---chHHHHHHHHHHHHhh
Confidence 999999999999999999999997322 2333344455554433
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=383.38 Aligned_cols=255 Identities=31% Similarity=0.556 Sum_probs=223.5
Q ss_pred ccceeeccccccccceEEEEEEEcCCC-cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.++|++.+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 347999999999999999999876654 78999999765444444566788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK---DGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEecCCCCeecCCC
Confidence 99999999999999998888999999999999999999999999999999999999964 455999999999876432
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++ +.+++.+.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHH
Confidence 345679999999999874 689999999999999999999999998888777777776654433 3578999999
Q ss_pred HHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
|.+||+.||++|+ |+.++++||||...
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=358.37 Aligned_cols=266 Identities=36% Similarity=0.637 Sum_probs=235.9
Q ss_pred cccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 54 ISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 54 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
|.+-|.+. +.||+|+|+.|--++...+|..||||++.+.. ......+.+|++++.+...|+||++++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 44456664 57999999999999999999999999998763 335678899999999999999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+|||.+.||+|.++|.++..++|.++..+.+.|+.||.+||.+||.||||||+|||....+.-..||||||.+...+.-
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998777777899999998764432
Q ss_pred C--------CcccccccCcccCchhhhc---c---cCCCcccHHHHHHHHHHHHhCCCCCCCCC---------------H
Q 014722 213 G--------EQFNEIVGSPYYMAPEVLK---R---NYGPEVDVWSAGVILYILLCGVPPFWAET---------------E 263 (419)
Q Consensus 213 ~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~ 263 (419)
. ..+.+.+|+-.|||||+.. + .|+.++|.||||||+|.||+|.+||.+.- .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 2 2234678889999999763 2 48999999999999999999999996542 3
Q ss_pred HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
..+.+.|..+.+.|+...|..+|.++++|+..+|..|+.+|.++.++++|||++.....
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 55778899999999999999999999999999999999999999999999999976543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=387.53 Aligned_cols=259 Identities=29% Similarity=0.491 Sum_probs=219.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||+|+||+||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876554455567889999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~---~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL---DGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC---CCCEEEeeCcCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999964 4569999999875321000
Q ss_pred ----------------------------------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHH
Q 014722 215 ----------------------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 247 (419)
Q Consensus 215 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 247 (419)
.....+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012357999999999986 468999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC--CCCCCCCCHHHHhcCCccccC
Q 014722 248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN--PDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 248 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~--~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+|+|++|.+||...+.......+.........+.+..+++++.+||.+||. .+|..|+++.++++||||...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999998877766666555433333344445689999999999664 455569999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=377.35 Aligned_cols=248 Identities=29% Similarity=0.563 Sum_probs=217.2
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||+|+||.||+|++..+++.||+|++.............+.+|+.+++++ +||||+++++++.+.+..|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999999765444444567788999999999 99999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccccC
Q 014722 144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGS 222 (419)
Q Consensus 144 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt 222 (419)
|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ---GHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC---CcEEEEECcccccCccCCCccccccCC
Confidence 99999888889999999999999999999999999999999999999644 4599999999875432 2233456799
Q ss_pred cccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCC
Q 014722 223 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301 (419)
Q Consensus 223 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 301 (419)
+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+......++ ..+++++.+||.+||..||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCH
Confidence 99999999874 689999999999999999999999998888777777766544332 3578999999999999999
Q ss_pred CCCC---CHHHHhcCCccccC
Q 014722 302 KQRL---TAEEVLEHPWLQNA 319 (419)
Q Consensus 302 ~~R~---s~~~~l~~~~~~~~ 319 (419)
++|| ++.++++||||...
T Consensus 233 ~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHcCCCCCHHHHHcCCCcCCC
Confidence 9997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=362.54 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=222.9
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+......|.-.+.+|+|+||.||+|....+++.||||.+-...- .-.+|+++|+.+ +|||||++.-+|....
T Consensus 19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSST 90 (364)
T ss_pred CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecC
Confidence 34566679999999999999999999999999999999865432 223699999999 9999999998886322
Q ss_pred -----eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 131 -----AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 131 -----~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
+..+||||++. +|.+.+.. +..++...++-++.||++||+|||+.||+||||||.|+|++.+ .+.+||
T Consensus 91 ~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEe
Confidence 45689999974 99888874 5678999999999999999999999999999999999999854 467999
Q ss_pred eecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--
Q 014722 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-- 277 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-- 277 (419)
||||.|+....++...++..|..|+|||.+.+ .|+.+.||||.||++.||+-|++-|.+.+...++..|.+....+
T Consensus 168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99999999988888888999999999998874 79999999999999999999999999999888887776432111
Q ss_pred ------------------CCCCC-----ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 278 ------------------KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 278 ------------------~~~~~-----~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
....| ...++++.+|+.++|.++|.+|.++.|++.||||...+..
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11122 3478999999999999999999999999999999876544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=387.89 Aligned_cols=259 Identities=28% Similarity=0.524 Sum_probs=218.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 3699999999999999999999999999999998765433344566788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~---~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR---GGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC---CCCEEEeecccccccccccc
Confidence 999999999999988888999999999999999999999999999999999999964 44599999999863211000
Q ss_pred ------------------------------------------------ccccccCcccCchhhhc-ccCCCcccHHHHHH
Q 014722 216 ------------------------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 246 (419)
Q Consensus 216 ------------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~ 246 (419)
....+||+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 01246999999999986 46899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCccccC
Q 014722 247 ILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR---LTAEEVLEHPWLQNA 319 (419)
Q Consensus 247 il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~s~~~~l~~~~~~~~ 319 (419)
++|+|++|.+||.+.+.......+.........+....++.++.+||.+||. +|.+| +|+.+++.||||+..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999998888777666666533222223334578999999999998 66665 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=357.88 Aligned_cols=260 Identities=30% Similarity=0.504 Sum_probs=222.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC-eeeeeeEEEeCC---
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSLKDTYEDDS--- 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn-Iv~l~~~~~~~~--- 130 (419)
...|..+++||+|+||+||+|+++.+|+.||+|.+....-.. ..-....+|+.+++.| +|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence 346888999999999999999999999999999998664321 1224567899999999 8999 999999998877
Q ss_pred ---eEEEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 131 ---AVHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 131 ---~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
.+++|+||++ -+|..++...+ .++...+..++.||+.||+|||+++|+||||||+|||+++ .+.+||+|
T Consensus 88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~---~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS---SGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC---CCcEeeec
Confidence 8999999996 59999988755 5788899999999999999999999999999999999976 45599999
Q ss_pred cccceecc-CCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 204 FGLSVFFR-PGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 204 fg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
||+|+... +...+...++|.+|+|||++.+ .|+...||||+|||++||+++.+-|.+..+.++...|.+..-.....
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999766 4455677889999999999875 59999999999999999999999999999988888887654433333
Q ss_pred CCcc--------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 281 PWPK--------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 281 ~~~~--------------------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.|+. .+++..+++.+||+++|.+|.|+..+|.||||....
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 3322 235789999999999999999999999999999753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=384.23 Aligned_cols=260 Identities=32% Similarity=0.511 Sum_probs=223.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+|+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence 45799999999999999999999999999999999765443334455678899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~---~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC---CCCEEEEeccceeeccCCC
Confidence 9999999999988765 46899999999999999999999999999999999999964 4559999999998764332
Q ss_pred --cccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 215 --QFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.........+....+|.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2235679999999998853 378899999999999999999999999888777777776543333334446899
Q ss_pred HHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
++.+||.+||+.+|.+ |+|+.++++||||+..
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 9999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=387.24 Aligned_cols=258 Identities=31% Similarity=0.536 Sum_probs=221.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 589999999999999999999999999999999765443344566788999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC---
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--- 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--- 213 (419)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~---~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC---CCCEEEeECCCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999964 455999999997532100
Q ss_pred ---------------------------------------------CcccccccCcccCchhhhc-ccCCCcccHHHHHHH
Q 014722 214 ---------------------------------------------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 247 (419)
Q Consensus 214 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~i 247 (419)
......+||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012346999999999986 479999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCccccC
Q 014722 248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA 319 (419)
Q Consensus 248 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~~l~~~~~~~~ 319 (419)
+|+|++|.+||.+.+..+....+.........+.+..+++++.++|.+|+ .+|++|++ +.++++||||+..
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999999988877666666654444444445678999999999987 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=371.37 Aligned_cols=265 Identities=39% Similarity=0.682 Sum_probs=239.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+..=|.+.+.||+|-|++|-+|++..||+.||||++.+.++.+. ....+..|++.|+.+ +|||||++|++......+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHh-cCcCeeeeeehhcccceE
Confidence 355569999999999999999999999999999999998876543 456788899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+|+|+=++|+|+++|.+. ..+.|..+.+++.||+.|+.|+|+..+|||||||+|+.+.. .-+.|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--KlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--KLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee--ecCceEeeeccccccCC
Confidence 9999999999999999875 45999999999999999999999999999999999998864 34679999999999999
Q ss_pred CCCcccccccCcccCchhhhcc-cCC-CcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYG-PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
+++.+.+.+|+..|.|||++.+ .|+ +++||||||||||.|++|++||...++.+.+-.|+...+..+ ..++.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHH
Confidence 9999999999999999999886 464 689999999999999999999999999999988887766554 3679999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~ 325 (419)
++||..||..||.+|.|.+++..++|++........
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 999999999999999999999999999976554433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=387.73 Aligned_cols=258 Identities=29% Similarity=0.507 Sum_probs=220.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++++ +||||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEE
Confidence 699999999999999999999999999999999765433333456788999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC---
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--- 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--- 213 (419)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC---CCCEEEEeCCCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999964 445999999997532100
Q ss_pred -----------------------------------------CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHH
Q 014722 214 -----------------------------------------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYIL 251 (419)
Q Consensus 214 -----------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 251 (419)
.......||+.|+|||++. ..++.++|||||||++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011347999999999987 4689999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCccccC
Q 014722 252 LCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNA 319 (419)
Q Consensus 252 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~~l~~~~~~~~ 319 (419)
++|..||.+....+....+.........+.+..+++++.++|.+|+ .+|.+|+ |+.++++||||+..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 9999999988877666666544333333444578999999999977 5999999 99999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-50 Score=370.53 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=211.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||.|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence 3699999999999999999999999999999998754321 1234677899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEECcCcceeeccCCC
Confidence 999975 8988887644 47999999999999999999999999999999999999654 459999999987654322
Q ss_pred -cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----------
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----------- 280 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 280 (419)
......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+..+....+.+........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 2344578999999998763 58999999999999999999999998887766665554322111000
Q ss_pred ---------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 281 ---------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+.+++++++||.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=384.30 Aligned_cols=259 Identities=35% Similarity=0.628 Sum_probs=225.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.++..+ +||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 3699999999999999999999999999999999865543434566788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEeecCCCCccCcccCc
Confidence 9999999999999888889999999999999999999999999999999999999654 459999999987654332
Q ss_pred -----------------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q 014722 215 -----------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 264 (419)
Q Consensus 215 -----------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 264 (419)
......||+.|+|||++. ..++.++|||||||++|+|++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 223457999999999987 46899999999999999999999999988877
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCccccC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQNA 319 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-~~~~l~~~~~~~~ 319 (419)
.....+.........+....+++++.+||.+||. ||.+||+ +.++++||||+..
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7777776633333333334579999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=376.87 Aligned_cols=250 Identities=30% Similarity=0.567 Sum_probs=217.6
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999865544444567788999999999 999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|.+.+.....+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD---GHIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC---CcEEEecCcCCccCCCccccccccc
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875432 22334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCC
Confidence 999999999986 4689999999999999999999999988877776666655443332 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccccC
Q 014722 300 DPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
||++|+ ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=376.68 Aligned_cols=250 Identities=32% Similarity=0.586 Sum_probs=218.2
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4689999999999999999999999999865444444566778899999999 999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC---CCEEecccHHhccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875422 23334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......++ ..+++++.+||.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999986 5689999999999999999999999988887777766665544332 35789999999999999
Q ss_pred CCCCCC-----CHHHHhcCCccccC
Q 014722 300 DPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
||++|| ++.++++||||...
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999998 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=382.27 Aligned_cols=261 Identities=31% Similarity=0.503 Sum_probs=222.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+++.+|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence 446899999999999999999999999999999999765443444456678899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~---~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH---GHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC---CCEEEEecccceecccC
Confidence 999999999999988654 68999999999999999999999999999999999999644 45999999999876433
Q ss_pred Cc--ccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 214 EQ--FNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.. .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+.........+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 245679999999999863 27889999999999999999999999888877777777644333333334679
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
..+++++.+||..+|.+ |+|+.++++||||+..
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866654 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=375.46 Aligned_cols=251 Identities=31% Similarity=0.560 Sum_probs=218.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999997654333345567788999998876799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~---~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeeCCCCeecCcCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875432 23334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+.......+ ..+++++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccc
Confidence 999999999987 4689999999999999999999999999888888777776544332 34789999999999999
Q ss_pred CCCCCCCH------HHHhcCCccccC
Q 014722 300 DPKQRLTA------EEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~------~~~l~~~~~~~~ 319 (419)
||++||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=370.77 Aligned_cols=248 Identities=28% Similarity=0.425 Sum_probs=212.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcE-EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-eEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEK-FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~~~l 134 (419)
+..+.+.||+|+||+||+|. ..|+. ||+|++......... .+.+.+|+.+|.++ +|||||+++|++.+.. .++|
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred HhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceEE
Confidence 45566779999999999998 45666 999999876554433 77999999999999 9999999999999887 7999
Q ss_pred EEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 135 VMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
||||+++|+|.+++.. .+.++...+..++.||+.|+.|||+++ ||||||||+|||++.+. .++||+|||+++...
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKV 195 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeec
Confidence 9999999999999988 578999999999999999999999999 99999999999997543 369999999998766
Q ss_pred CC-CcccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PG-EQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.. .......||+.|||||++.+ .|+.|+||||||+++|||+||..||.+....+....+.........+ ..+++
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~ 273 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP--KECPP 273 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--ccCCH
Confidence 44 33444789999999999985 49999999999999999999999999988866666555443322221 23899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+..|+.+||..||++||++.+++.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999865
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=373.92 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=221.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||+|+||.||+|++..+++.||+|++.+.........+.+..|+.++..+..|++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986544344456778889999999954567899999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCCc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~~ 215 (419)
||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE---GHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC---CCEEEeecCcceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999654 459999999987532 2233
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. ..++.++||||+||++|+|+||..||.+.+.......+......++ ..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 34567999999999987 4689999999999999999999999998888877777766544332 357899999999
Q ss_pred HhcCCCCCCCCCH-----HHHhcCCccccC
Q 014722 295 KMLNPDPKQRLTA-----EEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s~-----~~~l~~~~~~~~ 319 (419)
+||..||.+|+++ .++++||||...
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=367.06 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=211.1
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+.+|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEE
Confidence 69999999999999999999999999999999976532 223456778899999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN---DVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CcEEEeeccCcccccccccc
Confidence 999987776554445679999999999999999999999999999999999999644 459999999998764332
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-----------------
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----------------- 276 (419)
......||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+..+....+......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 233457899999999886 46899999999999999999999999887665544333221100
Q ss_pred --cCC---------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 --FKR---------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 --~~~---------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+. ..+..+|.++.+||.+||++||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0012368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=372.56 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=223.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|++..+++.||+|++.+..............|..++..+.+||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999986544334445667788888888867899999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~ 215 (419)
||+++|+|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC---CcEEEccCCCceecCCCCCc
Confidence 999999999999888889999999999999999999999999999999999999654 4599999999875432 223
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. +.++.++|||||||++|+|+||..||.+.+.......+......++ ..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHH
Confidence 34567999999999987 5689999999999999999999999999888888877776554333 357899999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||+.||++|++ ..++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=377.43 Aligned_cols=258 Identities=31% Similarity=0.500 Sum_probs=222.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|.+.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEE
Confidence 699999999999999999999999999999999866543444556788899999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~---~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR---TGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC---CCCEEeccCCCCeECCCCCc
Confidence 999999999999875 67999999999999999999999999999999999999964 44599999999987654332
Q ss_pred c--cccccCcccCchhhhc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 216 F--NEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 216 ~--~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
. ....||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+.........+..+.++
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 2 2346899999999875 347789999999999999999999998888777777666543222223334689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+++.+||.+||. +|.+|||+.++++||||...
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=372.58 Aligned_cols=251 Identities=28% Similarity=0.521 Sum_probs=218.6
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++.............+..|..++..+.+||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999999999999999998654434445567778999998776899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE---GHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeecccceecccCCccccccc
Confidence 9999999888889999999999999999999999999999999999999654 4599999999876432 22334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||...+.......+......++ ..+++++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhcc
Confidence 999999999987 4689999999999999999999999999988888877776544322 24789999999999999
Q ss_pred CCCCCC-------CHHHHhcCCccccC
Q 014722 300 DPKQRL-------TAEEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~-------s~~~~l~~~~~~~~ 319 (419)
||++|| ++.++++||||...
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999 99999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=380.66 Aligned_cols=259 Identities=29% Similarity=0.523 Sum_probs=220.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++.+.+.+.+|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999999765443344566788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~---~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA---KGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC---CCCEEEeeccCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999964 4559999999986542110
Q ss_pred -----------------------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCC
Q 014722 215 -----------------------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 215 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 258 (419)
.....+||+.|+|||++. ..++.++|||||||++|+|++|.+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 012357999999999987 46899999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCccccC
Q 014722 259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNA 319 (419)
Q Consensus 259 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~~l~~~~~~~~ 319 (419)
.+.+.......+.........+....+++++++||.+|+. ||.+|+ ++.++++||||+..
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 9888877777766533222222223578999999999874 999998 58999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=368.40 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=207.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|++..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEE
Confidence 5799999999999999999999999999999998754321 1234567899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+. ++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD---TGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC---CCCEEECCCCcceeccCCC
Confidence 99996 5787777654 56899999999999999999999999999999999999964 345999999998754322
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCC---------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDP--------- 281 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~--------- 281 (419)
.......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+... ......+...........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22344678999999998763 578899999999999999999999977543 222222221110000000
Q ss_pred -----------------Cc--cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 282 -----------------WP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 282 -----------------~~--~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
|. ..++++.+|+.+||+.||++|||+.|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 11 235788999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=372.86 Aligned_cols=250 Identities=30% Similarity=0.538 Sum_probs=211.7
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++++...........+..|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999999999999999998765544455667889999999987899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec-cCCCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~ 220 (419)
|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++... ..........
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEECcCccccccccCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999654 45999999998753 2233345567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||.... .....+.+....... ...++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----p~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----CCCCCHHHH
Confidence 999999999987 468999999999999999999999995321 112233333333222 235789999
Q ss_pred HHHHHhcCCCCCCCCC------HHHHhcCCcccc
Q 014722 291 DLVKKMLNPDPKQRLT------AEEVLEHPWLQN 318 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s------~~~~l~~~~~~~ 318 (419)
++|.+||+.||.+||| +.++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999997 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=374.53 Aligned_cols=250 Identities=31% Similarity=0.582 Sum_probs=217.5
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+++++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999876544444556778899999999 999999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCCccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEI 219 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~ 219 (419)
|+|..++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC---CCEEEecCCCCeecCCCCcccccc
Confidence 9999999888889999999999999999999997 799999999999999654 459999999987543 22333456
Q ss_pred ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 220 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
.||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.......+......++ ..+++++.+||.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhh
Confidence 7999999999986 4689999999999999999999999988887777666655544332 3578999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCccccC
Q 014722 299 PDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
.||++|+ ++.++++||||...
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 9999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=369.42 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=214.6
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+|+.||+|++................|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999998654322334556777888888665899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD---GHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEeCccCCCeecccCCCceeccC
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875322 22334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+.......+.......+ ..++.++.+||.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccC
Confidence 999999999987 4689999999999999999999999998888777776655433222 24789999999999999
Q ss_pred CCCCCCCH-HHHhcCCccccC
Q 014722 300 DPKQRLTA-EEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~-~~~l~~~~~~~~ 319 (419)
||++||++ .++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999998 588999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=376.43 Aligned_cols=260 Identities=31% Similarity=0.497 Sum_probs=221.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.+.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999764443344455678899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++||+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~---~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC---CCCEEEEeCCceeEcCcCC
Confidence 99999999999988654 6899999999999999999999999999999999999964 4459999999998765332
Q ss_pred --cccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 215 --QFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.........+....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 2235679999999999863 278899999999999999999999999888777777776543333334457899
Q ss_pred HHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
.++++|.+||..++.+ |+++.++++||||++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999854443 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=363.31 Aligned_cols=259 Identities=32% Similarity=0.505 Sum_probs=218.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++.+++.+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 488999999999999999999999999999999765443333345677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+.+|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD---YGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC---CCCEEEeeCCCceecCCCC
Confidence 999999999887653 45899999999999999999999999999999999999964 4559999999998765544
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......||+.|+|||++. ..++.++||||+||++|+|++|..||.+.........+..............++..+.+|+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 445567899999999986 4688999999999999999999999987765544444433322222223346889999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 294 KKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
.+||..||++|| ++.++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999 99999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=369.64 Aligned_cols=251 Identities=31% Similarity=0.559 Sum_probs=218.1
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999998665444445667788999999887899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++..... ........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC---CcEEecccCCCeecCcCCCccccee
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875322 22334457
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..+++.+.+||.+||..
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccC
Confidence 999999999987 4789999999999999999999999988887777776665544322 35789999999999999
Q ss_pred CCCCCCCH-----HHHhcCCccccC
Q 014722 300 DPKQRLTA-----EEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~-----~~~l~~~~~~~~ 319 (419)
||++|||+ .++++||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-49 Score=373.46 Aligned_cols=260 Identities=30% Similarity=0.581 Sum_probs=213.7
Q ss_pred ceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+..|+.+++.+.+||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 47899999999754322 2233456788999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~---~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC---CCEEEeeCcCCccccc
Confidence 9999999999999999888889999999999999999999999999999999999999654 4599999999876533
Q ss_pred CC--cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+..............+++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 2234679999999999874 4788999999999999999999999643322111222222222222233467999
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+.+++.+||+.||++|| ++.++++||||+..
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=368.17 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=214.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++...........+....|..++..+.+||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999999999999999998654333334556677888887665899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-Ccccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 220 (419)
|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~---~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD---GHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC---CCEEEccCcCCeECCCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999644 45999999999765332 2334567
Q ss_pred cCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++ ..++.++.+|+.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccC
Confidence 9999999999874 689999999999999999999999998888777776654432221 34789999999999999
Q ss_pred CCCCCCCH-HHHhcCCccccC
Q 014722 300 DPKQRLTA-EEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~-~~~l~~~~~~~~ 319 (419)
||++||++ .++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=369.34 Aligned_cols=253 Identities=30% Similarity=0.532 Sum_probs=216.3
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHH---hCCCCCCeeeeeeEEEeCCeEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK---HLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~---~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|++++. .+ +||||+++++++.+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 678899999999999999999999999999998654333334566777776654 55 79999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-C
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-G 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~ 213 (419)
||||++|++|...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~---~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC---CcEEeCcccCCccCCCCC
Confidence 9999999999887754 579999999999999999999999999999999999999654 4599999999875432 2
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..+++.+.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 2334567999999999987 4689999999999999999999999998888877777766544332 3578999999
Q ss_pred HHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
|.+||+.||.+|| ++.++++||||+..
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=370.40 Aligned_cols=259 Identities=30% Similarity=0.490 Sum_probs=210.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC-----Ce
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----SA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-----~~ 131 (419)
+|++.+.||+|+||.||+|++..+|..||+|.+.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999986432 2223345788999999999 899999999987543 35
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~---~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCcEEEccCccccccc
Confidence 899999995 689999988888999999999999999999999999999999999999964 4459999999987543
Q ss_pred CCC----cccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----------
Q 014722 212 PGE----QFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------- 274 (419)
Q Consensus 212 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---------- 274 (419)
... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123457999999999876 368899999999999999999999998766543332221100
Q ss_pred -----------------cccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 275 -----------------IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 275 -----------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.......++.+++.+.+++.+||+.||++|||+.++++||||+....
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00001123457888999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=370.23 Aligned_cols=251 Identities=29% Similarity=0.531 Sum_probs=211.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++.++.+||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899999999999999999999999998765545555667888999998876899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 220 (419)
|+|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~---~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CCEEEeeCCccccccCCCCcccccc
Confidence 9999999888889999999999999999999999999999999999999654 459999999987532 233344567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||... ........+....... ...++..+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----p~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----PRSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC----CCCCCHHHH
Confidence 999999999987 46899999999999999999999999521 1112223333332222 235789999
Q ss_pred HHHHHhcCCCCCCCCC------HHHHhcCCccccC
Q 014722 291 DLVKKMLNPDPKQRLT------AEEVLEHPWLQNA 319 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s------~~~~l~~~~~~~~ 319 (419)
+||.+||+.||++||| +.++++||||+..
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=376.74 Aligned_cols=258 Identities=32% Similarity=0.487 Sum_probs=218.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-----CeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-----NIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-----nIv~l~~~~~ 127 (419)
.+..+|++.+.||+|+||.|.+|.+..|++.||||+++... .-..+...|+.+|..|.+|. |+|+++++|.
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 34558999999999999999999999999999999998653 23567778999999995343 8999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
..++.|||+|.++ .+|+++++.+. .++...++.++.||+.||.+||+.||||+||||||||+...+. ..|||+|||
T Consensus 259 fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r-~~vKVIDFG 336 (586)
T KOG0667|consen 259 FRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKR-SRIKVIDFG 336 (586)
T ss_pred cccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCc-CceeEEecc
Confidence 9999999999995 69999998764 4889999999999999999999999999999999999987654 479999999
Q ss_pred cceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-------- 276 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 276 (419)
+|+..... .-+++.+..|+|||++.| +|+.+.||||||||++||++|.+.|.+.++.+++..|..-.-.
T Consensus 337 SSc~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 337 SSCFESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred cccccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99875433 337889999999999875 8999999999999999999999999999998888777532100
Q ss_pred -------cCC-C-------------------------------CCc------------cCCHHHHHHHHHhcCCCCCCCC
Q 014722 277 -------FKR-D-------------------------------PWP------------KVSENAKDLVKKMLNPDPKQRL 305 (419)
Q Consensus 277 -------~~~-~-------------------------------~~~------------~~~~~~~~li~~~L~~dp~~R~ 305 (419)
+.. . ..+ .-...+.+||.+||..||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 000 0 000 0123578999999999999999
Q ss_pred CHHHHhcCCcccc
Q 014722 306 TAEEVLEHPWLQN 318 (419)
Q Consensus 306 s~~~~l~~~~~~~ 318 (419)
|+.|+|+||||..
T Consensus 495 tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 495 TPAQALNHPFLTG 507 (586)
T ss_pred CHHHHhcCccccc
Confidence 9999999999984
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=369.59 Aligned_cols=255 Identities=34% Similarity=0.576 Sum_probs=231.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe-EEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA-VHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~-~~l 134 (419)
++|..++.+|.|+||.+++++++.++..+|+|.+........ ......+|+.+++++ .|||||.+.+.|..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 469999999999999999999999999999999988776544 344788899999999 99999999999998888 999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||+||+||++.+.|.+.. .++++.+..++.|++.|+.|||+++|+|||||+.||+++.++. |||+|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence 999999999999998754 5899999999999999999999999999999999999976544 89999999999887
Q ss_pred CC-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ...+.+|||.||+||++.+ +|+.|+|||||||++|||++-+++|.+.+......+|.+....... ...+.+++
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp---~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP---SMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC---ccccHHHH
Confidence 76 5678899999999999985 8999999999999999999999999999999999999988754333 35689999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+|..||..+|..||++.++|.+|.+..
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999998864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=381.62 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=209.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
...+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ +||||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence 3457999999999999999999999999999999885432 2335799999999 999999999887432
Q ss_pred ----CeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 130 ----SAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 130 ----~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~--~~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN--THTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCC--CCceee
Confidence 257799999975 6766554 34569999999999999999999999999999999999999643 235999
Q ss_pred eecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---
Q 014722 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--- 276 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--- 276 (419)
+|||+|+............||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+.+....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987765555556788999999998763 6899999999999999999999999988776665555432111
Q ss_pred --------------cCCCC--------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 --------------FKRDP--------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 --------------~~~~~--------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++... ....++++.+||.+||++||.+|||+.|+|+||||....
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 01000 113578999999999999999999999999999998653
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=366.90 Aligned_cols=256 Identities=28% Similarity=0.500 Sum_probs=221.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+..|+.+++.+.+||+|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47888999999999999999999999999999986544333445677889999998866788999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-Cc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~ 215 (419)
||++||+|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~---~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEeccccccccCCCCcc
Confidence 999999999999888889999999999999999999999999999999999999654 45999999998754322 22
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. +.++.++||||+||++|+|++|.+||.+.........+.......+ ..++.++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence 34567999999999987 4689999999999999999999999999888877777776554332 357899999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||+.+|.+|++ ..++++||||...
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=366.20 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=216.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++++.||+|+||.||+|++..+|..+|+|++.... .....+.+.+|+++++.+ +||||+++++++.+.+.+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 457999999999999999999999999999999987542 233456789999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC---CcEEEccCccccccccc
Confidence 999999999999998888899999999999999999999986 69999999999999654 45999999998765432
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-----------------
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------------- 275 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------------- 275 (419)
......||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 234567999999999987 4689999999999999999999999976655443322211100
Q ss_pred -------------------------cc--CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 -------------------------DF--KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 -------------------------~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. +......+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00 0001123678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=365.29 Aligned_cols=251 Identities=28% Similarity=0.479 Sum_probs=213.8
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|++..+++.||+|++................|..++..+.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999998654322234456677888887655899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|.+++.....+++.++..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD---GHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC---CCEEEccCCcceECCCCCCceeeec
Confidence 9999999887789999999999999999999999999999999999999654 4599999999875422 22334567
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+......++ ..++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhcc
Confidence 999999999987 4689999999999999999999999988887777666654432221 24789999999999999
Q ss_pred CCCCCCCHH-HHhcCCccccC
Q 014722 300 DPKQRLTAE-EVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~~-~~l~~~~~~~~ 319 (419)
||++||++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 89999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=359.31 Aligned_cols=252 Identities=29% Similarity=0.503 Sum_probs=209.5
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||+|+||+||+|.+..+++.||+|.+...........+.+..|+.+++.+ +||||+++.+++.....+|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999999999999999999765444434456778899999999 99999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-ccc
Q 014722 144 LFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-FNE 218 (419)
Q Consensus 144 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 218 (419)
|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN---DGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEeeCccceecCCCCccccc
Confidence 9887743 346899999999999999999999999999999999999964 44599999999976654332 334
Q ss_pred cccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhc
Q 014722 219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297 (419)
Q Consensus 219 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 297 (419)
..||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..............+++.+.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 57899999999987 57889999999999999999999999765433222222222222222223468999999999999
Q ss_pred CCCCCCCC-----CHHHHhcCCccccC
Q 014722 298 NPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 298 ~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+.||++|| +++++++||||+..
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999 88999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=359.49 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=208.1
Q ss_pred ceeeccccccccceEEEEEEEcC-CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEE-----e
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYE-----D 128 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~-----~ 128 (419)
+|++.+.||+|+||.||+|++.. +++.||+|++........ ......+|+.+++.+. +||||+++++++. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 69999999999999999999854 578899999875433221 2234556777777653 6999999999885 3
Q ss_pred CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
...+++||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~---~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC---CCEEEccccc
Confidence 456899999996 5898888653 358999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----- 280 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 280 (419)
+.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 98765554445667999999999886 578999999999999999999999999888777776665432111111
Q ss_pred ------------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 281 ------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 281 ------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+.+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=366.26 Aligned_cols=250 Identities=34% Similarity=0.605 Sum_probs=215.0
Q ss_pred cccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 62 RELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
+.||+|+||.||+|++. .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++..++.+|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 67999999999999864 47899999999764332 223345678899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcc
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQF 216 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~ 216 (419)
|++|++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEeeCcCCeecccCCCcc
Confidence 99999999999888889999999999999999999999999999999999999644 4599999999875432 2223
Q ss_pred cccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+....... .+.+++.+.+||.+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~ 233 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL----PPYLTPEARDLLKK 233 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHH
Confidence 44679999999999874 68899999999999999999999999888877777776654432 23578999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 296 MLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 296 ~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
||+.||++|| ++.++++||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 89999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=365.53 Aligned_cols=260 Identities=28% Similarity=0.522 Sum_probs=217.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 3699999999999999999999999999999999764433444556788899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK---NGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC---CCCEEEEECCceeecCCCC
Confidence 999999999999976 457999999999999999999999999999999999999964 4459999999987654433
Q ss_pred cc--cccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCccC
Q 014722 215 QF--NEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKV 285 (419)
Q Consensus 215 ~~--~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 285 (419)
.. ....||+.|+|||++. +.++.++||||+||++|+|++|..||.+....+....+......+. ......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 22 2346999999999985 3478899999999999999999999988877776666654332221 1223457
Q ss_pred CHHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
++.+++||.+||..++++ |+++.++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999999765444 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=367.24 Aligned_cols=250 Identities=28% Similarity=0.538 Sum_probs=213.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
+.||+|+||+||+|++..+|+.||+|++.............+..|.. +++.+ +||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36899999999999999999999999997654333333445556655 45677 89999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI 219 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 219 (419)
||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC---CcEEEeccCCCcccccCCCccccc
Confidence 99999999888889999999999999999999999999999999999999654 4599999999875432 2233456
Q ss_pred ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 220 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...+..+....+....... .+.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRL----KPNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhh
Confidence 7999999999987 468999999999999999999999999888877777776654332 24679999999999999
Q ss_pred CCCCCCCCH----HHHhcCCccccC
Q 014722 299 PDPKQRLTA----EEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~s~----~~~l~~~~~~~~ 319 (419)
.||.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999999987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=365.19 Aligned_cols=251 Identities=29% Similarity=0.504 Sum_probs=211.8
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++.+||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999998765444455677889999999987899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~ 220 (419)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD---GHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC---CCEEEeccccceeccCCCCceeccc
Confidence 9999999888889999999999999999999999999999999999999654 459999999987532 233345577
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+...... ....++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----IPRFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence 999999999986 468999999999999999999999995321 12223333332222 223578999999
Q ss_pred HHHhcCCCCCCCCC------HHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLT------AEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s------~~~~l~~~~~~~~ 319 (419)
+.+||+.||++|++ +.++++||||+..
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=368.47 Aligned_cols=250 Identities=32% Similarity=0.565 Sum_probs=213.7
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
||+|+||+||+|++..+|+.||+|++.+..............|..++..+. +||||+++++++.+...+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999997654433334445566777777654 799999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCcccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~ 220 (419)
|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT---GHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEecCCcCcCCCCCCCCccCcc
Confidence 9999999888889999999999999999999999999999999999999654 4599999999875432 23344567
Q ss_pred cCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 221 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 221 gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......++. ..+++++.+||.+||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999999863 4889999999999999999999999988887777777655444332 2478999999999999
Q ss_pred CCCCCCC----CHHHHhcCCccccC
Q 014722 299 PDPKQRL----TAEEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~----s~~~~l~~~~~~~~ 319 (419)
.||.+|| ++.++++||||...
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=354.98 Aligned_cols=257 Identities=32% Similarity=0.518 Sum_probs=213.3
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++++ +|+||+.+++.+.+.+.+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEE
Confidence 77888999999999999999999999999998765444333445677899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH---GHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC---CCEEEeeccceeecCCCcc
Confidence 99999999888653 358999999999999999999999999999999999999653 4599999999887655444
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. ..++.++||||+|+++|+|++|..||..........................+++++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCK 237 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHH
Confidence 45567999999999986 46899999999999999999999999765432111111111111112223467899999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCcccc
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQN 318 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~ 318 (419)
+||+.||++||| +.|+++||||+.
T Consensus 238 ~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 238 MLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=369.16 Aligned_cols=252 Identities=24% Similarity=0.424 Sum_probs=205.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+++++++ +||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEE
Confidence 3579999999999999999999999999999996532 3467899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|+|++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~---~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP---GDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC---CCEEEEeCCccccccccc
Confidence 999995 6899998888889999999999999999999999999999999999999654 45999999998753321
Q ss_pred -CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhccc---------
Q 014722 214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVI--------- 275 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~--------- 275 (419)
.......||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2234567999999999987 468999999999999999999998875432 1111111111100
Q ss_pred -------------------ccCCCCCc---cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 -------------------DFKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 -------------------~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
......|. .++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00011121 3467899999999999999999999999999998753
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.33 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=206.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEEe-----C
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYED-----D 129 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~-----~ 129 (419)
+|++.+.||+|+||+||+|++..+++.||+|.+....... .......+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4899999999999999999999999999999987643222 12234556777776652 69999999998864 3
Q ss_pred CeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 SAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..+++|+||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~---~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccCcc
Confidence 458999999975 888888663 348999999999999999999999999999999999999654 45999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------- 279 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 279 (419)
.............||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765444445567899999999886 56899999999999999999999999887776665555432111000
Q ss_pred ----------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 ----------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ----------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
...+.++..+.+|+.+||++||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=364.05 Aligned_cols=250 Identities=28% Similarity=0.535 Sum_probs=212.9
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI-MKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
+.||+|+||+||+|++..+|+.||+|++.............+..|... ++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 468999999999999999999999999976543333344556666654 5667 99999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI 219 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 219 (419)
||+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~---~~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEEeecCCcccCCCCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999654 4599999999875432 2333456
Q ss_pred ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 220 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
.||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+....... .+..+..+.++|.+||.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhc
Confidence 7999999999987 468999999999999999999999999888777777776654332 23578999999999999
Q ss_pred CCCCCCCCH----HHHhcCCccccC
Q 014722 299 PDPKQRLTA----EEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~s~----~~~l~~~~~~~~ 319 (419)
.+|.+||++ .++++||||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999976 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=361.78 Aligned_cols=260 Identities=27% Similarity=0.492 Sum_probs=218.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 3699999999999999999999999999999999754333333445678899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~---~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC---CCCEEEeecchheecccCC
Confidence 999999999999977 457899999999999999999999999999999999999964 3459999999987654332
Q ss_pred c--ccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCccC
Q 014722 215 Q--FNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKV 285 (419)
Q Consensus 215 ~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~ 285 (419)
. .....||+.|+|||++. +.++.++|||||||++|+|++|..||...+.......+......... ..+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 23457999999999875 35788999999999999999999999988877777777654432221 223467
Q ss_pred CHHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
++++++|+.+||..+|.+ |+++.++++||||...
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=365.93 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=209.5
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++++.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...+.+++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence 457999999999999999999999999999999986442 233456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||+.+++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA---KNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEcccccceeccccc
Confidence 9999999998642 345788889999999999999999999999999999999654 459999999998764332
Q ss_pred -cccccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 215 -QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
......||..|+|||++.. ..+.++|||||||++|+|++|..||...........+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2345679999999998742 235689999999999999999999974433222222221111222223346789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+||.+||..||++|||+.|+++||||.....
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 9999999999999999999999999999997643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=351.96 Aligned_cols=252 Identities=27% Similarity=0.469 Sum_probs=207.0
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||+|+||.||++.+..+|+.||+|.+.............+..|+++++++ +||||+++++++.++..+|+||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 79999999999999999999999999765443333344566799999999 99999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccccc
Q 014722 144 LFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221 (419)
Q Consensus 144 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 221 (419)
|.+.+.... .+++..+..++.|++.||.|||+.||+||||||+||+++. +..++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD---QGNCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC---CCCEEEeeceeeeecCCCceeeccCC
Confidence 988876543 4889999999999999999999999999999999999965 44599999999987665544455678
Q ss_pred CcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-CCCCCccCCHHHHHHHHHhcCC
Q 014722 222 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-KRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 222 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 299 (419)
|+.|+|||++. ..++.++||||+||++|+|++|..||...........+....... .......+++++.+|+.+||++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999986 468999999999999999999999997654322222222222111 1112235789999999999999
Q ss_pred CCCCCCCH----HHHhcCCccccC
Q 014722 300 DPKQRLTA----EEVLEHPWLQNA 319 (419)
Q Consensus 300 dp~~R~s~----~~~l~~~~~~~~ 319 (419)
||++||++ .+++.||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 99999999 678899999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=362.06 Aligned_cols=260 Identities=26% Similarity=0.478 Sum_probs=218.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3799999999999999999999999999999999764333334455678899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC---CCEEEEeccceeeccCCC
Confidence 999999999999987 4679999999999999999999999999999999999999644 459999999998765433
Q ss_pred cc--cccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCccC
Q 014722 215 QF--NEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKV 285 (419)
Q Consensus 215 ~~--~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~ 285 (419)
.. ....||+.|+|||++.+ .++.++||||+||++|+|++|..||...+..+....+......+. ...+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 23569999999998863 578899999999999999999999988887777766665432222 1223457
Q ss_pred CHHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccC
Q 014722 286 SENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNA 319 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~ 319 (419)
++++.+++.+||..++.+ |++++++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 899999999999876654 5699999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=363.55 Aligned_cols=249 Identities=28% Similarity=0.544 Sum_probs=214.7
Q ss_pred cccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEe
Q 014722 62 RELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~ 138 (419)
+.||+|+||.||++++. .+|+.||+|++...... ......+.+|+.+++++ +||||+++++++.+++.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 57999999999999863 57899999999765432 22345677899999999 899999999999999999999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-Cccc
Q 014722 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFN 217 (419)
Q Consensus 139 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~ 217 (419)
+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC---CcEEEeeccCCcccCCCCCcee
Confidence 9999999999888889999999999999999999999999999999999999654 45999999998765433 2334
Q ss_pred ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHh
Q 014722 218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296 (419)
Q Consensus 218 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (419)
...||+.|+|||++. ..++.++|||||||++|+|++|..||...........+.......+ ..+++.+.+||.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence 567999999999987 4688999999999999999999999998887777777766544332 35789999999999
Q ss_pred cCCCCCCCCC-----HHHHhcCCccccC
Q 014722 297 LNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 297 L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
|+.||++||| +.++++||||...
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=363.26 Aligned_cols=259 Identities=32% Similarity=0.631 Sum_probs=234.4
Q ss_pred cceee--ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDL--GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.-|++ .+.||+|.||+||-|++..+|+.||||+|.+..+... ...++++|+.+|+.+ .||.||.+--.|+..+.++
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l-~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNL-HHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEE
Confidence 34665 3689999999999999999999999999998877554 347899999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIV--ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|||.+.| +..+.|. +.+++++.....++.||+.||.|||-+||+|.||||+|||+.+...-.++||||||+|+.+.
T Consensus 640 VVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 640 VVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 99999975 5555554 36789999999999999999999999999999999999999887777789999999999998
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
......+.+|||.|+|||++. +.|+..-|+||+|||+|--++|..||.. .+++..+|.+..+-++..+|..+++++.
T Consensus 719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~Ai 796 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAI 796 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHH
Confidence 777778899999999999987 5799999999999999999999999954 3456778888889999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+||..+|+..-.+|.|.++.|.|||+++.
T Consensus 797 dlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 797 DLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99999999999999999999999999875
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=361.36 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=211.2
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|.. +++.+ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999999999999999997654333333445556655 56778 99999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI 219 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 219 (419)
|++|...+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC---CCEEEccCCCCccCCCCCCccccc
Confidence 99999988888889999999999999999999999999999999999999654 4599999999875322 2233456
Q ss_pred ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 220 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
.||+.|+|||++. ..++.++|||||||++|+|++|.+||...+.......+.......+ +..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcc
Confidence 7999999999987 4689999999999999999999999998887777776665443322 3568899999999999
Q ss_pred CCCCCCCCH----HHHhcCCccccC
Q 014722 299 PDPKQRLTA----EEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~s~----~~~l~~~~~~~~ 319 (419)
.||.+||++ .++++|+||...
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 999999975 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=361.54 Aligned_cols=250 Identities=28% Similarity=0.521 Sum_probs=211.6
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
+.||+|+||+||+|++..+++.||+|++.............+..|.. +++.+ +||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36899999999999999999999999997654322223344555554 46677 89999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CCccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEI 219 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 219 (419)
||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~---~~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC---CCEEEccCCCCcccccCCCCcccc
Confidence 99999999888889999999999999999999999999999999999999654 4599999999875432 2233456
Q ss_pred ccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 220 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 220 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
.||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+...... ..+.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcc
Confidence 79999999999874 6899999999999999999999999988887777776654432 234689999999999999
Q ss_pred CCCCCCCCHH----HHhcCCccccC
Q 014722 299 PDPKQRLTAE----EVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~s~~----~~l~~~~~~~~ 319 (419)
.||.+||++. ++++|+||...
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCCC
Confidence 9999999876 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=351.02 Aligned_cols=258 Identities=32% Similarity=0.518 Sum_probs=219.6
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.+ +|+||+.+++++..++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 77788999999999999999999999999999765544333445678899999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|+.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ ..++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~---~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY---GHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC---CCEEEecCCcceecCCCCc
Confidence 99999998887653 369999999999999999999999999999999999999644 4599999999876654444
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....|++.|+|||++. ..++.++|+||+|+++|+|++|..||...........+............+.++.++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 45567999999999986 56899999999999999999999999877665554444443333333334568899999999
Q ss_pred HhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||+.||++||+ +.++++|+||+..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=350.63 Aligned_cols=254 Identities=41% Similarity=0.730 Sum_probs=212.7
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.+++++ +||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987643222 223345699999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec-cCCCcc
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQF 216 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~-~~~~~~ 216 (419)
|+.+++|.+++...+.+++..+..++.|++.||.+||++||+||||||+||+++.+ +.++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~---~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN---GEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT---SEEEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 99999999999877889999999999999999999999999999999999999744 44899999998863 333445
Q ss_pred cccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccccCCCCCccCCHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG---VAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
....+|+.|+|||++. ..++.++||||||+++|+|++|..||....... ................+...++.+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 6677899999999987 568999999999999999999999998873322 33333322222222222223489999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+|.+||+.||++|||+.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=358.19 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=213.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+++++.+ +||||+++++++.+.+.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEE
Confidence 467999999999999999999999999999999987542 233456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||+++++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~---~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC---CCEEEeeCCcchhhhhh
Confidence 999999999999998888899999999999999999999985 79999999999999654 45999999998755322
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--------------------- 271 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--------------------- 271 (419)
......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2244578999999999874 68899999999999999999999997654433221110
Q ss_pred -------------------hcccccCCCC--CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 272 -------------------RSVIDFKRDP--WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 272 -------------------~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
........+. ....+.++.+||.+||+.||++|||+.|++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000000 11257889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=364.63 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=208.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-- 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 130 (419)
.+..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence 355689999999999999999999999999999999875432 333456778999999999 8999999999986443
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 131 ----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 131 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~---~~~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEecCCC
Confidence 57999999975 5666553 358899999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---------- 275 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 275 (419)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 976554444455678999999999874 689999999999999999999999987765443332221110
Q ss_pred ------------ccCC----------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 276 ------------DFKR----------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 276 ------------~~~~----------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.... ......++++++||.+||..||++|||+.|+|+||||..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000 000124678999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=356.61 Aligned_cols=258 Identities=27% Similarity=0.454 Sum_probs=212.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|.+.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++++ +||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence 4699999999999999999999999999999998754322 1234567899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++ +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECccccceecCCCc
Confidence 999975 8888776543 48999999999999999999999999999999999999654 459999999987643322
Q ss_pred -cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---------------
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------------- 276 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------------- 276 (419)
......+|+.|+|||++.+ .++.++||||+||++|+|+||.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2334568999999998763 5789999999999999999999999887766555544332110
Q ss_pred ----cCC-------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 ----FKR-------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ----~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++. ...+.+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 11235788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.98 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=204.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----CCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hpnIv~l~~~~~~~ 129 (419)
..+|++++.||+|+||+||+|.+..+++.||||++.... ........|+.+++.+. +|++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 468999999999999999999999999999999986421 12234556777777661 345689999988764
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCC------------
Q 014722 130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKE------------ 195 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~------------ 195 (419)
..+|+|||++ |++|.+++.+.+.+++..+..|+.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 77899999888889999999999999999999998 59999999999999976432
Q ss_pred -CCCeEEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014722 196 -SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 196 -~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 273 (419)
...+||+|||.+.... ......+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+.+..+....+...
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2359999999876432 22345789999999999874 6999999999999999999999999887765554443322
Q ss_pred ccccCC----------------------C--------------CCc--cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 274 VIDFKR----------------------D--------------PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 274 ~~~~~~----------------------~--------------~~~--~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
...++. . .+. ..++.+.+||.+||++||++|||+.|+|+|||
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 111000 0 000 01356789999999999999999999999999
Q ss_pred cccCc
Q 014722 316 LQNAK 320 (419)
Q Consensus 316 ~~~~~ 320 (419)
|....
T Consensus 441 ~~~~~ 445 (467)
T PTZ00284 441 VLKYY 445 (467)
T ss_pred ccccC
Confidence 98743
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=363.70 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=213.6
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-----e
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----A 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-----~ 131 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.+ +||||+++++++.... .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence 4788999999999999999999999999999986432 2333456788999999999 8999999999998776 7
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.|+|+||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~---~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC---CCCEEeccccceeecc
Confidence 999999996 588888887788999999999999999999999999999999999999964 4459999999998654
Q ss_pred CCC--cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc------------
Q 014722 212 PGE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------------ 275 (419)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------------ 275 (419)
... ......+|+.|+|||++.+ .++.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2334568999999998864 478999999999999999999999988876665554432110
Q ss_pred -----------ccCC-----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 276 -----------DFKR-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 276 -----------~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..+. ......++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0000 1112457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=339.44 Aligned_cols=259 Identities=31% Similarity=0.598 Sum_probs=237.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-++|..++.||+|.||.|-+++.+.+|+.+|+|++++.-+-.......-..|-++|+.. +||.+..+--.|+..+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 35799999999999999999999999999999999988766655666677899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee-ccCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF-FRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~-~~~~ 213 (419)
||||..||.|+-++.....+++.-++.+...|+.||.|||+++||+||||.+|.|++. ++++||+|||+++. +..+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk---DGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK---DGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc---CCceEeeecccchhccccc
Confidence 9999999999999999889999999999999999999999999999999999999965 45599999999974 3456
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
....+.+|||.|+|||++. ..|+.++|.|.+||++|||++|+.||+..+.....+.|+-..+.+++ .++++++.|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr----~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR----TLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc----cCCHHHHHH
Confidence 6778999999999999998 57999999999999999999999999999999999999988888775 689999999
Q ss_pred HHHhcCCCCCCCC-----CHHHHhcCCccccCcc
Q 014722 293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNAKK 321 (419)
Q Consensus 293 i~~~L~~dp~~R~-----s~~~~l~~~~~~~~~~ 321 (419)
+..+|.+||.+|. .+.++..|+||.....
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 9999999999997 6899999999987543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=367.00 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=222.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
++.|+|+..||.|+||.||+|..+.++-..|.|+|... ....++++.-||.||..+ +||+||++++.|..++.++|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEE
Confidence 45699999999999999999999989988999998654 455788999999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-
Q 014722 135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP- 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~- 212 (419)
+.|||.||-+...+.. ...+++.++..+++|++.||.|||+++|||||||+.|||++-++. |+|+|||.+.....
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKST 183 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhH
Confidence 9999999999887776 456999999999999999999999999999999999999987665 99999998754322
Q ss_pred CCcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 213 GEQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
-..-.+++|||+|||||+.. .+|+.++||||||++|.+|.-+.+|....+...++-+|.+........ ....+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq-PS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ-PSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC-cchhh
Confidence 23346789999999999764 469999999999999999999999998888877777776654332221 13457
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..+.||+.+||.+||..||+++++|+||||++.
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 889999999999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=370.65 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=217.9
Q ss_pred ccceeeccccccccceEEEEEEEcCC-CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+... .......+.+|+.+++.+ +||||+++++++...+.+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEE
Confidence 34599999999999999999998877 788999977543 333445678899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+||||++||+|.+++.. ..++++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~---~~~kL~DFgla~~ 218 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT---GIIKLGDFGFSKQ 218 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC---CcEEEEeCcCcee
Confidence 99999999999887753 3468999999999999999999999999999999999999654 4599999999987
Q ss_pred ccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+..+.... ....+
T Consensus 219 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~ 295 (478)
T PTZ00267 219 YSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCPV 295 (478)
T ss_pred cCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCccC
Confidence 654322 34457999999999987 468999999999999999999999999888877777776654321 12357
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
++++.++|.+||..||++|||+.+++.|+|++.
T Consensus 296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 899999999999999999999999999999974
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=371.53 Aligned_cols=258 Identities=26% Similarity=0.477 Sum_probs=219.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-- 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 130 (419)
....+|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.++..+ +|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceeccccc
Confidence 345689999999999999999999999999999999976543 334566788999999999 9999999988775332
Q ss_pred ------eEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 131 ------AVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 131 ------~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~---~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN---GLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC---CCEE
Confidence 378999999999999988653 468999999999999999999999999999999999999754 4599
Q ss_pred EeecccceeccCC---CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 201 AIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 201 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
|+|||+++..... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9999999865432 2234567999999999987 46899999999999999999999999988877777766655432
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
. ..+.+++++.+++.+||+.||.+|||+.++++|||++.
T Consensus 264 ~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 264 P---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2 22467899999999999999999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=359.62 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=210.6
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhc-CCCCccccceeeccccccc
Confidence 45689999999999999999999999999999999875432 233456778899999999 899999999987543
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC---CcEEEEeCCCc
Confidence 357999999975 67776643 48899999999999999999999999999999999999654 45999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------- 277 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------- 277 (419)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 87654444456679999999999874 68999999999999999999999998887766555554321100
Q ss_pred -------------C----------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 278 -------------K----------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 278 -------------~----------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
. .......+..+++||.+||+.||.+|||+.++|+||||..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 0001113567899999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=382.80 Aligned_cols=264 Identities=30% Similarity=0.512 Sum_probs=218.8
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-- 128 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-- 128 (419)
+.....+|++++.||.|+||+||+|.+..++..+|+|++..... .......+..|+.+++.| +||||++++++|.+
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecC
Confidence 45566789999999999999999999999999999999976543 233456788999999999 89999999998854
Q ss_pred CCeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCEeeCCCCCcEEeecC----
Q 014722 129 DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-------GVMHRDLKPENFLFANK---- 193 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-------~ivHrDlkp~NIl~~~~---- 193 (419)
...+||||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+. +|+||||||+|||++..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999998865 25699999999999999999999985 49999999999999642
Q ss_pred ----------CCCCCeEEeecccceeccCCCcccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCC
Q 014722 194 ----------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWA 260 (419)
Q Consensus 194 ----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~ 260 (419)
+....+||+|||++.............||+.|+|||++. ..++.++||||||||+|+|+||..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 123458999999998765444445667999999999885 3488999999999999999999999976
Q ss_pred CCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..........+... +..+....+.++.+||..||..+|.+|||+.|+|.|||++..
T Consensus 246 ~~~~~qli~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHHHHHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 65544333333322 222234568999999999999999999999999999999754
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=360.15 Aligned_cols=257 Identities=35% Similarity=0.624 Sum_probs=234.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-...|.+...||+|.|++|.+|++..++..||||++.+...... ....+.+|+++|+.| +|||||+++.+.+....+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeE
Confidence 34579999999999999999999999999999999998876544 445589999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+.+|.+++++.+.+...+..++.++.|+++|++|||+++|+|||||++|||++. +.++||+|||++..+..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~---~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE---NMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc---ccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999964 445999999999999988
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
....+.+|++.|.|||++.+ .-++++|+||+|+++|-|+.|.+||.+.+..+.....+.+.+..+. .++-++.+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~ 284 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCED 284 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc----eeechhHH
Confidence 88899999999999999985 3578999999999999999999999999888888877777665543 46889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+|.++|..+|.+|++.++++.|.|....
T Consensus 285 lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 285 LLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred HHHHhhccCccccCCHHHhhhhcccchh
Confidence 9999999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=358.74 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=209.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+..+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence 355689999999999999999999999999999999875432 333456778899999999 899999999988643
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..+|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~---~~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC---CCCEEEeeCcc
Confidence 357999999975 66666643 5889999999999999999999999999999999999964 44599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc---------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID--------- 276 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~--------- 276 (419)
+.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987655444456689999999999874 6899999999999999999999999877654443333221100
Q ss_pred -------------c----------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 277 -------------F----------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 277 -------------~----------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
. ........+.++++||.+||..||++|||+.|+|+||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 000111245678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=353.07 Aligned_cols=242 Identities=29% Similarity=0.422 Sum_probs=208.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.+.+++.||+|.||.||.|.. .....||+|.++..... .+.+.+|+++|++| +|+|||++++++..++.+||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMS----PEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccC----hhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEEE
Confidence 366788999999999999994 33459999999866443 35778999999999 9999999999999988999999
Q ss_pred EecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||++.|+|.++|.. ...+...+.+.++.||++|++||+++++|||||.+.||||+ ++..+||+|||+|+...++.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCCc
Confidence 99999999999987 45689999999999999999999999999999999999995 45569999999999554433
Q ss_pred ccccccc---CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 QFNEIVG---SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
. ....| ...|.|||++. +.++.+||||||||+||||+| |+.||.+.+..+.++.+.++.- .+....+|+++
T Consensus 358 Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR---lp~P~~CP~~v 433 (468)
T KOG0197|consen 358 Y-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR---LPRPEGCPDEV 433 (468)
T ss_pred e-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc---CCCCCCCCHHH
Confidence 2 22222 34699999988 789999999999999999999 9999999999999998887653 22235799999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHh
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l 311 (419)
.+++..||..+|++|||++.+.
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999998653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=345.49 Aligned_cols=253 Identities=32% Similarity=0.640 Sum_probs=221.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+++++++ +||||+++++++.+...+|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEE
Confidence 699999999999999999999999999999999765544444567788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~---~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD---GYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC---CCEEEeeCCCccccCCC--C
Confidence 999999999999888889999999999999999999999999999999999999654 45999999998876543 3
Q ss_pred cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
....|++.|+|||.+. ..++.++||||||+++|+|++|..||...........+.......+ ..++..+.++|.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~ 231 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRN 231 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHH
Confidence 4456899999999876 4678899999999999999999999988776666666554433222 3468999999999
Q ss_pred hcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 296 MLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 296 ~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
||..||.+|+ ++.++++||||+..
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=348.86 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=212.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.+ +||||+++++++.....+++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence 3699999999999999999999999999999998754322 1234567899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC---CcEEECcCcchhccCCCC
Confidence 99997 5888887653 468999999999999999999999999999999999999654 45999999998754322
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------------ 279 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 279 (419)
.......+++.|+|||++.+ .++.++|||||||++|+|++|.+||...+..+....+.........
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567899999998764 4788999999999999999999999887766655444332111100
Q ss_pred --------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 280 --------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 280 --------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...+.+++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01134688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=351.48 Aligned_cols=249 Identities=27% Similarity=0.501 Sum_probs=193.9
Q ss_pred ccccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeEEEEE
Q 014722 61 GRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVHIVM 136 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~lv~ 136 (419)
..+||+|+||+||+|++. .+++.||+|.+..... ...+.+|+.+++++ +||||+++++++.. ...+|+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence 458999999999999965 4678999999865432 23567899999999 99999999999854 45689999
Q ss_pred EecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCCCCeEEeeccc
Q 014722 137 ELCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGL 206 (419)
Q Consensus 137 e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~ 206 (419)
||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ ...+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9996 5887776532 248999999999999999999999999999999999999643 2446799999999
Q ss_pred ceeccCCC----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Q 014722 207 SVFFRPGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 271 (419)
Q Consensus 207 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~ 271 (419)
+....... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98764321 2345678999999998864 5899999999999999999999999654321 1112221
Q ss_pred hccccc---------------------CC-------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 272 RSVIDF---------------------KR-------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 272 ~~~~~~---------------------~~-------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
...... .. ......+.++.+||.+||+.||++|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 110000 00 0011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=340.70 Aligned_cols=256 Identities=31% Similarity=0.512 Sum_probs=217.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence 36899999999999999999999999999999987543 233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
+||+++++|.+++... ++++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE---GDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEcccccceeeccccc
Confidence 9999999999988765 78999999999999999999999999999999999999654 45999999999876543 2
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......|++.|+|||.+. ..++.++||||||+++|+|++|.+||...+.......+...... ......++..+.+++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 231 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--SLEGNKFSKPFKDFV 231 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--CCcccccCHHHHHHH
Confidence 334567889999999887 46899999999999999999999999776655544444433211 111122788999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+||..+|++|||+.++++||||++..
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=338.50 Aligned_cols=255 Identities=30% Similarity=0.517 Sum_probs=214.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++|.+.+.||+|++|.||.|.+..+++.+|+|.+....... ......+.+|+.+++++ +||||+++++++.+....+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 36899999999999999999999999999999987543221 22345788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+|+||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~---~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecccc
Confidence 999999999999999888889999999999999999999999999999999999999644 45999999998765432
Q ss_pred Cc----ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 214 EQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 214 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.. .....|++.|+|||.+.+ .++.++||||+|+++|+|++|..||...........+...... ......++..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCC--CCCCccCCHH
Confidence 21 133567889999999874 5889999999999999999999999776555444443332221 1222357899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+++.+||..+|++|||+.++++||||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=381.94 Aligned_cols=261 Identities=30% Similarity=0.504 Sum_probs=231.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.+||++++.||+|+||.|.+++++.|++.||+|++.+.......+..-|..|-.+|..- +.+-|++++-.|+++.++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceE
Confidence 345899999999999999999999999999999999876555555566788888899877 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|..++.+..++++..++.++..|+.||.-||+.|+|||||||+|||++. .++|||+|||.+..+..+
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~---~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK---SGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc---cCcEeeccchhHHhcCCC
Confidence 99999999999999999889999999999999999999999999999999999999964 556999999998877633
Q ss_pred C--cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--ccccCCCCCc
Q 014722 214 E--QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VIDFKRDPWP 283 (419)
Q Consensus 214 ~--~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 283 (419)
. .....+|||-|.|||++. +.|++.+|+||+||++|||+.|..||+..+..++..+|++- .+.|+ .-.
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~ 306 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DET 306 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--ccc
Confidence 3 245678999999999985 35899999999999999999999999999999999999876 45555 334
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCccccCcc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNAKK 321 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s---~~~~l~~~~~~~~~~ 321 (419)
.+|+++++||.+++. +|+.|.. ++++-+||||....+
T Consensus 307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 699999999999996 5889998 999999999987543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.50 Aligned_cols=259 Identities=26% Similarity=0.460 Sum_probs=210.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+.++|++++.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence 355689999999999999999999999999999999875432 222345677899999999 899999999987543
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..+|++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~---~~~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED---CELRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC---CCEEEcCCcc
Confidence 4578999998 678877664 4579999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-------- 276 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 276 (419)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 986543 2345678999999999864 5889999999999999999999999876655444443321100
Q ss_pred ---------------cCC----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 ---------------FKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ---------------~~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+. ..+...++.+.+||.+||..||++|||+.|+|+||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000 01223567789999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=339.65 Aligned_cols=254 Identities=31% Similarity=0.502 Sum_probs=212.0
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999987543 22345678899999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|+||+++++|.+++...+.+++.++..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN---GHVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEECcceeeeEccCcc
Confidence 99999999999999888889999999999999999999999999999999999999644 459999999987654322
Q ss_pred -cccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCccCCHH
Q 014722 215 -QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKVSEN 288 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 288 (419)
......|++.|+|||++. +.++.++|||||||++|+|++|..||..................... .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 224457899999999873 35888999999999999999999999765544333333222221111 111246789
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
+.+++.+||..+|++|||+.++++|||
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=341.20 Aligned_cols=254 Identities=31% Similarity=0.494 Sum_probs=208.1
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|++|.||+|++..++..||+|.+..... .......+.+|+.+++++ +||||+++++++.++..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence 58999999999999999999999999999999875432 222345778899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 137 ELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||++ ++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC---CcEEECcccceeecCCC
Confidence 9997 5888877542 468999999999999999999999999999999999999654 45999999998755322
Q ss_pred C-cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------------
Q 014722 214 E-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------------- 277 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------- 277 (419)
. ......+++.|+|||++.+ .++.++||||||+++|+|+||.+||.+.........+.......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467889999998763 47889999999999999999999998776544433332211100
Q ss_pred ------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 ------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 ------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
....+..+++++.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=345.97 Aligned_cols=258 Identities=31% Similarity=0.553 Sum_probs=220.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|++|.||+|.+..+++.||+|.+.............+.+|+++++.+ +||||+++++++.+....|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEE
Confidence 699999999999999999999999999999999876554434567789999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES---GHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC---CCEEEeecchhhcccccc
Confidence 999999999988754 468999999999999999999999999999999999999754 459999999886543211
Q ss_pred ------------------------------cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCH
Q 014722 215 ------------------------------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE 263 (419)
Q Consensus 215 ------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 263 (419)
......||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1123468899999999874 688899999999999999999999988877
Q ss_pred HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCCccccCc
Q 014722 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT----AEEVLEHPWLQNAK 320 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s----~~~~l~~~~~~~~~ 320 (419)
......+......+.. ...+++.+.++|.+||..||++||| +.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 238 DETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 7666666544433322 1237899999999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=340.22 Aligned_cols=256 Identities=30% Similarity=0.577 Sum_probs=212.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++++ +||||+++++++.....+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence 3699999999999999999999999999999998754321 22235678899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||+++++|..++.....+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ---GQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC---CcEEECccccceecCCCcc
Confidence 9999998888777666679999999999999999999999999999999999999654 459999999998765433
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 276 (419)
......++..|+|||++.+ .++.++||||+|+++|+|++|.+||.+....+....+......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334568889999998763 4788999999999999999999999877665544433221100
Q ss_pred ---cCC--------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 ---FKR--------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 ---~~~--------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+. ..++.++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0123568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=353.37 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=220.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..|.-++.||+|+||.||-|++..+.+.||||.+....-.......++..|+..|++| .|||++.+-++|..+...|+|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHH
Confidence 4588889999999999999999999999999999766555556678899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||-| +-.|++. .+.++.+.+++.|..+.+.||+|||+++.||||||..|||++ +.+.|||+|||.|....+
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc--
Confidence 999964 6666654 345799999999999999999999999999999999999995 456699999999876543
Q ss_pred cccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-ccCCCCCccCCHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-DFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~ 289 (419)
.++++|||+|||||++. |+|+-++||||||++..||...++|+...+....+-.|-+... ..... ..|..+
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~---eWS~~F 254 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSN---EWSDYF 254 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCc---hhHHHH
Confidence 46789999999999864 6899999999999999999999999988887766666655432 22333 347889
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++||..||++-|..|||.+++|+|+|....+
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 9999999999999999999999999998643
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=343.60 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=212.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+++++++ +||||+++++++.+++.+++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEe
Confidence 6999999999999999999999999999999986542 233456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||++|++|.+++...+.+++..+..++.|++.||.|||+ .+++||||||+||+++.+ +.+||+|||++...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC---CcEEEccCCCccccccc-c
Confidence 999999999999888889999999999999999999998 599999999999999754 45999999998765322 2
Q ss_pred ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----------------
Q 014722 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----------------- 277 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----------------- 277 (419)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 345678999999998864 58889999999999999999999997655433222221110000
Q ss_pred -----------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 278 -----------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 278 -----------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+..+...++.++.+|+.+||..+|++|||+.++++||||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000112367889999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=338.66 Aligned_cols=252 Identities=28% Similarity=0.500 Sum_probs=217.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+++++++ +||||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 489999999999999999999989999999999876554444567899999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||+.|++|.+++....++++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ---GHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC---CCEEEeecccccccCCCccc
Confidence 999999999999887789999999999999999999999999999999999999754 45999999998876554444
Q ss_pred cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...+. ......... .........+..+.++
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET----ADVLYPATWSTEAIDA 232 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc----ccccCcccCcHHHHHH
Confidence 5567889999999987 4578999999999999999999999987663 222222211 1222234578999999
Q ss_pred HHHhcCCCCCCCCCH--HHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTA--EEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~--~~~l~~~~~ 316 (419)
|.+||..||.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.56 Aligned_cols=253 Identities=31% Similarity=0.520 Sum_probs=212.9
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++....+||||+++++++..++.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999999999999999987654322223344555665555444899999999999999999999999999
Q ss_pred cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccccc
Q 014722 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221 (419)
Q Consensus 142 g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 221 (419)
++|.+++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.+ ..++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT---GHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CcEEEeecccceeccc---cccCCC
Confidence 9999999888889999999999999999999999999999999999999653 4599999998875432 234568
Q ss_pred CcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCC
Q 014722 222 SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300 (419)
Q Consensus 222 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 300 (419)
++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+.......+......+.......+++++.+++.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 899999998864 5789999999999999999999999888877777766665555544444568999999999999999
Q ss_pred CCCCC---CHHHHhcCCccccCc
Q 014722 301 PKQRL---TAEEVLEHPWLQNAK 320 (419)
Q Consensus 301 p~~R~---s~~~~l~~~~~~~~~ 320 (419)
|++|| ++.|+++||||++..
T Consensus 236 p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHHccCCCcHHHHHcChHhhcCC
Confidence 99999 557999999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=351.06 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=200.5
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 457999999999999999999752 356789999987432 2334567889999999997899999999988754
Q ss_pred -CeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 014722 130 -SAVHIVMELCEGGELFDRIVAR--------------------------------------------------------- 151 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 151 (419)
..+++||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988652
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCc
Q 014722 152 -----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSP 223 (419)
Q Consensus 152 -----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~ 223 (419)
..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........ .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC---CCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23778888999999999999999999999999999999964 34599999999986543222 12344678
Q ss_pred ccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCC
Q 014722 224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301 (419)
Q Consensus 224 ~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 301 (419)
.|+|||++. ..++.++|||||||++|+|++ |..||.+................. .....+++.+.+++.+||+.||
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCh
Confidence 899999876 568999999999999999997 999998765433332222221111 1224578999999999999999
Q ss_pred CCCCCHHHHhc
Q 014722 302 KQRLTAEEVLE 312 (419)
Q Consensus 302 ~~R~s~~~~l~ 312 (419)
++|||+.++++
T Consensus 319 ~~RPs~~el~~ 329 (338)
T cd05102 319 KERPTFSALVE 329 (338)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=342.39 Aligned_cols=258 Identities=30% Similarity=0.526 Sum_probs=220.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.+ +||||+++++.+..++.+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEE
Confidence 699999999999999999999999999999998765433334456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++. .+.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~---~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC---CCCEEEeeCCCccccCcCccc
Confidence 99999999999988888999999999999999999999999999999999999964 4459999999886421100
Q ss_pred --------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 215 --------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 215 --------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
......|+..|+|||.+. ..++.++|+||||+++|+|++|..||.+....+....+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 011245788999999876 56899999999999999999999999988877777766665444333
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCccccC
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNA 319 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s---~~~~l~~~~~~~~ 319 (419)
... .++.++.++|.+||+.||++||+ +.++++||||...
T Consensus 238 ~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 238 GDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 322 57899999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=331.79 Aligned_cols=252 Identities=27% Similarity=0.477 Sum_probs=217.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+ +||||+++++++.+.+.+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence 488889999999999999999999999999998765433 34567888999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||++|++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~---~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC---CCEEEcccccceeccCcc
Confidence 999999999998764 568999999999999999999999999999999999999754 459999999988765433
Q ss_pred c-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
. .....|++.|+|||++. +.++.++|+||||+++|+|++|..||...+.......+......... ..++..+.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS---QMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---cccCHHHHHH
Confidence 2 23456889999999876 46889999999999999999999999888776666666554332211 2578899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+||+.+|++||++.++++|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=339.86 Aligned_cols=260 Identities=28% Similarity=0.409 Sum_probs=214.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999998899999999986532 333456788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 136 MELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|||++|++|..++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++. ++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC---CCCEEEeecCCccccc
Confidence 9999999998887663 368999999999999999999997 59999999999999975 4459999999987653
Q ss_pred CCCcccccccCcccCchhhhcc-------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
.. ......|++.|+|||.+.+ .++.++||||+||++|+|++|..||...........+............+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2234568889999998752 257899999999999999999999976554443333222111112222345
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
+++++.+||.+||+.+|++||++.++++||||......
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 88999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=337.36 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=210.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.+ +||||+++++++...+.++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEE
Confidence 34579999999999999999999999999999999865422 2345678899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||++......
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN---GDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC---CCEEECcCccceeeccc
Confidence 999999999999999888889999999999999999999999999999999999999644 45999999998865432
Q ss_pred C-cccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-CCccCCH
Q 014722 214 E-QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-PWPKVSE 287 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~ 287 (419)
. ......|++.|+|||.+. ..++.++||||+||++|+|++|..||...........+.......... ....++.
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSS 239 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCH
Confidence 2 223456889999999874 347889999999999999999999996554333222222221111111 1124688
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
.+.+|+.+||..+|++|||++++++|+|
T Consensus 240 ~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 240 TFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=339.34 Aligned_cols=253 Identities=32% Similarity=0.548 Sum_probs=211.8
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++...+.+|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999999999999999999765443333455667899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccccc
Q 014722 144 LFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221 (419)
Q Consensus 144 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 221 (419)
|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH---GNVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC---CCEEEccCcchhhhccCCccccccC
Confidence 999987755 69999999999999999999999999999999999999654 4599999999876654444445678
Q ss_pred CcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCC
Q 014722 222 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300 (419)
Q Consensus 222 t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 300 (419)
+..|+|||++. +.++.++||||+|+++|+|++|..||...........+..............+++.+.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999876 46888999999999999999999999766542223333333333333333467999999999999999
Q ss_pred CCCCC-----CHHHHhcCCccccCc
Q 014722 301 PKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 301 p~~R~-----s~~~~l~~~~~~~~~ 320 (419)
|++|| ++.++++||||+...
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcCC
Confidence 99999 899999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=336.64 Aligned_cols=255 Identities=31% Similarity=0.498 Sum_probs=215.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+ +||||+++++++...+..++|+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEE
Confidence 478999999999999999999999999999998643 234566788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
||+++++|..++.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++...... .
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~---~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC---CCEEEcccccccccccccc
Confidence 99999999887765 4579999999999999999999999999999999999999654 45999999998754322 2
Q ss_pred cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 215 QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
......||+.|+|||++. ..++.++||||+||++|+|++|.+||...+.......+....... ......++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSE 237 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHH
Confidence 234457899999999873 247789999999999999999999998877666555554432211 1112357889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+||.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=334.99 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=215.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.+ +||||+++++.+...+.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence 36999999999999999999998899999999987544322 567889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 136 MELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|++++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~---~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED---GSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEcccchHHHhcc
Confidence 9999999999998764 458999999999999999999999999999999999999754 4599999999876654
Q ss_pred CCcc-----cccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC--CCc
Q 014722 213 GEQF-----NEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD--PWP 283 (419)
Q Consensus 213 ~~~~-----~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~ 283 (419)
.... ....|+..|+|||++.. .++.++|+||||+++|+|++|..||...+.................. .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3222 33468999999998863 58899999999999999999999998776655555554432221111 124
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+++.+.+++.+||..||++|||+.++++||||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=338.48 Aligned_cols=256 Identities=32% Similarity=0.509 Sum_probs=216.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|+||.||+|.+..++..+|+|++... .....+.+.+|+.+++++ +||||+++++++..+...|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEE
Confidence 5699999999999999999999889999999998643 344556788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~---~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD---GDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC---CCEEEccCccchhhcccc
Confidence 9999999999988763 569999999999999999999999999999999999999654 45999999987654322
Q ss_pred CcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 214 EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.......||+.|+|||.+. ..++.++||||||+++|+|++|.+||...........+....... ......++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT-LDQPSKWSS 236 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC-cCCcccCCH
Confidence 2223456899999999874 236779999999999999999999998877666555554432211 111235788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
++.+++.+||+.+|.+|||+.++++||||.+.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=346.34 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=204.2
Q ss_pred eccccccc--cceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 60 LGRELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 60 ~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
++++||+| +||+||++.+..+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 7899999999999999999999765432 33456788899999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CC
Q 014722 138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GE 214 (419)
Q Consensus 138 ~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~ 214 (419)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++++||+.+..... +.
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~---~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC---CcEEEcccchhhccccccc
Confidence 99999999988653 458999999999999999999999999999999999999754 3599999986543221 11
Q ss_pred c-------ccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC------
Q 014722 215 Q-------FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK------ 278 (419)
Q Consensus 215 ~-------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 278 (419)
. .....++..|+|||++.+ .++.++|||||||++|+|++|..||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0 112346778999999863 588999999999999999999999976654443333322211100
Q ss_pred ------------------------------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 279 ------------------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 279 ------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+....+++++.+|+.+||+.||++|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00011346789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=335.93 Aligned_cols=254 Identities=26% Similarity=0.461 Sum_probs=210.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
..+.|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3457999999999999999999999999999999986542 23457788999999986799999999998753
Q ss_pred --CeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 130 --SAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
..+|+||||+.+++|.+++... ..+++..+..++.|++.||+|||+++|+||||+|+||+++.+ ..++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~---~~~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN---AEVKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC---CCEEEccCC
Confidence 4689999999999999988763 358999999999999999999999999999999999999654 459999999
Q ss_pred cceeccCCC-cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 206 LSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 206 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
++....... ......|++.|+|||++. ..++.++||||+||++|+|++|..||...........+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--AP 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CC
Confidence 988654322 234567899999999874 247889999999999999999999997665544433332221 12
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
......++..+.+|+.+||..+|.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.64 Aligned_cols=254 Identities=29% Similarity=0.496 Sum_probs=205.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|++..+|+.+|+|.+...... ......+.+|+.+++++ +||||+++++++.+...+++|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence 488999999999999999999999999999999754322 22234677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...... .
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN---GELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC---CcEEECccchhhccCCCCC
Confidence 9997 478777765 5679999999999999999999999999999999999999754 45999999998765432 2
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcccc--------------c
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVID--------------F 277 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~--------------~ 277 (419)
......+++.|+|||++.+ .++.++|||||||++|+|+||..|| .+.+.......+...... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2334567899999998764 4788999999999999999988875 444444433333221100 0
Q ss_pred ---C--------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 ---K--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 ---~--------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
. ....+.+++++.+||.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=338.43 Aligned_cols=259 Identities=31% Similarity=0.523 Sum_probs=216.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+.+|+.+++.+ +||||+++++.+......|
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence 345899999999999999999999999999999998765432 346788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~---~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCEEECccccchhcccc
Confidence 99999999999998864 468999999999999999999999999999999999999643 45999999988765433
Q ss_pred Cc-ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 EQ-FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.. .....|++.|+|||.+.+ .++.++|||||||++|+|++|..||...........+..... ........++..+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHHHH
Confidence 22 234578999999998864 578999999999999999999999987765443333322211 111122457889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+||..+|++|||+.++++||||.....
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 278 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence 999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=337.67 Aligned_cols=242 Identities=18% Similarity=0.216 Sum_probs=205.5
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----CCeEEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSAVHIVME 137 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~~~lv~e 137 (419)
..||+|++|.||+|.. +|+.||+|.+...........+.+.+|+.+|+++ +||||+++++++.+ ...+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999985 7899999999765443333357788999999999 99999999999876 457899999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
|++||+|.+++.+...+++.....++.|++.||.|||+. +++||||||+||+++.+ +.+||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~---~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN---YKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC---CcEEEcccchHhhhcccc--
Confidence 999999999998888899999999999999999999985 99999999999999654 459999999987654322
Q ss_pred cccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
....||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+..+....+.........+ ...++.+.+|+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP--LDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCcHHHHHHH
Confidence 2356889999999986 368999999999999999999999999888777776665544332221 25789999999
Q ss_pred HHhcCCCCCCCCCHHHHhcC
Q 014722 294 KKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+||+.||++|||+.++++.
T Consensus 256 ~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HHHhcCCcccCcCHHHHHHH
Confidence 99999999999999999753
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=338.28 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=207.5
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++ +||||+++++++...+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEE
Confidence 6889999999999999999999999999999986542 233446788999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~---~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC---CCEEEeeCCcceecccc-cc
Confidence 99999988543 357899999999999999999999999999999999999654 45999999998765432 23
Q ss_pred cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcccccCCCCCccCCHH
Q 014722 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
....||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+.... .........+++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 228 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--PPVLPVGQFSEK 228 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--CCCCCCCcCCHH
Confidence 4467899999999876 46899999999999999999999999653211 1111111111 111123357889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.+++.+||+.+|++||++.++++||||....
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 99999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=337.59 Aligned_cols=260 Identities=29% Similarity=0.477 Sum_probs=216.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...+.|++++.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.+ +||||+++++++..++.+
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeE
Confidence 3446799999999999999999999999999999998654 334567788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+||||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~kl~dfg~~~~~~ 161 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD---GDIKLADFGVSAKNV 161 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC---CCEEEccCccceecc
Confidence 999999999999887755 4568999999999999999999999999999999999999643 459999999887543
Q ss_pred CC-CcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 212 PG-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 212 ~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
.. .......+++.|+|||.+. ..++.++|||||||++|+|++|.+||...+.......+...... .......
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~ 240 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSK 240 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCcc
Confidence 22 2234556889999999874 24678999999999999999999999876655544444332211 1111235
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++.++.+++.+||..+|++||++.++++||||....
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 688999999999999999999999999999998644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=343.64 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=202.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|+++++||+||.+.||++.. .+.+.||+|.+.... .+...+..+.+||.+|.+|.+|.+||++++|-..++.+|+||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred hhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 599999999999999999995 445677777665443 355568899999999999999999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||= ..+|...|.+.... +...++.+..||+.|+.++|+.||||.||||.|+|+. .+.+||+|||.|..+.+...
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV----kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV----KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----eeeEEeeeechhcccCcccc
Confidence 975 46998888876553 3358899999999999999999999999999999995 35599999999998875543
Q ss_pred ---ccccccCcccCchhhhcc------------cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCC
Q 014722 216 ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKR 279 (419)
Q Consensus 216 ---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~ 279 (419)
..+.+||+.|||||++.. ..+.++||||||||||+|+.|++||..... ..-+..|..-.. .
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~---~ 591 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH---E 591 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc---c
Confidence 346789999999998741 156789999999999999999999954432 111222222111 1
Q ss_pred CCCccC--CHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 280 DPWPKV--SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 280 ~~~~~~--~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
-.++.+ ..++.++++.||..||++|||+.++|+|||++-
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 122222 234999999999999999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=342.55 Aligned_cols=260 Identities=32% Similarity=0.531 Sum_probs=231.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|+.-+.||+|+||.||.++...||+-+|+|.+.++.+.........++|-.+|.++ +.|.||.+--.|+..+.+++|+
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEE
Confidence 477778899999999999999999999999999887766555556778999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
..|.||+|.-+|.+.+ .++++.++.++.+|+.||.+||+.+||+|||||+|||++. .++|+|+|+|+|..+..+.
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd---~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD---HGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc---CCCeEeeccceEEecCCCC
Confidence 9999999988887755 6999999999999999999999999999999999999964 4569999999999999888
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....+||.+|||||+++ +.|+...|.|||||++|+|+.|+.||.......-.+.+.+.....+.....++|+++++|.
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc 421 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLC 421 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHH
Confidence 888889999999999997 5699999999999999999999999987766555556655555555555568999999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCCccccCc
Q 014722 294 KKMLNPDPKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 294 ~~~L~~dp~~R~-----s~~~~l~~~~~~~~~ 320 (419)
..+|++||++|. +++++-+||||+...
T Consensus 422 ~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 422 EGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred HHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 999999999998 677999999999754
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=339.75 Aligned_cols=263 Identities=30% Similarity=0.523 Sum_probs=217.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
+...+|.+++.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEE
Confidence 445689999999999999999999999999999999875432 2346688899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~---~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEECcCccceEccC
Confidence 999999999999998865 468999999999999999999999999999999999999643 4599999999876544
Q ss_pred CCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
... .....+++.|+|||.+. ..++.++|+||+||++|++++|..||...+.......+.... .........++..+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 246 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFR 246 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHH
Confidence 332 23456889999999886 468899999999999999999999997765433222222111 111112235788999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCccCCC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~ 324 (419)
+|+.+||..+|++|||+.++++||||+.....+.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 9999999999999999999999999997665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=352.73 Aligned_cols=255 Identities=24% Similarity=0.438 Sum_probs=206.2
Q ss_pred CccccceeeccccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+++.+ +||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEeeC
Confidence 345668999999999999999999753 45688999987643 2345799999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..+|+|||++. ++|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~---~~~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP---ENAVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEccCccccc
Confidence 99999999995 6888988777889999999999999999999999999999999999999654 4599999999876
Q ss_pred ccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccc----ccC
Q 014722 210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVI----DFK 278 (419)
Q Consensus 210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~----~~~ 278 (419)
...... .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.... .....+.+... .++
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 23467999999999987 46899999999999999999999999765421 12222221100 000
Q ss_pred ------------------CCCC--------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 279 ------------------RDPW--------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 279 ------------------~~~~--------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...+ ...+.++.++|.+||..||++|||+.++|.||||++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000 1246788999999999999999999999999999863
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.70 Aligned_cols=252 Identities=26% Similarity=0.532 Sum_probs=213.1
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-CCeEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVHIV 135 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~lv 135 (419)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+.+|+.+++++ +|||++++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999999999999999875443 233456788999999999 89999999998764 4468999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||+++++|.+.+... ..+++.++..++.|++.||.+||++|++||||+|+||+++. ++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~---~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR---TNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec---CCcEEEecccceEEeccc
Confidence 9999999999988763 35899999999999999999999999999999999999964 445999999998876432
Q ss_pred C-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 E-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. ......|++.|+|||++. ..++.++||||+|+++|+|++|..||...+.......+..+... ......++.+.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence 2 233456899999999876 46889999999999999999999999887766665555554331 122457899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
++.+||+.||++|||+.++++||||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=332.94 Aligned_cols=253 Identities=29% Similarity=0.500 Sum_probs=212.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh------hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA------VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+|.+...||.|++|.||+|.+..+++.+|+|.+........ ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence 37788899999999999999988999999998875433221 1235688999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..++|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++. +..++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~---~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN---KGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC---CCCEEecccCCCccc
Confidence 99999999999999999988888999999999999999999999999999999999999964 445999999998766
Q ss_pred cCCC-------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 211 RPGE-------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 211 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
.... ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...+.......+.... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---SPEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---CCcCC
Confidence 4221 112345888999999886 468889999999999999999999998766544443333321 11222
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..++..+.++|.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 3578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=332.74 Aligned_cols=250 Identities=32% Similarity=0.595 Sum_probs=213.8
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||.|++|.||+|++..+++.+|+|++...........+.+.+|+.+++.+ +||||+++++++.++..+++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 69999999999999889999999999866544444557899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCc
Q 014722 144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223 (419)
Q Consensus 144 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~ 223 (419)
|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.............|++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC---CCEEEeeCCcccccCcccccccccCCc
Confidence 99999887789999999999999999999999999999999999999654 459999999998765543334567899
Q ss_pred ccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCC
Q 014722 224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPD 300 (419)
Q Consensus 224 ~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 300 (419)
.|+|||.+. ..++.++|+||+|+++|+|++|..||.... .......+.........+ ...++++.++|.+||..+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP--NYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHccCC
Confidence 999999876 468899999999999999999999997776 444555544322211111 234889999999999999
Q ss_pred CCCCCC-----HHHHhcCCccccC
Q 014722 301 PKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 301 p~~R~s-----~~~~l~~~~~~~~ 319 (419)
|++||+ +.|+++||||+..
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=335.36 Aligned_cols=249 Identities=27% Similarity=0.506 Sum_probs=215.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.-|.++++||+|+||.||+|.++.+|+.+|||.+... .+++++..||.+++++ +.|++|++|+.|.....+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence 4589999999999999999999999999999998754 3678999999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
||||..|++.+.+.. +.++++.++..+++..+.||.|||...=+|||||..|||++.+ +..||+|||.|..+.+.
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~---G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD---GIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc---chhhhhhccccchhhhhH
Confidence 999999999998875 4579999999999999999999999999999999999999654 45899999999876543
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---C---ccCC
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP---W---PKVS 286 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~---~~~~ 286 (419)
...++..|||.|||||++.. .|+.++||||||++..||..|++||....... ..+-.+..+ + ...|
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------AIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR-------AIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-------eeEeccCCCCCCCCChHhhh
Confidence 23467899999999999985 79999999999999999999999996544321 111111111 1 1247
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.++.+||++||.++|++|-|+.++++|||+++..
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 8899999999999999999999999999998753
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=351.51 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=198.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++++ +||||+++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999985432 234689999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+|++. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||++.......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV---DQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEecCccccccccCc
Confidence 99995 588888765 4568999999999999999999999999999999999999654 459999999987544333
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCC-CCCCHH---------HHHHHHHhccc----ccC-
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF-WAETEQ---------GVAQAIIRSVI----DFK- 278 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~---------~~~~~i~~~~~----~~~- 278 (419)
......||+.|+|||++. ..++.++|||||||++|+|+++..|+ ...... .....+..... .++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 444567999999999886 47899999999999999999855444 322110 11111111100 000
Q ss_pred -----------------CC--------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 279 -----------------RD--------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 279 -----------------~~--------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.. ....++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 01245677889999999999999999999999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=333.82 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=202.9
Q ss_pred cceeecccc--ccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGREL--GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+.+||||+++++++...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 457777776 99999999999999999999999987543221 12223333337999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+++++|.+++.....+++.++..++.|++.||.|||+.|++||||+|+||+++.++ ..++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK--DRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC--CeEEEecCccceecCCC
Confidence 9999999999999998877899999999999999999999999999999999999997544 25999999998765432
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
....|++.|+|||++. ..++.++||||+|+++|+|++|..||.......................++..++.+.+|
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHH
Confidence 2346889999999987 468899999999999999999999997554433211111111122223344689999999
Q ss_pred HHHhcCCCCCCCCC-HHHHhcCCcccc
Q 014722 293 VKKMLNPDPKQRLT-AEEVLEHPWLQN 318 (419)
Q Consensus 293 i~~~L~~dp~~R~s-~~~~l~~~~~~~ 318 (419)
|.+||+.+|.+||+ ++++|+||||++
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999996 699999999974
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=355.37 Aligned_cols=267 Identities=29% Similarity=0.503 Sum_probs=222.5
Q ss_pred CCCCccccceeecc-----ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeee
Q 014722 49 PSGQDISIDYDLGR-----ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123 (419)
Q Consensus 49 ~~~~~~~~~y~~~~-----~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~ 123 (419)
+.+..+.-+|+..+ .||+|.||+||.|+|..|....|||.+..+. ....+-+..||.+.++| .|.|||+++
T Consensus 563 ~ane~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~L-rHkNIVrYL 638 (1226)
T KOG4279|consen 563 PANEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTL-RHKNIVRYL 638 (1226)
T ss_pred CcccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHH-hhHhHHHHh
Confidence 33444566666543 4999999999999999999999999997553 23456688899999999 999999999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 124 DTYEDDSAVHIVMELCEGGELFDRIVAR-GHY--TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
|.+..++++-|.||-++||+|.+++... +++ .|..+..+.+||++||.|||++.|||||||-+|+|++. -.+.+|
T Consensus 639 Gs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT--ySGvlK 716 (1226)
T KOG4279|consen 639 GSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT--YSGVLK 716 (1226)
T ss_pred hccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee--ccceEE
Confidence 9999999999999999999999998764 566 88999999999999999999999999999999999974 356799
Q ss_pred EeecccceeccCC-CcccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 201 AIDFGLSVFFRPG-EQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 201 l~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
|+|||-++....- .-..++.||..|||||++. +.|+.++|||||||++.||.||++||....... .....-+.+.
T Consensus 717 ISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyK 795 (1226)
T KOG4279|consen 717 ISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYK 795 (1226)
T ss_pred ecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hhhhhhccee
Confidence 9999998876533 3345788999999999997 369999999999999999999999997654432 2223334444
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
...+....++.++++||.+|+.+||..||||.++|..||++...+.
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk 841 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKK 841 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCC
Confidence 4444445688899999999999999999999999999999876443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=339.22 Aligned_cols=261 Identities=31% Similarity=0.511 Sum_probs=214.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 4888999999999999999999999999999997654321 12234567899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||+ +++|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.+ +.++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~---~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC---CCEEEccceeeeeccCC
Confidence 99999 889999987765 79999999999999999999999999999999999999754 45999999999876543
Q ss_pred -CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-----------
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----------- 279 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 279 (419)
.......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+.........+.........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 22334457888999998753 5788999999999999999999888877665554444332111000
Q ss_pred -------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 280 -------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
..+...+..+.++|.+||..||++|||+.++++||||++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 0123457889999999999999999999999999999985443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=337.42 Aligned_cols=257 Identities=32% Similarity=0.544 Sum_probs=217.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||.|++|.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.....+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEE
Confidence 469999999999999999999999999999999875432 2346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
+||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||+|+||+++. ++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~---~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEccCccchhcccccc
Confidence 999999999988765 46899999999999999999999999999999999999964 34599999999876543322
Q ss_pred -ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 216 -FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 216 -~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....|++.|+|||.+. +.++.++|||||||++|+|++|..||...+.......+..... ........+++.+.++|
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 249 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSPIFRDFL 249 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-cccCCcccCCHHHHHHH
Confidence 23456889999999886 4588999999999999999999999988776554444433221 11222346789999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.+||..||++|||+.++++||||+....
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 9999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-45 Score=334.89 Aligned_cols=270 Identities=27% Similarity=0.451 Sum_probs=221.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..|+..+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++++ +||||+++++++.++..+++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence 45888999999999999999998999999999987543 233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC---CCEEEcccccceeccCCcc
Confidence 999999999998865 578999999999999999999999999999999999999754 459999999987654332
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......++..|+|||.+. ..++.++|+||||+++|+|++|.+||...........+.... .......++..+.+++
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li 233 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFI 233 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC---CCCCchhhhHHHHHHH
Confidence 223456888999999886 468899999999999999999999998776555444332221 1122235678899999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhh
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (419)
.+||+.+|++||++.++++||||.+.... .+....+++++++
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~--~~~~~~~~~~~~~ 275 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKNAKK--TSYLTELIDRFKR 275 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhcchh--hhHHHHHHHHHHh
Confidence 99999999999999999999999865432 3333444555444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=337.55 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=213.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++++ +||||+++++++.....+++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence 589999999999999999999999999999998765432 23356788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
||+ +++|.+++.. ...+++.++..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA---DGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC---CCcEEEeeeeecccccCCCC
Confidence 999 9999998865 456899999999999999999999999999999999999975 3459999999988665432
Q ss_pred -cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------------
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-------------- 277 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------------- 277 (419)
......|+..|+|||++.+ .++.++||||+|+++|+|++|.+||.+.........+.......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578999999998753 46889999999999999999999998777655554444321110
Q ss_pred -----CC-------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 278 -----KR-------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 278 -----~~-------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
.. ..++..+..+.+||.+||..+|++|||+.++++||||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 11234678999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=333.45 Aligned_cols=258 Identities=26% Similarity=0.478 Sum_probs=212.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+|+..+.||+|++|.||+|.+..+++.+|+|++....... ....+.+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999987543221 12356788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+|+||++|++|.+++...+++++..+..++.|++.||.|||++|++||||+|+||+++.++ ..+||+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~--~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG--QRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEEcccccccccccc
Confidence 9999999999999998888899999999999999999999999999999999999996432 34999999998766432
Q ss_pred Cc-----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-cCCCCCccCC
Q 014722 214 EQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-FKRDPWPKVS 286 (419)
Q Consensus 214 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~ 286 (419)
.. .....||..|+|||.+. ..++.++||||+|+++|+|++|..||...........+...... ........++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 11 12346888999999876 46889999999999999999999999655433222222221111 1112223578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
+++.+++.+||..+|++|||+.++++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 8999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=328.02 Aligned_cols=252 Identities=31% Similarity=0.519 Sum_probs=218.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence 589999999999999999999999999999998765433 33456788999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+++++|.+++... ..+++.++..++.|++.||.|||+.|++||||+|+||+++.+ ..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~---~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA---GLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC---CCEEECcCcceEEccccc
Confidence 999999999998764 458999999999999999999999999999999999999754 459999999988764433
Q ss_pred -cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|++.|+|||.+.+ .++.++||||+|+++|+|++|..||......+....+........ ...++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence 3345678999999998764 578899999999999999999999988887777777665443221 24578999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+||..+|.+|||+.++++|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=329.05 Aligned_cols=253 Identities=28% Similarity=0.486 Sum_probs=218.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence 589999999999999999999999999999999765443 33467889999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +..+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~--~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH--KMVVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC--CCEEEEccCCCceecCCCc
Confidence 999999999999764 348999999999999999999999999999999999999643 3358999999998776554
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......|++.|+|||.+. ..++.++||||+|+++|+|++|..||...+.......+...... .....+++++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA---PISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC---CCCCCcCHHHHHHH
Confidence 444567899999999987 45788999999999999999999999887776666665544322 12235789999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCcc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+||..+|++|||+.++++||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=337.88 Aligned_cols=256 Identities=27% Similarity=0.492 Sum_probs=212.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+.+|+.+++.+ +||||+++++++.+++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence 36999999999999999999998899999999987543322 2345678899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
+||+++++|.........+++.++..++.|++.||.|||+.|++||||+|+||+++. ++.++|+|||++...... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~---~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ---SGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC---CCcEEEEeeeeeeeccCCcc
Confidence 999999888887766667999999999999999999999999999999999999965 345999999998865433 2
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------------- 277 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------- 277 (419)
......++..|+|||++.+ .++.++||||||+++|+|++|.+||......+....+......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2344568899999998763 47889999999999999999999997766544433333211100
Q ss_pred ----C--------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 ----K--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 ----~--------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+ ...++.++..+.+|+.+||..+|++||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 01134678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.52 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=202.1
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhC--CCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--PKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l--~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
.||+|+||.||+|.+..+++.+|+|.+...............+|..+++.+ .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999999765443332223334444433332 279999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 220 (419)
|++|.+++...+.+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~---~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC---CCEEEccCCcceeccccC-ccCcC
Confidence 99999999888889999999999999999999999999999999999999644 459999999987554322 23456
Q ss_pred cCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcC
Q 014722 221 GSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLN 298 (419)
Q Consensus 221 gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~ 298 (419)
||+.|+|||.+. ..++.++||||+||++|+|++|..||........ ..+............+.++.++.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 899999999875 3578999999999999999999999975432211 1122222222223334678999999999999
Q ss_pred CCCCCCC-----CHHHHhcCCccccCc
Q 014722 299 PDPKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 299 ~dp~~R~-----s~~~~l~~~~~~~~~ 320 (419)
.||.+|| |+.++++||||+...
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 9999999 699999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=330.12 Aligned_cols=253 Identities=32% Similarity=0.522 Sum_probs=214.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++++ +||||+++++++.+...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEE
Confidence 479999999999999999999988999999999975532 2467889999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++++|.+++... ..+++.++..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED---GDVKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC---CCEEECccccchhhhhhh
Confidence 9999999999988776 689999999999999999999999999999999999999754 459999999987654332
Q ss_pred -cccccccCcccCchhhhc-c---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCCccCCHH
Q 014722 215 -QFNEIVGSPYYMAPEVLK-R---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPWPKVSEN 288 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~-~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 288 (419)
......++..|+|||.+. . .++.++||||||+++|+|++|.+||...+.......+......... ......+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 234457888999999875 3 5788999999999999999999999877665554444433222111 112345788
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
+.+++.+||..+|.+|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=330.20 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=208.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~ 132 (419)
+|++.+.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 699999999999999999999999999999998754322 223456788999999999 89999999999875 3678
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++++||+++++|.+.+.....+++.....++.|++.||.|||+.+|+||||+|+||+++.+ ..+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~---~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCCCcccccc
Confidence 9999999999999999887789999999999999999999999999999999999999643 4599999999876532
Q ss_pred C----CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 G----EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
. .......++..|+|||.+.+ .++.++||||+||++|+|++|..||...........+...... ......+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCH
Confidence 1 11233568899999998874 6889999999999999999999999776554443333221111 111124678
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
.+.+++ +||..+|++|||+.|+++||||+
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 889998 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.42 Aligned_cols=251 Identities=28% Similarity=0.494 Sum_probs=212.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|....+++.+|+|.+.... ..+.+.+|+++++.+ +||||+++++++.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence 47999999999999999999998889999999986432 257899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~---~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE---GQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC---CcEEEcccccchhcccCc
Confidence 999999999999875 4568999999999999999999999999999999999999754 459999999988765433
Q ss_pred -cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|+..|+|||++.+ .++.++||||+|+++|+|++|..||...........+...... .......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence 2334568899999999874 6889999999999999999999999776554433333221111 111123467899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+||+.||++|||+.++|.||||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=330.57 Aligned_cols=254 Identities=29% Similarity=0.463 Sum_probs=210.7
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC---ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+|.+.+.||.|+||.||+|.+ .+|+.+|+|.+...... .......+.+|+.+++++ +||||+++++++.+.+.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 488899999999999999986 57899999998754321 122345688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP- 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~- 212 (419)
+|+||++|++|.+++.+...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN---GIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC---CeEEeccchhhHhhhhc
Confidence 999999999999999887889999999999999999999999999999999999999644 4599999998875421
Q ss_pred ------CCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 213 ------GEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 213 ------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
........|++.|+|||.+.+ .++.++||||||+++|+|++|..||...........+...... .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CCCCCCCC
Confidence 111234568999999999874 6889999999999999999999999776654443333322111 11222457
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.++.++|.+||..+|++||++.++++||||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=335.62 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=209.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe----
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA---- 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~---- 131 (419)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999999865432 222345678899999999667999999999887665
Q ss_pred -EEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 132 -VHIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 132 -~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||+|+||+++.+ ++.+||+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence 8999999986 788877642 357999999999999999999999999999999999999752 3469999999
Q ss_pred cceeccCC-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC---
Q 014722 206 LSVFFRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR--- 279 (419)
Q Consensus 206 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--- 279 (419)
++...... .......+++.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+.......+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98765322 22233457889999998753 5789999999999999999999999887766555544432111110
Q ss_pred ---------------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 280 ---------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 280 ---------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
...+.+++++.+||.+||.+||.+|||+.+++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 01135788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.18 Aligned_cols=252 Identities=29% Similarity=0.531 Sum_probs=207.0
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHIV 135 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~lv 135 (419)
|++.+.||+|+||.||+|.+..+++.||+|++..... .. ......+|+..++++.+||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999875432 22 2234457899999996699999999999987 899999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+||+. ++|.+.+... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence 99997 4888877763 56899999999999999999999999999999999999975 569999999998765544
Q ss_pred cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 014722 215 QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 276 (419)
......+++.|+|||.+. +.++.++||||+||++|+|++|.+||.+.+..+....+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 445567899999999764 34788999999999999999999999887765544444321100
Q ss_pred --cCCC-------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 --FKRD-------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 --~~~~-------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
++.. ..+.++..+.++|.+||.++|++|||+.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 012467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.98 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=202.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|++++++| +||||+++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEE
Confidence 4479999999999999999999999999999996421 2356799999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||++. ++|.+++... ..+++..+..|+.|++.||.|||++||+||||||+|||++.+ ..+||+|||++......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~---~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP---EDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC---CCEEEcccCCceecccc
Confidence 999995 6888888664 469999999999999999999999999999999999999654 45999999999865432
Q ss_pred Cc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcccc-----
Q 014722 214 EQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--------EQGVAQAIIRSVID----- 276 (419)
Q Consensus 214 ~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~----- 276 (419)
.. .....||+.|+|||++. ..++.++|||||||++|||++|..|+.... ...+...+......
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 22456999999999987 468999999999999999999876553321 12222222221110
Q ss_pred ----------------------cCCCCCc---cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 277 ----------------------FKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 277 ----------------------~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.....|. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111122 35668999999999999999999999999999974
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.09 Aligned_cols=248 Identities=26% Similarity=0.481 Sum_probs=191.5
Q ss_pred cccccccceEEEEEEEcC--CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE--eCCeEEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAVHIVME 137 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~~~~~lv~e 137 (419)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+++.+ +||||+++++++. .+..+++|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEe
Confidence 579999999999999653 668999999865432 23567899999999 8999999999885 4567899999
Q ss_pred ecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCCCCeEEeecccc
Q 014722 138 LCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLS 207 (419)
Q Consensus 138 ~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~a 207 (419)
|+.+ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+..+ ...+.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9964 777776421 248899999999999999999999999999999999999643 24467999999999
Q ss_pred eeccCCC----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHh
Q 014722 208 VFFRPGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAIIR 272 (419)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~i~~ 272 (419)
....... ......||+.|+|||++.+ .++.++||||+||++|+|+||.+||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 8664322 2344578999999998864 4789999999999999999999999654321 11111111
Q ss_pred cccccC----------------------------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 273 SVIDFK----------------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 273 ~~~~~~----------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
...... .......+..+.+|+.+||+.||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000000 00001235568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.05 Aligned_cols=252 Identities=27% Similarity=0.574 Sum_probs=216.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence 589999999999999999999999999999998754332 23456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+.+++|.+.+.... .+++.++..++.|++.||.|||++|++|+||+|+||+++.+ ..++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~---~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEEeeccceeecCcch
Confidence 9999999999887643 57899999999999999999999999999999999999654 459999999987654332
Q ss_pred c-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
. .....|++.|+|||++. +.++.++|+||||+++|+|++|..||......+....+..+.... ....++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence 2 23456888999999976 467889999999999999999999998877777766665544321 123578899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
|.+||+.+|++||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=337.96 Aligned_cols=259 Identities=31% Similarity=0.487 Sum_probs=211.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~ 133 (419)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+....... .......+|+.+++++ +||||+++++++.+. +.++
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 46999999999999999999999999999999987543222 1123456799999999 899999999998755 5689
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+||||+.+ +|.+.+.. ...+++.++..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECccceeeecCC
Confidence 99999974 78887765 3568999999999999999999999999999999999999644 4599999999987654
Q ss_pred CC-cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC----------
Q 014722 213 GE-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR---------- 279 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 279 (419)
.. ......+++.|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+..+....+.........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 32 2233456788999998763 5789999999999999999999999988877776666542211100
Q ss_pred ---------CC-------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 280 ---------DP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 280 ---------~~-------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. ....++++.+||.+||+.||++|||+.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 00 123578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=327.53 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=213.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++++ +||||+++++++...+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence 588999999999999999999889999999999766432 34567899999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ- 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 215 (419)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++. ++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~---~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC---CCCEEEcccccccccCCCCCc
Confidence 99999999999988777999999999999999999999999999999999999975 44599999999887643322
Q ss_pred ----ccccccCcccCchhhhcc-c---CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 216 ----FNEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 216 ----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.....+++.|+|||++.+ . ++.++||||||+++|++++|..||.....................+.+..+++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 223567889999999863 3 78899999999999999999999976533222222222222222333445689
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+.++|.+||+.+|++|||+.+++.|||+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=332.77 Aligned_cols=256 Identities=26% Similarity=0.446 Sum_probs=210.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++.+|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4568999999999999999999999999999999986432 12356778999999987899999999998643
Q ss_pred -CeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 130 -SAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
..+++|+||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+||
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~---~~~kl~df 172 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDF 172 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEeec
Confidence 468999999999999988753 3568999999999999999999999999999999999999654 44999999
Q ss_pred ccceeccCCC-cccccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 014722 205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
|++....... ......|+..|+|||.+.. .++.++|||||||++|+|++|.+||...........+.......
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 9987654332 2234568899999998752 26789999999999999999999998776655554444332211
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
. ......+..+.+||.+||+.+|++|||+.++++||||+
T Consensus 253 ~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 L-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred C-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1 11124677899999999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=348.87 Aligned_cols=254 Identities=24% Similarity=0.459 Sum_probs=219.1
Q ss_pred eeccccccccceEEEEEEEcCCCcEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe--EEEE
Q 014722 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA--VHIV 135 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~--~~lv 135 (419)
+....||+|+|-+||+|.|..+|..||.-.++...+ ..+...+.+..|+.+|+.| +||||+++|++|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeee
Confidence 345679999999999999999999999766654443 3455678999999999999 99999999999987655 8899
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+|++..|+|..|+.+.+.++...+..|++||+.||.|||++. |+|||||.+||+++ +..+.|||+|+|+|.....+
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 999999999999999999999999999999999999999985 99999999999997 55677999999999987654
Q ss_pred CcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.. ...+|||.|||||+....|+..+||||||+++.||+|+..||... +..++..++..+...-.... --.+++++|
T Consensus 200 ~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~f 276 (632)
T KOG0584|consen 200 HA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREF 276 (632)
T ss_pred cc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHH
Confidence 43 448999999999999999999999999999999999999999665 45566667766654322211 126899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
|.+||.. .+.|||+.|+|+||||...
T Consensus 277 IekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 277 IEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHhcC-chhccCHHHHhhChhhccc
Confidence 9999999 9999999999999999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.75 Aligned_cols=255 Identities=30% Similarity=0.504 Sum_probs=210.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~ 133 (419)
.+|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 3699999999999999999999989999999999755432 22234567899999999 899999999998877 8999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|+||+.+ +|.+.+.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CcEEEeecCceeeccC
Confidence 99999974 8988887643 58999999999999999999999999999999999999654 4599999999887654
Q ss_pred C-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc------------
Q 014722 213 G-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------------ 277 (419)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------------ 277 (419)
. .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|.+||...........+.......
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567899999998864 46889999999999999999999998877665555443321100
Q ss_pred --------------CCCCCcc--CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 --------------KRDPWPK--VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 --------------~~~~~~~--~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
....++. +++.+.++|.+||+.+|++|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0011222 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=333.05 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=208.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE----
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE---- 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~---- 127 (419)
....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+.+||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 3456789999999999999999999999999999998764321 23567789999999967999999999873
Q ss_pred -eCCeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 128 -DDSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 128 -~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
.+..+++||||++|++|.+.+.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~---~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC---CCEEEc
Confidence 45679999999999999887653 3468899999999999999999999999999999999999754 449999
Q ss_pred ecccceeccCCC-cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 014722 203 DFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 203 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
|||++....... ......|++.|+|||++. ..++.++||||+||++|+|++|..||...........+.....
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 246 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPP 246 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCC
Confidence 999988764332 223456899999999874 3478899999999999999999999977665443333222211
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.........+..+.+|+.+||+.||++|||+.++++|+||
T Consensus 247 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1111112357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.36 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=211.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-------hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-------AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+....... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 5888999999999999999998899999999886432111 11235678899999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+.+++|+||+++++|.+++...+.+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~---~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC---CCeEEEeecccccc
Confidence 999999999999999999988888999999999999999999999999999999999999964 44599999999876
Q ss_pred ccCCC---cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cccCCCC
Q 014722 210 FRPGE---QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--IDFKRDP 281 (419)
Q Consensus 210 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 281 (419)
..... ......|+..|+|||.+.. .++.++|+||||+++|++++|..||...........+.... ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43221 1234568899999998763 37889999999999999999999997655444333332221 1222223
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+.++..+.+++.+||..+|++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 34678999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=333.77 Aligned_cols=254 Identities=29% Similarity=0.482 Sum_probs=208.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++++.||.|++|.||+|++..+|+.||+|.+..... .......+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999999875432 222335788899999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+++||||+|+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~---~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEeeccchhhcccCc
Confidence 9996 588888765 3468999999999999999999999999999999999999754 459999999987654322
Q ss_pred -cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC------------
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR------------ 279 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 279 (419)
......+++.|+|||.+.+ .++.++||||||+++|+|+||..||.+.+.......+.........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998764 3688999999999999999999999887765544443322111000
Q ss_pred -------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 -------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
...+.++++++++|.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=331.71 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=213.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+++++.+ +||||+++++++.....+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999999999999986542 233456889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++. ++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~---~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS---RGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC---CCcEEEccCCcccchhhh-
Confidence 9999999999998887889999999999999999999997 59999999999999964 445999999988654322
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcccccCCCCC
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----------GVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~ 282 (419)
......|+..|+|||++. +.++.++||||+||++|+|++|..||...... +....+.... ......
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 235 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--PPRLPS 235 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--CCCCCc
Confidence 223457899999999875 57889999999999999999999999765442 1122222111 111112
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..++.++.+|+.+||+.||++|||+.++++|+||.....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 237789999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=345.74 Aligned_cols=235 Identities=26% Similarity=0.424 Sum_probs=203.4
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
++-||+|+.|.||+|+ -.++.||||.+... -..+|+-|++| +||||+.+.++|.....+|||||||.
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el----------kETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL----------KETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhh----------hhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeeccc
Confidence 5679999999999999 46899999987522 23478899999 99999999999999999999999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccc
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 220 (419)
.|.|...|+....++......+..+|+.|+.|||.+.|||||||.-||||..++ .|||+|||-++..........+.
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d---~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD---VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc---eEEeccccchHhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999997654 49999999998877666677899
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||..|||||+++ ...++|+|||||||+|||||||..||..-+...++-.+-...+. .+....+|+-++=||++||+-
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~--LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLH--LPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccc--ccCcccCchHHHHHHHHHHhc
Confidence 999999999998 57899999999999999999999999766554332222222222 222346889999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014722 300 DPKQRLTAEEVLEH 313 (419)
Q Consensus 300 dp~~R~s~~~~l~~ 313 (419)
.|..|||+.++|.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999998
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=326.45 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=209.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEeccccc--CChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--Ce
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~ 131 (419)
.+|++.+.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 369999999999999999999999999999998864321 1223456788999999999 899999999998763 56
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++||||++|++|.+++.....+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~---~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV---GNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC---CCEEECcCccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999643 459999999987543
Q ss_pred CC----CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PG----EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.. .......|+..|+|||.+. ..++.++||||||+++|+|++|..||...........+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCC--CCCCchhhC
Confidence 21 1223456889999999876 4688999999999999999999999977654444333322211 111123567
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
..+.+++.+||. +|++||+++++++|||+.
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 889999999995 899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.36 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=204.3
Q ss_pred cccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
-.++|++.+.||+|+||.||+|++..+ +..||+|.+.... .....+.+.+|+.+++.+.+||||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999986443 3579999997543 223456788999999999779999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR--------------------------------------------------------- 151 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 151 (419)
...+++|||||++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc--
Q 014722 152 -------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-- 216 (419)
Q Consensus 152 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 216 (419)
.++++..++.++.||+.||.|||++||+||||||+|||++. +..+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~---~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD---GRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC---CCeEEEeeceeeeeccCCcceee
Confidence 13678889999999999999999999999999999999964 345999999998765433221
Q ss_pred -cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 217 -NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 217 -~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
....+++.|+|||++. +.++.++|||||||++|+|++ |..||.....................+ ..+++++.+++
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li 348 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIM 348 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHH
Confidence 1233566799999876 578999999999999999997 999997765544443444333222221 24689999999
Q ss_pred HHhcCCCCCCCCCHHHHhcC
Q 014722 294 KKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+||+.||++|||+.++++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~ 368 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQL 368 (374)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=332.44 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=211.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||.|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++.+...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 3699999999999999999999999999999998654322 22345678899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||++ ++|.+.+..... +++..+..++.||+.||.|||++|++||||+|+||+++..+ ..+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~--~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT--NALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC--CEEEEcccccccccCCC
Confidence 99996 588887765443 57888999999999999999999999999999999997432 35899999998754322
Q ss_pred -CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC----------
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD---------- 280 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 280 (419)
.......+++.|+|||.+.+ .++.++||||+|+++|+|+||.+||......+....+..........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 22334567899999998764 47889999999999999999999998776655554443211111000
Q ss_pred ---------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 281 ---------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
..+.+++++.+++.+||+.+|++||++.++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 1235688999999999999999999999999999998654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=345.02 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=203.5
Q ss_pred ccceeeccccccccceEEEEEEE-----cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+|++.+.||+|+||.||+|.. ..++..||+|++.... .....+.+.+|+.+++.+.+||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 3467789999986443 2234567889999999997899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC---------------------------------------------------------
Q 014722 130 SAVHIVMELCEGGELFDRIVARG--------------------------------------------------------- 152 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 152 (419)
+..++|||||+||+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886432
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 153 ------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 153 ------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
.+++..+..++.||+.||.|||++||+||||||+|||++. +..+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH---GRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC---CCcEEEecCccceeccCcc
Confidence 3678889999999999999999999999999999999964 3459999999998664332
Q ss_pred cc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 QF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |..||.................... .....+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHH
Confidence 21 1233456799999886 478999999999999999998 8999977654443333333322211 123467899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+|+.+||+.||++|||+.++++.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.85 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=211.6
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+.+++++ +||||+++++++.....+++|+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEE
Confidence 68899999999999999999999999999999876532 23456788999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~---~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS---RGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC---CCCEEEeecccchhhHHHH
Confidence 999999999998775 779999999999999999999999 99999999999999975 3459999999987654322
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcccccCCCCCccCCHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
. ....++..|+|||.+. ..++.++||||+|+++|+|++|..||.... .......+..... ...+...++.+
T Consensus 156 ~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 232 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--PRLPSGKFSPD 232 (265)
T ss_pred h-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--CCCChhhcCHH
Confidence 2 2267889999999886 468899999999999999999999996542 2222222222211 11111127889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.++|.+||..||++|||+.+++.||||+..
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=319.43 Aligned_cols=264 Identities=30% Similarity=0.524 Sum_probs=210.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-CC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~ 130 (419)
..|+++..||+|.||.||+|..++++- .+|||.++.+.-.+... ...-+|+.+++.+ .|||++.+..+|.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhccCc
Confidence 359999999999999999997665543 78999987654333222 3556799999999 99999999999877 78
Q ss_pred eEEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeec
Q 014722 131 AVHIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDF 204 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Df 204 (419)
.+++++||.+. +|+..|.-. ..++...+..|+.||+.|+.|||++-|+||||||.|||+..++ +.+.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999975 898888532 3589999999999999999999999999999999999997653 3478999999
Q ss_pred ccceeccCC----CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q 014722 205 GLSVFFRPG----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE---------QGVAQA 269 (419)
Q Consensus 205 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~~ 269 (419)
|+++.+... ......+-|.+|+|||.+.+ .|+++.||||+|||+.||+|-.+.|.+... ..++..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987543 23355678999999999874 799999999999999999999888855321 233444
Q ss_pred HHhcccccCCCCCcc---------------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 270 IIRSVIDFKRDPWPK---------------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 270 i~~~~~~~~~~~~~~---------------------------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
|..-.-......|+. -++.+.+|+.+||++||.+|+|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 443322222222221 24457899999999999999999999999999
Q ss_pred ccCccC
Q 014722 317 QNAKKA 322 (419)
Q Consensus 317 ~~~~~~ 322 (419)
......
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 976433
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=330.62 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=208.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE------e
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE------D 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~------~ 128 (419)
.+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++.+||||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 357999999999999999999999999999999986432 234567889999999877999999999985 3
Q ss_pred CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
...+|++|||+.+|+|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~---~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN---AEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCcc
Confidence 56789999999999999988753 358899999999999999999999999999999999999644 4599999999
Q ss_pred ceeccCC-CcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 207 SVFFRPG-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 207 a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
+...... .......|++.|+|||.+. ..++.++|||||||++|+|++|..||...........+.... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~ 245 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PPK 245 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CCC
Confidence 8755322 2234467899999999874 247889999999999999999999997665544333332221 111
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.....++.++.+||.+||+.||.+|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=334.29 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=211.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++++ +||||+++++++..+..+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEE
Confidence 458889999999999999999988999999999875432 23456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~---~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC---CCEEEccccccccccCcch
Confidence 999999999988754 568999999999999999999999999999999999999654 4599999999876543322
Q ss_pred -ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 216 -FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 216 -~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...........+..... .......+.++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li 233 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---PTLEGQYSKPFKEFV 233 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC---CCCCcccCHHHHHHH
Confidence 233468889999999874 688899999999999999999999976655444433322211 111124678899999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+||..+|++|||+.++++||||...
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=324.64 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=214.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+|+..+.||+|++|.||+|.+..+++.|++|.+...... .....+.+.+|+.+++.+ +||||+++++++.+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 477888999999999999999889999999998654321 223456788999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~---~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN---GVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEccCccceeccccc
Confidence 99999999999999888789999999999999999999999999999999999999654 459999999988765444
Q ss_pred cccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|++.|+|||.+.. . ++.++|+||||+++|+|++|..||...........+.... ........+++.+.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHH
Confidence 3455678999999998763 4 7899999999999999999999997766444443333211 1112234578999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+||+.+|.+|||+.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=330.80 Aligned_cols=257 Identities=26% Similarity=0.355 Sum_probs=204.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+..|+..+.+..+||||+++++++...+..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3699999999999999999999999999999998765322 12345556766644443899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~---~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR---NGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC---CCCEEEeeccccccc
Confidence 99997 577776654 34689999999999999999999997 9999999999999965 445999999998865
Q ss_pred cCCCcccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccccCCCCCcc
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..........|+..|+|||.+.+ .++.++|+||+|+++|+|++|..||.... ..+....+..... ...+...
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence 43333334568899999998752 46889999999999999999999996432 2222223322211 1111234
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+|.++.++|.+||..+|++|||+.++++||||....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 789999999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=331.95 Aligned_cols=254 Identities=27% Similarity=0.474 Sum_probs=203.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence 46999999999999999999998899999999987543211 223466899999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC---CCEEECccccccccCCCC
Confidence 999975 898888664 468999999999999999999999999999999999999654 45999999998754322
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccccCC-----------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKR----------- 279 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~----------- 279 (419)
.......+++.|+|||++.+ .++.++||||+|+++|+|++|..||.+.. ..+....+.+.......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11223356889999998763 57889999999999999999999997655 22222222211100000
Q ss_pred ---------------CCCccCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 ---------------DPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ---------------~~~~~~~--~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..++.++ .++.+++.+||+.+|++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0112334 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=328.27 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=209.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---- 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~---- 130 (419)
.++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++.+||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4679999999999999999999988999999999875432 34678899999999967999999999997644
Q ss_pred --eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 131 --AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 131 --~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~---~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN---AEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC---CeEEECCC
Confidence 48999999999999988765 3578999999999999999999999999999999999999654 45999999
Q ss_pred ccceeccCCC-cccccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc
Q 014722 205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
|++....... ......|++.|+|||++.. .++.++||||||+++|+|++|.+||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 9987654322 2234568999999998742 36789999999999999999999997665555444444432211
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.. .....+..+.+|+.+||..||++|||+.++++|||+
T Consensus 238 ~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LK-SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11 112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=328.92 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=212.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEEeCCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~~~~~~l 134 (419)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. .|||++++++++..+..+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999986542 2234567889999999983 39999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++. .+.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~---~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC---CCCEEEccCCceeecCCCc
Confidence 9999999999988765 47999999999999999999999999999999999999975 4459999999988765433
Q ss_pred c-ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 215 Q-FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. .....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+... ..+.......+.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2 234568999999998763 4688999999999999999999999776654433322221 1111112237889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++.+||+.||++||++.+++.||||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=333.81 Aligned_cols=261 Identities=31% Similarity=0.529 Sum_probs=216.9
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.+ +||||+++++.+...+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDEL 94 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeE
Confidence 34556777788999999999999998899999999986432 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~---~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD---GRIKLSDFGFCAQVSK 170 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---CCEEEccCcchhhccc
Confidence 999999999999887754 568999999999999999999999999999999999999654 4599999999875432
Q ss_pred CC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ......|++.|+|||.+. ..++.++||||+|+++|+|++|..||...........+.... ..........+..+.
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (292)
T cd06658 171 EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL-PPRVKDSHKVSSVLR 249 (292)
T ss_pred ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCccccccccCHHHH
Confidence 22 223456899999999886 468899999999999999999999998777655554443322 111122235688999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
+++.+||..||.+|||+.++++||||......
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999999975544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=332.48 Aligned_cols=255 Identities=33% Similarity=0.564 Sum_probs=210.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+++++++ +||||+++++++...+..++|+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEE
Confidence 69999999999999999999999999999999875432 223356788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
||++++.+..+..+...+++..+..++.|++.||.|||+.|++||||+|+||+++. ++.+||+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~---~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE---SGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC---CCCEEEEeeecccccCCCccc
Confidence 99998777666666667999999999999999999999999999999999999965 4559999999988765443
Q ss_pred cccccccCcccCchhhhc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 014722 215 QFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 276 (419)
......++..|+|||++. . .++.++||||+|+++|+|++|.+||.+....+....+......
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 334567889999999876 3 5788999999999999999999999876655433332211100
Q ss_pred ---cCC--------CCCc-cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 ---FKR--------DPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 ---~~~--------~~~~-~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.. ..++ .++.++.+||.+||..+|++|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 0011 248889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.01 Aligned_cols=252 Identities=33% Similarity=0.569 Sum_probs=214.7
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~l 134 (419)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence 58899999999999999999999999999999876543 334556788999999999 89999999998753 456899
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 135 VMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCH-----EQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-----~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
+|||+++++|.+++.. ..++++..+..++.|++.||.||| +.+++||||+|+||+++.+ +.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~---~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN---NNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC---CCEEEeccc
Confidence 9999999999998865 357899999999999999999999 8999999999999999753 459999999
Q ss_pred cceeccCCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 206 LSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 206 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
++........ .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---Ccc
Confidence 9887654443 34567899999999886 468889999999999999999999998877666666555443321 123
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+..+.+++.+||+.+|++|||+.++++|||+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=326.88 Aligned_cols=248 Identities=17% Similarity=0.256 Sum_probs=206.5
Q ss_pred cceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+..++.+ +||||+++++++..++..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCc
Confidence 46999999999999999999764 456789999987542 233446788999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++. +..++++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~---~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS---DLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC---CCcEEECCCccccccc
Confidence 9999999999999988764 46899999999999999999999999999999999999964 4459999999876543
Q ss_pred CCCccc--ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
...... ...++..|+|||.+. +.++.++|||||||++|++++ |..||...+..+....+..... .+....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 235 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR---LPAPRNCPN 235 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---CCCCCCCCH
Confidence 222111 233567899999876 578999999999999999775 9999998888777666654422 122346789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=341.77 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=208.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcc
Confidence 45689999999999999999999999999999999865432 233445677899999999 999999999988643
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
...|+||||+. ++|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~---~~~kL~Dfg~~ 165 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA 165 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEccCccc
Confidence 35799999996 4888877544 8999999999999999999999999999999999999654 45999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------- 277 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------- 277 (419)
.............+|+.|+|||.+. ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 8765444444567899999999876 468999999999999999999999998776544444332211000
Q ss_pred -------------C---------CC--------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 278 -------------K---------RD--------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 278 -------------~---------~~--------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
. .. .....++.+.++|.+||+.||++|||+.|+|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 00 01124567899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.51 Aligned_cols=259 Identities=29% Similarity=0.483 Sum_probs=214.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
......|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCe
Confidence 34556799999999999999999999889999999998755433444456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.|+|+||+. |++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++...
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~---~~~kL~dfg~~~~~ 165 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP---GTVKLADFGSASLV 165 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC---CCEEEeecCcceec
Confidence 999999997 467666653 4568999999999999999999999999999999999999654 45999999998765
Q ss_pred cCCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
... ....|++.|+|||++. +.++.++||||||+++|+|++|.+||...........+..... +.......+
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 240 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWS 240 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhC
Confidence 432 3456888999999863 4588899999999999999999999987776555444432211 111112357
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
..+.+++.+||..+|++|||+.+++.||||....
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 8899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=326.34 Aligned_cols=252 Identities=29% Similarity=0.540 Sum_probs=208.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 4699999999999999999999999999999998765444455566788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~---~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC---CCEEECccccceecc
Confidence 999999999887753 3458999999999999999999999999999999999999654 459999999988764
Q ss_pred CCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||..... ......+... ..+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence 3322 23456889999999876 4688899999999999999999999965432 2333333221 122222335678
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+.+++.+||..+|++|||+.++++.
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=332.53 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=201.5
Q ss_pred ccceeeccccccccceEEEEEEEcC----------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVN----------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn 118 (419)
..+|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++++ +|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence 3579999999999999999997532 34579999987542 233456788999999999 8999
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCE
Q 014722 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-------------------HYTERAAAAVMKTIVEVVQVCHEQGVM 179 (419)
Q Consensus 119 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~LH~~~iv 179 (419)
|+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 357788999999999999999999999
Q ss_pred eeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh--
Q 014722 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-- 253 (419)
Q Consensus 180 HrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-- 253 (419)
||||||+|||++.+ +.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++
T Consensus 161 H~dlkp~Nill~~~---~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGEN---LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcCC---ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999654 4599999999986543322 12344578899999876 578999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHhccc----ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014722 254 GVPPFWAETEQGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 254 g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l 311 (419)
+..||...+.......+..... .......+.+++.+.+|+.+||+.||++|||+.++.
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 6688877766655544332111 111112235788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=325.92 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=216.5
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+..+.++ +||||+++++++.....+++|+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEE
Confidence 689999999999999999999999999999998765321 3457889999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|+||+++.+ +.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~---~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK---GEVKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC---CCEEEccCccceecccCCC
Confidence 999999999999887889999999999999999999999 999999999999999654 4599999999887654333
Q ss_pred c-cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccccCCCCCcc-CCHHH
Q 014722 216 F-NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVIDFKRDPWPK-VSENA 289 (419)
Q Consensus 216 ~-~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~-~~~~~ 289 (419)
. ....++..|+|||.+. ..++.++|+||||+++|+|++|..||.... ..+....+...... ..... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP---SLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC---CCCcccCCHHH
Confidence 2 2556889999999876 467889999999999999999999997763 33334444322211 11123 78899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.++|.+||..+|++|||+.++++|||++..
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=340.03 Aligned_cols=263 Identities=30% Similarity=0.471 Sum_probs=213.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|.+.+.||.|+||+||+|++..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence 34579999999999999999999999999999999875432 222345677899999999 899999999987644
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...|+|+||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.+ +.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~---~~~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECcCcccc
Confidence 35899999996 6899988888889999999999999999999999999999999999999654 459999999988
Q ss_pred eccCC-CcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 014722 209 FFRPG-EQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---------- 275 (419)
Q Consensus 209 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 275 (419)
..... .......++..|+|||.+. ..++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 66443 2234456889999999875 3588999999999999999999999977654333322221100
Q ss_pred -------------ccC----CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 276 -------------DFK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 276 -------------~~~----~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
... ...++.+++++.++|.+||+.+|++|||+.++++||||......
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000 01134678999999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=339.48 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=208.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence 4568999999999999999999999999999999986422 222345677899999999 899999999987644
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...|+|+||+. ++|.+.+. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC---CCEEECccccee
Confidence 35899999996 48877664 4579999999999999999999999999999999999999644 459999999987
Q ss_pred eccCCCc----ccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc------
Q 014722 209 FFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID------ 276 (419)
Q Consensus 209 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------ 276 (419)
....... .....||+.|+|||.+. ..++.++||||+||++|+|++|++||.+.+.......+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6543221 23356899999999864 35889999999999999999999999776544433322211000
Q ss_pred -----------------cCCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 277 -----------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 277 -----------------~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.... ..+..++++.++|.+||+.+|++|||+.++++||||+.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000 123467889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=345.62 Aligned_cols=249 Identities=35% Similarity=0.567 Sum_probs=214.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+...|++...+|.|+|+.|..+.+..+++..++|++.+... +..+|+.++....+||||+++.+++.+..+
T Consensus 318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred CCcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCce
Confidence 4567789999999999999999999999999999999987632 234577777777799999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.|+|||++.|+.+.+.+.....+. .++..|+.+|+.|+.|||++|+|||||||+|||++ +..++++|+|||.++..+
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELE 467 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCc
Confidence 999999999999999888776555 88889999999999999999999999999999996 345669999999998776
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.. ..+.+-|..|.|||++. ..|++++||||||++||+||+|..||...... ++...+....+. ..+|..+
T Consensus 468 ~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~A 539 (612)
T KOG0603|consen 468 RS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEA 539 (612)
T ss_pred hh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHH
Confidence 54 44455688899999988 57999999999999999999999999877666 333333322221 4689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
++||.+||+.||.+||++.+++.||||..
T Consensus 540 KdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 540 KDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred HHHHHHhccCChhhCcChhhhccCcchhc
Confidence 99999999999999999999999999933
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.95 Aligned_cols=247 Identities=32% Similarity=0.508 Sum_probs=206.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeee-EEEe------
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD-TYED------ 128 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~-~~~~------ 128 (419)
.+++|.+.|.+|||+.||+|.+...|..||+|++-.. +....+.+.+||.+|+.|++|+|||.+++ ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3688999999999999999999888899999998644 56678899999999999988999999999 3321
Q ss_pred CCeEEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 129 DSAVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
.-.++|.||||.||.|.+++.+ +..|+|.++++|+.|+++|+.+||... |||||||-||||+..++ .+|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g---~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG---NYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC---CEEeCcc
Confidence 2358899999999999999985 345999999999999999999999998 99999999999996544 5999999
Q ss_pred ccceeccCCC-ccc---------ccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014722 205 GLSVFFRPGE-QFN---------EIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270 (419)
Q Consensus 205 g~a~~~~~~~-~~~---------~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 270 (419)
|.|...-... ... ....|+.|+|||++. ...++|+|||+|||+||-|+....||...... .|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eE
Confidence 9886432221 110 134699999999985 26899999999999999999999999765332 45
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~ 314 (419)
+.+.+.++. +++.+..+++||..||+.||++||++.|++.+-
T Consensus 267 lng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 267 LNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred EeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 566555544 468899999999999999999999999998753
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=330.04 Aligned_cols=253 Identities=29% Similarity=0.520 Sum_probs=208.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|++|.||+|++..+|+.||+|++..... ......+.+|+.+++.+ +||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence 58999999999999999999999999999999876532 22345677899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 137 ELCEGGELFDRIVAR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~---~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR---GELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC---CcEEEeecchhhhhcCC
Confidence 99985 888887654 358999999999999999999999999999999999999644 45999999998755332
Q ss_pred C-cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC----------
Q 014722 214 E-QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD---------- 280 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 280 (419)
. ......+|+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+....+..........
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 2234567889999998764 46889999999999999999999998877666555544321111000
Q ss_pred ---------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 281 ---------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 281 ---------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+.++..+.+++.+||+.||.+||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=331.95 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=206.1
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|...+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++.+||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 577888999999999999999999999999998754322 345678899999999955999999999999999999999
Q ss_pred EecCCcchHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 137 ELCEGGELFDR---IV--ARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 137 e~~~~g~L~~~---l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
||+.+ ++.++ +. ....+++..+..++.|++.||+|||+. +++||||||+||+++.+ +.+||+|||++...
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN---GNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC---CcEEEeecchhHHh
Confidence 99864 54443 22 235699999999999999999999975 99999999999999654 45999999998765
Q ss_pred cCCCcccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcc-cccCCCCCcc
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSV-IDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~ 284 (419)
..........|++.|+|||.+.+ .++.++||||+|+++|+|++|.+||..... .+....+.... .......+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 44433344568999999999864 488999999999999999999999966542 11112221111 1112222235
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
++.++.+|+.+||+.+|++|||+.++++||||+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 78999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=329.66 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=209.6
Q ss_pred cceeeccccccccceEEEEEEEcCCC-----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNG-----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++++ +||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence 36999999999999999999876554 679999886442 333456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC
Q 014722 131 AVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~ 194 (419)
..+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~- 160 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG- 160 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC-
Confidence 999999999999999998764 457888999999999999999999999999999999999654
Q ss_pred CCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014722 195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 269 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 269 (419)
..++|+|||++........ .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....
T Consensus 161 --~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 161 --LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred --CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4599999999876543321 23345678899999876 578999999999999999998 9999998887777666
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+....... ....+++++.+|+.+||+.||.+|||+.+++++
T Consensus 239 i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 239 IRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 65543321 224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.57 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=212.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
-|++.+.||+|+||.||+|.+..+++.+|+|++..... ......+.+|+.+++++ +||||+++++++..+..+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEE
Confidence 37888999999999999999988999999999865432 23456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-c
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~ 215 (419)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~---~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC---CCEEEeecccceecccchhh
Confidence 99999999988764 468999999999999999999999999999999999999654 459999999987654322 2
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....|+..|+|||.+. ..++.++|+||+||++|+|++|..||...........+..... ......++.++.+++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~ 234 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLKEFVE 234 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC---CCCCcccCHHHHHHHH
Confidence 23456888999999886 4678899999999999999999999987666555544433221 1112346889999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCccccC
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+||+.+|++||++.++++||||.+.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.72 Aligned_cols=257 Identities=33% Similarity=0.557 Sum_probs=215.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|...+.||+|++|.||+|.+..+++.+|+|.+... .....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence 3566677999999999999999899999999988543 223345688999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
+||++|++|.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD---GRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC---CcEEEcccccchhhccCCc
Confidence 999999999998877 678999999999999999999999999999999999999654 459999999876543322
Q ss_pred cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......|++.|+|||.+.+ .++.++||||+|+++|+|++|..||...+.......+........ .....++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHH
Confidence 2234568999999999864 688999999999999999999999988776666555554422111 11224788999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.+||..+|++|||+.++++||||++...
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHcccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=325.71 Aligned_cols=250 Identities=35% Similarity=0.617 Sum_probs=214.2
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||.|+||.||+|++..+|+.+|+|++...........+.+.+|+++++++ +||||+++++.+..+...|+|+||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999889999999999765544444567889999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC---------
Q 014722 144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--------- 214 (419)
Q Consensus 144 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--------- 214 (419)
|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN---GHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC---CCEEEEecccchhcccCcccccccccc
Confidence 99999887789999999999999999999999999999999999999754 459999999887543321
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......++..|+|||.+. ..++.++||||||+++|++++|..||...........+......++.. ..++..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 223456788999999876 458889999999999999999999998888777776666543332221 12489999999
Q ss_pred HHhcCCCCCCCCCH---HHHhcCCccccC
Q 014722 294 KKMLNPDPKQRLTA---EEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~s~---~~~l~~~~~~~~ 319 (419)
.+||+.+|++|||+ .++|+||||++.
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999999 999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.46 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=202.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-----
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----- 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----- 130 (419)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++++ +||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 36999999999999999999999999999999986543221 1223556899999999 8999999999986543
Q ss_pred ---eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 131 ---AVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 131 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..++||||+. ++|.+.+.... .+++.++..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD---GILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC---CcEEECcCCC
Confidence 4599999996 47877776543 68999999999999999999999999999999999999644 4599999999
Q ss_pred ceeccCCCc-----ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 207 SVFFRPGEQ-----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 207 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
+........ .....++..|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+.......+.......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 876543221 123457889999998764 4788999999999999999999999877665544433332111110
Q ss_pred CCC----------------------------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 DPW----------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ~~~----------------------------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+ ...++.+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 0135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=325.29 Aligned_cols=265 Identities=30% Similarity=0.482 Sum_probs=213.3
Q ss_pred CCCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-C----Ceeee
Q 014722 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-P----NIVSL 122 (419)
Q Consensus 48 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p----nIv~l 122 (419)
...|..+..+|.++..+|+|.||.|..+.+..++..||+|+++.-. .-.+..+-|+++|+++..+ | -+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 3445677889999999999999999999999999999999986321 1235566799999999332 3 38889
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC------
Q 014722 123 KDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK------ 194 (419)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~------ 194 (419)
.++|...++.|||+|.+ |.++++++.+++ +++...++.++.|++.++++||+.+++|.||||+|||+.+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 99999999999999998 679999998865 588999999999999999999999999999999999985421
Q ss_pred -----------CCCCeEEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 014722 195 -----------ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET 262 (419)
Q Consensus 195 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 262 (419)
.+..|+|+|||.|.... +...+.+.|..|+|||++.+ .++..+||||+||||+|+.||...|++..
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 13469999999998754 33477889999999999875 89999999999999999999999998887
Q ss_pred HHHHH---HHHHhcccc-------------cCCCCCccC--------------------------CHHHHHHHHHhcCCC
Q 014722 263 EQGVA---QAIIRSVID-------------FKRDPWPKV--------------------------SENAKDLVKKMLNPD 300 (419)
Q Consensus 263 ~~~~~---~~i~~~~~~-------------~~~~~~~~~--------------------------~~~~~~li~~~L~~d 300 (419)
..+.+ +.|+..... -..-.|+.. -.++.|||.+||.+|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 66533 333211000 001112110 124779999999999
Q ss_pred CCCCCCHHHHhcCCccccC
Q 014722 301 PKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 301 p~~R~s~~~~l~~~~~~~~ 319 (419)
|.+|+|+.|+|.||||+..
T Consensus 394 P~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARL 412 (415)
T ss_pred ccccccHHHHhcCHHhhcC
Confidence 9999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.93 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=209.7
Q ss_pred cceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+ +||||+++++++.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERL 82 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCC
Confidence 569999999999999999999876 77889999876432 233446788899999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 131 AVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
..++||||++|++|.+++...+ .+++..+..++.||+.||.|||+++++||||||+||+++.++....+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999987653 488999999999999999999999999999999999998766556799999
Q ss_pred cccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC
Q 014722 204 FGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 204 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
||++......... ....++..|+|||++. ..++.++|||||||++|+|++ |..||.+.+.......+.....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--- 239 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR--- 239 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 9998865322211 1223356799999976 569999999999999999997 9999988777666555443221
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......++..+.+++.+||+.+|++|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11124578999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=332.06 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=203.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEE--EEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKF--ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++|++.+.||+|+||.||+|.+..++..+ |+|.+... ........+.+|+.++.++.+||||+++++++...+.+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 36999999999999999999987777654 66665432 233445678899999999978999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 134 IVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.+ .
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~---~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---Y 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC---C
Confidence 9999999999999987542 47899999999999999999999999999999999999654 4
Q ss_pred CeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 014722 198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
.+||+|||++.............++..|+|||.+. ..++.++|||||||++|+|+| |.+||.+.+..+....+....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~- 240 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 240 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-
Confidence 59999999986432211112223466799999876 457899999999999999998 999998877766555543321
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....+...++++.+|+.+||+.+|++|||+.+++.+
T Consensus 241 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111223578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=328.67 Aligned_cols=254 Identities=31% Similarity=0.617 Sum_probs=218.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++.+||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36999999999999999999999999999999997755544445577889999999993399999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~---~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD---MHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC---CCEEecCCccccccCCccc
Confidence 9999999999999988889999999999999999999999999999999999999643 459999999987654321
Q ss_pred --------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014722 215 --------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 215 --------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 273 (419)
......|+..|+|||++. ..++.++||||||++++++++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112345788999999876 46888999999999999999999999887766655555543
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCcc
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA----EEVLEHPWL 316 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~----~~~l~~~~~ 316 (419)
...++ ..+++.+.+++.+||+.+|++|||+ .++++||||
T Consensus 238 ~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 33222 3568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=326.01 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=201.6
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHH---HHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV---QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei---~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
.||+|+||.||+|.+..+++.||+|.+................|. ..++.. +||||+++++++.+.+.+++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 489999999999999999999999999765443222222233333 344445 7999999999999999999999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccc
Q 014722 140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219 (419)
Q Consensus 140 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 219 (419)
.|++|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++.+ +.+||+|||++...... .....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~---~~~kl~dfg~~~~~~~~-~~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSKK-KPHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC---CCEEEccCcCccccCcc-CCcCc
Confidence 999999999888889999999999999999999999999999999999999643 45999999998765432 22345
Q ss_pred ccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhc
Q 014722 220 VGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297 (419)
Q Consensus 220 ~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 297 (419)
.|+..|+|||.+.+ .++.++||||+|+++|+|++|..||.......... +...........+...++++.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 78999999999863 58899999999999999999999997663221111 1111111112222356899999999999
Q ss_pred CCCCCCCC-----CHHHHhcCCccccCc
Q 014722 298 NPDPKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 298 ~~dp~~R~-----s~~~~l~~~~~~~~~ 320 (419)
..+|.+|| ++.++++||||+...
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 99999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=308.71 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=204.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-----C
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-----D 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-----~ 129 (419)
+.+|++.+.||+|||+.||+++...+++.||+|.+.... ..+++..++|++..+++ +|||+++++++... .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCc
Confidence 457999999999999999999999999999999998764 44678899999999999 99999999987643 3
Q ss_pred CeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 130 SAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
...||+++|+..|+|.+.+.. ...++|.++..|+.++++||.+||+.. +.||||||.|||+.. .+.++|.|
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~---~~~~vl~D 172 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD---SGLPVLMD 172 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC---CCceEEEe
Confidence 459999999999999998864 336999999999999999999999998 999999999999965 45599999
Q ss_pred cccceeccCC----Cc------ccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH--HHH
Q 014722 204 FGLSVFFRPG----EQ------FNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVA 267 (419)
Q Consensus 204 fg~a~~~~~~----~~------~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~ 267 (419)
||.+....-. .. ...-..|..|+|||.+. ...++++|||||||+||.|+.|..||...-.+ .+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998764311 11 11234688999999886 24688999999999999999999999432111 111
Q ss_pred HHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 268 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
-.+....+.++... .+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 253 LAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22333444454443 389999999999999999999999999864
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=325.55 Aligned_cols=257 Identities=31% Similarity=0.466 Sum_probs=206.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~l 134 (419)
+|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++++ +||||+++++++.+ .+.+|+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEE
Confidence 68999999999999999999999999999999875432 23456788999999999 89999999998864 347899
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 135 VMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ ..++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~---~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK---GQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC---CeEEEeeccccccc
Confidence 9999999999887653 3458999999999999999999999999999999999999754 44999999998754
Q ss_pred cCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhccccc-CCCCC-
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVIDF-KRDPW- 282 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~~i~~~~~~~-~~~~~- 282 (419)
.... .....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+....... .....
T Consensus 156 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd06621 156 VNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234 (287)
T ss_pred cccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCC
Confidence 3222 22345788999999876 578999999999999999999999997652 223333333211111 11110
Q ss_pred -ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 283 -PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 283 -~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...++.+.+++.+||..+|++|||+.|+++||||++..
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=290.17 Aligned_cols=257 Identities=30% Similarity=0.536 Sum_probs=219.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|.-.++||+|.||+||+|+...+++.||+|.+....-.+. --....+||-+++.| .|.|||+++++.-.+..+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkel-khknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeH
Confidence 47778899999999999999999999999999986653222 234678899999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
|||. .+|..+... ++.++.+.++.++.|++.||.++|++++.|||+||.|.|++.++ .+||+|||+++.+.-. .
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng---elkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG---ELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC---cEEecccchhhhcCCceE
Confidence 9996 488777765 56799999999999999999999999999999999999997555 4999999999876432 2
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV------ 285 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~------ 285 (419)
-++..+-|.+|++|.++-+ -|+...|+||.|||+.|+.. |++.|.+.+..+++..|.+..-....+.|+.+
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 3455677999999999875 59999999999999999986 89999999999999888876655555555432
Q ss_pred -------------------CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 286 -------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 286 -------------------~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+..-++|+.++|.-+|.+|++++++++||||...
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 3346799999999999999999999999999864
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=321.14 Aligned_cols=248 Identities=31% Similarity=0.561 Sum_probs=211.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|+||.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+.+|+|+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 5889999999999999999999999999999986443 233456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN---GKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC---CcEEEcccCcceeecccc
Confidence 999999999988653 358999999999999999999999999999999999999643 459999999987664332
Q ss_pred -cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|++.|+|||++.+ .++.++|+||+|+++|+|++|..||...+.......+....... ....++..+.+|
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence 2234678999999999874 68899999999999999999999998877766666555443322 123578899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcC
Q 014722 293 VKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~ 313 (419)
|.+||+.||++|||+.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.24 Aligned_cols=257 Identities=29% Similarity=0.526 Sum_probs=214.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..|+....||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..++..|+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEE
Confidence 346666789999999999999988999999999865432 2345688999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~---~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC---CcEEEeechhHhhcccccc
Confidence 999999999887654 568999999999999999999999999999999999999654 459999999987554322
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......|++.|+|||++. ..++.++||||||+++|+|++|..||......+....+..... .....+..++..+.++|
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i 251 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNAHKISPVLRDFL 251 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-CCccccCCCCHHHHHHH
Confidence 234467899999999987 4688999999999999999999999987766555554433221 12223346788999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.+||+.+|++|||+.++++||||.+...
T Consensus 252 ~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 252 ERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.67 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=204.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+++++++ +||||+++++++.+++..|+|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999999765433344456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 136 MELCEGGELFDRIVAR-----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
|||++|++|.+++... ...+...+..++.||+.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d---g~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF---GEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC---CCEEEEec
Confidence 9999999999988641 234566788999999999999999999999999999999654 45999999
Q ss_pred ccceeccCCC-------------------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q 014722 205 GLSVFFRPGE-------------------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 264 (419)
Q Consensus 205 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 264 (419)
|++....... .....+||+.|+|||++. ..++.++||||+||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998652110 012346999999999887 46899999999999999999999999775543
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
........ .......++..+++.+.+++.+||..||++||+..+.+.+
T Consensus 238 ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 238 KISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33221110 0011112345688999999999999999999887666644
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=337.70 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=211.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE----eCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~----~~~ 130 (419)
..+|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCc
Confidence 4679999999999999999999999999999999875432 222456777899999999 8999999999875 345
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+++|+||+. ++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~---~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEecccccceee
Confidence 7899999995 689998887778999999999999999999999999999999999999965 445999999998765
Q ss_pred cCCCc-----ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------
Q 014722 211 RPGEQ-----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--------- 274 (419)
Q Consensus 211 ~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------- 274 (419)
..... .....|+..|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 43221 134578999999998753 58899999999999999999999997766544333222110
Q ss_pred --------------cccCCCC----CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 275 --------------IDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 275 --------------~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
....... ++..++++.++|.+||+.+|++|||+.+++.||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0001111 2356899999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.35 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=208.1
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.+ +||||+++++++.+.+..|+|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence 67788999999999999999999999999998755322 22235678899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 138 LCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|++ ++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~---~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR---EGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC---CCcEEEeecccccccCCCcc
Confidence 995 68999887765 6899999999999999999999999999999999999975 4459999999987553221
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 276 (419)
......+++.|+|||++.+ .++.++||||||+++|+|++|.+||...+.......+.+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233456889999998763 4788999999999999999999999877665444433321100
Q ss_pred ---------cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 ---------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 ---------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
......+.++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011124567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=327.74 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=201.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|.+.+.||+|+||.||+|.+..+|..||+|++....... ....+.+|+.+++.+ +||||+++++++..+...|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999987543221 223567899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL---GELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC---CcEEEeccccccccCCCC
Confidence 99996 577776654 3467889999999999999999999999999999999999654 45999999998754322
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc--------------cc
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV--------------ID 276 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~--------------~~ 276 (419)
.......+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.... +....+.... ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22334457899999998764 4788999999999999999999999765432 1121111100 00
Q ss_pred cCC------------CCCc--cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 FKR------------DPWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 ~~~------------~~~~--~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.. ..|. ..+..+.+++.+||..||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 0011 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=327.53 Aligned_cols=261 Identities=29% Similarity=0.507 Sum_probs=234.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-..+|.++..||.|+||.|.+|..+.+.+.+|||++++.-+-...+.+--..|-++|....+-|.+++++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34579999999999999999999999999999999998876666666767788889987767789999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec-cC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~-~~ 212 (419)
+||||+.||+|.-++++-+.+.|..+..++..|+.||-+||++||++||||.+|||++.+ +++||+|||+++.. -.
T Consensus 427 FVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e---GHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIFD 503 (683)
T ss_pred eEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC---CceEeeecccccccccC
Confidence 999999999999999999999999999999999999999999999999999999999754 45999999999753 34
Q ss_pred CCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
+....+.+|||.|+|||++. +.|+.++|+||+||+||||+.|.+||.+.++.++.+.|......++. .+|.++.+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK----slSkEAv~ 579 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK----SLSKEAVA 579 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc----cccHHHHH
Confidence 55667899999999999877 78999999999999999999999999999999999999987776654 57999999
Q ss_pred HHHHhcCCCCCCCCC-----HHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLT-----AEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s-----~~~~l~~~~~~~~~~ 321 (419)
+.+.+|.+.|.+|.. -.++-.||||+....
T Consensus 580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 999999999999974 368899999987643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=328.10 Aligned_cols=261 Identities=31% Similarity=0.586 Sum_probs=212.4
Q ss_pred ceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
+|++.+.||.|+||.||.|.+. .+|..||+|++...... .....+.+.+|+.+++++.+||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47899999998754322 1223456788999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++. ++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC---CCCEEEeeCccceeccc
Confidence 999999999999999988888999999999999999999999999999999999999964 45699999999876543
Q ss_pred CC--cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.. ......|+..|+|||.+.. .++.++||||||+++|+|++|..||...........+.........+....+++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 22 2234568999999998763 467899999999999999999999964432222222222221111122235789
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHHHHhcCCccccCc
Q 014722 288 NAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNAK 320 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~~ 320 (419)
.+.+++.+||+.||++|| ++.+++.||||+...
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=321.22 Aligned_cols=253 Identities=27% Similarity=0.557 Sum_probs=214.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|.+.+.||.|+||.||+|.+..+|..+|+|.+...... ....+.+.+|+.+++.+ +||||+++++.+......++|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence 588999999999999999999999999999998765432 22456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++ ..+||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG--MVAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCC--CeEEecccccchhccCCc
Confidence 9999999999887643 479999999999999999999999999999999999997542 347999999987664332
Q ss_pred c-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 Q-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
. .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+...... ...+..+..+.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC---CCCCCCCHHHHHH
Confidence 2 23356899999999876 46889999999999999999999999877766655555443322 2223578899999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
|.+||..+|++|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=323.21 Aligned_cols=251 Identities=29% Similarity=0.549 Sum_probs=207.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|.+..+++.+|+|.+.............+.+|+.+++.+ +||||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 3689999999999999999999999999999988765444444556888999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEECcchhhhccc
Confidence 999999999988763 3458999999999999999999999999999999999999654 459999999987654
Q ss_pred CCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....|++.|+|||.+. ..++.++|+||||+++|+|++|..||.+.... .....+... ..+...+...++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 3322 23456889999999986 46888999999999999999999999765432 222222221 222223345788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.+++.+||..||++|||+.++++
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=353.00 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=195.5
Q ss_pred CCccccceeeccccccccceEEEEEEEcCC-CcEEEEEE--------------ecccccCChhhHHHHHHHHHHHHhCCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKS--------------ISKKKLRTAVDIEDVRREVQIMKHLPK 115 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~--------------~~~~~~~~~~~~~~~~~Ei~~l~~l~~ 115 (419)
+..+..+|++++.||+|+||+||+|..... +...+.|. +.+...........+.+|+.+++++ +
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~ 221 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-N 221 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-C
Confidence 345667899999999999999999875432 22222221 1111111222345688999999999 9
Q ss_pred CCCeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEe
Q 014722 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF 190 (419)
Q Consensus 116 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~ 190 (419)
||||+++++++.+.+..|+|++++. ++|.+++... .......++.|+.||+.||.|||++||+||||||+|||+
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 5777776542 123467788999999999999999999999999999999
Q ss_pred ecCCCCCCeEEeecccceeccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCC-C--CHH
Q 014722 191 ANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-E--TEQ 264 (419)
Q Consensus 191 ~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~--~~~ 264 (419)
+.+ +.+||+|||++..+..... .....||+.|+|||++. ..++.++|||||||++|+|++|..++.. . ...
T Consensus 301 ~~~---~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 301 NCD---GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCC---CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 654 4599999999987654322 23467999999999987 4689999999999999999998754432 2 122
Q ss_pred HHHHHHHhccc----ccCC------------------CC------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 265 GVAQAIIRSVI----DFKR------------------DP------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 265 ~~~~~i~~~~~----~~~~------------------~~------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.....+..... .++. .. ...++.++.++|.+||+.||.+|||+.|+|.||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 22222221110 0000 00 01256678889999999999999999999999999
Q ss_pred ccC
Q 014722 317 QNA 319 (419)
Q Consensus 317 ~~~ 319 (419)
...
T Consensus 458 ~~~ 460 (501)
T PHA03210 458 SAE 460 (501)
T ss_pred hcC
Confidence 864
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=307.31 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=217.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+.+++..||+|+-|.|++++...+|...|||.+.+.. +....+.++..+.++..-.+.|+||+.+++|..+..++|.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4566788999999999999999999999999998654 44566788888888877646899999999999999999999
Q ss_pred EecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|.|.. -+..++.. .++++|..+-.+...++.||.||.++ ||+|||+||+|||++ +.+++||||||.+..+.++.
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD---e~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD---ERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc---cCCCEEeecccccceeeccc
Confidence 99852 23233322 46799999999999999999999865 899999999999996 45569999999999888777
Q ss_pred cccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
......|-+.|||||.+. ..|+.++||||||++++||.||..||.+. .+.+++-.+++... ...+.-..+|+.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCCcccCcCHHH
Confidence 777788999999999886 35899999999999999999999999874 45677777777443 2222223489999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.+|+..||++|+.+||...++|+|||+......
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 999999999999999999999999999876543
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=338.80 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=217.4
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCC----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD 124 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~ 124 (419)
+.+...+.+..+.++||+|+||.||+|..+..+ ..||+|....+.......+.++.+|.++|+.+ +|||||++||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEE
Confidence 344556667778899999999999999865532 23899998864445566788999999999999 9999999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 125 TYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 125 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
+......++||||+|+||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-.+|+|+..+ ..+||+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~---~~vKISD 305 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK---GVVKISD 305 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC---CeEEeCc
Confidence 9999999999999999999999999877 49999999999999999999999999999999999999643 3489999
Q ss_pred cccceeccCCCccc-ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 204 FGLSVFFRPGEQFN-EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 204 fg~a~~~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
||+++......... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....+....|.......+.+
T Consensus 306 FGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~ 385 (474)
T KOG0194|consen 306 FGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP 385 (474)
T ss_pred cccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC
Confidence 99987643111111 112346799999987 679999999999999999998 889999999999999886655443333
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...|.++..++.+|+..+|++|||+.++.+
T Consensus 386 --~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 386 --SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred --CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 356888999999999999999999999865
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=320.63 Aligned_cols=249 Identities=28% Similarity=0.488 Sum_probs=202.7
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
...||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++..++..++|+||++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCC
Confidence 347999999999999998999999999886542 33456788999999999 89999999999999999999999999
Q ss_pred CcchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-cc
Q 014722 141 GGELFDRIVAR-GHY--TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QF 216 (419)
Q Consensus 141 ~g~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 216 (419)
+++|.+.+... ..+ ++..+..++.|++.||.|||++||+||||||+||+++.+ ...++|+|||++....... ..
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC--CCeEEEecchhheecccCCCcc
Confidence 99999988764 445 888899999999999999999999999999999999642 3459999999987654322 22
Q ss_pred cccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
....|++.|+|||.+.+ .++.++||||+|+++|+|++|..||............ .............+++++.+++
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCHHHHHHH
Confidence 34568899999998753 3788999999999999999999999654332211111 1111111112235788999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCcc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+||+.+|++|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.10 Aligned_cols=258 Identities=31% Similarity=0.544 Sum_probs=213.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence 357999999999999999999998899999999986432 22346788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~---~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC---CCEEEccCcceecccccc
Confidence 99999999999988654 58899999999999999999999999999999999999654 459999999887654332
Q ss_pred -cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|++.|+|||.+. +.++.++|+||||+++|++++|..||...+.......+.... ......+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence 233456889999999876 568899999999999999999999997765543322222111 11111233567889999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+.+||..+|++||++.+++.||||+....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=317.71 Aligned_cols=252 Identities=29% Similarity=0.571 Sum_probs=217.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|+||.||++.+..++..+|+|++..... .......+.+|+++++.+ +|||++++.+.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999998999999999976543 234566788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 137 ELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 137 e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~---~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN---GLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC---CcEEECCccceeeccc
Confidence 999999999988764 679999999999999999999999999999999999999653 4599999999887654
Q ss_pred CC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ......|++.|+|||.+. ..++.++|+||+|+++|+|++|..||................... ....++..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP---IPSQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 33 234457899999999876 468899999999999999999999998877666666655443221 1125789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+++.+||..+|++|||+.++|+||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=333.00 Aligned_cols=264 Identities=30% Similarity=0.460 Sum_probs=213.8
Q ss_pred ccccceee-ccccccccceEEEEEEEcCCCcEEEEEEecccccCChh-----------hHHHHHHHHHHHHhCCCCCCee
Q 014722 53 DISIDYDL-GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----------DIEDVRREVQIMKHLPKHPNIV 120 (419)
Q Consensus 53 ~~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~Ei~~l~~l~~hpnIv 120 (419)
.+.++|.. .+.||.|+||+||+|.+..+++.||+|++......... ....+.+|+.+++++ +||||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence 34567875 46799999999999999999999999998654322100 012467899999999 899999
Q ss_pred eeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 121 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~---~~~k 159 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICK 159 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC---CCEE
Confidence 99999999999999999997 5899999887789999999999999999999999999999999999999644 4599
Q ss_pred EeecccceeccCC---------------CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH
Q 014722 201 AIDFGLSVFFRPG---------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE 263 (419)
Q Consensus 201 l~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 263 (419)
|+|||++...... .......+++.|+|||.+.+ .++.++|||||||++|+|++|.+||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998765411 11223456888999998864 478899999999999999999999988877
Q ss_pred HHHHHHHHhcccccCCC------------------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 264 QGVAQAIIRSVIDFKRD------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+....+.......... ..+..+.++.++|.+||+.+|++|||+.++|.||||+..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 66665554322111111 012457889999999999999999999999999999875
Q ss_pred cc
Q 014722 320 KK 321 (419)
Q Consensus 320 ~~ 321 (419)
..
T Consensus 320 ~~ 321 (335)
T PTZ00024 320 PL 321 (335)
T ss_pred CC
Confidence 43
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=325.44 Aligned_cols=253 Identities=32% Similarity=0.546 Sum_probs=210.2
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHIV 135 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~lv 135 (419)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +|||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999899999999998654 2222345678899999999 899999999999988 899999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
+||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~---~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND---GVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC---CCEEEccccceeeccCCC
Confidence 999975 888888765 579999999999999999999999999999999999999654 459999999988765433
Q ss_pred --cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC--------
Q 014722 215 --QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-------- 282 (419)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 282 (419)
......++..|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+...........|
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334567889999997653 5789999999999999999999999888776666555443221111111
Q ss_pred ------------------cc-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 283 ------------------PK-VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 283 ------------------~~-~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.. +++.+.+++.+||..+|.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 27889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=331.88 Aligned_cols=258 Identities=30% Similarity=0.522 Sum_probs=203.5
Q ss_pred ceeeccccccccceEEEEEEEcC--CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~ 132 (419)
+|++.+.||+|+||.||+|.+.. +++.||+|.+...........+.+.+|+.+++.+ +||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 8999999999864322222345678899999999 899999999999988 889
Q ss_pred EEEEEecCCcchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCCCCeEEeeccc
Q 014722 133 HIVMELCEGGELFDRIVAR-----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGL 206 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~ 206 (419)
++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ ...+.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999975 676666432 268999999999999999999999999999999999999752 2256699999999
Q ss_pred ceeccCCCc----ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 014722 207 SVFFRPGEQ----FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------VAQAII 271 (419)
Q Consensus 207 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------~~~~i~ 271 (419)
+........ .....+|+.|+|||++.+ .++.++||||||+++|+|++|.+||.+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886543221 234567899999998763 57899999999999999999999997654322 111111
Q ss_pred hccc---------------------ccCCCCCc------------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 272 RSVI---------------------DFKRDPWP------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 272 ~~~~---------------------~~~~~~~~------------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.... ......++ ..+.++.+++.+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1000 00011111 456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=324.23 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=208.6
Q ss_pred cceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|.+.+.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+++++.+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence 468999999999999999998643 46889999986543 222456889999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 131 AVHIVMELCEGGELFDRIVARG--------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~--- 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--- 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC---
Confidence 9999999999999999987542 37888999999999999999999999999999999999654
Q ss_pred CCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014722 197 SPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 271 (419)
+.+||+|||++........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||...+.......+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 5599999999876533221 12334578899999886 578999999999999999998 999998888777777766
Q ss_pred hcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+..... ...++..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 239 QGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred cCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443222 2357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=325.57 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=216.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
......|...+.||+|+||.||+|++..++..+|+|.+.............+.+|+.+++.+ +|||++++++++.+...
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHT 99 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCe
Confidence 44555689999999999999999999999999999998765443444456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+.| +|.+.+.. ..++++.++..++.|++.||.|||++||+||||+|+||+++.+ +.++|+|||++...
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~---~~~kl~dfg~~~~~ 175 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASIA 175 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC---CCEEEecCCCcccc
Confidence 9999999975 77776654 5568999999999999999999999999999999999999653 45999999988654
Q ss_pred cCCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.. .....|++.|+|||.+. +.++.++||||+||++|+|++|..||...........+...... .......+
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 250 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEWS 250 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCcccc
Confidence 32 23456889999999863 46888999999999999999999999887766655555544321 11223568
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.+.+++.+||+.+|.+||++.++++|+|+....
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 8999999999999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.14 Aligned_cols=253 Identities=34% Similarity=0.566 Sum_probs=213.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~l 134 (419)
+|.+.+.||+|++|.||+|.+..+++.+++|++...... ....+.+.+|+.+++++ +||||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence 478889999999999999999889999999998765432 34567889999999999 899999999999988 89999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD---GVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC---CCEEEcccccEEeccccc
Confidence 99999999999999887789999999999999999999999999999999999999753 459999999998776554
Q ss_pred c---ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 Q---FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
. .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+... .........++..+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHH
Confidence 3 345678899999998874 58899999999999999999999997765 22222222110 11112223568999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+++.+||+.+|++||++.++++||||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.89 Aligned_cols=254 Identities=30% Similarity=0.525 Sum_probs=210.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccc--cCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--Ce
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK--LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~ 131 (419)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 36999999999999999999999999999999875421 11233456888999999999 899999999998764 56
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++|+||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA---GNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC---CCEEECccccccccc
Confidence 88999999999999999887789999999999999999999999999999999999999653 459999999987653
Q ss_pred CC----CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PG----EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.. .......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+..... .......++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccC
Confidence 21 12234568999999998874 588999999999999999999999977655544443332211 122234678
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.+.+++.+||. +|.+||++.+++.|||.
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=323.39 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=206.7
Q ss_pred cceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 46999999999999999999853 34567899988643 233456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 131 AVHIVMELCEGGELFDRIVARG-------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
.+++||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.+ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~---~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN---L 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC---C
Confidence 9999999999999999987543 38999999999999999999999999999999999999644 4
Q ss_pred CeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014722 198 PLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 272 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 272 (419)
.+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 599999999876543221 12234577899999887 568999999999999999998 9999988887777777766
Q ss_pred cccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.... .....+.++.+|+.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 54321 12357889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=333.20 Aligned_cols=258 Identities=31% Similarity=0.474 Sum_probs=209.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|++.+.||.|+||.||+|.+..+|..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence 45689999999999999999999999999999999875542 3456788899999999 999999999876544
Q ss_pred ----------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 130 ----------SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 130 ----------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
...|+|+||++ ++|.+.+.. +.+++..+..++.|++.||.|||+.||+||||||+||+++.+ +..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~--~~~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTE--DLVL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC--CceE
Confidence 35899999997 588877754 468999999999999999999999999999999999999643 3458
Q ss_pred EEeecccceeccCCCc----ccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014722 200 KAIDFGLSVFFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 200 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 273 (419)
||+|||.+........ .....|+..|+|||.+. ..++.++|||||||++|+|++|..||...+.......+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999876543211 12345788999999865 35788999999999999999999999877665554444332
Q ss_pred ccc----------------------cCCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 274 VID----------------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 274 ~~~----------------------~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
... .... ..+.++.++.+||.+||+.||++|||+.+++.||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 110 0000 123578899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=334.48 Aligned_cols=261 Identities=34% Similarity=0.524 Sum_probs=218.6
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-----e
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----A 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-----~ 131 (419)
+|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.+ +||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999998899999999987543 1233456788999999999 8999999999988775 7
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+||||+. ++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||.+....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~---~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN---CDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEcccCceEeec
Confidence 899999997 5898888877789999999999999999999999999999999999999754 559999999998765
Q ss_pred CCC----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----
Q 014722 212 PGE----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----- 280 (419)
Q Consensus 212 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 280 (419)
... ......+|+.|+|||++.+ .++.++|+||+|+++|+|++|.+||.+.+..+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 2345578999999998863 58889999999999999999999998888766665554422111110
Q ss_pred ----------------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCC
Q 014722 281 ----------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323 (419)
Q Consensus 281 ----------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~ 323 (419)
..+.++..+.++|.+||+.+|++|||+.+++.||||+.....+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 1134678899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=322.20 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=205.4
Q ss_pred cccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 4568999999999999999999864 245789999885432 223345688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 129 DSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
+...++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++||||||+||+++. ++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~---~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC---CCC
Confidence 999999999999999999886532 3567888999999999999999999999999999999974 445
Q ss_pred eEEeecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014722 199 LKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 273 (419)
++|+|||++......... ....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 999999998755432221 1234577899999886 568999999999999999999 78999888777666655543
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.... ....++..+.+++.+||+.||++|||+.+++++
T Consensus 238 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 238 GLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3211 123578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.85 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=214.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...+.|...+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.+ +|||++++++++.+....
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEE
Confidence 3444577888899999999999999999999999999765444444556788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+||||+. +++.+.+.. ..++++.++..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++....
T Consensus 97 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~---~~~kL~dfg~~~~~~ 172 (313)
T cd06633 97 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP---GQVKLADFGSASKSS 172 (313)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC---CCEEEeecCCCcccC
Confidence 99999996 577777654 4568999999999999999999999999999999999999644 459999999886432
Q ss_pred CCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
..+...|+..|+|||.+. +.++.++||||||+++|+|++|..||...+.......+..... +......++.
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTD 247 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCH
Confidence 234567889999999873 4588899999999999999999999988776555555543322 2222234678
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+.+|+.+||+.+|.+||++.+++.||||...
T Consensus 248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 89999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.59 Aligned_cols=259 Identities=35% Similarity=0.560 Sum_probs=218.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.....|++...||+|++|.||+|.+..++..+|+|++..... ..+.+.+|+..++.+ +||||+++++++......
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEE
Confidence 455679999999999999999999988899999999875432 456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+|+||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~---~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD---GSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC---CCEEECccchhhhhc
Confidence 99999999999999998876 79999999999999999999999999999999999999754 459999999876554
Q ss_pred CCC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
... ......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+...... .......++..+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 246 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEF 246 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHH
Confidence 322 223456788999999876 46899999999999999999999999877665544444333221 111223478899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.++|.+||+.+|.+|||+.+++.||||++..
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=314.02 Aligned_cols=250 Identities=34% Similarity=0.562 Sum_probs=212.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.+ +||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 48889999999999999999988999999999875432 3457888999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||+++++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.+ +.++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~---~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC---CeEEEeecccccccccccc
Confidence 999999999988775 579999999999999999999999999999999999999753 4599999999887655443
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC-ccCCHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-PKVSENAKDLV 293 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~li 293 (419)
.....|+..|+|||.+. ..++.++|+||||+++|+|++|..||...+.......+..... ..... ..++..+.+++
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP--PGLRNPEKWSDEFKDFL 231 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC--CCcCcccccCHHHHHHH
Confidence 44567889999999887 4578899999999999999999999977755444443333211 11111 12488999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
.+||+.||++|||+.++++|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.33 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=204.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCc--EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.+++++.+||||+++++++...+.++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 469999999999999999999877665 4688877532 233345678899999999967999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 134 IVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
+|+||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++. +.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~---~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE---NL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC---CC
Confidence 9999999999999987532 4788999999999999999999999999999999999964 44
Q ss_pred CeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 014722 198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
.+||+|||++..............+..|+|||.+. ..++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 59999999986432211111122345799999876 468999999999999999997 9999988887776666554321
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......++..+.+|+.+||..+|.+|||+.++++.
T Consensus 237 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 ---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11223578999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=348.59 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=214.5
Q ss_pred ceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+.+..+.||+|+||+||+|+... ....||||.++... +.....+|++|++++..| +|||||+++|++..++.
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGDP 563 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCCe
Confidence 57778999999999999998543 45679999987553 444678999999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 132 VHIVMELCEGGELFDRIVARG--------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
+|+|+|||..|||.++|.... +++..+...|+.||+.|+.||-++.+|||||-..|+|| ++..
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV---GENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee---ccce
Confidence 999999999999999997532 27889999999999999999999999999999999999 5667
Q ss_pred CeEEeecccceeccCCCccccc---ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014722 198 PLKAIDFGLSVFFRPGEQFNEI---VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 272 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~~~~---~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 272 (419)
.|||+|||+++.+...+.+... .-..+|||||.+. ++|+.+|||||+||+|||+++ |..||.+...+++++.+.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 7999999999987655543322 2246899999765 899999999999999999998 9999999999999999998
Q ss_pred cccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014722 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310 (419)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~ 310 (419)
+.. ...+ .++|.++.+|+..||+.+|.+|||+.||
T Consensus 721 g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 721 GQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 877 3333 4799999999999999999999999998
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=333.18 Aligned_cols=261 Identities=29% Similarity=0.492 Sum_probs=214.4
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe-
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA- 131 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~- 131 (419)
.+.++|++...||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.+ +||||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence 456789999999999999999999999999999999865422 223345677899999999 99999999998876554
Q ss_pred -----EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 132 -----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 132 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~---~~~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC---CCEEEccccc
Confidence 89999999 6699887765 469999999999999999999999999999999999999653 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------- 277 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 277 (419)
+...... .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.........+.......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 8765432 345578899999998754 57889999999999999999999998877665555544321100
Q ss_pred ----------------CC----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 278 ----------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 278 ----------------~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.. ..+...++.+.++|.+||+.+|++|||+.++++||||......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 00 0112468899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=326.17 Aligned_cols=259 Identities=32% Similarity=0.540 Sum_probs=210.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS- 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 130 (419)
....++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence 34556899999999999999999999999999999998754322 22335677899999999 8999999999987654
Q ss_pred ---------eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 131 ---------AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 131 ---------~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
.+++|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.+ +.+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~---~~~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CcEE
Confidence 79999999976 676766653 468999999999999999999999999999999999999644 4599
Q ss_pred EeecccceeccCCC--cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 201 AIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 201 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
|+|||++....... ......++..|+|||.+.+ .++.++||||+||++|+|++|++||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999988664332 1223356788999998753 4788999999999999999999999877766655555442211
Q ss_pred cCC--------------------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 277 FKR--------------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 277 ~~~--------------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
... ..+..++..+.+++.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 100 1123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=331.09 Aligned_cols=260 Identities=28% Similarity=0.490 Sum_probs=211.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-- 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 130 (419)
.+.++|.+++.||+|+||.||+|.+..+|..||+|++.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 35678999999999999999999999999999999986432 2222345688999999999 9999999999987553
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 131 ----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 131 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+++||||+ |++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~---~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED---CELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeccc
Confidence 468999999 678887765 4579999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-------- 276 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 276 (419)
+..... ......+++.|+|||.+.+ .++.++|+||+|+++|++++|.+||.+.+.......+......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 876532 2234567899999998764 5788999999999999999999999877655444443321110
Q ss_pred ---------------cC----CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 277 ---------------FK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 277 ---------------~~----~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.. ...++.+++.+.++|.+||..||++|||+.+++.||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 00 0112457888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=316.99 Aligned_cols=251 Identities=28% Similarity=0.540 Sum_probs=208.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 4699999999999999999999889999999998765444444567889999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 136 MELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~---~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC---CcEEEeccceeeecc
Confidence 999999999988864 3458999999999999999999999999999999999999654 459999999987654
Q ss_pred CCC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
... ......|++.|+|||.+. ..++.++||||||+++|+|++|..||..... ......+..... ...+....+.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY--PPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC--CCCChhhcCH
Confidence 332 223456889999999876 4688999999999999999999999965432 223333332221 1222235788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.++|.+||..+|++|||+.++++
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.62 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=201.7
Q ss_pred ccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+|++++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++++..||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45799999999999999999986433 3579999986542 2334567899999999995599999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc----------------------------------------------------------
Q 014722 130 SAVHIVMELCEGGELFDRIVAR---------------------------------------------------------- 151 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------- 151 (419)
...|+|||||++|+|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999887642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC
Q 014722 152 --------------------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193 (419)
Q Consensus 152 --------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~ 193 (419)
..+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999753
Q ss_pred CCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014722 194 KESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 268 (419)
Q Consensus 194 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 268 (419)
..+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||..........
T Consensus 274 ---~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 274 ---KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred ---CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 4599999999886543222 22345678899999876 468999999999999999997 999997765433333
Q ss_pred HHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.......... ....++..+.+++.+||+.||++|||+.++.+
T Consensus 351 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 3333222221 22357899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.18 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=207.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEE
Confidence 46899999999999999999998999999999986432 2356788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE---NHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCcEEeCCCccccccccc
Confidence 9999999999998754 35899999999999999999999999999999999999964 445999999998876533
Q ss_pred Ccc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 214 EQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 214 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
... ....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+....+....+.... .......++.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---RMERPEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHH
Confidence 221 1223456799999876 568899999999999999998 999998877766666554432 112224578999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+||..||++|||+.++++.
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHH
Confidence 999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=313.47 Aligned_cols=252 Identities=32% Similarity=0.586 Sum_probs=216.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+++++++ +|||++++++++.+.+.+++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence 588999999999999999999889999999999766432 34567899999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ- 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 215 (419)
||+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++. ++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC---CCCEEEeccccceecCCCccc
Confidence 99999999999988888999999999999999999999999999999999999975 34599999999987654332
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....++..|+|||.+. ..++.++||||+|+++|+|++|..||................ .......++..+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD---HPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---CCCCCCCCCHHHHHHHH
Confidence 23456889999999876 357889999999999999999999998766544443333221 12223467899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCcc
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+||..+|++|||+.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.26 Aligned_cols=245 Identities=36% Similarity=0.648 Sum_probs=212.6
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||.|+||.||++.+..+++.+|+|++.............+.+|+.+++.+ +||||+++++.+..+...++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 69999999999999888999999999876655445667889999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-CcccccccC
Q 014722 144 LFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-EQFNEIVGS 222 (419)
Q Consensus 144 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt 222 (419)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD---GHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC---CcEEEeecCcceecccCCCcccCCcCC
Confidence 99999888789999999999999999999999999999999999999654 45999999998776543 234456788
Q ss_pred cccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCC
Q 014722 223 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301 (419)
Q Consensus 223 ~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 301 (419)
..|+|||...+ ..+.++|+||||+++|++++|..||...........+...... .....+..+.+++.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR----FPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhcCCH
Confidence 99999998764 5788999999999999999999999877765555555543222 223458999999999999999
Q ss_pred CCCCCH---HHHhcCCcc
Q 014722 302 KQRLTA---EEVLEHPWL 316 (419)
Q Consensus 302 ~~R~s~---~~~l~~~~~ 316 (419)
++|||+ .++++||||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.79 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=207.9
Q ss_pred cccceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 34689999999999999999997542 35589999876442 223345678899999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
....|+||||+++|+|.+++... ...+...+..++.|++.||.|||+++|+||||||+||+++. +..
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~---~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH---DFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC---CCc
Confidence 99999999999999999999753 23466788999999999999999999999999999999965 445
Q ss_pred eEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014722 199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 273 (419)
++|+|||+++....... .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876533221 11234567899999876 568999999999999999998 78999887776666555443
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc------CCccccC
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE------HPWLQNA 319 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~------~~~~~~~ 319 (419)
.... .....++.+.+++.+||+.||++|||+.++++ ||||...
T Consensus 238 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 238 GYLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 2211 11346789999999999999999999999987 8888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=330.53 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=201.4
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED- 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~- 128 (419)
.++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 457999999999999999999743 345789999986432 233456778899999999779999999998764
Q ss_pred CCeEEEEEEecCCcchHHHHHhc---------------------------------------------------------
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR--------------------------------------------------------- 151 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------- 151 (419)
+..+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46789999999999999888542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcc
Q 014722 152 ----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPY 224 (419)
Q Consensus 152 ----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~ 224 (419)
..+++..+..++.|++.||.|||++||+||||||+|||++. +..++|+|||++..+..... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~---~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC---CCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788999999999999999999999999999999999974 34599999999987543221 223456778
Q ss_pred cCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCC
Q 014722 225 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPK 302 (419)
Q Consensus 225 y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 302 (419)
|+|||++. ..++.++|||||||++|+|++ |..||.+....+.............. ....++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA--PEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCC--CccCCHHHHHHHHHHccCChh
Confidence 99999876 579999999999999999998 99999775543333333322221111 135688999999999999999
Q ss_pred CCCCHHHHhcC
Q 014722 303 QRLTAEEVLEH 313 (419)
Q Consensus 303 ~R~s~~~~l~~ 313 (419)
+||++.++++|
T Consensus 319 ~RPs~~ell~~ 329 (337)
T cd05054 319 DRPTFSELVEI 329 (337)
T ss_pred hCcCHHHHHHH
Confidence 99999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=330.96 Aligned_cols=255 Identities=18% Similarity=0.296 Sum_probs=201.9
Q ss_pred cccccc--cceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
..||.| +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++..++..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999875533 233457888999999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-c-
Q 014722 140 EGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q- 215 (419)
Q Consensus 140 ~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~- 215 (419)
.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++++||+.+....... .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~---~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC---CcEEEechHHHhhhhccCccc
Confidence 999999988764 348999999999999999999999999999999999999754 459999998543322111 0
Q ss_pred ------ccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc---------
Q 014722 216 ------FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------- 277 (419)
Q Consensus 216 ------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------- 277 (419)
.....++..|+|||++.+ .++.++||||+||++|+|++|.+||...................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 011234667999999864 47889999999999999999999998766544433332211100
Q ss_pred ----------------------------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 278 ----------------------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 278 ----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..+.....++.+.+|+.+||+.||++|||+.++|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00011235678999999999999999999999999999986543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.54 Aligned_cols=242 Identities=26% Similarity=0.369 Sum_probs=199.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.+ +||||+++++++.....+++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46999999999999999999999999886432 233456788999999999 899999999999999999999999999
Q ss_pred cchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc---c
Q 014722 142 GELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---N 217 (419)
Q Consensus 142 g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~ 217 (419)
++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++......... .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK---NVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC---CcEEECccccCcccccccccccCC
Confidence 99999987644 58999999999999999999999999999999999999644 45999999998754422111 1
Q ss_pred ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 218 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
...++..|+|||.+. +.++.++||||||+++|+|++ |.+||...........+..... .......+..+.+|+.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---LPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCcccCCHHHHHHHHH
Confidence 112345699999876 568999999999999999998 9999977766555554443221 12223568999999999
Q ss_pred hcCCCCCCCCCHHHHhc
Q 014722 296 MLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 296 ~L~~dp~~R~s~~~~l~ 312 (419)
||+.+|++|||+.++++
T Consensus 232 ~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=320.64 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=206.0
Q ss_pred cceeeccccccccceEEEEEEEc----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++++ +||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence 36899999999999999999853 456889999987432 333456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC
Q 014722 132 VHIVMELCEGGELFDRIVAR-----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~ 194 (419)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~- 160 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ- 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC-
Confidence 99999999999999988532 237888999999999999999999999999999999999754
Q ss_pred CCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014722 195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 269 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 269 (419)
..+||+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |.+||.+.......+.
T Consensus 161 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 161 --LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred --CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4599999999976543321 22344567899999876 568999999999999999998 9999988776666555
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+..... ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 239 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 239 VRKRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 544332 12234678999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=320.63 Aligned_cols=254 Identities=30% Similarity=0.485 Sum_probs=207.8
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEEeCCe----
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYEDDSA---- 131 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~~~~---- 131 (419)
|++.+.||+|+||.||+|++..+++.+|+|.+....... .....+.+|+.+++++. +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999998889999999997543222 12345667887777663 59999999999988776
Q ss_pred -EEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 132 -VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 132 -~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
++++|||+.+ +|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~---~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD---GQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC---CCEEEeccCcce
Confidence 9999999975 8888876643 48999999999999999999999999999999999999754 559999999988
Q ss_pred eccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---------
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------- 278 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 278 (419)
............+++.|+|||++. ..++.++|+||+|+++|+|++|.+||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 765544444556889999999886 4688899999999999999999999988887776666654221100
Q ss_pred --------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 279 --------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 279 --------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
....+.+++.+.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00012356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=321.84 Aligned_cols=256 Identities=32% Similarity=0.549 Sum_probs=213.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|.....||+|+||.||++....+++.||+|.+... .......+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEE
Confidence 455557899999999999999999999999988543 223456788999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-c
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~ 215 (419)
||+++++|.+++. .+.+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~---~~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CCEEEcccccceeccccccc
Confidence 9999999988764 4568999999999999999999999999999999999999654 459999999887654322 2
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||.+.........+..... ........+++.+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence 33456889999999876 4678999999999999999999999987766555544433222 111223457899999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+||..+|.+||++.+++.||||.....
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHHhccCC
Confidence 999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.88 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=205.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|.. .++..+|+|.+..... ....+.+|+.+++++ +||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~-~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAM----SEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEe-ccCceEEEEecccCCc----cHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence 3689999999999999999986 4566899998764432 235788899999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.+ ..+||+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC---CeEEECCCCCccccCCCc
Confidence 999999999998875 3468999999999999999999999999999999999999643 459999999987654322
Q ss_pred cc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 QF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 ~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+........ ....+..+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHH
Confidence 22 1223556899999986 568899999999999999999 9999988887777777765432211 123578899
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=315.55 Aligned_cols=243 Identities=25% Similarity=0.388 Sum_probs=208.1
Q ss_pred cccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEe
Q 014722 62 RELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~ 138 (419)
+.||+|+||.||+|.+... +..+|+|.+....... ..+.+.+|+..++.+ +||||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence 4689999999999998765 8999999987654322 467889999999999 799999999999999999999999
Q ss_pred cCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 139 CEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 139 ~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~---~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED---LVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC---CcEEEcccccccc
Confidence 9999999999875 679999999999999999999999999999999999999654 5599999999987
Q ss_pred ccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 210 FRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 210 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..... ......+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 65432 223455788999999887 478999999999999999999 6999988877777776665321 122235
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++++.+++.+||..+|++|||+.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 68999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=326.48 Aligned_cols=256 Identities=29% Similarity=0.473 Sum_probs=205.2
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC-----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----- 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~----- 129 (419)
.++|++.+.||+|+||.||+|.+..+++.+|+|++........ ......+|+++++.+ +||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 4689999999999999999999999999999999875443221 224567899999999 899999999987543
Q ss_pred ---CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
..+++|+||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEECcCc
Confidence 357999999965 67666654 3469999999999999999999999999999999999999654 459999999
Q ss_pred cceeccCCCc------------ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 014722 206 LSVFFRPGEQ------------FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 271 (419)
Q Consensus 206 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 271 (419)
++........ .....|++.|+|||.+.+ .++.++||||+|+++|+|++|.+||.+.+.......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9876532211 123457889999998753 47899999999999999999999998877766555544
Q ss_pred hcccccCC--------------------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 272 RSVIDFKR--------------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 272 ~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
........ ..+...++.+.++|.+||+.||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 32111100 0112345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=323.45 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=212.8
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
....|...+.||.|+||.||+|++..+++.+|+|.+.............+.+|+.+++.+ +|||++++++++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence 445688899999999999999999999999999998754333444456788899999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|+||+. |++.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~---~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC---CCcEEECCcccceeecC
Confidence 9999996 577776654 456899999999999999999999999999999999999964 34599999999876543
Q ss_pred CCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
. ....|++.|+|||.+. +.++.++|||||||++|+|++|..||...........+...... .......+..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccHH
Confidence 2 3456889999999874 35788999999999999999999999776655544444433221 1112357889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+||.+||..+|++||++.++++|||+...
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=321.26 Aligned_cols=251 Identities=23% Similarity=0.291 Sum_probs=206.0
Q ss_pred cceeeccccccccceEEEEEEEcCCC----------------cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNG----------------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnI 119 (419)
.+|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+++++++ +||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCCE
Confidence 47999999999999999999876543 568999887543 234567888999999999 89999
Q ss_pred eeeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 120 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
+++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999987755 689999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAET 262 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~pf~~~~ 262 (419)
+++.+ ..++|+|||++........ .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||...+
T Consensus 162 li~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 162 LVGKN---YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eecCC---CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 99654 5599999999876543321 22345678899999876 478999999999999999998 778987776
Q ss_pred HHHHHHHHHhccc----ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 263 EQGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 263 ~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
............. .......+..+.++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6665555543211 1111112346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.41 Aligned_cols=251 Identities=30% Similarity=0.522 Sum_probs=215.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.+ +||||+++++++.+....++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence 588999999999999999999999999999998765432 33456778899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 137 ELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 137 e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +..+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~---~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec---CCcEEEeeccchhhhcc
Confidence 99999999998866 356899999999999999999999999999999999999975 34599999999887654
Q ss_pred CCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. ......+++.|+|||.+. ..++.++|+||+|+++|+|++|..||...+.......+........ ....+.++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHH
Confidence 4 333456889999999986 4688899999999999999999999988877666665554433211 1357889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
++.+||..+|++|||+.++++||++
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=334.19 Aligned_cols=259 Identities=31% Similarity=0.534 Sum_probs=236.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+.+++..||-|+||.|-++........+|+|++++..+-+....+.+..|-++|... +.|.||++|.-|.+..++|+.|
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhhH
Confidence 577788899999999999986666566999999998887777888999999999999 7999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
|-|-||.|+..+..++.+.+..++.++.-+++|++|||++|||+|||||+|.+++. ++.+||.|||+|+.+..+...
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~---~Gy~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN---RGYLKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc---CCceEEeehhhHHHhccCCce
Confidence 99999999999999999999999999999999999999999999999999999964 455999999999999999999
Q ss_pred cccccCcccCchhhh-cccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
.+++|||.|.|||++ ++..+.++|.||||+++|||++|.+||.+.+...+.+.|+++.-...-+ ..++..+.+||++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--RRITKTATDLIKK 654 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc--cccchhHHHHHHH
Confidence 999999999999975 5789999999999999999999999999999999999999876433222 3689999999999
Q ss_pred hcCCCCCCCCC-----HHHHhcCCccccCcc
Q 014722 296 MLNPDPKQRLT-----AEEVLEHPWLQNAKK 321 (419)
Q Consensus 296 ~L~~dp~~R~s-----~~~~l~~~~~~~~~~ 321 (419)
+...+|.+|.. +.++-+|.||.....
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 99999999985 899999999987543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.21 Aligned_cols=248 Identities=21% Similarity=0.308 Sum_probs=202.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcE----EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .....+.+.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-C
Confidence 4699999999999999999997666654 8999886432 233456788999999999 999999999998764 5
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++|+||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+ ..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~---~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP---QHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC---CcEEEccccccccc
Confidence 77999999999999999874 358899999999999999999999999999999999999644 45999999999876
Q ss_pred cCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+....+....+ ......+. .+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~--~~~~ 236 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQ--PPIC 236 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCCCCC--CCCC
Confidence 543322 2223467899999876 578999999999999999997 99999877665544333 32222222 2356
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.++.+++.+||..+|++|||+.+++.+
T Consensus 237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 237 TIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.95 Aligned_cols=253 Identities=33% Similarity=0.551 Sum_probs=208.5
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||+|++|+||+|....+++.||+|.+...... .......+|+..++++.+||||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999889999999998654321 1223455799999999339999999999999999999999
Q ss_pred ecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 138 LCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|+ +|+|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++. ++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~---~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG---PEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC---CCCEEEeecccceeccCCCC
Confidence 99 789999887764 6899999999999999999999999999999999999965 44599999999987765544
Q ss_pred ccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--------------
Q 014722 216 FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-------------- 279 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 279 (419)
.....++..|+|||++. ..++.++|+||||+++++|++|.+||...........+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 55567899999999875 35789999999999999999999999877665554443321111000
Q ss_pred ------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 ------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
...+..+..+.+++.+||+.+|++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0112336789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=332.84 Aligned_cols=252 Identities=22% Similarity=0.382 Sum_probs=209.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
...-++..+...||+|.||+||+|..- -.||||++..... ++...+.|++|+.++++- +|.||+-+.|++.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL 462 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc---cceEEEEEecCCC-CHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce
Confidence 344456778899999999999999953 3699999987765 445889999999999999 99999999999998777
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.||+.+|+|.+|+.++.- ...|.....+.|++|+++|+.|||.++|||||||..||++.++ +.|||+|||++..-
T Consensus 463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~---~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED---LKVKIGDFGLATVK 538 (678)
T ss_pred -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC---CcEEEecccceeee
Confidence 999999999999999875 3468889999999999999999999999999999999999643 56999999998643
Q ss_pred ---cCCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCC
Q 014722 211 ---RPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPW 282 (419)
Q Consensus 211 ---~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~ 282 (419)
..........|...|||||++. ..|++.+||||||+++|||+||..||...+...++-.+-++..... ....
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 2344556677888999999986 3699999999999999999999999986555544444434422211 1223
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.++++++|+..||.+++++||.+.++|.
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 467889999999999999999999999987
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=314.72 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=205.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||.|... .+..+|+|.+..... ..+.+.+|+.+++++ +||||+++++++.....+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence 36999999999999999999864 345699998864432 235788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~---~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC---CCCEEECCCccceecCCCc
Confidence 9999999999998764 46899999999999999999999999999999999999964 3459999999987654332
Q ss_pred cc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 QF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 ~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+.......+.+...... ....+..+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHH
Confidence 21 1223567899999987 568999999999999999998 9999988777776666665433221 124688999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+||..+|++|||+.+++.+
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=321.91 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=208.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+..|+.++..+.+||||+++++++.+....|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 33579999999999999999999988899999999875432 2234556678877777756999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++. ++.+||+|||++....
T Consensus 91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~---~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA---SGNVKLCDFGISGRLV 166 (296)
T ss_pred EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC---CCCEEECccccchhcc
Confidence 9999985 467666654 4578999999999999999999997 59999999999999964 4569999999987665
Q ss_pred CCCcccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
.........+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... .+....+...... ..+....+
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 245 (296)
T cd06618 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP-SLPPNEGF 245 (296)
T ss_pred CCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC-CCCCCCCC
Confidence 4433344567889999998863 378899999999999999999999965332 2333333333211 11111247
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.++.+|+.+||..||++|||+.+++.||||....
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 88999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.37 Aligned_cols=261 Identities=33% Similarity=0.589 Sum_probs=209.8
Q ss_pred ceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCC-hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
+|++.+.||+|++|.||+|.+. .+++.||+|++....... ....+.+.+|+.++.++.+||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999854 467899999987543221 223456788999999997799999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||||+++++|.+.+.....+++..+..++.|++.||.|||+.+++||||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~---~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE---GHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC---CCEEEEECcccccccc
Confidence 9999999999999999887789999999999999999999999999999999999999643 4599999999876543
Q ss_pred CCc--ccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GEQ--FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
... .....|++.|+|||.+.+ ..+.++||||||+++|+|++|..||...........+.+............++.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 223468899999998764 268899999999999999999999964332222222222222222222345788
Q ss_pred HHHHHHHHhcCCCCCCCCC---HHHHhcCCccccCc
Q 014722 288 NAKDLVKKMLNPDPKQRLT---AEEVLEHPWLQNAK 320 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s---~~~~l~~~~~~~~~ 320 (419)
.+.+++.+||+.||++||| +.++|+||||+...
T Consensus 238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 9999999999999999998 56779999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=327.04 Aligned_cols=259 Identities=30% Similarity=0.465 Sum_probs=208.5
Q ss_pred ceeeccccccccceEEEEEEEcCC--CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----CC
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DS 130 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~ 130 (419)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ........+.+|+.+++++.+||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986432 2222345678899999999679999999987532 24
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+++||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~---~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC---CCEEeCcCCCceec
Confidence 5789999985 6899988887889999999999999999999999999999999999999654 45999999999865
Q ss_pred cCCC-----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--------
Q 014722 211 RPGE-----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-------- 275 (419)
Q Consensus 211 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 275 (419)
.... ......||+.|+|||.+.+ .++.++||||+|+++|+|++|.+||...+.......+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4322 1234578999999998753 588999999999999999999999987665444433332110
Q ss_pred ---------------ccC----CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 ---------------DFK----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 ---------------~~~----~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
... ...++..+..+.+|+.+||+.||++|||+.+++.|||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000 112345688999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=315.00 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=206.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|+++++||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEE
Confidence 35799999999999999999986 466789999876432 2356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~---~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE---SLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC---CCcEEECCCccceecCC
Confidence 99999999999988653 45888999999999999999999999999999999999965 34599999999987643
Q ss_pred CCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.... ..+....++.+
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPDE 232 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence 321 12234567899999876 568889999999999999998 999998887777666655432 12233467899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+++.+||..+|++|||+.++++
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 233 LYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.00 Aligned_cols=253 Identities=32% Similarity=0.553 Sum_probs=210.1
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||+|++|.||+|.+..+|+.+++|.+...... ......+.+|+.+++++ +||||+++++++.++...++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence 67788999999999999999889999999998765432 23456788899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-c
Q 014722 138 LCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~ 215 (419)
|+++ +|.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.+ +.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~---~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE---GVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC---CcEEEeeeeeeEecCCCccc
Confidence 9975 88887766 3578999999999999999999999999999999999999643 459999999988765443 2
Q ss_pred ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--------------
Q 014722 216 FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-------------- 279 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 279 (419)
.....++..|+|||.+.+ .++.++|+||+|+++|+|++|..||...+..+....+.........
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 334568889999998763 5888999999999999999999999887765554444332111000
Q ss_pred ------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 280 ------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 280 ------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..++.++.++.++|.+||+.||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=317.96 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=200.1
Q ss_pred eeccccccccceEEEEEEEc----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 59 DLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+.+.||.|+||.||+|... ..+..|+||.+... ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 45678999999999999976 45678999999542 2344578899999999999 99999999999998888999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||+++|+|.+++... ..+++..+..|+.|++.||.|||+++++||||+|+||+++.++ .+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~---~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG---QVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT---EEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccc
Confidence 99999999999999886 6799999999999999999999999999999999999997544 599999999987632
Q ss_pred CCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
... .....+...|+|||.+. ..++.++||||||+++||+++ |..||...+.......+.+..... ....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---IPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT---SBTTSBH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccce---eccchhH
Confidence 222 12344677899999987 458999999999999999999 789998888888777775543321 2235789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.++|.+||..||++|||+.++++
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.72 Aligned_cols=264 Identities=33% Similarity=0.517 Sum_probs=212.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-- 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-- 129 (419)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++++.+||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 346678999999999999999999998899999999886432 22233456778999999997899999999998643
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..+|+||||+. ++|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++. ++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~---~~~~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS---DCRVKLADFGLARS 156 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC---CCcEEEeeccchhc
Confidence 46899999997 5998888765 7899999999999999999999999999999999999964 44599999999876
Q ss_pred ccCCC------cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-----
Q 014722 210 FRPGE------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----- 276 (419)
Q Consensus 210 ~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 276 (419)
..... ......||+.|+|||.+. ..++.++||||||+++|+|++|.+||.+.........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 54322 223456899999999875 35788999999999999999999999876655443333222100
Q ss_pred ----------------------cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 277 ----------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 277 ----------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
......+.++.++.++|.+||+.||++|||+.++++||||+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 001112346889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.81 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=136.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|.+++.||.|+||.||+|.+..+++.||+|++.............+..|+.+++.+ +||||+++++++.....+|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 4799999999999999999999999999999999876555555567888999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
|||+.|++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~---~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN---EGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC---CCCEEEEeCCCCc
Confidence 999999999999988788999999999999999999999999999999999999964 3459999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=317.37 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=207.0
Q ss_pred cccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~ 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVST 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC
Confidence 346899999999999999999987643 4889999986442 223445788999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 129 DSAVHIVMELCEGGELFDRIVARG----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.+ +.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~---~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED---LT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC---CC
Confidence 999999999999999999886532 36788999999999999999999999999999999999654 45
Q ss_pred eEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Q 014722 199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~ 273 (419)
+||+|||++........ .....++..|+|||.+. +.++.++|||||||++|++++ |..||.+.+.......+...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999999876543321 22345678899999876 568999999999999999998 99999888777766655533
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
... ......+.++.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 238 GHL---DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 211 1123468999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=320.44 Aligned_cols=254 Identities=23% Similarity=0.339 Sum_probs=206.9
Q ss_pred CccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
....++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... .....+.+.+|+.+++++.+||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 445568999999999999999999752 345689999886543 2234567889999999996799999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
...+..++||||+.+|+|.+++.... .+++.++..++.|++.||.|||+++|+||||||+|||++. +..++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH---GKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC---CCeEEECCC
Confidence 99999999999999999999987643 3899999999999999999999999999999999999964 445999999
Q ss_pred ccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 205 GLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 205 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
|++........ .....+++.|+|||.+. +.++.++||||+||++|+|++ |..||...................
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-- 263 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-- 263 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--
Confidence 99876543221 12234577899999876 568999999999999999998 999998776555444443332221
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
......++++.+++.+||..+|++|||+.++++
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 122356899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=314.96 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=207.2
Q ss_pred cceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
++|++.+.||+|+||.||+|....+ ...||+|.+.... .......+.+|+.+++.+ +||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence 4699999999999999999987644 4589999886543 333456788899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++. +..++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~---~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC---CCCEEECccchhhccc
Confidence 9999999999999998764 46899999999999999999999999999999999999964 4459999999998764
Q ss_pred CCC-ccc--ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PGE-QFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
... ... ...+++.|+|||.+. ..++.++||||||+++|+|++ |..||...........+...... +.....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---PPPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCC
Confidence 211 111 223467899999887 568999999999999999998 99999887777666666543211 1223578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=319.37 Aligned_cols=248 Identities=21% Similarity=0.338 Sum_probs=206.7
Q ss_pred ceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+|++.+.||.|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.++..+ +||||+++++++.....
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCc
Confidence 58899999999999999998754 35789999987442 223346788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC
Q 014722 132 VHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE 195 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~ 195 (419)
.++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~-- 160 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-- 160 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC--
Confidence 99999999999999988532 247888899999999999999999999999999999999643
Q ss_pred CCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014722 196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 270 (419)
Q Consensus 196 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 270 (419)
..+||+|||+++....... .....+++.|+|||.+. +.++.++|||||||++|+|++ |..||.+....+....+
T Consensus 161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred -CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 4599999999876543222 22345678899999875 678999999999999999998 88999888877777776
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
........ ...++..+.+|+.+||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 240 RNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 66543221 23578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=328.86 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=208.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|.+...||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence 45689999999999999999999999999999999875432 222345678899999999 999999999998754
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..+++|+||+.. +|...+ ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~---~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED---CELKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEeeCCCC
Confidence 346999999964 676554 3468999999999999999999999999999999999999654 45999999998
Q ss_pred eeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---------- 275 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---------- 275 (419)
..... ......+|+.|+|||.+.+ .++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 75432 2234567899999998764 588899999999999999999999988765554444332110
Q ss_pred -------------ccCCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 276 -------------DFKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 276 -------------~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..... .++..++.+.+||.+||+.||++|||+.+++.||||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00111 12356788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=322.13 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=206.7
Q ss_pred ccccceeeccccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~ 125 (419)
...++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+.+||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 344679999999999999999998643 33579999987542 233456788899999999779999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
+...+..|+||||+++|+|.+++.... .++..++..++.|++.||+|||++|++||||||+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 3788999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 264 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 264 (419)
++.+ +.+||+|||.+......... ....+++.|+|||++. ..++.++|||||||++|+|++ |..||.+.+..
T Consensus 173 l~~~---~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 173 VTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred EcCC---CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 9644 45999999998765432211 1223456899999886 468999999999999999998 89999887766
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+....+..... ......++.++.+|+.+||..+|++|||+.+++++
T Consensus 250 ~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 250 ELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHcCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66555544321 12234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=312.81 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=199.8
Q ss_pred ccccccceEEEEEEE--cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 63 ELGRGEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
.||+|+||.||+|.. ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCC
Confidence 689999999999964 4578899999986543 2333456788999999999 9999999999886 456789999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc----
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---- 216 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~---- 216 (419)
+++|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++. +..+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT---QHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC---CCeEEECCCccccccCCCCCeeeec
Confidence 9999999988788999999999999999999999999999999999999965 345999999998765433221
Q ss_pred cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+....+..+.. .+....+++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---MECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHH
Confidence 1223457899999886 468889999999999999998 9999988777766666654332 1122358999999999
Q ss_pred HhcCCCCCCCCCHHHHhc
Q 014722 295 KMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~ 312 (419)
+||+.||++|||+.++..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.59 Aligned_cols=253 Identities=32% Similarity=0.542 Sum_probs=210.5
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|++.+.||+|++|.||+|+...+++.+|+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+.+++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence 6677899999999999999999999999999976542 222345677899999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-c
Q 014722 138 LCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-Q 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~ 215 (419)
|++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++. ++.++|+|||.+....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~---~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---DGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC---CCCEEEecCCcccccCCCccc
Confidence 997 5899998876 57999999999999999999999999999999999999965 4559999999987664332 2
Q ss_pred ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc----------------
Q 014722 216 FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF---------------- 277 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------------- 277 (419)
.....++..|+|||.+.+ .++.++||||||+++|++++|.+||.+....+....+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 334456788999998753 68889999999999999999999998877665555443321100
Q ss_pred ---------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 ---------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
....++.++..+.++|.+||..||++||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001223457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=306.97 Aligned_cols=258 Identities=29% Similarity=0.535 Sum_probs=216.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE--------
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-------- 127 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-------- 127 (419)
..|+-..+||+|.||.||+|+..++|+.||+|++-.+.-..... ....+|+.+|..| .|+|++.+++++.
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~l-kHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLL-KHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence 35888899999999999999999999999998875433222222 3456799999999 9999999998874
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
+...+|+|+.+|+. +|..++... -.++..++..++.+++.||.|+|+..|+|||+||.|+|++. ++.+||+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~---dgilklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK---DGILKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC---CceEEeecccc
Confidence 33459999999975 888877654 46999999999999999999999999999999999999964 45699999999
Q ss_pred ceeccCCC-----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 207 SVFFRPGE-----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 207 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
++.+...+ .+...+-|.+|++||.+.+ +|+++.|||..|||+.+|+||.+.+.+.+++.++..|....-+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97664332 2344567999999998864 7999999999999999999999999999999998888776666666
Q ss_pred CCCccC-------------------------------CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 280 DPWPKV-------------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 280 ~~~~~~-------------------------------~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.||++ .+++.+|+.++|..||.+|+++.++|+|.||.+.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 666543 2367899999999999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=328.13 Aligned_cols=260 Identities=27% Similarity=0.478 Sum_probs=208.8
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 355689999999999999999999999999999999875322 222345678899999999 899999999988643
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
...|++++++ |++|.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~---~~~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGL 166 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC---CCEEEecccc
Confidence 3478888887 7789776654 469999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--------- 275 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------- 275 (419)
+.... .......||+.|+|||.+.+ .++.++||||+||++|+|++|.+||...+.......+.....
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 167 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 87643 22344578999999998754 578899999999999999999999987665544443322110
Q ss_pred --------------ccCC----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 276 --------------DFKR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 276 --------------~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..+. ..+...++++.++|.+||+.||.+|||+.+++.||||++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 0000 011235788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=320.00 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=208.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
..-..+|++.+.||+|+||.||++..... ...+|+|.+.... .......+.+|+.+++++.+||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34456799999999999999999987643 3789999987542 2334567889999999996799999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEe
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF 190 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~ 190 (419)
...+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998642 358899999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 014722 191 ANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 265 (419)
Q Consensus 191 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 265 (419)
+. ++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 166 ~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 166 TE---DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred cC---CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 64 44599999999986643321 11223456799999876 568999999999999999997 999998887766
Q ss_pred HHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 266 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....+..... . ......+..+.+|+.+||..||++|||+.+++++
T Consensus 243 ~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYR-M--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCc-C--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6665554321 1 1223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=318.44 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=205.4
Q ss_pred cceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence 36899999999999999999853 345678888876432 33446788999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC
Q 014722 131 AVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~ 194 (419)
..++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~- 159 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN- 159 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence 9999999999999999987542 37899999999999999999999999999999999999654
Q ss_pred CCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014722 195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 269 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 269 (419)
..++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|+| |..||...+.......
T Consensus 160 --~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 160 --LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred --CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4599999999876543221 12345678899999876 568899999999999999999 9999988777766666
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+....... .....+..+.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 238 ITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred HhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 55443321 123468899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=315.52 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=202.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||+||+|....+|+ .||+|++.... .......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-ST 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CC
Confidence 479999999999999999999777766 48999886442 333456788999999999 89999999999875 45
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++++||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++++ ..+||+|||++...
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~---~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP---NHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC---CcEEECCCCceeec
Confidence 78999999999999998764 468999999999999999999999999999999999999643 44999999999876
Q ss_pred cCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||...........+..... . +.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~ 236 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER-L--PQPPIC 236 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-C--CCCccC
Confidence 533221 1233467899999876 568999999999999999998 9999977766555544443221 1 223467
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.++.+++.+||..||++||++.++++.
T Consensus 237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 237 TIDVYMIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=314.53 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=202.9
Q ss_pred eeeccccccccceEEEEEEEcC---CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe---
Q 014722 58 YDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA--- 131 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~--- 131 (419)
|.+.+.||+|+||.||+|.... ++..||+|.+..... .......+.+|+..++.+ +||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 5678899999999999998754 347899999875432 334567889999999999 89999999998765444
Q ss_pred ---EEEEEEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 132 ---VHIVMELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 132 ---~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
.++|+||+++|+|..++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. +..+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE---DMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC---CCeEEEC
Confidence 89999999999999887542 35899999999999999999999999999999999999964 3459999
Q ss_pred ecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 014722 203 DFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 203 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
|||++......... ....++..|+|||.+. ..++.++|||||||++|+|++ |.+||.+.........+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL- 234 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence 99999876433221 1223467899999886 468999999999999999999 99999887777666655544321
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.....+++.+.+++.+||+.||++|||+.+++++
T Consensus 235 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 --KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223578999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=313.90 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred cccccccceEEEEEEEcCCCc--EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
+.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.+++++.+||||+++++++...+.+++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999888776 4578877632 233345678899999999978999999999999999999999999
Q ss_pred CCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 140 EGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 140 ~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
++|+|.+++.... .+++.++..++.|++.||+|||++|++||||||+||+++. +..+||+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~---~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE---NYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC---CCeEEECC
Confidence 9999999987543 4788999999999999999999999999999999999964 44599999
Q ss_pred cccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
||++..............+..|+|||++. ..++.++||||||+++|+|++ |..||.+.+.......+.... ....
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence 99986332111111122356799999876 468899999999999999997 999998877766665554331 1122
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...++.++.+++.+||..||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 23578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=325.26 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=197.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-eE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~~ 132 (419)
.+++|.-...||+|+||.||+|.. .+|..||||++....... ..++.+|+.++.++ +|||+|+++|||.+.+ ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccEEEEEecCCceE
Confidence 446788888999999999999995 455999999776543211 35699999999999 7999999999999888 59
Q ss_pred EEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 133 HIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQG---VMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
+||+||+++|+|.+++.... .++|.....|+.+++.||+|||... |+||||||+|||++. +.+.||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~---~~~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE---DFNAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC---CCCEEccCccCc
Confidence 99999999999999998765 8999999999999999999999854 999999999999964 455999999999
Q ss_pred eeccC-CCccccc-ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhc-cc-c
Q 014722 208 VFFRP-GEQFNEI-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQ---AIIRS-VI-D 276 (419)
Q Consensus 208 ~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~---~i~~~-~~-~ 276 (419)
+.... ....... .||.+|+|||+.. +..+.++|||||||++.|++||+.|..... ...... ..... .+ .
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~e 304 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLRE 304 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhh
Confidence 77654 3333333 8999999999986 689999999999999999999998876432 111111 11111 11 1
Q ss_pred cCCCCC--ccCC-----HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 277 FKRDPW--PKVS-----ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 277 ~~~~~~--~~~~-----~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...+.. ...+ ..+..+..+|++.+|..||++.|+++.
T Consensus 305 iiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 305 IVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred eeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111111 1222 235677889999999999999997543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=314.09 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=208.2
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|.+.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.+ +||||+++++++.+...+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence 3479999999999999999999876 8999999987543 22356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..+||+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~---~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED---LVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC---ceEEEccccchhhcCC
Confidence 99999999999999753 358999999999999999999999999999999999999654 4599999999876543
Q ss_pred CCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 213 GEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 213 ~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...+..+....+..... .+....+++.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR---MPCPAKCPQEI 233 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc---CCCCCCCCHHH
Confidence 221 12334567899999876 568899999999999999998 8999988877776666654321 22224678999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+++.+||+.||++|||+.++++
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=313.27 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=205.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++++ +||||+++++++..++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 479999999999999999999765443 79999886542 233456889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+||||+++++|.+++... +.+++.++..++.|++.||.|||++|++||||||+||+++. +..++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~---~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC---CCeEEeCCCCcccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999964 4459999999988764
Q ss_pred CCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... ....++..|+|||.+. +.++.++|+||||+++|++++ |..||......+....+.... .. +....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RL--PAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cC--CCCCCC
Confidence 33221 1122356899999987 578999999999999999886 999998877766666555432 11 222357
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+.+++.+||+.+|.+|||+.++++
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=315.45 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=205.0
Q ss_pred cceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|.+.++||+|+||.||+|... .++..+|+|.+... .......+.+|+++++.+ +||||+++++++.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCC
Confidence 46889999999999999999743 35678999987643 334567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC
Q 014722 131 AVHIVMELCEGGELFDRIVARG---------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE 195 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~ 195 (419)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~--- 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ--- 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC---
Confidence 9999999999999999987643 4788999999999999999999999999999999999964
Q ss_pred CCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014722 196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 270 (419)
Q Consensus 196 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 270 (419)
+..+||+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |.+||...........+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 45599999999876543221 12234567899999876 568999999999999999998 99999877776666655
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...... .....+++.+.+++.+||+.||.+||++.++++
T Consensus 238 ~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 544221 122357899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=311.44 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=203.5
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.+ +||||+++++++...+..|+||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEE
Confidence 5889999999999999999875 567899999864432 234678899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~---~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED---NVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC---CcEEECCcccceecccccc
Confidence 999999999998763 468999999999999999999999999999999999999654 4599999999876543221
Q ss_pred c--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 216 F--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 216 ~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||...+..+....+..... . ......+..+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 232 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-L--YRPKLAPTEVYT 232 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-C--CCCCCCCHHHHH
Confidence 1 1122345799999876 578999999999999999999 8999988777666665544321 1 122357899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+||..+|++|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=321.56 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=199.8
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|.+.+.+|.| |.||.+++..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+..+++||
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e 79 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSP 79 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEe
Confidence 3444445444 5556666667999999999976532 334567899999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 138 LCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.+||+|||.+........
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~---~~~kl~d~~~~~~~~~~~~ 156 (314)
T cd08216 80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD---GKVVLSGLRYSVSMIKHGK 156 (314)
T ss_pred ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC---CceEEecCccceeeccccc
Confidence 99999999988763 458999999999999999999999999999999999999754 4599999998865532211
Q ss_pred --------ccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 014722 216 --------FNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------- 277 (419)
Q Consensus 216 --------~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 277 (419)
.....++..|+|||++.. .++.++||||+||++|+|++|..||..............+....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCch
Confidence 123457788999999864 48899999999999999999999998765544332222211100
Q ss_pred -------C----------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 278 -------K----------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 278 -------~----------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
. ......++.++.+|+.+||..||++|||+.++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0 000012346788999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.83 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=204.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.+.||+|++|.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLW-NNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEe-cCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence 45699999999999999999986 4567899999875432 245788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN---NICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC---CCEEECCcceEEEccC
Confidence 999999999999987654 68999999999999999999999999999999999999754 4599999999987653
Q ss_pred CCcc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.... .....+..|+|||.+. ..++.++||||||+++|+|++ |..||.+.+.......+..... . ......+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCHH
Confidence 2211 1112245799999876 468999999999999999999 9999988877766666554321 1 122357899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=293.84 Aligned_cols=255 Identities=30% Similarity=0.588 Sum_probs=214.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAV 132 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~ 132 (419)
.++|++++++|+|.|++||.|.+..+++.++||+++. ...+.+.+|+.+|+.|+.||||++++++..+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4579999999999999999999999999999999853 34578999999999998899999999998765 457
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
.+|+||..+.+...+. ..++...++.++.+++.||.|+|+.||+|||+||.|++++.. ...++|+|+|+|.++-+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~--~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechh--hceeeeeecchHhhcCC
Confidence 8999999887765543 458889999999999999999999999999999999999854 34599999999999999
Q ss_pred CCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhc-------------cc-
Q 014722 213 GEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRS-------------VI- 275 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~-------------~~- 275 (419)
+...+..+.+..|.-||.+- +.|+..-|+|||||++..|++.+-|| .+.+..+++-+|.+- .+
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 99999999999999999886 57999999999999999999988887 444444444433211 00
Q ss_pred ----------ccCCCCCc---------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 ----------DFKRDPWP---------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 ----------~~~~~~~~---------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...+.+|. -.++++.||+.++|.+|..+|+||.|++.||||....
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 11223332 1469999999999999999999999999999997543
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.62 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=205.0
Q ss_pred cccceeeccccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
-..+|.+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++++.+||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 34579999999999999999998632 34578999886432 2334567889999999996699999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEe
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLF 190 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~ 190 (419)
.+.+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 9999999999999999999998753 247888999999999999999999999999999999999
Q ss_pred ecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 014722 191 ANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 265 (419)
Q Consensus 191 ~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~ 265 (419)
+.+ +.+||+|||+++....... .....+++.|+|||++. +.++.++||||||+++|+|++ |..||.+....+
T Consensus 168 ~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 168 TED---NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred cCC---CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 644 4599999999976543221 11223456799999876 568999999999999999999 899998887766
Q ss_pred HHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 266 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
....+..... ......++.++.+++.+||..+|++|||+.++++
T Consensus 245 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 6665544321 1122457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.91 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=208.8
Q ss_pred CccccceeeccccccccceEEEEEEEc-------CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeee
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD 124 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~ 124 (419)
.....+|.+.+.||+|+||.||+|++. .++..+|+|.+.... .......+.+|+.+++.+.+||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345568999999999999999999753 234579999886432 23345678899999999977999999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 125 TYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 125 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
++......|+||||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999987642 367788999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCH
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE 263 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 263 (419)
+++. ++.+||+|||++........ .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.+.+.
T Consensus 169 li~~---~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTE---NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcC---CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9964 34599999999987643221 12234567899999886 468999999999999999998 8899988887
Q ss_pred HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+....+...... .....++.++.+|+.+||..+|++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 7776666543321 1224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=363.11 Aligned_cols=260 Identities=27% Similarity=0.488 Sum_probs=219.5
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+.+..+|.-...||.|.||.||-|.+..+|+..|+|-+...... ......+.+|..++..+ +|||+|+++++-.+.+.
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHH
Confidence 34556788889999999999999999999999999999866543 44567788999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++|.||||+||+|.+.+...+..+|.....+..|++.|++|||++|||||||||.||+++.++ .+|++|||.|..+.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g---~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG---LIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC---cEEeecccceeEec
Confidence 999999999999999988877788888999999999999999999999999999999997544 59999999998876
Q ss_pred CCC-----cccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCC
Q 014722 212 PGE-----QFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDP 281 (419)
Q Consensus 212 ~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 281 (419)
.+. .....+||+.|||||++.+ ...-+.|||||||++.||+||+.||...+..- +.-.+-.+.. +. .
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~--Pq-~ 1462 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK--PQ-I 1462 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC--CC-C
Confidence 543 2456789999999999864 35668999999999999999999996654432 2222222221 11 1
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...+|++.++||.+||+.||++|+++.|+++|.|-+..
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 13489999999999999999999999999999987654
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=317.79 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=201.3
Q ss_pred cceeeccccccccceEEEEEEEcCC--------------CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeee
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNN--------------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~ 121 (419)
.+|++.+.||+|+||.||+|++..+ ...||+|.+.... .......+.+|+++++++ +||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcCe
Confidence 4799999999999999999986543 2358999987542 233456788999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 122 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCCCH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAETE 263 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~ 263 (419)
++.+ ..+||+|||++........ .....+++.|+|||++. +.++.++||||||+++|+|++ |..||...+.
T Consensus 162 l~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNH---YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCC---CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9643 4599999999876543321 12234567899999876 578999999999999999988 6788887766
Q ss_pred HHHHHHHHhccc----ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 264 QGVAQAIIRSVI----DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 264 ~~~~~~i~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
......+..... .......+..++.+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 555544432111 0111122357899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=328.53 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=204.6
Q ss_pred CccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
..-..+|.+.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.++.++..||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 344457999999999999999999853 356789999997543 2223457889999999994499999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC------------------------------------------------------
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARG------------------------------------------------------ 152 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------------------------------ 152 (419)
...+..++||||+++|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999886532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 153 --------------------------------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 153 --------------------------------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
.+++..+..++.|++.||.|||+.+++||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677888999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCH
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE 263 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 263 (419)
|++. ...+||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|||++ |..||.....
T Consensus 271 Ll~~---~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICE---GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeC---CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9964 34599999999986532221 12345678899999886 468899999999999999998 8999977655
Q ss_pred HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+............ .....++.++.+|+.+||..+|.+||++.++++.
T Consensus 348 ~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55444433332221 1223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.99 Aligned_cols=241 Identities=22% Similarity=0.343 Sum_probs=199.4
Q ss_pred cccccccceEEEEEEEcCCC---cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEe
Q 014722 62 RELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~ 138 (419)
+.||+|+||.||+|....++ ..+|+|.+...... ...+.+.+|+.+++.+ +||||+++++++. .+.+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEe
Confidence 46999999999999865554 78999998765432 3456788999999999 8999999999876 4568999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccc-
Q 014722 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN- 217 (419)
Q Consensus 139 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~- 217 (419)
+++++|.+++.....+++..+..++.|++.||.|||+.+++||||||+||+++.+ +.+||+|||++..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~---~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR---HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC---CcEEeccccccceeecCCcccc
Confidence 9999999999887789999999999999999999999999999999999999654 459999999988664433211
Q ss_pred ---ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 218 ---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 218 ---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
...++..|+|||.+. ..++.++||||||+++|++++ |.+||...+..+....+..... ......++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER---LPRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc---CCCCCCCCHHHHHH
Confidence 112346799999876 568999999999999999998 9999988777666555544321 12224578999999
Q ss_pred HHHhcCCCCCCCCCHHHHhc
Q 014722 293 VKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+||..+|++|||+.++++
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=320.81 Aligned_cols=260 Identities=33% Similarity=0.509 Sum_probs=208.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-CCeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~ 132 (419)
+.++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcE
Confidence 56789999999999999999999999999999998865432 223346778899999999 89999999999865 5678
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++. ++.++|+|||.+.....
T Consensus 86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~---~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE---NCDLKICDFGLARIQDP 160 (328)
T ss_pred EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC---CCCEEeCccccccccCC
Confidence 9999999 5688776654 46889999999999999999999999999999999999964 45599999999875432
Q ss_pred CCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------------
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--------------- 275 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------------- 275 (419)
......+++.|+|||.+.+ .++.++||||+|+++|+|++|.+||...........+.+...
T Consensus 161 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 161 --QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred --CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 2234567889999998753 588999999999999999999999977654332222111000
Q ss_pred -----cc---C----CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 276 -----DF---K----RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 276 -----~~---~----~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.. . ....+.+++.+.++|.+||+.+|++|||+.+++.||||......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00 0 01123567899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.57 Aligned_cols=245 Identities=24% Similarity=0.325 Sum_probs=201.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.++||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++++ +||||+++++++. ....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEE
Confidence 45799999999999999999987655 5699999875432 235788999999999 8999999999875 456899
Q ss_pred EEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++. ++.++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~---~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC---CCcEEeccCCceeeccc
Confidence 99999999999999763 35789999999999999999999999999999999999965 44599999999976643
Q ss_pred CCcc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.... ....++..|+|||.+. +.++.++||||||+++|+|+| |.+||.+....+....+..... ......++..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC---CCCccccCHH
Confidence 3221 2334667899999876 578999999999999999999 8999988777666665544321 1112457899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+++.+||+.+|++|||+.++++
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHH
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=325.02 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=198.7
Q ss_pred cceeeccccccccceEEEEEEE-----cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-C
Q 014722 56 IDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-D 129 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~ 129 (419)
++|++.+.||.|+||.||+|.+ ..+++.||+|++.... .......+.+|+.++.++.+||||+++++++.. +
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4799999999999999999984 3567899999987543 223356788999999999778999999998764 4
Q ss_pred CeEEEEEEecCCcchHHHHHhcC---------------------------------------------------------
Q 014722 130 SAVHIVMELCEGGELFDRIVARG--------------------------------------------------------- 152 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------------------------- 152 (419)
..+++|||||++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56899999999999999886431
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc---cccc
Q 014722 153 ----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEI 219 (419)
Q Consensus 153 ----------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 219 (419)
.++...+..++.|++.||.|||++||+||||||+||+++. +..+||+|||++........ ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE---NNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC---CCcEEEEecccccccccCcchhhcCCC
Confidence 3577788899999999999999999999999999999964 44599999999876533221 1223
Q ss_pred ccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhc
Q 014722 220 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297 (419)
Q Consensus 220 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 297 (419)
.+++.|+|||.+. ..++.++||||||+++|+|++ |..||.....................+ ...++++.+++.+||
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl 319 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCW 319 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHc
Confidence 4567899999876 568999999999999999997 999997654333222222222211111 236789999999999
Q ss_pred CCCCCCCCCHHHHhcC
Q 014722 298 NPDPKQRLTAEEVLEH 313 (419)
Q Consensus 298 ~~dp~~R~s~~~~l~~ 313 (419)
+.||++|||+.++++|
T Consensus 320 ~~~p~~Rps~~eil~~ 335 (343)
T cd05103 320 HGEPSQRPTFSELVEH 335 (343)
T ss_pred cCChhhCcCHHHHHHH
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.44 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=206.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+..|+.+++.+ +||||+++++++.++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence 358999999999999999999877665 69999986542 344567899999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++++|.+++.. .+.+++.++..++.|++.||.|||++|++||||||+||+++. +..+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~---~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC---CCcEEECCCccccccc
Confidence 999999999999998876 356899999999999999999999999999999999999964 4459999999987654
Q ss_pred CCCcc---cccc---cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 212 PGEQF---NEIV---GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 212 ~~~~~---~~~~---gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
..... .... .+..|+|||.+. +.++.++||||+|+++|++++ |..||...........+... . ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~-~--~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD-Y--RLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-C--cCCCcc
Confidence 32221 1111 235799999886 578999999999999999886 99999888777666665432 1 222234
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.++..+.+++.+||..+|.+||++.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.33 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=202.2
Q ss_pred ceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence 47889999999999999998643 23578888886442 233456788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCc
Q 014722 132 VHIVMELCEGGELFDRIVAR------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN 187 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 187 (419)
.++|+||+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999987642 247788999999999999999999999999999999
Q ss_pred EEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 014722 188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 262 (419)
Q Consensus 188 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 262 (419)
|+++.+ ..+||+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+..
T Consensus 158 ill~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEG---RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCC---CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999643 4599999999876533221 12234567899999876 468999999999999999998 999998877
Q ss_pred HHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 263 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.......+.... .. .....++.++.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGY-RM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCC-CC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 766665544332 21 222457899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.66 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=200.5
Q ss_pred eeeccccccccceEEEEEEEcCCCc--EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC------
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD------ 129 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~------ 129 (419)
|.+.+.||+|+||.||+|....++. .+|+|.++... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 3467889999999999999877665 68999887543 2344567888999999999 899999999976422
Q ss_pred CeEEEEEEecCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 130 SAVHIVMELCEGGELFDRIVA------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
...++|+||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++. +..+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE---NMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC---CCCEEECC
Confidence 247899999999999887743 134789999999999999999999999999999999999964 44599999
Q ss_pred cccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC
Q 014722 204 FGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 204 fg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
||++......... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+......
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-- 233 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-- 233 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 9999876433221 2234567899999886 468999999999999999999 89999887776666655543321
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...+.++..+.+++.+||+.||++|||+.+++++
T Consensus 234 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 -KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1224578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=312.82 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=200.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcE----EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||+||+|....+++. +++|.+.... .......+..|+..++++ +||||+++++++. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GAS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCc
Confidence 4799999999999999999998777764 6667664221 222345777888899999 8999999999875 456
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++. +..+||+|||++...
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~---~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS---DSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEEcCCccceec
Confidence 7889999999999999976 456899999999999999999999999999999999999964 445999999999866
Q ss_pred cCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
.+... .....++..|+|||.+. +.++.++||||||+++|++++ |..||.+.........+..+.. .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER-LA--QPQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc-CC--CCCCC
Confidence 43321 23345677899999876 579999999999999999998 9999988776655444433221 11 12245
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.++.+++.+||..||++|||+.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7789999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=312.32 Aligned_cols=252 Identities=29% Similarity=0.512 Sum_probs=207.7
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.+ +||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 588999999999999999998888777777776543221 112334567799999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 135 VMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+||+++++|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ..++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999887753 356899999999999999999999999999999999999963 34999999998776
Q ss_pred cCCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
..... .....|++.|+|||.+. ..++.++|+||+|+++|+|++|..||...........+...... .....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP---SLPETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC---CCcchhcHH
Confidence 43322 33456889999999876 46788999999999999999999999877665555554433221 112357889
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
+.++|.+||..+|++||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.35 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=205.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+.+|+.+++.+ +||||+++.+++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCc
Confidence 468889999999999999999876554 79999886542 233456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++. +..+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~---~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC---CCcEEECCCccceecc
Confidence 9999999999999988764 56899999999999999999999999999999999999964 4459999999987654
Q ss_pred CCCcc--c--ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQF--N--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... . ....++.|+|||++. +.++.++|||||||++|+|++ |..||...+.......+.... ..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~ 235 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC 235 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCCC
Confidence 32211 1 112345799999876 568999999999999999997 999998887777666665432 11222357
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.82 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=205.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEE
Confidence 4689999999999999999985 489999999875432 457889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~---~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE---DLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC---CCCEEEcccccccccccc
Confidence 99999999999997765 6899999999999999999999999999999999999964 445999999998876332
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.. ...++..|+|||.+. +.++.++||||||+++|++++ |..||...+.......+..... .......++.+.+
T Consensus 156 ~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 230 (256)
T cd05039 156 QD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYK 230 (256)
T ss_pred cc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHH
Confidence 22 333456799999876 578889999999999999997 9999988877666555544321 1122357899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+||..+|++|||+.++++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred HHHHHhccChhhCcCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=308.91 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=203.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++ +||||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcE
Confidence 4467999999999999999999864 667799999875432 235688999999999 8999999999885 45688
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. +..++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~---~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC---CceEEeCCceeeeecc
Confidence 999999999999988763 35899999999999999999999999999999999999965 3459999999998654
Q ss_pred CCCcc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
..... ....++..|+|||.+. ..++.++||||||+++|+|++ |.+||.+.+..+....+.... ..+.....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY---RMPCPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCH
Confidence 33221 1233556799999876 568899999999999999999 999998877777666665432 1122245788
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.+|+.+||.++|++|||+.++..
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.99 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=208.0
Q ss_pred CCccccceeeccccccccceEEEEEEEcCC-------CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeee
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNN-------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~ 123 (419)
......+|.+++.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++++.+||||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 344556799999999999999999986432 3468999876432 2334578889999999997799999999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCc
Q 014722 124 DTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN 187 (419)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 187 (419)
+++...+..++|+||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999987532 36778889999999999999999999999999999
Q ss_pred EEeecCCCCCCeEEeecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 014722 188 FLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 262 (419)
Q Consensus 188 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 262 (419)
|+++.+ ..+||+|||+++........ ....++..|+|||++. ..++.++||||||+++|+|++ |..||.+.+
T Consensus 165 ill~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 165 VLVTED---NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred EEEcCC---CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 999644 45999999998765432211 1223456799999886 468899999999999999998 899998888
Q ss_pred HHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 263 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+....+..... .......+.++.+++.+||+.+|++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776666554322 11223568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=307.97 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=196.4
Q ss_pred ccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 63 ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
.||+|+||.||+|... .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++. ....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 4899999999999764 445679999986542 233456788999999999 9999999999886 457899999999
Q ss_pred CcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc---
Q 014722 141 GGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--- 216 (419)
Q Consensus 141 ~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~--- 216 (419)
+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++. +..+||+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~---~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN---QHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC---CCcEEeccCCccccccCCccceec
Confidence 9999998875 456899999999999999999999999999999999999964 345999999998765433221
Q ss_pred -cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 217 -NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 217 -~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
....+++.|+|||.+. +.++.++||||||+++|++++ |..||......+....+..+... ......++++.+++
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL---DCPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---CCCCCCCHHHHHHH
Confidence 1122357899999876 568899999999999999996 99999888777666555443321 12235689999999
Q ss_pred HHhcCCCCCCCCCHHHHhcC
Q 014722 294 KKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+||..+|++||++.++.+.
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.46 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.9
Q ss_pred cce-eeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--
Q 014722 56 IDY-DLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-- 128 (419)
Q Consensus 56 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-- 128 (419)
++| ++.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+++++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 455 899999999999998764 34578899999987542 223456788999999999 89999999998765
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+ ..++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~---~~~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND---RLVKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC---CcEEEeeccccc
Confidence 34689999999999999988764 59999999999999999999999999999999999999653 459999999988
Q ss_pred eccCCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH--H------------HHH
Q 014722 209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--V------------AQA 269 (419)
Q Consensus 209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~------------~~~ 269 (419)
........ ....++..|+|||.+. ..++.++||||||+++|+|++|..||......- . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 66433221 1234566799999876 568999999999999999999999985433210 0 000
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
....... .+....++..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 236 LLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000 1112346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=307.46 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=207.4
Q ss_pred eeccccccccceEEEEEEEcCCC----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 59 DLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+.+.||.|+||.||+|.+...+ ..+|+|.+.... .......+.+|+..++.+ +||||+++++++.+.+..++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEE
Confidence 56788999999999999987766 899999986543 222467889999999999 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|||+++++|.+++..... +++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~---~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC---CeEEEcccCCceeccc
Confidence 9999999999999876544 8999999999999999999999999999999999999654 3599999999987654
Q ss_pred CCccc--ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
..... ...+++.|+|||.+. ..++.++||||+|+++|+|++ |.+||...+.......+....... .....+.+
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---KPENCPPE 232 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCcCCHH
Confidence 42222 133678999999886 468999999999999999998 899998877777777666544322 12347899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+++.+||..+|++|||+.++++
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=341.77 Aligned_cols=256 Identities=29% Similarity=0.490 Sum_probs=202.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----- 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----- 128 (419)
...+|+.++.||+||||.||+|+++-+|+.||||+|.... .......+.+|+..|.+| +|||||+++..|..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcc
Confidence 5568999999999999999999999999999999998664 334456788999999999 99999999865410
Q ss_pred --------------------------------------------------------------------------------
Q 014722 129 -------------------------------------------------------------------------------- 128 (419)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (419)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CeEEEEEEecCCcchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 014722 129 --------------------------D--------SAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVC 173 (419)
Q Consensus 129 --------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~L 173 (419)
+ ..+||-||||+..+|.+++..+... ....++.++++|+.||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 2478999999987777766665443 4778899999999999999
Q ss_pred HHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-------------------CCCcccccccCcccCchhhhcc-
Q 014722 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-------------------PGEQFNEIVGSPYYMAPEVLKR- 233 (419)
Q Consensus 174 H~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~- 233 (419)
|+.|||||||||.||+++.+ ..|||+|||+|.... +.......+||--|+|||++.+
T Consensus 714 H~~giIHRDLKP~NIFLd~~---~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSR---NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCceeeccCCcceeEEcCC---CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999754 449999999998621 0012345789999999999862
Q ss_pred ---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014722 234 ---NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEE 309 (419)
Q Consensus 234 ---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~ 309 (419)
.|+.|+|+||||+|++||+. ||....+.. ++..+..+.+..+...+.+--+.-..+|..||+.||.+||||.|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 59999999999999999984 575544433 33444444444442223333455678999999999999999999
Q ss_pred HhcCCcccc
Q 014722 310 VLEHPWLQN 318 (419)
Q Consensus 310 ~l~~~~~~~ 318 (419)
+|++.||..
T Consensus 868 LL~s~llpp 876 (1351)
T KOG1035|consen 868 LLNSELLPP 876 (1351)
T ss_pred HhhccCCCc
Confidence 999999874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.92 Aligned_cols=249 Identities=21% Similarity=0.320 Sum_probs=205.2
Q ss_pred ccceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence 3579999999999999999998743 67899999986542 233456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCc
Q 014722 130 SAVHIVMELCEGGELFDRIVARG----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPEN 187 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~N 187 (419)
..+++|+||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36788899999999999999999999999999999
Q ss_pred EEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCC
Q 014722 188 FLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 262 (419)
Q Consensus 188 Il~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~ 262 (419)
|+++. ++.++|+|||++........ .....+++.|+|||.+. ..++.++|||||||++|+|++ |..||.+..
T Consensus 161 il~~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGE---NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecC---CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99964 44599999999876533221 12233466799999876 578999999999999999997 889998877
Q ss_pred HHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 263 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
..+....+....... ....++.++.+|+.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 777666555443211 12357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.15 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=204.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...++|+++++||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++++ +||||+++++++. .+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCc
Confidence 3556899999999999999999985 4678899999875432 346788999999999 8999999999875 4578
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
++||||+.+++|.+++... ..+++.++..++.|++.||.|||+.|++||||||+||+++.+ ..++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~---~~~~l~dfg~~~~~ 152 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET---LCCKIADFGLARLI 152 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC---CCEEEccCcceeec
Confidence 9999999999999988653 358999999999999999999999999999999999999654 45999999998766
Q ss_pred cCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
..... .....++..|+|||++. ..++.++||||||+++|++++ |.+||.+.+..+....+..... .+.....+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 229 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCP 229 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCC
Confidence 53221 12234567899999886 568899999999999999999 9999988877666665544321 12234578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.++.+++.+||..+|++|||+++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 230 EELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.12 Aligned_cols=258 Identities=29% Similarity=0.535 Sum_probs=228.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|+++..||+|+|+.|.+++.++|.+.+|+|+++++-..+..++.-++.|-.+..+.++||.+|.++.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 47999999999999999999999999999999999998888888889999999999999999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee-ccCCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF-FRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~-~~~~~ 214 (419)
.||++||+|.-++.+++.++++.++.+...|+.||.|||++||++||||.+|+|++.++ ++||+|+|+++. +.++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg---hikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG---HIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC---ceeecccchhhcCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999997554 599999999875 35667
Q ss_pred cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCC-------C-CHHHHHHHHHhcccccCCCCCccC
Q 014722 215 QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA-------E-TEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~-------~-~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..++.+|||.|.|||++.+ .|+..+|.|+|||+++||+.|+.||.- . ++.-..+.|+...+..++ .+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr----sl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc----ee
Confidence 7889999999999999996 699999999999999999999999932 1 223344555555555444 45
Q ss_pred CHHHHHHHHHhcCCCCCCCC------CHHHHhcCCccccCc
Q 014722 286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQNAK 320 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~------s~~~~l~~~~~~~~~ 320 (419)
|-.+..+++..|.+||.+|. ...++-.|+||+...
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 77788899999999999996 568999999998543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=311.64 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=207.8
Q ss_pred cceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+|++++.||.|+||.||+|+... +...+++|.+.... .......+.+|+++++++ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence 479999999999999999999653 35678999876542 222456789999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 131 AVHIVMELCEGGELFDRIVARG---------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++.+ +.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ---REVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC---CcEEE
Confidence 9999999999999999998765 68999999999999999999999999999999999999654 45999
Q ss_pred eecccceeccCCC--cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 014722 202 IDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 202 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
+|||++....... ......++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223445677899999876 567889999999999999998 889998777666666655444332
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.. ...++..+.+++.+||+.+|++|||+.+++..
T Consensus 239 ~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 22 23578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=318.08 Aligned_cols=265 Identities=30% Similarity=0.478 Sum_probs=219.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA----VDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
..++++|-++..||.|+|+.||+|.|....+.||+|+-.....-.. .-.+...+|.++.+.| +||.||++|++|.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeee
Confidence 4577789999999999999999999999999999998654332111 1123456899999999 9999999999996
Q ss_pred -eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 128 -DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--GVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 128 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
+.+.+|-|+|||+|.+|.-++.....+++++++.|+-||+.||.||.+. -|||-||||.|||+.+....+.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 6678999999999999999999988999999999999999999999987 4999999999999998777888999999
Q ss_pred ccceeccCCCc--------ccccccCcccCchhhhc-c----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHH--
Q 014722 205 GLSVFFRPGEQ--------FNEIVGSPYYMAPEVLK-R----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQ-- 268 (419)
Q Consensus 205 g~a~~~~~~~~--------~~~~~gt~~y~aPE~~~-~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~-- 268 (419)
|+++.+..... .....||.||++||.+- + ..+.++||||+|||+|..+.|+.||.....+. +++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99998864322 23467999999999864 2 47889999999999999999999996544322 221
Q ss_pred HHHh-cccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 269 AIIR-SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 269 ~i~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.|++ ....|+ +-+.++.++++||.+||++.-+.|....++..||+|...
T Consensus 698 TIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 698 TILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred chhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 1111 122233 234689999999999999999999999999999999753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=307.02 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=200.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE-EeCCeEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY-EDDSAVHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~-~~~~~~~l 134 (419)
.+|++.+.||+|+||.||+|.. .|..+|+|.+.... ..+.+.+|+.+++++ +|||++++++++ ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence 3699999999999999999975 48889999885432 245788999999999 899999999975 45567999
Q ss_pred EEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~---~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED---NVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC---CcEEecCCccceeccc
Confidence 999999999999987644 37899999999999999999999999999999999999654 4599999999876543
Q ss_pred CCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ....++..|+|||++. ..++.++|||||||++|+|++ |.+||...........+.... .....+.+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCCHHHH
Confidence 22 2334466799999887 468899999999999999997 999998877766666554432 1222346789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+++.+||..+|++|||+.++++
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=313.62 Aligned_cols=251 Identities=21% Similarity=0.292 Sum_probs=199.8
Q ss_pred cceeeccccccccceEEEEEEEcC----------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN----------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnI 119 (419)
.+|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~i 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPNI 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCc
Confidence 469999999999999999986432 34578999986542 233456788999999999 89999
Q ss_pred eeeeeEEEeCCeEEEEEEecCCcchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-----------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 120 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999887642 366788999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh--CCCCCCCCC
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAET 262 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~--g~~pf~~~~ 262 (419)
+++. +..++|+|||++..+..... .....+++.|+|||... +.++.++|||||||++|+|++ |..||...+
T Consensus 162 li~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 162 LVGK---NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred EEcC---CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9964 44599999999876543321 12233467899999765 678999999999999999998 779997766
Q ss_pred HHHHHHHHHhc---c-cccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 263 EQGVAQAIIRS---V-IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 263 ~~~~~~~i~~~---~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
........... . .....+....+++.+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 65544433211 0 01111122356789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=305.99 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=201.7
Q ss_pred cccccccceEEEEEEEcC-CC--cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEe
Q 014722 62 RELGRGEFGVTYLCTDVN-NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~ 138 (419)
+.||+|++|.||+|.+.. ++ ..||+|.+...... ...+.+.+|+.+++++ +||||+++++++.+ ..+++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999755 33 36899999766542 4567889999999999 89999999999988 899999999
Q ss_pred cCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-
Q 014722 139 CEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ- 215 (419)
Q Consensus 139 ~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 215 (419)
+++++|.+.+.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~---~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD---DKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC---CEEEeccccccccccccccc
Confidence 99999999997754 68999999999999999999999999999999999999754 4599999999887643221
Q ss_pred ---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 216 ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 216 ---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..+....+........ .....+..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHH
Confidence 12345678899999887 478999999999999999998 9999987777776666554222211 1134688999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+++.+||..+|++|||+.++++
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=309.28 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=205.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||.||+|.+..+|+ .+|+|.+.... .......+.+|+.+++++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-Cc
Confidence 479999999999999999999876665 58999876543 233456788999999999 89999999999887 78
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++|+||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.+ ..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP---QHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC---CeEEECCCcccccc
Confidence 99999999999999998764 468999999999999999999999999999999999999643 45999999999876
Q ss_pred cCCCccc---ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQFN---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
....... ...++..|+|||.+. +.++.++|+||||+++|++++ |..||.+....+....+..... .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~ 236 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-LP--QPPIC 236 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-CC--CCCCC
Confidence 5333211 122356799999876 578999999999999999998 9999988887776666654322 11 12346
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.++.+++.+||..+|..|||+.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=305.78 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=200.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.+ +||||+++++++. .+..++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEE
Confidence 5699999999999999999987544 4699998764332 235678899999999 8999999999886 4568899
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++. +..++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~---~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD---NLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC---CCeEEECCCccceEccCC
Confidence 99999999999987643 4789999999999999999999999999999999999964 345999999999765433
Q ss_pred Cc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 214 EQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.. .....++..|+|||.+. +.++.++||||||+++|+|++ |.+||.+....+....+.... ........+..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---RMPCPQGCPESL 232 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHHH
Confidence 21 12234567899999876 568899999999999999999 999998887776666554432 112234578999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+++.+||..||++||++.++++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=309.65 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=204.8
Q ss_pred ccceeeccccccccceEEEEEEEcC----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-C
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVN----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-D 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~ 129 (419)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ........+.+|+.+++.+ +||||+++++++.. +
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 3579999999999999999999865 3688999987633 2344567788999999999 99999999998765 5
Q ss_pred CeEEEEEEecCCcchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 130 SAVHIVMELCEGGELFDRIVAR--------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
...++++||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.+ ..+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~---~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE---LQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC---CcEEE
Confidence 7789999999999999988653 358899999999999999999999999999999999999643 55999
Q ss_pred eecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 014722 202 IDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
+|||+++.+.+.... ....++..|+|||.+. ..++.++||||||+++|++++ |.+||...+..+....+.... .
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-R 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-C
Confidence 999999865433221 2234567899999876 468999999999999999999 999998877666555444332 1
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
. .....+++++.+++.+||..||++|||+.++++
T Consensus 238 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1 122357899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=324.86 Aligned_cols=258 Identities=29% Similarity=0.526 Sum_probs=220.9
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|..++.||-|+||+|.++....|...||.|.+.+...........+..|-.||..- +++-||+||-.|++.+.+|+||+
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEe
Confidence 67788999999999999998899999999999888776666677788999999998 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc------
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR------ 211 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~------ 211 (419)
|++||++..+|.+-+-|.|..++.++..+..|+++.|..|+|||||||+||||+. +++|||+|||++.-+.
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr---dGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR---DGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc---CCceeeeeccccccceeccccc
Confidence 9999999999999999999999999999999999999999999999999999964 4569999999986321
Q ss_pred ---CCCc----------------------------------ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh
Q 014722 212 ---PGEQ----------------------------------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC 253 (419)
Q Consensus 212 ---~~~~----------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 253 (419)
.+.. ....+||+.|+|||++. ..|+..+|+||.|||||||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1000 12357999999999987 579999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCccccCc
Q 014722 254 GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAK 320 (419)
Q Consensus 254 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~~l~~~~~~~~~ 320 (419)
|.+||...+..+...++++..-...-....++|+++.++|.++.. +++.|. .++|+-.||||+.+.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 999998888777666665443333333445799999999998764 578887 577899999998753
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.84 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=206.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++ +||||+++++++......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceE
Confidence 4568999999999999999999964 568899999875432 346788999999999 8999999999999989999
Q ss_pred EEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC---CCEEECccccceecc
Confidence 9999999999999987643 58999999999999999999999999999999999999654 559999999987664
Q ss_pred CCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....++..|+|||.+. +.++.++||||+|+++|++++ |+.||.+.........+..... .......+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 231 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCPE 231 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCH
Confidence 3211 11223456899999887 468899999999999999998 9999988877777766654321 122234688
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+++.+||..+|++||++.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.51 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=199.4
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||+|+||.||+|.. .++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 3689999999999985 578899999886542 233345688999999999 899999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc--cc
Q 014722 142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NE 218 (419)
Q Consensus 142 g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~ 218 (419)
++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++. +..+||+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~---~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE---NNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC---CCeEEECCCccceeccccccccCCC
Confidence 9999988753 45799999999999999999999999999999999999964 345999999998764432211 12
Q ss_pred cccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHh
Q 014722 219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296 (419)
Q Consensus 219 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (419)
..+++.|+|||++. +.++.++||||||+++|++++ |..||...........+..... ......++..+.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR---MSCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHH
Confidence 23456799999887 568899999999999999998 9999988877666655544321 122345789999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 014722 297 LNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 297 L~~dp~~R~s~~~~l~~ 313 (419)
|..+|++|||+.++++.
T Consensus 231 l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 231 WDYKPENRPKFSELQKE 247 (250)
T ss_pred cccCcccCCCHHHHHHH
Confidence 99999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=306.75 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=203.2
Q ss_pred cceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|.+.+.||.|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCc
Confidence 4688999999999999999987543 3568999886442 233456788999999999 89999999999875 457
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~---~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP---DCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC---CCeEEccCceeeecc
Confidence 89999999999999997643 58999999999999999999999999999999999999754 459999999988665
Q ss_pred CCCccc--ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQFN--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
...... ...+++.|+|||.+. ..++.++||||||+++|++++ |..||.+....+....+...... .....++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~ 235 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPP 235 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCH
Confidence 432221 223456799999876 568899999999999999986 99999888776666555443221 22346789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+.+++.+||..+|++|||+.+++..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.95 Aligned_cols=240 Identities=18% Similarity=0.258 Sum_probs=192.4
Q ss_pred cccccccceEEEEEEEcCCCc-------EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGE-------KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+.+|+.+++.+ +||||+++++++..+...++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence 469999999999999765544 38888775432 23346788899999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC-----CCCeEEeecccce
Q 014722 135 VMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-----SSPLKAIDFGLSV 208 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~-----~~~~kl~Dfg~a~ 208 (419)
||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++. ...++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999987644 5899999999999999999999999999999999999976532 1347999999886
Q ss_pred eccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... ....+++.|+|||++.+ .++.++||||||+++|+|++| .+||.......... +.......+ ...
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~----~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLP----APK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCC----CCC
Confidence 54322 33567889999999874 478899999999999999998 46665554443322 222222222 235
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.++.+|+.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=310.47 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=197.6
Q ss_pred ceeeccccccccceEEEEEEE----cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--C
Q 014722 57 DYDLGRELGRGEFGVTYLCTD----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--S 130 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~ 130 (419)
.|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 378999999999999999973 4678999999986442 233456789999999999 999999999998765 6
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~---~~~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE---HQVKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC---CCEEECCCccccc
Confidence 7899999999999999886643 58999999999999999999999999999999999999653 4599999999886
Q ss_pred ccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHH
Q 014722 210 FRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--------------QGVAQAI 270 (419)
Q Consensus 210 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------------~~~~~~i 270 (419)
...... .....++..|+|||++. +.++.++||||||+++|+|+++..|+..... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 643322 12345677899999876 4688999999999999999998766532111 0001111
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.... ...+.+..++..+.+|+.+||+.+|++|||+.+++++
T Consensus 239 ~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 239 LEEG--KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHcC--ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111 1122234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.47 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=211.7
Q ss_pred cceeeccccccccceEEEEEEEcCC-C----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNN-G----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~-~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+-.+...||+|+||.||.|.-..- | ..||+|.+.+. .+.....++.+|..+|+.+ +|||||+++|++.+..
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence 3567788999999999999985432 2 34888887644 4667788999999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 131 AVHIVMELCEGGELFDRIVAR-------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
..+|++|||.||+|..+|.+. ..++......++.||+.|+.||+++++|||||..+|+|++.. ..|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcc
Confidence 999999999999999999875 348899999999999999999999999999999999999644 6799999
Q ss_pred cccceeccCCCcccc---cccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccC
Q 014722 204 FGLSVFFRPGEQFNE---IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 204 fg~a~~~~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
||+|+.+...+.+.. ..-...|||||.+. +.++.++|||||||++||++| |..||.+.+..++......+. .
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence 999995543332211 12235799999988 789999999999999999999 999999999988888777665 2
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.++.+.++..+.+++..||+.+|++||++..+++
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 3344579999999999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.27 Aligned_cols=228 Identities=25% Similarity=0.371 Sum_probs=187.8
Q ss_pred ccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcchHH
Q 014722 67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD 146 (419)
Q Consensus 67 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 146 (419)
|.+|.||+|++..+++.||+|.+.... ....|...+... .||||+++++++.+.+.+++||||++||+|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 122344445555 69999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccC
Q 014722 147 RIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226 (419)
Q Consensus 147 ~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~ 226 (419)
++.+...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++++|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR---GHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC---CCEEEecccchhccccc--cccCCcCcccc
Confidence 99887789999999999999999999999999999999999999754 44999999987654322 23345677899
Q ss_pred chhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC
Q 014722 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305 (419)
Q Consensus 227 aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 305 (419)
|||.+. +.++.++||||+|+++|+|++|..|+....... ....... ..+.+++.+.++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLN--IPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccC--CcccCCHHHHHHHHHHccCCHHHhc
Confidence 999886 468899999999999999999999875432210 0011111 1134789999999999999999999
Q ss_pred CH-----HHHhcCCcc
Q 014722 306 TA-----EEVLEHPWL 316 (419)
Q Consensus 306 s~-----~~~l~~~~~ 316 (419)
++ .++++||||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 85 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.95 Aligned_cols=245 Identities=26% Similarity=0.431 Sum_probs=204.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+|++.+.||.|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++++ +||||+++++++......++|+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEE
Confidence 6899999999999999999874 477899999875432 235688899999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 137 ELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 137 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||+.+++|.+++... +.+++..+..++.|++.||.|||+.+++||||||+||+++. +..++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~---~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE---NQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC---CCeEEECCCcceeecccCcc
Confidence 999999999988764 46899999999999999999999999999999999999964 34599999999876533221
Q ss_pred --ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 216 --FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 216 --~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+........ ....+..+.+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYE 232 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHH
Confidence 11233467899999877 578889999999999999998 9999988777766666554322111 1236889999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~ 313 (419)
|+.+||+.+|++|||+.+++++
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=305.00 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=191.8
Q ss_pred cccccccceEEEEEEEcC--CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++.....+++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence 368999999999996432 44578888775432 233456788899999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 140 EGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 140 ~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
++|+|.+++.... ..++..+..++.||+.||.|||++||+||||||+||+++.+ ..+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~---~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD---LSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC---CcEEEeccccccccccch
Confidence 9999999987643 24677889999999999999999999999999999999654 459999999986543221
Q ss_pred c---ccccccCcccCchhhhc--------ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cccCCCC
Q 014722 215 Q---FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-IDFKRDP 281 (419)
Q Consensus 215 ~---~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 281 (419)
. .....+++.|+|||++. ..++.++|||||||++|+|++ |.+||......+....+.... ...+.+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12334567899999874 246789999999999999999 888998776665555444332 2222222
Q ss_pred C-ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 282 W-PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 282 ~-~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+ ..+++.+.+++..|+ .||++|||+.++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 2 257888999999998 599999999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.74 Aligned_cols=252 Identities=30% Similarity=0.522 Sum_probs=208.4
Q ss_pred ceeeccccccccceEEEEEEEcC-CCcEEEEEEeccccc-------CChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKL-------RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~-------~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
+|.+.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 688999998864321 1223455677899988764389999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 129 DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
++..++||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .+++||||+|+||+++.+ +.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~---~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED---DKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC---CcEEEec
Confidence 9999999999999999887743 3468999999999999999999996 789999999999999654 4599999
Q ss_pred cccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
||.+.............|+..|+|||.+. +.++.++||||||+++|+|++|.+||...........+....... ...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--LPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc--CCc
Confidence 99998765544445567899999999887 468899999999999999999999998777766666655443321 112
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...++.+.+++.+||+.||++||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 2568999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=306.50 Aligned_cols=245 Identities=27% Similarity=0.368 Sum_probs=199.4
Q ss_pred cccccccceEEEEEEEcCCC------cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNG------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
+.||+|+||.||+|++.... ..+|+|.+.... .......+.+|+.+++.+ +||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEE
Confidence 36899999999999875433 689999886442 223456788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeeccc
Q 014722 136 MELCEGGELFDRIVAR-------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGL 206 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~ 206 (419)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ ....++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999998642 2378899999999999999999999999999999999998654 233699999999
Q ss_pred ceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 207 SVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 207 a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
+........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||...+.......+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~ 234 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---RLQK 234 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---ccCC
Confidence 876543221 12234567899999886 578999999999999999998 999998777666555543322 1122
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...+|..+.+++.+||..+|.+|||+.++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3457899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=304.22 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=191.5
Q ss_pred cccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
+.||+|+||.||+|... .++..+|+|.+.... .......+.+|+.+++++ +||||+++++++.+...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence 36899999999999854 356789999886543 222345788899999999 8999999999999999999999999
Q ss_pred CCcchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 140 EGGELFDRIVARG-----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 140 ~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
++|+|.+++.... ..++..+..++.|++.||.|||+.+++||||||+||+++. ...+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~---~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC---CCcEEECCccccccccCcc
Confidence 9999999886532 3567788899999999999999999999999999999964 4559999999987543222
Q ss_pred c---ccccccCcccCchhhhcc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc-ccccCCCC
Q 014722 215 Q---FNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS-VIDFKRDP 281 (419)
Q Consensus 215 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 281 (419)
. .....|++.|+|||++.+ .++.++||||||+++|+|++ |..||......+........ ......+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1 123457788999998753 25789999999999999996 99999776655543333222 12222222
Q ss_pred C-ccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 282 W-PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 282 ~-~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
. ...++.+.+++.+|+ .+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 1 236788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.92 Aligned_cols=242 Identities=25% Similarity=0.335 Sum_probs=199.8
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~ 141 (419)
+.||.|+||.||+|.+.. ++.||+|.+..... ......+.+|+.+++++ +||||+++++++.+....++|+||+.|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 468999999999999877 99999999875432 23456789999999999 899999999999999999999999999
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc---c
Q 014722 142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---N 217 (419)
Q Consensus 142 g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~ 217 (419)
++|.+++... ..+++..+..++.|++.||.|||+++++||||+|+||+++.+ +.+||+|||++......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~---~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC---CcEEEeeccccccccCCcceeccc
Confidence 9999998663 468999999999999999999999999999999999999644 45999999998765422111 1
Q ss_pred ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHH
Q 014722 218 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295 (419)
Q Consensus 218 ~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 295 (419)
...++..|+|||.+. +.++.++|+||||+++|+|++ |..||...........+.... . .......+..+.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-R--MPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-C--CCCCccCCHHHHHHHHH
Confidence 122356799999876 568999999999999999999 899998777665555544321 1 11223578899999999
Q ss_pred hcCCCCCCCCCHHHHhcC
Q 014722 296 MLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 296 ~L~~dp~~R~s~~~~l~~ 313 (419)
||..+|++|||+.++++.
T Consensus 231 ~l~~~p~~Rp~~~ell~~ 248 (251)
T cd05041 231 CWAYDPENRPSFSEIYNE 248 (251)
T ss_pred HhccChhhCcCHHHHHHH
Confidence 999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.81 Aligned_cols=240 Identities=20% Similarity=0.214 Sum_probs=190.7
Q ss_pred cccccccceEEEEEEEcC------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 62 RELGRGEFGVTYLCTDVN------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
+.||+|+||.||+|+... ....+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 368999999999998432 23358888875432 22345678899999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC----CCCeEEeec
Q 014722 130 SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE----SSPLKAIDF 204 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~----~~~~kl~Df 204 (419)
...++||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++. ...++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888765 356899999999999999999999999999999999999975432 123899999
Q ss_pred ccceeccCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 205 GLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 205 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
|++...... ....++..|+|||.+. +.++.++|||||||++|+|+ +|..||......+.. ........ .
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----~ 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----L 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----C
Confidence 988654322 3356788999999875 46889999999999999997 588998765544332 22222211 1
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....++++.+|+.+||+.||++||++.+++++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 22346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.44 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=200.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||++. .+++.+|+|.+.... ..+.+.+|+.+++++ +||||+++++++..+ ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence 469999999999999999987 578899999986432 235788999999999 899999999998765 47999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~---~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED---GVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC---CcEEECCCccceecccc
Confidence 99999999999987643 47899999999999999999999999999999999999654 45999999998764322
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
......+..|+|||.+. +.++.++|+||||+++|+|++ |.+||......+....+.+.. .......++..+.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---RMEPPEGCPADVYV 228 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---CCCCCCcCCHHHHH
Confidence 22233456799999876 578899999999999999997 999998887776666554432 11223467899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+||+.+|++||++.+++.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=301.31 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++.+.||+|+||.||+|.+ ..+..+|+|.+.... ...+.+.+|+.+++.+ +|+||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh----hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeE
Confidence 456799999999999999999985 456779999886432 2346788999999999 89999999999887 7889
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++. ...+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~---~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCCcceeecc
Confidence 999999999999998763 35788899999999999999999999999999999999964 4459999999987654
Q ss_pred CCCcc--cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQF--NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
..... ....++..|+|||.+. +.++.++|+||||+++|++++ |..||.+.+.......+..... .+.....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---CCCcccCCH
Confidence 33221 1234567799999887 468889999999999999998 9999988777666665544321 222346789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+++.+||..+|++||++.+++.
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHH
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.65 Aligned_cols=239 Identities=18% Similarity=0.199 Sum_probs=190.4
Q ss_pred ccccccceEEEEEEEcC------------------------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC
Q 014722 63 ELGRGEFGVTYLCTDVN------------------------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~------------------------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn 118 (419)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.+ +|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence 69999999999997422 12458888875432 22345677889999999 8999
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC---
Q 014722 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--- 194 (419)
Q Consensus 119 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--- 194 (419)
|+++++++.+....++||||+++|+|..++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888865 45689999999999999999999999999999999999997532
Q ss_pred -CCCCeEEeecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 014722 195 -ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAI 270 (419)
Q Consensus 195 -~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i 270 (419)
....+|++|||++...... ....++..|+|||.+.+ .++.++||||||+++|+++ +|..||...........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~- 233 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF- 233 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence 2234899999987643221 23457888999998863 5889999999999999984 69999987665544332
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.......+ ...++.+.+++.+||+.+|++|||+.+++++
T Consensus 234 ~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 234 YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22222111 2346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=306.82 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=195.7
Q ss_pred cceeeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--C
Q 014722 56 IDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--D 129 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~ 129 (419)
.+|++.+.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+++++.+ +||||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence 369999999999999999997 4567899999998644 233456788999999999 89999999998643 4
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
..+++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~---~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC---CeEEECCCcccc
Confidence 5689999999999999998764 468999999999999999999999999999999999999644 459999999998
Q ss_pred eccCCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------
Q 014722 209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ--------------- 268 (419)
Q Consensus 209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------------- 268 (419)
........ ....++..|+|||++. ..++.++||||||+++|+|++|..|+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHH
Confidence 76443221 1122345699999887 4688999999999999999998776543221 1110
Q ss_pred -HHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 269 -AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 269 -~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+...... .+....++.++.+|+.+||..+|++|||+.++++.
T Consensus 236 ~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 236 IELLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred HHHHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 11111111 11224578899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.46 Aligned_cols=237 Identities=18% Similarity=0.201 Sum_probs=190.8
Q ss_pred cccccccceEEEEEEEcCCC----------cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 62 RELGRGEFGVTYLCTDVNNG----------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~----------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence 46899999999999987766 3577787654321 156788999999999 89999999999887 77
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC----CCCCeEEeeccc
Q 014722 132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK----ESSPLKAIDFGL 206 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~----~~~~~kl~Dfg~ 206 (419)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ ....+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 789999999999999999999999999999999999997654 223599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
+..... .....++..|+|||++.+ .++.++||||||+++|+|++ |..||...+.......... ....+
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~---- 226 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLP---- 226 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCC----
Confidence 876543 223456778999999864 58889999999999999999 5888866654333222221 11111
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
......+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 112378999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.76 Aligned_cols=256 Identities=14% Similarity=0.151 Sum_probs=188.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhh--------HHHHHHHHHHHHhCCCCCCee
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVD--------IEDVRREVQIMKHLPKHPNIV 120 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~--------~~~~~~Ei~~l~~l~~hpnIv 120 (419)
.....+|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..+ +|+||+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~ 86 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP 86 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence 34556899999999999999999998777 6677887654322111000 01122334455667 899999
Q ss_pred eeeeEEEeCC----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 121 SLKDTYEDDS----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 121 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
+++++..... ..++++|++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~--- 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN--- 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---
Confidence 9998765443 4578888874 4666666655557899999999999999999999999999999999999643
Q ss_pred CCeEEeecccceeccCCC--------cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 014722 197 SPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGV 266 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~ 266 (419)
..++|+|||+|....... ......||+.|+|||+..+ .++.++|||||||++|+|++|.+||.+... ...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 459999999998653221 1123469999999998874 689999999999999999999999977632 222
Q ss_pred HHHHHhc---ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 267 AQAIIRS---VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 267 ~~~i~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
....... .+.......+..++++.+++..|+..+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111110 011111223456899999999999999999999999875
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=308.28 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=200.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||.||+|.+..+|. .+|+|.+.... .......+.+|+.+++.+ +||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-C
Confidence 468999999999999999999877776 46888876432 222344688999999999 899999999998754 5
Q ss_pred EEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+ ..+||+|||++...
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~---~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP---NHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC---CceEEccccccccc
Confidence 678999999999999987644 58999999999999999999999999999999999999643 45999999999865
Q ss_pred cCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... .....++..|+|||.+. ..++.++||||||+++|+|++ |..||.+.........+... ... ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--~~~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ERL--PQPPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCC--CCCCCC
Confidence 43322 12234567899999876 568999999999999999997 99999877655544433322 222 222456
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+..+.+++.+||..+|++||++.++++.
T Consensus 237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 237 TIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999774
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=300.90 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=193.0
Q ss_pred cccccccceEEEEEEEcC---CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE-eCCeEEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-DDSAVHIVME 137 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-~~~~~~lv~e 137 (419)
+.||+|+||.||+|.+.. .+..+|+|.+.... .....+.+.+|+.+++.+ +||||+++++++. .+...++|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 368999999999998643 34579999875322 333456788999999999 9999999999765 4566899999
Q ss_pred ecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 138 LCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 138 ~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
|+.+++|.+++... ...++..+..++.|++.||.|||+.+++||||||+|||++. +..+||+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~---~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE---SFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC---CCcEEECCccccccccCCcce
Confidence 99999999998764 34677888999999999999999999999999999999964 3459999999987553321
Q ss_pred ---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 ---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
......+++.|+|||.+. ..++.++||||||+++|+|++ |.+||...+.......+...... .....+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRL---LQPEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCcCCHHH
Confidence 112334577899999876 578899999999999999999 57778776666555554433211 1112468899
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+||..+|++||++.++++.
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=328.37 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=177.6
Q ss_pred cccceeeccccccccceEEEEEEEcCC----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNN----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT---- 125 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~---- 125 (419)
-.++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+....+ .++.. .+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~-~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRA-CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence 345899999999999999999999888 99999998753221 1111111 12222 23333332222
Q ss_pred --EEeCCeEEEEEEecCCcchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCEeeCC
Q 014722 126 --YEDDSAVHIVMELCEGGELFDRIVARGH--------------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183 (419)
Q Consensus 126 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 183 (419)
......+++|+||+.+++|.+++..... ..+..+..++.||+.||.|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456679999999999999998865421 123456789999999999999999999999
Q ss_pred CCCcEEeecCCCCCCeEEeecccceeccCCC--cccccccCcccCchhhhc-c----------------------cCCCc
Q 014722 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK-R----------------------NYGPE 238 (419)
Q Consensus 184 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 238 (419)
||+|||++.+ ...+||+|||+|....... ......+|+.|+|||.+. . .++.+
T Consensus 282 KP~NILl~~~--~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSEG--SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeCC--CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999742 3459999999998654332 234567899999999653 1 23456
Q ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hhccccc-------CC----------CCCccCCHHHHHHHHHhcCCC
Q 014722 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAI-IRSVIDF-------KR----------DPWPKVSENAKDLVKKMLNPD 300 (419)
Q Consensus 239 ~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~~~~~~~-------~~----------~~~~~~~~~~~~li~~~L~~d 300 (419)
+||||+||++|||+++..|+.. .......+ .....+. .. ..+...+....+||.+||++|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 7999999999999997766432 21111111 1111000 00 000112334568999999999
Q ss_pred CCCCCCHHHHhcCCccccCcc
Q 014722 301 PKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 301 p~~R~s~~~~l~~~~~~~~~~ 321 (419)
|++|||+.++|+||||+....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999987543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=324.36 Aligned_cols=202 Identities=32% Similarity=0.533 Sum_probs=178.0
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC------C
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD------S 130 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~------~ 130 (419)
-|...+.||+||||.||+++++.+|+.||||.+.... .....+..-+|+++|++| +|||||+++++-+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence 4777889999999999999999999999999987654 233567788999999999 799999999986543 3
Q ss_pred eEEEEEEecCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeeccc
Q 014722 131 AVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGL 206 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~ 206 (419)
...+|||||.||+|...+.+ ...+++.+.+.++..+..||.|||++||+||||||.||++.... .....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 57899999999999998865 23599999999999999999999999999999999999986533 334579999999
Q ss_pred ceeccCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE 261 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~ 261 (419)
|+..+++..+.+.+||+.|.+||... +.|+.-+|.|||||++|+..||..||...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99999999999999999999999987 56888999999999999999999999543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=292.82 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=211.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+.+-+..||.|+||+|++-.++.+|+..|||.|..... ..+..+++.|.....+-++.||||++||..-.++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 45567789999999999999999999999999986653 4456788899998888779999999999999999999999
Q ss_pred EecCCcchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 137 ELCEGGELFDRI-----VARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 137 e~~~~g~L~~~l-----~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+|+ .+|..+. .++..++|..+..|..-.+.||.||-. ..|+|||+||+|||++..+ .|||||||.+..+
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G---~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG---DVKLCDFGICGQL 218 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC---CEeeecccchHhH
Confidence 9996 3553322 235679999999999999999999986 5899999999999997554 4999999999877
Q ss_pred cCCCcccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCCC--cc
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPW--PK 284 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~--~~ 284 (419)
..+-....-.|-..|||||.+. ..|+.+|||||||++|||+.||..||.+.+. .+++..+..+......... -.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 6554445567888999999886 2599999999999999999999999976543 3444445544433222111 24
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+..++.+|..||.+|-+.||+..+++++||++...
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 788999999999999999999999999999998654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=300.98 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=199.6
Q ss_pred eeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC----
Q 014722 58 YDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---- 130 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~---- 130 (419)
|.+.+.||+|+||.||+|... .+++.||+|++..... .....+.+.+|+++++.+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence 667889999999999999854 3578999999975432 344567788999999999 8999999999886432
Q ss_pred --eEEEEEEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 131 --AVHIVMELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 131 --~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
..++++||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++. +..+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~---~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE---NMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC---CCCEEEC
Confidence 347899999999998877532 24788999999999999999999999999999999999964 4459999
Q ss_pred ecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccccc
Q 014722 203 DFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 203 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
|||++.....+.. .....+++.|++||.+. +.++.++||||||+++|+|++ |.+||.+.+.......+......
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~- 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRL- 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcC-
Confidence 9999886543321 12334567899999876 468889999999999999999 89999887776665555443211
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...+..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 235 --~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 --KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1113567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=301.91 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=200.0
Q ss_pred cceeeccccccccceEEEEEEEc----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--C
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--D 129 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~ 129 (419)
.+|++.+.||+|+||.||+|... .++..+|+|++...... .....+.+|+.+++.+ .||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence 35888899999999999999854 35889999998755322 3457899999999999 89999999999877 6
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+ ..++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~---~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE---DLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC---CCEEEccccccc
Confidence 68999999999999999997654 58999999999999999999999999999999999999654 559999999988
Q ss_pred eccCCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHH
Q 014722 209 FFRPGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA 269 (419)
Q Consensus 209 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------------~~~~ 269 (419)
........ ....++..|+|||.+. ..++.++||||||+++|+|++|..||....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76533221 1223456799999876 568889999999999999999999986543221 1111
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
........ .....++.++.+++.+||..+|++|||+.++++.
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 238 LLKEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred HHHcCCcC--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22221111 1123567899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=320.88 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=216.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE-----eCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-----DDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-----~~~ 130 (419)
+-|++.+.||.|.+|.||+++++.+++.+|+|+..... ...+++..|.++++.+++|||++.++++|. .++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34999999999999999999999999999999986443 233678889999999999999999999985 357
Q ss_pred eEEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 131 AVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
.+|||||||.||+.-|+++. ...+.|..++.|++.++.||.+||.+.++|||||=.|||++.++. |||+|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeeeee
Confidence 89999999999999998875 456899999999999999999999999999999999999986655 9999999998
Q ss_pred eccCCC-cccccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 209 FFRPGE-QFNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 209 ~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
...... ..++.+|||.|||||++.. .|+..+|+||||++..||.-|.+|+.+......+-.|.+... .....
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP-PkLkr 250 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP-PKLKR 250 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC-ccccc
Confidence 876443 3567899999999998752 377799999999999999999999987766544443333221 11222
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|.+-++++.+||..||.+|-++||+..++|+|||++.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 4456889999999999999999999999999999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=296.84 Aligned_cols=243 Identities=20% Similarity=0.306 Sum_probs=190.2
Q ss_pred ccccccceEEEEEEEcCC--CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 63 ELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
.||+|+||.||+|....+ ...+++|.+.... .....+.+.+|+.+++.+ +||||+++++++.+....|+||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCC
Confidence 699999999999975332 3345667665432 223456889999999999 99999999999999999999999999
Q ss_pred CcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 141 GGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 141 ~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
+|+|.+++.+. ...++..+..++.|++.||.|||+++++||||||+|||++. ++.+||+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~---~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC---CccEEecccccccccCcchhh
Confidence 99999998753 23567778899999999999999999999999999999964 3459999999876432211
Q ss_pred -cccccccCcccCchhhhcc--------cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc-cccCCCCC-
Q 014722 215 -QFNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV-IDFKRDPW- 282 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~- 282 (419)
......|++.|+|||++.. .++.++||||||+++|+|++ |..||......+....+.... .....+.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 1234567889999998742 35778999999999999997 578887777766666554432 22222222
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...++.+.+++..|| .+|++|||+.++++
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 246888999999999 67999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.14 Aligned_cols=242 Identities=45% Similarity=0.770 Sum_probs=205.5
Q ss_pred cceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcchHHH
Q 014722 68 EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDR 147 (419)
Q Consensus 68 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 147 (419)
+||.||+|....+|+.+|+|++........ .+.+.+|++.++++ +|+||+++++++......++++||+.+++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999876543221 57889999999999 999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCc
Q 014722 148 IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227 (419)
Q Consensus 148 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a 227 (419)
+.....++...+..++.+++.+|.+||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED---GHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC---CcEEEccccceeeeccccccccccCCcCCCC
Confidence 8877668999999999999999999999999999999999999754 4599999999987765545556678899999
Q ss_pred hhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCC
Q 014722 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL 305 (419)
Q Consensus 228 PE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~ 305 (419)
||.+. ..++.++||||+|+++|++++|..||.. .........+....... ...+..++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-PPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-ccccccCCHHHHHHHHHHccCCchhcc
Confidence 99886 5688899999999999999999999977 44444444333332222 222222789999999999999999999
Q ss_pred CHHHHhcCCcc
Q 014722 306 TAEEVLEHPWL 316 (419)
Q Consensus 306 s~~~~l~~~~~ 316 (419)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=293.99 Aligned_cols=264 Identities=26% Similarity=0.484 Sum_probs=199.8
Q ss_pred CCccc-cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC----CC---Ceeee
Q 014722 51 GQDIS-IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK----HP---NIVSL 122 (419)
Q Consensus 51 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~----hp---nIv~l 122 (419)
|..|+ .+|.+.++||.|-|++||+|.|.++.+.||+|+++..... .+....||++|+++.. |+ .||+|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 56677 7999999999999999999999999999999999865433 3567789999998853 32 69999
Q ss_pred eeEEE----eCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCC
Q 014722 123 KDTYE----DDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKE 195 (419)
Q Consensus 123 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~ 195 (419)
++.|. .+.++|+|+|++ |.+|...|... +.++...+.+|++||+.||.|||.. ||||.||||+|||+.....
T Consensus 148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~ 226 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEI 226 (590)
T ss_pred eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecccc
Confidence 99996 456899999999 77999988764 3599999999999999999999975 9999999999999833200
Q ss_pred --------------------------------------------------------------------------------
Q 014722 196 -------------------------------------------------------------------------------- 195 (419)
Q Consensus 196 -------------------------------------------------------------------------------- 195 (419)
T Consensus 227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~ 306 (590)
T KOG1290|consen 227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE 306 (590)
T ss_pred chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 014722 196 -------------------------------------------------------------------------------- 195 (419)
Q Consensus 196 -------------------------------------------------------------------------------- 195 (419)
T Consensus 307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~ 386 (590)
T KOG1290|consen 307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL 386 (590)
T ss_pred cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence
Q ss_pred ---CCCeEEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC------HHH
Q 014722 196 ---SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQG 265 (419)
Q Consensus 196 ---~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~ 265 (419)
+..|||+|||-|+.+. ..+..-+.|..|+|||++.+ .|+..+||||++|++|||+||...|.... +.+
T Consensus 387 ~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 387 PECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred CccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0013445555444321 22333456889999999875 79999999999999999999998883221 122
Q ss_pred HHHHHHhcccccC-------------------------CCCCcc-------------CCHHHHHHHHHhcCCCCCCCCCH
Q 014722 266 VAQAIIRSVIDFK-------------------------RDPWPK-------------VSENAKDLVKKMLNPDPKQRLTA 307 (419)
Q Consensus 266 ~~~~i~~~~~~~~-------------------------~~~~~~-------------~~~~~~~li~~~L~~dp~~R~s~ 307 (419)
.+..|+......+ ..+|+- -..++.+|+.-||+.+|++||||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 2222222111000 112221 12467899999999999999999
Q ss_pred HHHhcCCccccCcc
Q 014722 308 EEVLEHPWLQNAKK 321 (419)
Q Consensus 308 ~~~l~~~~~~~~~~ 321 (419)
.++|+|||++....
T Consensus 545 ~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccCCCC
Confidence 99999999996544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=299.54 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=205.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
....+.++||+|.||.|.+|. ...+..||+|.++... +.....++.+||++|.+| +||||++++++|..++.+++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hheehhhhhcCcccceeEEEE-ecCceEEEEeecCccc--chhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHH
Confidence 357788999999999999998 3557999999987654 333468899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||++.|+|.+++.+.. .........|+.||++|++||.+.++|||||.+.|+|++ .+.++||+|||+++.+..+
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~---~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD---GEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec---CcccEEecCcccccccccC
Confidence 99999999999998863 345566678999999999999999999999999999995 4556999999999977665
Q ss_pred Cccc---ccccCcccCchhhh-cccCCCcccHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHhcccccCC----CCCc
Q 014722 214 EQFN---EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLC--GVPPFWAETEQGVAQAIIRSVIDFKR----DPWP 283 (419)
Q Consensus 214 ~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwslG~il~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~ 283 (419)
+.+. ..+-..+|||||.+ .++++.++|+|+||+++||+++ ...||...+..+..++.-...-.... ...+
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~ 770 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP 770 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence 5433 23446789999965 5899999999999999999765 78999887777666554332222111 1123
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l 311 (419)
-++..+.+++.+||..|.++|||++++-
T Consensus 771 ~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 771 ACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred cCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 5788999999999999999999999993
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.76 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=203.6
Q ss_pred eeccccccccceEEEEEEEcC--CC--cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 59 DLGRELGRGEFGVTYLCTDVN--NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~--~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+.+.||.|.||.||+|.-.. .| -.||||..+... +..+.+.|..|.-+|+.+ +||||++++|++.+ ...||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeec-cceeE
Confidence 345679999999999998432 23 357888877543 455688999999999999 99999999999975 57899
Q ss_pred EEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+++.|.|..++..+. .++......++.||+.||.|||++++|||||-..|||+.+. ..|||+|||+++.+...
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp---~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP---QCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc---ceeeecccchhhhcccc
Confidence 999999999999998754 58889999999999999999999999999999999999654 45999999999998776
Q ss_pred Cccccccc--CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 214 EQFNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 214 ~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
..+....| ..-|||||.++ +.++.++|||-|||++||++. |..||.+-...++.-.+.++.. .+..+++|+.+
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---lP~P~nCPp~L 621 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---LPCPPNCPPAL 621 (974)
T ss_pred chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC---CCCCCCCChHH
Confidence 65554444 34699999988 789999999999999999887 9999998877766655555432 22335799999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHh
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l 311 (419)
..|+.+||.++|.+||.+.++.
T Consensus 622 YslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 622 YSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999987764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=286.92 Aligned_cols=255 Identities=28% Similarity=0.471 Sum_probs=209.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
...+|.-++.+|.|+- .|..|-|.-+++.||+|..... +.+....+...+|+.++..+ +|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHH
Confidence 4457888999999999 8888999999999999998766 33344557788999999999 999999999998633
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..+|+|||++. .+|...+. -.++...+..|+.|++.|+.|||+.||+||||||+||++. .++.+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~---~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN---SDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec---chhheeeccchhh
Confidence 35899999996 58888776 3478889999999999999999999999999999999995 4566999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------- 276 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------- 276 (419)
+.....-..+.++.|..|.|||++.+ .|.+.+||||+|||+.||++|..-|.+.+.-++..++......
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 87655545567889999999998764 6999999999999999999999999888766655555432211
Q ss_pred ---------------------cCCCCCc-------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 277 ---------------------FKRDPWP-------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 277 ---------------------~~~~~~~-------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
++...|+ .-+..+++++.+||..||++|.|+.++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111121 1134689999999999999999999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=302.68 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=214.1
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-----CCCeeeeeeE
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-----HPNIVSLKDT 125 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----hpnIv~l~~~ 125 (419)
|..+..+|.+....|.|-||+|..|.+...|..||||+|..... -.+.-+.|+++|++|.. .-|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 45566789999999999999999999999999999999986543 23456779999999931 2379999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
|...+++|+|+|-+. .+|.+.+.+-+ .+....++.++.|++.||..|-..||+|.||||+|||++. ....+|||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE--~k~iLKLC 579 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE--SKNILKLC 579 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc--Ccceeeec
Confidence 999999999999885 58999998754 4788899999999999999999999999999999999974 34569999
Q ss_pred ecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD- 280 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 280 (419)
|||.|..+..++. ..+.-+..|.|||++.| .|+...|+||+||+||||.||+..|++.+...++...+.....++..
T Consensus 580 DfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 580 DFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cCccccccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9999988765554 34445677999998875 89999999999999999999999999998888776554332221110
Q ss_pred --------------------------------------C----------CccCC-------HHHHHHHHHhcCCCCCCCC
Q 014722 281 --------------------------------------P----------WPKVS-------ENAKDLVKKMLNPDPKQRL 305 (419)
Q Consensus 281 --------------------------------------~----------~~~~~-------~~~~~li~~~L~~dp~~R~ 305 (419)
+ .+.++ ..+++|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0 00011 3578999999999999999
Q ss_pred CHHHHhcCCcccc
Q 014722 306 TAEEVLEHPWLQN 318 (419)
Q Consensus 306 s~~~~l~~~~~~~ 318 (419)
|..|+|.||||..
T Consensus 739 t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 739 TVNQALKHPFITE 751 (752)
T ss_pred CHHHHhcCCcccC
Confidence 9999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=313.57 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=215.8
Q ss_pred ceeeccccccccceEEEEEEEcCCC---cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...|.+.||.|.||.|++|+.+..| ..||||.++... ......+|+.|..||.++ +||||++|.++......+.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeE
Confidence 3567788999999999999976655 579999997654 455678999999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||+|||++|+|..+|.++ +.++..+...+++.|+.|++||-+.|+|||||.+.|||++ .+..+|++|||+++.+.+
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN---snLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 783 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec---cceEEEeccccceeeccc
Confidence 999999999999999864 5799999999999999999999999999999999999995 456699999999998865
Q ss_pred CC--ccccccc--CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 213 GE--QFNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 213 ~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
+. ...+..| ..+|.|||++. +.++.+|||||+|++|||.++ |.-||+..+.++++..|.++. ..++...+|
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy---RLPpPmDCP 860 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY---RLPPPMDCP 860 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc---CCCCCCCCc
Confidence 43 1223333 35899999987 789999999999999998776 999999999999998888754 344456899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+.+|+..||++|-.+||.+.|++.+
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 999999999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=305.78 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=186.7
Q ss_pred cccceeeccccccccceEEEEEEEc----------------CCCcEEEEEEecccccCChh-----------hHHHHHHH
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDV----------------NNGEKFACKSISKKKLRTAV-----------DIEDVRRE 106 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~~aiK~~~~~~~~~~~-----------~~~~~~~E 106 (419)
-.++|++.++||+|+||+||+|... ..++.||+|.+......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999742 24568999998643211000 11223347
Q ss_pred HHHHHhCCCCCC-----eeeeeeEEEe--------CCeEEEEEEecCCcchHHHHHhcC---------------------
Q 014722 107 VQIMKHLPKHPN-----IVSLKDTYED--------DSAVHIVMELCEGGELFDRIVARG--------------------- 152 (419)
Q Consensus 107 i~~l~~l~~hpn-----Iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~--------------------- 152 (419)
+.++.++ .|.+ ++++++++.. .+..++|+||+++++|.+++....
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777 4544 3667777643 356899999999999998876421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccc--cccCcccCc
Q 014722 153 ---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSPYYMA 227 (419)
Q Consensus 153 ---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~gt~~y~a 227 (419)
.+++..+..++.|++.+|.|||+.+|+||||||+|||++.+ ..+||+|||++........... ..+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD---GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC---CcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 23456788999999999999999999999999999999654 4599999999976544333332 234889999
Q ss_pred hhhhccc---------------------CC--CcccHHHHHHHHHHHHhCCC-CCCCCCHHH-----------HHHHHHh
Q 014722 228 PEVLKRN---------------------YG--PEVDVWSAGVILYILLCGVP-PFWAETEQG-----------VAQAIIR 272 (419)
Q Consensus 228 PE~~~~~---------------------~~--~~~DiwslG~il~~ll~g~~-pf~~~~~~~-----------~~~~i~~ 272 (419)
||.+... |+ .+.||||+||++|+|++|.. ||....... ....+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9987421 11 24799999999999999875 764321111 1111111
Q ss_pred cccccCCCCCccCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCCcccc
Q 014722 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDP---KQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~s~~~~l~~~~~~~ 318 (419)
... ....|...++.+++|+.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cCC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 222 233466789999999999999866 68999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.45 Aligned_cols=265 Identities=23% Similarity=0.382 Sum_probs=218.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+.....+||-|.||.||.|..++-.-.||||.++.. ....++|+.|..+|+.+ .|||+|+++++|..+..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence 345567899999999999999888899999998754 33578999999999999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 137 ELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||..|+|.+++.+.. .++.-....++.||.+|+.||..+++|||||-..|+|+ +++..||++|||+++.+..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCc
Confidence 9999999999998754 36777888999999999999999999999999999999 566779999999999886443
Q ss_pred ccccccc---CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 215 QFNEIVG---SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 215 ~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
+..-.| ...|.|||-+. ..++.|+|||+|||+|||+.| |-.||.+.+..++...+.++ +... ....+++..
T Consensus 420 -YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-yRM~--~PeGCPpkV 495 (1157)
T KOG4278|consen 420 -YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-YRMD--GPEGCPPKV 495 (1157)
T ss_pred -eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-cccc--CCCCCCHHH
Confidence 333333 34699999887 679999999999999999998 89999998877766555443 3322 335799999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhh
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (419)
.+|+..||+.+|.+||++.++ |.-|... ....++.+.+.+.+.+
T Consensus 496 YeLMraCW~WsPsDRPsFaei--HqafEtm--f~~sSisdEV~keLgk 539 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEI--HQAFETM--FSSSSISDEVQKELGK 539 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHH--HHHHHHH--hccccccHHHHHHHhh
Confidence 999999999999999999998 4334432 2234555666555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=310.94 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=197.6
Q ss_pred eeeccccccccce-EEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 58 YDLGRELGRGEFG-VTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 58 y~~~~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
|.-.+.+|.|+.| .||+|. ..|+.||||.+-... ..-..+|+..|+.-.+|||||++++.-.+..+.||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 3334678999987 478888 678999999985442 3456889999999889999999999999999999999
Q ss_pred EecCCcchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccceec
Q 014722 137 ELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFF 210 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a~~~ 210 (419)
|.|. .+|.+++...+. ......+.++.|++.||++||+.+||||||||.|||+...+ ....++|+|||+++..
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9996 599999977411 11145688999999999999999999999999999998742 3357899999999988
Q ss_pred cCCCc----ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 211 RPGEQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..+.. .....||-+|+|||++.. .-+.++||+|+||++|+.++| ..||...... ..+|+.+......-. +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~-~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLE-PL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeec-cC
Confidence 65543 355779999999999985 456689999999999998885 8999554433 234555444322111 01
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...++.+||.+||.++|..||+|.++|.||||=..
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 11289999999999999999999999999999653
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=301.01 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=214.4
Q ss_pred cceeeccccccccceEEEEEEEcC-CC--cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
++..+.++||+|+||+|++|.... +| ..||||.+....... ...+|++|+.+|.+| +|||+++||++..+ ...
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-chh
Confidence 457778899999999999998654 33 468999998765432 568999999999999 99999999999987 678
Q ss_pred EEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+|++++|+|.+.|.+ +..|.......++.||+.|+.||.++++|||||-..|+|+.. ...|||+|||+.+.+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceecc
Confidence 899999999999999987 445888889999999999999999999999999999999965 455999999999988
Q ss_pred cCCCcccccc----cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 211 RPGEQFNEIV----GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~~~~~~----gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..++...... -...|+|||.++ +.++.++|||++||++|||+| |..||.+.....+++.|..+.. ..+ .+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-LpR--Pk~ 339 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-LPR--PKY 339 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-CCC--CCC
Confidence 7666544332 244699999998 689999999999999999998 8999999999999888874432 222 246
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+++++.++++.||..+|.+|||+..+...-+...
T Consensus 340 csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 8999999999999999999999999976555544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=273.16 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=208.8
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC-----Ce
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-----SA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-----~~ 131 (419)
+.+-.+.||.|+||+||.+.|..+|+.||+|.+..- +.+...-+.+.+|+.+|..+ +|.|++..++..+-. ..
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHH
Confidence 455567899999999999999999999999988643 22344567888999999999 999999999887543 24
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+++|++. .+|...|..-..++...+.-+++||+.||+|||+.+|.||||||.|.|++ .+..+||||||+++...
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEecccccccccc
Confidence 788999995 48888888777899999999999999999999999999999999999995 56779999999999765
Q ss_pred CCCc--ccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---------
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--------- 278 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------- 278 (419)
..+. +..-+-|.+|+|||++.+ .|+.+.||||+|||+.||+..+..|...+.-+.++.|........
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 4433 344567899999999985 799999999999999999999999988777666666543221110
Q ss_pred ------------CCCC---------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 279 ------------RDPW---------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 279 ------------~~~~---------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+.. ..-..+...++.++|..||++|++.++++.|++..+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 0000 0123467889999999999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.94 Aligned_cols=259 Identities=30% Similarity=0.494 Sum_probs=220.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++|+++..+|+|.||.||+|+++.+++..|+|+++... ..+...++.|+-+++.. +||||+.+++.|...+..+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecC-CCcChHHHHhhhhhhcCcE
Confidence 4468999999999999999999999999999999998653 34567788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|+||||.||+|.+...-.+++++.++....+..++||+|||+.|=+|||||=.|||++..++ +|+.|||.+..+...
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitat 165 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITAT 165 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhh
Confidence 99999999999998888889999999999999999999999999999999999999976655 999999988765422
Q ss_pred -CcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-CCCCccCCH
Q 014722 214 -EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKVSE 287 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~ 287 (419)
.....+.|||+|||||+.. +.|+..+|||++|+...|+---++|..............+..+..+ ...-..-++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 2345688999999999753 6799999999999999999988888766555444444444333322 122234578
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+-+|++.+|.++|++|||++.+|.|||....
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 89999999999999999999999999998764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=249.31 Aligned_cols=213 Identities=24% Similarity=0.358 Sum_probs=176.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++...+..||+|++|.|-+.++..+|...|+|.+...- +....+.+++|+.+..+...+|.+|.+|+.+.+...++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3445667788999999999999999999999999997653 23456678889999888779999999999999999999
Q ss_pred EEEEecCCcchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 134 IVMELCEGGELFDR----IVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 134 lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
|.||.|+ .+|..+ +.+.+.++|..+-+|+..++.||.|||++ .++|||+||+|||++. .++||+||||.+.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~---~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY---DGQVKICDFGISG 197 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc---CCcEEEcccccce
Confidence 9999996 366443 34466799999999999999999999986 8999999999999964 4559999999998
Q ss_pred eccCCCcccccccCcccCchhhhcc-----cCCCcccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIR 272 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~ 272 (419)
.+.++-....-.|-..|||||.+.. .|+.++||||||+++.||.+++.||.. .+..+++.++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7765544444567888999998862 588999999999999999999999954 345555555543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.71 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=182.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|.....||+|+||.||+|++..++..||+|.+..... ....|++.++++ +|||||++++++.+.+..|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEE
Confidence 46667789999999999999989999999999864321 112468899999 9999999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH---EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||+++|+|.+++. .+++..+..|+.|++.||+||| +.+|+||||||+||+++.+.. .++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCTD 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-eccccccccC
Confidence 9999999999885 3789999999999999999999 669999999999999975433 4543 6654432211
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh-----cccccCC-CC
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-----QGVAQAIIR-----SVIDFKR-DP 281 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~-----~~~~~~~-~~ 281 (419)
....||+.|+|||++. ..++.++|||||||++|||+||+.||..... ......... ...+... ..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 2346889999999887 4699999999999999999999999843211 111111000 0000000 00
Q ss_pred C---ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 282 W---PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 282 ~---~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
. .....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 0112356789999999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=276.02 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=202.9
Q ss_pred CccccceeeccccccccceEEEEEEEcC---CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+...|.++.+||+|.|++||++.+.. .++.||+|.+.... ....+.+|+++|..+..+.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3456679999999999999999999877 78999999986543 235689999999999999999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
++.+.+|+||++..+..++.. .++..++..+++.++.||.++|.+|||||||||+|+|++.... .-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhHH
Confidence 999999999999888777664 4678999999999999999999999999999999999986544 46789999987
Q ss_pred ecc-----------------C--CC--------------c------------ccccccCcccCchhhhc--ccCCCcccH
Q 014722 209 FFR-----------------P--GE--------------Q------------FNEIVGSPYYMAPEVLK--RNYGPEVDV 241 (419)
Q Consensus 209 ~~~-----------------~--~~--------------~------------~~~~~gt~~y~aPE~~~--~~~~~~~Di 241 (419)
... + +. . .-...||++|+|||++. +.-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 210 0 00 0 00246999999999987 467889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH--------------hcc---------------------c------c---
Q 014722 242 WSAGVILYILLCGVPPFWAETE-QGVAQAII--------------RSV---------------------I------D--- 276 (419)
Q Consensus 242 wslG~il~~ll~g~~pf~~~~~-~~~~~~i~--------------~~~---------------------~------~--- 276 (419)
||.|||+..++++..||..... ......+. .+. + .
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999843321 11111100 000 0 0
Q ss_pred --cCCCCCc-cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 277 --FKRDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 277 --~~~~~~~-~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.....|. -.+..+.+|+.+||+.||.+|+|++++|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0001111 134578999999999999999999999999999843
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=295.65 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=204.5
Q ss_pred ceeeccccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
+..+.+.||+|+||.|++|.-.. ....||+|..+.... ..+.+.+..|+.+|+.+..||||+.+++++...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44566799999999999997321 146799998875542 356789999999999998999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC
Q 014722 130 SAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~ 193 (419)
+.+++|+||+..|+|.+++...+ .++..+...++.||+.|++||++.+++||||-+.|||+..
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~- 453 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK- 453 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC-
Confidence 99999999999999999998765 3888999999999999999999999999999999999964
Q ss_pred CCCCCeEEeecccceeccCCCcccc--ccc--CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCC-HHHH
Q 014722 194 KESSPLKAIDFGLSVFFRPGEQFNE--IVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET-EQGV 266 (419)
Q Consensus 194 ~~~~~~kl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~ 266 (419)
+..+||+|||+|+.......... ..| ...|||||.+. ..|+.++||||+|++|||++| |..||.+.. ..+.
T Consensus 454 --~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 454 --NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred --CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 45699999999997655443321 222 23599999988 479999999999999999998 899998855 5555
Q ss_pred HHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+.+..+. .... ...+++++.+++..||+.+|++||++.++.+
T Consensus 532 ~~~l~~G~-r~~~--P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 532 LEFLKEGN-RMEQ--PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHhcCC-CCCC--CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55444332 2222 2357999999999999999999999999965
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=281.36 Aligned_cols=199 Identities=33% Similarity=0.561 Sum_probs=175.7
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhh-----HHHHHHHHHHHHhCCC---CCCeeeeeeEEEe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-----IEDVRREVQIMKHLPK---HPNIVSLKDTYED 128 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----~~~~~~Ei~~l~~l~~---hpnIv~l~~~~~~ 128 (419)
+|..++.+|+|+||.|++|.++.....|+||.|.++.+..... +-.+-.||++|..| + |+||++++++|++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFED 640 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheeec
Confidence 5899999999999999999999999999999998876543222 22456799999999 6 9999999999999
Q ss_pred CCeEEEEEEec-CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 DSAVHIVMELC-EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
++++||+||-- +|.+|+++|..+..++|.++..|++|++.|+++||+.||||||||-+|+.++. ++-+||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~---~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS---NGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEec---CCeEEEeeccch
Confidence 99999999976 46799999999999999999999999999999999999999999999999964 456999999988
Q ss_pred eeccCCCcccccccCcccCchhhhccc--CCCcccHHHHHHHHHHHHhCCCCCCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWA 260 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~ 260 (419)
..... ..+..++||..|.|||++.+. .+..-|||++|++||.++....||+.
T Consensus 718 a~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76554 446788999999999999863 46789999999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=264.01 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=188.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHh--CCCCCCeeeeeeEEEeC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH--LPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hpnIv~l~~~~~~~ 129 (419)
+.+..+..+.+.||+|.||.||+|. ..|+.||||++... +...+.+|.++.+. | +|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr------dE~SWfrEtEIYqTvmL-RHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR------DERSWFRETEIYQTVML-RHENILGFIAADNKD 277 (513)
T ss_pred HhhhheeEEEEEecCccccceeecc--ccCCceEEEEeccc------chhhhhhHHHHHHHHHh-ccchhhhhhhccccC
Confidence 3466789999999999999999998 67999999999644 23567788888775 5 899999999875422
Q ss_pred ----CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeeCCCCCcEEeecCCCCC
Q 014722 130 ----SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 130 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~NIl~~~~~~~~ 197 (419)
.++|||++|.+.|+|+|+|.. ..++......++..++.||++||.. .|.|||||..|||+.+ ++
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk---n~ 353 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NG 353 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc---CC
Confidence 368999999999999999987 5799999999999999999999952 4999999999999965 45
Q ss_pred CeEEeecccceeccCCC-----cccccccCcccCchhhhcccCC-------CcccHHHHHHHHHHHHhC----------C
Q 014722 198 PLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLKRNYG-------PEVDVWSAGVILYILLCG----------V 255 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~~ll~g----------~ 255 (419)
.+.|+|+|+|....... ..+..+||.+|||||++....+ ..+||||||.++||+... .
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 59999999998765442 2456789999999999975332 248999999999998752 4
Q ss_pred CCCCCCCH----HHHHHHHHh-ccc-ccCCCCCccCC--HHHHHHHHHhcCCCCCCCCCHHHH
Q 014722 256 PPFWAETE----QGVAQAIIR-SVI-DFKRDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEV 310 (419)
Q Consensus 256 ~pf~~~~~----~~~~~~i~~-~~~-~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~s~~~~ 310 (419)
+||++..+ .+...++.. ..+ ......|...+ ..+..+++.||..||..|.|+--+
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 78855322 222222211 111 11222343322 245678999999999999998665
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=266.75 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=186.5
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCCeeeeeeEEEeCC----e
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-KHPNIVSLKDTYEDDS----A 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~hpnIv~l~~~~~~~~----~ 131 (419)
...+.+.||+|.||.||+|. -+++.||||++... +.+.+.+|-.+.+... .|+||++++++-.... .
T Consensus 211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhh--ccCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 46678899999999999998 45799999998643 4567788877777531 7999999999876554 8
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE---------QGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---------~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
++||+||.+.|+|.+++..+ .+++....+|+..+++||+|||+ ..|+|||||..|||+.+ +.+..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~---DlTccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN---DLTCCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc---CCcEEee
Confidence 99999999999999999875 68999999999999999999996 25999999999999954 5569999
Q ss_pred ecccceeccCCCc---ccccccCcccCchhhhcccCC-------CcccHHHHHHHHHHHHhCCC------------CCC-
Q 014722 203 DFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKRNYG-------PEVDVWSAGVILYILLCGVP------------PFW- 259 (419)
Q Consensus 203 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~DiwslG~il~~ll~g~~------------pf~- 259 (419)
|||+|..+.++.. ....+||.+|||||++.+..+ .+.||||+|.+|||+++... ||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999998876543 334789999999999986322 25899999999999998532 332
Q ss_pred ----CCCHHHHHHHHHhcccc-cCCCCCcc--CCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014722 260 ----AETEQGVAQAIIRSVID-FKRDPWPK--VSENAKDLVKKMLNPDPKQRLTAEEV 310 (419)
Q Consensus 260 ----~~~~~~~~~~i~~~~~~-~~~~~~~~--~~~~~~~li~~~L~~dp~~R~s~~~~ 310 (419)
..+..++...+.+.... .....|.. -..-+++.+..||..||+.|.|+.=+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 11223333333332221 11222332 23457899999999999999998643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=282.78 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=204.3
Q ss_pred eeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.+..++||+|+||+||+|...-.|+ +||||++.... ....-.++..|+-+|.+| +|||++++++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence 4446789999999999998655454 67888876543 333457889999999999 9999999999998665 88
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||++|+++|.|.++++. +..+..+..+.|..||++|+.|||.+++|||||-+.|||+.+. ..+|+.|||+++...+
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP---~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP---NHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC---CeEEEEecchhhccCc
Confidence 99999999999999986 4568999999999999999999999999999999999999644 4599999999998765
Q ss_pred CCc-cccccc--CcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GEQ-FNEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
... +....| .+.|||-|.+. +.|+.++||||+||++||++| |..|+.+....++...+..+.. . +..+.++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-L--sqPpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-L--SQPPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-C--CCCCCccH
Confidence 433 332222 45688888776 689999999999999999998 9999999998887776665543 2 23357899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.-++.+||..|+..||+++++...
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~ 953 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEE 953 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHH
Confidence 99999999999999999999988653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=252.29 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE-EEeCC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT-YEDDS 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~-~~~~~ 130 (419)
-.+.+.|.|.+.||+|.||.+-+|++..++..+|+|.+.... ..+.++.+|...--.|+.|.||+.-|++ |+..+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 457788999999999999999999999999999999987543 3467899999988888889999998875 78888
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+++++||++.|+|.+-+... .+.|.....++.|+++||.|+|++++||||||.+|||+-..+ ...|||||||.....
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDAD-FYRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCC-ccEEEeeeccccccc
Confidence 999999999999998877664 488999999999999999999999999999999999997543 347999999987643
Q ss_pred cCCCcccccccCcccCchhhhc----c--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHH--HHHHHhcccccCCC
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK----R--NYGPEVDVWSAGVILYILLCGVPPFWAETE--QGV--AQAIIRSVIDFKRD 280 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~--~~~i~~~~~~~~~~ 280 (419)
. ......--+..|.+||.+. + ...+.+|||.||+++|..+||.+||..... ... ........-.-...
T Consensus 174 g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 174 G--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred C--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 2 2222233455699999764 2 357789999999999999999999963211 111 11222222222223
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCcccc
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQR---LTAEEVLEHPWLQN 318 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R---~s~~~~l~~~~~~~ 318 (419)
.+..+++.+..+.++-|..+|++| .++.......|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 345688999999999999999999 56666666667643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=239.70 Aligned_cols=211 Identities=44% Similarity=0.768 Sum_probs=184.6
Q ss_pred cccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcc
Q 014722 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGE 143 (419)
Q Consensus 64 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 143 (419)
||+|++|.||++.+..+++.+++|++....... ....+.+|++.++.+ .|++|+++++++......++++|++.|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999988889999999987654321 346789999999999 89999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-ccccccc
Q 014722 144 LFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVG 221 (419)
Q Consensus 144 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~g 221 (419)
|.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++.. ...++|+|||.+....... ......+
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD--NGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCC--CCcEEEecCCceEEccCCcchhhcccC
Confidence 99988765 468999999999999999999999999999999999999752 3459999999988665432 1334567
Q ss_pred CcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 222 SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 222 t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
+..|++||.+.. .++.++|+|++|++++++ ..+.+++.+||..
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhC
Confidence 888999999875 778899999999999999 5788999999999
Q ss_pred CCCCCCCHHHHhcCC
Q 014722 300 DPKQRLTAEEVLEHP 314 (419)
Q Consensus 300 dp~~R~s~~~~l~~~ 314 (419)
+|++||++.++++|+
T Consensus 201 ~p~~R~~~~~l~~~~ 215 (215)
T cd00180 201 DPEKRPSAKEILEHL 215 (215)
T ss_pred CcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.69 Aligned_cols=199 Identities=20% Similarity=0.272 Sum_probs=148.3
Q ss_pred CC-CCeeeeeeEE-------EeCCeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCC
Q 014722 115 KH-PNIVSLKDTY-------EDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185 (419)
Q Consensus 115 ~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 185 (419)
.| +||.++++++ .....++.++|++ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 45 5777788876 2334677888987 5699999965 34599999999999999999999999999999999
Q ss_pred CcEEeecC----------------CCCCCeEEeecccceeccCCC-----------------cccccccCcccCchhhhc
Q 014722 186 ENFLFANK----------------KESSPLKAIDFGLSVFFRPGE-----------------QFNEIVGSPYYMAPEVLK 232 (419)
Q Consensus 186 ~NIl~~~~----------------~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~ 232 (419)
+|||++.. +.+..+|++|||+++...... ......||++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 99999642 223457888888876432100 011246899999999876
Q ss_pred -ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014722 233 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 233 -~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l 311 (419)
..|+.++|||||||+||||++|.+|+.... .....+..... + +.+....+...+++.+||.++|.+|||+.|++
T Consensus 189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 189 GSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--P-PQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred cCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--C-hhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 579999999999999999999998875322 12222222111 1 11112245677899999999999999999999
Q ss_pred cCCccccC
Q 014722 312 EHPWLQNA 319 (419)
Q Consensus 312 ~~~~~~~~ 319 (419)
+||||...
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=238.61 Aligned_cols=210 Identities=42% Similarity=0.756 Sum_probs=179.6
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++++ +|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence 56778999999999999999888999999999765432 2467888999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 138 LCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
++++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.+ ..++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~---~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD---GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeeCceeeEecCcccc
Confidence 9999999999987766 8999999999999999999999999999999999999754 559999999988765443
Q ss_pred cccccccCcccCchhhh-c-ccCCCcccHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHhc
Q 014722 215 QFNEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPPFWA--ETEQGVAQAIIRS 273 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~~i~~~ 273 (419)
......++..|++||.+ . ..++.++|+||||+++++|++|+.||.. .+...+.+.+..+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 33456788899999987 4 4577899999999999999999999977 3333555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=232.88 Aligned_cols=248 Identities=18% Similarity=0.254 Sum_probs=200.9
Q ss_pred cceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE-EeC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY-EDD 129 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~-~~~ 129 (419)
.+++....+-+|.||.||.|.... +.+.|-+|.++... ++.....+..|-..+..+ .|||+..+.++. ++.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence 467788889999999999996433 33456677765432 455667888899999999 799999999986 456
Q ss_pred CeEEEEEEecCCcchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 130 SAVHIVMELCEGGELFDRIVAR--------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
...++++.+..-|+|..++... ..++..+...++.|++.|++|||++|+||.||-..|.+++. ..+|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd---~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD---QLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh---heeEEe
Confidence 7788999999989999998731 24777889999999999999999999999999999999964 467999
Q ss_pred eecccceeccCCCccc---ccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccc
Q 014722 202 IDFGLSVFFRPGEQFN---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
+|=.+++..-+.+... .--....|||||.+. ..|+.++|||||||++|||+| |+.||..-+..++..-+..+..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR- 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR- 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-
Confidence 9999998776543210 111245699999987 579999999999999999998 9999999999888877776542
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
. ...-++|+++..++.-||...|++|||++|+..
T Consensus 517 l--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 L--AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred e--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 1 122378999999999999999999999999854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=215.88 Aligned_cols=162 Identities=25% Similarity=0.324 Sum_probs=126.5
Q ss_pred cchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccc
Q 014722 142 GELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220 (419)
Q Consensus 142 g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 220 (419)
|+|.+++..+ ..+++..++.|+.|++.||.|||+.+ ||+|||++.+ +.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~---~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD---GLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc---cceee--ccceEeecccc----CC
Confidence 6899999864 45999999999999999999999999 9999999643 45888 99988754322 26
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCC---CCCccCCH--HHHHHH
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKR---DPWPKVSE--NAKDLV 293 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~~~--~~~~li 293 (419)
||+.|||||++. ..++.++|||||||++|+|+||..||..... ......+......... .....++. ++.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999987 5789999999999999999999999966543 2233333332221111 11122333 699999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+||..+|++|||+.++++|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=256.66 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=198.4
Q ss_pred eccccccccceEEEEEEEcCCCcEEEEEEeccc--ccCChhh-HHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKK--KLRTAVD-IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~-~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
....+|.|++|.|+.+......+.++.|.+... ....... ...+..|+.+-..| .|||++..+..+.+....+-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhh
Confidence 456799999999988887777777777765422 1111111 12266677788888 8999998888877776666669
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC--
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-- 214 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-- 214 (419)
|||++ +|+.++...+.++..++-.+++|++.||+|+|+.||.|||+||+|+++... +.+||+|||.+......-
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~---g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN---GILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC---CceEEeecCcceeeccCcch
Confidence 99999 999999988889999999999999999999999999999999999999754 469999999987664322
Q ss_pred ---cccccccCcccCchhhhcc-cCCC-cccHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH---hcccccCCCCCcc
Q 014722 215 ---QFNEIVGSPYYMAPEVLKR-NYGP-EVDVWSAGVILYILLCGVPPFWAETEQGVA--QAII---RSVIDFKRDPWPK 284 (419)
Q Consensus 215 ---~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~---~~~~~~~~~~~~~ 284 (419)
.....+|+..|+|||++.+ .|++ ..||||.|++++.|++|+.||......+.. .... ......+...|..
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL 556 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence 2345789999999999874 6766 589999999999999999999544332221 1111 1111112233445
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++.+.+.+|.+||+.||.+|.|+.+|++.+||+...
T Consensus 557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred chhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 788899999999999999999999999999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-27 Score=222.23 Aligned_cols=253 Identities=25% Similarity=0.330 Sum_probs=193.3
Q ss_pred ceeeccccccccceEEEEEEEcCCC-cEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---CCCeeeeeeEE-EeCCe
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---HPNIVSLKDTY-EDDSA 131 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---hpnIv~l~~~~-~~~~~ 131 (419)
+|.+.+.||+|+||.||.|.+..++ ..+|+|.......... ..+..|+.++..+.. -+++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7999999999999999999987774 6788888765432111 156778898988842 35899999999 57888
Q ss_pred EEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccc
Q 014722 132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLS 207 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a 207 (419)
.|+||+.+ |.+|.++.... +.++..++..|+.|++.+|.+||+.|++||||||+|+++.... ....+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 78999977554 4799999999999999999999999999999999999997643 2256999999999
Q ss_pred eecc---CCC-------c-ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 014722 208 VFFR---PGE-------Q-FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 208 ~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
+... ... . .....||..|+++.+..+ ..+.+.|+||++.++.+++.|..||.+.........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 111 1 123459999999998774 789999999999999999999999976654333333332222
Q ss_pred ccCCC-CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRD-PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..... .....+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 222345677777777777888888888777554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-27 Score=219.26 Aligned_cols=256 Identities=37% Similarity=0.607 Sum_probs=207.4
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-CeeeeeeEEEeCCeEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~~~~~~~~~~~lv~ 136 (419)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+ .|+ +|+++.+++......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence 778889999999999999976 88999999876554433467889999999999 666 8999999998888889999
Q ss_pred EecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 137 ELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+++.++++.+.+.... .+++.....++.|++.++.|+|+.+++|||+||+||+++..+. .++++|||.+......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP 155 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence 9999999997776664 7999999999999999999999999999999999999975431 4899999998865443
Q ss_pred C-------cccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccc-c
Q 014722 214 E-------QFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVID-F 277 (419)
Q Consensus 214 ~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~-~ 277 (419)
. ......||..|+|||.+.+ .++...|+||+|++++++++|..||..... ......+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 2466789999999998864 678899999999999999999999877663 3444444333322 1
Q ss_pred CCCCCccC----CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 278 KRDPWPKV----SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 278 ~~~~~~~~----~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
........ ...+.+++.+++..+|..|.+..+...++|....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 11111111 2578999999999999999999999998776643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=210.18 Aligned_cols=206 Identities=23% Similarity=0.399 Sum_probs=175.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.-+|+++++||+|+||+++.|+..-+++.||||.-..+. ...++..|.+..+.|...++|..++-+...+.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 347999999999999999999999999999999865443 235788999999999888999999988888888999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccceecc
Q 014722 135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a~~~~ 211 (419)
|+|++ |.+|.|+..= .+.|+.++++.++.|++.-++|+|++.+|.|||||+|+||...+ ....|.++|||+|+.+.
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99998 7888887753 55799999999999999999999999999999999999997543 23468999999999886
Q ss_pred CCCc--------ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014722 212 PGEQ--------FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266 (419)
Q Consensus 212 ~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 266 (419)
+... ..+..||-+||+-.... +.-+.+.|+-|||-++.++|-|.+||.+......
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 5432 34678999999977544 4678899999999999999999999987654433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=202.19 Aligned_cols=249 Identities=20% Similarity=0.256 Sum_probs=195.9
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.....|+++++||+|+||.+|.|....+|+.||||+-.... .-.++..|..+.+.|..-..|+.+..+..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45567999999999999999999999999999999865432 2246778999999996678899999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.+||+++ |.+|.++..- .+.++..++..++.|++.-++|+|.++++||||||+|+|..-......+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 7899887753 4569999999999999999999999999999999999999765556679999999999775
Q ss_pred CCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcccccCC
Q 014722 212 PGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVIDFKR 279 (419)
Q Consensus 212 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 279 (419)
+... -....||.+|.+-.+..+ .-+...|+-|+|.+|.++.-|..||.+...... .+.|.......+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 4322 234679999999776553 567889999999999999999999988765443 3344433332221
Q ss_pred -CCCccCCHHHHHHHHHhcCCCCCCCCCH
Q 014722 280 -DPWPKVSENAKDLVKKMLNPDPKQRLTA 307 (419)
Q Consensus 280 -~~~~~~~~~~~~li~~~L~~dp~~R~s~ 307 (419)
......|.++.-.+.-|=..--++-|..
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 1234567777777777765554455543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=225.29 Aligned_cols=166 Identities=20% Similarity=0.250 Sum_probs=129.8
Q ss_pred CccccceeeccccccccceEEEEEEEcC-CCcEEEEEEeccccc--CChhhHHHHHHHHHHHHhCCCCCCeee-eeeEEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPKHPNIVS-LKDTYE 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hpnIv~-l~~~~~ 127 (419)
..+..+|.+.+.||+|+||+||+|.+.. +++.+|||++..... ........+.+|+++|+++ +|+||+. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~--- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA--- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---
Confidence 4567789999999999999999999876 678889998753311 1223456789999999999 8999885 443
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCC-CCCcEEeecCCCCCCeEEeeccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL-KPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl-kp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+..|+||||++|++|.. +. ... ...++.|++.||.|||++||+|||| ||+|||++.+ +.+||+|||+
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~---~~ikLiDFGl 158 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD---GEAAVIDFQL 158 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC---CCEEEEECcc
Confidence 246799999999999963 21 111 2568899999999999999999999 9999999643 4599999999
Q ss_pred ceeccCCC---------cccccccCcccCchhhhc
Q 014722 207 SVFFRPGE---------QFNEIVGSPYYMAPEVLK 232 (419)
Q Consensus 207 a~~~~~~~---------~~~~~~gt~~y~aPE~~~ 232 (419)
|....... ......+++.|+|||.+.
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 98765332 123456888999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=233.90 Aligned_cols=242 Identities=26% Similarity=0.490 Sum_probs=204.5
Q ss_pred ccccccceEEEEEEE---cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 63 ELGRGEFGVTYLCTD---VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
.+|.|+||.|++++. ...|..+|+|+..+......... .-..|-.++....+||.++++...++.+...+++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999998763 24577899999877655433222 44557788888866999999999999999999999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccc
Q 014722 140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219 (419)
Q Consensus 140 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 219 (419)
.||+|...+.+...+++...+.+...++-+++++|+.+|+|||+|++||+++.+ +++++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~---Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE---GHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc---CccccCCchhhhHhHhhhhc---
Confidence 999999999988889999999999999999999999999999999999999654 55999999999876443332
Q ss_pred ccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 220 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
+||..|||||+.+ ....++|.||+|+++++|+||..||.+ ++...|.......+. .++..+.+++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 8999999999998 667889999999999999999999977 666777776555544 4678899999999999
Q ss_pred CCCCCCC-----HHHHhcCCccccCc
Q 014722 300 DPKQRLT-----AEEVLEHPWLQNAK 320 (419)
Q Consensus 300 dp~~R~s-----~~~~l~~~~~~~~~ 320 (419)
+|.+|.- +.++++|+||+.+.
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeee
Confidence 9999984 57999999998654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=195.90 Aligned_cols=175 Identities=20% Similarity=0.220 Sum_probs=135.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHH------HHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED------VRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~------~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
.+..+|++++.||.|+||.||++.+ ++..+|+|++.......+..... +.+|++.+.++ .||+|..+.+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEee
Confidence 4667899999999999999999764 47789999997665444433333 57899999999 999999999886
Q ss_pred EeC--------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 127 EDD--------SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 127 ~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
... ...++||||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||++|+||+++.+ +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~---g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN---G- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC---C-
Confidence 643 3588999999999997763 2333 346699999999999999999999999999743 3
Q ss_pred eEEeecccceeccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHH
Q 014722 199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILL 252 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll 252 (419)
++|+|||.+........... =++...|+.++|+||||+++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 99999998765432221111 123356788999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=190.32 Aligned_cols=142 Identities=20% Similarity=0.222 Sum_probs=111.2
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhh-----------------------HHHHHHHHHHHHhCCCCC
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-----------------------IEDVRREVQIMKHLPKHP 117 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-----------------------~~~~~~Ei~~l~~l~~hp 117 (419)
...||+|+||.||+|.+. +|+.||+|+++......... ......|++++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 468999999999999986 89999999997643211100 12234599999999 777
Q ss_pred CeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEeeCCCCCcEEeecCCCC
Q 014722 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-HEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 118 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
++.....+... . .+|||||++|+++.........+++..+..++.|++.+|.++ |+.||+||||||+|||++.
T Consensus 80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---- 153 (190)
T cd05147 80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---- 153 (190)
T ss_pred CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC----
Confidence 76544433222 2 389999999887766655567899999999999999999999 7999999999999999973
Q ss_pred CCeEEeecccceec
Q 014722 197 SPLKAIDFGLSVFF 210 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~ 210 (419)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 34999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=223.61 Aligned_cols=224 Identities=31% Similarity=0.541 Sum_probs=178.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|+.++.|..|+||.||.++|+.+.+.+|+|+ .++.+ +.+. ++... .+|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a-~npfvv------------ 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFA-GNPFVV------------ 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--ccccc-CCccee------------
Confidence 455689999999999999999999999999999954 32221 1111 33333 555555
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+-...+..-++++... +.+++|||+.||+|||+||+|.+++.- +++|++|||+++..-.
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m---GhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec---ccccccchhhhhhhhh
Confidence 45455555555565544 778999999999999999999999754 4599999998764321
Q ss_pred C--------C------c--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 014722 213 G--------E------Q--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 213 ~--------~------~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
. . . -...+|||.|.|||++. +.|+..+|+|++|+|+|+++-|..||.+.+.+++...++...+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 1 0 0 12458999999999865 6799999999999999999999999999999999999999888
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCccccCcc
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRL---TAEEVLEHPWLQNAKK 321 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---s~~~~l~~~~~~~~~~ 321 (419)
.++...+ .+++++.+++.++|+.+|..|. .+-++.+|+||+....
T Consensus 276 ~wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 276 EWPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred cccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 8888754 6789999999999999999996 6778899999986543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=197.71 Aligned_cols=234 Identities=26% Similarity=0.420 Sum_probs=151.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---------CCCeeeeeeEE-
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---------HPNIVSLKDTY- 126 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---------hpnIv~l~~~~- 126 (419)
.+...+.||.|+++.||.++|..||+.+|+|+............+++.+|.-....+.. |-.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46677899999999999999999999999999876654344467778777765555422 22233333322
Q ss_pred --------EeC---C-----eEEEEEEecCCcchHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHcCCEeeCC
Q 014722 127 --------EDD---S-----AVHIVMELCEGGELFDRIV---ARGHY----TERAAAAVMKTIVEVVQVCHEQGVMHRDL 183 (419)
Q Consensus 127 --------~~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~----~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 183 (419)
... . ..+++|+-+. ++|.+.+. ..... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 2366777774 58876643 22222 22233456689999999999999999999
Q ss_pred CCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhcc---------cCCCcccHHHHHHHHHHHHhC
Q 014722 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR---------NYGPEVDVWSAGVILYILLCG 254 (419)
Q Consensus 184 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~DiwslG~il~~ll~g 254 (419)
+|+|++++.+ +.+.|+||+...... ........+..|.+||.... .++.+.|.|+||+++|.|++|
T Consensus 172 ~~~nfll~~~---G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQD---GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TT---S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCC---CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999754 459999998765432 22222344578999997642 378899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCC
Q 014722 255 VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR 304 (419)
Q Consensus 255 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 304 (419)
..||........... .+... .++|+.+++||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~~C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFSRC--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cchhc--CCcCHHHHHHHHHHccCCcccC
Confidence 999965533211110 22222 2789999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=223.93 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=180.9
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccc-cCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK-LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
+|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-....+...|++ .... +|||.+.+.-+.......|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~-~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALM-KAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhh-cCCcccchHHHHHhhHHHHHH
Confidence 6888899999999999999964 455 8899987654 222233445555666 4445 899999999888888889999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc--CC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--PG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~--~~ 213 (419)
-+|.. .+|+|.+..+..+...+...|+.|++.||.-+|..||+|||||.+|||+++-+- +.|+||..-+... .+
T Consensus 100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW---~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW---LYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech---hhhhcccccCCccCCCC
Confidence 99995 599999999988999999999999999999999999999999999999986544 8899998655321 11
Q ss_pred --Ccccccc----cCcccCchhhhcc------------cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014722 214 --EQFNEIV----GSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 274 (419)
Q Consensus 214 --~~~~~~~----gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 274 (419)
..+.-+. .-.+|.|||.+.. ..+++-||||+||+++||++ |.+||.-. ++-....+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccC
Confidence 1122222 2346999997631 14678999999999999988 89999311 111111110
Q ss_pred cccCCCCCcc-CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 275 IDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 275 ~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
-......... -+..++.||..|++.||++|.||++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000000 13468999999999999999999999985
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=194.41 Aligned_cols=193 Identities=26% Similarity=0.416 Sum_probs=142.6
Q ss_pred CCCCCeeeeeeEEEe---------------------------CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHH
Q 014722 114 PKHPNIVSLKDTYED---------------------------DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166 (419)
Q Consensus 114 ~~hpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi 166 (419)
..|||||++...|.+ +..+|+||--++ .+|..++..+ ..+....+.|+.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHH
Confidence 479999999887632 346899998886 4899988765 46788899999999
Q ss_pred HHHHHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeecccceeccC-------CCcccccccCcccCchhhhcc---c-
Q 014722 167 VEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRP-------GEQFNEIVGSPYYMAPEVLKR---N- 234 (419)
Q Consensus 167 ~~~l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~- 234 (419)
++|+.|||++||.|||+|.+|||+.-++ .-..+.|+|||.+..-+. ....-...|.-.-||||+... .
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999997543 335678999997653221 111123457778999999762 2
Q ss_pred ---CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014722 235 ---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310 (419)
Q Consensus 235 ---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~ 310 (419)
.-.++|.|+.|.+.||+++...||++..+......-.+.. ........+++.+++++..+|+.||++|+|+.-+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--hCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 1237999999999999999999998743322111111111 0111223578999999999999999999986543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=180.72 Aligned_cols=189 Identities=21% Similarity=0.303 Sum_probs=141.5
Q ss_pred eeccccccccceEEEEEEEcCCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
.+...|++|+||+||.+.. .+..++.+.+.....- .......+.+|+++|++|.+|++|++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3456899999999998774 7788887776543321 111123578999999999667889999886 34689999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCC-CCCcEEeecCCCCCCeEEeecccceeccCCCcc
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDL-KPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl-kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 216 (419)
|+.|.+|...+.. ....++.|++.+|.++|++||+|||| ||+|||++.+ +.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~---g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED---GSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC---CCEEEEECCCceecCCcchH
Confidence 9999888654321 12457889999999999999999999 7999999643 45999999999865433311
Q ss_pred --------------cccccCcccCchhhhc--ccCC-CcccHHHHHHHHHHHHhCCCCCCCCCH
Q 014722 217 --------------NEIVGSPYYMAPEVLK--RNYG-PEVDVWSAGVILYILLCGVPPFWAETE 263 (419)
Q Consensus 217 --------------~~~~gt~~y~aPE~~~--~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~ 263 (419)
.....++.|++|+.-. ...+ ...+.++.|.-+|.++|+..|+++.++
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0123578899998533 2334 567888999999999999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=181.77 Aligned_cols=143 Identities=18% Similarity=0.187 Sum_probs=112.7
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCC---------------------hh--hHHHHHHHHHHHHhCCCCC
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---------------------AV--DIEDVRREVQIMKHLPKHP 117 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------------------~~--~~~~~~~Ei~~l~~l~~hp 117 (419)
.+.||+|++|.||+|.+. +|+.||+|++....... .. .......|...+.++ .|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 468999999999999986 89999999997652110 00 012345789999999 889
Q ss_pred CeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCC
Q 014722 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 118 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~ 196 (419)
+|.....+.... .++||||++|+++.........+++..+..++.|++.+|.++|+ .||+||||||+||+++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~----~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH----D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE----C
Confidence 875544443332 48999999988665544455678899999999999999999999 9999999999999996 2
Q ss_pred CCeEEeecccceecc
Q 014722 197 SPLKAIDFGLSVFFR 211 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~ 211 (419)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 459999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=176.66 Aligned_cols=138 Identities=18% Similarity=0.232 Sum_probs=109.0
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC----CCCCeeeeeeEEEeCC---eEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----KHPNIVSLKDTYEDDS---AVH 133 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hpnIv~l~~~~~~~~---~~~ 133 (419)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+. +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6777666 6998865432 23467899999999993 4799999999999874 434
Q ss_pred -EEEEe--cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeecccc
Q 014722 134 -IVMEL--CEGGELFDRIVARGHYTERAAAAVMKTIVEVV-QVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLS 207 (419)
Q Consensus 134 -lv~e~--~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~a 207 (419)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ .|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5579999999664 56666 46688888877 999999999999999999998644 3347999994433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=203.41 Aligned_cols=193 Identities=24% Similarity=0.392 Sum_probs=158.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---CCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---HPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---hpnIv~l~~~~~~~~~~ 132 (419)
..|.|.+.||.|+||.||+|.+.+ |+.||+|+-+....- ++.--.+++.+| + -+-|.++...+...+.-
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERL-KPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhh-chhhhcchHHHHHHHccCCcc
Confidence 468999999999999999999766 999999986543321 112223444444 2 24567777777777888
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC----CCCCCeEEeecccce
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK----KESSPLKAIDFGLSV 208 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~----~~~~~~kl~Dfg~a~ 208 (419)
++|+||.+.|+|.+++...+.+++..+..++.|++..|+.||..+||||||||+|+|+... ....-++|+|||.+.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999999999999999988889999999999999999999999999999999999999642 224459999999887
Q ss_pred ec---cCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCC
Q 014722 209 FF---RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVP 256 (419)
Q Consensus 209 ~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~ 256 (419)
.+ .++..+....+|-.+-.+|+..| .|++..|.|.++.++|-||+|+.
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 54 34556778889999999999885 79999999999999999999964
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=173.41 Aligned_cols=242 Identities=17% Similarity=0.246 Sum_probs=185.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+..++-+|.+.-.|+.|+|+ ..|..+++|++........ .-.++..|.-.|+-+ .||||+.+++.+.....+.++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~r-isrdfneefp~lrif-shpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTAR-ISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchh-hcchhhhhCcceeee-cCCchhhhhhhccCCCCceEee
Confidence 34566678899999999998 4567788888876654332 235688888899888 8999999999999999999999
Q ss_pred EecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 137 ELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
.|++.|+|+..+.+... .+..++.+++.+++.|++|||+.. |.---|....++++.+- ...+-.+|--++..-
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfqe-- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQE-- 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeeec--
Confidence 99999999999987654 577899999999999999999974 44446888889996432 223444454333221
Q ss_pred CCcccccccCcccCchhhhccc----CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
....-.|.||+||.+++. .-.++|+|||++++|||.|...||......+.--++--..+. ....+.++..
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~h 417 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRH 417 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHH
Confidence 122336789999998742 234799999999999999999999887766554444333222 2233578999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHh
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVL 311 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l 311 (419)
+..|+.-|+..||.+||.+..++
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999987763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=173.38 Aligned_cols=146 Identities=18% Similarity=0.139 Sum_probs=114.0
Q ss_pred ceeeccccccccceEEEEEE-EcCCCcEEEEEEecccccCC-------------------hh--hHHHHHHHHHHHHhCC
Q 014722 57 DYDLGRELGRGEFGVTYLCT-DVNNGEKFACKSISKKKLRT-------------------AV--DIEDVRREVQIMKHLP 114 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~~aiK~~~~~~~~~-------------------~~--~~~~~~~Ei~~l~~l~ 114 (419)
-|.+.+.||+|+||.||+|. +..+|+.||+|++....... .. ....+.+|+.+++++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 48899999999999999999 77899999999997543210 00 112456899999999
Q ss_pred CCC--CeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CEeeCCCCCcEEee
Q 014722 115 KHP--NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFA 191 (419)
Q Consensus 115 ~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-ivHrDlkp~NIl~~ 191 (419)
.+. .++++++ .. ..++||||++|++|.........+....+..++.|++.+|.+||+.| |+||||||+||+++
T Consensus 108 ~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 542 3344443 22 35899999999888766545556777778899999999999999999 99999999999997
Q ss_pred cCCCCCCeEEeecccceecc
Q 014722 192 NKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 192 ~~~~~~~~kl~Dfg~a~~~~ 211 (419)
...++|+|||.+....
T Consensus 184 ----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 ----DGKVVIIDVSQSVELD 199 (237)
T ss_pred ----CCCEEEEEChhhhccC
Confidence 2359999999887543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=183.48 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=163.7
Q ss_pred eeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeee------eEEE-
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK------DTYE- 127 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~------~~~~- 127 (419)
+.+.+..+..+++.+........ .+.++-+..... .........+++-.+.....|+..+..- ..+.
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 45555566666666665543222 233333333222 2122334445555555553455433221 1111
Q ss_pred ----eCCeEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 128 ----DDSAVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 128 ----~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
...++||.|++|...+|.+.+..+.. -+......++.|+..|+.| ++.+|||+||.||.+..+. .+|
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~---q~k 396 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD---QLK 396 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch---hhh
Confidence 13468999999999999999975443 5677889999999999999 9999999999999996544 599
Q ss_pred EeecccceeccCCC-------cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014722 201 AIDFGLSVFFRPGE-------QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271 (419)
Q Consensus 201 l~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 271 (419)
|.|||+........ .....+||++||+||.+. ++|+.++||||||+||+|++. =..+|. .......+.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r 473 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---RIATLTDIR 473 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhh
Confidence 99999988776544 445678999999999988 579999999999999999997 222221 112222333
Q ss_pred hcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.+.+. ...+.+ -++-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 474 ~g~ip--~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 474 DGIIP--PEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred cCCCC--hHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 33322 111122 2345689999999999999988887777764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-22 Score=201.96 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=208.2
Q ss_pred cceeeccccccccceEEEEEEEcC-CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ........+..|..+-+.+.+|+|++++++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 358888999999999999887643 34556667665443 2233445666788888888569999999999999999999
Q ss_pred EEEecCCcchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 135 VMELCEGGELFDRI-VARG-HYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 135 v~e~~~~g~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++|..|+++.+.+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+. .+++.|||+|..+.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhcccc
Confidence 99999999999988 5544 6788899999999999999999 999999999999999976542 59999999998776
Q ss_pred C-CC---ccccccc-CcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccccCCCCCc
Q 014722 212 P-GE---QFNEIVG-SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWP 283 (419)
Q Consensus 212 ~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 283 (419)
. .. ......| ++.|+|||...+ ...+..|+||+|+++.-+++|..|+......... .........+...+|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 5 21 2345678 999999998775 4577899999999999999999998554433211 1111111223456788
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.++....+++.++|..+|..|.+..++-.+||+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 89999999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-19 Score=159.48 Aligned_cols=137 Identities=29% Similarity=0.391 Sum_probs=113.5
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
+.||+|++|.||+|.. .|..+++|+......... .....+.+|+.++..+ .|++|+....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999985 778899998654332211 1234577899999999 8999887777777788899999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
||++|++|.+.+.... . ....++.+++.+|.++|+.|++|||++|.|||++ ...++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9999999998886543 2 8889999999999999999999999999999997 24499999998865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=174.40 Aligned_cols=198 Identities=21% Similarity=0.314 Sum_probs=153.1
Q ss_pred HhCCCCCCeeeeeeEEEeCCeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-EeeCCCCCcE
Q 014722 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGV-MHRDLKPENF 188 (419)
Q Consensus 111 ~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i-vHrDlkp~NI 188 (419)
+.+ .|.|+.++++.+.++...++|.+||.-|+|.+.+.. .-.++..-...+++.++.||.|||...| .|+.+++.|.
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457 899999999999999999999999999999999987 3357777888999999999999998866 9999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCC---CcccccccCcccCchhhhccc--------CCCcccHHHHHHHHHHHHhCCCC
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLKRN--------YGPEVDVWSAGVILYILLCGVPP 257 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwslG~il~~ll~g~~p 257 (419)
+++. ...+||+|||+....... .......-...|.|||.+... .+.+.||||+|++++|+++...|
T Consensus 81 lvd~---~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDS---RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeee---eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9964 455999999988765321 111112234569999998742 46789999999999999999999
Q ss_pred CCCCCH----HHHHHHHHhcccccCCCCCc---cCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 258 FWAETE----QGVAQAIIRSVIDFKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 258 f~~~~~----~~~~~~i~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
|..... .++...+........++... ..++++..++..||..+|..||++.++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 965322 23444444412222222111 35567999999999999999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.3e-19 Score=155.29 Aligned_cols=134 Identities=26% Similarity=0.355 Sum_probs=106.4
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
.||+|+||.||+|. .+|..+++|......... ......+.+|++++..+ .|+++....-++......++|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 48999999999998 567899999865433221 11235677899999999 77766555555556667789999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ .+.++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 9999999887754321 8899999999999999999999999999997 345999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.7e-19 Score=176.49 Aligned_cols=141 Identities=23% Similarity=0.301 Sum_probs=111.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-----ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
..|...+.||+|+||.||+|... +..+++|+....... .....+.+.+|+++++.+ +|++|+....++.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCC
Confidence 34567889999999999999853 444555543222111 112245688999999999 8999988877777777
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..++||||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||++ +..++|+|||+++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~----~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR----DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence 8899999999999988775 4578999999999999999999999999999993 234999999999764
Q ss_pred c
Q 014722 211 R 211 (419)
Q Consensus 211 ~ 211 (419)
.
T Consensus 478 ~ 478 (535)
T PRK09605 478 D 478 (535)
T ss_pred C
Confidence 3
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=154.66 Aligned_cols=139 Identities=24% Similarity=0.294 Sum_probs=106.5
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-------------------hhhHHHHHHHHHHHHhCCCCCC
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-------------------AVDIEDVRREVQIMKHLPKHPN 118 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------------------~~~~~~~~~Ei~~l~~l~~hpn 118 (419)
|.+.+.||+|+||.||+|.. .+|+.||||++....... .........|+.++..+ .|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 88889999999999999986 489999999876432100 00112366789999988 6764
Q ss_pred --eeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 119 --IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 119 --Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
++..++ ....++||||++|++|..... ......++.+++.++.++|+.||+||||+|+||+++. +
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~---~ 161 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD---D 161 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC---C
Confidence 444443 345689999999998865432 1346788899999999999999999999999999964 4
Q ss_pred CCeEEeecccceecc
Q 014722 197 SPLKAIDFGLSVFFR 211 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~ 211 (419)
..++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 459999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=149.33 Aligned_cols=140 Identities=21% Similarity=0.244 Sum_probs=98.4
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHH---------------------HHHHHHHHHHhCCCCC--
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE---------------------DVRREVQIMKHLPKHP-- 117 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~---------------------~~~~Ei~~l~~l~~hp-- 117 (419)
.+.||+|+||.||+|.+. +|+.||+|++............ ....|...+.++ .+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence 467999999999999976 8999999998754321111111 113566666666 333
Q ss_pred CeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCC
Q 014722 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 118 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~ 196 (419)
.+++.+++ ...++||||++|+++........... ..+..++.+++.++.++|. .||+||||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~----~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD----D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----C
Confidence 24444433 24589999999854432211111111 6788999999999999999 9999999999999997 3
Q ss_pred CCeEEeecccceecc
Q 014722 197 SPLKAIDFGLSVFFR 211 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~ 211 (419)
..++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 459999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.7e-17 Score=143.85 Aligned_cols=138 Identities=20% Similarity=0.290 Sum_probs=103.3
Q ss_pred cccc-cccceEEEEEEEcCCCcEEEEEEeccccc----------CChhhHHHHHHHHHHHHhCCCCCCe--eeeeeEEEe
Q 014722 62 RELG-RGEFGVTYLCTDVNNGEKFACKSISKKKL----------RTAVDIEDVRREVQIMKHLPKHPNI--VSLKDTYED 128 (419)
Q Consensus 62 ~~lg-~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~~hpnI--v~l~~~~~~ 128 (419)
..|| .|+.|+||.+.. .+..+++|.+..... .+......+.+|+.++.+| .|++| +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 888899998874 478899998854221 0112345678899999999 78774 677766433
Q ss_pred C-Ce---EEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 129 D-SA---VHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 129 ~-~~---~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
. .. .++|||+++| .+|.+++.. ..+++.. +.|++.+|.+||++||+||||||.|||++.++ .++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~---~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG---KFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC---CEEEEE
Confidence 2 22 3599999997 688877654 4566543 57899999999999999999999999997543 599999
Q ss_pred cccceec
Q 014722 204 FGLSVFF 210 (419)
Q Consensus 204 fg~a~~~ 210 (419)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=159.07 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=199.1
Q ss_pred cccceeecccccc--ccceEEEEEEE--cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 54 ISIDYDLGRELGR--GEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. .........=.+|+...+.+..|+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccC
Confidence 4456778889999 99999999998 788999999973321 122222233456788888887899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 130 SAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVE----VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~----~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
+..|+-+|+|. .+|.++...... +++..++.++.+..+ ||.++|+.+++|-|+||.||+...+. ...+++||
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTDF 267 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCCc
Confidence 99999999995 788888876554 889999999999999 99999999999999999999997542 45899999
Q ss_pred ccceeccCCCccc------ccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 205 GLSVFFRPGEQFN------EIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 205 g~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
|+...+.++.... ...|...|++||.+++-++...|++|+|.+..+..+|..++....... ...+.+.. .+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~--ip 344 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGY--IP 344 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccccccc--Cc
Confidence 9988776554221 225777899999999999999999999999998888765553321110 11111111 12
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+.....+..+...+..|++.+|-.|+++..+++|+++..
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2222345666777999999999999999999999998874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=132.27 Aligned_cols=133 Identities=23% Similarity=0.298 Sum_probs=109.8
Q ss_pred eccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CCeeeeeeEEEeCCeEEEEEEe
Q 014722 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~lv~e~ 138 (419)
+++.||.|.++.||++... +..+++|....... ...+.+|+.+++.+.++ +++++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 3567999999999999963 37899998864421 35788899999999433 6899999988888899999999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 139 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+.|+.+... +......++.+++.+|.++|.. +++|||++|+||+++. ...++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~---~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD---GKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC---CcEEEEEecccccC
Confidence 998877543 5667788899999999999985 7999999999999975 34599999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8e-18 Score=168.99 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=206.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
+.+.+.+-+-+|+++.++.+.-..+|...++|+..........+.+.++.+-.++-.. .+|-++...--+......++|
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchh
Confidence 4577888999999999999997788888888776554332222334444444444333 567777665556667789999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc----
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR---- 211 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~---- 211 (419)
++|+.|++|...+...+..+++.++..+..+..+++|||...+.|||++|.|++.. .++..++.|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccccccccC
Confidence 99999999999999888889999999999999999999999999999999999995 44558999998322110
Q ss_pred -----------------CC-----------CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 014722 212 -----------------PG-----------EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 262 (419)
Q Consensus 212 -----------------~~-----------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 262 (419)
.. .......||+.|.+||.+. ......+|+|++|+++++.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 00 0012356899999999876 467889999999999999999999999999
Q ss_pred HHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHH---HHhcCCccccCccC
Q 014722 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAE---EVLEHPWLQNAKKA 322 (419)
Q Consensus 263 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~---~~l~~~~~~~~~~~ 322 (419)
.+.+.+.+......++..+ ...+.++.+++.++|..+|.+|..+. ++-.|+||+.....
T Consensus 1040 pq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred hhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence 9999888888776655443 24688999999999999999999888 88999999875543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=6e-14 Score=120.06 Aligned_cols=143 Identities=14% Similarity=0.126 Sum_probs=103.6
Q ss_pred ccccccccceEEEEEEEcC------CCcEEEEEEeccccc--CC-----------------hhhHHHHH----HHHHHHH
Q 014722 61 GRELGRGEFGVTYLCTDVN------NGEKFACKSISKKKL--RT-----------------AVDIEDVR----REVQIMK 111 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~--~~-----------------~~~~~~~~----~Ei~~l~ 111 (419)
...||.|--+.||.|.... .+..+|+|+++.... .. ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 358999999863211 00 11122333 8999999
Q ss_pred hCCCC-CCeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCEeeCCCCCcEE
Q 014722 112 HLPKH-PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-HEQGVMHRDLKPENFL 189 (419)
Q Consensus 112 ~l~~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~ivHrDlkp~NIl 189 (419)
++... -++++++++ ...+|||||+.+..+.....+...+++.++..+..+++.+|..| |+.||+||||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98332 467777754 45679999997654433233334566677888899999999998 8999999999999999
Q ss_pred eecCCCCCCeEEeecccceecc
Q 014722 190 FANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+.. +.+.|+|||.+....
T Consensus 158 ~~~----~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD----GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEC----CcEEEEECCCceeCC
Confidence 963 348999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-14 Score=139.74 Aligned_cols=147 Identities=21% Similarity=0.321 Sum_probs=94.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--------------------------C-h----hhHHH---
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--------------------------T-A----VDIED--- 102 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------~-~----~~~~~--- 102 (419)
+|+. +.||+|++|.||+|+...+|+.||||+....-.. . . ...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 6899999999999998878999999999754100 0 0 01122
Q ss_pred ---HHHHHHHHHhCC---CCCCeeeeeeEEE-eCCeEEEEEEecCCcchHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 014722 103 ---VRREVQIMKHLP---KHPNIVSLKDTYE-DDSAVHIVMELCEGGELFDR--IVARG----HYTERAAAAVMKTIVEV 169 (419)
Q Consensus 103 ---~~~Ei~~l~~l~---~hpnIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~--l~~~~----~~~~~~~~~i~~qi~~~ 169 (419)
+.+|...+.++. .+.+.+.+=.+|. .....+|||||+.|+.+.+. +...+ .+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 233443333331 1222233223332 23456799999999999764 33333 234444555555554
Q ss_pred HHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeecccceecc
Q 014722 170 VQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 170 l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~a~~~~ 211 (419)
..|++|+|++|.||+++.++ ..+.++++|||++..++
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 58999999999999997643 22469999999987664
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1e-14 Score=129.38 Aligned_cols=236 Identities=17% Similarity=0.222 Sum_probs=153.6
Q ss_pred EEEEEEcCCCcEEEEEEecccccCChhh-HHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-----eEEEEEEecCCcchH
Q 014722 72 TYLCTDVNNGEKFACKSISKKKLRTAVD-IEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-----AVHIVMELCEGGELF 145 (419)
Q Consensus 72 V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-----~~~lv~e~~~~g~L~ 145 (419)
||++-+...|..|+.-.+......+... .+....-...|-++ .|.|||+++.|+.+.. ...+++||+..|++.
T Consensus 82 v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 82 VYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 5555555666666543332211111111 11222223344455 6999999999986544 478899999999999
Q ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccceecc---CCC--
Q 014722 146 DRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR---PGE-- 214 (419)
Q Consensus 146 ~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~---~~~-- 214 (419)
++|++- ..+......+++.||+.||.|||+.. |+|+++..+.|++. .++.+|+.--....... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEecccCccccchhhhhhhHh
Confidence 998763 34788889999999999999999984 99999999999996 34446653221111100 000
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
......|-++|.|||.=. .+.+-++|||++|....+|..|..- -.+......-..+.+-.+... ...-+++
T Consensus 238 Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~ 310 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGS 310 (458)
T ss_pred hhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCc
Confidence 111234567899999643 4566789999999999999887653 222222222222322222211 2234578
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+.+||+..|..||++.+++-||.+-+
T Consensus 311 i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 311 ITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred CcccccCCCCCCcchhhhhcCceeee
Confidence 99999999999999999999997654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.3e-14 Score=135.73 Aligned_cols=141 Identities=20% Similarity=0.276 Sum_probs=94.9
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCC--------------------------hhh-----------HHHHH
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--------------------------AVD-----------IEDVR 104 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------~~~-----------~~~~~ 104 (419)
+.||+|++|.||+|+. .+|+.||||+....-... ... .-++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4699999999999985 579999999985431000 000 00234
Q ss_pred HHHHHHHhC----CCCCCe--eeeeeEEEeCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHc
Q 014722 105 REVQIMKHL----PKHPNI--VSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVE-VVQVCHEQ 176 (419)
Q Consensus 105 ~Ei~~l~~l----~~hpnI--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~-~l~~LH~~ 176 (419)
+|...+.++ .++|++ ++++. ......++||||++|++|.+..... ... ....++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 455555554 234443 23332 2334578999999999998866432 122 23445666655 47889999
Q ss_pred CCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 177 ~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|++|+|++|.||++..+ +.++++|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~---g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKD---GKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCC---CcEEEEeCCCeeECC
Confidence 99999999999999643 459999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.9e-15 Score=139.95 Aligned_cols=252 Identities=23% Similarity=0.236 Sum_probs=186.6
Q ss_pred cccceeeccccccccceEEEEEEEc-CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...+|..+..||.|.|+.|+.+... .++..|++|...........++. -..|+.+...+..|.+++.+...|......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4457889999999999999987744 57889999988766544443333 345777777777899999999888888888
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+--|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++ ...++.|||....+.-
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAF 419 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccce
Confidence 89999999998877665445688889999999999999999999999999999999997653 5579999998764211
Q ss_pred CCcccccccCcccC-chhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 213 GEQFNEIVGSPYYM-APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 213 ~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
......++-+++ .+|++.. .+..+.|++|||.-+.+.++|.+--+.... ...+..+.. +..+..+.++
T Consensus 420 --~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~~~----p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 --SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSGDT----PNLPGLKLQL 490 (524)
T ss_pred --ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecccc----cCCCchHHhh
Confidence 111222334455 3666553 467799999999999999998653222111 112222211 1223344678
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
..+.+.++..++..||++.++..|+-|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 8899999999999999999998887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-13 Score=116.22 Aligned_cols=129 Identities=19% Similarity=0.198 Sum_probs=94.4
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecC
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
++.|+.|.++.||++.. .+..|++|+...... .......|+.+++.+.+...+++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 35688999999999985 478899998754321 12345778999998833333455555433 34579999999
Q ss_pred CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----EeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 141 GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGV-----MHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 141 ~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-----vHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
|.++... ......++.+++.+|+.||+.++ +|||++|.||+++ + ..++++|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~---~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D---GRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C---CeEEEEecccccC
Confidence 9887543 11224567899999999999985 9999999999997 2 2489999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.4e-12 Score=107.25 Aligned_cols=147 Identities=20% Similarity=0.265 Sum_probs=112.1
Q ss_pred eccccccccceEEEEEEEcCCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+..|-+|+-+.|+++. ..|+.++||.-..+.+.-+ -......+|+++|.++ .--.|.-..=++.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 45678899999999988 6789988887554444332 2345667899999987 43344444444666777789
Q ss_pred EEEecCC-cchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 135 VMELCEG-GELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 135 v~e~~~~-g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+|||++| .++.+++.... ....+....+++++-+.+.-||.++|+||||..+||++.+++....+.++|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999987 47778877642 233344478999999999999999999999999999999888887789999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.3e-12 Score=126.90 Aligned_cols=183 Identities=19% Similarity=0.216 Sum_probs=135.2
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|.+ ....-++.+.+-.|..+.++.+|.+..++...- .....+.+-++-|+.+ +||||+++++.++..+..|||+|
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEee
Confidence 555 444444444332466678899999998876542 2345677889999999 99999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc-
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ- 215 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 215 (419)
-+. .|..++.+.+ .......+.||+.||.||| +.+++|++|..+.|+++..+ ..||++|.++........
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G---eWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG---EWKLGGLELVSKASGFNAP 161 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC---cEEEeeeEEEeccccCCcc
Confidence 985 6767776643 7788889999999999998 56899999999999996554 499999988754432211
Q ss_pred ccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhC
Q 014722 216 FNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCG 254 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g 254 (419)
.....--..|..|+.+... .-..|.|-||+++++++.|
T Consensus 162 ~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 AKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 1111112236666654321 1346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.6e-12 Score=105.35 Aligned_cols=135 Identities=25% Similarity=0.336 Sum_probs=99.9
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChh-----hHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
..+++|+-+.+|.+. .-|..+++|.-..+.+..+. ..+.-.+|.+++..+ .--.|.-.+=+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence 357899999999985 34666777775555444332 233556799999887 4444444443445667778999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
||.+|..|.+.+... ...++..+=.-+.-||..||+|+||+++||++...+ +.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCccccc
Confidence 999998888888665 256777777788889999999999999999996432 899999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.5e-11 Score=106.93 Aligned_cols=143 Identities=24% Similarity=0.392 Sum_probs=105.1
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCCeeeeeeEEEeC---CeEEEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDD---SAVHIVME 137 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~---~~~~lv~e 137 (419)
+.|+.|..+.||++... +|+.+++|+....... .....+..|..+++.+.. +.++++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 46899999999999863 3689999997654321 123567889999999933 23467777766553 36789999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE------------------------------------------ 175 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~------------------------------------------ 175 (419)
|++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 356777777888888888888873
Q ss_pred --------------cCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 176 --------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 176 --------------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..++|+|+.|.||+++.+ ....+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 235899999999999753 123478999997764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=9.4e-10 Score=104.06 Aligned_cols=212 Identities=17% Similarity=0.254 Sum_probs=154.5
Q ss_pred cceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE----eCCeEEEEEEecCC-c
Q 014722 68 EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDSAVHIVMELCEG-G 142 (419)
Q Consensus 68 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~----~~~~~~lv~e~~~~-g 142 (419)
--.+.|++....+|..|++|++.-...... .....-+++++++ .|+|+|++.++|. .+..+++|++|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 446889999999999999999943322211 1223457888999 8999999999986 34568999999985 5
Q ss_pred chHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 143 ELFDRIVA---------------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 143 ~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
+|.++... ....+|..++.++.|+..||.++|+.|+.-+-|.|.+||++.+ .+++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~---~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK---MRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc---ceEEEecccce
Confidence 77775432 2246789999999999999999999999999999999999643 35899888876
Q ss_pred eeccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCC-CCCHHHH-HHHHHhcccccCCCCCccC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFW-AETEQGV-AQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~-~~~i~~~~~~~~~~~~~~~ 285 (419)
..+..+. .+| +. --.+-|.=-||.+++.|.||..--+ ....++. +..|. +..
T Consensus 441 Dvl~~d~-----------~~~--le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y 494 (655)
T KOG3741|consen 441 DVLQEDP-----------TEP--LE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY 494 (655)
T ss_pred eeecCCC-----------Ccc--hh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence 6554333 011 11 0224688899999999999965422 2222222 22221 356
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.+++++|.-+...+++. -++.+++.|
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 889999999999998887 688888776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.6e-10 Score=96.54 Aligned_cols=129 Identities=24% Similarity=0.279 Sum_probs=83.3
Q ss_pred EEEEEEEcCCCcEEEEEEecccccC-----------------------ChhhHHHHHHHHHHHHhCCCCC--CeeeeeeE
Q 014722 71 VTYLCTDVNNGEKFACKSISKKKLR-----------------------TAVDIEDVRREVQIMKHLPKHP--NIVSLKDT 125 (419)
Q Consensus 71 ~V~~~~~~~~~~~~aiK~~~~~~~~-----------------------~~~~~~~~~~Ei~~l~~l~~hp--nIv~l~~~ 125 (419)
.||.|.. .+|..+|+|+....... .........+|.+.|.++ ..- ++++++++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l-~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRL-YEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHC-CCTT-SS--EEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHH-HHCCccCCcEEEE
Confidence 3899885 56889999998542110 011234567899999999 443 57777755
Q ss_pred EEeCCeEEEEEEecC--CcchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 126 YEDDSAVHIVMELCE--GGELFDRIVARGHYTERAAAAVMKTIVEVVQV-CHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
. ..+|||||++ |..+.. +... .++......++.+++..+.. +|..||+||||.+.|||++.+ .+.++
T Consensus 79 ~----~~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE-
T ss_pred e----CCEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEE
Confidence 3 2369999998 655544 3332 22355667788888885555 689999999999999999754 49999
Q ss_pred ecccceecc
Q 014722 203 DFGLSVFFR 211 (419)
Q Consensus 203 Dfg~a~~~~ 211 (419)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=8e-10 Score=100.09 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=92.9
Q ss_pred EEEEEEcCCCcEEEEEEecccccC----C----hhhHHHHHHHHHHHHhCCCCCC--eeeeeeEEEe-----CCeEEEEE
Q 014722 72 TYLCTDVNNGEKFACKSISKKKLR----T----AVDIEDVRREVQIMKHLPKHPN--IVSLKDTYED-----DSAVHIVM 136 (419)
Q Consensus 72 V~~~~~~~~~~~~aiK~~~~~~~~----~----~~~~~~~~~Ei~~l~~l~~hpn--Iv~l~~~~~~-----~~~~~lv~ 136 (419)
|+++. ..|+.|.||........ . ......+.+|...+.+| ..-+ .+.++.+.+. ....++||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 55544 35678888866332200 0 00112466788888776 3223 2334444443 23578999
Q ss_pred EecCCc-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC----CCCCCeEEeeccccee
Q 014722 137 ELCEGG-ELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK----KESSPLKAIDFGLSVF 209 (419)
Q Consensus 137 e~~~~g-~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~----~~~~~~kl~Dfg~a~~ 209 (419)
|++++. +|.+++.. ....+......++.+++..+.-||+.||+|||++|.|||++.+ ++...+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999875 78888753 3456677888999999999999999999999999999999752 2345699999997753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4e-11 Score=117.01 Aligned_cols=152 Identities=20% Similarity=0.318 Sum_probs=109.5
Q ss_pred HHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccc----------ccccCcccCchhhhcc
Q 014722 165 TIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN----------EIVGSPYYMAPEVLKR 233 (419)
Q Consensus 165 qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPE~~~~ 233 (419)
+++.|+.|+|.. ++||++|.|++|.++.. +.+||+.|+++....++..+. ...-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~---~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN---GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC---cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344999999975 89999999999999654 449999999887655422211 1123557999999875
Q ss_pred -cCCCcccHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHhcccccC-CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014722 234 -NYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFK-RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310 (419)
Q Consensus 234 -~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~ 310 (419)
..+.++|++|+|+++|.+. .|+.-+.......... ......+.. ...-.++++++++=+.++|..++.-||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 5678999999999999998 5666554443221111 111111111 11114789999999999999999999999999
Q ss_pred hcCCccccCc
Q 014722 311 LEHPWLQNAK 320 (419)
Q Consensus 311 l~~~~~~~~~ 320 (419)
+..|||....
T Consensus 263 ~~~~ff~D~~ 272 (700)
T KOG2137|consen 263 LSIPFFSDPG 272 (700)
T ss_pred hcccccCCch
Confidence 9999998743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1e-08 Score=94.93 Aligned_cols=238 Identities=17% Similarity=0.188 Sum_probs=154.4
Q ss_pred eccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE------EEeCC-eE
Q 014722 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT------YEDDS-AV 132 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~------~~~~~-~~ 132 (419)
....||+|+-+.+|-.-. -...+.|++..-.. ....+ -+..|.....||-+-.=+.+ ..+.+ ..
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Ppp---a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPP---AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCc---hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 356799999999996442 23345688764432 11111 23344455567644331111 11222 26
Q ss_pred EEEEEecCCcc-hHHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 133 HIVMELCEGGE-LFDRIV---AR---GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 133 ~lv~e~~~~g~-L~~~l~---~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
-+.|..++|.. +..++. ++ ....+.-+...++.++.+.+.||..|.+-||+.++|+|+.... .|.|+|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~---~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS---KVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc---eEEEEccc
Confidence 67888887642 222221 11 2367788999999999999999999999999999999996544 48888866
Q ss_pred cceeccCCCcccccccCcccCchhhhc-c-----cCCCcccHHHHHHHHHHHHhC-CCCCCCCCHH----HHHH-HHHhc
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-R-----NYGPEVDVWSAGVILYILLCG-VPPFWAETEQ----GVAQ-AIIRS 273 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~----~~~~-~i~~~ 273 (419)
.-.....+..+...+|.+.|.+||... + .-+...|.|.||+++++++.| +.||.+.... .-.+ .|-.+
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 444434455566778999999999765 2 346689999999999999886 9999654211 0111 22222
Q ss_pred cc------------ccCCCCCccCCHHHHHHHHHhcCC--CCCCCCCHHH
Q 014722 274 VI------------DFKRDPWPKVSENAKDLVKKMLNP--DPKQRLTAEE 309 (419)
Q Consensus 274 ~~------------~~~~~~~~~~~~~~~~li~~~L~~--dp~~R~s~~~ 309 (419)
.+ .....+|.-+++.+..|..+|+.. ++.-|||++.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11 112234566899999999999975 3668998753
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.2e-10 Score=89.90 Aligned_cols=74 Identities=23% Similarity=0.312 Sum_probs=64.8
Q ss_pred hhhHhhhhhhh-hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 346 KRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 346 ~~~l~~~~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|.... ..+..++++.+|+.||.|++|+|+..+|+.+|+.+|..++++|++.|++.+|.| |.|+|++|+
T Consensus 75 ~~Fl~~ms~~~~~~~~~Eel~~aF~~fD~d~dG~Is~~eL~~vl~~lge~~~deev~~ll~~~d~d~dG~i~~~eF~ 151 (160)
T COG5126 75 PEFLTVMSVKLKRGDKEEELREAFKLFDKDHDGYISIGELRRVLKSLGERLSDEEVEKLLKEYDEDGDGEIDYEEFK 151 (160)
T ss_pred HHHHHHHHHHhccCCcHHHHHHHHHHhCCCCCceecHHHHHHHHHhhcccCCHHHHHHHHHhcCCCCCceEeHHHHH
Confidence 44556666665 445578999999999999999999999999999999999999999999999975 899999984
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.3e-09 Score=91.13 Aligned_cols=110 Identities=17% Similarity=0.241 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHhCCC-CCCeeeeeeEEEeC----CeEEEEEEecCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014722 101 EDVRREVQIMKHLPK-HPNIVSLKDTYEDD----SAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174 (419)
Q Consensus 101 ~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH 174 (419)
....+|...+..|.. .=.+++.+.+.+.. ...++|+|++++. +|.+++......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 456677777766621 12345555555442 2458999999874 78888877555778888999999999999999
Q ss_pred HcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 175 ~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
++||+|+|++|.|||++.++....+.++||+.+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999987765567999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1e-08 Score=90.14 Aligned_cols=138 Identities=23% Similarity=0.327 Sum_probs=100.4
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEeccccc-----------------CC--hhhHHHHHHHHHHHHhCCCC-C
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----------------RT--AVDIEDVRREVQIMKHLPKH-P 117 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----------------~~--~~~~~~~~~Ei~~l~~l~~h-p 117 (419)
+.++..||-|--|.||.|.+. .|.++|+|.=..... .+ ........+|.++|.+|..+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 556788999999999999964 799999997432110 00 11344677899999999333 2
Q ss_pred CeeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 118 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
.+++.+++ +...+||||.+|-.|... +++.+....++..|+.-+.-+-..||||+|+++-||+++.++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 57777643 556799999999777542 2245566667777777776666899999999999999976544
Q ss_pred CeEEeecccce
Q 014722 198 PLKAIDFGLSV 208 (419)
Q Consensus 198 ~~kl~Dfg~a~ 208 (419)
+.++||=.+.
T Consensus 241 -~~vIDwPQ~v 250 (304)
T COG0478 241 -IVVIDWPQAV 250 (304)
T ss_pred -EEEEeCcccc
Confidence 9999996554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-10 Score=113.11 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=172.9
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC-eeeeeeEEEeCC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSLKDTYEDDS 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn-Iv~l~~~~~~~~ 130 (419)
.+-..-|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.++ +||| .+..++-++.+.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLEDYDGED 307 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccccCCccc
Confidence 334445777778999999999999876665554 6666432 3455689999999 9999 777788888888
Q ss_pred eEEEEEEecCCc-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 131 AVHIVMELCEGG-ELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 131 ~~~lv~e~~~~g-~L~~~l-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
..+++++++.++ +..... ...-.+.+-+...+.+.-+.+++++|+.-=+||| ||+..+ ...+..||+...
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~----~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE----EEVKLLDFAVPP 379 (829)
T ss_pred ccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc----cccccccccCCc
Confidence 999999999887 221111 1111244455667777888899999998778999 888754 337999999888
Q ss_pred eccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--ccc-CCCCCcc
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--IDF-KRDPWPK 284 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~~-~~~~~~~ 284 (419)
.+......++..+|+.++|||+.. +.+....|+||+|+-..++--|.+|-..... ....+-.+. ... ....|..
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~p~s~~L~~~~aw~~ 457 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNGPNSPMLTDKSAWSP 457 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCCCCccccchhhhcCc
Confidence 776655567788999999999766 5788999999999877777777776533110 000000000 000 0011211
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
. .-.++...|+...|..|+....++.|.+|.....
T Consensus 458 ~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 458 V--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred c--cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 1 1125778899999999999999999999987543
|
|
| >cd05022 S-100A13 S-100A13: S-100A13 domain found in proteins similar to S100A13 | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.9e-09 Score=78.72 Aligned_cols=59 Identities=14% Similarity=0.145 Sum_probs=54.8
Q ss_pred HhhHHHHHhhhCC-CCCCcccHHHHHHHHHh-CCCCCCH-HHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDT-NKRGKINLEELRLGLLK-GGQNIPE-ADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~-~~~g~i~~~el~~~l~~-lg~~~~~-~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++|+.||. +++|+|+..||+.+|+. +|..++. +++++||+.+|.| |.|+|+||+
T Consensus 7 i~~l~~~F~~fd~~~~~g~i~~~ELk~ll~~elg~~ls~~~~v~~mi~~~D~d~DG~I~F~EF~ 70 (89)
T cd05022 7 IETLVSNFHKASVKGGKESLTASEFQELLTQQLPHLLKDVEGLEEKMKNLDVNQDSKLSFEEFW 70 (89)
T ss_pred HHHHHHHHHHHhCCCCCCeECHHHHHHHHHHHhhhhccCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 4578999999999 99999999999999999 9998998 9999999999987 799999994
|
S100A13 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A13 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100A13 is involved in the cellular export of interleukin-1 (IL-1) and of fibroblast growth factor-1 (FGF-1), which plays an important role in angiogenesis and tissue regeneration. Export is based on the CuII-dependent formation of multiprotein complexes containing the S100A13 protein. Assembly of these complexes occurs near the inner surface of the plasma membrane. Binding of two Ca(II) ions per monomer triggers key conformational changes leading to the creation of two identical and symmetrical Cu(II)-binding sites on the surface of the protein, close to the interface between the two monomers. These Cu |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.1e-08 Score=82.59 Aligned_cols=139 Identities=16% Similarity=0.182 Sum_probs=98.9
Q ss_pred ccccceEEEEEEEcCCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHhCCCCC--CeeeeeeEEE-e----CCeEEE
Q 014722 65 GRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHP--NIVSLKDTYE-D----DSAVHI 134 (419)
Q Consensus 65 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hp--nIv~l~~~~~-~----~~~~~l 134 (419)
|.||-|-|+.... .|..+-+|.-......+ +.....+.+|+..+.+| ..- .++++. ++. . .-.-+|
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L-~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKEL-ERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHH-HHcCCCCCccc-eeeeeccCCceEEEE
Confidence 5688888998663 34467788765222111 33457889999988887 322 244544 222 1 123679
Q ss_pred EEEecCC-cchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 135 VMELCEG-GELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 135 v~e~~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
|+|-+.| -+|.+.+.+. .+.++.....++.+++.++.-||+.|+.|+|+-+.||+++.++ ...++++||.-++
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r 178 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSR 178 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccc
Confidence 9998764 4777776553 3457788889999999999999999999999999999997544 3459999998654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.7e-08 Score=84.98 Aligned_cols=141 Identities=21% Similarity=0.270 Sum_probs=89.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHH------HHHHHHHHHHhCC--CCCCeeeeeeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE------DVRREVQIMKHLP--KHPNIVSLKDT 125 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~------~~~~Ei~~l~~l~--~hpnIv~l~~~ 125 (419)
+..+|.+.+.+-......|.+.. -+|..+++|.........+.... ...+++..+.++. .--....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45578888888777777777655 56789999987654322211111 1233444333331 11222222222
Q ss_pred E-----EeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 126 Y-----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 126 ~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
. .-....+++|||++|..|.+.. .+++ .+...+.+++.-||+.|++|+|..|.|+++++++ ++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i~ 174 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----IR 174 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----EE
Confidence 2 2234567899999998886543 1333 3446677889999999999999999999997432 89
Q ss_pred Eeecccce
Q 014722 201 AIDFGLSV 208 (419)
Q Consensus 201 l~Dfg~a~ 208 (419)
++||+..+
T Consensus 175 iID~~~k~ 182 (229)
T PF06176_consen 175 IIDTQGKR 182 (229)
T ss_pred EEECcccc
Confidence 99998554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05027 S-100B S-100B: S-100B domain found in proteins similar to S100B | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-08 Score=74.69 Aligned_cols=59 Identities=12% Similarity=0.064 Sum_probs=54.3
Q ss_pred HhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|+.+| .+++| .|+.+||+.+|+. +|...++++++.+|+.+|.| |.|+|.+|+
T Consensus 7 ~~~l~~aF~~fD~~dgdG~~I~~~eL~~ll~~~~~~~lg~~~~~~~v~~~i~~~D~n~dG~v~f~eF~ 74 (88)
T cd05027 7 MVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFM 74 (88)
T ss_pred HHHHHHHHHHhcccCCCcCEECHHHHHHHHHHHhHHHhcCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 457899999998 79999 5999999999999 89999999999999999987 689999994
|
S100B is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100B group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100B is most abundant in glial cells of the central nervous system, predominately in astrocytes. S100B is involved in signal transduction via the inhibition of protein phoshorylation, regulation of enzyme activity and by affecting the calcium homeostasis. Upon calcium binding the S100B homodimer changes conformation to expose a hydrophobic cleft, which represents the interaction site of S100B with its more than 20 known target proteins. These target proteins include several cellular architecture proteins such as tubulin and GFAP; S100B can inhibit polymerization of these oligomeric molecules. Furthermore, S100B i |
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.6e-08 Score=83.90 Aligned_cols=60 Identities=22% Similarity=0.329 Sum_probs=56.1
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++++|+.+|.|++|+|+..||+.+|..+|.+.+.++++.+++.+|.| |.|+|++|+
T Consensus 83 ~~~el~eaF~~fD~d~~G~Is~~el~~~l~~lg~~~~~~e~~~mi~~~d~d~dg~i~f~ef~ 144 (151)
T KOG0027|consen 83 SSEELKEAFRVFDKDGDGFISASELKKVLTSLGEKLTDEECKEMIREVDVDGDGKVNFEEFV 144 (151)
T ss_pred cHHHHHHHHHHHccCCCCcCcHHHHHHHHHHhCCcCCHHHHHHHHHhcCCCCCCeEeHHHHH
Confidence 355899999999999999999999999999999999999999999999975 799999984
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-08 Score=78.11 Aligned_cols=68 Identities=21% Similarity=0.233 Sum_probs=59.2
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHc-CCCCCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV-SIICLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~-d~~g~i~~~~f~ 419 (419)
+++.-.+...+++.+.++.||++++|.|...||+.+|.++|..++++|++.++... |.+|.|+|+.|+
T Consensus 78 vaknk~q~t~edfvegLrvFDkeg~G~i~~aeLRhvLttlGekl~eeEVe~Llag~eD~nG~i~YE~fV 146 (152)
T KOG0030|consen 78 VAKNKDQGTYEDFVEGLRVFDKEGNGTIMGAELRHVLTTLGEKLTEEEVEELLAGQEDSNGCINYEAFV 146 (152)
T ss_pred HHhccccCcHHHHHHHHHhhcccCCcceeHHHHHHHHHHHHhhccHHHHHHHHccccccCCcCcHHHHH
Confidence 33334455677889999999999999999999999999999999999999999876 566999999985
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1e-07 Score=98.58 Aligned_cols=206 Identities=20% Similarity=0.203 Sum_probs=145.6
Q ss_pred HHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE----EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 014722 100 IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH----IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175 (419)
Q Consensus 100 ~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~ 175 (419)
+....-|+..+..+ .|+|++.++.|.......- +..++|..-++...+...+.++....+.+..+++.||.|+|+
T Consensus 226 i~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 226 IQTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 44455677788888 8999999998875443332 445899999999999988899999999999999999999999
Q ss_pred cCCEeeCCCCCcEEeecCCCCCCeEEe--ecccceeccCCCcccccccCcccCchhhhccc-C--CCcccHHHHHHHHHH
Q 014722 176 QGVMHRDLKPENFLFANKKESSPLKAI--DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-Y--GPEVDVWSAGVILYI 250 (419)
Q Consensus 176 ~~ivHrDlkp~NIl~~~~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~--~~~~DiwslG~il~~ 250 (419)
....|.-+..+...-......+.+.++ ||+.+..............+..+-+||....+ + ....|+|.+|..+..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 977766665553332222333445666 88877766544443444456678888877643 2 334699999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 251 LLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 251 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+..|..+-... .....++. . .......+++.+|+.-++++|+++.+++.|+|.+..
T Consensus 385 ~~~~~~i~~~~---~~~~~~l~-------~---~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKS---AVPVSLLD-------V---LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccc---cchhhhhc-------c---ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 98876542110 11111111 0 111267789999999999999999999999998753
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-08 Score=69.94 Aligned_cols=57 Identities=26% Similarity=0.349 Sum_probs=49.3
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHH----HHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ----ILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~----~~~~~~d~~--g~i~~~~f~ 419 (419)
.++++|+.+|+|++|+|+.+|++.++..++...+++++. .++..+|.| |.|+|+||+
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~ 63 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRRALKHLGRDMSDEESDEMIDQIFREFDTDGDGRISFDEFL 63 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHTTSHSTHHHHHHHHHHHHHHHTTTSSSSEEHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHHHHHHhcccccHHHHHHHHHHHHHHhCCCCcCCCcHHHHh
Confidence 378999999999999999999999999999777665554 459999987 799999984
|
... |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.1e-08 Score=76.97 Aligned_cols=71 Identities=28% Similarity=0.432 Sum_probs=61.5
Q ss_pred hhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCcccc
Q 014722 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLV 418 (419)
Q Consensus 346 ~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f 418 (419)
++..+.+...+.+.+.++++++|..+|.|.+|.|++++|+.+|..+|...++++++.||.++. |-|+|--|
T Consensus 16 ~rasSnvFamf~q~QIqEfKEAF~~mDqnrDG~IdkeDL~d~~aSlGk~~~d~elDaM~~Ea~--gPINft~F 86 (171)
T KOG0031|consen 16 KRASSNVFAMFDQSQIQEFKEAFNLMDQNRDGFIDKEDLRDMLASLGKIASDEELDAMMKEAP--GPINFTVF 86 (171)
T ss_pred ccccchHHHHhhHHHHHHHHHHHHHHhccCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHhCC--CCeeHHHH
Confidence 344455566778899999999999999999999999999999999999999999999999874 66666555
|
|
| >COG5126 FRQ1 Ca2+-binding protein (EF-Hand superfamily) [Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.7e-08 Score=79.22 Aligned_cols=68 Identities=28% Similarity=0.315 Sum_probs=62.2
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC-CCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII-CLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-g~i~~~~f~ 419 (419)
....++.++.++++++|..+|.|++|.|+..||..+|+.+|..+++.++.+|+..+|.+ +.|+|.+|+
T Consensus 10 ~~~~~t~~qi~~lkeaF~l~D~d~~G~I~~~el~~ilr~lg~~~s~~ei~~l~~~~d~~~~~idf~~Fl 78 (160)
T COG5126 10 TFTQLTEEQIQELKEAFQLFDRDSDGLIDRNELGKILRSLGFNPSEAEINKLFEEIDAGNETVDFPEFL 78 (160)
T ss_pred hcccCCHHHHHHHHHHHHHhCcCCCCCCcHHHHHHHHHHcCCCCcHHHHHHHHHhccCCCCccCHHHHH
Confidence 34456889999999999999999999999999999999999999999999999999973 689999984
|
|
| >smart00027 EH Eps15 homology domain | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.8e-08 Score=73.36 Aligned_cols=62 Identities=24% Similarity=0.291 Sum_probs=56.2
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|++.+|+.+| ++++++..++..+|.+ |.|+|++|+
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~Is~~el~~~l~~~~--~~~~ev~~i~~~~d~~~~g~I~~~eF~ 67 (96)
T smart00027 4 ISPEDKAKYEQIFRSLDKNQDGTVTGAQAKPILLKSG--LPQTLLAKIWNLADIDNDGELDKDEFA 67 (96)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCCcCHHHHH
Confidence 3567788999999999999999999999999999976 6889999999999876 789999994
|
Pair of EF hand motifs that recognise proteins containing Asn-Pro-Phe (NPF) sequences. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.6e-07 Score=77.77 Aligned_cols=140 Identities=18% Similarity=0.154 Sum_probs=94.0
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCChh----------------hH-----HHHHHHHHHHHhCC-CCCCee
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV----------------DI-----EDVRREVQIMKHLP-KHPNIV 120 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----------------~~-----~~~~~Ei~~l~~l~-~hpnIv 120 (419)
.|++|--+.||+|.. .++..+|+|++......-.. .. .-...|...|+++. .+=.++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 677888889999984 67899999998754321100 11 12346777777762 133455
Q ss_pred eeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCe
Q 014722 121 SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 121 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
+.+.+.. -.|||||+.....-.-..+.-++...++..+..++++.+.-|-. .++||+||+.-|||+. ++.+
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~~p 205 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DGEP 205 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CCeE
Confidence 6665543 35899999643111111112234444788888999999888776 8999999999999996 2338
Q ss_pred EEeecccceecc
Q 014722 200 KAIDFGLSVFFR 211 (419)
Q Consensus 200 kl~Dfg~a~~~~ 211 (419)
.++|||.|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999887554
|
|
| >KOG0027 consensus Calmodulin and related proteins (EF-Hand superfamily) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.5e-08 Score=79.24 Aligned_cols=63 Identities=33% Similarity=0.447 Sum_probs=58.6
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++..+++++|+.+|+|++|+|+..||..+++.+|..+++.++..++.++|.+ |.|+|++|+
T Consensus 3 ~~~~~~el~~~F~~fD~d~~G~i~~~el~~~lr~lg~~~t~~el~~~~~~~D~dg~g~I~~~eF~ 67 (151)
T KOG0027|consen 3 SEEQILELKEAFQLFDKDGDGKISVEELGAVLRSLGQNPTEEELRDLIKEIDLDGDGTIDFEEFL 67 (151)
T ss_pred CHHHHHHHHHHHHHHCCCCCCcccHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 356678899999999999999999999999999999999999999999999987 789999994
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.4e-07 Score=87.61 Aligned_cols=145 Identities=18% Similarity=0.229 Sum_probs=90.7
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCC---------------------------hhh----------HHHHH
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---------------------------AVD----------IEDVR 104 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------------------------~~~----------~~~~~ 104 (419)
..|+.++-|.||+|+- .+|+.||||+....-... ... .-++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4689999999999995 569999999975321100 000 01233
Q ss_pred HHHHHHHhC----CCCCCeeeeeeEEEeCCeEEEEEEecCCcchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 014722 105 REVQIMKHL----PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGHYTERAAAAVMKTIVEVVQVCHEQGV 178 (419)
Q Consensus 105 ~Ei~~l~~l----~~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 178 (419)
+|...+.++ .+.|++.-..=+++..+.-.++|||++|-.+.+.. .. ..++.+.+.....++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 454444443 23454332222334445667999999998888764 33 3455333333222222 223334799
Q ss_pred EeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 179 vHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
.|.|..|.||++..+ +.+.+.|||+...+.+.
T Consensus 287 fHaDpHpGNi~v~~~---g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSD---GRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecC---CcEEEEcCcceecCCHH
Confidence 999999999999755 45999999998766543
|
|
| >cd05029 S-100A6 S-100A6: S-100A6 domain found in proteins similar to S100A6 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.8e-07 Score=69.37 Aligned_cols=60 Identities=15% Similarity=0.196 Sum_probs=53.3
Q ss_pred HHhhHHHHHhhhCC-CC-CCcccHHHHHHHHH---hCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDT-NK-RGKINLEELRLGLL---KGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~-~~-~g~i~~~el~~~l~---~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+...|..+|. |+ +|+|+.+||+.+|+ .+|.+++++|++++|+.+|.| |.|+|.+|+
T Consensus 8 ~~~~~i~~F~~y~~~~~~~g~Is~~EL~~~l~~~~~lg~k~t~~ev~~m~~~~D~d~dG~Idf~EFv 74 (88)
T cd05029 8 AIGLLVAIFHKYSGREGDKNTLSKKELKELIQKELTIGSKLQDAEIAKLMEDLDRNKDQEVNFQEYV 74 (88)
T ss_pred HHHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhcCCCCCCCcHHHHH
Confidence 34577899999998 77 89999999999997 379999999999999999987 799999994
|
S100A6 is a member of the S100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A6 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100A6 is normally expressed in the G1 phase of the cell cycle in neuronal cells. The function of S100A6 remains unclear, but evidence suggests that it is involved in cell cycle regulation and exocytosis. S100A6 may also be involved in tumorigenesis; the protein is overexpressed in several tumors. Ca2+ binding to S100A6 leads to a conformational change in the protein, which exposes a hydrophobic surface for interact |
| >cd05031 S-100A10_like S-100A10_like: S-100A10 domain found in proteins similar to S100A10 | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-07 Score=71.28 Aligned_cols=59 Identities=10% Similarity=0.085 Sum_probs=52.8
Q ss_pred HhhHHHHHhhhCC-CC-CCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDT-NK-RGKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~-~~-~g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++|..+|. |+ +|.|+.+|++.+|+. +|..++++++..++..+|.+ |.|+|++|+
T Consensus 7 ~~~l~~~F~~~D~~dg~dG~Is~~El~~~l~~~~g~~lg~~~s~~ei~~~~~~~D~~~dg~I~f~eF~ 74 (94)
T cd05031 7 MESLILTFHRYAGKDGDKNTLSRKELKKLMEKELSEFLKNQKDPMAVDKIMKDLDQNRDGKVNFEEFV 74 (94)
T ss_pred HHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHhHHHhhccccHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4678999999997 97 799999999999987 57788999999999999987 689999994
|
S100A10 is a member of the S100 family of EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1_like group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. A unique feature of S100A10 is that it contains mutation in both of the calcium binding sites, making it calcium insensitive. S100A10 has been detected in brain, heart, gastrointestinal tract, kidney, liver, lung, spleen, testes, epidermis, aorta, and thymus. Structural data supports the homo- and hetero-dimeric as well as hetero-tetrameric nature of the protein. S100A10 has multiple binding partners in its calcium free state and is therefore involved in many diverse biological functions. |
| >KOG0031 consensus Myosin regulatory light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.4e-07 Score=73.30 Aligned_cols=74 Identities=20% Similarity=0.245 Sum_probs=65.1
Q ss_pred hhhHhhhhhhhh-hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 346 KRALQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 346 ~~~l~~~~~~~~-~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
-.++.++.+.++ .+..+.+..+|..||.++.|.|..+.|+.+|...|..++++||+.|++.+..| |.++|..|+
T Consensus 84 t~FLTmfGekL~gtdpe~~I~~AF~~FD~~~~G~I~~d~lre~Ltt~gDr~~~eEV~~m~r~~p~d~~G~~dy~~~~ 160 (171)
T KOG0031|consen 84 TVFLTMFGEKLNGTDPEEVILNAFKTFDDEGSGKIDEDYLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFDYKAFT 160 (171)
T ss_pred HHHHHHHHHHhcCCCHHHHHHHHHHhcCccCCCccCHHHHHHHHHHhcccCCHHHHHHHHHhCCcccCCceeHHHHH
Confidence 345677788773 45567899999999999999999999999999999999999999999999875 899998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.50 E-value=5e-06 Score=71.68 Aligned_cols=134 Identities=21% Similarity=0.289 Sum_probs=96.3
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEeccccc-------------CChhhHHHHHHHHHHHHhCC-----CCCCeeeee
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-------------RTAVDIEDVRREVQIMKHLP-----KHPNIVSLK 123 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~~Ei~~l~~l~-----~hpnIv~l~ 123 (419)
..||+|+.-.||. | ..+...+||+...... .......+..+|+.....+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4789999999995 3 3456677899876650 01122456677777777762 267899999
Q ss_pred eEEEeCCeEEEEEEecCC------cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 124 DTYEDDSAVHIVMELCEG------GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
|+.+++...-+|+|.... .+|.+++.. +.+++ .. ...+-+-..||-+++|+.+|++|.||++...++..
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998742 367777744 34665 33 33344455788899999999999999998766554
Q ss_pred -CeEEee
Q 014722 198 -PLKAID 203 (419)
Q Consensus 198 -~~kl~D 203 (419)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.4e-06 Score=75.90 Aligned_cols=73 Identities=22% Similarity=0.253 Sum_probs=54.2
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CCeeeeeeEEEeCCeEEEEEEecC
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAVHIVMELCE 140 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~lv~e~~~ 140 (419)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+... -.+++.+++..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 46899999999973 25567888875422 234578899999988322 235778888888888899999999
Q ss_pred Ccc
Q 014722 141 GGE 143 (419)
Q Consensus 141 ~g~ 143 (419)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3e-07 Score=73.30 Aligned_cols=69 Identities=22% Similarity=0.278 Sum_probs=59.8
Q ss_pred hhhhhhh-hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 350 QVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 350 ~~~~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.+|...+ ..+..++++.+|+.+|.|++|.|+..+|+.+.+.||.+++++|+.+|++++|.| |.|+-+||
T Consensus 93 ~~mt~k~~e~dt~eEi~~afrl~D~D~~Gkis~~~lkrvakeLgenltD~El~eMIeEAd~d~dgevneeEF 164 (172)
T KOG0028|consen 93 RVMTVKLGERDTKEEIKKAFRLFDDDKTGKISQRNLKRVAKELGENLTDEELMEMIEEADRDGDGEVNEEEF 164 (172)
T ss_pred HHHHHHHhccCcHHHHHHHHHcccccCCCCcCHHHHHHHHHHhCccccHHHHHHHHHHhcccccccccHHHH
Confidence 3444444 234567899999999999999999999999999999999999999999999987 68998888
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.3e-06 Score=73.16 Aligned_cols=129 Identities=19% Similarity=0.248 Sum_probs=91.0
Q ss_pred cceeeccccccccc-eEEEEEEEcCCCcEEEEEEecccccCCh------------------hhHHHHHHHHHHHHhCC--
Q 014722 56 IDYDLGRELGRGEF-GVTYLCTDVNNGEKFACKSISKKKLRTA------------------VDIEDVRREVQIMKHLP-- 114 (419)
Q Consensus 56 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------------~~~~~~~~Ei~~l~~l~-- 114 (419)
.+++.++.||.|+- |.||+++ -.|+.+|+|+...-.+... .-..-+.+|.+...+|.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 9999998 4688999999332111100 11235778988888873
Q ss_pred CCCCe--eeeeeEEEeC------------------CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 014722 115 KHPNI--VSLKDTYEDD------------------SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174 (419)
Q Consensus 115 ~hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH 174 (419)
++.++ |+.+++..-. ....||.||.+... .++ ..-+.+|++-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 23345 8888886311 12467888876543 222 333567777888899
Q ss_pred HcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 175 ~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..||+-+|+++.|.. + -||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----G----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----C----CEEEecccC
Confidence 999999999999987 2 289999964
|
|
| >cd05025 S-100A1 S-100A1: S-100A1 domain found in proteins similar to S100A1 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.8e-07 Score=69.34 Aligned_cols=59 Identities=10% Similarity=0.059 Sum_probs=51.4
Q ss_pred HhhHHHHHhhhC-CCCCCc-ccHHHHHHHHHh-CCC----CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMD-TNKRGK-INLEELRLGLLK-GGQ----NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D-~~~~g~-i~~~el~~~l~~-lg~----~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|..+| .+++|+ |+..|++.+|+. +|. .+++++++.+|..+|.+ |.|+|.+|+
T Consensus 8 ~~~l~~~F~~fDd~dg~G~~Is~~El~~~l~~~lg~~~~~~~s~~~v~~i~~~~D~d~~G~I~f~eF~ 75 (92)
T cd05025 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSDFLDAQKDADAVDKIMKELDENGDGEVDFQEFV 75 (92)
T ss_pred HHHHHHHHHHHhcccCCCCeECHHHHHHHHHHHHHHHccCCCCHHHHHHHHHHHCCCCCCcCcHHHHH
Confidence 357899999997 999994 999999999986 543 56899999999999987 689999994
|
S100A1 is a calcium-binding protein belonging to a large S100 vertebrate-specific protein family within the EF-hand superfamily of calcium-binding proteins. Note that the S-100 hierarchy, to which this S-100A1 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. As is the case with many other members of S100 protein family, S100A1 is implicated in intracellular and extracellular regulatory activities, including interaction with myosin-associated twitchin kinase, actin-capping protein CapZ, sinapsin I, and tubulin. Structural data suggests that S100A1 proteins exist within cells as antiparallel homodimers, while heterodimers with S100A4 and S100B also has been reported. Upon binding calcium S100A1 changes conformation to expose a hydrophobic cleft which is the interaction site of S100A1 with its more that 20 known target proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.4e-06 Score=78.53 Aligned_cols=75 Identities=13% Similarity=0.151 Sum_probs=54.6
Q ss_pred cccccc-eEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCc
Q 014722 64 LGRGEF-GVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGG 142 (419)
Q Consensus 64 lg~G~~-g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g 142 (419)
|-.|.. +.||++.. .+..+++|+..... ...+.+|+++++.+..+--+++++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 78999874 34688888875432 2356779999998865656778888887777789999999987
Q ss_pred chHH
Q 014722 143 ELFD 146 (419)
Q Consensus 143 ~L~~ 146 (419)
+|..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05026 S-100Z S-100Z: S-100Z domain found in proteins similar to S100Z | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.4e-07 Score=68.87 Aligned_cols=59 Identities=12% Similarity=0.058 Sum_probs=50.5
Q ss_pred HhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-C----CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-G----GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-l----g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++|+.+| .|++| .|+..||+.+|.. + +...++.+++.++.++|.| |.|+|.||+
T Consensus 9 ~~~~~~~F~~~dd~dgdg~~Is~~EL~~ll~~~~~~~~~~~~~~~~v~~i~~elD~n~dG~Idf~EF~ 76 (93)
T cd05026 9 MDTLIRIFHNYSGKEGDRYKLSKGELKELLQRELTDFLSSQKDPMLVDKIMNDLDSNKDNEVDFNEFV 76 (93)
T ss_pred HHHHHHHHHHHHccCCCCCEECHHHHHHHHHHHhHHhcccccCHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 457889999999 78998 5999999999977 3 3445788999999999987 799999994
|
S100Z is a member of the S100 domain family within the EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100Z group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately.S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control. S100Z is normally expressed in various tissues, with its highest level of expression being in spleen and leukocytes. The function of S100Z remains unclear. Preliminary structural data suggests that S100Z is homodimer, however a heterodimer with S100P has been reported. S100Z is capable of binding calcium ions. When calcium binds to S110Z, the protein experiences a conformational change, which exposes hydrophobic surfac |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-06 Score=75.65 Aligned_cols=79 Identities=23% Similarity=0.236 Sum_probs=55.2
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CCeeeeeeEE---EeCCeEEEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTY---EDDSAVHIVM 136 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~---~~~~~~~lv~ 136 (419)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|..+ ..+++++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 3568999999999998543 58999987533 2456777888888887433 2356666543 2334578999
Q ss_pred EecCCcchHH
Q 014722 137 ELCEGGELFD 146 (419)
Q Consensus 137 e~~~~g~L~~ 146 (419)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd00213 S-100 S-100: S-100 domain, which represents the largest family within the superfamily of proteins carrying the Ca-binding EF-hand motif | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.4e-07 Score=68.33 Aligned_cols=62 Identities=8% Similarity=0.118 Sum_probs=53.8
Q ss_pred hHHHhhHHHHHhhhCC--CCCCcccHHHHHHHHHh-CCCCC----CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLK-GGQNI----PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~-lg~~~----~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|..+|+ |++|.|+.+|++.+++. +|..+ +.+++..++..+|.+ |.|+|++|+
T Consensus 4 ~~~~~~l~~~F~~~D~~~~~~G~Is~~el~~~l~~~~g~~~~~~~~~~ei~~i~~~~d~~~~g~I~f~eF~ 74 (88)
T cd00213 4 EKAIETIIDVFHKYSGKEGDKDTLSKKELKELLETELPNFLKNQKDPEAVDKIMKDLDVNKDGKVDFQEFL 74 (88)
T ss_pred HHHHHHHHHHHHHHhhccCCCCcCcHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHhccCCCCcCcHHHHH
Confidence 3556789999999999 89999999999999986 56544 589999999999886 789999994
|
Note that this S-100 hierarchy contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins are expressed exclusively in vertebrates, and are implicated in intracellular and extracellular regulatory activities. Intracellularly, S100 proteins act as Ca-signaling or Ca-buffering proteins. The most unusual characteristic of certain S100 proteins is their occurrence in extracellular space, where they act in a cytokine-like manner through RAGE, the receptor for advanced glycation products. Structural data suggest that many S100 members exist within cells as homo- or heterodimers and even oligomers; oligomerization contributes to their functional diversification. Upon binding calcium, most S100 proteins change conformation to a more open structure exposing a hydrophobic cleft. This hydrophobic surface represents th |
| >cd00052 EH Eps15 homology domain; found in proteins implicated in endocytosis, vesicle transport, and signal transduction | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.1e-07 Score=63.10 Aligned_cols=53 Identities=23% Similarity=0.198 Sum_probs=48.4
Q ss_pred HHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 365 ~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+++|..+|.|++|.|+.+|++.+++.+|. +.+++..++..+|.+ |.|+|.+|+
T Consensus 2 ~~~F~~~D~~~~G~i~~~el~~~l~~~g~--~~~~~~~i~~~~d~~~~g~i~~~ef~ 56 (67)
T cd00052 2 DQIFRSLDPDGDGLISGDEARPFLGKSGL--PRSVLAQIWDLADTDKDGKLDKEEFA 56 (67)
T ss_pred hHHHHHhCCCCCCcCcHHHHHHHHHHcCC--CHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 57899999999999999999999999874 888999999999876 789999984
|
The alignment contains a pair of EF-hand motifs, typically one of them is canonical and binds to Ca2+, while the other may not bind to Ca2+. A hydrophobic binding pocket is formed by residues from both EF-hand motifs. The EH domain binds to proteins containing NPF (class I), [WF]W or SWG (class II), or H[TS]F (class III) sequence motifs. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.35 E-value=5.4e-06 Score=87.72 Aligned_cols=148 Identities=22% Similarity=0.390 Sum_probs=91.6
Q ss_pred ccccccccceEEEEEEEcCCC--cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCe--eeeeeEEEeC---CeEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI--VSLKDTYEDD---SAVH 133 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnI--v~l~~~~~~~---~~~~ 133 (419)
+..++.|.++.+|+......+ ..+++|+....... .....+.+|.++++.+..|+++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 457899999999998754332 46777876543221 1234678999999999446654 7788777664 4678
Q ss_pred EEEEecCCcchHH--------------------HH---HhcC-----------C--CCHHHHHHHHHH------------
Q 014722 134 IVMELCEGGELFD--------------------RI---VARG-----------H--YTERAAAAVMKT------------ 165 (419)
Q Consensus 134 lv~e~~~~g~L~~--------------------~l---~~~~-----------~--~~~~~~~~i~~q------------ 165 (419)
+||||++|..+.+ .+ ..-. + +...++..+..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 11 1100 0 001122222111
Q ss_pred ---HHHHHHHHHH-----------cCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 166 ---IVEVVQVCHE-----------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 166 ---i~~~l~~LH~-----------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+...+.+|.. ..+||+|++|.||+++.++ ...+-|.||+++..-.
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~-~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTE-DRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCC-CeEEEEEeeeccccCC
Confidence 2234556632 2499999999999997532 2345789999887644
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.8e-06 Score=68.41 Aligned_cols=132 Identities=22% Similarity=0.290 Sum_probs=89.7
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC-eeeeeeEEEeCCeEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN-IVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn-Iv~l~~~~~~~~~~~lv~ 136 (419)
-++.+.|++|.+|.||+|. ..|..+|+|+-... .....+..|.++|..+ .-.+ -.+++.|-.+ ++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil-~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRD-----SPRRNLEKEAKILEIL-AGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEee--ccCceEEEEEecCC-----cchhhHHHHHHHHHHh-hhcCCCceEEEechh----hhhh
Confidence 3456789999999999998 56779999986533 2456788999999988 4433 3456555433 3559
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCC-CCcEEeecCCCCCCeEEeecccceecc
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK-PENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk-p~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
||..|-.|.+..... + ++-+..++++-.-|-..||-|+.|. |..+++.++. .+.|+||..|....
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At~k~ 157 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSATFKK 157 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchhhcc
Confidence 999998886544321 1 2333445555555677899999986 4444443322 38999999887443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.7e-06 Score=79.95 Aligned_cols=155 Identities=15% Similarity=0.150 Sum_probs=95.2
Q ss_pred CCCccccceeec--cccccccceEEEEEEEcCCCcEEEEEEecccccCCh-----------------------------h
Q 014722 50 SGQDISIDYDLG--RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----------------------------V 98 (419)
Q Consensus 50 ~~~~~~~~y~~~--~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------------------------~ 98 (419)
.|..+.+=|... +.||.-+.|.|++|+.+ .|+.||||+-...- ... .
T Consensus 153 lG~~ie~if~~f~~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE 230 (538)
T KOG1235|consen 153 LGAPIEDIFSEFDEEPIAAASLAQVHRARLK-NGEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDE 230 (538)
T ss_pred hCCCHHHHHHhcCcchhhhcchhheEEEEec-CCCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHH
Confidence 455555555543 46999999999999965 49999999964321 110 0
Q ss_pred hHHH------HHHHHHHHH----hCCCCCC------eeeeeeEEEeCCeEEEEEEecCCcchHH--HHHhcCCCCHHHHH
Q 014722 99 DIED------VRREVQIMK----HLPKHPN------IVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAA 160 (419)
Q Consensus 99 ~~~~------~~~Ei~~l~----~l~~hpn------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~--~l~~~~~~~~~~~~ 160 (419)
-.+. +.+|.+... .+ .|-+ |++++..+ .....|+||||+|..+.+ .+.+. .++...+.
T Consensus 231 ~~~~L~~ELDF~~EA~Nae~~~~~f-~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~ 306 (538)
T KOG1235|consen 231 IAKSLPQELDFTKEAKNAERFRENF-KDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDIL 306 (538)
T ss_pred HHhhhHhhcchHHHHHhHHHHHHHH-HhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHH
Confidence 0111 223333222 22 3334 55555443 345679999999987754 34444 35555443
Q ss_pred HHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCCCCeEEeecccceeccC
Q 014722 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 161 ~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~a~~~~~ 212 (419)
.-+.+... .-|=..|++|+|-.|.||++..+ ..+..+.+-|||+...+..
T Consensus 307 ~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 307 NKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 33333222 22235689999999999999854 2456799999999876543
|
|
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=98.23 E-value=1e-06 Score=58.99 Aligned_cols=45 Identities=29% Similarity=0.336 Sum_probs=42.1
Q ss_pred CCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 375 KRGKINLEELRLGLLKGGQN-IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 375 ~~g~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++|.|+.++++.+|..+|.. ++++++..++..+|.+ |.|+|+||+
T Consensus 1 ~~G~i~~~~~~~~l~~~g~~~~s~~e~~~l~~~~D~~~~G~I~~~EF~ 48 (54)
T PF13833_consen 1 KDGKITREEFRRALSKLGIKDLSEEEVDRLFREFDTDGDGYISFDEFI 48 (54)
T ss_dssp SSSEEEHHHHHHHHHHTTSSSSCHHHHHHHHHHHTTSSSSSEEHHHHH
T ss_pred CcCEECHHHHHHHHHHhCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Confidence 47999999999999999999 9999999999999987 799999994
|
... |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.3e-05 Score=73.88 Aligned_cols=80 Identities=19% Similarity=0.277 Sum_probs=55.2
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEeccccc---CC-hhhHHHHHHHHHHHHhCCCC--CCeeeeeeEEEeCCeEEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RT-AVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~-~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~lv 135 (419)
+.||.|.+..||++.....++.++||.-....- .. +...+....|.+.|+.+..+ .++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 578999999999999754446899998542110 00 12445677788888876433 467788766 45667899
Q ss_pred EEecCCcc
Q 014722 136 MELCEGGE 143 (419)
Q Consensus 136 ~e~~~~g~ 143 (419)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998644
|
|
| >KOG0030 consensus Myosin essential light chain, EF-Hand protein superfamily [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-06 Score=67.85 Aligned_cols=63 Identities=22% Similarity=0.210 Sum_probs=57.7
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC----CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII----CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----g~i~~~~f~ 419 (419)
+.++..+++++|..||.++||+|+......+|+++|+++|+.|+.+.+.+.+.+ ..|+|++|+
T Consensus 6 ~~d~~~e~ke~F~lfD~~gD~ki~~~q~gdvlRalG~nPT~aeV~k~l~~~~~~~~~~~rl~FE~fL 72 (152)
T KOG0030|consen 6 TPDQMEEFKEAFLLFDRTGDGKISGSQVGDVLRALGQNPTNAEVLKVLGQPKRREMNVKRLDFEEFL 72 (152)
T ss_pred CcchHHHHHHHHHHHhccCcccccHHHHHHHHHHhcCCCcHHHHHHHHcCcccchhhhhhhhHHHHH
Confidence 456678999999999999999999999999999999999999999999998887 479999884
|
|
| >cd05023 S-100A11 S-100A11: S-100A11 domain found in proteins similar to S100A11 | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.8e-06 Score=62.33 Aligned_cols=60 Identities=10% Similarity=0.087 Sum_probs=51.3
Q ss_pred HHhhHHHHHhh-hCCCCCC-cccHHHHHHHHHhC-----CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEM-MDTNKRG-KINLEELRLGLLKG-----GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~-~D~~~~g-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|.. +|++++| +|+.+||+.++... +...++.+++.+++.+|.| |.|+|+||+
T Consensus 7 ~i~~l~~~F~~y~~~dg~~~~Ls~~Elk~ll~~e~~~~~~~~~~~~~~~~ll~~~D~d~DG~I~f~EF~ 75 (89)
T cd05023 7 CIESLIAVFQKYAGKDGDSYQLSKTEFLSFMNTELASFTKNQKDPGVLDRMMKKLDLNSDGQLDFQEFL 75 (89)
T ss_pred HHHHHHHHHHHHhccCCCcCeECHHHHHHHHHHhhhHhhcCCCCHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 34678899999 8888876 99999999999886 4466788999999999887 799999994
|
S100A11 is a member of the S-100 domain family within EF-hand Ca2+-binding proteins superfamily. Note that the S-100 hierarchy, to which this S-100A11 group belongs, contains only S-100 EF-hand domains, other EF-hands have been modeled separately. S100 proteins exhibit unique patterns of tissue- and cell type-specific expression and have been implicated in the Ca2+-dependent regulation of diverse physiological processes, including cell cycle regulation, differentiation, growth, and metabolic control . S100 proteins have also been associated with a variety of pathological events, including neoplastic transformation and neurodegenerative diseases such as Alzheimer's, usually via over expression of the protein. S100A11 is expressed in smooth muscle and other tissues and involves in calcium-dependent membrane aggregation, which is important for cell vesiculation . As is the case for many other S100 proteins, S |
| >KOG0037 consensus Ca2+-binding protein, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=68.10 Aligned_cols=58 Identities=17% Similarity=0.250 Sum_probs=53.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC--CCCcCcccc
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI--ICLLSYFLV 418 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~--~g~i~~~~f 418 (419)
....+.+|+.+|.|++|.|+..||+++|..+|..++++-++.++++.|. +|.|+|++|
T Consensus 123 i~~Wr~vF~~~D~D~SG~I~~sEL~~Al~~~Gy~Lspq~~~~lv~kyd~~~~g~i~FD~F 182 (221)
T KOG0037|consen 123 INQWRNVFRTYDRDRSGTIDSSELRQALTQLGYRLSPQFYNLLVRKYDRFGGGRIDFDDF 182 (221)
T ss_pred HHHHHHHHHhcccCCCCcccHHHHHHHHHHcCcCCCHHHHHHHHHHhccccCCceeHHHH
Confidence 4567899999999999999999999999999999999999999999984 478999998
|
|
| >KOG0028 consensus Ca2+-binding protein (centrin/caltractin), EF-Hand superfamily protein [Cytoskeleton; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.6e-06 Score=67.23 Aligned_cols=64 Identities=27% Similarity=0.385 Sum_probs=58.9
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+++++.+.++++|..||.+++|+|+..||+.+++++|-.+..+|+.+++..+|.+ |.|+|++|+
T Consensus 27 l~~~q~q~i~e~f~lfd~~~~g~iD~~EL~vAmralGFE~~k~ei~kll~d~dk~~~g~i~fe~f~ 92 (172)
T KOG0028|consen 27 LTEEQKQEIKEAFELFDPDMAGKIDVEELKVAMRALGFEPKKEEILKLLADVDKEGSGKITFEDFR 92 (172)
T ss_pred ccHHHHhhHHHHHHhhccCCCCcccHHHHHHHHHHcCCCcchHHHHHHHHhhhhccCceechHHHH
Confidence 3566678999999999999999999999999999999999999999999999987 689999983
|
|
| >cd00051 EFh EF-hand, calcium binding motif; A diverse superfamily of calcium sensors and calcium signal modulators; most examples in this alignment model have 2 active canonical EF hands | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.4e-06 Score=56.43 Aligned_cols=56 Identities=23% Similarity=0.415 Sum_probs=51.7
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.+|..+|.+++|.|+.+|+..++..+|...+.+++..++..+|.+ |.|+|++|+
T Consensus 2 ~~~~f~~~d~~~~g~l~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ef~ 59 (63)
T cd00051 2 LREAFRLFDKDGDGTISADELKAALKSLGEGLSEEEIDEMIREVDKDGDGKIDFEEFL 59 (63)
T ss_pred HHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 56889999999999999999999999999999999999999999875 689999884
|
Ca2+ binding induces a conformational change in the EF-hand motif, leading to the activation or inactivation of target proteins. EF-hands tend to occur in pairs or higher copy numbers. |
| >PF14658 EF-hand_9: EF-hand domain | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-06 Score=57.24 Aligned_cols=54 Identities=22% Similarity=0.257 Sum_probs=49.8
Q ss_pred HHHhhhCCCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHHcCCC---CCcCccccC
Q 014722 366 EAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAVSII---CLLSYFLVC 419 (419)
Q Consensus 366 ~~F~~~D~~~~g~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~---g~i~~~~f~ 419 (419)
.+|+.+|.++.|.+...+|+..|+.+|. .+++.+++.+..++|.+ |.|+|+.||
T Consensus 2 ~~F~~fD~~~tG~V~v~~l~~~Lra~~~~~p~e~~Lq~l~~elDP~g~~~~v~~d~F~ 59 (66)
T PF14658_consen 2 TAFDAFDTQKTGRVPVSDLITYLRAVTGRSPEESELQDLINELDPEGRDGSVNFDTFL 59 (66)
T ss_pred cchhhcCCcCCceEeHHHHHHHHHHHcCCCCcHHHHHHHHHHhCCCCCCceEeHHHHH
Confidence 3699999999999999999999999987 99999999999999987 469999985
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=6.1e-06 Score=68.09 Aligned_cols=65 Identities=31% Similarity=0.379 Sum_probs=57.6
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++..|..+|.+++|.|+.+|+..++..+|..++.+++..++..+|.+ |.|+|++|+
T Consensus 4 ~~~~~~~~~~~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 70 (149)
T PTZ00184 4 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 70 (149)
T ss_pred ccCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHhcCcCCCCcCcHHHHH
Confidence 35567778899999999999999999999999999999888988999999999876 689999884
|
|
| >KOG0041 consensus Predicted Ca2+-binding protein, EF-Hand protein superfamily [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.4e-06 Score=68.17 Aligned_cols=65 Identities=22% Similarity=0.227 Sum_probs=59.7
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++..+.+.+...|..+|.+.||+|+..||+.+|.+||.+.|.=-++.||.++|.| |.|+|-+|+
T Consensus 92 eFsrkqIk~~~~~Fk~yDe~rDgfIdl~ELK~mmEKLgapQTHL~lK~mikeVded~dgklSfrefl 158 (244)
T KOG0041|consen 92 EFSRKQIKDAESMFKQYDEDRDGFIDLMELKRMMEKLGAPQTHLGLKNMIKEVDEDFDGKLSFREFL 158 (244)
T ss_pred HHHHHHHHHHHHHHHHhcccccccccHHHHHHHHHHhCCchhhHHHHHHHHHhhcccccchhHHHHH
Confidence 44667788899999999999999999999999999999999998999999999987 899999883
|
|
| >PTZ00183 centrin; Provisional | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.6e-05 Score=64.18 Aligned_cols=59 Identities=24% Similarity=0.311 Sum_probs=54.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.+++|.|+.+|+..++..+|..++.+++..++..+|.+ |.|+|++|+
T Consensus 89 ~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~l~~~~~~~~~~~~d~~~~g~i~~~ef~ 149 (158)
T PTZ00183 89 REEILKAFRLFDDDKTGKISLKNLKRVAKELGETITDEELQEMIDEADRNGDGEISEEEFY 149 (158)
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 35688999999999999999999999999999999999999999999866 789999983
|
|
| >PTZ00184 calmodulin; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.4e-05 Score=65.90 Aligned_cols=59 Identities=20% Similarity=0.357 Sum_probs=54.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.+++|.|+.+|++.++...|..++.+++..++..+|.+ |.|+|++|+
T Consensus 83 ~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 143 (149)
T PTZ00184 83 EEEIKEAFKVFDRDGNGFISAAELRHVMTNLGEKLTDEEVDEMIREADVDGDGQINYEEFV 143 (149)
T ss_pred HHHHHHHHHhhCCCCCCeEeHHHHHHHHHHHCCCCCHHHHHHHHHhcCCCCCCcCcHHHHH
Confidence 35678999999999999999999999999999999999999999999876 789999983
|
|
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=98.01 E-value=7.3e-06 Score=46.60 Aligned_cols=29 Identities=41% Similarity=0.554 Sum_probs=26.6
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
+++++|+.+|+|++|+|+.+|+..++++|
T Consensus 1 E~~~~F~~~D~d~dG~I~~~Ef~~~~~~L 29 (29)
T PF00036_consen 1 ELKEAFREFDKDGDGKIDFEEFKEMMKKL 29 (29)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHHHHHHT
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHhC
Confidence 46899999999999999999999999875
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >cd00252 SPARC_EC SPARC_EC; extracellular Ca2+ binding domain (containing 2 EF-hand motifs) of SPARC and related proteins (QR1, SC1/hevin, testican and tsc-36/FRP) | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.5e-05 Score=62.04 Aligned_cols=58 Identities=19% Similarity=0.110 Sum_probs=49.7
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
......+.-.|..+|.|++|.|+.+||..+. ....+..+..++..+|.| |.|+++||+
T Consensus 44 ~~~~~~l~w~F~~lD~d~DG~Ls~~EL~~~~----l~~~e~~~~~f~~~~D~n~Dg~IS~~Ef~ 103 (116)
T cd00252 44 PMCKDPVGWMFNQLDGNYDGKLSHHELAPIR----LDPNEHCIKPFFESCDLDKDGSISLDEWC 103 (116)
T ss_pred HHHHHHHHHHHHHHCCCCCCcCCHHHHHHHH----ccchHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 4455788999999999999999999999876 234578899999999987 799999985
|
SPARC (BM-40) is a multifunctional glycoprotein, a matricellular protein, that functions to regulate cell-matrix interactions; binds to such proteins as collagen and vitronectin and binds to endothelial cells thus inhibiting cellular proliferation. The EC domain interacts with a follistatin-like (FS) domain which appears to stabilize Ca2+ binding. The two EF-hands interact canonically but their conserved disulfide bonds confer a tight association between the EF-hand pair and an acid/amphiphilic N-terminal helix. Proposed active form involves a Ca2+ dependent symmetric homodimerization of EC-FS modules. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.2e-05 Score=67.90 Aligned_cols=74 Identities=18% Similarity=0.157 Sum_probs=45.7
Q ss_pred cccccccce-EEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--CeeeeeeEEEeC---CeEEEE
Q 014722 62 RELGRGEFG-VTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP--NIVSLKDTYEDD---SAVHIV 135 (419)
Q Consensus 62 ~~lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp--nIv~l~~~~~~~---~~~~lv 135 (419)
+.|+.|+.. .||+. +..+++|+..... ....+.+|.++++.|..+- .++++++..... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456766665 58875 2357778654321 2347888999999884331 345555443322 245889
Q ss_pred EEecCCcchH
Q 014722 136 MELCEGGELF 145 (419)
Q Consensus 136 ~e~~~~g~L~ 145 (419)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 419 | ||||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-64 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-63 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-63 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-63 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-63 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-63 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-62 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-61 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-61 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-61 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-61 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-61 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-60 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-60 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-60 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-59 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-59 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-59 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-58 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-58 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-58 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-58 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-57 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-57 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-57 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-56 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-56 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-56 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-56 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-56 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-55 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-54 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-53 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-53 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-53 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-52 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-52 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-51 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-51 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-50 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-50 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-50 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-50 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-50 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-50 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-50 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-50 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-50 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-50 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-50 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-50 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-50 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-50 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-50 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-50 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-50 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-49 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-49 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-49 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-46 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-46 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-46 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-46 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-46 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-46 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-46 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-46 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-46 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-46 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-46 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-46 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-45 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-45 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-45 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-45 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-45 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-45 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-45 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-45 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-44 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-44 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-44 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-44 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-44 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-44 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-44 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-43 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-43 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-43 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-43 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-43 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-42 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-42 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-42 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-42 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-42 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-42 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-42 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-42 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-42 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-42 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-42 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-42 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-41 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-41 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-41 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-41 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-41 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-41 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-41 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-41 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-41 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-41 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-41 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-40 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-40 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-40 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-40 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-40 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-40 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-40 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-40 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-40 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-40 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-40 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-40 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-40 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-40 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-40 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-40 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-40 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-40 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-40 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-40 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-39 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-39 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-39 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-39 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-39 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-39 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-38 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-38 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-38 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-38 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-38 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-38 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-38 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-37 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-37 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-34 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-34 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-34 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-34 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-33 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-33 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-33 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-32 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-32 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-32 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-32 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-32 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-32 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-32 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-32 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-32 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-32 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-31 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-31 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-31 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-31 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-31 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-31 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-31 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-31 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-31 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-31 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-31 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-31 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-31 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-31 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-31 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-30 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-30 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-30 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-29 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-29 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-29 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-29 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-28 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-28 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-28 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-28 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-28 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-28 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-28 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-28 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-28 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-28 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-28 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-28 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-28 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-28 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-28 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-28 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-28 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-28 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-28 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-28 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-28 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-28 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-28 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-28 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-28 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-28 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-28 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-28 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-27 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-27 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-27 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-27 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-27 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-27 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-27 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-27 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-27 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-27 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-26 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-26 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-26 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-26 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-26 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-26 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-26 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-26 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-26 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-26 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-26 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-26 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-26 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-26 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-26 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-26 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-26 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-26 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-26 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-26 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-26 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-25 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-25 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-25 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-25 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-25 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-25 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-25 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-25 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-25 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-25 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-25 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-25 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-23 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-23 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-22 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-22 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-22 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-22 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-22 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-22 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-22 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-22 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-22 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-22 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-22 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-22 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-22 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-22 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-22 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-21 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-21 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-21 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-21 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-21 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-20 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-20 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-20 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-20 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-20 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-19 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-19 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-18 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-18 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-18 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-18 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-18 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-18 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-18 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-18 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-17 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-17 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-16 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-16 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-14 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-13 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-12 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-10 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 4e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-09 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-09 | ||
| 2aao_A | 166 | Regulatory Apparatus Of Calcium Dependent Protein K | 6e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 9e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-05 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-05 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-05 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-05 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-05 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-05 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-05 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-05 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 |
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2AAO|A Chain A, Regulatory Apparatus Of Calcium Dependent Protein Kinase From Arabidopsis Thaliana Length = 166 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 573 bits (1480), Expect = 0.0
Identities = 131/374 (35%), Positives = 201/374 (53%), Gaps = 21/374 (5%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ Y++ LG+G FG C D +++A K I+K + D + REV+++K
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKK 77
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
L HPNI+ L + ED S+ +IV EL GGELFD I+ R ++E AA ++K + +
Sbjct: 78 L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
H+ ++HRDLKPEN L +K++ +K IDFGLS F+ + + +G+ YY+APEVL+
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
Y + DVWSAGVILYILL G PPF+ + E + + + F W +S++AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQN----AKKAPNVSLGETVKARLKQFSVMNKLKKRA 348
++KML P R+TA + LEHPW+Q ++ E+ ++QF KL + A
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316
Query: 349 LQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK--------------GGQ 393
L +A L+ ++E L E F +DTN G ++ +EL G +
Sbjct: 317 LLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEG 376
Query: 394 NIPEADLQILMEAV 407
+ E + LM +
Sbjct: 377 STIEDQIDSLMPLL 390
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 570 bits (1472), Expect = 0.0
Identities = 132/378 (34%), Positives = 207/378 (54%), Gaps = 17/378 (4%)
Query: 45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
++ + S Y R LG+G FG LC D G++ A K ISK++++ D E +
Sbjct: 16 FVQHSTA-IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
REVQ++K L HPNI+ L + +ED ++V E+ GGELFD I++R ++E AA +++
Sbjct: 75 REVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
++ + H+ ++HRDLKPEN L +K + + ++ IDFGLS F ++ + +G+ Y
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
Y+APEVL Y + DVWS GVILYILL G PPF E + + + + F+ W K
Sbjct: 194 YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGETVKARLKQFSVM 341
VSE+AKDL++KML P R++A + L+H W+Q K + +V + ++QF
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGT 313
Query: 342 NKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---------- 390
KL + AL + L S +E L F MD N G+++ EL G +
Sbjct: 314 QKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDAS 373
Query: 391 -GGQNIPEADLQILMEAV 407
+ E ++ +++AV
Sbjct: 374 MLDASAVEHEVDQVLDAV 391
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 566 bits (1460), Expect = 0.0
Identities = 123/386 (31%), Positives = 197/386 (51%), Gaps = 24/386 (6%)
Query: 44 CVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV----- 98
+++ G I Y R+LG G +G LC + N + A K I K +
Sbjct: 25 MYVRKKEG-KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 99 -----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
E++ E+ ++K L HPNI+ L D +ED ++V E EGGELF++I+ R
Sbjct: 84 KNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
+ E AA +MK I+ + H+ ++HRD+KPEN L NK +K +DFGLS FF
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 214 EQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
+ + +G+ YY+APEVLK+ Y + DVWS GVI+YILLCG PPF + +Q + + + +
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK---APNVSLGET 330
F + W +S+ AK+L+K ML D +R TAEE L W++ +
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322
Query: 331 VKARLKQFSVMNKLKKRALQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLGLL 389
+ +++F KL + A+ + L+ +EE L + F+ +D N G+++ +EL G
Sbjct: 323 ALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGYN 382
Query: 390 KGGQ--------NIPEADLQILMEAV 407
E ++ +++ V
Sbjct: 383 VLRNFKNELGELKNVEEEVDNILKEV 408
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 562 bits (1449), Expect = 0.0
Identities = 132/399 (33%), Positives = 207/399 (51%), Gaps = 16/399 (4%)
Query: 22 KPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNG 81
+ G E + G + G +S Y ++LG G +G LC D
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKG-HLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 82 EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG 141
+ A K I K + T+ + EV ++K L HPNI+ L D +ED ++VME +G
Sbjct: 63 VERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 142 GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201
GELFD I+ R + E AA ++K ++ V H+ ++HRDLKPEN L +K++ + +K
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE 261
+DFGLS F ++ E +G+ YY+APEVL++ Y + DVWS GVIL+ILL G PPF +
Sbjct: 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240
Query: 262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
T+Q + + + + F W VSE AKDL+K+ML D ++R++A++ LEHPW++
Sbjct: 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300
Query: 322 AP----NVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKR 376
+ +++F KL + AL +A L S EE L + F +D N
Sbjct: 301 KKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGD 360
Query: 377 GKINLEELRLGLLKGGQN--------IPEADLQILMEAV 407
G+++ +EL G K E+++ ++ A
Sbjct: 361 GQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAA 399
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 551 bits (1422), Expect = 0.0
Identities = 130/362 (35%), Positives = 199/362 (54%), Gaps = 8/362 (2%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+ + +Y L ELG+G F V C V G+++A I+ KKL +A D + + RE +I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
+ L KHPNIV L D+ ++ +++ +L GGELF+ IVAR +Y+E A+ ++ I+E
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAP 228
V CH+ GV+HR+LKPEN L A+K + + +K DFGL++ + + G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
EVL+++ YG VD+W+ GVILYILL G PPFW E + + Q I DF W V+
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 347
AKDL+ KML +P +R+TA E L+HPW+ + + + LK+F+ KLK
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302
Query: 348 ALQVVA--EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
L V+ SV + +K ++++ G E G L L+E
Sbjct: 303 ILTVMLATRNFSVRKQEIIKVTEQLIEAISNGDF--ESYTKMCDPGMTAFEPEALGNLVE 360
Query: 406 AV 407
+
Sbjct: 361 GL 362
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 537 bits (1386), Expect = 0.0
Identities = 122/350 (34%), Positives = 189/350 (54%), Gaps = 6/350 (1%)
Query: 34 ANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKK 93
G + R + S +YD+ ELG+G F V C G +FA K I+ KK
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 94 LRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH 153
L +A D + + RE +I + L +HPNIV L D+ +++S ++V +L GGELF+ IVAR
Sbjct: 67 L-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
Y+E A+ ++ I+E + CH G++HR+LKPEN L A+K + + +K DFGL++
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 214 EQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
E ++ G+P Y++PEVLK++ Y VD+W+ GVILYILL G PPFW E + + I
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
D+ W V+ AK L+ ML +PK+R+TA++ L+ PW+ N ++ + +
Sbjct: 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 304
Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLE 382
LK+F+ KLK L + + ++ L E
Sbjct: 305 DCLKKFNARRKLKGAILTTMI---ATRNLSNLGRNLLNKKEQGPPSTIKE 351
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 113/325 (34%), Positives = 172/325 (52%), Gaps = 10/325 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTAVDIEDVRREVQIMKHLPK 115
Y+L +G+G F V C + G++FA K + K + ED++RE I L K
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-K 84
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----YTERAAAAVMKTIVEVVQ 171
HP+IV L +TY D +++V E +G +L IV R Y+E A+ M+ I+E ++
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEV 230
CH+ ++HRD+KP L A+K+ S+P+K FG+++ G VG+P++MAPEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+KR YG VDVW GVIL+ILL G PF+ T++ + + II+ W +SE+A
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESA 263
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
KDLV++ML DP +R+T E L HPWL+ + +L++F+ KLK L
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVL 323
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTN 374
V+ E +
Sbjct: 324 AAVSSHKFNSFYGDPPEELPDFSED 348
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 514 bits (1327), Expect = 0.0
Identities = 130/350 (37%), Positives = 188/350 (53%), Gaps = 11/350 (3%)
Query: 7 RPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGR 66
SS + +++V + +S +++ ELGR
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD-ALSDFFEVESELGR 63
Query: 67 GEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126
G + Y C + +A K + K D + VR E+ ++ L HPNI+ LK+ +
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIF 117
Query: 127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE 186
E + + +V+EL GGELFDRIV +G+Y+ER AA +K I+E V HE G++HRDLKPE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAG 245
N L+A +PLK DFGLS + G+P Y APE+L+ YGPEVD+WS G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 246 VILYILLCGVPPFWAET-EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQR 304
+I YILLCG PF+ E +Q + + I+ F W +VS NAKDLV+K++ DPK+R
Sbjct: 238 IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297
Query: 305 LTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354
LT + L+HPW+ KA N +T + +L++F+ KLK VVA
Sbjct: 298 LTTFQALQHPWVTG--KAANFVHMDTAQKKLQEFNARRKLKAAVKAVVAS 345
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 512 bits (1322), Expect = 0.0
Identities = 111/329 (33%), Positives = 173/329 (52%), Gaps = 16/329 (4%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQ 108
+++ YD G ELG G+F V C + + G ++A K I K++ R V ED+ REV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
I+K + +HPN+++L + YE+ + V +++EL GGELFD + + TE A +K I+
Sbjct: 67 ILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
V H + H DLKPEN + ++ +K IDFGL+ G +F I G+P ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
PE++ G E D+WS GVI YILL G PF +T+Q + +F+ + + S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
AKD ++++L DPK+R+T ++ L+HPW++ +S R M K KK
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS-------RKASAVNMEKFKK 298
Query: 347 RALQVVAEFLSVEEVAGLKEAFEMMDTNK 375
A + + S GL + FE
Sbjct: 299 FAARKKSNNGS---GGGLNDIFEAQKIEW 324
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 499 bits (1286), Expect = e-179
Identities = 114/281 (40%), Positives = 172/281 (61%), Gaps = 4/281 (1%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
S +YD+ ELG+G F V C G +FA K I+ KKL +A D + + RE +I +
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRK 61
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
L +HPNIV L D+ +++S ++V +L GGELF+ IVAR Y+E A+ ++ I+E +
Sbjct: 62 L-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
CH G++HR+LKPEN L A+K + + +K DFGL++ E ++ G+P Y++PEVLK
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
++ Y VD+W+ GVILYILL G PPFW E + + I D+ W V+ AK
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN-AKKAPNVSLGETV 331
L+ ML +PK+R+TA++ L+ PW+ N + A + +TV
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 497 bits (1281), Expect = e-178
Identities = 117/278 (42%), Positives = 169/278 (60%), Gaps = 4/278 (1%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+ DI+ Y L +GRG +G + + A K I K + D++ ++E++I
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEI 59
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
MK L HPNI+ L +T+ED++ +++VMELC GGELF+R+V + + E AA +MK ++
Sbjct: 60 MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
V CH+ V HRDLKPENFLF SPLK IDFGL+ F+PG+ VG+PYY++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 230 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
VL+ YGPE D WSAGV++Y+LLCG PPF A T+ V I F W VS A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
+ L++++L PKQR+T+ + LEH W + + +L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 497 bits (1282), Expect = e-178
Identities = 88/317 (27%), Positives = 162/317 (51%), Gaps = 12/317 (3%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+++ Y + +LGRGEFG+ + C + ++ + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVV 170
+H NI+ L +++E + ++ E G ++F+RI ER + + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
Q H + H D++PEN ++ + SS +K I+FG + +PG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
D V ++L + K R+TA E L+HPWL+ + + V LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK----VIRTLKHRRYYHTLIKKDL 290
Query: 350 QVVAEFLSVEEVAGLKE 366
+V + ++
Sbjct: 291 NMVVSAARISCGGAIRS 307
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 493 bits (1271), Expect = e-176
Identities = 108/266 (40%), Positives = 160/266 (60%), Gaps = 2/266 (0%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ Y++ LG+G FG C D +++A K I+K + D + REV+++K
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKK 77
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
L HPNI+ L + ED S+ +IV EL GGELFD I+ R ++E AA ++K + +
Sbjct: 78 L-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK 232
H+ ++HRDLKPEN L +K++ +K IDFGLS F+ + + +G+ YY+APEVL+
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR 196
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
Y + DVWSAGVILYILL G PPF+ + E + + + F W +S++AKDL
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQN 318
++KML P R+TA + LEHPW+Q
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 495 bits (1275), Expect = e-175
Identities = 108/381 (28%), Positives = 167/381 (43%), Gaps = 23/381 (6%)
Query: 8 PDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRG 67
+ + P+P H L+ I + LG G
Sbjct: 14 FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 68 EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127
G + EKFA K + RREV++ + P+IV + D YE
Sbjct: 74 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125
Query: 128 D----DSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHR 181
+ + IVME +GGELF RI RG +TER A+ +MK+I E +Q H + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVD 240
D+KPEN L+ +K+ ++ LK DFG + +PYY+APEVL Y D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 241 VWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296
+WS GVI+YILLCG PPF++ G+ I +F W +VSE K L++ +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL 356
L +P QR+T E + HPW+ + K P L + + + + ++ + +
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRV 365
Query: 357 SVEEVAGLKEAFEMMDTNKRG 377
E++ + ++ D +
Sbjct: 366 DYEQI----KIKKIEDASNPL 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-175
Identities = 86/304 (28%), Positives = 155/304 (50%), Gaps = 6/304 (1%)
Query: 50 SGQDISIDYDL-GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
S ++ + Y L +ELGRG+F V C + G+++A K + K++ ++ E+
Sbjct: 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIA 80
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTI 166
+++ P +++L + YE+ S + +++E GGE+F + +E ++K I
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
+E V H+ ++H DLKP+N L ++ +K +DFG+S + EI+G+P Y+
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200
Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
APE+L + D+W+ G+I Y+LL PF E Q I + +D+ + + V
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET-VKARLKQFSVMNKL 344
S+ A D ++ +L +P++R TAE L H WLQ ET ++ + SV +
Sbjct: 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSE 320
Query: 345 KKRA 348
K +
Sbjct: 321 DKTS 324
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 491 bits (1266), Expect = e-175
Identities = 109/327 (33%), Positives = 165/327 (50%), Gaps = 19/327 (5%)
Query: 40 VHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD 99
VH + + + Y++ ++G G + V C +FA K I K K
Sbjct: 6 VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------ 59
Query: 100 IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA 159
D E++I+ +HPNI++LKD Y+D V++V EL +GGEL D+I+ + ++ER A
Sbjct: 60 -RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA 118
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLSVFFRPGEQ-FN 217
+AV+ TI + V+ H QGV+HRDLKP N L+ ++ ++ DFG + R
Sbjct: 119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 218 EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRS 273
+ ++APEVL+R Y D+WS GV+LY +L G PF +T + + I
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
W VS+ AKDLV KML+ DP QRLTA VL HPW+ + + P L
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAP 298
Query: 334 RLKQ------FSVMNKLKKRALQVVAE 354
L + +S +N+ + L+ V
Sbjct: 299 HLVKGAMAATYSALNRNQSPVLEPVGR 325
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 489 bits (1262), Expect = e-174
Identities = 103/324 (31%), Positives = 158/324 (48%), Gaps = 28/324 (8%)
Query: 52 QDISIDYDLG---RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
YDL + LG G F + C + + FA K ISK+ + ++E+
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEIT 57
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
+K HPNIV L + + D +VMEL GGELF+RI + H++E A+ +M+ +V
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS 117
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMA 227
V H+ GV+HRDLKPEN LF ++ ++ +K IDFG + P + + +Y A
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVIDFKR 279
PE+L +N Y D+WS GVILY +L G PF + + + I + F+
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237
Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL---------GET 330
+ W VS+ AKDL++ +L DP +RL + + WLQ+ + + L G
Sbjct: 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297
Query: 331 VKARLK-QFSVMNKLKKRALQVVA 353
V +K F NK K+ +
Sbjct: 298 VHTCVKATFHAFNKYKREGFCLQN 321
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 490 bits (1264), Expect = e-174
Identities = 110/354 (31%), Positives = 174/354 (49%), Gaps = 10/354 (2%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQ 108
Q + YD+G ELG G+F + C + + G ++A K I K++ R V E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
I++ + HPNI++L D YE+ + V +++EL GGELFD + + +E A + +K I++
Sbjct: 68 ILRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
V H + + H DLKPEN + +K P +K IDFGL+ G +F I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
PE++ G E D+WS GVI YILL G PF +T+Q I DF + + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMNKL 344
E AKD ++K+L + ++RLT +E L HPW+ + E K+ V +
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRW 306
Query: 345 KK--RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
K + + E + + R L ++
Sbjct: 307 KLSFSIVSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRRSST 360
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 490 bits (1263), Expect = e-174
Identities = 102/325 (31%), Positives = 161/325 (49%), Gaps = 15/325 (4%)
Query: 5 CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGREL 64
R D S + +K N ++ + + ++ YD +
Sbjct: 43 SLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVI 102
Query: 65 GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD-----IEDVRREVQIMKHLPKHPNI 119
GRG V C G +FA K + R + + E RRE I++ + HP+I
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
++L D+YE S + +V +L GELFD + + +E+ ++M++++E V H ++
Sbjct: 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK------- 232
HRDLKPEN L ++ ++ DFG S PGE+ E+ G+P Y+APE+LK
Sbjct: 223 HRDLKPENILLD---DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
YG EVD+W+ GVIL+ LL G PPFW + + + I+ F W S KDL
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339
Query: 293 VKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ ++L DP+ RLTAE+ L+HP+ +
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFFE 364
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 485 bits (1252), Expect = e-173
Identities = 105/311 (33%), Positives = 167/311 (53%), Gaps = 9/311 (2%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRRE 106
Q + YD+G ELG G+F + C + + G ++A K I K++ R V E++ RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
V I++ + H N+++L D YE+ + V +++EL GGELFD + + +E A + +K I
Sbjct: 66 VSILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYY 225
++ V H + + H DLKPEN + +K P +K IDFGL+ G +F I G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 226 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
+APE++ G E D+WS GVI YILL G PF +T+Q I DF + +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGE--TVKARLKQFSVMN 342
SE AKD ++K+L + ++RLT +E L HPW+ + E ++ V
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRR 304
Query: 343 KLKKRALQVVA 353
+ K + +V+
Sbjct: 305 RWKL-SFSIVS 314
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 482 bits (1244), Expect = e-172
Identities = 101/272 (37%), Positives = 157/272 (57%), Gaps = 8/272 (2%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
I + R+LG G FG +L + ++G + K+I+K + + V +E + E++++K
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLK 75
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIV 167
L HPNI+ + + +ED ++IVME CEGGEL +RIV+ +E A +MK ++
Sbjct: 76 SL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
+ H Q V+H+DLKPEN LF + SP+K IDFGL+ F+ E G+ YMA
Sbjct: 135 NALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194
Query: 228 PEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
PEV KR+ + D+WSAGV++Y LL G PF + + V Q ++ + P ++
Sbjct: 195 PEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTP 253
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
A DL+K+ML DP++R +A +VL H W + A
Sbjct: 254 QAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 477 bits (1230), Expect = e-170
Identities = 101/276 (36%), Positives = 159/276 (57%), Gaps = 6/276 (2%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQI 109
+ Y++G ELG G+F + C G+++A K I K++L R V E++ REV I
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
++ + +HPNI++L D +E+ + V +++EL GGELFD + + TE A +K I++
Sbjct: 62 LREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 170 VQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
V H + + H DLKPEN + +K + +K IDFG++ G +F I G+P ++AP
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
E++ G E D+WS GVI YILL G PF ET+Q I DF + + SE
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
AKD ++++L DPK+R+T + LEH W++ ++
Sbjct: 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 480 bits (1237), Expect = e-170
Identities = 107/376 (28%), Positives = 173/376 (46%), Gaps = 31/376 (8%)
Query: 10 SSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEF 69
G + +GK + P D++ V + +K+ + YD+ ELG G F
Sbjct: 8 HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ---GSVYDYYDILEELGSGAF 64
Query: 70 GVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129
GV + C + G F K I+ +D V+ E+ IM L HP +++L D +ED
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDK 120
Query: 130 SAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188
+ +++E GGELFDRI A + +E M+ E ++ HE ++H D+KPEN
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180
Query: 189 LFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVI 247
+ K ++S +K IDFGL+ P E + + APE++ R G D+W+ GV+
Sbjct: 181 MCETK-KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 248 LYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTA 307
Y+LL G+ PF E + Q + R +F D + VS AKD +K +L +P++RLT
Sbjct: 240 GYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 299
Query: 308 EEVLEHPWLQNAKKAPNVSLGETVK---------------------ARLKQFSVMNKLKK 346
+ LEHPWL+ + + R+ FS + K +
Sbjct: 300 HDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 359
Query: 347 RALQVVAEFLSVEEVA 362
+ Q+ + +E
Sbjct: 360 QEYQIYDSYFDRKEAV 375
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 473 bits (1219), Expect = e-168
Identities = 99/288 (34%), Positives = 152/288 (52%), Gaps = 16/288 (5%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVR--- 104
S +Y+ LGRG V C +++A K I +A +++++R
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 105 -REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
+EV I++ + HPNI+ LKDTYE ++ +V +L + GELFD + + +E+ +M
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 164 KTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP 223
+ ++EV+ H+ ++HRDLKPEN L + +K DFG S PGE+ E+ G+P
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 224 YYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276
Y+APE+++ YG EVD+WS GVI+Y LL G PPFW + + + I+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247
Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
F W S+ KDLV + L P++R TAEE L HP+ Q
Sbjct: 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 467 bits (1205), Expect = e-166
Identities = 111/319 (34%), Positives = 157/319 (49%), Gaps = 18/319 (5%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-----RTAVDIEDVRRE 106
+ + +Y + + LG G G L + +K A K ISK+K R A +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
++I+K L HP I+ +K+ ++ + +IV+EL EGGELFD++V E +
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
+ VQ HE G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 227 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDP 281
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 341
W +VSE A DLVKK+L DPK R T EE L HPWLQ+ + L + +
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK------FQDLLSEENES 297
Query: 342 NKLKKRALQVVAEFLSVEE 360
L + Q E
Sbjct: 298 TALPQVLAQPSTSRKRPRE 316
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-165
Identities = 108/328 (32%), Positives = 162/328 (49%), Gaps = 23/328 (7%)
Query: 47 KEPSGQDISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
EP ++ DY L ++ LG G G C G+K A K + R+
Sbjct: 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQ 70
Query: 106 EVQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAA 159
EV P+IV + D YE+ + I+ME EGGELF RI RG +TER A
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA 130
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
A +M+ I +Q H + HRD+KPEN L+ +K++ + LK DFG +
Sbjct: 131 AEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTP 189
Query: 220 VGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---- 274
+PYY+APEVL Y D+WS GVI+YILLCG PPF++ T Q ++ + R +
Sbjct: 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ 249
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
F W +VSE+AK L++ +L DP +RLT + + HPW+ + P L +
Sbjct: 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQ 309
Query: 335 LKQFSVMNKLKKRALQVVAEF-LSVEEV 361
+ +++K+ +A + ++V
Sbjct: 310 -EDKDHWDEVKEEMTSALATMRVDYDQV 336
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 473 bits (1220), Expect = e-164
Identities = 108/408 (26%), Positives = 174/408 (42%), Gaps = 17/408 (4%)
Query: 6 ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
GK +GK + + D YV + +K + YD+ ELG
Sbjct: 112 GYDVDEQGKIVRGKGTVSSNY--DNYVFDIWKQYYPQPVEIKH---DHVLDHYDIHEELG 166
Query: 66 RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
G FGV + T+ G FA K + D E VR+E+Q M L +HP +V+L D
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDA 222
Query: 126 YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK 184
+EDD+ + ++ E GGELF+++ +E A M+ + + + HE +H DLK
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 185 PENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWS 243
PEN +F K+ + LK IDFGL+ P + G+ + APEV + + G D+WS
Sbjct: 283 PENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
GV+ YILL G+ PF E + + + + + +SE+ KD ++K+L DP
Sbjct: 342 VGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNT 401
Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAG 363
R+T + LEHPWL S + +R + K K A + ++
Sbjct: 402 RMTIHQALEHPWLTPGNAPGRDS--QIPSSRYTKIRDSIKTKYDA--WPEPLPPLGRISN 457
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIIC 411
+ + + + P ++ + C
Sbjct: 458 YSSLRKHRPQEYSIRDAFWDRSEAQPRFIVK-PYGTEVGEGQSANFYC 504
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 460 bits (1186), Expect = e-163
Identities = 95/305 (31%), Positives = 143/305 (46%), Gaps = 35/305 (11%)
Query: 53 DISIDYDLGRE-LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
Y L + LG G C ++ +++A K I K+ V REV+++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLY 65
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
H N++ L + +E++ ++V E GG + I R H+ E A+ V++ + +
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI--------VGSP 223
H +G+ HRDLKPEN L + + SP+K DF L + + I GS
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 224 YYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE---------------T 262
YMAPEV++ Y D+WS GVILYILL G PPF
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
+ + ++I +F W +S AKDL+ K+L D KQRL+A +VL+HPW+Q A
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG--CA 303
Query: 323 PNVSL 327
P +L
Sbjct: 304 PENTL 308
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-159
Identities = 101/347 (29%), Positives = 171/347 (49%), Gaps = 18/347 (5%)
Query: 6 ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGR--E 63
S++ + + + A + HR+ K+ ++ Y + +
Sbjct: 40 KEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQ---GAVNSFYTVSKTEI 96
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLK 123
LG G FG + C + G K A K I + ++ D E+V+ E+ +M L H N++ L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQL-DHANLIQLY 152
Query: 124 DTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRD 182
D +E + + +VME +GGELFDRI+ + TE MK I E ++ H+ ++H D
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDV 241
LKPEN L N+ ++ +K IDFGL+ ++P E+ G+P ++APEV+ + D+
Sbjct: 213 LKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 242 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDP 301
WS GVI Y+LL G+ PF + + I+ D + + + +SE AK+ + K+L +
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 302 KQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRA 348
R++A E L+HPWL + K +S A+ K+ +
Sbjct: 332 SWRISASEALKHPWLSDHKLHSRLS------AQKKKNRGSDAQDFVT 372
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 442 bits (1139), Expect = e-154
Identities = 109/305 (35%), Positives = 155/305 (50%), Gaps = 16/305 (5%)
Query: 28 GDEYVVANGSTVVHRLCVL----KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEK 83
E ++ V L + + + +Y + + LG G G L + +K
Sbjct: 103 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKK 162
Query: 84 FACKSISKKKL-----RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMEL 138
A + ISK+K R A +V E++I+K L HP I+ +K+ ++ + +IV+EL
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLEL 220
Query: 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198
EGGELFD++V E ++ VQ HE G++HRDLKPEN L ++++E
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280
Query: 199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCG 254
+K DFG S + G+P Y+APEVL Y VD WS GVIL+I L G
Sbjct: 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
Query: 255 VPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
PPF T+ + I +F + W +VSE A DLVKK+L DPK R T EE L H
Sbjct: 341 YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400
Query: 314 PWLQN 318
PWLQ+
Sbjct: 401 PWLQD 405
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 437 bits (1127), Expect = e-154
Identities = 99/319 (31%), Positives = 144/319 (45%), Gaps = 39/319 (12%)
Query: 45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
L+ I + LG G G + EKFA K + R
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKAR 58
Query: 105 REVQIMKHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERA 158
REV++ + P+IV + D YE+ + IVME +GGELF RI RG +TER
Sbjct: 59 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
A+ +MK+I E +Q H + HRD+KPEN L+ +K+ ++ LK DFG
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------ 166
Query: 219 IVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSV 274
A E Y D+WS GVI+YILLCG PPF++ G+ I
Sbjct: 167 --------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
+F W +VSE K L++ +L +P QR+T E + HPW+ + K P L + +
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 278
Query: 335 LKQFSVMNKLKKRALQVVA 353
+ +K+ +A
Sbjct: 279 EDKER-WEDVKEEMTSALA 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-153
Identities = 99/341 (29%), Positives = 157/341 (46%), Gaps = 53/341 (15%)
Query: 37 STVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR- 95
+ + S ++ Y L +G+G +GV + + A K ++K K+R
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 96 -TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH- 153
D+E ++ EV++MK L HPNI L + YED+ + +VMELC GG L D++
Sbjct: 67 INPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 154 ---------------------------------------YTERAAAAVMKTIVEVVQVCH 174
E+ + +M+ I + H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPE 229
QG+ HRD+KPENFLF+ +S +K +DFGLS F G+PY++APE
Sbjct: 186 NQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 230 VLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
VL +YGP+ D WSAGV+L++LL G PF + ++ + F+ + +S
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLS 304
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWL-QNAKKAPNVS 326
A+DL+ +LN + +R A L+HPW+ Q + K +S
Sbjct: 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-118
Identities = 81/367 (22%), Positives = 155/367 (42%), Gaps = 29/367 (7%)
Query: 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
I + LG G G T + + + A K I + REVQ+++
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVC 173
+HPN++ T +D +I +ELC L + + + + +++ +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAI--DFGLSVFFRPGEQ----FNEIVGSPYYMA 227
H ++HRDLKP N L + +KA+ DFGL G + + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 228 PEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
PE+L K N VD++SAG + Y ++ G PF ++ A ++ + P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QANILLGACSLDCLHPE 253
Query: 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 342
A++L++KM+ DP++R +A+ VL+HP+ + +K + + V R+++ S+
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK--QLQFFQDVSDRIEKESLDG 311
Query: 343 KLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN----IPEA 398
+ K+ + + ++ + D K +R LL+ +N E
Sbjct: 312 PIVKQLERGGRAVVKMDWRENITVPL-QTDLRKFRTYKGGSVR-DLLRAMRNKKHHYREL 369
Query: 399 DLQILME 405
++
Sbjct: 370 PAEVRET 376
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-114
Identities = 83/401 (20%), Positives = 148/401 (36%), Gaps = 61/401 (15%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
Q + + LG G G G A K + + E++++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-------TERAAAAVMK 164
HPN++ + D ++I +ELC L D + ++ E ++++
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKK----------ESSPLKAIDFGLSVFFRPGE 214
I V H ++HRDLKP+N L + E+ + DFGL G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 215 Q-----FNEIVGSPYYMAPEVL--------KRNYGPEVDVWSAGVILYILLC-GVPPFWA 260
N G+ + APE+L KR +D++S G + Y +L G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 261 ETEQGVAQAIIRSVIDF---KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ + IIR + K + A DL+ +M++ DP +R TA +VL HP
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300
Query: 318 NAKKAPN----VSLGETVKARLKQFSVMNKLKKRALQVV-----AEFLSVEEVAGLKE-- 366
K VS ++ R +++ K + V+ + L+
Sbjct: 301 PKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYR 360
Query: 367 ---AFEMMDTNK--RGKINL-EELRLGLLKGGQNIPEADLQ 401
+ ++MD + R K + +L + + +P+
Sbjct: 361 KYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPDGFYD 401
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-101
Identities = 63/309 (20%), Positives = 111/309 (35%), Gaps = 43/309 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ L LG+G + G+ FA K + ++ RE +++K L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL-NH 66
Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
NIV L E+ + H +ME C G L+ + + E V++ +V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 172 VCHEQGVMHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
E G++HR++KP N + + S K DFG + EQF + G+ Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 231 LKR---------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------ 275
+R YG VD+WS GV Y G PF + ++ +I
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 276 ---------------DFKRDPWPKVSENAKDLVK----KMLNPDPKQRLTAEEVLEHPWL 316
+S + L+ +L D ++ ++
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 317 QNAKKAPNV 325
+ +
Sbjct: 307 ILHRGNSHH 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 2e-98
Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 28/294 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + +++G G + + + +A K ++ ++ ++ R E+ + L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQ-TLDSYRNEIAYLNKL-QQ 85
Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+ I+ L D D +++VME C +L + + + K ++E V H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE---IVGSPYYMAPEVL 231
+ G++H DLKP NFL + LK IDFG++ +P VG+ YM PE +
Sbjct: 145 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 232 KRN------------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
K P+ DVWS G ILY + G PF Q AII + +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 258
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
+ ++ +D++K L DPKQR++ E+L HP++Q N T +
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 1e-97
Identities = 81/328 (24%), Positives = 139/328 (42%), Gaps = 34/328 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + +++G G + + + +A K ++ ++ ++ R E+ + L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQ 66
Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+ I+ L D D +++VME C +L + + + K ++E V H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVL 231
+ G++H DLKP NFL + LK IDFG++ +P + VG+ YM PE +
Sbjct: 126 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 232 KR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
K P+ DVWS G ILY + G PF Q AII + +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 239
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET------VK 332
+ ++ +D++K L DPKQR++ E+L HP++Q N T V
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 299
Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEE 360
+L + N + K A + + E
Sbjct: 300 GQLVGLNSPNSILKAAKTLYEHYSGGES 327
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-97
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 41/296 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG + + +A K I + + + EV ++ L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL-NH 61
Query: 117 PNIVSLKDTYEDDSAVH-------------IVMELCEGGELFDRIVARGHYTERAAAA-V 162
+V + + I ME CE G L+D I + +R +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--------------- 207
+ I+E + H QG++HRDLKP N ES +K DFGL+
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 208 VFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 265
+ +G+ Y+A EVL +Y ++D++S G+I + ++ P
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN 236
Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
+ + + I+F D + K +++ +++ DP +R A +L WL +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 5e-97
Identities = 86/264 (32%), Positives = 125/264 (47%), Gaps = 10/264 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y GR LG+G F + +D + E FA K + K L E + E+ I + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
++V +ED+ V +V+ELC L + R TE A ++ IV Q H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN- 234
V+HRDLK N E +K DFGL+ GE+ + G+P Y+APEVL +
Sbjct: 135 RVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L++
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQ 247
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQN 318
KML DP R T E+L + +
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTS 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 1e-96
Identities = 64/334 (19%), Positives = 116/334 (34%), Gaps = 45/334 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ L LG+G + G+ FA K + ++ RE +++K L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL-NH 66
Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQ 171
NIV L E+ + H +ME C G L+ + + E V++ +V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 172 VCHEQGVMHRDLKPENFL-FANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
E G++HR++KP N + + S K DFG + EQF + G+ Y+ P++
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 231 LKRN---------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------ 275
+R YG VD+WS GV Y G PF + ++ +I
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 276 ---------------DFKRDPWPKVSENAKDLVK----KMLNPDPKQRLTAEEVLEHPWL 316
+S + L+ +L D ++ ++
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
Query: 317 QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQ 350
+ +V + + + +
Sbjct: 307 ILHRMVIHVF--SLQQMTAHKIYIHSYNTATIFH 338
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-96
Identities = 84/263 (31%), Positives = 122/263 (46%), Gaps = 10/263 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y GR LG+G F + +D + E FA K + K L E + E+ I + L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 100
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
++V +ED+ V +V+ELC L + R TE A ++ IV Q H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLKRN- 234
V+HRDLK N E +K DFGL+ + + G+P Y+APEVL +
Sbjct: 161 RVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L++
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLIQ 273
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQ 317
KML DP R T E+L +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFT 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-96
Identities = 81/327 (24%), Positives = 138/327 (42%), Gaps = 34/327 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + +++G G + + + +A K ++ ++ ++ R E+ + L +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQ 113
Query: 117 PN--IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
+ I+ L D D +++VME C +L + + + K ++E V H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE---IVGSPYYMAPEVL 231
+ G++H DLKP NFL + LK IDFG++ +P VG+ YM PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 232 KR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFK 278
K P+ DVWS G ILY + G PF Q AII + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHE 286
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGET------VK 332
+ ++ +D++K L DPKQR++ E+L HP++Q N T V
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVL 346
Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVE 359
+L + N + K A + + E
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEHYSGGE 373
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 5e-95
Identities = 88/275 (32%), Positives = 145/275 (52%), Gaps = 11/275 (4%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ +G LG+G F Y ++ G + A K I KK + A ++ V+ EV+I L KH
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHE 175
P+I+ L + +ED + V++V+E+C GE+ + R ++E A M I+ + H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN 234
G++HRDL N L +K DFGL+ P E+ + G+P Y++PE+ R+
Sbjct: 131 HGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 235 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
+G E DVWS G + Y LL G PPF +T + ++ + D++ + +S AKDL+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--DYEMPSF--LSIEAKDLI 243
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG 328
++L +P RL+ VL+HP++ + G
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-92
Identities = 95/277 (34%), Positives = 150/277 (54%), Gaps = 11/277 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++GR LG+G+FG YL + + A K + K +L A +RREV+I HL +H
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PNI+ L + D + V++++E G ++ + + E+ A + + + CH +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-Y 235
V+HRD+KPEN L + E LK DFG SV P + ++ G+ Y+ PE+++ +
Sbjct: 129 RVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
+VD+WS GV+ Y L G PPF A T Q + I R +F + V+E A+DL+ +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLISR 240
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ-NAKKAPNVSLGETV 331
+L +P QR EVLEHPW+ N+ K N E+
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 3e-92
Identities = 53/310 (17%), Positives = 92/310 (29%), Gaps = 44/310 (14%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--- 113
L L G+ V +L DV E FA K + + ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 114 --------------------PKHPNIVSLKDTYEDDSAVH--IVMELCEG------GELF 145
P L +D + + ++M L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 146 DRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205
V RG A + ++ + +G++H P+N L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239
Query: 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAET 262
+ G + Y E L + + ++ W G+ +Y + C PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 263 EQGVAQAIIRSVIDFKRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
S+ D + + K L+ + LN D ++RL E +E P
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 318 NAKKAPNVSL 327
+ + SL
Sbjct: 358 QLQNEISSSL 367
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 1e-91
Identities = 93/292 (31%), Positives = 156/292 (53%), Gaps = 11/292 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+Y L + +G+G F L + G + A K I K +L ++ + REV+IMK L H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PNIV L + E + ++++ME GGE+FD +VA G E+ A + + IV VQ CH++
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
++HRDLK EN L +K DFG S F G + + G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 236 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
GPEVDVWS GVILY L+ G PF + + + + ++R ++ + +S + ++L+K
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
+ L +P +R T E++++ W+ + + + + ++ +
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVG 298
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-90
Identities = 92/279 (32%), Positives = 157/279 (56%), Gaps = 10/279 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+D+GR LG+G+FG YL + N A K + K +L +RRE++I HL +H
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PNI+ + + + D +++++E GEL+ + G + E+ +A M+ + + + CHE+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY 235
V+HRD+KPEN L K E LK DFG SV P + + G+ Y+ PE++ + +
Sbjct: 134 KVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTH 189
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
+VD+W AGV+ Y L G+PPF + + + I+ D K P+ +S+ +KDL+ K
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLISK 245
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
+L P QRL + V+EHPW++ + + ++ +++
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQSK 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 4e-90
Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 34/312 (10%)
Query: 47 KEPSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
+ PS + +++ LG G FG + GE+ A K ++ + + E
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCL 61
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVH------IVMELCEGGELFDRIVARGH---YTE 156
E+QIMK L HPN+VS ++ + + + ME CEGG+L + + E
Sbjct: 62 EIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
++ I ++ HE ++HRDLKPEN + + K ID G + GE
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180
Query: 217 NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
E VG+ Y+APE+L+ + Y VD WS G + + + G PF + +R
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 276 DFKRDPWPKVSEN--------------------AKDLVKKMLNPDPKQRLTAEEVLEHPW 315
+ + ++ + ++ ML +QR T +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 LQNAKKAPNVSL 327
Q ++ L
Sbjct: 301 FQALDSILSLKL 312
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 9e-90
Identities = 98/268 (36%), Positives = 134/268 (50%), Gaps = 10/268 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LG LG G FG + G K A K ++++K+R+ + ++RE+Q +K +HP
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHP 71
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+I+ L + +VME GGELFD I G E A + + I+ V CH
Sbjct: 72 HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 132 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GPEVD+WS GVILY LLCG PF E + + I F + ++ + L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLMH 244
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
ML DP +R T +++ EH W + +
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 2e-88
Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 22/284 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMK 111
Y LG G FG + D ++ K I K+K+ IED V E+ I+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
+ +H NI+ + D +E+ +VME G +LF I E A+ + + +V V
Sbjct: 85 RV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
+ ++HRD+K EN + A +K IDFG + + G+ F G+ Y APEV
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 231 LKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
L N Y GPE+++WS GV LY L+ PF E + + I P+ VS+
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI---HPPYL-VSKE 250
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
LV +L P P++R T E+++ PW+ + + E +
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFR 294
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-88
Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 14/266 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+DL + LG G +G L + E A K + K+ E++++E+ I K L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NHE 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
N+V + + ++ +E C GGELFDRI E A ++ V H G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-KR 233
+ HRD+KPEN L + LK DFGL+ FR + N++ G+ Y+APE+L +R
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 234 NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKD 291
+ VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
L+ K+L +P R+T ++ + W
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYN 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 4e-88
Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 22/289 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
+Y LG LG+G FG + + + + A K I + ++ + D EV ++ +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 114 ---PKHPNIVSLKDTYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
HP ++ L D +E +V+E +LFD I +G E + +V
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
+Q CH +GV+HRD+K EN L K IDFG + + G+ Y PE
Sbjct: 152 IQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPE 208
Query: 230 VLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
+ Y VWS G++LY ++CG PF + E I+ + + F VS
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP----AHVSP 258
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLK 336
+ L+++ L P P R + EE+L PW+Q + ++ + A L
Sbjct: 259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLA 307
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 5e-88
Identities = 78/266 (29%), Positives = 124/266 (46%), Gaps = 14/266 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+DL + LG G +G L + E A K + K+ E++++E+ I K L H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NHE 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
N+V + + ++ +E C GGELFDRI E A ++ V H G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVL-KR 233
+ HRD+KPEN L + LK DFGL+ FR + N++ G+ Y+APE+L +R
Sbjct: 126 ITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 234 NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKD 291
+ VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLA 240
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
L+ K+L +P R+T ++ + W
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYN 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 8e-88
Identities = 47/326 (14%), Positives = 97/326 (29%), Gaps = 66/326 (20%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--- 113
G LG+ + TD GE F + + I+ ++ EV ++ L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 114 ---------------------PKHPNIVSLKDTYEDDSA--VHIVMELCE------GGEL 144
P+ ++ ++ D + + G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 145 FDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204
A + ++ ++ H G++H L+P + + + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGF 250
Query: 205 GLSVFFRPGEQFNEIVGSPYYMAPEVLKRN------------YGPEVDVWSAGVILYILL 252
V S + PE+ R D W+ G+++Y +
Sbjct: 251 EHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 253 CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
C P + G ++ I RS + + + + L++ L + RL + +E
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 313 HPWLQNAKKAPNVSLGETVKARLKQF 338
P + L + A L +
Sbjct: 360 TPEYEQ--------LRTELSAALPLY 377
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 1e-87
Identities = 87/264 (32%), Positives = 129/264 (48%), Gaps = 10/264 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
YD +++G G FGV L D E A K I + E+V+RE+ + L +HP
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSL-RHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
NIV K+ + + I+ME GGEL++RI G ++E A + ++ V CH
Sbjct: 77 NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
+ HRDLK EN L + + LK DFG S Q VG+P Y+APEVL ++ Y
Sbjct: 137 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--DFKRDPWPKVSENAKDLV 293
G DVWS GV LY++L G PF E + I+ ++ + ++S L+
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 294 KKMLNPDPKQRLTAEEVLEHPWLQ 317
++ DP R++ E+ H W
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFL 279
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 8e-87
Identities = 103/330 (31%), Positives = 161/330 (48%), Gaps = 13/330 (3%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y + LG G FG L T +K A K IS++ L+ + V RE+ +K L +HP
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP 69
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+I+ L D + + +V+E GGELFD IV + TE + I+ ++ CH
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY- 235
++HRDLKPEN L + +K DFGLS G GSP Y APEV+ + Y
Sbjct: 129 IVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GPEVDVWS G++LY++L G PF E + + + + + +S A+ L+++
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIRR 241
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARL--KQFSVMNKLKKRALQVVA 353
M+ DP QR+T +E+ PW + E + + S + + + +
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIV 301
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEE 383
E L +E +KEA+ ++ N+ + LE
Sbjct: 302 EALRSDENNEVKEAYNLLHENQVIQEKLEH 331
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-86
Identities = 109/337 (32%), Positives = 159/337 (47%), Gaps = 18/337 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LG LG G FG + G K A K ++++K+R+ + +RRE+Q +K +HP
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHP 76
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+I+ L S + +VME GGELFD I G E+ + + + I+ V CH
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL-KRNY- 235
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 137 VVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
GPEVD+WS+GVILY LLCG PF + + + I F + ++ + L+K
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLKH 249
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ------FSVMNKLKKRAL 349
ML DP +R T +++ EH W + + P E V K +
Sbjct: 250 MLQVDPMKRATIKDIREHEWFK--QDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRL 386
+V++ + L A+ ++ N+R ++ L
Sbjct: 308 EVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYL 344
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 1e-86
Identities = 85/290 (29%), Positives = 139/290 (47%), Gaps = 37/290 (12%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD------------------ 99
Y L E+G+G +GV L + N+ +A K +SKKKL
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 100 -----IEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI--VMELCEGGELFDRIVARG 152
IE V +E+ I+K L HPN+V L + +D + H+ V EL G + + +
Sbjct: 75 QPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
+E A + +++ ++ H Q ++HRD+KP N L +K DFG+S F+
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFKG 189
Query: 213 GEQF-NEIVGSPYYMAPEVL---KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
+ + VG+P +MAPE L ++ + G +DVW+ GV LY + G PF E +
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
I + P ++E+ KDL+ +ML+ +P+ R+ E+ HPW+
Sbjct: 250 SKIKSQ--ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-86
Identities = 82/269 (30%), Positives = 129/269 (47%), Gaps = 20/269 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
Y +G LG G FG Y V++ A K + K ++ ++ + V EV ++K +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 114 P-KHPNIVSLKDTYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
++ L D +E + +++E E +LFD I RG E A + ++E V+
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
CH GV+HRD+K EN L + LK IDFG + + + G+ Y PE +
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWI 220
Query: 232 K-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+ Y G VWS G++LY ++CG PF + E IIR + F+ +VS
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 270
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ L++ L P R T EE+ HPW+Q+
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 5e-86
Identities = 67/335 (20%), Positives = 122/335 (36%), Gaps = 50/335 (14%)
Query: 47 KEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDI----- 100
K +D I DY + R L +G+F LC + + +A K K L D
Sbjct: 21 KYVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNN 78
Query: 101 ---------EDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR 151
+D + E+QI+ + K+ ++ + + V+I+ E E +
Sbjct: 79 DKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 152 GH--------YTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAI 202
+ ++K+++ H + + HRD+KP N L +K
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLS 194
Query: 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFW 259
DFG S + ++ G+ +M PE G +VD+WS G+ LY++ V PF
Sbjct: 195 DFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS 253
Query: 260 AETEQ----------------GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
+ + +S D +K L +P +
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
R+T+E+ L+H WL + + + + K+
Sbjct: 314 RITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 1e-85
Identities = 72/263 (27%), Positives = 110/263 (41%), Gaps = 13/263 (4%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ LG G +G + +G +A K S R D EV + + +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVVQVCHE 175
P V L+ +E+ +++ ELC G L A G E ++ + + H
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
QG++H D+KP N + K DFGL V G P YMAPE+L+ +Y
Sbjct: 176 QGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232
Query: 236 GPEVDVWSAGVILYILLCGVP-PFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
G DV+S G+ + + C + P E Q + Q + +S + ++
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLV 286
Query: 295 KMLNPDPKQRLTAEEVLEHPWLQ 317
ML PDPK R TAE +L P L+
Sbjct: 287 MMLEPDPKLRATAEALLALPVLR 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 3e-83
Identities = 84/277 (30%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ +G G +G ++G+ K + + T + + + EV +++ L KH
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 64
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVV 170
PNIV D D ++ ++IVME CEGG+L I R + E VM + +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 171 QVCHEQG-----VMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
+ CH + V+HRDLKP N FL + +K DFGL+ F VG+P
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGTP 180
Query: 224 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282
YYM+PE + +Y + D+WS G +LY L +PPF A +++ +A I
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----RRI 236
Query: 283 PKV-SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
P S+ +++ +MLN R + EE+LE+P +
Sbjct: 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 4e-82
Identities = 71/271 (26%), Positives = 139/271 (51%), Gaps = 16/271 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y +++G G FG L +G ++ K I+ ++ ++ + E+ RREV ++ ++ KH
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KH 82
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH 174
PNIV ++++E++ +++IVM+ CEGG+LF RI A+ + E I ++ H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 175 EQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPYYMAPEVLK 232
++ ++HRD+K +N FL + ++ DFG++ + +G+PYY++PE+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP-KVSENAK 290
Y + D+W+ G +LY L F A + + + II P S + +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF----PPVSLHYSYDLR 254
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
LV ++ +P+ R + +LE ++ +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-79
Identities = 65/298 (21%), Positives = 111/298 (37%), Gaps = 34/298 (11%)
Query: 48 EPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
G + I Y ++LG G F L +++G +A K I + + D E+ +
Sbjct: 18 YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQ 74
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVAR----GHYTE 156
RE + + HPNI+ L + +++ + G L++ I TE
Sbjct: 75 READMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG--- 213
++ I ++ H +G HRDLKP N L ++ + +D G
Sbjct: 134 DQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACIHVEG 190
Query: 214 -------EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAET 262
+ + + Y APE+ DVWS G +LY ++ G P+
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 263 EQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW-LQNA 319
++G + A+ P+ S L+ M+ DP QR +L LQ
Sbjct: 251 QKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 9e-79
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 20/271 (7%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-VRREVQIMKHLPKH 116
Y +G LG G +G D + A K + KKKLR + E V++E+Q+++ L +H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH 65
Query: 117 PNIVSLKDTYEDDSAVHI--VMELCEGG--ELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
N++ L D ++ + VME C G E+ D + + A +++ ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEY 124
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF---FRPGEQFNEIVGSPYYMAPE 229
H QG++H+D+KP N L LK G++ F + GSP + PE
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 230 VL--KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
+ + G +VD+WSAGV LY + G+ PF + + + I + +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--CG 237
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
DL+K ML +P +R + ++ +H W +
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 4e-77
Identities = 64/284 (22%), Positives = 109/284 (38%), Gaps = 38/284 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ +G G FG + +G+ + K + E REV+ + L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DH 63
Query: 117 PNIVSLKDTYEDDSA----------------VHIVMELCEGGELFDRIVAR--GHYTERA 158
NIV ++ + I ME C+ G L I R +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
A + + I + V H + +++RDLKP N + K+ +K DFGL + +
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTSLKNDGKRTR 180
Query: 219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF 277
G+ YM+PE + ++YG EVD+++ G+IL LL + +I
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTDLRDGIIS- 237
Query: 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
+ K L++K+L+ P+ R E+L +
Sbjct: 238 -----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-76
Identities = 76/278 (27%), Positives = 131/278 (47%), Gaps = 16/278 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ + +++GRG+F Y + +G A K + L A D +E+ ++K L H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQV 172
PN++ ++ +D+ ++IV+EL + G+L I ER + ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 173 CHEQGVMHRDLKPEN-FLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEV 230
H + VMHRD+KP N F+ A +K D GL F + +VG+PYYM+PE
Sbjct: 152 MHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVIDFKRDPWPKVSE 287
+ N Y + D+WS G +LY + PF+ + + + I + D+ P SE
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 265
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
+ LV +NPDP++R V + +A A ++
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-73
Identities = 78/300 (26%), Positives = 128/300 (42%), Gaps = 40/300 (13%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ + LGRG FGV + + + +A K I + E V REV+ + L +H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EH 62
Query: 117 PNIVSLKDTYEDDSA------------VHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
P IV + + + + ++I M+LC L D + R ER + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 165 T---IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-------------V 208
I E V+ H +G+MHRDLKP N F +K DFGL
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLT 179
Query: 209 FFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
+ VG+ YM+PE + +Y +VD++S G+IL+ LL PF + E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
+R+ + F + +V+ ML+P P +R A ++E+ ++ L
Sbjct: 237 LTDVRN-LKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-71
Identities = 75/308 (24%), Positives = 116/308 (37%), Gaps = 44/308 (14%)
Query: 51 GQDISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
GQ + + + R L G F Y DV +G ++A K + + + +EV
Sbjct: 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEV 76
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSA--------VHIVMELCEGG--ELFDRIVARGHYTER 157
MK L HPNIV ++ ELC+G E ++ +RG +
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 158 AAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-- 213
+ VQ H Q ++HRDLK EN L +N+ +K DFG +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPD 193
Query: 214 -----------EQFNEIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPF 258
E+ +P Y PE++ G + D+W+ G ILY+L PF
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 259 WAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
E G I+ P L++ ML +P++RL+ EV+
Sbjct: 254 ----EDGAKLRIVNGKYSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307
Query: 319 AKKAPNVS 326
A + N
Sbjct: 308 AARNVNPK 315
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-69
Identities = 44/303 (14%), Positives = 91/303 (30%), Gaps = 55/303 (18%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL---- 113
G LG+ + TD GE F + + I+ ++ EV ++ L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 114 --------------------PKHPNIVSLKDTYEDDSAVH--IVMELCEG------GELF 145
P+ ++ ++ D + + + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 146 DRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205
A + ++ ++ H G++H L+P + + + + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 206 LSVFFRPGE----QFNEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCGV 255
V R G P A +L D W+ G+ +Y + C
Sbjct: 257 HLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 256 PPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
P + G ++ I RS + + + + L++ L + RL + +E P
Sbjct: 315 LPNTDDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366
Query: 316 LQN 318
+
Sbjct: 367 YEQ 369
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 5e-69
Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 32/291 (10%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ ++ ++G GEFG + C +G +A K SKK L +VD ++ REV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAV 66
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVE 168
L +H ++V + +D + I E C GG L D I ++ E ++ +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI----------------DFGLSVFFRP 212
++ H ++H D+KP N + + D G
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TR 183
Query: 213 GEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
G ++A EVL+ N + P+ D+++ + + P G
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHE 239
Query: 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
IR R P +S+ +L+K M++PDP++R +A +++H L +A +
Sbjct: 240 IRQ-GRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-64
Identities = 54/314 (17%), Positives = 102/314 (32%), Gaps = 38/314 (12%)
Query: 57 DYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+ LG G F Y T D N +KF K + + ++ +K
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERA-----AAAVMKTI 166
+ + + +V EL G L + I + E+ + +
Sbjct: 123 PS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSP--------LKAIDFGLSV---FFRPGEQ 215
+ +++ H+ ++H D+KP+NF+ N L ID G S+ F G
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 216 FNEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
F + + E+L + + ++D + +Y +L G +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
+ D W + MLN L + ++L KK ++A
Sbjct: 302 L-PHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL----KKVFQQHYTNKIRAL 349
Query: 335 LKQFSVMNKLKKRA 348
+ V+ KR+
Sbjct: 350 RNRLIVLLLECKRS 363
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 24/272 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ G+ LG G F L ++ ++A K + K+ + + V RE +M L H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 89
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
P V L T++DD ++ + + GEL I G + E A IV ++
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA---EIVSALEYL 146
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGEQFNEIVGSPYYMAPEV 230
H +G++HRDLKPEN L ++ DFG + + N VG+ Y++PE+
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
L D+W+ G I+Y L+ G+PPF A E + Q II+ DF K A
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 259
Query: 290 KDLVKKMLNPDPKQRLT------AEEVLEHPW 315
+DLV+K+L D +RL + HP+
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-59
Identities = 67/326 (20%), Positives = 118/326 (36%), Gaps = 26/326 (7%)
Query: 5 CARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGREL 64
+ + S AK ++ P N ++ + ++ +
Sbjct: 14 ASLAKTWSSGSAKLQRLGPET-------EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV 66
Query: 65 GRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD 124
GRG FG + D G + A K + + R E+ L P IV L
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYG 117
Query: 125 TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK 184
+ V+I MEL EGG L I G E A + +E ++ H + ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 185 PENFLFANKKESSPLKAIDFGLS------VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGP 237
+N L ++ S DFG + + + I G+ +MAPEV+
Sbjct: 178 ADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKML 297
+VD+WS+ ++ +L G P+ + I + P P + +++ L
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-PSCAPLTAQAIQEGL 294
Query: 298 NPDPKQRLTAEEVLEHPWLQNAKKAP 323
+P R +A E+ +
Sbjct: 295 RKEPVHRASAMELRRKVGKALQEVGG 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-59
Identities = 76/289 (26%), Positives = 128/289 (44%), Gaps = 25/289 (8%)
Query: 48 EPSGQDISIDYDLGRE-----LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED 102
+ + DY+ LG+G +G+ Y D++N + A K I R + +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65
Query: 103 VRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG---HYTERAA 159
+ E+ + KHL KH NIV ++ ++ + I ME GG L + ++ E+
Sbjct: 66 LHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNE 218
K I+E ++ H+ ++HRD+K +N L S LK DFG S
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTET 182
Query: 219 IVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275
G+ YMAPE++ + YG D+WS G + + G PP + E + A A+ + +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFK--V 238
Query: 276 DFKRDPWP---KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
+ +S AK + K PDP +R A ++L +L+ + K
Sbjct: 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-57
Identities = 78/279 (27%), Positives = 135/279 (48%), Gaps = 23/279 (8%)
Query: 47 KEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
+ PS + +D + LG G FG L +G +A K + K+K+ IE
Sbjct: 31 ETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAV 162
E +I++ + P +V L+ +++D+S +++VME GGE+F + G ++E A AA
Sbjct: 91 EKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA- 148
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
IV + H +++RDLKPEN L + ++ DFG + R + + G+
Sbjct: 149 --QIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAK--RVKGRTWTLCGT 201
Query: 223 PYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281
P +APE++ Y VD W+ GV++Y + G PPF+A+ + + I+ + F
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH- 260
Query: 282 WPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
S + KDL++ +L D +R ++ H W
Sbjct: 261 ---FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-56
Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 16/267 (5%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
E+GRG F Y D + A + +KL T + + + E +++K L +HPNI
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNI 87
Query: 120 V----SLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
V S + T + + +V EL G L + + + + I++ +Q H
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 176 QG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
+ ++HRDLK +N +F S +K D GL+ R ++G+P +MAPE+ +
Sbjct: 148 RTPPIIHRDLKCDN-IFITGPTGS-VKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE 204
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI-DFKRDPWPKV-SENAKD 291
Y VDV++ G+ + + P ++E + A I R V K + KV K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP-YSECQN--AAQIYRRVTSGVKPASFDKVAIPEVKE 261
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+++ + + +R + +++L H + Q
Sbjct: 262 IIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 9e-56
Identities = 70/270 (25%), Positives = 131/270 (48%), Gaps = 16/270 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+++ R +G+G FG + + + +A K ++K+K ++ +V +E+QIM+ L +H
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EH 74
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V+L +++D+ + +V++L GG+L + H+ E + +V + Q
Sbjct: 75 PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRN-- 234
++HRD+KP+N L E + DF ++ Q + G+ YMAPE+
Sbjct: 135 RIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 235 --YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
Y VD WS GV Y LL G P+ + + + + +V+ + S+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEM 247
Query: 290 KDLVKKMLNPDPKQRL-TAEEVLEHPWLQN 318
L+KK+L P+P QR +V P++ +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-55
Identities = 82/269 (30%), Positives = 126/269 (46%), Gaps = 16/269 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ + +GRG FG L + + +A K +SK ++ D E IM
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NS 128
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L ++DD +++VME GG+L +++ E+ A +V + H
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKR- 233
G +HRD+KP+N L +S LK DFG + + VG+P Y++PEVLK
Sbjct: 188 GFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 234 ----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
YG E D WS GV LY +L G PF+A++ G I+ +S+ A
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304
Query: 290 KDLVKKMLNPDPKQRLT---AEEVLEHPW 315
K+L+ L D + RL EE+ H +
Sbjct: 305 KNLICAFLT-DREVRLGRNGVEEIKRHLF 332
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 6e-55
Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 22/268 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ + R LG G FG +L +NG +A K + K+ + +E E ++ + H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-TH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AAVMKTIVEVVQVC 173
P I+ + T++D + ++M+ EGGELF + + A AA + ++
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEYL 122
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233
H + +++RDLKPEN L +K DFG + + + G+P Y+APEV+
Sbjct: 123 HSKDIIYRDLKPENILLDKNGH---IKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 234 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
Y +D WS G+++Y +L G PF+ + I+ + + F +E+ KDL
Sbjct: 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDL 233
Query: 293 VKKMLNPDPKQRL-----TAEEVLEHPW 315
+ +++ D QRL E+V HPW
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 72/334 (21%), Positives = 119/334 (35%), Gaps = 81/334 (24%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-------SKKKLRTAVDI--------- 100
D++ + +GRG FGV + + + +A K I +++K+ V
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 101 ---------------------------------------EDVRREVQIMKHLPKHPNIVS 121
+ +++ M N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF-STKNTVG 125
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV---MKTIVEVVQVCHEQGV 178
++I M+LC L D + R +R I E V+ H +G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLS-------------VFFRPGEQFNEIVGSPYY 225
MHRDLKP N F +K DFGL VG+ Y
Sbjct: 186 MHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 226 MAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
M+PE + NY +VD++S G+IL+ LL F + E+ +R+ + F K
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-LKFPLLFTQK 298
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+V+ ML+P P +R A +++E+ +N
Sbjct: 299 -YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-54
Identities = 89/334 (26%), Positives = 156/334 (46%), Gaps = 23/334 (6%)
Query: 6 ARPDSSSGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
S + + E A VV D + D ++G
Sbjct: 5 HHHSSGVDLGTENLYFQS-GVVTHEQFKAALRMVV---------DQGDPRLLLDSYVKIG 54
Query: 66 RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
G G+ L + ++G + A K + LR E + EV IM+ +H N+V + +
Sbjct: 55 EGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKS 110
Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185
Y + ++ME +GG L D IV++ E A V + +++ + H QGV+HRD+K
Sbjct: 111 YLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 186 ENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWS 243
++ L +K DFG + + +VG+PY+MAPEV+ R+ Y EVD+WS
Sbjct: 170 DSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWS 226
Query: 244 AGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQ 303
G+++ ++ G PP+++++ + + S ++ KVS +D +++ML DP++
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS-HKVSPVLRDFLERMLVRDPQE 285
Query: 304 RLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
R TA+E+L+HP+L L ++ KQ
Sbjct: 286 RATAQELLDHPFLLQTG--LPECLVPLIQLYRKQ 317
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 4e-54
Identities = 87/286 (30%), Positives = 143/286 (50%), Gaps = 13/286 (4%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
S D Y ++G+G G Y DV G++ A + + L+ E + E+ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILV 70
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
M+ K+PNIV+ D+Y + +VME GG L D +V E AAV + ++
Sbjct: 71 MREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMAP 228
++ H V+HRD+K +N L +K DFG + + +VG+PY+MAP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
EV+ R YGP+VD+WS G++ ++ G PP+ E I + ++P K+S
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSA 244
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKA 333
+D + + L D ++R +A+E+L+H +L+ AK P SL + A
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK--PLSSLTPLIAA 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-53
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 13/288 (4%)
Query: 37 STVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
S +R K Q ++ + R LG+G FG C G+ +ACK + KK+++
Sbjct: 164 SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK 223
Query: 96 TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI--VARGH 153
E QI++ + +VSL YE A+ +V+ L GG+L I + +
Sbjct: 224 KRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG 282
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
+ E A I ++ H + +++RDLKPEN L + ++ D GL+V G
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEG 339
Query: 214 EQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
+ VG+ YMAPEV+K Y D W+ G +LY ++ G PF ++ + + R
Sbjct: 340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
Query: 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
V + + + S A+ L ++L DP +RL +A EV EHP
Sbjct: 400 LVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 22/293 (7%)
Query: 37 STVVHRLCVLKEPSGQD-ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL 94
S R C K +++ D+ + R +GRG FG Y C + G+ +A K + KK++
Sbjct: 168 SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 95 RTAVDIEDVRREVQIMK--HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG 152
+ E ++ P IV + + + +++L GG+L + G
Sbjct: 228 KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG 287
Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
++E I+ ++ H + V++RDLKP N L E ++ D GL+ F
Sbjct: 288 VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDF-S 343
Query: 213 GEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETE---QGVA 267
++ + VG+ YMAPEVL++ Y D +S G +L+ LL G PF +
Sbjct: 344 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
+ + ++ S + L++ +L D +RL A+EV E P+
Sbjct: 404 RMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 75/272 (27%), Positives = 131/272 (48%), Gaps = 18/272 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG FG + N + FA K ++K ++ + R E ++ +
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DS 133
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHE 175
I +L ++DD+ +++VM+ GG+L + E A + +V + H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVL-- 231
+HRD+KP+N L + ++ DFG + + VG+P Y++PE+L
Sbjct: 194 LHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-PKVS 286
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ VS
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310
Query: 287 ENAKDLVKKMLNPDPKQRLT---AEEVLEHPW 315
ENAKDL+++++ + RL E+ +HP+
Sbjct: 311 ENAKDLIRRLIC-SREHRLGQNGIEDFKKHPF 341
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-52
Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 28/287 (9%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY+L +G G V EK A K I+ +K +T ++++ +E+Q M H
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQC-HH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMKTIVE 168
PNIVS ++ + +VM+L GG + D G E A +++ ++E
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF------NEIVGS 222
++ H+ G +HRD+K N L ++ DFG+S F G VG+
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 223 PYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS------V 274
P +MAPEV+++ Y + D+WS G+ L G P+ V +++
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
++ K ++ + ++ L DP++R TA E+L H + Q AK
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 15/270 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+++ R LG+G FG L G+ +A K + K + D+E E +I+ H
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ + VME GG+L I + E A I+ + H++
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N L K DFG+ G G+P Y+APE+L+
Sbjct: 144 GIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YGP VD W+ GV+LY +LCG PF AE E + +AI+ + + + E+A ++K
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILK 256
Query: 295 KMLNPDPKQRL------TAEEVLEHPWLQN 318
+ +P RL +L HP+ +
Sbjct: 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 14/269 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG L E +A K + K + D+E E +++ K
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ ++ VME GG+L I G + E A I + +
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N + +K DFG+ G G+P Y+APE++
Sbjct: 141 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 197
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YG VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + K
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 253
Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
++ P +RL ++ EH + +
Sbjct: 254 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 12/280 (4%)
Query: 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
+ D + ++G+G FG + D + A K I ++ +IED+++E+
Sbjct: 14 QNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEI 71
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
++ P + +Y D+ + I+ME GG D ++ G E A +++ I+
Sbjct: 72 TVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREIL 129
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYM 226
+ + H + +HRD+K N L + E +K DFG++ + N VG+P++M
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 186
Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
APEV+K++ Y + D+WS G+ L G PP V I ++ +
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY--- 243
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
S+ K+ V+ LN +P R TA+E+L+H ++ K +
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 10/265 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ L + LG+G FG +L + FA K++ K + D+E E +++ +H
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + + T++ + VME GG+L I + + A I+ +Q H +
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 137
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N L + +K DFG+ + N G+P Y+APE+L
Sbjct: 138 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 194
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
Y VD WS GV+LY +L G PF + E+ + +I + R + + AKDL+
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLV 250
Query: 295 KMLNPDPKQRLTA-EEVLEHPWLQN 318
K+ +P++RL ++ +HP +
Sbjct: 251 KLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-51
Identities = 86/349 (24%), Positives = 141/349 (40%), Gaps = 49/349 (14%)
Query: 7 RPDSSSGKRAKGKKEKPNPFYGDEYVV-ANGSTVVHRLCVLKEPSGQDISIDYDLGRELG 65
RP ++S + ++P+ F + +GS V + + + + Y + +G
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 66 RGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125
G FGV Y ++GE A K + + K RE+QIM+ L H NIV L+
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHCNIVRLRYF 115
Query: 126 Y------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT----IVEVVQVCHE 175
+ +D+ +++V++ ++ + +K + + H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KR 233
G+ HRD+KP+N L + +++ LK DFG + GE + S YY APE++
Sbjct: 175 FGICHRDIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-------RSVIDF--------- 277
+Y +DVWSAG +L LL G P F ++ II R I
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292
Query: 278 ----KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
K PW P+ A L ++L P RLT E H +
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-51
Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 29/312 (9%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
D + RE+G G FG Y DV N E A K +S ++ +D+ +EV+
Sbjct: 48 FKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRF 107
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
++ L +HPN + + Y + +VME C G V + E AAV ++
Sbjct: 108 LQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 166
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYM 226
+ H ++HRD+K N L + E +K DFG + N VG+PY+M
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA------SIMAPANSFVGTPYWM 217
Query: 227 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP- 281
APEV+ + Y +VDVWS G+ L PP + I + +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNESP 271
Query: 282 ---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQF 338
SE ++ V L P+ R T+E +L+H ++ + P + + ++
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAV 329
Query: 339 SVMNKLKKRALQ 350
++ L+ R ++
Sbjct: 330 RELDNLQYRKMK 341
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 69/274 (25%), Positives = 123/274 (44%), Gaps = 20/274 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++ + +GRG F + G+ +A K ++K + ++ R E ++ +
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DR 120
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHE 175
I L ++D++ +++VME GG+L + G A + IV + H
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLKR 233
G +HRD+KP+N L ++ DFG + R VG+P Y++PE+L+
Sbjct: 181 LGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 234 --------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
+YGPE D W+ GV Y + G PF+A++ I+ +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 285 VSENAKDLVKKMLNPDPKQRLT---AEEVLEHPW 315
V E A+D ++++L P+ RL A + HP+
Sbjct: 298 VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-51
Identities = 76/301 (25%), Positives = 140/301 (46%), Gaps = 15/301 (4%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+ +D+ +LG G +G Y G+ A K + + D++++ +E+ I
Sbjct: 23 LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISI 77
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVE 168
M+ P++V +Y ++ + IVME C G + D I R TE A ++++ ++
Sbjct: 78 MQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLK 136
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIVGSPYYMA 227
++ H +HRD+K N L + K DFG++ + N ++G+P++MA
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQLTDTMAKRNTVIGTPFWMA 193
Query: 228 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
PEV++ Y D+WS G+ + G PP+ I + R P S
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP-ELWS 252
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
+N D VK+ L P+QR TA ++L+HP++++AK L + + + + ++
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK--GVSILRDLINEAMDVKLKRQESQQ 310
Query: 347 R 347
R
Sbjct: 311 R 311
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-50
Identities = 80/306 (26%), Positives = 142/306 (46%), Gaps = 47/306 (15%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
Y+ ++G G +GV + C + + G+ A K K + D ++ RE++++K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEVV 170
L KHPN+V+L + + +H+V E C+ DR + E ++ ++ V
Sbjct: 59 L-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAV 115
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPE 229
CH+ +HRD+KPEN L +K DFG + P + +++ V + +Y +PE
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172
Query: 230 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQ 268
+L YGP VDVW+ G + LL GVP + +++ Q +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 269 AIIRSVIDFK--------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
S + +P +S A L+K L+ DP +RLT E++L HP+ +N +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 321 KAPNVS 326
+ +++
Sbjct: 293 EIEDLA 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-50
Identities = 84/269 (31%), Positives = 136/269 (50%), Gaps = 15/269 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+D + LG+G FG L + G +A K + K+ + ++ E +++++ +H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH 64
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + +LK ++ + VME GGELF + +TE A IV ++ H +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
V++RD+K EN + + +K DFGL G G+P Y+APEVL+ N
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YG VD W GV++Y ++CG PF+ + + + + I+ I F R +S AK L+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLA 237
Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
+L DPKQRL A+EV+EH + +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 7e-50
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 14/269 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ LG+G FG L E +A K + K + D+E E +++ K
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + L ++ ++ VME GG+L I G + E A I + +
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N + +K DFG+ G G+P Y+APE++
Sbjct: 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
YG VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + K
Sbjct: 519 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICK 574
Query: 295 KMLNPDPKQRL-----TAEEVLEHPWLQN 318
++ P +RL ++ EH + +
Sbjct: 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-50
Identities = 77/283 (27%), Positives = 129/283 (45%), Gaps = 26/283 (9%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
D + +++ ELG G FG Y + G A K I ++ ++ED E++I+
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILA 71
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY-TERAAAAVMKTIVEVV 170
HP IV L Y D + I++E C GG + ++ TE V + ++E +
Sbjct: 72 TC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSPYYMAPE 229
H + ++HRDLK N L + + ++ DFG+S ++ + +G+PY+MAPE
Sbjct: 131 NFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 230 VL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP-- 281
V+ Y + D+WS G+ L + PP V I K DP
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA------KSDPPT 241
Query: 282 ---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
K S +D +K L+ +P+ R +A ++LEHP++ +
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 57 DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
++L R LG+G +G + T N G+ FA K + K + R A D + E I++
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+ KHP IV L ++ +++++E GGELF ++ G + E A + I +
Sbjct: 78 V-KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVL 231
H++G+++RDLKPEN + ++ +K DFGL G + G+ YMAPE+L
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEIL 193
Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
R+ + VD WS G ++Y +L G PPF E + I++ ++ +++ A+
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEAR 249
Query: 291 DLVKKMLNPDPKQRL-----TAEEVLEHPW 315
DL+KK+L + RL A EV HP+
Sbjct: 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+DL R +GRG + L +A K + K+ + DI+ V+ E + + H
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L ++ +S + V+E GG+L + + E A I + HE+
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N L +K D+G+ RPG+ + G+P Y+APE+L+
Sbjct: 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 186
Query: 235 YGPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVIDFKRDPWPKV 285
YG VD W+ GV+++ ++ G PF TE + Q I+ I R +
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----L 242
Query: 286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQN 318
S A ++K LN DPK+RL ++ HP+ +N
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 79/294 (26%), Positives = 132/294 (44%), Gaps = 22/294 (7%)
Query: 37 STVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
S R K Q + + R LGRG FG + C G+ +ACK ++KK+L+
Sbjct: 165 SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK 224
Query: 96 TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYT 155
+ E +I+ + IVSL +E + + +VM + GG++ I
Sbjct: 225 KRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 156 -----ERAA--AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
RA A IV ++ H++ +++RDLKPEN L + ++ D GL+V
Sbjct: 284 PGFQEPRAIFYTA---QIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAV 337
Query: 209 -FFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266
+ G+P +MAPE+L Y VD ++ GV LY ++ PF A E+
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397
Query: 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
+ + + V++ K S +KD + +L DP++RL + + + HP
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-48
Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 26/292 (8%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+ +D + ++L +G G +G Y V G+ A K + + + E++++E+ +
Sbjct: 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINM 73
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVH------IVMELCEGGELFD--RIVARGHYTERAAAA 161
+K H NI + + + +VME C G + D + E A
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV-FFRPGEQFNEIV 220
+ + I+ + H+ V+HRD+K +N L E +K +DFG+S R + N +
Sbjct: 134 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFGVSAQLDRTVGRRNTFI 190
Query: 221 GSPYYMAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274
G+PY+MAPEV+ + Y + D+WS G+ + G PP I R+
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250
Query: 275 I-DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
K W S+ + ++ L + QR E++++HP++++ V
Sbjct: 251 APRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+DL R +GRG + L +A + + K+ + DI+ V+ E + + H
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P +V L ++ +S + V+E GG+L + + E A I + HE+
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN- 234
G+++RDLK +N L +K D+G+ RPG+ + G+P Y+APE+L+
Sbjct: 173 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 235 YGPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVIDFKRDPWPKV 285
YG VD W+ GV+++ ++ G PF TE + Q I+ I R +
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----L 285
Query: 286 SENAKDLVKKMLNPDPKQRL------TAEEVLEHPWLQN 318
S A ++K LN DPK+RL ++ HP+ +N
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 84/309 (27%), Positives = 149/309 (48%), Gaps = 17/309 (5%)
Query: 16 AKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISI-DYDLGRELGRGEFGVTYL 74
A G K++ + ++ + V +++ +++ + LG+G FG L
Sbjct: 107 ADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVIL 166
Query: 75 CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134
+ G +A K + K+ + ++ E +++++ +HP + +LK +++ +
Sbjct: 167 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225
Query: 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANK 193
VME GGELF + ++E A IV + H E+ V++RDLK EN +
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD-- 283
Query: 194 KESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYIL 251
+ +K DFGL + G G+P Y+APEVL+ N YG VD W GV++Y +
Sbjct: 284 -KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342
Query: 252 LCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL-----T 306
+CG PF+ + + + + I+ I F R + AK L+ +L DPKQRL
Sbjct: 343 MCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 307 AEEVLEHPW 315
A+E+++H +
Sbjct: 399 AKEIMQHRF 407
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 73/289 (25%), Positives = 122/289 (42%), Gaps = 32/289 (11%)
Query: 46 LKEPSGQDISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
L S D+ + +G+G FG L +A K + KK + + + +
Sbjct: 27 LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAA---AA 161
E ++ KHP +V L +++ ++ V++ GGELF + + E A AA
Sbjct: 87 SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL------KAIDFGLS-VFFRPGE 214
I + H +++RDLKPEN L L DFGL
Sbjct: 147 ---EIASALGYLHSLNIVYRDLKPENIL---------LDSQGHIVLTDFGLCKENIEHNS 194
Query: 215 QFNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
+ G+P Y+APEVL + Y VD W G +LY +L G+PPF++ + I+
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
Query: 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRL----TAEEVLEHPWLQN 318
+ K + ++ +A+ L++ +L D +RL E+ H +
Sbjct: 255 PLQLKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 74/318 (23%), Positives = 131/318 (41%), Gaps = 51/318 (16%)
Query: 41 HRLCVLKEPSGQDISID----YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT 96
H + +++ Y+ +G G +G+ C + + G A K K
Sbjct: 6 HHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLE 60
Query: 97 AVDIEDVR----REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVA 150
+ D + V+ RE++++K L +H N+V+L + + ++V E + + +
Sbjct: 61 SDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF-- 117
Query: 151 RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
+ + I+ + CH ++HRD+KPEN L + +K DFG +
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTL 174
Query: 211 R-PGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 267
PGE +++ V + +Y APE+L YG VDVW+ G ++ + G P F +++
Sbjct: 175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 268 QAIIR--------------SVIDFK-------------RDPWPKVSENAKDLVKKMLNPD 300
I+ F +PK+SE DL KK L+ D
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 301 PKQRLTAEEVLEHPWLQN 318
P +R E+L H + Q
Sbjct: 295 PDKRPFCAELLHHDFFQM 312
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 69/269 (25%), Positives = 126/269 (46%), Gaps = 19/269 (7%)
Query: 57 DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
++L + LG+G FG +L + + + +A K + K L D + E I+ +
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEV 83
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
HP IV L ++ + ++++++ GG+LF R+ +TE + + +
Sbjct: 84 -NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQFNEIVGSPYYMAPEVLK 232
H G+++RDLKPEN L + +K DFGLS ++ G+ YMAPEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
R + D WS GV+++ +L G PF + + I+++ + + +S A+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQS 255
Query: 292 LVKKMLNPDPKQRL-----TAEEVLEHPW 315
L++ + +P RL EE+ H +
Sbjct: 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 82/274 (29%), Positives = 146/274 (53%), Gaps = 19/274 (6%)
Query: 57 DYDLGRELGRGEFGVTYLC---TDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKH 112
+++L + LG G +G +L + + G+ +A K + K + + A E R E Q+++H
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+ + P +V+L ++ ++ +H++++ GGELF + R +TE + IV ++
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS--VFFRPGEQFNEIVGSPYYMAPEV 230
H+ G+++RD+K EN L + + DFGLS E+ + G+ YMAP++
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 231 LKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VS 286
++ + VD WS GV++Y LL G PF + E+ I R I P+P+ +S
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQEMS 290
Query: 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPW 315
AKDL++++L DPK+RL A+E+ EH +
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 79/308 (25%), Positives = 134/308 (43%), Gaps = 59/308 (19%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
DY L R+LGRG++ + ++ N EK K + V + ++RE++I+++
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86
Query: 113 LPKHPNIVSLKDTYEDDSA---VHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
L PNI++L D +D + + + +L+ + T+ M I+
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL------TDYDIRFYMYEIL 140
Query: 168 EVVQVCHEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
+ + CH G+MHRD+KP N + ++K L+ ID+GL+ F+ PG+++N V S Y+
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRK----LRLIDWGLAEFYHPGQEYNVRVASRYF 196
Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA-----------------ETEQGV 266
PE+L + Y +D+WS G +L ++ PF+ E
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256
Query: 267 AQAI--------IRSVIDFKRDPW---------PKVSENAKDLVKKMLNPDPKQRLTAEE 309
+ R W VS A D + K+L D + RLTA E
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
Query: 310 VLEHPWLQ 317
+EHP+
Sbjct: 317 AMEHPYFY 324
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-47
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 55/301 (18%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-------RTAVDIEDVRREVQI 109
Y +LG G + Y A K I +L TA+ REV +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVSL 53
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIV 167
+K L KH NIV+L D + ++ +V E + + D + ++
Sbjct: 54 LKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQLL 110
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYY 225
+ CH Q V+HRDLKP+N L + E LK DFGL+ P + + NE+V + +Y
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVV-TLWY 166
Query: 226 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------- 272
P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 273 --------SVIDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
++ + P++ + DL+ K+L + + R++AE+ ++HP+
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
Query: 318 N 318
+
Sbjct: 287 S 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 88/301 (29%), Positives = 133/301 (44%), Gaps = 56/301 (18%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--------RTAVDIEDVRREVQ 108
Y ++G G +GV Y + N GE FA K I +L T + RE+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI---RLEKEDEGIPSTTI------REIS 52
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTI 166
I+K L KH NIV L D + +V E + +L D G A + + +
Sbjct: 53 ILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQL 109
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPY 224
+ + CH++ V+HRDLKP+N L + E LK DFGL+ F P ++ +EIV + +
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIV-TLW 165
Query: 225 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---------- 272
Y AP+VL + Y +D+WS G I ++ G P F +E I R
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 273 ----SVIDFK-----------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ + + E+ DL+ KML DP QR+TA++ LEH + +
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 318 N 318
Sbjct: 286 E 286
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-46
Identities = 81/302 (26%), Positives = 133/302 (44%), Gaps = 56/302 (18%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--------RTAVDIEDVRREVQ 108
Y+ ++G G +G + + E A K + +L +A+ RE+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REIC 53
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTI 166
++K L KH NIV L D D + +V E C+ + FD G + + +
Sbjct: 54 LLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPY 224
++ + CH + V+HRDLKP+N L E LK +FGL+ F P + E+V + +
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 225 YMAPEVL--KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR--------- 272
Y P+VL + Y +D+WSAG I + G P F + I R
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 273 -----SVIDFKRDP-----------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ D+K P PK++ +DL++ +L +P QR++AEE L+HP+
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 317 QN 318
+
Sbjct: 287 SD 288
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-46
Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 49/305 (16%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
+G+ I Y + +G G FGV + V + E A K + + K RE+QI
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQI 85
Query: 110 MKHLPKHPNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVM 163
M+ + KHPN+V LK + +D+ +++V+E ++ + ++
Sbjct: 86 MRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 164 KT----IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
K ++ + H G+ HRD+KP+N L + S LK IDFG + GE
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 220 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----- 272
+ S YY APE++ NY +D+WS G ++ L+ G P F E+ II+
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 273 --SVIDF-------------KRDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
I + P+ P+ +A DL+ ++L P RLTA E L
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 313 HPWLQ 317
HP+
Sbjct: 322 HPFFD 326
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 83/304 (27%), Positives = 126/304 (41%), Gaps = 46/304 (15%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMK 111
Y +LG G +G Y D E A K I + TA+ REV ++K
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLLK 88
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
L +H NI+ LK + +H++ E E +L + + R + + ++ V
Sbjct: 89 EL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSP--LKAIDFGLSVFF-RPGEQF-NEIVGSPYYMA 227
CH + +HRDLKP+N L + S LK DFGL+ F P QF +EI+ + +Y
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRP 205
Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 272
PE+L R+Y VD+WS I +L P F ++E I
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 273 -------------SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
KR + + DL+ ML DP +R++A+ LEHP+ +
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325
Query: 320 KKAP 323
P
Sbjct: 326 DFDP 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 77/308 (25%), Positives = 121/308 (39%), Gaps = 60/308 (19%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-------RTAVDIEDVRREVQI 109
+ +LG G + Y + G A K + KL TA+ RE+ +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REISL 56
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGG-----ELFDRIVARGHYTERAAAAVMK 164
MK L KH NIV L D ++ + +V E + +
Sbjct: 57 MKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGS 222
+++ + CHE ++HRDLKP+N L + + LK DFGL+ F P F +E+V +
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVV-T 171
Query: 223 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------- 272
+Y AP+VL R Y +D+WS G IL ++ G P F ++ + I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 273 ---SVID-------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEV 310
SV + + N D + +L +P RL+A++
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 311 LEHPWLQN 318
L HPW
Sbjct: 292 LHHPWFAE 299
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMK 111
Y ++G G +GV Y D + G A K I TA+ RE+ ++K
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAI------REISLLK 74
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEV 169
L HPNIVSL D + + +V E E ++ D + + + ++
Sbjct: 75 EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRG 131
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYYMA 227
V CH+ ++HRDLKP+N L + LK DFGL+ F P + +E+V + +Y A
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVV-TLWYRA 187
Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 272
P+VL + Y VD+WS G I ++ G P F T+ I
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 273 -SVIDFK------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
+ +K P + DL+ ML DP +R++A + + HP+ ++
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 320 KK 321
Sbjct: 308 DP 309
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 57/339 (16%), Positives = 115/339 (33%), Gaps = 62/339 (18%)
Query: 53 DISIDYDLGRELGRGE--FGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
Y+L +G+G L GE + I+ + + ++ E+ +
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE-MVTFLQGELHVS 80
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVE 168
K HPNIV + T+ D+ + +V G D E A A +++ +++
Sbjct: 81 KLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP--------GEQFNEIV 220
+ H G +HR +K + L + + + ++ + V
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 221 GSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF------------------- 258
+++PEVL++N Y + D++S G+ L G PF
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256
Query: 259 ----------------------WAETEQGVAQAIIRSVIDFKRDPWPKV-SENAKDLVKK 295
++ S D P+ + S + V++
Sbjct: 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKAR 334
L +P R +A +L H + + K+ + +L E ++
Sbjct: 317 CLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPV 355
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-44
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 45/297 (15%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED-----VRREVQIMK 111
Y+ LG G+F Y D N + A K I KL + +D RE+++++
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQ 67
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAVMKTIVEV 169
L HPNI+ L D + S + +V + E + T A M ++
Sbjct: 68 EL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQG 124
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQF-NEIVGSPYYMA 227
++ H+ ++HRDLKP N L LK DFGL+ F P + +++V + +Y A
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVV-TRWYRA 180
Query: 228 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----------- 274
PE+L R YG VD+W+ G IL LL VP +++ I ++
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 275 ------IDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ FK P + ++ DL++ + +P R+TA + L+ + N
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-44
Identities = 70/312 (22%), Positives = 122/312 (39%), Gaps = 40/312 (12%)
Query: 48 EPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
GQ D + E+G G G + G A K + + + + +
Sbjct: 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRIL 71
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
++ ++ P IV T+ ++ V I MEL + +G ER +
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 165 TIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI---- 219
IV+ + E+ GV+HRD+KP N L + + +K DFG+S G ++
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDR 183
Query: 220 -VGSPYYMAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAII 271
G YMAPE + Y DVWS G+ L L G P+ +T+ V ++
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 272 RSVIDFKRDPWPKV------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
++ P + S + + VK L D ++R ++LEH +++ + V
Sbjct: 244 -------QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET-LEV 295
Query: 326 SLGETVKARLKQ 337
+ K + +
Sbjct: 296 DVASWFKDVMAK 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-44
Identities = 68/265 (25%), Positives = 108/265 (40%), Gaps = 35/265 (13%)
Query: 58 YDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHL 113
Y++ + G G YL D N NG K L + D E E Q + +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAERQFLAEV 136
Query: 114 PKHPNIVSLKDTYED-----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
HP+IV + + E D +IVME G L A A + I+
Sbjct: 137 -VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILP 193
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
+ H G+++ DLKPEN + ++ LK ID G F + G+P + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYGTPGFQAP 246
Query: 229 EVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
E+++ D+++ G L L +P G+ + DP K ++
Sbjct: 247 EIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDPVLKTYDS 296
Query: 289 AKDLVKKMLNPDPKQR-LTAEEVLE 312
L+++ ++PDP+QR TAEE+
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAEEMSA 321
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 69/320 (21%), Positives = 113/320 (35%), Gaps = 35/320 (10%)
Query: 40 VHRLCVLKEPSGQDISI---DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT 96
+ LK Q D E+GRG +G +G+ A K I
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--D 60
Query: 97 AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR----- 151
+ + + ++ ++ P IV + I MEL FD+
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVL 118
Query: 152 -GHYTERAAAAVMKTIVEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209
E + V+ + E ++HRD+KP N L +K DFG+S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS-- 173
Query: 210 FRPGEQFNEI-----VGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFW 259
G+ + I G YMAPE + + Y DVWS G+ LY L G P+
Sbjct: 174 ---GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP 230
Query: 260 A-ETEQGVAQAIIRS-VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ +++ + S + + V L D +R +E+L+HP++
Sbjct: 231 KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
Query: 318 NAKKAPNVSLGETVKARLKQ 337
++ V + V L Q
Sbjct: 291 MYEERA-VEVACYVCKILDQ 309
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 76/316 (24%), Positives = 123/316 (38%), Gaps = 51/316 (16%)
Query: 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---- 104
P G + Y+ E+G G +G Y D ++G A K +R
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPI 56
Query: 105 ---REVQIMKHL--PKHPNIVSLKD-----TYEDDSAVHIVMELCEG--GELFDRIVARG 152
REV +++ L +HPN+V L D + + V +V E + D+ G
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 153 HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
+M+ + + H ++HRDLKPEN L + +K DFGL+ +
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSY 172
Query: 213 GEQF-NEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270
+V + +Y APEVL + Y VD+WS G I + P F +E I
Sbjct: 173 QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 271 IR--------------SVIDFKRDPW---------PKVSENAKDLVKKMLNPDPKQRLTA 307
S+ P P++ E+ L+ +ML +P +R++A
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA 291
Query: 308 EEVLEHPWLQNAKKAP 323
L+H +L + P
Sbjct: 292 FRALQHSYLHKDEGNP 307
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-42
Identities = 71/337 (21%), Positives = 127/337 (37%), Gaps = 58/337 (17%)
Query: 47 KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRRE 106
K+ G+ D++ ELG G GV + + +G A K I + + RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRE 81
Query: 107 VQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
+Q++ P IV + D + I ME +GG L + G E+ V +
Sbjct: 82 LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 167 VEVVQVCHEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI----VG 221
++ + E+ +MHRD+KP N L ++ E +K DFG+S G+ + + VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVG 192
Query: 222 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
+ YM+PE L+ Y + D+WS G+ L + G P + + V +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 281 PWPKV----------------------------------------SENAKDLVKKMLNPD 300
P+ S +D V K L +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 301 PKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQ 337
P +R ++++ H +++ + V + + +
Sbjct: 313 PAERADLKQLMVHAFIKRSDA-EEVDFAGWLCSTIGL 348
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 30/292 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D + ELGRG +GV V +G+ A K I + + + + ++ I
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDC 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGG--ELFDRIVAR-GHYTERAAAAVMKTIVEVVQVC 173
P V+ + V I MEL + + + +++ + E + +IV+ ++
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 174 HEQG-VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----VGSPYYMA 227
H + V+HRD+KP N L + +K DFG+S G +++ G YMA
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYMA 177
Query: 228 PEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVI-DFKRD 280
PE + + Y + D+WS G+ + L P+ + T + ++ D
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVK 332
+ S D + L + K+R T E+++HP+ + + VK
Sbjct: 238 KF---SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES-KGTDVASFVK 285
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 76/263 (28%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHLP 114
Y + +LG G YL D K A K+I + E + REV L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQL- 68
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
H NIVS+ D E+D ++VME EG L + I + G + A I++ ++ H
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK 232
+ ++HRD+KP+N L + K LK DFG++ Q N ++G+ Y +PE K
Sbjct: 129 DMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 233 RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVIDFKRDPWPKVSENAK 290
D++S G++LY +L G PPF ET +A + I SV + D + ++
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 291 DLVKKMLNPDPKQR-LTAEEVLE 312
+++ + D R T +E+ +
Sbjct: 246 NVILRATEKDKANRYKTIQEMKD 268
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 6e-41
Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 57/310 (18%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLR--------TAVDIEDVRREV 107
Y+ E+G G +G + D+ N G A K + +++ + + REV
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTI------REV 62
Query: 108 QIMKHL--PKHPNIVSLKD-----TYEDDSAVHIVMELCEG--GELFDRIVARGHYTERA 158
+++HL +HPN+V L D + ++ + +V E + D++
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTET 121
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-N 217
+M ++ + H V+HRDLKP+N L + + +K DFGL+ + +
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTS 178
Query: 218 EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---- 272
+V + +Y APEVL + +Y VD+WS G I + P F ++ I+
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 273 ---------------SVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ P + E KDL+ K L +P +R++A L H
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 314 PWLQNAKKAP 323
P+ Q+ ++
Sbjct: 298 PYFQDLERCK 307
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-41
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 1/101 (0%)
Query: 308 EEVLEHPWL-QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKE 366
H +N +V L T+ LK F N+LKK AL ++A+ L E+ L+
Sbjct: 2 HHHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRN 61
Query: 367 AFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
F +D + G ++ +E+ GL K G D+ ++ +
Sbjct: 62 IFIALDVDNSGTLSSQEILDGLKKIGYQKIPPDIHQVLRDI 102
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 81/326 (24%), Positives = 125/326 (38%), Gaps = 55/326 (16%)
Query: 36 GSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR 95
GS + + + + + R G+G FG L + + G A K + + R
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-R 61
Query: 96 TAVDIEDVRREVQIMKHLP--KHPNIVSLKDTY-------EDDSAVHIVMELCEGGELFD 146
RE+QIM+ L HPNIV L+ + D +++VME L
Sbjct: 62 FR------NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 147 RIVARGHYTERAAAAVMKT----IVEVVQVCHEQ--GVMHRDLKPENFLFANKKESSPLK 200
++K ++ + H V HRD+KP N L N+ LK
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNE-ADGTLK 172
Query: 201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF 258
DFG + P E + S YY APE++ ++Y VD+WS G I ++ G P F
Sbjct: 173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
Query: 259 WAETEQGVAQAII-------RSVIDF-------------KRDPWPKV--------SENAK 290
+ G I+ R V+ K PW V ++ A
Sbjct: 233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWL 316
DL+ +L P++R+ E L HP+
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPYF 318
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 71/314 (22%), Positives = 122/314 (38%), Gaps = 66/314 (21%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR----REVQIMKH 112
Y+ ++G+G FG + G+K A K K+ + E RE++I++
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQL 72
Query: 113 LPKHPNIVSLKD--------TYEDDSAVHIVMELCEG--GELFDRIVARGHYTERAAAAV 162
L KH N+V+L + ++++V + CE L + +T V
Sbjct: 73 L-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRV 129
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
M+ ++ + H ++HRD+K N L LK DFGL+ F + +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP---N 183
Query: 223 PY--------YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
Y Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 273 -------------------SVIDFKRD---------PWPKVSENAKDLVKKMLNPDPKQR 304
++ + A DL+ K+L DP QR
Sbjct: 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303
Query: 305 LTAEEVLEHPWLQN 318
+ +++ L H + +
Sbjct: 304 IDSDDALNHDFFWS 317
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 50/303 (16%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
++ Y +G G +G D G + A K +S+ ++ + + RE++++KH
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 84
Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
+ KH N++ L D + E+ + V++V L D IV T+ ++
Sbjct: 85 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
I+ ++ H ++HRDLKP N E LK +DFGL+ R V +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLA---RHTADEMTGYVATR 193
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 262
+Y APE++ +Y VD+WS G I+ LL G F AE
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ + A+ I+S+ + + + A DL++KML D +R+TA + L H
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 315 WLQ 317
+
Sbjct: 314 YFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-40
Identities = 78/303 (25%), Positives = 136/303 (44%), Gaps = 51/303 (16%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
++ Y +G G +G D +GEK A K +S+ ++ + + RE+ ++KH
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKH 79
Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
+ +H N++ L D + + ++VM + D +I+ ++E ++
Sbjct: 80 M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSEEKIQYLVY 133
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GEQFNEIVGSP 223
+++ ++ H GV+HRDLKP N E LK +DFGL+ R + V +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLA---RHADAEMTGYVVTR 187
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF----------------------- 258
+Y APEV+ +Y VD+WS G I+ +L G F
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 259 WAETEQGVAQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ A++ I+S+ R + P+ S A DL++KML D +RLTA + L HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 315 WLQ 317
+ +
Sbjct: 308 FFE 310
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-40
Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 22/281 (7%)
Query: 49 PSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR----TAVDIE 101
P + ++ + +++G+G FG+ + V + A KS+ +
Sbjct: 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68
Query: 102 DVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAA 160
+ +REV IM +L HPNIV L + +VME G+L+ R++ + H
Sbjct: 69 EFQREVFIMSNL-NHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 161 AVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSP--LKAIDFGLSVFFRPGEQF 216
+M I ++ Q ++HRDL+ N + E++P K DFGLS
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSV 183
Query: 217 NEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
+ ++G+ +MAPE + + +Y + D +S +ILY +L G P + E G + I
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMI 242
Query: 274 VIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ R P+ +++++ + DPK+R +++
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-40
Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 27/269 (10%)
Query: 56 IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
IDY + +GRG FGV + A K ++ + + + E++ +
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIK-----QIESESERKAFIVELRQLSR 57
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ- 171
+ HPNIV L + V +VME EGG L++ + AA M ++ Q
Sbjct: 58 V-NHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 172 -----VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
+ ++HRDLKP N L LK DFG + + GS +M
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNKGSAAWM 170
Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK- 284
APEV + + Y + DV+S G+IL+ ++ PF + G A I+ +V + R P K
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLIKN 228
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ + + L+ + + DP QR + EE+++
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 81/305 (26%), Positives = 126/305 (41%), Gaps = 50/305 (16%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
D+ Y +G G +G+ D N + A K IS + RE++I+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLR 81
Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKT 165
+H NI+ + D T E V+IV +L E D +++ H + +
Sbjct: 82 F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQ 136
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN----EIVG 221
I+ ++ H V+HRDLKP N L N + LK DFGL+ P E V
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 222 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WA 260
+ +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 261 ETEQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
E + A+ + S+ + PW P A DL+ KML +P +R+ E+ L
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 313 HPWLQ 317
HP+L+
Sbjct: 314 HPYLE 318
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 76/303 (25%), Positives = 137/303 (45%), Gaps = 50/303 (16%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
++ Y + +G G +G D G K A K + + ++ + + RE++++KH
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKH 80
Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMK 164
+ +H N++ L D T +D + ++VM D +++ E ++
Sbjct: 81 M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSP 223
+++ ++ H G++HRDLKP N L N E LK +DFGL+ R + V +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGN-LAVN--EDCELKILDFGLA---RQADSEMTGYVVTR 189
Query: 224 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 262
+Y APEV+ Y VD+WS G I+ ++ G F AE
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 263 EQGV----AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
Q + A+ ++ + + ++ + S A +L++KML D +QR+TA E L HP
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 315 WLQ 317
+ +
Sbjct: 310 YFE 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 76/331 (22%), Positives = 117/331 (35%), Gaps = 78/331 (23%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
S Y LG+ LG G FG+ D+ +G++FA K + + RE+ IMK L
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVL 57
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAA------------ 161
H NI+ L D + G +
Sbjct: 58 -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 162 ----------VMKTIVEVVQV-------------------CHEQGVMHRDLKPENFLFAN 192
V+K+ + + H G+ HRD+KP+N L N
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL-VN 175
Query: 193 KKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYI 250
+ + LK DFG + P E + S +Y APE++ Y P +D+WS G +
Sbjct: 176 -SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 251 LLCGVPPFWAETEQGVAQAII-------RSVIDF-------------KRDPWPKV----- 285
L+ G P F ET II + + K W K+
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
A DL++++L +P R+ E + HP+
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 58/313 (18%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
D+ Y + LG G G+ + D + ++ A K I L ++ RE++I++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRR 64
Query: 113 LPKHPNIVSLKD--------------TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE 156
L H NIV + + + + ++V+IV E E D ++ +G E
Sbjct: 65 L-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLE 119
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
A M ++ ++ H V+HRDLKP N LF N ++ LK DFGL+ P
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINTEDLV-LKIGDFGLARIMDPHYSH 177
Query: 217 N----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------ 258
E + + +Y +P +L NY +D+W+AG I +L G F
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237
Query: 259 -------WAETEQGV---AQAIIRSVIDFKRDPW----PKVSENAKDLVKKMLNPDPKQR 304
E Q + IR+ + P P +S A D ++++L P R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297
Query: 305 LTAEEVLEHPWLQ 317
LTAEE L HP++
Sbjct: 298 LTAEEALSHPYMS 310
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 23/97 (23%), Positives = 49/97 (50%), Gaps = 1/97 (1%)
Query: 311 LEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEM 370
+ H ++ + G V K + ++ K +K A+ ++A+ + +V LK F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 371 MDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+D + +G I E+L+ GL K G +P + +L++ +
Sbjct: 61 LDEDGKGYITKEQLKKGLEKDGLKLPY-NFDLLLDQI 96
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 20/268 (7%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDV---RREVQIMKHLP 114
Y+LG LG G +L D+ + A K + + A D RRE Q L
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAAL- 69
Query: 115 KHPNIVSLKDTYEDDSAVH----IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
HP IV++ DT E ++ IVME +G L D + G T + A V+ + +
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNEIVGSPYYM 226
H+ G++HRD+KP N + + +K +DFG++ Q ++G+ Y+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 227 APEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
+PE + + DV+S G +LY +L G PPF ++ VA +R +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246
Query: 286 SENAKDLVKKMLNPDPKQR-LTAEEVLE 312
S + +V K L +P+ R TA E+
Sbjct: 247 SADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 91/327 (27%), Positives = 137/327 (41%), Gaps = 86/327 (26%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQI 109
+IS D+ L LG G +GV T GE A I KK+ RE++I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVA---I--KKIEPFDKPLFALRTLREIKI 62
Query: 110 MKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE------ 156
+KH KH NI+++ + ++E+ + V+I+ EL + D R+++ ++
Sbjct: 63 LKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117
Query: 157 -----RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211
RA +K + H V+HRDLKP N L N + LK DFGL+
Sbjct: 118 IYQTLRA----VKVL-------HGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGLARIID 163
Query: 212 PGEQFNEIVGSP-----------YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVP-- 256
N +Y APEV+ Y +DVWS G IL L P
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 257 ------------------PFWAETEQGV----AQAIIRSVIDFKRDPW----PKVSENAK 290
P + + A+ I+S+ + P P+V+
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283
Query: 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
DL+++ML DP +R+TA+E LEHP+LQ
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQ 310
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 72/311 (23%), Positives = 127/311 (40%), Gaps = 55/311 (17%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ Y + +G G G+ D A K +S+ + + RE+ +MK
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 117
Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKT 165
+ H NI+SL + T E+ V++VMEL + + V + + ++
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
++ ++ H G++HRDLKP N + K LK +DFGL+ V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 265
APEV L Y VD+WS G I+ ++ F E +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 266 V---AQAIIRSVIDFKRDPWPKV----------------SENAKDLVKKMLNPDPKQRLT 306
+ + + + + +PK+ + A+DL+ KML DP +R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 307 AEEVLEHPWLQ 317
++ L+HP++
Sbjct: 350 VDDALQHPYIN 360
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 15/262 (5%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y L R +GRG G Y D A K +S+ V ++RE + L + P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEP 94
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
++V + D E D +++ M L G +L + +G A A+++ I + H G
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLK 232
HRD+KPEN L + +DFG++ Q VG+ YYMAPE
Sbjct: 155 ATHRDVKPENILVS---ADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 233 RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
++ D+++ +LY L G PP+ + V A I I P +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDA 267
Query: 292 LVKKMLNPDPKQR-LTAEEVLE 312
++ + + +P+ R +T ++
Sbjct: 268 VIARGMAKNPEDRYVTCGDLSA 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-38
Identities = 55/294 (18%), Positives = 116/294 (39%), Gaps = 55/294 (18%)
Query: 52 QDISIDYD---LGRELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRR 105
Q+ I ++ +G +G+G FG Y +V A + I ++ ++ +R
Sbjct: 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERD-NEDQLKAFKR 78
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
EV + +H N+V + I+ LC+G L+ + + +
Sbjct: 79 EVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD------VNK 131
Query: 166 IVEV-VQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS------VFFRP 212
++ ++ H +G++H+DLK +N + N K + DFGL R
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR 187
Query: 213 GEQFNEIVGSPYYMAPEVLKRN----------YGPEVDVWSAGVILYILLCGVPPFWAET 262
++ G ++APE++++ + DV++ G I Y L PF
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---- 243
Query: 263 EQGV-AQAIIRSVIDFKRDPWPKVS--ENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ A+AII + + ++ + D++ + ++R T ++++
Sbjct: 244 -KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 33/282 (11%)
Query: 49 PSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRR 105
G D+ I + + ++G G FG + +G A K + ++ A + + R
Sbjct: 27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDF-HAERVNEFLR 83
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
EV IMK L +HPNIV + IV E G L+ + H + +
Sbjct: 84 EVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL----HKSGAREQLDERR 138
Query: 166 IVEV-VQVC------HEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLS-VFFRPGEQ 215
+ + V H + ++HR+LK N L K +K DFGLS +
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLS 195
Query: 216 FNEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIR 272
G+P +MAPEVL+ + DV+S GVIL+ L P+ + AQ +
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQVVAA 250
Query: 273 SVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
KR P+ ++ +++ +P +R + +++
Sbjct: 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 7e-37
Identities = 71/325 (21%), Positives = 123/325 (37%), Gaps = 70/325 (21%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKH 116
G ++GRG +G Y D + + +A K I + +A RE+ +++ L KH
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC------REIALLREL-KH 77
Query: 117 PNIVSLKD--TYEDDSAVHIVMELCE--------GGELFDRIVARGHYTERAAAAVMKTI 166
PN++SL+ D V ++ + E +++ I
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESS-PLKAIDFGLSVFF----RPGEQFNEIVG 221
++ + H V+HRDLKP N L + +K D G + F +P + +V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 222 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---------I 270
+ +Y APE+L R+Y +D+W+ G I LL P F E I
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257
Query: 271 IR---------------------SVIDFKRDPW-------------PKVSENAKDLVKKM 296
+ DF+R+ + K A L++K+
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317
Query: 297 LNPDPKQRLTAEEVLEHPWLQNAKK 321
L DP +R+T+E+ ++ P+
Sbjct: 318 LTMDPIKRITSEQAMQDPYFLEDPL 342
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 55/311 (17%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ Y + +G G G+ D A K +S+ + + RE+ +MK
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 80
Query: 113 LPKHPNIVSLKD------TYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKT 165
+ H NI+ L + + E+ V+IVMEL + + V + + ++
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
++ ++ H G++HRDLKP N + K LK +DFGL+ V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 226 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 265
APEV L Y VD+WS G I+ ++ G F E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 266 V---AQAIIRSVIDFKRDPW----------------PKVSENAKDLVKKMLNPDPKQRLT 306
+ + + + + + + A+DL+ KML D +R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 307 AEEVLEHPWLQ 317
+E L+HP++
Sbjct: 313 VDEALQHPYIN 323
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 67/312 (21%), Positives = 119/312 (38%), Gaps = 56/312 (17%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVR--- 104
+ Y + R + G +G D + G A K + D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 105 REVQIMKHLPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFD--RIVARGHY--T 155
RE++++ H HPNI+ L+D +++V EL D +++ +
Sbjct: 78 REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVIS 132
Query: 156 ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
+ M I+ + V HE GV+HRDL P N L +++ + DF L+
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNIL-LA--DNNDITICDFNLAREDTADAN 189
Query: 216 FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------------- 258
V +Y APE++ + + VD+WSAG ++ + F
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
Query: 259 --------WAETEQGVAQAIIRSVI-DFKRDPW----PKVSENAKDLVKKMLNPDPKQRL 305
A+ +R+ + + W P A DL+ KML +P++R+
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
Query: 306 TAEEVLEHPWLQ 317
+ E+ L HP+ +
Sbjct: 310 STEQALRHPYFE 321
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 38/258 (14%), Positives = 69/258 (26%), Gaps = 35/258 (13%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y L G + D + A + + + +++ + + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+ + D + +V E GG L + VA + A M+++ H G
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGP 237
V P + G V + P M P
Sbjct: 150 VALSIDHPSRVRVS-----------IDGDVV-----------LAYPATMPDA------NP 181
Query: 238 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW---PKVSENAKDLVK 294
+ D+ G LY LL P + R +P + +
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 295 KMLNPDPKQRLTAEEVLE 312
+ + D R +A +L
Sbjct: 242 RSVQGDGGIR-SASTLLN 258
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 26/274 (9%)
Query: 56 IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMK 111
ID+ L +G G FG Y G++ A K+ + IE+VR+E ++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
L KHPNI++L+ + + +VME GG L +++ I +
Sbjct: 62 ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMN 119
Query: 172 VCHEQG---VMHRDLKPENFLFANKKESSP-----LKAIDFGLSVFFRPGEQFNEIVGSP 223
H++ ++HRDLK N L K E+ LK DFGL+ + + + G+
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAY 178
Query: 224 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVIDFKRD 280
+MAPEV++ + + DVWS GV+L+ LL G PF +G+ ++
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLAL 233
Query: 281 PWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
P P E L++ NPDP R + +L+
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-34
Identities = 70/336 (20%), Positives = 121/336 (36%), Gaps = 74/336 (22%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHL--- 113
Y L R+LG G F +L D+ N A K + K A + E +++++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE-----IKLLQRVNDA 75
Query: 114 -------PKHPNIVSLKD--TYEDDSAVH--IVMELCEGGELFDRIVARGH--YTERAAA 160
+I+ L D ++ + VH +V E+ G L I H
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK 134
Query: 161 AVMKTIVEVVQVCH-EQGVMHRDLKPENFLFANKKES---SPLKAIDFGLSVFFRPGEQF 216
+ K ++ + H G++H D+KPEN L +K D G + + E +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHY 192
Query: 217 NEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV-------AQ 268
+ + Y +PEV L +G D+WS +++ L+ G F + AQ
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252
Query: 269 AI--------------------------IRSVIDFKRDPWPKVSENA-----------KD 291
I +R++ K P V D
Sbjct: 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
+ ML DP++R A ++ HPWL++ + +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-34
Identities = 83/376 (22%), Positives = 135/376 (35%), Gaps = 81/376 (21%)
Query: 12 SGKRAKGKKEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGV 71
G AK ++ Y GS V ++ Y++ + +G+G FG
Sbjct: 61 LGLNAKKRQGMTGGPNNGGYDDDQGSYVQV--------PHDHVAYRYEVLKVIGKGSFGQ 112
Query: 72 TYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP-----NIVSLKDT 125
D + A K + ++K+ E ++I++HL K N++ + +
Sbjct: 113 VVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEHLRKQDKDNTMNVIHMLEN 167
Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+ + + + EL L++ I ++ +I++ + H+ ++H DL
Sbjct: 168 FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDL 226
Query: 184 KPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-LKRNYGPEVDVW 242
KPEN L + S +K IDFG S + ++ + S +Y APEV L YG +D+W
Sbjct: 227 KPENILLKQQG-RSGIKVIDFGSSCY--EHQRVYTYIQSRFYRAPEVILGARYGMPIDMW 283
Query: 243 SAGVILYILLCGVPPFWAETEQG------------------------------------- 265
S G IL LL G P E E
Sbjct: 284 SLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343
Query: 266 --------VAQAIIRSVIDFKRDP-----WPKVSENAKD-----LVKKMLNPDPKQRLTA 307
V RS R P W + D +K+ L DP R+T
Sbjct: 344 VTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403
Query: 308 EEVLEHPWLQNAKKAP 323
+ L HPWL+ P
Sbjct: 404 GQALRHPWLRRRLPKP 419
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 62/319 (19%), Positives = 114/319 (35%), Gaps = 44/319 (13%)
Query: 56 IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
G LG+G FG T GE K + + +EV++M+
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRC 63
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQ 171
L +HPN++ D ++ + E +GG L I + V
Sbjct: 64 L-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP------WSQRVSFAKD 116
Query: 172 VC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---------------VFF 210
+ H ++HRDL N L +E+ + DFGL+ +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 269
++ +VG+PY+MAPE++ R+Y +VDV+S G++L ++ V
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYLPRTMD 231
Query: 270 IIRSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLG 328
+V F P + + + + DP++R + ++ WL+ + L
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRMHLAGHLP 289
Query: 329 ETVKARLKQFSVMNKLKKR 347
+ ++
Sbjct: 290 LGPQLEQLDRGFWETYRRG 308
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 60/290 (20%)
Query: 56 IDYD---LGRELGRGEFGVTYL---CTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
I +G+ +G G FG Y DV A K ++ T ++ + EV +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 110 MKHLPKHPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
++ +H NI+ IV + CEG L+ + A E MK
Sbjct: 74 LRKT-RHVNILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE------MK 120
Query: 165 TIVEV-VQVC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS---VFFRPGE 214
++++ Q H + ++HRDLK N E + +K DFGL+ +
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKSRWSGSH 177
Query: 215 QFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQ 268
QF ++ GS +MAPEV++ Y + DV++ G++LY L+ G P+ +
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRD 232
Query: 269 AIIRSVI-DFKRDPWPKVSENA----KDLVKKMLNPDPKQRLTAEEVLEH 313
II V KV N K L+ + L +R + +L
Sbjct: 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 75/362 (20%), Positives = 128/362 (35%), Gaps = 113/362 (31%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ +Y + +GRG +G YL D N + A K ++ + +D + + RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81
Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTE----------- 156
L K I+ L D ++IV+E+ + +L TE
Sbjct: 82 L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
I HE G++HRDLKP N L N + +K DFGL+ +
Sbjct: 140 LG----ENFI-------HESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDT 185
Query: 217 NEIVGSP-----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYIL 251
N + +Y APE++ + NY +D+WS G I L
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 252 LC-----------------GVPPFWAETEQGVAQAIIRSVID------------------ 276
L G F ++ + +S D
Sbjct: 246 LNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305
Query: 277 ----------------FKRDPW----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
K P +S++ +L++ ML +P +R+T ++ L+HP+L
Sbjct: 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
Query: 317 QN 318
++
Sbjct: 366 KD 367
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 72/379 (18%), Positives = 130/379 (34%), Gaps = 98/379 (25%)
Query: 14 KRAKGKKEKPNPFYGDE---YVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFG 70
+E DE + G + + + + R++G G FG
Sbjct: 5 HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNA---------------FLVIRKMGDGTFG 49
Query: 71 VTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP----NIVSLKDT 125
LC ++N + +A K + + KK + IE I+K + NIV
Sbjct: 50 RVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADILKKIQNDDINNNNIVKYHGK 104
Query: 126 YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDL 183
+ + ++ E G L++ I + + I++ + + + H DL
Sbjct: 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163
Query: 184 KPENFLFAN----------------------KKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
KPEN L + + +S+ +K IDFG + F + I+
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF--KSDYHGSIIN 221
Query: 222 SPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRS 273
+ Y APEV L + D+WS G +L L G F + Q I ++
Sbjct: 222 TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN 281
Query: 274 VID----------FKRDP----WPKVSENAK---------------------DLVKKMLN 298
++ +D WP+ + + D + +L
Sbjct: 282 MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341
Query: 299 PDPKQRLTAEEVLEHPWLQ 317
DP R + E+L+H +L+
Sbjct: 342 IDPTLRPSPAELLKHKFLE 360
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-32
Identities = 41/276 (14%), Positives = 91/276 (32%), Gaps = 36/276 (13%)
Query: 56 IDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
ID+ +L G + G K + + + D E ++
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRI 63
Query: 113 LPKHPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
HPN++ + ++ G L++ + ++ + AV +
Sbjct: 64 F-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL---- 118
Query: 171 QVC--------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
+ E + L + + + + F Q + +
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSF----QSPGRMYA 171
Query: 223 PYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
P ++APE L++ D+WS V+L+ L+ PF + + ++ ++
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGL 228
Query: 279 RDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
R P +S + L+K +N DP +R + ++
Sbjct: 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 77/347 (22%), Positives = 131/347 (37%), Gaps = 101/347 (29%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ Y+L ++LG+G +G+ + D GE A K I + + D + RE+ I+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTE 64
Query: 113 LPKHPNIVSLKD--TYEDDSAVHIVMELCEGGELFD--RIVARGHYTE-----------R 157
L H NIV+L + ++D V++V + E D ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQLIK 120
Query: 158 AAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN 217
+K + H G++HRD+KP N + N +K DFGLS F +
Sbjct: 121 V----IKYL-------HSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRVT 166
Query: 218 EIVGSP----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILLC 253
+ +Y APE+L Y +D+WS G IL +LC
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 254 GVPPF-------------------WAETEQGV----AQAIIRSVIDFKRDPW-------- 282
G P F E + + A+ +I S+ +
Sbjct: 227 GKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT 286
Query: 283 ------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+E A DL+ K+L +P +R++A + L+HP++
Sbjct: 287 KWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 69/359 (19%), Positives = 120/359 (33%), Gaps = 99/359 (27%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
I Y++ +G G +G D A K I + +D + + RE+ I+
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNR 108
Query: 113 LPKHPNIVSLKD-----TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIV 167
L H ++V + D E +++V+E+ + + + TE ++ ++
Sbjct: 109 L-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 168 EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSP---- 223
V+ H G++HRDLKP N L N + +K DFGL+ E N +
Sbjct: 167 VGVKYVHSAGILHRDLKPANCL-VN--QDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 224 ------------------------YYMAPEVL--KRNYGPEVDVWSAGVIL--------- 248
+Y APE++ + NY +DVWS G I
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 249 ----------------YILLCGVPPFWAETEQGVAQAI-----IRSVI------------ 275
L + + I +++
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343
Query: 276 -----DFKRD--PWPKV---------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ R S +A L+K+ML +P +R+T E L HP+ +
Sbjct: 344 KEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 73/327 (22%), Positives = 116/327 (35%), Gaps = 74/327 (22%)
Query: 58 YDLGRELGRGEFGVTYLCTD-VNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
Y++ LG G FG C D + A K I + K R A R E+ ++K + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKE 75
Query: 116 H-----PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVE 168
V + D + + I EL G F+ + Y + +
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRP 212
++ HE + H DLKPEN LF N + +++ ++ DFG + F
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--D 192
Query: 213 GEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------ 265
E IV + +Y PEV L+ + DVWS G IL+ G F +
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252
Query: 266 ----------VAQAIIRSVIDFKRDPWPKVSENAK------------------------D 291
+ + + W + S + + D
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQN 318
L+++ML DP QR+T E L HP+
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 78/331 (23%), Positives = 118/331 (35%), Gaps = 74/331 (22%)
Query: 58 YDLGRELGRGEFGVTYLCTDV-NNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
Y++ LG G FG C D G A K + + + A E +Q+++HL
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLEHLNT 70
Query: 116 H-----PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVE 168
V + + +E + IV EL G +D I G + + I +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKK----------------ESSPLKAIDFGLSVFFRP 212
V H + H DLKPEN LF + +K +DFG + +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY--D 187
Query: 213 GEQFNEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG------ 265
E + +V + +Y APEV L + DVWS G IL G F +
Sbjct: 188 DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 266 ----------VAQAIIRSVIDFKRDPWPKVSENAK------------------------D 291
+ + R R W + S + D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322
L++KML DP +R+T E L+HP+ KK+
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 64/302 (21%), Positives = 115/302 (38%), Gaps = 55/302 (18%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK-H 112
++ D L +G+G +G + + GE A K S + D + RE ++
Sbjct: 6 VARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSR------DEKSWFRETELYNTV 57
Query: 113 LPKHPNIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV- 167
+ +H NI+ D S+ ++ E G L+D + + ++ +I
Sbjct: 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIAS 116
Query: 168 -------EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI- 219
E+ + + HRDLK +N L K++ D GL+V ++
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 220 ----VGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGV----------PPF 258
VG+ YMAPEVL + VD+W+ G++L+ + + PPF
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 259 WAETEQGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEV 310
+ + +R V+ R P + L+K+ +P RLTA +
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 311 LE 312
+
Sbjct: 294 KK 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 79/386 (20%), Positives = 136/386 (35%), Gaps = 100/386 (25%)
Query: 8 PDSSSGKRAKGKKEKP--NPFYGDE---YVVANGSTVVHRLCVLKEPSGQDISIDYDLGR 62
+ + KKE+ N Y D+ Y+V NG + R Y++
Sbjct: 16 ENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDR---------------YEIDS 60
Query: 63 ELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPKHP---- 117
+G+G FG D E A K I +KK + EV++++ + KH
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTEMK 115
Query: 118 -NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCH 174
IV LK + + + +V E+ L+D + + + + +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV-L 231
E ++H DLKPEN L N K S +K +DFG S G++ + + S +Y +PEV L
Sbjct: 175 TPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLL 231
Query: 232 KRNYGPEVDVWSA---------GVILY------------ILLCGVPPFW----------- 259
Y +D+WS G L+ + + G+PP
Sbjct: 232 GMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF 291
Query: 260 -----------------AETEQGVAQAIIRSVIDFKRDPWPKVSENA-----------KD 291
+ + +++ + KD
Sbjct: 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQ 317
L+ +ML+ DPK R+ L+H + +
Sbjct: 352 LILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 60/302 (19%), Positives = 111/302 (36%), Gaps = 55/302 (18%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR-REVQIMKH 112
I+ L +G+G FG + GE+ A K + + R E+
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVK-----IFSSREERSWFREAEIYQTVM 92
Query: 113 LPKHPNIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV- 167
L +H NI+ D ++ + +V + E G LFD + R T + +
Sbjct: 93 L-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTAS 150
Query: 168 -------EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI- 219
E+V + + HRDLK +N L K++ D GL+V +I
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 220 ----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----------PPF 258
VG+ YMAPEVL + + D+++ G++ + + P+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267
Query: 259 WAETEQGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEV 310
+ + +R V+ + R P ++ ++++ + RLTA +
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327
Query: 311 LE 312
+
Sbjct: 328 KK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 59/312 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI--MKHLPKHP 117
+ +++G+G +G ++ GEK A K + RE +I + +H
Sbjct: 41 MVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTT------EEASWFRETEIYQTVLM-RHE 91
Query: 118 NIVSLK--DTYEDDSAVH--IVMELCEGGELFDRIVARGHYTERAAAAVMKTIV------ 167
NI+ D S ++ + E G L+D + ++ + + V
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 168 --EVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI-----V 220
E+ + + HRDLK +N L K++ D GL+V F +I V
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 221 GSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----------PPFWAETE 263
G+ YM PEVL + D++S G+IL+ + P+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 264 QGVAQAIIRSVIDFK--RDPWPKVSENA------KDLVKKMLNPDPKQRLTAEEVLEHPW 315
+ +R ++ K R +P + L+ + +P RLTA V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT-- 325
Query: 316 LQNAKKAPNVSL 327
L ++ ++ L
Sbjct: 326 LAKMSESQDIKL 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 69/310 (22%), Positives = 114/310 (36%), Gaps = 73/310 (23%)
Query: 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
S+ L RG FG + E A K EV + +
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPI----QDKQSWQNEYEVYSLPGM- 75
Query: 115 KHPNIVSL--KDTYEDDSAVH--IVMELCEGGELFD-------------RI---VARG-- 152
KH NI+ + V ++ E G L D I +ARG
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA 135
Query: 153 --HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
H + ++ H+ + HRD+K +N L N + DFGL++ F
Sbjct: 136 YLH-----------EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA---CIADFGLALKF 181
Query: 211 RPGEQF---NEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG------- 254
G+ + VG+ YMAPEVL +R+ +D+++ G++L+ L
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 255 ----VPPFWAETEQGVAQAIIRSVIDFKR------DPWPKVSENAK--DLVKKMLNPDPK 302
+ PF E Q + ++ V+ K+ D W K + A + +++ + D +
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 303 QRLTAEEVLE 312
RL+A V E
Sbjct: 302 ARLSAGCVGE 311
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 73/373 (19%), Positives = 122/373 (32%), Gaps = 112/373 (30%)
Query: 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
G + Y + R+LG G F +L D+ + A K + K E E++++
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLL 87
Query: 111 KHL----PKHPN---IVSLKDTYEDDSA--VHI--VMELCEGGELFDRIVARGH--YTER 157
K + P PN +V L D ++ HI V E+ G L I+ +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146
Query: 158 AAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFA------------------------- 191
+++ +++ + H + ++H D+KPEN L +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 192 ---------------------NKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
E +K D G + + F E + + Y + EV
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEV 264
Query: 231 -LKRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVID----------- 276
+ Y D+WS + + L G F + E + I +I+
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 277 --------FKRD----------PWPKVS----------ENAK---DLVKKMLNPDPKQRL 305
F + PW E A D + ML P++R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 306 TAEEVLEHPWLQN 318
TA E L HPWL +
Sbjct: 385 TAAECLRHPWLNS 397
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} Length = 166 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 40/72 (55%), Positives = 53/72 (73%)
Query: 336 KQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI 395
KQFS MNK KK AL+V+AE LS EE+AGLKE F M+D +K G+I EEL+ GL + G N+
Sbjct: 1 KQFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANL 60
Query: 396 PEADLQILMEAV 407
E+++ LM+A
Sbjct: 61 KESEILDLMQAA 72
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 68/285 (23%), Positives = 108/285 (37%), Gaps = 47/285 (16%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
LG ++GRG FG + + A KS ++ +E +I+K HPNI
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQY-SHPNI 174
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC----- 173
V L ++IVMEL +GG+ + G +KT+++ V
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR------VKTLLQMVGDAAAGMEY 228
Query: 174 -HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
+ +HRDL N L K LK DFG+S R E Y
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNV---LKISDFGMS---R------EEADGVYAASGGLRQ 276
Query: 226 -----MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
APE L Y E DVWS G++L+ G P+ + Q + + + +
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGR 333
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
+ L+++ +P QR + + + LQ+ +K
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ--ELQSIRKRH 376
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-25
Identities = 17/83 (20%), Positives = 38/83 (45%), Gaps = 4/83 (4%)
Query: 327 LGETVKARLKQFSVMNKLKKRALQVVAEFLSV--EEVAGLKEAFEMMDTNKRGKINLEEL 384
+ V +K + + ++ + ++A LSV + + E F +DTN G ++ E+
Sbjct: 2 ISPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREI 61
Query: 385 RLGLLKGGQNIPEADLQILMEAV 407
L G + D+ +++A+
Sbjct: 62 YTVLASVGI--KKWDINRILQAL 82
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 26/131 (19%), Positives = 54/131 (41%), Gaps = 11/131 (8%)
Query: 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVM 341
++++ ++ K+ D K + E + A++ + G+ + + S++
Sbjct: 43 EAQIAQKEQEQKAKLAEYDQKVQN------EFDARERAEREREAARGDAAAEKQRLASLL 96
Query: 342 NKLKKRA-----LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
L+ A L+ LS E+ L++ F + GK + ++L+ L K IP
Sbjct: 97 KDLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIP 156
Query: 397 EADLQILMEAV 407
E L+ L V
Sbjct: 157 EGPLKKLFVMV 167
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A Length = 323 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 12/54 (22%), Positives = 24/54 (44%), Gaps = 1/54 (1%)
Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
++V ++A L F +DTN G ++ +E R ++ G + + A
Sbjct: 179 TLVAVANDLAALVADFRKIDTNSNGTLSRKEFREHFVRLGFDKKSVQDALFRYA 232
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} Length = 191 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-24
Identities = 20/91 (21%), Positives = 40/91 (43%), Gaps = 12/91 (13%)
Query: 329 ETVKARLKQFSVMNKLKKRALQVVAEFLS-VEEVAGLKEAFEMMDTNKRGKINLEELRLG 387
+K+F KL + A+ + L+ +EE L + F +D N G+++ +EL G
Sbjct: 6 TGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEG 65
Query: 388 LLKG-----------GQNIPEADLQILMEAV 407
K + EA++ ++++V
Sbjct: 66 YRKLMQWKGDTVSDLDSSQIEAEVDHILQSV 96
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-24
Identities = 63/323 (19%), Positives = 114/323 (35%), Gaps = 71/323 (21%)
Query: 48 EPSGQDISIDYD---LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
E + + S+D D L +GRG +G Y + + A K S + ++
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFA------NRQNFI 53
Query: 105 REVQIMKHLPK--HPNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTER 157
E I + +P H NI + T + +VME G L ++
Sbjct: 54 NEKNIYR-VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWV 111
Query: 158 AAAAVMKTIV--------EVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208
++ + ++ E+ + H + + HRDL N L K DFGLS+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSM 168
Query: 209 FFRPGEQF---------NEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYIL 251
VG+ YMAPEVL+ + +VD+++ G+I + +
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 252 LCGV-------------PPFWAETEQGVAQAIIRSVIDFKR------DPWPKVSENAKDL 292
F E ++ ++ ++ + W + S + L
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 293 VKKML---NPDPKQRLTAEEVLE 312
+ + + D + RLTA+ E
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEE 311
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} Length = 204 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 8/87 (9%)
Query: 321 KAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
P LG + M KL+ + L A + GL F +D + ++
Sbjct: 4 LVPRGPLGS---HMDAVDATMEKLRAQCLSRGAS-----GIQGLARFFRQLDRDGSRSLD 55
Query: 381 LEELRLGLLKGGQNIPEADLQILMEAV 407
+E R GL K G + +A+ + +
Sbjct: 56 ADEFRQGLAKLGLVLDQAEAEGVCRKW 82
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 65/287 (22%), Positives = 100/287 (34%), Gaps = 54/287 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LGR LG+GEFG F A K + K + + DIE+ RE MK H
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF-DH 84
Query: 117 PNIVSL------KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
P++ L +++ + G+L ++A + + +V
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 171 QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
+ + +HRDL N + A E + DFGLS R +I Y
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS---R------KIYSGDY 192
Query: 225 Y------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
Y +A E L Y DVW+ GV ++ I+ G P+ +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---- 248
Query: 271 IRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
+I R P + V M + DPKQR + +
Sbjct: 249 YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 68/296 (22%), Positives = 108/296 (36%), Gaps = 51/296 (17%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
L R LG G FG Y + + N A K++ ++ + D D E I+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF- 90
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC 173
H NIV I+MEL GG+L + + ++ M ++ V +
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
E +HRD+ N L K DFG++ R +I + YY
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRASYYRK 201
Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
M PE + + D WS GV+L+ I G P+ +++ Q V +
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEF 257
Query: 274 VIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
V R P +N V + M P+ R +LE ++ + P+V
Sbjct: 258 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYCTQDPDV 308
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 67/296 (22%), Positives = 108/296 (36%), Gaps = 51/296 (17%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
L R LG G FG Y + + N A K++ ++ + D D E I+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKF- 131
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVC 173
H NIV I++EL GG+L + + ++ M ++ V +
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
E +HRD+ N L K DFG++ R +I + YY
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---R------DIYRAGYYRK 242
Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
M PE + + D WS GV+L+ I G P+ +++ Q V +
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEF 298
Query: 274 VIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPNV 325
V R P +N V + M P+ R +LE ++ + P+V
Sbjct: 299 VTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILER--IEYCTQDPDV 349
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 59/286 (20%), Positives = 102/286 (35%), Gaps = 53/286 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LG+ LG GEFG A K++ K + +IE+ E MK H
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDF-SH 95
Query: 117 PNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
PN++ L + + + +++ + G+L ++ T + + +V
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
+ + +HRDL N + + + DFGLS + +I YY
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLS---K------KIYSGDYY 203
Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
+A E L R Y + DVW+ GV ++ I G+ P+ +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----Y 259
Query: 272 RSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
++ R P E+ D + + M DP R T +
Sbjct: 260 DYLLHGHRLKQP---EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 44/215 (20%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
R+LG G FG LC N GE+ A KS+ K I D+++E++I+++L
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-Y 81
Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
H NIV K T + + + ++ME G L + + + + + + + VQ+C
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKN---KNKINLKQQLKYAVQIC 136
Query: 174 ------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
+ +HRDL N L ++ + +K DFGL+ ++ YY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKE--------YYTV 185
Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY 249
APE L + DVWS GV L+
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 55/287 (19%)
Query: 60 LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
+ RELG+G FG+ Y V E A K++ + + + + E +MK
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEF- 85
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
++V L ++MEL G+L + + ++ +++Q+
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 175 ----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
+HRDL N + A E +K DFG++ R +I + Y
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---R------DIYETDY 193
Query: 225 Y------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
Y M+PE LK + DVWS GV+L+ I P+ + + V
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---- 249
Query: 271 IRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEH 313
+R V++ P +N D++ + M +PK R + E++
Sbjct: 250 LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 48/236 (20%), Positives = 90/236 (38%), Gaps = 47/236 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
+ LG G FG Y + GEK A K + ++ + +++ E +M +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV-D 75
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC 173
+P++ L + V ++ +L G L D + + + + ++ VQ+
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG-------SQYLLNWCVQIA 127
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
++ ++HRDL N L +K DFGL+ E+ Y
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEK--------EYHA 176
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
MA E + R Y + DVWS GV ++ ++ G P+ ++ +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+ +LG G++G Y A K++ + +++E+ +E +MK + KHPN+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNL 278
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVE-VVQVC--- 173
V L + +I+ E G L D R R + ++ Q+
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVVLLYMATQISSAM 331
Query: 174 ---HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY-YMA 227
++ +HR+L N L E+ +K DFGLS G+ + G+ P + A
Sbjct: 332 EYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 387
Query: 228 PEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
PE L + + DVW+ GV+L+ I G+ P+ V + + +
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+ LGR++G G FG YL T++ E+ A K + K + E +I + L
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGT 63
Query: 118 NIVSLKDTYEDDSAVHIVMELCEG---GELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
I +++ + +VM+L G +LF+ + + + ++ V+ H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH 120
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSPYYM 226
+ +HRD+KP+NFL + ++ + IDFGL+ +R P + + G+ Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 227 APEV-LKRNYGPEVDVWSAGVILYILLCGVPPFW 259
+ L D+ S G +L L G P W
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-W 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 44/233 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L +ELG G+FGV L A K I + ++ ++ +E Q M L HP +
Sbjct: 12 LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKL-SHPKL 65
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH---- 174
V + ++IV E G L + + + G E ++E+ VC
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLE------PSQLLEMCYDVCEGMAF 119
Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
+HRDL N L +K DFG++ R ++ Y
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---R------YVLDDQYVSSVGTKF 167
Query: 226 ----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APEV Y + DVW+ G++++ + G P+ T V + +
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-20
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 48/236 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+ +LG G++G Y A K++ + +++E+ +E +MK + KHPN+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNL 71
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEV-VQVCH-- 174
V L + +I+ E G L D R R + ++ + Q+
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS-------AVVLLYMATQISSAM 124
Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
++ +HRDL N L E+ +K DFGLS R ++ Y
Sbjct: 125 EYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS---R-------LMTGDTYTAHAG 171
Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE L + + DVW+ GV+L+ I G+ P+ V + + +
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 44/155 (28%), Positives = 73/155 (47%), Gaps = 7/155 (4%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LGR++G G FG YL TD+ GE+ A K K + E +I K +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGV 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
I +++ + +VMEL G L D ++ + + ++ ++ H +
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211
+HRD+KP+NFL K+ + + IDFGL+ +R
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 53/289 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
G+ LG G FG T G++ A ++ K L+ A + E + E++IM HL +H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-------RIVARGHYTERAAAAVMKTIVEV 169
NIV+L V ++ E C G+L + + + + A + ++
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 170 -VQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
QV + +HRD+ N L N K DFGL+ R +I+
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLA---R------DIMND 217
Query: 223 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
Y MAPE + Y + DVWS G++L+ I G+ P+ V
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL---VNS 274
Query: 269 AIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
+ V D + P A + M +P R T +++
Sbjct: 275 KFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 57/303 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLPKHP 117
L ELG G FG +L N + ++ K L+ A + D +RE +++ L +H
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQ 103
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMKTIVEVVQV 172
+IV + + +V E G+L A+ A + +++ V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 173 CH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
+HRDL N L + +K DFG+S R +I +
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---R------DIYST 211
Query: 223 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 268
YY M PE + R + E DVWS GV+L+ I G P++ +
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-- 269
Query: 269 AIIRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEHPWLQNAKKAPN 324
I + + P V M +P+QR + ++V LQ +AP
Sbjct: 270 --IDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHAR--LQALAQAPP 322
Query: 325 VSL 327
V L
Sbjct: 323 VYL 325
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 46/215 (21%)
Query: 60 LGRELGRGEFGVTYLC----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
R+LG G FG L T+ GE A K++ K ++E+ I++ L
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTL-Y 91
Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
H +I+ K +++ +VME G L D Y R + + + ++ Q+C
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQIC 144
Query: 174 ------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
H Q +HRDL N L +K DFGL+ + + +E YY
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLA---KAVPEGHE-----YYRV 193
Query: 226 ----------MAPEVLK-RNYGPEVDVWSAGVILY 249
APE LK + DVWS GV LY
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 56/216 (25%), Positives = 85/216 (39%), Gaps = 47/216 (21%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
++LG+G FG +C N GE A K + + T + D RE++I+K L +
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-Q 100
Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQV 172
H NIV K + ++ME G L D + + +++ Q+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI 154
Query: 173 C------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY- 225
C + +HRDL N L N+ +K DFGL+ ++ YY
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKE--------YYK 203
Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY 249
APE L + DVWS GV+LY
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 55/232 (23%), Positives = 81/232 (34%), Gaps = 50/232 (21%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
+LG+G FG LC N G A K + + D +RE+QI+K L
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKAL-H 82
Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQ 171
IV + ++ +VME G L D + R ++ Q
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD-------ASRLLLYSSQ 135
Query: 172 VC------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
+C + +HRDL N L ++ +K DFGL+ + YY
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPLDKD--------YY 184
Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 263
APE L + + DVWS GV+LY + E
Sbjct: 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 54/254 (21%)
Query: 45 VLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIE 101
V+ PS + +GRG FG Y T ++N K A KS+ ++ ++
Sbjct: 18 VVIGPSSLIVH----FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVS 71
Query: 102 DVRREVQIMKHLPKHPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAA 159
E IMK HPN++SL + + +V+ + G+L + I + T
Sbjct: 72 QFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---- 126
Query: 160 AAVMKTIVEV-VQVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
+K ++ +QV + +HRDL N + E +K DFGL+ R
Sbjct: 127 ---VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R- 176
Query: 213 GEQFNEIVGSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
++ YY MA E L+ + + + DVWS GV+L+ ++ G P
Sbjct: 177 -----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
Query: 257 PFWAETEQGVAQAI 270
P+ + +
Sbjct: 232 PYPDVNTFDITVYL 245
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L + +G+GEFG L G K A K ++ + E +M L +H N+
Sbjct: 197 LLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQL-RHSNL 248
Query: 120 VSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC-- 173
V L E+ ++IV E G L D + +RG R+ + + VC
Sbjct: 249 VQL---LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG----RSVLGGDCLLKFSLDVCEA 301
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY-YM 226
+HRDL N L + E + K DFGL+ + E + P +
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K--EASSTQDTGKLPVKWT 353
Query: 227 APEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
APE L+ + + DVWS G++L+ I G P+ + V +
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-19
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 47/216 (21%)
Query: 60 LGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
++LG+G FG +C N GE A K + + T + D RE++I+K L +
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSL-Q 69
Query: 116 HPNIVSLKD--TYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQV 172
H NIV K + ++ME G L D + + +++ Q+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERID------HIKLLQYTSQI 123
Query: 173 C------HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY- 225
C + +HRDL N L N+ +K DFGL+ ++ ++
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDKE--------FFK 172
Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY 249
APE L + DVWS GV+LY
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-19
Identities = 52/233 (22%), Positives = 88/233 (37%), Gaps = 44/233 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+ELG G+FGV A K I + ++ ++ E ++M +L H +
Sbjct: 28 FLKELGTGQFGVVKYGK-WRGQYDVAIKMIKE----GSMSEDEFIEEAKVMMNL-SHEKL 81
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH---- 174
V L + I+ E G L + + H + + ++E+ VC
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEY 135
Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
+ +HRDL N L + +K DFGLS R ++ Y
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLS---R------YVLDDEYTSSVGSKF 183
Query: 226 ----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
PEVL + + D+W+ GV+++ I G P+ T A+ I +
Sbjct: 184 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-19
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 42/230 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+E+G G+FG+ +L N +K A K+I + A+ ED E ++M L HP +
Sbjct: 12 FVQEIGSGQFGLVHLGY-WLNKDKVAIKTIRE----GAMSEEDFIEEAEVMMKL-SHPKL 65
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH----- 174
V L + + + +V E E G L D + + M + VC
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-----CLDVCEGMAYL 120
Query: 175 -EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-------- 225
E V+HRDL N L E+ +K DFG++ R ++ Y
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMT---R------FVLDDQYTSSTGTKFP 168
Query: 226 ---MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
+PEV Y + DVWS GV+++ + G P+ + V + I
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 61/295 (20%), Positives = 109/295 (36%), Gaps = 61/295 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
G+ LG G FG T + A +++ K L+ + E + E++++ +L H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD--------RIVARGHYTERAAAAVMKTIVE 168
NIV+L ++ E C G+L + I ++ + + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 169 VVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
++ + + +HRDL N L K DFGL+ R +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA---R------D 194
Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
I Y MAPE + Y E DVWS G+ L+ + G P+
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----P 249
Query: 265 GVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
G+ + + + R P E+A + M + DP +R T +++++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 50 SGQDISID--YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
SGQ+ + Y +GR +G G FGV + T++ N ++ A K ++ D +R E
Sbjct: 2 SGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEY 56
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFD-RIVARGHYTERAAAAVMKTI 166
+ K L I ++ ++ +V++L G L D + ++ + A K +
Sbjct: 57 RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQM 115
Query: 167 VEVVQVCHEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFR--------PGEQF 216
+ VQ HE+ +++RD+KP+NFL N K ++ + +DFG+ F+R P +
Sbjct: 116 LARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 217 NEIVGSPYYMAPEVLKRNYGPEV----DVWSAGVILYILLCGVPPFW 259
+ G+ YM+ + + G E D+ + G + L G P W
Sbjct: 176 KNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMYFLRGSLP-W 218
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 68/308 (22%), Positives = 106/308 (34%), Gaps = 62/308 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF--ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+G G FG +G + A K + K+ + D D E++++ L HP
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFD------RIVARGHYTERAAAAVMKTIVEVVQ 171
NI++L E +++ +E G L D + + + A + +++
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 172 VCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
++ +HRDL N L K DFGLS R E
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLS---RGQE------- 193
Query: 222 SPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
Y MA E L Y DVWS GV+L+ I+ G P+ T
Sbjct: 194 --VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT----C 247
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH--PWLQNAKK 321
+ + R P N D V M P +R + ++L L+ K
Sbjct: 248 AELYEKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
Query: 322 APNVSLGE 329
N +L E
Sbjct: 305 YVNTTLYE 312
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 66/297 (22%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
LG+ LGRG FG + C++++ K L+ T + + E++I+ H+ H
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 117 PNIVSLKDTY----EDDSAVHIVMELCEGGELFD------RIVARGHYTERAAAAVMKTI 166
N+V+L + + +++E C+ G L T+
Sbjct: 91 LNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 167 VEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
++ + +HRDL N L + E + +K DFGL+ R
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA---R----- 196
Query: 217 NEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 262
+I P Y MAPE + R Y + DVWS GV+L+ I G P+
Sbjct: 197 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 251
Query: 263 EQGVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
GV + R + + R P + + + ML + +P QR T E++EH
Sbjct: 252 -PGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 59/239 (24%), Positives = 84/239 (35%), Gaps = 45/239 (18%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
L +LG G FGV A K + L ++D REV M L H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DH 80
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC- 173
N++ L + +V EL G L DR+ +GH+ + T+ VQV
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFL-------LGTLSRYAVQVAE 132
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
+ +HRDL N L A + +K DFGL + +Y
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRS 273
APE LK R + D W GV L+ + G P+ + I +
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 8e-19
Identities = 41/238 (17%), Positives = 74/238 (31%), Gaps = 41/238 (17%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPK 115
LG+G F + + +V + + + K L E +M L
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-S 70
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH 174
H ++V +V E + G L + + + +EV Q+
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN------ILWKLEVAKQLAA 124
Query: 175 ------EQGVMHRDLKPENFLFANKKESSPL-----KAIDFGLSVFFRPGEQFNEIVGSP 223
E ++H ++ +N L +++ K D G+S ++
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---I------TVLPKD 175
Query: 224 YY------MAPEVLK--RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
+ PE ++ +N D WS G L+ I G P A Q Q
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 44/231 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L + +G+GEFG L G K A K ++ + E +M L +H N+
Sbjct: 25 LLQTIGKGEFGDVMLGDY--RGNKVAVKC-----IKNDATAQAFLAEASVMTQL-RHSNL 76
Query: 120 VSLKDTY----EDDSAVHIVMELCEGGELFD--RIVARGHYTERAAAAVMKTIVEV-VQV 172
V L E+ ++IV E G L D R R +++ + V
Sbjct: 77 VQL---LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG-------GDCLLKFSLDV 126
Query: 173 CH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS--PY 224
C +HRDL N L + E + K DFGL+ + E + P
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLT---K--EASSTQDTGKLPV 178
Query: 225 -YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
+ APE L+ + + + DVWS G++L+ I G P+ + V + +
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-18
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 54/243 (22%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
R +G+G FGV Y ++ + A KS+ ++ +E RE +M+ L H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGL-NH 81
Query: 117 PNIVSLKDTY----EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQ 171
PN+++L + H+++ G+L I + +K ++ +Q
Sbjct: 82 PNVLAL---IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR------NPTVKDLISFGLQ 132
Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
V EQ +HRDL N + ES +K DFGL+ R +I+ YY
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---R------DILDREYY 180
Query: 226 --------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 269
A E L+ + + DVWS GV+L+ +L G PP+ +
Sbjct: 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240
Query: 270 IIR 272
+ +
Sbjct: 241 LAQ 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 49/236 (20%), Positives = 82/236 (34%), Gaps = 47/236 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
+ LG G FG + + GE K I + + V + + L
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSL-D 73
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVE-VVQVC 173
H +IV L S + +V + G L D + RG + ++ VQ+
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALG-------PQLLLNWGVQIA 125
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
E G++HR+L N L S ++ DFG++ P ++
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDK--------QLLY 174
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
MA E + Y + DVWS GV ++ ++ G P+ V +
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 23/183 (12%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+ +G+++G G FG L ++ E A K + K R + E + K L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQLGSGD 65
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGG----ELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
I + +V+EL G +LFD ++ + + ++ ++
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYV 121
Query: 174 HEQGVMHRDLKPENFLF--ANKKESSPLKAIDFGLSVFFR--------PGEQFNEIVGSP 223
H + +++RD+KPENFL K + IDF L+ + P + + G+
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 224 YYM 226
YM
Sbjct: 182 RYM 184
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 34/228 (14%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L +LG+G FG ++ T N + A K++ + E +E Q+MK L +H +
Sbjct: 188 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKL 241
Query: 120 VSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVE-VVQVC- 173
V L Y + ++IV E G L D + E + +V+ Q+
Sbjct: 242 VQL---YAVVSEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIAS 291
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY-YM 226
+HRDL+ N L E+ K DFGL+ E P +
Sbjct: 292 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 227 APEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + + DVWS G++L + G P+ + V + R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 87 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 2e-18
Identities = 25/58 (43%), Positives = 40/58 (68%)
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ +AE LS EE+ GLKE F+M+DT+ G I +EL+ GL + G + E++++ LM+A
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 12/96 (12%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMM 371
+ L N + +G + + ++ + + +++ + + F +
Sbjct: 6 ANFCLWNLQPIQGSWMG-----AACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGV 60
Query: 372 DTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
D ++ G + + EL +G GG + +M
Sbjct: 61 DRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIF 96
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A Length = 220 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 10/54 (18%), Positives = 21/54 (38%), Gaps = 1/54 (1%)
Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
EF+++ + + F M + G + E+ L + G I + +L
Sbjct: 108 EFMAMYKFMELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRL 161
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 48/235 (20%), Positives = 88/235 (37%), Gaps = 45/235 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
+ LG G FG Y + GEK A K + ++ + +++ E +M +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASV-D 75
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC- 173
+P++ L + V ++ +L G L D + + ++ VQ+
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIG------SQYLLNWCVQIAK 128
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
++ ++HRDL N L +K DFGL+ E+ Y
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 226 --------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
MA E + R Y + DVWS GV ++ ++ G P+ ++ +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 58/240 (24%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L LG G+FG ++ N K A KS+ + ++ + E +MK L +H +
Sbjct: 17 LVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQ----GSMSPDAFLAEANLMKQL-QHQRL 70
Query: 120 VSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEV-VQ 171
V L ++ ++I+ E E G L D + T + ++++ Q
Sbjct: 71 VRLYAVVTQE------PIYIITEYMENGSLVD-------FLKTPSGIKLTINKLLDMAAQ 117
Query: 172 VCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY 225
+ E+ +HRDL+ N L + ++ K DFGL+ R I + Y
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLA---R------LIEDNEYT 165
Query: 226 -----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + + + DVWS G++L I+ G P+ T V Q + R
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L ++LG G+FG ++ T N K A K++ ++ +E E +MK L +H +
Sbjct: 192 LEKKLGAGQFGEVWMATY-NKHTKVAVKTMKP----GSMSVEAFLAEANVMKTL-QHDKL 245
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH----- 174
V L + ++I+ E G L D + + E + + K I Q+
Sbjct: 246 VKLHAVVTKEP-IYIITEFMAKGSLLDFLKSD----EGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 175 -EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-------- 225
++ +HRDL+ N L + S K DFGL+ I + Y
Sbjct: 301 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARV---------IEDNEYTAREGAKFP 348
Query: 226 ---MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + ++ + DVWS G++L I+ G P+ + V +A+ R
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 56/228 (24%), Positives = 89/228 (39%), Gaps = 34/228 (14%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
L +LG+G FG ++ T N + A K++ + E +E Q+MK L +H +
Sbjct: 271 LEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKL 324
Query: 120 VSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVE-VVQVC- 173
V L Y + ++IV E G L D + E + +V+ Q+
Sbjct: 325 VQL---YAVVSEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIAS 374
Query: 174 -----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS-PY-YM 226
+HRDL+ N L E+ K DFGL+ E P +
Sbjct: 375 GMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431
Query: 227 APEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + + DVWS G++L + G P+ + V + R
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 63/241 (26%), Positives = 95/241 (39%), Gaps = 55/241 (22%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LGR +G G+FG + + N A K+ K + E +E M+ H
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMRQF-DH 75
Query: 117 PNIVSL-----KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VV 170
P+IV L ++ V I+MELC GEL + R + + + +++
Sbjct: 76 PHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKYSLD------LASLILYAY 123
Query: 171 QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
Q+ + +HRD+ N L + + +K DFGLS R + S Y
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTY 171
Query: 225 Y-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
Y MAPE + R + DVW GV ++ IL+ GV PF V I
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
Query: 272 R 272
Sbjct: 232 N 232
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-18
Identities = 71/300 (23%), Positives = 113/300 (37%), Gaps = 58/300 (19%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE--DVRREVQIMKHLPKHP 117
L RELG G FG +L N ++ K L+ D +RE +++ +L +H
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHE 77
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVEVVQ 171
+IV D + +V E + G+L + A G + + +++
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 172 VCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVG 221
+ Q +HRDL N L + +K DFG+S R ++
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---R------DVYS 185
Query: 222 SPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 267
+ YY M PE + R + E DVWS GVIL+ I G P++ + V
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV- 244
Query: 268 QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEHPWLQNAKKAP 323
I + + P V ML +P+QRL +E+ + L KA
Sbjct: 245 ---IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLNIKEIYKI--LHALGKAT 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 5e-18
Identities = 66/236 (27%), Positives = 92/236 (38%), Gaps = 45/236 (19%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
L R LG G FG Y A K+ KK T + E E IMK+L H
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMKNL-DH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH- 174
P+IV L E++ I+MEL GEL + + + + T+V +Q+C
Sbjct: 73 PHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLK------VLTLVLYSLQICKA 125
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
+HRD+ N L A +K DFGLS R I YY
Sbjct: 126 MAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---R------YIEDEDYYKASV 173
Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
M+PE + R + DVW V ++ IL G PF+ + V + +
Sbjct: 174 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-18
Identities = 63/236 (26%), Positives = 94/236 (39%), Gaps = 45/236 (19%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
LGR +G G+FG + + N A K+ K + E +E M+ H
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMRQF-DH 450
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVC-- 173
P+IV L ++ V I+MELC GEL + R + + +++ Q+
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLD------LASLILYAYQLSTA 503
Query: 174 ----HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
+ +HRD+ N L + + +K DFGLS R + S YY
Sbjct: 504 LAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS---R------YMEDSTYYKASK 551
Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
MAPE + R + DVW GV ++ IL+ GV PF V I
Sbjct: 552 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 55/239 (23%), Positives = 96/239 (40%), Gaps = 50/239 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+GRG FG Y T ++N K A KS+ ++ ++ E IMK H
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF-SH 149
Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEV-VQVC 173
PN++SL + + +V+ + G+L + I + T +K ++ +QV
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT-------VKDLIGFGLQVA 202
Query: 174 H------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY-- 225
+ +HRDL N + E +K DFGL+ R ++ +
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---R------DMYDKEFDSV 250
Query: 226 ------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
MA E L+ + + + DVWS GV+L+ ++ G PP+ + +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 58/293 (19%)
Query: 60 LGRELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
LG+ LG G FG L ++ + ++ K L+ T D+ D+ E+++MK +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV---- 170
KH NI++L D +++++E G L + + AR + E +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 171 ------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
QV + +HRDL N L E + +K DFGL+ R +
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLA---R------D 240
Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
I YY MAPE L R Y + DVWS GV+L+ I G P+ +
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
+ + + + R P N + + M + P QR T ++++E
Sbjct: 301 EL----FKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 9e-18
Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 61/293 (20%)
Query: 60 LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
ELG FG Y GE+ A K++ K E+ R E + L
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARL- 69
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK------TIVE 168
+HPN+V L D + ++ C G+L + +V R +++ + + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 169 VVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
V + V+H+DL N L + +K D GL R E
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---R------E 177
Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
+ + YY MAPE + + + D+WS GV+L+ + G+ P+ + Q
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 237
Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
V + + + + P P ++ V M+ N P +R +++
Sbjct: 238 DV----VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A Length = 109 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-18
Identities = 16/88 (18%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 323 PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLE 382
++ E +K + F+ + + + L + +K+ F ++D +K G I +
Sbjct: 3 TDLLSAEDIKKAIGAFTAADSFDHKKFFQMVG-LKKKSADDVKKVFHILDKDKSGFIEED 61
Query: 383 ELRLGL---LKGGQNIPEADLQILMEAV 407
EL L +++ + + LM A
Sbjct: 62 ELGSILKGFSSDARDLSAKETKTLMAAG 89
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 72/294 (24%), Positives = 119/294 (40%), Gaps = 60/294 (20%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISK---KKLR---TAVDIEDVRREVQIMKHL 113
LG+ LG G FG + +K K K L+ T D+ D+ E+++MK +
Sbjct: 85 LGKPLGEGCFGQVVMAE-AVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV--- 170
KH NI++L D +++++E G L + + AR + + + E +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 171 -------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFN 217
Q+ Q +HRDL N L E++ +K DFGL+ R
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---R------ 251
Query: 218 EIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 263
+I YY MAPE L R Y + DVWS GV+++ I G P+
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
+ + + + + R P N + + M + P QR T ++++E
Sbjct: 312 EEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 58/293 (19%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLP 114
LG+ LG G FG ++ + +++ K L+ T D+ D+ E+++MK +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV---- 170
KH NI++L D +++++E G L + + AR + + + E +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 171 ------QVCH------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
Q+ Q +HRDL N L +K DFGL+ R +
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA---R------D 206
Query: 219 IVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 264
I YY MAPE L R Y + DVWS GV+++ I G P+ +
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKK-ML---NPDPKQRLTAEEVLEH 313
+ + + + R P N + + M + P QR T ++++E
Sbjct: 267 EL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 66/300 (22%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
G+ LG G FG T + ++ K L+ + + E + E+++M L H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-------------RIVARGHYTERAAAAVM 163
NIV+L ++++ E C G+L + E +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 164 KTIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
T +++ + + +HRDL N L +K DFGL+ R
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLA---R-- 220
Query: 214 EQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 259
+I+ Y MAPE L Y + DVWS G++L+ I GV P+
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY- 275
Query: 260 AETEQGVA--QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
G+ + + + + P A + + M D ++R + +
Sbjct: 276 ----PGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 66/274 (24%), Positives = 99/274 (36%), Gaps = 50/274 (18%)
Query: 20 KEKPNPFYGDEYVVANGSTVVHRLCVLKEPSGQDISIDYDLGRELGRGEFGVTY--LCTD 77
+ P E ++ + + LK + I ELG G FG +
Sbjct: 306 RPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI------ELGCGNFGSVRQGVYRM 359
Query: 78 VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137
A K + K+ D E++ RE QIM L +P IV L + ++ + +VME
Sbjct: 360 RKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAEA-LMLVME 415
Query: 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH------EQGVMHRDLKPENFLF 190
+ GG L +V + + + E + QV E+ +HR+L N L
Sbjct: 416 MAGGGPLHKFLVGKREEIP------VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL 469
Query: 191 ANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------------MAPEVLK-RNYGP 237
N+ K DFGLS + YY APE + R +
Sbjct: 470 VNRHY---AKISDFGLSKALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 238 EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
DVWS GV ++ L G P+ V I
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 55/237 (23%), Positives = 82/237 (34%), Gaps = 43/237 (18%)
Query: 60 LGRELGRGEFGV----TYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
+ +G GEFG + A K++ K T D E IM
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQF-S 104
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV-VQVCH 174
H NI+ L+ + I+ E E G L E+ + +V + +
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAA 158
Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
+HRDL N L + K DFGLS R E E Y
Sbjct: 159 GMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS---RVLEDDPE----ATYTTS 208
Query: 226 --------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 272
APE + R + DVWS G++++ ++ G P+W + V +AI
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 55/234 (23%), Positives = 80/234 (34%), Gaps = 42/234 (17%)
Query: 60 LGRELGRGEFGVTY---LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ + +G G+ G L A K++ K T D E IM H
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQF-DH 109
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH- 174
PNI+ L+ IV E E G L + + +V + V
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAG 163
Query: 175 -----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY---- 225
+ G +HRDL N L + K DFGLS Y
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPD-------AAYTTTG 213
Query: 226 -------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
APE + R + DVWS GV+++ +L G P+W T + V ++
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 36/180 (20%), Positives = 67/180 (37%), Gaps = 24/180 (13%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+ LG+++G G FG+ YL N EK A + + + E++ + + K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKD 94
Query: 118 NIVSLKDTYEDDSA----VH--------------IVMELCEGGELFDRIVARGHYTERAA 159
I + + D + +VME G +L G + +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 160 AAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219
+ +++V++ HE +H D+K N L K + D+GLS + P +
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGLSYRYCPNGNHKQY 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 57/236 (24%), Positives = 84/236 (35%), Gaps = 48/236 (20%)
Query: 60 LGRELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+ELG G FG + A K + K + +++ E +M+ L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNP 78
Query: 118 NIVSLKDTYE--DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH 174
IV + + + +VME+ E G L + H K I+E V QV
Sbjct: 79 YIVRM---IGICEAESWMLVMEMAELGPLNKYLQQNRHVK-------DKNIIELVHQVSM 128
Query: 175 ------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--- 225
E +HRDL N L + K DFGLS R E YY
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADEN--------YYKAQ 177
Query: 226 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
APE + + + DVWS GV+++ G P+ V +
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 62/232 (26%), Positives = 88/232 (37%), Gaps = 44/232 (18%)
Query: 62 RELGRGEFGVTY--LCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
ELG G FG + A K + K+ D E++ RE QIM L +P I
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQL-DNPYI 72
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE-VVQVCH---- 174
V L + ++ + +VME+ GG L +V + + + E + QV
Sbjct: 73 VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIP------VSNVAELLHQVSMGMKY 125
Query: 175 --EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY------- 225
E+ +HRDL N L N+ K DFGLS + YY
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADD--------SYYTARSAGK 174
Query: 226 -----MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
APE + R + DVWS GV ++ L G P+ V I
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 Length = 188 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-17
Identities = 25/55 (45%), Positives = 38/55 (69%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
AE LS EE+ GLKE F+M+DT+ G I +EL+ GL + G + E++++ LM+A
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 55
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 61/233 (26%), Positives = 90/233 (38%), Gaps = 40/233 (17%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ + +G GEFG +K A K++ K T D E IM H
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF-DH 105
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-- 174
PNI+ L+ V IV E E G L + R H A V++ + + +
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKH---DAQFTVIQLVGMLRGIASGM 160
Query: 175 ----EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY----- 225
+ G +HRDL N L + K DFGL R E E Y
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLG---RVLEDDPE----AAYTTRGG 210
Query: 226 ------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 270
+PE + R + DVWS G++L+ ++ G P+W + Q V +A+
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 69/316 (21%), Positives = 110/316 (34%), Gaps = 71/316 (22%)
Query: 60 LGRELGRGEFGVTYLCT--DVNNGEKF---ACKSISKKKLRTAVDIEDVRREVQIMKHLP 114
R++G G FG + + E F A K + K+ +A D +RE +M
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEF- 107
Query: 115 KHPNIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMK----- 164
+PNIV L + ++ E G+L + + + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 165 ----TIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
+ E + + E+ +HRDL N L E+ +K DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLS--- 221
Query: 211 RPGEQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 256
R I + YY M PE + Y E DVW+ GV+L+ I G+
Sbjct: 222 R------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275
Query: 257 PFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLE 312
P++ + V I V D P EN + M + P R + +
Sbjct: 276 PYYGMAHEEV----IYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFCSIHR 328
Query: 313 HPWLQNAKKAPNVSLG 328
LQ + ++G
Sbjct: 329 I--LQRMCERAEGTVG 342
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 64/300 (21%), Positives = 117/300 (39%), Gaps = 67/300 (22%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
LG+ LG GEFG T + + +++ K L+ + ++ D+ E ++K + H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NH 85
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD-----RIVARGHYTERAAAAVMK------- 164
P+++ L D + +++E + G L R V G+ +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 165 --TIVEVVQVCH----------EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212
T+ +++ E ++HRDL N L A ++ +K DFGLS R
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDFGLS---R- 198
Query: 213 GEQFNEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 258
++ Y MA E L Y + DVWS GV+L+ I+ G P+
Sbjct: 199 -----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 259 WAETEQGVA-QAIIRSVIDFKRDPWPKVSENAKDLV-KKML---NPDPKQRLTAEEVLEH 313
G+ + + + R P +N + + + ML +P +R ++ +
Sbjct: 254 -----PGIPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A Length = 108 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-14
Identities = 16/80 (20%), Positives = 38/80 (47%), Gaps = 4/80 (5%)
Query: 331 VKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
+ A L++ + + + LS + +K+ F +D ++ G ++ +EL+ L K
Sbjct: 11 IAAALQECQDPDTFEPQKF-FQTSGLSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQK 69
Query: 391 ---GGQNIPEADLQILMEAV 407
+ + E++ + LM+A
Sbjct: 70 FQSDARELTESETKSLMDAA 89
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* Length = 195 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-14
Identities = 12/68 (17%), Positives = 24/68 (35%), Gaps = 5/68 (7%)
Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEAD 399
K A+++ +F + + K F+ +D N GKI L+E+ +
Sbjct: 3 SKYAVKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTK 62
Query: 400 LQILMEAV 407
+
Sbjct: 63 RHQVCVEA 70
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A Length = 108 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-14
Identities = 15/82 (18%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 329 ETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGL 388
+ A L+ + + ++ +S + + LKE F ++D ++ G I +EL+ L
Sbjct: 9 SDIAAALRDCQAPDSFSPKKFFQISG-MSKKSSSQLKEIFRILDNDQSGFIEEDELKYFL 67
Query: 389 LK---GGQNIPEADLQILMEAV 407
+ G + + ++ + + A
Sbjct: 68 QRFESGARVLTASETKTFLAAA 89
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-13
Identities = 15/68 (22%), Positives = 32/68 (47%), Gaps = 1/68 (1%)
Query: 341 MNKLKK-RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
M+K + + L E+ + EAF + D N G ++ EL++ + G +P+ +
Sbjct: 1 MSKNRSSLQSGPLNSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKRE 60
Query: 400 LQILMEAV 407
+ L++
Sbjct: 61 ILDLIDEY 68
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} PDB: 2gv5_A 2doq_A 3fwc_A Length = 161 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 15/63 (23%), Positives = 34/63 (53%), Gaps = 7/63 (11%)
Query: 349 LQVVAEFL----SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
V+ E + ++E +K AF++ D + GKI+++ LR + G+ + + +L+ ++
Sbjct: 82 YIVMGEKILKRDPLDE---IKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMI 138
Query: 405 EAV 407
E
Sbjct: 139 EEF 141
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... Length = 156 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 5e-13
Identities = 13/63 (20%), Positives = 33/63 (52%)
Query: 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
+A V L +++ +KEAF M+D ++ G ++ E+++ + G+ + +L +++
Sbjct: 2 DKAASGVLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK 61
Query: 406 AVS 408
Sbjct: 62 EAP 64
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... Length = 161 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-13
Identities = 19/68 (27%), Positives = 33/68 (48%), Gaps = 5/68 (7%)
Query: 341 MNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEAD 399
M+ + K A E L+ E+ K AF++ + G I+ +EL + GQN +
Sbjct: 1 MDDIYKAA----VEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEE 56
Query: 400 LQILMEAV 407
LQ +++ V
Sbjct: 57 LQEMIDEV 64
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} Length = 219 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 321 KAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAG----LKEAFEMMDTNKR 376
K G + K +K A + + + + E+ A E F+ D N+
Sbjct: 7 KGSTSDKG----LASDKDGKKAKDRKEAWERIRQAIPREKTAEAKQRRIELFKKFDKNET 62
Query: 377 GKINLEELRLGLLK-GGQNIPEADLQILMEAV 407
GK+ +E+ G L+ + + ++ + +
Sbjct: 63 GKLCYDEVYSGCLEVLKLDEFTSRVRDITKRA 94
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 24/179 (13%), Positives = 58/179 (32%), Gaps = 27/179 (15%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIE----DVRREVQIMKHL 113
+ L R G+ Y + + +K + ++ ++ + E +
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDS----GPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 114 PKHPNIVSLKDTY---------------EDDSAVHIVMELCEGGELFD--RIVARGHYTE 156
K + K Y D +V+ G L + + +E
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE 158
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215
R+ V +++ ++ HE +H ++ EN + +S + +G + + P +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSGK 216
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A Length = 179 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-12
Identities = 21/55 (38%), Positives = 32/55 (58%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
A+ L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++ V
Sbjct: 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 56
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 1f54_A 1f55_A Length = 147 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 4e-12
Identities = 17/55 (30%), Positives = 30/55 (54%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
++ L+ E++A KEAF + D + G I+ EL + G + EA++ LM +
Sbjct: 2 SQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEI 56
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 31/186 (16%), Positives = 61/186 (32%), Gaps = 33/186 (17%)
Query: 58 YDLGRELGRGEFGVTYLC-----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ +G +G+G FG YL V + K + E++ +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-------LFTELKFYQR 89
Query: 113 LPKHPNIVSLKDTYEDDSA----VH--------------IVMELCEGGELFDRIVARG-H 153
K I T + ++M+ G +L A
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR 148
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
++ + + I+++++ HE +H D+K N L N K + +D+GL+ + P
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRYCPE 207
Query: 214 EQFNEI 219
Sbjct: 208 GVHKAY 213
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A Length = 153 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-12
Identities = 17/55 (30%), Positives = 25/55 (45%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L EE+ L+EAF D +K G IN +L + G E +L L + +
Sbjct: 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQI 56
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A Length = 169 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-12
Identities = 14/74 (18%), Positives = 37/74 (50%), Gaps = 4/74 (5%)
Query: 334 RLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ 393
+ K + +K+ L+ E+ ++EAF++ DT+ G I+ +EL++ + G
Sbjct: 4 KAKTVVSARRDQKKG----RVGLTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGF 59
Query: 394 NIPEADLQILMEAV 407
+ +++ ++ +
Sbjct: 60 EPKKEEIKKMISEI 73
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... Length = 148 | Back alignment and structure |
|---|
Score = 61.7 bits (151), Expect = 8e-12
Identities = 22/55 (40%), Positives = 32/55 (58%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
AE L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++ V
Sbjct: 1 AEQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 55
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} Length = 77 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 1e-11
Identities = 18/52 (34%), Positives = 31/52 (59%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
LS E+ +KEAF++ DTNK G I+ EL++ + G ++ + ++ LM
Sbjct: 1 LSEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEY 52
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A Length = 134 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 1e-11
Identities = 10/44 (22%), Positives = 23/44 (52%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ F+ +D N G ++ EE++ + K E LQ++ +++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... Length = 162 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-11
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 4/69 (5%)
Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
+ M + A FLS E +A K AF+M D + G I+ +EL + GQN +
Sbjct: 1 ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 399 DLQILMEAV 407
+L ++E V
Sbjct: 57 ELDAIIEEV 65
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 142 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 4e-11
Identities = 14/49 (28%), Positives = 24/49 (48%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
++V+ KEAFE+ D+ + G I E L+ L + G + A +
Sbjct: 3 DQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEA 51
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} Length = 107 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-11
Identities = 17/77 (22%), Positives = 36/77 (46%), Gaps = 3/77 (3%)
Query: 334 RLKQFSVMNKLKKRAL---QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
+ +Q ++++ K+ L + ++ ++ G KE + D N G I++ L+ L K
Sbjct: 1 KAQQEERLDEINKQFLDDPKYSSDEDLPSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEK 60
Query: 391 GGQNIPEADLQILMEAV 407
G +L+ L+ V
Sbjct: 61 LGVPKTHLELKKLIGEV 77
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 59.0 bits (144), Expect = 7e-11
Identities = 10/49 (20%), Positives = 29/49 (59%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
E+ ++EAF++ D + G I+++EL++ + G + +++ ++ +
Sbjct: 3 EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A Length = 143 | Back alignment and structure |
|---|
Score = 39.0 bits (92), Expect = 5e-04
Identities = 11/44 (25%), Positives = 28/44 (63%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ +AF++ D ++ GKI+ + L+ + G+N+ + +LQ +++
Sbjct: 81 ILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEA 124
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A Length = 158 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-10
Identities = 11/56 (19%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 353 AEFLSVEEVAGLKEAFEMMDT-NKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
LS +V L+ AF +T G+++ +++ + L G ++ ++ L++
Sbjct: 4 VSKLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEF 59
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 23/91 (25%), Positives = 44/91 (48%), Gaps = 4/91 (4%)
Query: 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR---TAVDIEDVRREVQIMKHLPKH 116
LG+ LGRG FG + C++++ K L+ T + + E++I+ H+ H
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 117 PNIVSLK-DTYEDDSAVHIVMELCEGGELFD 146
N+V+L + + +++E C+ G L
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 26/97 (26%)
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYY--------- 225
+ +HRDL N L + E + +K DFGL+ R +I P Y
Sbjct: 211 SRKCIHRDLAARNILLS---EKNVVKICDFGLA---R------DIYKDPDYVRKGDARLP 258
Query: 226 ---MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPP 257
MAPE + Y + DVWS GV+L+ I G P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} Length = 66 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 8e-10
Identities = 10/44 (22%), Positives = 23/44 (52%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ F+ +D N G ++ EE++ + K E LQ++ +++
Sbjct: 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSI 45
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-10
Identities = 14/70 (20%), Positives = 26/70 (37%), Gaps = 2/70 (2%)
Query: 338 FSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE 397
+ + L EE+A L+ F D N+ G++ EE R +
Sbjct: 3 HHHHHSSGRENLYFQGADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELRVR--P 60
Query: 398 ADLQILMEAV 407
AD + + + +
Sbjct: 61 ADAEAVFQRL 70
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} Length = 143 | Back alignment and structure |
|---|
Score = 55.2 bits (134), Expect = 2e-09
Identities = 16/53 (30%), Positives = 26/53 (49%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS 408
++ KEAF M+D N+ G I+ E+L L G+N + L+ +M
Sbjct: 1 FDQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSEAP 53
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 65/452 (14%), Positives = 125/452 (27%), Gaps = 167/452 (36%)
Query: 56 IDYDLGRELGRGEFGVTYLCTDV--NNGEKFA----CKSISKKKLRTAVDIEDVRREV-- 107
+D++ G Y D+ + F CK D++D+ + +
Sbjct: 7 MDFETGE--------HQYQYKDILSVFEDAFVDNFDCK-----------DVQDMPKSILS 47
Query: 108 -QIMKHLPKHPNIVS------------------------LKDTYE-----------DDSA 131
+ + H+ + VS L+ Y+ S
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSM 107
Query: 132 VHIVME-----LCEGGELFDRI-VARGH-YTE--------RAAAAV----M----KTIVE 168
+ + L ++F + V+R Y + R A V + KT V
Sbjct: 108 MTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV- 166
Query: 169 VVQVCHEQGVMHRDLKPENFL--------FANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
+ VC K + + N + + L P
Sbjct: 167 ALDVC-------LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 221 GSPYYMAPEVLK---------RNYGPEV-----DVWSAGVILY------ILLCGVPPFWA 260
S + ++ + Y +V +A ILL
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPY-ENCLLVLLNVQNAKAWNAFNLSCKILL-------- 270
Query: 261 ET--EQGVAQAII---RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315
T + V + + I + K L+ K L+ P Q L E + +P
Sbjct: 271 -TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP-QDLPREVLTTNPR 328
Query: 316 LQNAKKAPNVSL-GETVK---ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMM 371
+S+ E+++ A + +N K ++ L+V E A ++ F+
Sbjct: 329 R--------LSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPAEYRKMFDR- 377
Query: 372 DTNKRGKINLEELRLGLLKGGQNIPEADLQIL 403
L + +IP L ++
Sbjct: 378 --------------LSVFPPSAHIPTILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 3e-04
Identities = 59/367 (16%), Positives = 106/367 (28%), Gaps = 102/367 (27%)
Query: 21 EKPNPFYGDEYVVANGSTVVHRL--------CVLKEPSGQDISIDYDLGRELGRGEFGVT 72
E+ + Y D V A + V RL +L+ +++ ID G G T
Sbjct: 114 EQRDRLYNDNQVFAKYN--VSRLQPYLKLRQALLELRPAKNVLID-------GVLGSGKT 164
Query: 73 YLCTDVNNGEKFACKSISKKKLRTAV---DIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129
++ DV K CK K + ++++ +++ L K + T D
Sbjct: 165 WVALDVCLSYKVQCKMDFK------IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVM-----KTIVEVVQV-CHEQGVM-HRD 182
+ +I + + R++ Y V+ + C + ++ R
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYEN--CLLVLLNVQNAKAWNAFNLSC--KILLTTRF 274
Query: 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAP-EVLKRNYGPE 238
+ +FL A L L+ P E + + P EVL N P
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLT----PDEVKSLLLKYLDCRPQDLPREVLTTN--P- 327
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM-- 296
+ G+A D W V+ + + +
Sbjct: 328 ------------RRLSI--IAESIRDGLATW----------DNWKHVNCDKLTTIIESSL 363
Query: 297 --LNP-DPKQRLTA-----------EEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMN 342
L P + ++ +L W K V+N
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--------------MVVVN 409
Query: 343 KLKKRAL 349
KL K +L
Sbjct: 410 KLHKYSL 416
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 Length = 67 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 3e-09
Identities = 14/46 (30%), Positives = 21/46 (45%)
Query: 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ K FE D NK GK++L+E R L + D+ E +
Sbjct: 1 SSAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A Length = 90 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-09
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 4/69 (5%)
Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
+ M + A FLS E +A K AF+M D + G I+ +EL + GQN +
Sbjct: 1 ASMTDQQAEA----RAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 399 DLQILMEAV 407
+L ++E V
Sbjct: 57 ELDAIIEEV 65
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A Length = 226 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-09
Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 3/70 (4%)
Query: 333 ARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLK 390
L + L L SV E+ L E F+ + + G IN EE +L L K
Sbjct: 19 FDLDLYKQSGGLGDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK 78
Query: 391 -GGQNIPEAD 399
+ AD
Sbjct: 79 TNKKESLFAD 88
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-09
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 5/65 (7%)
Query: 348 ALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEADLQI 402
++ ++F + + K F +D N GKI+L+E+ G +A
Sbjct: 2 NSKLTSDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHK 61
Query: 403 LMEAV 407
Sbjct: 62 DAVEA 66
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A Length = 191 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 4e-04
Identities = 12/67 (17%), Positives = 22/67 (32%)
Query: 341 MNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
KL L+ A+ F+++D ++ G I L+E + G D
Sbjct: 88 WKKLATDELEKYAKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDC 147
Query: 401 QILMEAV 407
+
Sbjct: 148 EETFRVC 154
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B Length = 166 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-09
Identities = 18/67 (26%), Positives = 31/67 (46%), Gaps = 4/67 (5%)
Query: 343 KLKKRALQV---VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-EA 398
K K+RA + V E+ KEAF ++D N G I+ ++LR G+
Sbjct: 3 KAKRRAAEGSSNVFSMFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNE 62
Query: 399 DLQILME 405
+L +++
Sbjct: 63 ELDAMIK 69
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 6e-09
Identities = 38/248 (15%), Positives = 71/248 (28%), Gaps = 68/248 (27%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMK 111
++G G FG + + A K I+ + E++ E+ I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 112 HL--------PKHPNIVSLKDTY------------------------------EDDSAVH 133
L + + L + D +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFAN 192
IV+E GG +++ + + A +++ + + V HRDL N L
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 193 ---------------KKESSPLKA--IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNY 235
S L+ ID+ LS R G +V M ++ +
Sbjct: 198 TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG 253
Query: 236 GPEVDVWS 243
+ D++
Sbjct: 254 DYQFDIYR 261
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} Length = 196 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-09
Identities = 18/90 (20%), Positives = 35/90 (38%)
Query: 319 AKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGK 378
KKA + + +R+ V + +V KEAF+++D +K G
Sbjct: 14 KKKAEEEGGDAPAAPPAPKPPSQKRRAQRSGSNVFAMFTQHQVQEFKEAFQLIDQDKDGF 73
Query: 379 INLEELRLGLLKGGQNIPEADLQILMEAVS 408
I+ ++R G+ E +L ++
Sbjct: 74 ISKNDIRATFDSLGRLCTEQELDSMVAEAP 103
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A Length = 86 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 14/55 (25%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
A + +++A + F+ DTN GKI+ EL L G ++ +++ +M +
Sbjct: 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEI 55
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 13/52 (25%), Positives = 21/52 (40%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ + L E F +DT+ G I++ EL L G A + L+
Sbjct: 21 RHMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMY 72
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 Length = 191 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 9e-05
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 1/56 (1%)
Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS 408
EF + + ++E F D++ G+++ E+R LL G + E Q LM
Sbjct: 84 EFKDLHHFILSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFD 139
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A Length = 150 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-08
Identities = 16/83 (19%), Positives = 33/83 (39%), Gaps = 11/83 (13%)
Query: 336 KQFSVMNKLKKRALQVVAEF-----------LSVEEVAGLKEAFEMMDTNKRGKINLEEL 384
K F ++ ++R L + E++ KE + D N G+I+L L
Sbjct: 13 KAFGILKARQERRLAEINREFLCDQKYSDEENLPEKLTAFKEKYMEFDLNNEGEIDLMSL 72
Query: 385 RLGLLKGGQNIPEADLQILMEAV 407
+ + K G +++ ++ V
Sbjct: 73 KRMMEKLGVPKTHLEMKKMISEV 95
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} Length = 208 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 15/80 (18%), Positives = 37/80 (46%), Gaps = 6/80 (7%)
Query: 334 RLKQFSVMNKLKKRAL----QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLL 389
RL + + + R++ Q E L + ++ L + F+ D + GK+ ++E+
Sbjct: 4 RLNEQNNESYRYLRSVGNQWQFNVEDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPD 63
Query: 390 KGGQNIP--EADLQILMEAV 407
+ Q + + ++ + +AV
Sbjct: 64 RMRQLVNATDEQVEKMRDAV 83
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A Length = 207 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 8e-08
Identities = 16/82 (19%), Positives = 33/82 (40%), Gaps = 5/82 (6%)
Query: 331 VKARLKQFSVMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRL 386
++ K+ + M +++A +VEEV L E F+ + ++ G I+ EE +L
Sbjct: 4 SVSKKKKKNAMRPPGYEDPELLASVTPFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQL 63
Query: 387 GLLKGGQNIPEADLQILMEAVS 408
L + + +
Sbjct: 64 ALFRNRNR-RNLFADRIFDVFD 84
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A Length = 146 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-07
Identities = 9/53 (16%), Positives = 17/53 (32%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS 408
E+V + + GKI+++ K G D + + E
Sbjct: 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYG 61
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A Length = 147 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-07
Identities = 16/91 (17%), Positives = 33/91 (36%)
Query: 317 QNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKR 376
Q+ + G + ++ +NK + + ++ K + D N
Sbjct: 3 QSRDLQGGKAFGLLKAQQEERLEGINKQFLDDPKYSNDEDLPSKLEAFKVKYMEFDLNGN 62
Query: 377 GKINLEELRLGLLKGGQNIPEADLQILMEAV 407
G I++ L+ L K G +L+ L+ V
Sbjct: 63 GDIDIMSLKRMLEKLGVPKTHLELKRLIREV 93
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 Length = 105 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-07
Identities = 11/49 (22%), Positives = 18/49 (36%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ + FE DT K I+ EE R + Q + + L +
Sbjct: 21 SHYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEM 69
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A Length = 263 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 10/55 (18%), Positives = 24/55 (43%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII 410
S+ + E + D + G + +EL+ + + Q +A L++ E + +
Sbjct: 10 SSLITASQFFEIWLHFDADGSGYLEGKELQNLIQELLQARKKAGLELSPEMKTFV 64
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-07
Identities = 9/52 (17%), Positives = 23/52 (44%), Gaps = 1/52 (1%)
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAV 407
++ + + L F+ +D ++ G I+ EL+ L G ++ ++
Sbjct: 2 ALPDQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMF 53
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A Length = 172 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 5e-04
Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 1/52 (1%)
Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
EF V + + + F D + G I+ EL+ L G + + IL+
Sbjct: 65 EFTGVWKYITDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILI 116
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 52/227 (22%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++D +G G FG Y + +G K A K + + + IE+ E++ + +H
Sbjct: 40 NFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQ---GIEEFETEIETLSFC-RH 94
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFD------------------RI---VARG-HY 154
P++VSL ++ + + ++ + E G L I ARG HY
Sbjct: 95 PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 155 TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214
H + ++HRD+K N L K DFG+S +
Sbjct: 155 L------------------HTRAIIHRDVKSINILLDENFVP---KITDFGISKKGTELD 193
Query: 215 QFN---EIVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPP 257
Q + + G+ Y+ PE + E DV+S GV+L+ +LC
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 41/175 (23%), Positives = 61/175 (34%), Gaps = 59/175 (33%)
Query: 174 HEQGVMHRDLKPENFL----FANKKESSPLKAIDFGLSVFFRPGEQF---NEIVGSPYYM 226
HE +HRD+K N L F K S DFGL+ Q + IVG+ YM
Sbjct: 150 HENHHIHRDIKSANILLDEAF-TAKIS------DFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 227 APEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----- 281
APE L+ P+ D++S GV+L ++ G +D R+P
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIITG-----------------LPAVDEHREPQLLLD 245
Query: 282 --WPKVSENAK--------------DLVKKM-------LNPDPKQRLTAEEVLEH 313
E V+ M L+ +R ++V +
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A Length = 110 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 15/90 (16%), Positives = 35/90 (38%), Gaps = 6/90 (6%)
Query: 322 APNVSLGETVKARLKQFSVMNKLKKRA-LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
A ++ + +K L + +V +K+ F+ +D + G I
Sbjct: 3 AKDLLKADDIKKALDAVKAEGSFNHKKFFALVGLKAMSAN--DVKKVFKAIDADASGFIE 60
Query: 381 LEELRL---GLLKGGQNIPEADLQILMEAV 407
EEL+ G+++ +A+ + ++A
Sbjct: 61 EEELKFVLKSFAADGRDLTDAETKAFLKAA 90
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 1e-06
Identities = 13/52 (25%), Positives = 24/52 (46%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ +++ KEAFE+ D GKI + + GQN A++ ++
Sbjct: 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNP 55
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C Length = 151 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-05
Identities = 11/44 (25%), Positives = 20/44 (45%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
E F + D GK+ ELR L G+ + E +++ ++
Sbjct: 89 YLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGH 132
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-06
Identities = 12/52 (23%), Positives = 19/52 (36%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
S KEAF + D KI ++ GQN A++ ++
Sbjct: 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNP 53
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* Length = 149 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 8e-04
Identities = 11/44 (25%), Positives = 19/44 (43%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
E + D G + ELR L G+ + E +++ LM+
Sbjct: 87 FVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKGQ 130
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* Length = 155 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-06
Identities = 9/49 (18%), Positives = 22/49 (44%), Gaps = 4/49 (8%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+E+ L + F+ +D + G +++EE P +Q +++
Sbjct: 3 DEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQN--PL--VQRVIDIF 47
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A Length = 208 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 9/58 (15%), Positives = 22/58 (37%), Gaps = 3/58 (5%)
Query: 339 SVMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN 394
L+ L+ + + S ++ L F +D + G ++ E+ + + N
Sbjct: 4 RASTLLRDEELEEIKKETGFSHSQITRLYSRFTSLDKGENGTLSREDF-QRIPELAIN 60
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} Length = 145 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 5e-06
Identities = 13/49 (26%), Positives = 25/49 (51%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
++E F++ D + GK+++EEL L G+N A+L + +
Sbjct: 2 ASADQIQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQL 50
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A Length = 450 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 20/62 (32%), Positives = 32/62 (51%)
Query: 346 KRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
+ + L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++
Sbjct: 296 HKLEYNTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMIN 355
Query: 406 AV 407
V
Sbjct: 356 EV 357
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A Length = 174 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 10/53 (18%), Positives = 21/53 (39%), Gaps = 2/53 (3%)
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD--LQILMEAV 407
S V +K F +D +K G I + + + ++LM+++
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSL 53
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A Length = 272 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 8/44 (18%), Positives = 17/44 (38%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
+ + AG + ++ D + G I +EL + + D
Sbjct: 5 FANLDAAGFLQIWQHFDADDNGYIEGKELDDFFRHMLKKLQPKD 48
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A Length = 229 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 11/80 (13%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 321 KAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKIN 380
L ++V+ L+ +V ++ + L + +E+ L F+ + G +N
Sbjct: 26 GLIEAGLEDSVEDELEMATVRHRPEALELLEAQSKFTKKELQILYRGFKNECPS--GVVN 83
Query: 381 LEELRLGLLKGGQNIPEADL 400
E + +
Sbjct: 84 EETFKEIYSQFFPQGDSTTY 103
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A Length = 148 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-05
Identities = 11/47 (23%), Positives = 18/47 (38%)
Query: 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
K+ F + D +G I + L L G N +Q ++ A
Sbjct: 2 ATRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINA 48
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} Length = 256 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 13/113 (11%), Positives = 38/113 (33%), Gaps = 6/113 (5%)
Query: 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFS 339
D L K+ + R T + ++ ++ + ++ + L+ +
Sbjct: 12 DGNLLGDPGRIPLSKRESIKWQRPRFTRQALMRCCLIKWILSSAAPQGSDSSDSELELST 71
Query: 340 VMNKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
V + + L + + +E+ L F+ G ++ + +L +
Sbjct: 72 V--RHQPEGLDQLQAQTKFTKKELQSLYRGFKNECPT--GLVDEDTFKLIYSQ 120
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} Length = 202 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-05
Identities = 11/45 (24%), Positives = 18/45 (40%), Gaps = 2/45 (4%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
S + L F +D NK+G ++ +L + N P D
Sbjct: 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDL-QQIGALAVN-PLGD 64
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 Length = 204 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 5e-05
Identities = 6/67 (8%), Positives = 21/67 (31%), Gaps = 2/67 (2%)
Query: 342 NKLKKRALQVVAEFLSVEEVAGLKEAFE-MMDTNKRGKINLEELRLGLLKGGQNIPEADL 400
+ + + + A L+E ++ ++ G + + E + +
Sbjct: 3 QQFSWEEAEENGA-VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYV 61
Query: 401 QILMEAV 407
+ + A
Sbjct: 62 EAMFRAF 68
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} Length = 71 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 5e-05
Identities = 13/51 (25%), Positives = 25/51 (49%)
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ + L+ AF D + G I ++ELR + GQ +P+ +L ++
Sbjct: 1 ARAGLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREA 51
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A Length = 81 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 7e-05
Identities = 11/54 (20%), Positives = 29/54 (53%), Gaps = 1/54 (1%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAV 407
++ ++ + AF++ D N G I+ +E + + K G+ + +A+++ M+
Sbjct: 1 WVRQDDEEEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 54
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... Length = 156 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 8e-05
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 2/52 (3%)
Query: 356 LSVEEVAGLKEAFEMMD--TNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
LS +E+ LK+ FE+ D + G ++ +L G N D+ +
Sbjct: 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG 54
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 7/42 (16%), Positives = 17/42 (40%)
Query: 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ 393
+ E + +K + +D G I+ E+ L ++ +
Sbjct: 4 ITESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAK 45
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A Length = 186 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 9/49 (18%), Positives = 20/49 (40%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
V ++ +DT+K G ++L E + L G ++ + +
Sbjct: 99 MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTL 147
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} Length = 92 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 1e-04
Identities = 12/53 (22%), Positives = 30/53 (56%)
Query: 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ + LKEAF++ D ++ G I+ ELR ++ G+ + + +++ +++
Sbjct: 2 HMDTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEA 54
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 Length = 78 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 2e-04
Identities = 14/44 (31%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
++ F+ DTN GKI+L EL L G ++Q +M +
Sbjct: 5 MERIFKRFDTNGDGKISLSELTDALRTLGST-SADEVQRMMAEI 47
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 9/54 (16%), Positives = 21/54 (38%), Gaps = 1/54 (1%)
Query: 354 EFLSV-EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
EF + + + ++ D ++ G I EL G ++ E +++
Sbjct: 68 EFKYLWNNIKKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRR 121
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A Length = 173 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 9/43 (20%), Positives = 15/43 (34%), Gaps = 1/43 (2%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
EEV + F + +++ EL L K P+
Sbjct: 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTD 42
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 Length = 176 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 10/47 (21%), Positives = 19/47 (40%), Gaps = 4/47 (8%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLK----GGQNIPEADLQILMEA 406
LK+ F+ D + G + + G++ A++Q L A
Sbjct: 9 LKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNA 55
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} Length = 94 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 10/44 (22%), Positives = 23/44 (52%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
++EAF + D + G I+ ELR + G+ + + ++ ++
Sbjct: 31 IREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREA 74
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A Length = 108 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 3e-04
Identities = 11/47 (23%), Positives = 24/47 (51%), Gaps = 3/47 (6%)
Query: 364 LKEAFEMMDTNKRGKINLEELRL---GLLKGGQNIPEADLQILMEAV 407
+K+AF ++D +K G I +EL+L + + +A+ + +
Sbjct: 43 VKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADG 89
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 3e-04
Identities = 15/62 (24%), Positives = 31/62 (50%), Gaps = 8/62 (12%)
Query: 354 EFLSV-----EEVAGLKEAFEMMDTNKRGKINLEELRLGL---LKGGQNIPEADLQILME 405
F + + +K+AF ++D +K G I +EL+L L G + + +A+ + ++
Sbjct: 29 AFFAKVGLTAKSADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLK 88
Query: 406 AV 407
A
Sbjct: 89 AG 90
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 Length = 140 | Back alignment and structure |
|---|
Score = 39.4 bits (93), Expect = 4e-04
Identities = 11/43 (25%), Positives = 20/43 (46%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
+ + K+AF + D + G+I + L GQN A++
Sbjct: 2 TDDSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEIT 44
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 Length = 109 | Back alignment and structure |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 14/47 (29%), Positives = 27/47 (57%), Gaps = 3/47 (6%)
Query: 364 LKEAFEMMDTNKRGKINLEELRL---GLLKGGQNIPEADLQILMEAV 407
+KE FE++D ++ G I EEL+ G G+++ + + + L+ A
Sbjct: 43 VKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAG 89
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} Length = 211 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 9/64 (14%), Positives = 18/64 (28%), Gaps = 3/64 (4%)
Query: 345 KKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-PEADLQIL 403
+++ + + +E F M G L E + L G N + +
Sbjct: 5 NGKSIAGDQKAVPTQETHVWYRTF--MMEYPSGLQTLHEFKTLLGLQGLNQKANKHIDQV 62
Query: 404 MEAV 407
Sbjct: 63 YNTF 66
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 Length = 193 | Back alignment and structure |
|---|
Score = 39.4 bits (92), Expect = 8e-04
Identities = 9/61 (14%), Positives = 22/61 (36%), Gaps = 4/61 (6%)
Query: 342 NKLKKRALQVVAE--FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
+KL+ +Q + E + E+ + F + G +++EE + +
Sbjct: 6 SKLRPEVMQDLLESTDFTEHEIQEWYKGF--LRDCPSGHLSMEEFKKIYGNFFPYGDASK 63
Query: 400 L 400
Sbjct: 64 F 64
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 99.29 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.22 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 99.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 98.97 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 98.96 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 98.95 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.94 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 98.93 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.91 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 98.91 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 98.9 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 98.9 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 98.88 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 98.88 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 98.88 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 98.86 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.85 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 98.84 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.82 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 98.82 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 98.82 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.82 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 98.82 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.8 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 98.8 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 98.8 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 98.8 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 98.79 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 98.79 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 98.78 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.78 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.78 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 98.77 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.77 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.76 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 98.76 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 98.74 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.73 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.72 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 98.72 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 98.72 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 98.72 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 98.7 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 98.69 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 98.69 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 98.68 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 98.67 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 98.67 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 98.67 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 98.66 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 98.66 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 98.65 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 98.64 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 98.64 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 98.63 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 98.62 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 98.62 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 98.61 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 98.6 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 98.59 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 98.58 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 98.58 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 98.57 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 98.57 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 98.56 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 98.56 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 98.56 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 98.56 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 98.55 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 98.55 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.54 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 98.54 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 98.54 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 98.53 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.52 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 98.52 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 98.51 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.51 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.51 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 98.5 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.49 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 98.48 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.48 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 98.47 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.47 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.47 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.46 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 98.46 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.45 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.45 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.44 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.43 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.43 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 98.43 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.42 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 98.42 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 98.42 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 98.42 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.41 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.41 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 98.41 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.41 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 98.4 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 98.4 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 98.4 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 98.39 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.39 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.39 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 98.38 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.38 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 98.37 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 98.37 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 98.37 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.35 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.34 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 98.34 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 98.33 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 98.33 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.3 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.3 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 98.29 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 98.29 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.27 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.26 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 98.26 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 98.26 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 98.26 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.25 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.25 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 98.24 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 98.24 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 98.23 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 98.22 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.22 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 98.21 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.2 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 98.2 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.2 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 98.2 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 98.19 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.19 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.18 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 98.18 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.17 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 98.16 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 98.15 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.15 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 98.14 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 98.13 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 98.13 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 98.12 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 98.12 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 98.12 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 98.12 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 98.11 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.1 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 98.09 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 98.09 | |
| 2kld_A | 123 | Polycystin-2; PC2, PKD2, calcium binding domain, E | 98.09 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 98.09 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 98.08 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 98.08 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.08 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 98.08 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 98.06 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 98.06 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 98.04 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 98.04 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 98.03 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 98.03 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 98.0 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 97.99 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 97.98 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.97 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 97.96 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 97.94 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 97.94 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 97.93 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 97.91 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 97.9 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 97.9 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 97.89 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 97.86 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 97.85 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 97.85 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 97.84 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 97.83 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 97.81 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 97.8 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 97.79 | |
| 2jul_A | 256 | Calsenilin; EF-hand, calcium, LXXLL, DNA binding p | 97.76 | |
| 1g8i_A | 190 | Frequenin, neuronal calcium sensor 1; calcium bind | 97.76 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 97.76 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 97.75 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 97.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.73 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.73 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 97.73 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 97.73 | |
| 2f33_A | 263 | Calbindin; EF-hand, Ca2+-binding, metal binding pr | 97.72 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 97.71 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 97.7 | |
| 1djx_A | 624 | PLC-D1, phosphoinositide-specific phospholipase C, | 97.69 | |
| 1sjj_A | 863 | Actinin; 3-helix bundle, calponin homology domain, | 97.69 | |
| 1jba_A | 204 | GCAP-2, protein (guanylate cyclase activating prot | 97.69 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.62 | |
| 2hps_A | 186 | Coelenterazine-binding protein with bound coelent; | 97.61 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.57 | |
| 1bjf_A | 193 | Neurocalcin delta; calcium-binding, myristoylation | 97.56 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 97.54 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 97.52 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 97.52 | |
| 2be4_A | 272 | Hypothetical protein LOC449832; DR.36843, BC083168 | 97.51 | |
| 2l2e_A | 190 | Calcium-binding protein NCS-1; NCS1P, myristoylate | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 1fpw_A | 190 | Yeast frequenin, calcium-binding protein NCS-1; EF | 97.42 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 97.37 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 97.36 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 97.36 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 2d8n_A | 207 | Recoverin; structural genomics, NPPSFA, national p | 97.32 | |
| 3bow_A | 714 | Calpain-2 catalytic subunit; cysteine protease, in | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.3 | |
| 1qxp_A | 900 | MU-like calpain; M-calpain, MU-calpain, catalytic | 97.3 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 97.25 |
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-68 Score=526.26 Aligned_cols=368 Identities=36% Similarity=0.632 Sum_probs=328.8
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+.++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKG 99 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCC
Confidence 456788999999999999999999999999999999999876554445678899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++....++.+||+|||++...
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999999999998889999999999999999999999999999999999999976666678999999999887
Q ss_pred cCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
..........||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+.+..+....+......+..+.|..+|++++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 259 (484)
T 3nyv_A 180 EASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK 259 (484)
T ss_dssp CCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred ccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence 76666667789999999999998999999999999999999999999999999999999999888888888889999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCccC---CCCCcchHHHHHHhhhhhhhhhhhhhHhhhhhhh-hhHHHhhHHH
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA---PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKE 366 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~-~~~~~~~l~~ 366 (419)
+||.+||+.||++|||+.|+|+||||+..... ...........++++|...+++++.++.+++..+ +.++...+++
T Consensus 260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~~ 339 (484)
T 3nyv_A 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTA 339 (484)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHHH
Confidence 99999999999999999999999999865432 1233445677789999999999999999998876 7788899999
Q ss_pred HHhhhCCCCCCcccHHHH----HHHHHhCCCCCC-------HHHHHHHHHHcCCC--CCcCccccC
Q 014722 367 AFEMMDTNKRGKINLEEL----RLGLLKGGQNIP-------EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 367 ~F~~~D~~~~g~i~~~el----~~~l~~lg~~~~-------~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+|..+|.|++|.|+.+|+ ..+++.+|...+ ++++..++..+|.| |.|+|+||+
T Consensus 340 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~Ef~ 405 (484)
T 3nyv_A 340 IFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYSEFV 405 (484)
T ss_dssp HHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHHHHH
T ss_pred HHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 999999999999999999 555566788888 88999999999987 689999983
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-67 Score=525.57 Aligned_cols=367 Identities=34% Similarity=0.584 Sum_probs=325.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh----------hhHHHHHHHHHHHHhCCCCCCeee
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA----------VDIEDVRREVQIMKHLPKHPNIVS 121 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~Ei~~l~~l~~hpnIv~ 121 (419)
..+..+|++++.||+|+||+||+|.+..+++.||+|++........ ...+.+.+|+.+++++ +||||++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCe
Confidence 4577899999999999999999999999999999999986543221 2356789999999999 8999999
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 122 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
+++++.+...+|+|||||+||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999999998889999999999999999999999999999999999999987665567999
Q ss_pred eecccceeccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
+|||++.............||+.|+|||++.+.++.++||||+||++|+|++|.+||.+.+..+....+..+...+....
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 99999998876666677889999999999998899999999999999999999999999999999999998887777667
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCC---cchHHHHHHhhhhhhhhhhhhhHhhhhhhh-h
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS---LGETVKARLKQFSVMNKLKKRALQVVAEFL-S 357 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~-~ 357 (419)
|+.+|+++++||.+||+.||.+|||+.|+|+||||+......... .......++++|...+++++..+.+++..+ +
T Consensus 271 ~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~~~ 350 (504)
T 3q5i_A 271 WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTT 350 (504)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHTSC
T ss_pred cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccCCc
Confidence 788999999999999999999999999999999998754432211 123456788889999999999999998887 7
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC--------CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG--------GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|..+|.|++|.|+.+|+..+|..+ |...+++++..++..+|.| |.|+|+||+
T Consensus 351 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 422 (504)
T 3q5i_A 351 LEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYSEFI 422 (504)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 8888999999999999999999999999999988 6678899999999999987 689999983
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-68 Score=526.85 Aligned_cols=366 Identities=35% Similarity=0.596 Sum_probs=324.5
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+..+|++++.||+|+||+||+|++..++..||+|++....... .....+.+|+.+++.+ +||||+++++++.+...
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 110 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRN 110 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCE
Confidence 457789999999999999999999999999999999998654322 2356788999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+|||||+||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++....
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999999999988899999999999999999999999999999999999999876667789999999999887
Q ss_pred CCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.........||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+..+....+......+..+.|..+|+.+.+
T Consensus 191 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 191 NQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp TTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred CCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 66666778899999999999988999999999999999999999999999999999999998888888888899999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCccC----CCCCcchHHHHHHhhhhhhhhhhhhhHhhhhhhh-hhHHHhhHHH
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA----PNVSLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKE 366 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~-~~~~~~~l~~ 366 (419)
||.+||+.||.+|||+.|+|+||||+..... ...........++++|...+++++.++.+++..+ +.++...+++
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~ 350 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTD 350 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHH
Confidence 9999999999999999999999999864221 2223334567789999999999999999999887 7888899999
Q ss_pred HHhhhCCCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 367 AFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 367 ~F~~~D~~~~g~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+|..+|.|++|.|+.+|+..+|..+|. ..+++++..++..+|.| |.|+|+||+
T Consensus 351 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~EF~ 413 (494)
T 3lij_A 351 IFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYSEFV 413 (494)
T ss_dssp HHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 999999999999999999999998854 45688999999999987 789999993
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-68 Score=489.48 Aligned_cols=257 Identities=32% Similarity=0.578 Sum_probs=233.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++|++| +|||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999876544444567899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC--
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-- 213 (419)
||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~---~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC---CCCEEEEEcCCceecCCCCC
Confidence 999999999999999899999999999999999999999999999999999999964 455999999999987543
Q ss_pred -CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
....+.+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+..++...+.+..+.++ ..+|+++++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHH
Confidence 23456789999999999874 699999999999999999999999999999999999988776554 368999999
Q ss_pred HHHHhcCCCCCCCCCHHH------HhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEE------VLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~------~l~~~~~~~~~ 320 (419)
||.+||++||++|||+.| +++||||+...
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 999999999999999988 58999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-67 Score=521.73 Aligned_cols=365 Identities=36% Similarity=0.641 Sum_probs=323.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+..+|++++.||+|+||+||+|++..+++.||+|++....... .....+.+|+.+++++ +||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEE
Confidence 47778999999999999999999999999999999997543322 2457889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++..+.+..+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999998766677899999999987766
Q ss_pred CCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
........||+.|+|||++.+.|+.++||||+||++|+|++|.+||.+.+..+....+......+..+.|..+|+++++|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999999899999999999999999999999999999999999999888888888888999999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccCccCCCC----CcchHHHHHHhhhhhhhhhhhhhHhhhhhhh-hhHHHhhHHHH
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV----SLGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEA 367 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~-~~~~~~~l~~~ 367 (419)
|.+||+.||.+|||+.++|+||||+........ ........++++|...+++++..+.+++..+ +.++...++++
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~ 336 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEI 336 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHH
Confidence 999999999999999999999999875443211 1123456778899999999999999999887 77888999999
Q ss_pred HhhhCCCCCCcccHHHHHHHH----HhCCCCCC----------HHHHHHHHHHcCCC--CCcCccccC
Q 014722 368 FEMMDTNKRGKINLEELRLGL----LKGGQNIP----------EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 368 F~~~D~~~~g~i~~~el~~~l----~~lg~~~~----------~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
|..+|.|++|.|+.+|+..++ ..+|...+ ++++..++..+|.| |.|+|+||+
T Consensus 337 F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~Ef~ 404 (486)
T 3mwu_A 337 FRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYSEFI 404 (486)
T ss_dssp HHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHHHHH
T ss_pred HHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 999999999999999995554 45577666 88999999999987 789999993
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-67 Score=479.65 Aligned_cols=254 Identities=37% Similarity=0.655 Sum_probs=213.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++++ +|||||++++++.+++.+|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence 4799999999999999999999999999999999877655555567899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||| +|+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH---LNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---CCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC---CCEEEeecCCCeecCCCCc
Confidence 9999 68999999999999999999999999999999999999999999999999644 4599999999988776666
Q ss_pred ccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
..+.+||+.|||||++.+ .| +.++||||+||++|+|+||.+||.+.+.......+......++ ..+|+++++||
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 243 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLI 243 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 677899999999999985 44 6899999999999999999999999998888888887765443 46899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+||++||++|||+.|+++||||+.
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-67 Score=489.57 Aligned_cols=258 Identities=32% Similarity=0.548 Sum_probs=229.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.+ +|||||+++++|.+++.+|
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 356799999999999999999999999999999999765433 235678999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 148 ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC---CCEEEecCcCceecCCC
Confidence 99999999999998865 579999999999999999999999999999999999999654 45999999999987544
Q ss_pred -CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
....+.+||+.|||||++. ..|+.++|||||||++|||++|.+||.+.+..+....+.... ......|..+|+++++
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d 302 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKG 302 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHH
Confidence 3456789999999999987 479999999999999999999999999999888887776643 2334456689999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
||.+||++||++|||+.|+|+||||++..
T Consensus 303 li~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 303 FLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-66 Score=485.64 Aligned_cols=256 Identities=27% Similarity=0.552 Sum_probs=223.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++| +|||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999987654 344577899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||+||+|.+++..+ ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD---GTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT---CCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC---CCEEEcccccceeecCC
Confidence 9999999999999764 357999999999999999999999999999999999999654 45999999999876543
Q ss_pred C-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 E-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+..++...+...... +.+..+|+++++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence 2 2345789999999999885 6999999999999999999999999999999988888877543 234578999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
||.+||++||++|||+.|+|+||||++.
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-65 Score=470.67 Aligned_cols=254 Identities=23% Similarity=0.414 Sum_probs=218.6
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----CCeEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSAVH 133 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~~~ 133 (419)
|++.++||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.++++| +|||||+++++|++ +..+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEE
Confidence 4778889999999999999999999999999976654 344567899999999999 99999999999875 35689
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++. .++.+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS--TTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC--CCCCEEEEeCcCCEeCC
Confidence 99999999999999999889999999999999999999999998 999999999999963 23569999999998643
Q ss_pred CCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.....+.+||+.|||||++.+.|+.++|||||||++|+|+||.+||.+.... .+...+..... +...+...+++++
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK 260 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHH
T ss_pred -CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHH
Confidence 3445677899999999999989999999999999999999999999765543 34444443322 1112345789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+||.+||++||++|||+.|+|+||||++
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccC
Confidence 9999999999999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-64 Score=483.90 Aligned_cols=258 Identities=32% Similarity=0.548 Sum_probs=229.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++++.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.| +|||||+++++|.+++.+|
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEE
Confidence 346799999999999999999999999999999999765432 345688999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||||+||+|.+++.. +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 225 iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~---g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD---GRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT---CCEEECCCTTCEECCSS
T ss_pred EEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEecCccceECCCC
Confidence 99999999999998865 569999999999999999999999999999999999999654 45999999999877543
Q ss_pred -CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 -EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
....+.+||+.|||||++. ..|+.++|||||||++|||++|.+||.+.+..+....+.... ......+..+|+++++
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~d 379 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKG 379 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHH
Confidence 3456789999999999987 479999999999999999999999999999888887776653 2334456689999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
||.+||++||++|||+.|+|+||||++..
T Consensus 380 li~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 380 FLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-65 Score=472.34 Aligned_cols=255 Identities=27% Similarity=0.520 Sum_probs=220.5
Q ss_pred cceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|++++.||+|+||+||+|++. .+++.||+|++.+...... ....+.+|+.+|+++ +|||||++++++++++.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence 57999999999999999999974 4688999999976543222 234678899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|||||||+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~---g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE---GHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---SCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC---CCEEecccccceeccC
Confidence 9999999999999999999999999999999999999999999999999999999999654 4599999999986543
Q ss_pred C-CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 G-EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. ....+.+||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+..++...+.+....++ ..+|++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHH
Confidence 3 3456678999999999987 5799999999999999999999999999999999988888765443 46899999
Q ss_pred HHHHHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 291 DLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||.+||++||++||| ++|+++||||+..
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999999998 5899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-64 Score=467.95 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=221.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.++||+|+||+||+|+++.+|+.||||++...... .+|+.+++.| +|||||++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGL-SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999765432 3699999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDG--SRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTS--CCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCC--CEEEEeeCCCCeEccCCCc
Confidence 99999999999999988999999999999999999999999999999999999997543 2499999999997754321
Q ss_pred ------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 216 ------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 216 ------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+...+...+......+. ..++.+|++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHH
Confidence 234579999999999874 699999999999999999999999998887777777777654332 234678999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHH-------------hcCCccccCcc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEV-------------LEHPWLQNAKK 321 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~-------------l~~~~~~~~~~ 321 (419)
+.+||.+||++||++|||+.|+ |+|||+.....
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 9999999999999999999997 67999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-62 Score=465.71 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=225.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---- 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~---- 128 (419)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+... .....+.+.+|+++|++| +|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence 355689999999999999999999999999999999976542 344567788999999999 89999999998753
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 129 --DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~---~~~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN---CELKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC---CCEEEeecce
Confidence 467999999996 6899999988899999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCC-----CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC
Q 014722 207 SVFFRPG-----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR 279 (419)
Q Consensus 207 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (419)
|+.+... ....+.+||+.|||||++.+ .|+.++||||+|||+|||++|.+||.+.+..++...|......+..
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9866432 23456789999999999764 5799999999999999999999999999998888888654332221
Q ss_pred C---------------------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 280 D---------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 280 ~---------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
. .++.+++++++||.+||.+||++|||+.|+|+||||++..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 1 1245789999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=452.48 Aligned_cols=257 Identities=28% Similarity=0.495 Sum_probs=211.8
Q ss_pred ccccceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.+.++|++.+.||+|+||+||+|+++ .+++.||+|++.... ....+.+|+++|+.+.+||||++++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35678999999999999999999874 468899999986542 2356789999999997899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+++|+|||||+||+|.+++ +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~--~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCC--CCeEEECcCCCCcc
Confidence 9999999999999999988 359999999999999999999999999999999999999754 24599999999986
Q ss_pred ccCCC-----------------------------cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCC
Q 014722 210 FRPGE-----------------------------QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 210 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf 258 (419)
..+.. ...+.+||+.|||||++.+ .|+.++||||+||++|+|+||++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 1234579999999999864 5899999999999999999999999
Q ss_pred CC-CCHHHHHHHHHhcc--------------------------------------------------cccCCCCCccCCH
Q 014722 259 WA-ETEQGVAQAIIRSV--------------------------------------------------IDFKRDPWPKVSE 287 (419)
Q Consensus 259 ~~-~~~~~~~~~i~~~~--------------------------------------------------~~~~~~~~~~~~~ 287 (419)
.. .+..+....|.... .......|..+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54 44444444332210 0011234667899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+++|||.+||++||++|||++|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-61 Score=442.85 Aligned_cols=253 Identities=30% Similarity=0.500 Sum_probs=199.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-----
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----- 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----- 130 (419)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++| +|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence 47999999999999999999999999999999997543 344567889999999999 8999999999987554
Q ss_pred -------eEEEEEEecCCcchHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeE
Q 014722 131 -------AVHIVMELCEGGELFDRIVARGHY---TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLK 200 (419)
Q Consensus 131 -------~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~k 200 (419)
.+|+|||||+||+|.+++.....+ ++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~---~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC---CcEE
Confidence 379999999999999999876554 456788999999999999999999999999999999654 4599
Q ss_pred EeecccceeccCCCc-------------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-H
Q 014722 201 AIDFGLSVFFRPGEQ-------------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-G 265 (419)
Q Consensus 201 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~ 265 (419)
|+|||+|+....... ..+.+||+.|||||++.+ .|+.++|||||||++|||++ ||.+.... .
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999999987654321 234579999999999884 69999999999999999996 77543322 1
Q ss_pred HHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 266 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
....+.... + .+.++..++.+.+||.+||++||++|||+.|+|+||||+...
T Consensus 236 ~~~~~~~~~--~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNLK--F-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTTC--C-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcCC--C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 122222211 1 122334677889999999999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-60 Score=476.24 Aligned_cols=264 Identities=36% Similarity=0.658 Sum_probs=241.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+-++|++++.||+|+||+||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.| +|||||+++++|.+.+.+
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~ 229 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEM 229 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 34568999999999999999999999999999999997543 34567889999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|||||||+||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+|+.+.
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~-~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLD 308 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCSSCEECC
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC-CCCCEEEeeccceeEcc
Confidence 999999999999999864 4579999999999999999999999999999999999999754 23569999999999988
Q ss_pred CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
+.......+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+......+....|+.+|++++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 7777778899999999999874 699999999999999999999999999999999999998888887777889999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+||.+||+.||++|||+.|+|+||||+....
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=473.05 Aligned_cols=255 Identities=26% Similarity=0.466 Sum_probs=218.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHH---HHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+. .++.+++.+ +|||||+++++|++.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence 5799999999999999999999999999999999865432222223333 346677777 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~---~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE---HGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT---TSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC---CCCEEecccceeeecCC
Confidence 999999999999999999999999999999999999999999999999999999999965 45699999999987754
Q ss_pred CCcccccccCcccCchhhhc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
. ...+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+.+ ...+...+..... ..+..+|+
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~----~~p~~~S~ 419 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV----ELPDSFSP 419 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC----CCCTTSCH
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC----CCCccCCH
Confidence 3 345679999999999986 3 69999999999999999999999997643 3334444444433 33457899
Q ss_pred HHHHHHHHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
++++||.+||++||.+|++ +.|+++||||+..
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999998 7999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=433.56 Aligned_cols=252 Identities=24% Similarity=0.370 Sum_probs=216.3
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+|.+.+.||+|+||+||+|++. .++..||||++... .....+.+.+|+++|++| +|||||++++++.++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEG 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC
Confidence 457999999999999999999864 36889999999743 344567899999999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 130 SAVHIVMELCEGGELFDRIVAR-------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
+.+|||||||+||+|.+++... ..+++.++..|+.||+.||.|||+++|+||||||+|||++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~--- 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--- 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC---
Confidence 9999999999999999999764 359999999999999999999999999999999999999654
Q ss_pred CCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 014722 197 SPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 271 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~ 271 (419)
..+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 4599999999987654332 22356999999999987 579999999999999999998 999999999988888887
Q ss_pred hcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+... +....+|+++.+|+.+||+.||++|||+.++ ++|+++
T Consensus 245 ~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 245 QGRVL---QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred cCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 76432 2234689999999999999999999999999 456654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=440.81 Aligned_cols=301 Identities=39% Similarity=0.735 Sum_probs=267.0
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEES 101 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 35677899999999999999999999999999999999986544 344567889999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..|+||||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999999999988888999999999999999999999999999999999999987666677999999999887
Q ss_pred cCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
..........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+..+...++...|..+++++
T Consensus 182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 76665667789999999999875 69999999999999999999999999999999999998888888888888999999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhh
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 353 (419)
.+||.+||+.||++|||+.++|+||||............+.....+++|...++++..++..+.
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMI 325 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998643333333345667788888888888877665554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-59 Score=452.86 Aligned_cols=301 Identities=40% Similarity=0.726 Sum_probs=267.1
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+.++|++.+.||+|+||.||+|.+..+|+.+|+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 45677899999999999999999999999999999999986653 233566789999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+..++.+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999999999999999999999999999999999999999999999987656678999999999876
Q ss_pred cCCC-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.... ......||+.|+|||++.+ .|+.++||||+||++|+|++|.+||.+.+.......+..+...++.+.|+.++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 5433 3356789999999999875 6999999999999999999999999999999999999999988888889999999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhh
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 353 (419)
+.+||.+||+.||++|||+.|+|+||||+...........+.....+++|...++++..++..+.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~klk~~~~~~~~ 308 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVML 308 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHHHHHHHHHTTCSCEEC
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999998654333334446677889999999999998887664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-59 Score=429.25 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=205.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+++++.+.||+|+||+||+|+.. ..||||+++... .+....+.+.+|+.+++++ +|||||++++++.. +.+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEE
Confidence 357889999999999999999843 369999987543 2445678899999999999 99999999998764 56899
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||||+||+|.+++... +.+++.++..|+.||+.||.|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~---~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG---LTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT---EEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC---CcEEEeeccCceecccC
Confidence 99999999999999764 579999999999999999999999999999999999999754 45999999999876432
Q ss_pred ---CcccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--CCCCcc
Q 014722 214 ---EQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--RDPWPK 284 (419)
Q Consensus 214 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~ 284 (419)
......+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.+.......+.......+ ...++.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 23456789999999999853 489999999999999999999999988766555544444332221 233457
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+|+++.+|+.+||+.||++|||+.|++++
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=432.05 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=208.8
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+|.+.++||+|+||+||+|+.. .+++.||||++... .....+.+.+|+++|++| +|||||++++++.+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEG 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence 357999999999999999999854 46889999999743 344567899999999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC
Q 014722 130 SAVHIVMELCEGGELFDRIVAR---------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~ 194 (419)
+.+|||||||++|+|.+++... +++++.++..|+.|++.||.|||+++|+||||||+|||++.+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~- 194 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence 9999999999999999998753 358999999999999999999999999999999999999754
Q ss_pred CCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014722 195 ESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 269 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 269 (419)
..+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..+....
T Consensus 195 --~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 195 --LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp --TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred --CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4599999999987644322 23467999999999987 579999999999999999999 9999999998888888
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+..+.. .+....+|+++.+|+.+||+.||++|||+.|++++
T Consensus 273 i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 273 ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 776532 12234689999999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=429.30 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=214.2
Q ss_pred cceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.++++.++||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.++++| +|||||++++++.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECC
Confidence 46889999999999999999843 467899999997543 233467899999999999 9999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC
Q 014722 131 AVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK 194 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~ 194 (419)
.++||||||++|+|.+++..+ ..+++.++..|+.||+.||.|||+++||||||||+|||++.+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~- 181 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK- 181 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC-
Confidence 999999999999999999653 358999999999999999999999999999999999999754
Q ss_pred CCCCeEEeecccceeccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 014722 195 ESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 269 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~ 269 (419)
+.+||+|||+|+...... ......||+.|||||++. +.|+.++|||||||++|||+| |..||.+.+..++...
T Consensus 182 --~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 182 --LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp --GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred --CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 459999999998764332 234567999999999887 679999999999999999998 8999999998888888
Q ss_pred HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 270 IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 270 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+..+... +..+.+|+++.+|+.+||+.||++|||+.|++++
T Consensus 260 i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7765432 2234689999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=426.43 Aligned_cols=267 Identities=38% Similarity=0.705 Sum_probs=241.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+.++|++.+.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe
Confidence 5678899999999999999999999999999999999986543221 2357889999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC-CCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~-~~~~kl~Dfg~a 207 (419)
...+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999975442 236999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......+....|..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 98876666677889999999999874 79999999999999999999999999999999998888887777666677899
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+++++||.+||..||++|||+.|+|+||||+..
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 999999999999999999999999999999854
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-57 Score=426.87 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=210.5
Q ss_pred cccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
-.++|++.+.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+.+|+++.+|||||++++++..
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 356899999999999999999987654 4689999987543 344567899999999999556999999999865
Q ss_pred -CCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEee
Q 014722 129 -DSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA 191 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~ 191 (419)
++.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+|||++
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 219 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence 45789999999999999999753 3489999999999999999999999999999999999997
Q ss_pred cCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014722 192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 266 (419)
Q Consensus 192 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 266 (419)
.+ +.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |..||.+....+.
T Consensus 220 ~~---~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 220 EK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp GG---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CC---CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 54 4599999999987654432 23467999999999987 579999999999999999998 9999988765444
Q ss_pred HHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...+........ ....+++++.+|+.+||+.||++|||+.|+++|
T Consensus 297 ~~~~i~~g~~~~--~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCC--CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 433333322222 224689999999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=425.43 Aligned_cols=301 Identities=36% Similarity=0.651 Sum_probs=243.8
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence 457788999999999999999999999999999999997543211 12357889999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 130 SAVHIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
+.+|+|||||+|++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999998877653 358999999999999999999999999999999999999876666779999999
Q ss_pred cceeccCCCc-ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 206 LSVFFRPGEQ-FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 206 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||.+. .......+...........|.
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 9987754432 34568999999999987 46899999999999999999999999875 445666666666555555566
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhhh
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAE 354 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~ 354 (419)
.+++++.+||.+||..||++|||+.++|+||||+.................++++...++++..++..++.
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 328 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSS 328 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHHHHHHHHC-----------
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999987543222222234556777787777777776665543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=413.34 Aligned_cols=260 Identities=36% Similarity=0.655 Sum_probs=233.8
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
....++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKT 88 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCE
Confidence 3455689999999999999999999999999999999976543 444567889999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD---MNIKIADFGFSNEFT 165 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTCCGGGS
T ss_pred EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC---CCEEEeeccCceecC
Confidence 99999999999999999988899999999999999999999999999999999999999644 459999999998877
Q ss_pred CCCcccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.........||+.|+|||++.+ .+ +.++||||+||++|+|++|..||.+.+.......+..+....+ ..+++++
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~ 241 (328)
T 3fe3_A 166 VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDC 241 (328)
T ss_dssp SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHH
Confidence 6666777889999999999874 44 4789999999999999999999999999888888887765433 2579999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+|+.+||..||.+|||+.|+++||||+...
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-55 Score=415.42 Aligned_cols=295 Identities=42% Similarity=0.734 Sum_probs=237.4
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
...+.++|++.+.||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPT 121 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEecCC
Confidence 4567788999999999999999999999999999999987542 335678899999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+++||||++|++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999999988888999999999999999999999999999999999999986555677999999999876
Q ss_pred cCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||....... ....+......+..+.|..++.+
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 281 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN 281 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred CcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence 65555566789999999999874 68999999999999999999999997765544 56666666666666667789999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhh
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVA 353 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~ 353 (419)
+.+||.+||..||++|||+.|+|+||||+..... ....+.....++++....++++.....++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN--FVHMDTAQKKLQEFNARRKLKAAVKAVVA 344 (349)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC--CSCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCccc--hhhhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999875432 23345667778888888888777665544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=414.52 Aligned_cols=263 Identities=31% Similarity=0.639 Sum_probs=237.9
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence 3567899999999999999999999999999999998643 23456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+ .++.+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECC
Confidence 99999999999999997653 69999999999999999999999999999999999999753 24679999999999887
Q ss_pred CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.+.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......+....|+.+|+++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 7666677889999999999875 579999999999999999999999999999999999988887777666778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+||.+||..||.+|||+.|+|+||||+....
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=411.97 Aligned_cols=267 Identities=37% Similarity=0.713 Sum_probs=238.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 457778999999999999999999999999999999997654322 12467889999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~a 207 (419)
...+++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999997654 2336999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....++.++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 9876666666778999999999987 578999999999999999999999999998888888887766655555556789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999999999999999854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=399.35 Aligned_cols=268 Identities=41% Similarity=0.797 Sum_probs=245.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF 79 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence 4577899999999999999999999999999999999976654 344567888999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999999988889999999999999999999999999999999999999877666779999999998877
Q ss_pred CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+.......+...+..+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 6666667789999999999874 689999999999999999999999999999999988888888888777888999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+||.+||+.||++|||+.|+++||||++...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=416.03 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=226.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.+.+||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998654433445677889999999987899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~ 214 (419)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+... ...
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~---g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE---GHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCC---
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC---CCEEEccccceeecccCCc
Confidence 9999999999999988899999999999999999999999999999999999999654 459999999998643 233
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+....+......++ ..+++++.+||
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li 255 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGIL 255 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 445678999999999987 4699999999999999999999999999999999999988766544 24799999999
Q ss_pred HHhcCCCCCCCCCH------HHHhcCCccccC
Q 014722 294 KKMLNPDPKQRLTA------EEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~s~------~~~l~~~~~~~~ 319 (419)
.+||+.||++||++ .++++||||+..
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999999 899999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=409.53 Aligned_cols=256 Identities=32% Similarity=0.581 Sum_probs=228.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence 4799999999999999999999999999999999765432233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~ 214 (419)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC---CCEEEeeccchhhcccCCC
Confidence 9999999999999988889999999999999999999999999999999999999654 459999999998643 334
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++ ..+++++.+||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence 456678999999999987 4689999999999999999999999999988888888877655443 35799999999
Q ss_pred HHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 294 KKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
.+||+.||++|| ++.++++||||+..
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999 99999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=417.16 Aligned_cols=258 Identities=34% Similarity=0.559 Sum_probs=208.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++++.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEE
Confidence 345799999999999999999999999999999999754322 25678999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++ ...+||+|||++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~-~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS-SCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CceEEEeecCcccccccc
Confidence 9999999999999998888899999999999999999999999999999999999997532 345999999999865544
Q ss_pred CcccccccCcccCchhhhcc-cCCCc-ccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcccccCCCCCccCCH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPE-VDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.......||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+... ......+...... .+....+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS--IPDDIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC--CCTTSCCCH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC--CCCcCCCCH
Confidence 44566789999999999864 45544 8999999999999999999977544 3333334333322 223346899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
++.+||.+||+.||++|||+.|+++||||.+.
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=398.70 Aligned_cols=266 Identities=44% Similarity=0.828 Sum_probs=241.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+.++|++.+.||+|+||.||+|.+..++..+|+|++...... ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCe
Confidence 35677899999999999999999999999999999999765432 356789999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++..++.+..+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999988889999999999999999999999999999999999999655566779999999998877
Q ss_pred CCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......++...+..+++.+.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666777899999999999888999999999999999999999999999988888888887766665556678999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
||.+||+.||++|||+.++|+||||++...
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 999999999999999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=407.73 Aligned_cols=265 Identities=38% Similarity=0.664 Sum_probs=232.3
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+|++++.++.+||||+++++++.+..
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 34677899999999999999999999999999999999976542 23468888888868999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~a~~ 209 (419)
.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+... +....+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999999988889999999999999999999999999999999999998643 2334699999999987
Q ss_pred ccCC-CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHhcccccCCCCCcc
Q 014722 210 FRPG-EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
.... .......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+ .+..+....+..+...+....|..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 6543 33456789999999999875 589999999999999999999999975 456677788888888777777889
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
+++++.+||.+||..||++|||+.++++||||......
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~~ 287 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGGS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcccc
Confidence 99999999999999999999999999999999764433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=411.47 Aligned_cols=264 Identities=35% Similarity=0.659 Sum_probs=237.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++.+...+
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999987542 33456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-CCCceEEEecccceecC
Confidence 99999999999999887654 69999999999999999999999999999999999999743 23569999999999877
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......+....+..+++++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 665556678999999999987 4689999999999999999999999999998888888888877777777788999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+||.+||+.||++|||+.|+|+||||+....
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=413.56 Aligned_cols=258 Identities=30% Similarity=0.548 Sum_probs=222.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++++.+||||+++++++.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35799999999999999999999999999999999877655554556788999999887689999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec-cCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~-~~~ 213 (419)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.. ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC---CCEEEeecceeeecccCC
Confidence 99999999999999988899999999999999999999999999999999999999654 45999999999863 344
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHhcccccCCCCCc
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||... ........+......++ .
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----R 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----T
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----C
Confidence 5566788999999999987 46899999999999999999999999643 22334455555544333 3
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCccccC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQNA 319 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~------~~~l~~~~~~~~ 319 (419)
.+++++.+||.+||+.||.+||++ .|+++||||+..
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 589999999999999999999985 899999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=395.48 Aligned_cols=262 Identities=38% Similarity=0.670 Sum_probs=225.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|.+.+.||+|+||.||+|.+..++..+|+|++..... ....+.+.+|+.+++++ +||||+++++++.+....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence 467789999999999999999999999999999999976542 23467889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 133 HIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
++||||+++|+|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++..+....+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3679999999999999999999999999999999999999766566779999999998
Q ss_pred eccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
............||+.|+|||++.+.++.++||||||+++|+|++|..||.+.........+.......... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 776655556678999999999998889999999999999999999999999988877776666554433322 2347899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+.+||.+||+.||++|||+.|+|+||||++
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999999999999985
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-54 Score=400.91 Aligned_cols=254 Identities=29% Similarity=0.592 Sum_probs=227.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence 4799999999999999999999999999999999765432233456788999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NGHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT---TSCEEECCCSSCEECSS--C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC---CCCEEEeecCcceecCC--c
Confidence 999999999999998888999999999999999999999999999999999999964 44599999999987543 2
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ +.+++++.+||.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence 34568999999999987 4689999999999999999999999999998888888887765443 357999999999
Q ss_pred HhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 295 KMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+||..||++|| ++.++++||||+..
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999 99999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=403.27 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=224.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++++.+||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998876666666778899999999887899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CCC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~~ 214 (419)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEEeccccccccCCCC
Confidence 9999999999999988889999999999999999999999999999999999999644 459999999998643 334
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHhcccccCCCCCcc
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA---------ETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
......||+.|+|||++. ..++.++|||||||++|+|++|.+||.. .........+......++ ..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~ 241 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RS 241 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CC
Confidence 456678999999999987 4689999999999999999999999965 233344455555444332 35
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCccccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTA------EEVLEHPWLQNA 319 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~------~~~l~~~~~~~~ 319 (419)
+++++.+||.+||+.||.+||++ .++++||||+..
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 79999999999999999999995 899999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=402.57 Aligned_cols=267 Identities=35% Similarity=0.659 Sum_probs=212.9
Q ss_pred ccccceeec---cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLG---RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~---~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.+..+|++. +.||+|+||.||+|.+..+|+.||+|++... ....+.+|+.+++.+.+||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 455678875 7899999999999999999999999999643 2456788999999995699999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
...|+||||++||+|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++....+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 99999999999999999999988999999999999999999999999999999999999998766556799999999987
Q ss_pred ccCC-CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhcccccCCC
Q 014722 210 FRPG-EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~~i~~~~~~~~~~ 280 (419)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ..+....+..+...+...
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp CCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred cCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 6543 2345667899999999987 468999999999999999999999997643 345666666666666666
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~ 325 (419)
.|..+++++.+||.+||+.||++|||+.++++||||+.....+..
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~ 283 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSN 283 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCS
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCC
Confidence 667799999999999999999999999999999999976554433
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-54 Score=407.01 Aligned_cols=259 Identities=28% Similarity=0.466 Sum_probs=228.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+..|..+++.+.+||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999765432223456788899999876689999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-C
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-G 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~ 213 (419)
||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC---CCEEEeEChhhhhcccCC
Confidence 99999999999999988889999999999999999999999999999999999999654 4599999999986432 3
Q ss_pred CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++ ..+++++.+|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHH
Confidence 34566789999999999874 689999999999999999999999999998888888877654433 3579999999
Q ss_pred HHHhcCCCCCCCCCHH-HHhcCCccccCc
Q 014722 293 VKKMLNPDPKQRLTAE-EVLEHPWLQNAK 320 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~-~~l~~~~~~~~~ 320 (419)
|.+||..||++||++. ++++||||+...
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 9999999999999998 999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=416.66 Aligned_cols=262 Identities=31% Similarity=0.486 Sum_probs=228.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 346899999999999999999999999999999999754322222234578899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~---g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS---GHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC---CCEEEeccceeEeeccC
Confidence 99999999999998865 469999999999999999999999999999999999999644 45999999999876544
Q ss_pred Cc--ccccccCcccCchhhhcc-c----CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 214 EQ--FNEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 214 ~~--~~~~~gt~~y~aPE~~~~-~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.. ....+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+.+.......+.........+.+..++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 346789999999999863 2 7889999999999999999999999999998888888765444445556789
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccCc
Q 014722 287 ENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~~ 320 (419)
+++++||.+||..+|.+ ||++.|+++||||+...
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999999999998 99999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=392.51 Aligned_cols=259 Identities=31% Similarity=0.532 Sum_probs=224.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||+||+|.+..+|+.||+|++...... ..+.+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEE
Confidence 3556899999999999999999999999999999999765432 346788999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITP 168 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCS
T ss_pred EEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC---CCEEEeeCCCceecCC
Confidence 9999999999999988765 69999999999999999999999999999999999999654 4599999999987654
Q ss_pred CC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+...... .......+++.+.
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFR 247 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHH
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHH
Confidence 43 334568999999999987 46899999999999999999999999888877666555443321 1222356899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+||.+||+.||++|||+.|+++||||+...
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 999999999999999999999999998654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-54 Score=405.95 Aligned_cols=258 Identities=27% Similarity=0.476 Sum_probs=229.2
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+..|..++..+.+||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999999865432333466788999999988789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~ 213 (419)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC---CcEEEEeCCcccccccCC
Confidence 99999999999999988889999999999999999999999999999999999999654 459999999998643 33
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..++...+......++ ..+++++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHH
Confidence 3456678999999999987 5789999999999999999999999999999888888888765543 3689999999
Q ss_pred HHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
|.+||..||.+|| ++.++++||||+..
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 9999999999999 47999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=403.48 Aligned_cols=256 Identities=29% Similarity=0.550 Sum_probs=229.6
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.-.+|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+...+|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence 446899999999999999999999999999999999765433333567888999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC---CCEEEcccccceeccCC
Confidence 999999999999999988889999999999999999999999999999999999999644 45999999999876433
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+......++ ..+++++.+|
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 268 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDL 268 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHH
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence 34568999999999987 4689999999999999999999999999998888888888765443 3579999999
Q ss_pred HHHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
|.+||+.||.+||+ +.++++||||+..
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999999998 9999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=397.97 Aligned_cols=248 Identities=21% Similarity=0.285 Sum_probs=190.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---- 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~---- 130 (419)
..+|.+.+.||+|+||+||+|+. +|+.||||++.... ........|+..+.++ +|||||++++++.+.+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCce
Confidence 45799999999999999999985 68999999986442 1112234566667788 8999999999997654
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
.+|||||||+||+|.+++... ++++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~---~~~Ki~ 150 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---GTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT---SCEEEC
T ss_pred EEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC---CCEEEE
Confidence 589999999999999999764 689999999999999999999987 99999999999999644 559999
Q ss_pred ecccceeccCCCc-----ccccccCcccCchhhhcc-------cCCCcccHHHHHHHHHHHHhCCCCCCCC---------
Q 014722 203 DFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAE--------- 261 (419)
Q Consensus 203 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~--------- 261 (419)
|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 9999987654432 234579999999999864 3677999999999999999997765321
Q ss_pred ------CHHHHHHHHHhcccccCCCC-C--ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 262 ------TEQGVAQAIIRSVIDFKRDP-W--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 262 ------~~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
........+.........+. + ...++.+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11222333332222211111 1 1133578899999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=405.95 Aligned_cols=260 Identities=27% Similarity=0.527 Sum_probs=226.8
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
....++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 34456899999999999999999999999999999999765433334567888999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH---GHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC---CCEEEeccceeeecc
Confidence 99999999999999999988889999999999999999999999999999999999999644 459999999999887
Q ss_pred CCCcccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcccccCCCCCcc
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAE---TEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
.........||+.|+|||++.. .|+.++|||||||++|+|++|..||... ........+......++ ..
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~ 242 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SA 242 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TT
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----Cc
Confidence 6666778899999999999852 4899999999999999999999999743 33444444444433322 35
Q ss_pred CCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCccccC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLT-AEEVLEHPWLQNA 319 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s-~~~~l~~~~~~~~ 319 (419)
+++++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 7999999999999999999998 9999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=398.52 Aligned_cols=267 Identities=37% Similarity=0.700 Sum_probs=236.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++++ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 5677889999999999999999999999999999999976543221 2367889999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC-CCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~-~~~~kl~Dfg~a 207 (419)
...+++||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999999988888999999999999999999999999999999999999975442 126999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+....+....+......+....+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8877665566778999999999987 568999999999999999999999999998888888877765554443345689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+.+||.+||..||++|||+.|+++||||+..
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999999999999999854
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=397.42 Aligned_cols=266 Identities=34% Similarity=0.594 Sum_probs=221.9
Q ss_pred Cccccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 52 QDISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 52 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
..+.++|++. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++.++.+||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3467789996 78999999999999999999999999997553 2235678899999999658999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999998888999999999999999999999999999999999999987665566999999998765
Q ss_pred cCCC--------cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH-------------
Q 014722 211 RPGE--------QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETE------------- 263 (419)
Q Consensus 211 ~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------- 263 (419)
.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 3221 123456999999999986 3589999999999999999999999976542
Q ss_pred --HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 264 --QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 264 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
......+......++...+..+++.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 334555666555554444557899999999999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=408.78 Aligned_cols=257 Identities=36% Similarity=0.605 Sum_probs=220.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.-++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 345799999999999999999999999999999999765332222345788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+ +|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....+
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN---LNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT---CCEEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC---CCEEEEEeccceeccCC
Confidence 999999 78999999988899999999999999999999999999999999999999644 45999999999887766
Q ss_pred CcccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.......||+.|+|||++.+ .+ ++++|||||||++|+|++|..||.+.........+... .......+++++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC----VYVMPDFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSS----CCCCCTTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC----CCCCcccCCHHHHH
Confidence 66677889999999999875 33 78999999999999999999999776543322222111 11222357999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
||.+||+.||.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=414.86 Aligned_cols=264 Identities=27% Similarity=0.479 Sum_probs=227.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence 3456899999999999999999999999999999999754322222234578899999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~---g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC---CCEEEcchhhhhhcc
Confidence 999999999999999987 5679999999999999999999999999999999999999644 459999999998765
Q ss_pred CCCc--ccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-CCC
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-DPW 282 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~ 282 (419)
.... ....+||+.|+|||++. +.|+.++|||||||++|||++|.+||.+.+..+....+......+.. ..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 4433 23468999999999885 35899999999999999999999999999988888888764332222 223
Q ss_pred ccCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCccccCc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQ--RLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~--R~s~~~~l~~~~~~~~~ 320 (419)
..+++++++||.+||..+|++ ||++.|+++||||+...
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 568999999999999999988 99999999999998654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=394.37 Aligned_cols=265 Identities=28% Similarity=0.473 Sum_probs=218.4
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++.+.++|++++.||+|+||+||+|++. +|+.||+|++..... .......+.+|+.+++++ +||||+++++++.+
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS 90 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc
Confidence 345677889999999999999999999984 599999999975432 222346788999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
...+++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a 166 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD---GALKLADFGLA 166 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTC
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC---CCEEEccCcCc
Confidence 9999999999975 888877664 459999999999999999999999999999999999999654 45999999999
Q ss_pred eeccCC-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---
Q 014722 208 VFFRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP--- 281 (419)
Q Consensus 208 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--- 281 (419)
...... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+...........
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 876533 33445678999999999864 589999999999999999999999988877776666654322221111
Q ss_pred -----------------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 282 -----------------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 282 -----------------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 124678999999999999999999999999999998753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=398.34 Aligned_cols=271 Identities=30% Similarity=0.555 Sum_probs=236.2
Q ss_pred CCCccccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 50 SGQDISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 50 ~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
.+..+.++|.+. +.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.+.+||||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 345678889998 889999999999999999999999999976543 233457889999999999778999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+.+++||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.....+.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999999988653 5699999999999999999999999999999999999998644456799999999
Q ss_pred ceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......+....+..+
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 260 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV 260 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhccc
Confidence 99876665566678999999999987 57899999999999999999999999999998888888888777777777889
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 999999999999999999999999999999987543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=393.95 Aligned_cols=266 Identities=27% Similarity=0.455 Sum_probs=217.5
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC--hhhHHHHHHHHHHHHhCC--CCCCeeeeeeEE
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT--AVDIEDVRREVQIMKHLP--KHPNIVSLKDTY 126 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~ 126 (419)
|..+..+|++++.||+|+||+||+|++..+|+.||+|++....... ......+.+|+.+++++. +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 4566779999999999999999999999999999999997543211 111245667777777662 499999999999
Q ss_pred EeCC-----eEEEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 127 EDDS-----AVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 127 ~~~~-----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
.... .+++||||+. ++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+ +.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT---SCE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC---CCE
Confidence 8765 5899999997 599999987654 9999999999999999999999999999999999999654 459
Q ss_pred EEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 200 KAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 200 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+........
T Consensus 160 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 160 KLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp EECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999998776666666778999999999986 5799999999999999999999999999998888877765433222
Q ss_pred CCCC-----------------------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 279 RDPW-----------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 279 ~~~~-----------------------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...| +.+++.+.+||.+||+.||++|||+.|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 2222 35789999999999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=388.32 Aligned_cols=258 Identities=28% Similarity=0.492 Sum_probs=216.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999976543 233456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+++ ++.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEeecccceecCCcc
Confidence 999976 55555544 6779999999999999999999999999999999999999654 45999999999876533
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccccCCCC---------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVIDFKRDP--------- 281 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~--------- 281 (419)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..| |.+.+.......+...........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33455678999999999864 389999999999999999987766 566666666666654332222111
Q ss_pred ----------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 282 ----------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 282 ----------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 23478999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=408.89 Aligned_cols=263 Identities=39% Similarity=0.697 Sum_probs=219.4
Q ss_pred ccccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 53 DISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 53 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
.+.++|.+. +.||+|+||+||+|.+..+|+.||+|++... ..+.+|+.++.++.+||||++++++|..
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 455678876 6899999999999999999999999998632 3567888888666589999999999876
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 -DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
...+|+|||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++..+.++.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 667999999999999999998753 59999999999999999999999999999999999999875556789999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcccccCCC
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVIDFKRD 280 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~~~~~~~~~ 280 (419)
++.............||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.... .....+......++..
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 289 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 289 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence 998776555566778999999999986 57999999999999999999999999765432 2455666677777777
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~ 323 (419)
.|..+++++.+||.+||+.||++|||+.|+++||||......+
T Consensus 290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~ 332 (400)
T 1nxk_A 290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332 (400)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSC
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCC
Confidence 7888999999999999999999999999999999998755443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=416.39 Aligned_cols=262 Identities=37% Similarity=0.633 Sum_probs=232.6
Q ss_pred CCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.+....++|.+.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP 88 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC
Confidence 3455567899999999999999999999999999999999765433233456789999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~---~~vkL~DFG~a~~ 165 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNM 165 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT---CCEEECCCSSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC---CCeEEEeccchhh
Confidence 9999999999999999999888889999999999999999999999999999999999999654 4599999999998
Q ss_pred ccCCCcccccccCcccCchhhhccc--CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
...+.......||+.|+|||++.+. .+.++|||||||++|+|++|..||.+.+.......+..+....+ ..+++
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 241 (476)
T 2y94_A 166 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNP 241 (476)
T ss_dssp CCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCH
T ss_pred ccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCH
Confidence 7766666778899999999998753 36799999999999999999999999888888888877654332 35789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
++.+||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 99999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=390.56 Aligned_cols=264 Identities=41% Similarity=0.738 Sum_probs=233.7
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+..+|++.+.||+|+||.||+|++..+|+.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKI-KHENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence 4577899999999999999999999999999999999975432 2335688999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||++...+.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888889999999999999999999999999999999999999655556679999999987643
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+....+..+++++.
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 N-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp C-BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred C-CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 2 2334567999999999987 4689999999999999999999999999998888888888877777777778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+||.+||..||++|||+.++++||||+...
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=401.67 Aligned_cols=258 Identities=28% Similarity=0.515 Sum_probs=219.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHH-HhCCCCCCeeeeeeEEEeCCeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM-KHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l-~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...+|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..++ +.+ +||||+++++++.+.+.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence 345899999999999999999999999999999999877655444556677787774 556 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR- 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~- 211 (419)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~---g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC---CCEEEeeCcccccccc
Confidence 9999999999999999988889999999999999999999999999999999999999654 459999999998643
Q ss_pred CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
........+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+......++ +.+++++.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~ 267 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSAR 267 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHH
Confidence 3344566789999999999874 689999999999999999999999999999888888887655433 46899999
Q ss_pred HHHHHhcCCCCCCCCCH----HHHhcCCccccC
Q 014722 291 DLVKKMLNPDPKQRLTA----EEVLEHPWLQNA 319 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~----~~~l~~~~~~~~ 319 (419)
+||.+||+.||.+||++ .++++||||+..
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999999986 699999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=389.50 Aligned_cols=265 Identities=41% Similarity=0.759 Sum_probs=239.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+..+|++++.||+|+||.||+|++..+++.||+|++...... ....+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeE
Confidence 4667899999999999999999999999999999999765432 23467889999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999999998888899999999999999999999999999999999999998766667899999999987665
Q ss_pred CCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+......+..+.+..+++++.+|
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 256 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred CCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence 55555667899999999998889999999999999999999999999999888888888877666666667889999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
|.+||..||++|||+.++++||||++.
T Consensus 257 i~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=408.33 Aligned_cols=263 Identities=26% Similarity=0.460 Sum_probs=224.9
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEE
Confidence 456899999999999999999999999999999999764332223345678899999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~---g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC---GHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC---CCEEEeechhheeccC
Confidence 9999999999999998754 79999999999999999999999999999999999999644 4599999999987754
Q ss_pred CCc--ccccccCcccCchhhhc--------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-C
Q 014722 213 GEQ--FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD-P 281 (419)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~ 281 (419)
... ....+||+.|+|||++. +.|+.++|||||||++|||++|.+||.+.+..+....+.........+ .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 294 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence 433 23468999999999986 358999999999999999999999999999888888887643222222 1
Q ss_pred CccCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCccccCcc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQR---LTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R---~s~~~~l~~~~~~~~~~ 321 (419)
...+|+++++||.+||. +|.+| |++.|+++||||+....
T Consensus 295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 24689999999999999 99998 59999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=402.43 Aligned_cols=261 Identities=35% Similarity=0.660 Sum_probs=227.5
Q ss_pred cccceee--ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 54 ISIDYDL--GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 54 ~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 3344555 668999999999999999999999999997543 33567889999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+..+ ....+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET-TTTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC-CCCcEEEEeCCCceec
Confidence 99999999999999988764 469999999999999999999999999999999999999643 2356999999999988
Q ss_pred cCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
..........||+.|+|||++. +.++.++|||||||++|+|++|..||.+.+.......+......+....++.+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 7666666778999999999987 468899999999999999999999999999988888888887776666677899999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=395.38 Aligned_cols=267 Identities=28% Similarity=0.465 Sum_probs=216.7
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
....++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE
Confidence 3455689999999999999999999999999999999975532 222345677899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a~~ 209 (419)
+++||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++..
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999997 59999999988899999999999999999999999999999999999996443 344599999999986
Q ss_pred ccCC-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc---
Q 014722 210 FRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP--- 283 (419)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~--- 283 (419)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+...........|+
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 6432 33445678999999999864 48999999999999999999999999988887777776543222222111
Q ss_pred -----------------------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 284 -----------------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 284 -----------------------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.+++++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 16789999999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=394.69 Aligned_cols=261 Identities=31% Similarity=0.529 Sum_probs=218.9
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|++++.||+|+||.||+|++..+++.||+|++...... ...+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence 4567899999999999999999999999999999999754322 2345688999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~---~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC---CCEEEEEeeccceecc
Confidence 9999999999999999888789999999999999999999999999999999999999654 4599999999986543
Q ss_pred CC---cccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 213 GE---QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 213 ~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.. ......||+.|+|||++.+ . ++.++|||||||++|+|++|..||................ ......+..+++
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDS 236 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCH
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCH
Confidence 22 2345689999999999874 3 4778999999999999999999997765532222222221 222334567899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=412.74 Aligned_cols=260 Identities=30% Similarity=0.557 Sum_probs=219.9
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
....++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCE
Confidence 34456899999999999999999999999999999999865444444556778899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+ +.+||+|||+|...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~---~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD---GHIKITDFGLCKEG 299 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS---SCEEECCCCCCCTT
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC---CCEEEccCCCceec
Confidence 99999999999999999988899999999999999999999998 999999999999999654 45999999999864
Q ss_pred c-CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 R-PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
. .........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......++ ..++++
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~ 375 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPE 375 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHH
Confidence 3 233455678999999999987 5799999999999999999999999999998888888877665443 357999
Q ss_pred HHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+.+||.+||+.||.+|| |+.|+++||||+..
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999999999 99999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=400.82 Aligned_cols=262 Identities=37% Similarity=0.724 Sum_probs=232.6
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-C----hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-T----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~----~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
+..+|++.+.||+|+||.||+|.+..+|+.||||++...... . ....+.+.+|+.+++++.+||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 446799999999999999999999989999999998754321 1 11245678999999998679999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
....|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~---~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN---MQIRLSDFGFSC 248 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC---CCEEEEecCccc
Confidence 99999999999999999999888889999999999999999999999999999999999999644 459999999999
Q ss_pred eccCCCcccccccCcccCchhhhcc-------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
............||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+..+.
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 328 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE 328 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8876666677889999999998853 478899999999999999999999999888888888877776665555
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|..+++.+.+||.+||+.||++|||+.++|+||||++
T Consensus 329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 6788999999999999999999999999999999973
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=412.72 Aligned_cols=264 Identities=40% Similarity=0.679 Sum_probs=218.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-----hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----AVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++++ +||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 35678999999999999999999999999999999998654321 11223578999999999 9999999999986
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
. +.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+..+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 568999999999999999988888999999999999999999999999999999999999987666678999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 282 (419)
.............||+.|+|||++. ..++.++|||||||++|+|++|.+||...... .....+......+....|
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 8876655566778999999999874 35788999999999999999999999765433 344445555544444445
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
..+++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 678999999999999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=386.31 Aligned_cols=257 Identities=32% Similarity=0.510 Sum_probs=213.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 7899999999975432 122346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+++ +|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEeECccccccCccc
Confidence 999975 898888764 679999999999999999999999999999999999999654 45999999998765432
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC-----------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD----------- 280 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 280 (419)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345678999999999864 58999999999999999999999999988877776665432111111
Q ss_pred --------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 281 --------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 281 --------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 123478999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=390.89 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=207.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEE
Confidence 479999999999999999999999999999999975532 22346788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 136 MELCEGGELFDRIVAR------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
|||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC---CCEEECcCcccee
Confidence 99998 5999988754 358999999999999999999999999999999999999654 4599999999987
Q ss_pred ccCC-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC------
Q 014722 210 FRPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD------ 280 (419)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 280 (419)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6533 33455679999999999864 58999999999999999999999999998887777765432211111
Q ss_pred ------------------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 281 ------------------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 281 ------------------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
....+++++.+||.+||+.||++|||+.|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 11246889999999999999999999999999999987543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=385.09 Aligned_cols=266 Identities=36% Similarity=0.679 Sum_probs=236.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC------hhhHHHHHHHHHHHHhCCCCCCeeeeeeE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT------AVDIEDVRREVQIMKHLPKHPNIVSLKDT 125 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~ 125 (419)
..+..+|++.+.||+|+||.||+|.+..+|+.||+|++....... ....+.+.+|+.+++++.+||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 456678999999999999999999999999999999997543211 12345778999999999569999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
+.+....++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg 169 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFG 169 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC---CcEEEeccc
Confidence 99999999999999999999999988889999999999999999999999999999999999999644 459999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc-------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+......+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred chhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 998877666666778999999999874 2478899999999999999999999999988888888888877777
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.+..+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 777778999999999999999999999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=389.84 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=216.4
Q ss_pred ccccceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
....+|++.+.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc
Confidence 34468999999999999999999985 68999999999765432 223445678899999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
.+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ---GHVKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT---SCEEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC---CcEEEEeCCccc
Confidence 99999999999999999999988889999999999999999999999999999999999999644 459999999987
Q ss_pred eccC-CCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 209 FFRP-GEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 209 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.... ........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+.......+......++ +.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCC
Confidence 6432 23345567999999999986 4689999999999999999999999999988888888877655433 3579
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+++.+||.+||..||.+|| ++.++++||||+..
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999999 89999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=385.21 Aligned_cols=266 Identities=38% Similarity=0.739 Sum_probs=229.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence 45689999999999999999999999999999999976543221 2367889999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC-CCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-ESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~-~~~~~kl~Dfg~a~~ 209 (419)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++ ....+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999997654 234699999999988
Q ss_pred ccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
...........||+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+......+....++.+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence 76655556677999999999987 56899999999999999999999999998888877777666554444344568999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.+|+.+||..||++|||+.++++||||+...
T Consensus 242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999999999999999999998654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=418.47 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=224.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEE
Confidence 3456799999999999999999999999999999999765433333456788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~---g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH---GHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC---CCeEEEecccceec
Confidence 999999999999999877543 9999999999999999999999999999999999999644 45999999999987
Q ss_pred cCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccccCCCCCccC
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..........||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.. ...+...+...... ....+
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~----~p~~~ 412 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE----YSERF 412 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC----CCTTS
T ss_pred ccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc----CCccC
Confidence 76666667789999999999874 69999999999999999999999998764 23344444433322 23468
Q ss_pred CHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 286 SENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
++++.+||.+||+.||.+|| ++.|+++||||+..
T Consensus 413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 99999999999999999999 89999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=402.80 Aligned_cols=262 Identities=31% Similarity=0.531 Sum_probs=210.9
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-- 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 130 (419)
.+..+|++++.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++++.+||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 4556899999999999999999999999999999998654 2345566778899999999955999999999997544
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE---CHVKVADFGLSRSF 159 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEES
T ss_pred EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC---CCEEecCCcccccc
Confidence 7999999997 589888876 479999999999999999999999999999999999999644 45999999999865
Q ss_pred cCC----------------------CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014722 211 RPG----------------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266 (419)
Q Consensus 211 ~~~----------------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 266 (419)
... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 12344689999999999864 689999999999999999999999999988887
Q ss_pred HHHHHhcccccC------------------------------C-------------CCCccCCHHHHHHHHHhcCCCCCC
Q 014722 267 AQAIIRSVIDFK------------------------------R-------------DPWPKVSENAKDLVKKMLNPDPKQ 303 (419)
Q Consensus 267 ~~~i~~~~~~~~------------------------------~-------------~~~~~~~~~~~~li~~~L~~dp~~ 303 (419)
...+........ . .++..+++++.+||.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 777653221110 0 012267899999999999999999
Q ss_pred CCCHHHHhcCCccccCc
Q 014722 304 RLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 304 R~s~~~~l~~~~~~~~~ 320 (419)
|||+.|+|+||||+...
T Consensus 320 R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 320 RISANDALKHPFVSIFH 336 (388)
T ss_dssp SCCHHHHTTSTTTTTTC
T ss_pred CCCHHHHhCCHHHHHhc
Confidence 99999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=386.98 Aligned_cols=257 Identities=33% Similarity=0.611 Sum_probs=215.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-----------------------hhhHHHHHHHHHHHH
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-----------------------AVDIEDVRREVQIMK 111 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------------------~~~~~~~~~Ei~~l~ 111 (419)
.++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999999999999999997654221 112356889999999
Q ss_pred hCCCCCCeeeeeeEEEe--CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 112 HLPKHPNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 112 ~l~~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
++ +||||+++++++.+ ...+|+||||+++++|.+++ ....+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99 89999999999986 67899999999999998754 3457999999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCC-cccccccCcccCchhhhccc----CCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQ 264 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 264 (419)
++.+ +.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||......
T Consensus 170 ~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 VGED---GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp ECTT---SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCC---CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9654 459999999998765433 23456799999999998743 367899999999999999999999988877
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.....+......++ ..+.+++++.+||.+||+.||++|||+.|+++||||++
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 77777766554433 23568999999999999999999999999999999963
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=393.49 Aligned_cols=265 Identities=40% Similarity=0.684 Sum_probs=222.5
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-----ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++++ +||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence 35667899999999999999999999999999999999765321 112234578999999999 999999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.... +|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7665 899999999999999998888899999999999999999999999999999999999998766667799999999
Q ss_pred ceeccCCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccccCCCC
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~ 281 (419)
+.............||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......+....
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98876554455667999999999873 46889999999999999999999999765433 33444444444333333
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+..+++.+.+||.+||..||++|||+.++++||||+.
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 4568999999999999999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=398.47 Aligned_cols=263 Identities=20% Similarity=0.308 Sum_probs=216.8
Q ss_pred cccceeeccccccc--cceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 54 ISIDYDLGRELGRG--EFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 54 ~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
-.++|++++.||+| +||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCE
Confidence 34579999999999 999999999999999999999986543 344567888999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||.+..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~---~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD---GKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---CCEEEccccccee
Confidence 99999999999999999875 679999999999999999999999999999999999999644 4599999998865
Q ss_pred ccCCC--------cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-
Q 014722 210 FRPGE--------QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF- 277 (419)
Q Consensus 210 ~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~- 277 (419)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 43221 1223478999999999875 58999999999999999999999998766554443333221110
Q ss_pred -----------------------------------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 278 -----------------------------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 278 -----------------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+.+..+++++.+||.+||+.||++|||+.|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 011234578899999999999999999999999999999
Q ss_pred ccCcc
Q 014722 317 QNAKK 321 (419)
Q Consensus 317 ~~~~~ 321 (419)
+....
T Consensus 338 ~~~~~ 342 (389)
T 3gni_B 338 KQIKR 342 (389)
T ss_dssp GGC--
T ss_pred HHHhh
Confidence 87644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=382.05 Aligned_cols=259 Identities=34% Similarity=0.621 Sum_probs=223.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++.+.||+|+||.||+|.+..++..||+|++.............+.+|+.+++++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEE
Confidence 45799999999999999999999999999999999765433333456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~---~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT---SCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC---CCEEEEeccccccCCcc-
Confidence 99999999999999988889999999999999999999999999999999999999644 45999999988654332
Q ss_pred cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++ ..+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li 238 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLI 238 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHH
Confidence 2345679999999999874 678899999999999999999999999888887777766544332 35789999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.+||+.||++|||+.|+++||||+.....
T Consensus 239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHhccChhhCCCHHHHhhCccccCCccC
Confidence 99999999999999999999999875443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=397.69 Aligned_cols=266 Identities=36% Similarity=0.682 Sum_probs=228.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCC
Confidence 4667899999999999999999999999999999999765321 233567899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 014722 131 AVHIVMELCEGGELFDRIVA----------------------------------------RGHYTERAAAAVMKTIVEVV 170 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~l 170 (419)
..++||||++||+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998742 11236788899999999999
Q ss_pred HHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-----cccccccCcccCchhhhc---ccCCCcccHH
Q 014722 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYMAPEVLK---RNYGPEVDVW 242 (419)
Q Consensus 171 ~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~Diw 242 (419)
.|||++||+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||++. ..++.++|||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 999999999999999999997543 3469999999998764321 234567999999999986 4688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 243 SAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 243 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
|||+++|+|++|..||.+....+....+......+..+.+..+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999999999888888888877777666677899999999999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=409.44 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=211.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+..+|++++.||+|+||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence 34568999999999999999999999999999999997653 3444567888999999999 999999999999654
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..+|+||||+++ +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~---~~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC---CCEEEEEEEe
Confidence 467999999976 5666664 358999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK------- 278 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 278 (419)
++...........+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98876665666788999999999987 4799999999999999999999999999988777777655321110
Q ss_pred ---------------CCCCc----c------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 279 ---------------RDPWP----K------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 279 ---------------~~~~~----~------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
...++ . .++++.+||.+||..||++|||+.|+|+||||+.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00000 0 1567999999999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=385.37 Aligned_cols=262 Identities=30% Similarity=0.577 Sum_probs=216.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEE
Confidence 57999999999999999999999999999999986553 2334456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
|||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH---SVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC---CCEEEeeCCCchhccCccc
Confidence 9999999999988888889999999999999999999999999999999999999644 45999999999876533 3
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc----------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID---------------- 276 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------------- 276 (419)
......||+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.........+......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3455679999999999864 6899999999999999999999999988877666555432111
Q ss_pred ---cCCC--------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccC
Q 014722 277 ---FKRD--------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKA 322 (419)
Q Consensus 277 ---~~~~--------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~ 322 (419)
.+.. .++.+++.+.+||.+||+.||++|||+.|+++||||++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 0000 124678999999999999999999999999999999976443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=406.06 Aligned_cols=263 Identities=27% Similarity=0.430 Sum_probs=202.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
..+.++|++++.||+|+||+||+|++..+|+.||||++... .......+.+.+|+.+|+++ +||||+++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc
Confidence 34667899999999999999999999999999999999654 23455667899999999999 89999999999843
Q ss_pred --CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 129 --DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
...+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~---~~~kl~DFGl 202 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD---CSVKVCDFGL 202 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---CCEEECCCTT
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC---CCEeeccccc
Confidence 35799999998 57999999888889999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCC----------------------------cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHh---
Q 014722 207 SVFFRPGE----------------------------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLC--- 253 (419)
Q Consensus 207 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~--- 253 (419)
|+...... .....+||+.|+|||++. ..|+.++||||||||+|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 98764221 234467899999999763 469999999999999999999
Q ss_pred --------CCCCCCCCCH--------------------HHHHHHHHhcc-----------------------cc----cC
Q 014722 254 --------GVPPFWAETE--------------------QGVAQAIIRSV-----------------------ID----FK 278 (419)
Q Consensus 254 --------g~~pf~~~~~--------------------~~~~~~i~~~~-----------------------~~----~~ 278 (419)
|.++|.+... ......+.... .. ..
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 7777766541 12222221110 00 00
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...++..++++.+||.+||..||++|||+.|+|+||||+...
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 112456799999999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=393.54 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=212.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence 4699999999999999999999999999999998654321 1112345799999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||++ |+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT---CCEEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC---CCEEEccCcccccccCCc
Confidence 99997 58988887654 58999999999999999999999999999999999999654 45999999999865432
Q ss_pred CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC---------
Q 014722 214 EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW--------- 282 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~--------- 282 (419)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.+.........|
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345678999999999864 5899999999999999999999999999988887777664333322222
Q ss_pred -----------------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 283 -----------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 283 -----------------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
+.+++++.+||.+||+.||++|||+.|+|+||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 246889999999999999999999999999999987644
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=423.81 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=231.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++++.||+|+||.||+|++..+++.||+|++.+.........+.+..|..++..+.+||||+++++++++.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999865432333456788899999998789999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc-CC
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~-~~ 213 (419)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~---g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE---GHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS---SCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC---CcEEEeecceeeccccCC
Confidence 99999999999999988899999999999999999999999999999999999999654 459999999998643 33
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++. ..|+.++|||||||++|||++|.+||.+.+..++...+......++ ..+++++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence 4456778999999999987 5799999999999999999999999999999999999888765544 3689999999
Q ss_pred HHHhcCCCCCCCCCH-----HHHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLTA-----EEVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s~-----~~~l~~~~~~~~ 319 (419)
|.+||+.||++||++ .|+++||||+..
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 999999999999997 999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=386.89 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=211.7
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+.++|++.+.||+|+||+||+|++..+|+.||+|++..... ..........|+..+..+.+||||+++++++.+.+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 45567889999999999999999999999999999999865432 33344455666666666658999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.+|+||||+ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~---~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG---RCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG---CEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC---CEEEccceeeee
Confidence 999999999 66898888764 4599999999999999999999999999999999999996544 599999999987
Q ss_pred ccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
...........||+.|+|||++.+.++.++|||||||++|+|++|..||.+.. ....+..... ....+..+++++
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~l 281 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSEL 281 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHHH
T ss_pred cccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHHH
Confidence 76555556677999999999999899999999999999999999977765432 2233332221 111224579999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+||.+||+.||++|||+.|+|+||||++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=400.88 Aligned_cols=263 Identities=30% Similarity=0.503 Sum_probs=215.0
Q ss_pred cCCCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 47 KEPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 47 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
....+.....+|++.+.||+|+||.||+|++..+++ +|+|++...... ..+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l-~h~niv~l~~~~ 101 (394)
T 4e7w_A 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIV-KHPNVVDLKAFF 101 (394)
T ss_dssp ESSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTC-CCTTBCCEEEEE
T ss_pred CCCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhC-CCCCcceEEEEE
Confidence 345567778899999999999999999999877666 888877543211 23699999999 899999999998
Q ss_pred EeCC------eEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 127 EDDS------AVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 127 ~~~~------~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
.... .+++||||++++ +...+. ....+++..++.++.||+.||.|||++||+||||||+|||++. .+
T Consensus 102 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~--~~ 178 (394)
T 4e7w_A 102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP--PS 178 (394)
T ss_dssp EEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET--TT
T ss_pred EecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC--CC
Confidence 6543 388999999865 433332 2567999999999999999999999999999999999999972 23
Q ss_pred CCeEEeecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Q 014722 197 SPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 274 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 274 (419)
+.+||+|||+|+............||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+.+..
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 179 GVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp TEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 4599999999998766666667789999999998864 58999999999999999999999999988877776665421
Q ss_pred cc-----------------cC---CC-----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 275 ID-----------------FK---RD-----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 275 ~~-----------------~~---~~-----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.. ++ .. ..+.+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 10 00 00 11247899999999999999999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=377.80 Aligned_cols=260 Identities=34% Similarity=0.659 Sum_probs=227.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
...++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++.+.+..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEE
Confidence 3446899999999999999999999999999999999754332222356788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAPS 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT---CCEEECCCTTCEECSS
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC---CCEEEecccccccCcc
Confidence 9999999999999999988889999999999999999999999999999999999999644 4599999999876543
Q ss_pred CCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++ +.+++.+.+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 241 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKD 241 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred c-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHH
Confidence 2 2345679999999999874 689999999999999999999999998888777777766544332 357999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
||.+||..||.+|||+.++++||||+....
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999986543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=390.55 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=222.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS- 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 130 (419)
..+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++++ +||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 86 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 86 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEET
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCC
Confidence 46778899999999999999999999999999999999876555555667889999999999 8999999999987654
Q ss_pred ---eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 131 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a 163 (311)
T 3ork_A 87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIA 163 (311)
T ss_dssp TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS---CEEECCCSCC
T ss_pred CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC---CEEEeeccCc
Confidence 3599999999999999999888999999999999999999999999999999999999997544 4999999999
Q ss_pred eeccCCC----cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 208 VFFRPGE----QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccccc
Confidence 8664332 2234569999999999874 6899999999999999999999999998887777766665444333334
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..+++++.+||.+||+.||++||++.+++.|+|++..
T Consensus 244 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 5689999999999999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=378.26 Aligned_cols=261 Identities=38% Similarity=0.640 Sum_probs=218.7
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
|....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCC
Confidence 455567899999999999999999999999999999999765432233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH---MNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT---SCEEECCCCGGGCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC---CCEEEeeccccccc
Confidence 999999999999999999888889999999999999999999999999999999999999644 45999999999877
Q ss_pred cCCCcccccccCcccCchhhhccc-C-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
..........||+.|+|||++.+. + +.++||||||+++|+|++|..||...........+.......+ ..++..
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 237 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRS 237 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHH
Confidence 655555566799999999998753 3 5799999999999999999999998888777777766543322 357899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.++|.+||+.||++|||+.++++||||++.
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=376.06 Aligned_cols=260 Identities=32% Similarity=0.494 Sum_probs=230.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEE
Confidence 456899999999999999999999999999999999876655566677899999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC---CCEEEEeccCceecccC
Confidence 999999999999999888889999999999999999999999999999999999999644 45999999999876532
Q ss_pred -CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+ ..+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 244 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 244 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHH
Confidence 33445679999999999874 588999999999999999999999998888777766665543322 357899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+||+.||++|||+.++++||||.....
T Consensus 245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 245 LIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 999999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=388.02 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=219.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe------
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------ 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------ 128 (419)
..+|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL-KHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence 458999999999999999999999999999999987654322 2345677899999999 89999999999987
Q ss_pred --CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 --DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
.+.+|+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg 169 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFG 169 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCT
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC---CCEEEccch
Confidence 4568999999975 777776653 569999999999999999999999999999999999999654 459999999
Q ss_pred cceeccCC-----CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 206 LSVFFRPG-----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 206 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876422 22345678999999998864 589999999999999999999999999998888877776554444
Q ss_pred CCCCccC----------------------------CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 279 RDPWPKV----------------------------SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 279 ~~~~~~~----------------------------~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...|+.. ++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 4444332 67899999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=390.43 Aligned_cols=263 Identities=24% Similarity=0.403 Sum_probs=221.1
Q ss_pred CCCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC----CCCCeeeee
Q 014722 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----KHPNIVSLK 123 (419)
Q Consensus 48 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hpnIv~l~ 123 (419)
...|..+.++|++++.||+|+||.||+|++..+++.||+|++... .........|+.+++.+. +||||++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 355677888999999999999999999999999999999998642 334566788999999994 399999999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC--------
Q 014722 124 DTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-------- 193 (419)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-------- 193 (419)
+++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++..
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 899999998754 49999999999999999999999999999999999999642
Q ss_pred --------------CCCCCeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCC
Q 014722 194 --------------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 194 --------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 258 (419)
.....+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 1256699999999986543 234567999999999987 47999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcccccCC---------------------CCCc---------------------cCCHHHHHHHHHh
Q 014722 259 WAETEQGVAQAIIRSVIDFKR---------------------DPWP---------------------KVSENAKDLVKKM 296 (419)
Q Consensus 259 ~~~~~~~~~~~i~~~~~~~~~---------------------~~~~---------------------~~~~~~~~li~~~ 296 (419)
.+.+..+....+.......+. ..|+ ..++.+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988877766665443221110 0011 1236788999999
Q ss_pred cCCCCCCCCCHHHHhcCCccc
Q 014722 297 LNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 297 L~~dp~~R~s~~~~l~~~~~~ 317 (419)
|+.||++|||+.|+|+||||+
T Consensus 340 L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCCHHHHTTSGGGC
T ss_pred hcCChhhCCCHHHHhcCcccC
Confidence 999999999999999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=389.52 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=214.8
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+..+|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 99 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcc
Confidence 45668999999999999999999999999999999986543 3444567889999999999 899999999999765
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~ 174 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGL 174 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTT
T ss_pred ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC---CCEEEEeeec
Confidence 3469999999 7899988876 579999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------- 277 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 277 (419)
+..... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+.......
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 987543 3455689999999998764 68999999999999999999999999988877766665422111
Q ss_pred ----------------CC----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 278 ----------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 278 ----------------~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. ..++..++.+.+||.+||..||++|||+.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 11 12346789999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=390.19 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=218.8
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh-----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA-----VDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.+..+|++.+.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 466789999999999999999999999999999999986543221 1234567899999999 8999999999999
Q ss_pred eCCeEEEEEEecCCc-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 128 DDSAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
+.+.+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED---FTIKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC---CcEEEeeccc
Confidence 999999999999766 999999988889999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
+.............||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ...........
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCcc
Confidence 998776666667789999999999874 34 7889999999999999999999965321 11111222335
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 799999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=382.90 Aligned_cols=260 Identities=32% Similarity=0.494 Sum_probs=230.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+.+|
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEE
Confidence 456899999999999999999999999999999999877655666678899999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+++++|.+++.....+++.++..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED---LEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC---CCEEEeeccCceecccC
Confidence 999999999999999888889999999999999999999999999999999999999654 45999999999876532
Q ss_pred -CcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+.......+ ..+++.+.+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 270 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAAS 270 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHH
Confidence 33455679999999999874 688999999999999999999999998887777777666544332 357899999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
||.+||+.||++|||+.|+++||||.....
T Consensus 271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 271 LIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=409.49 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=223.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++++ +||||+++++++.+...+|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEE
Confidence 346899999999999999999999999999999999765443333456788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 134 IVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~---g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD---GNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC---CCEEEeecceeee
Confidence 999999999999998763 369999999999999999999999999999999999999654 4599999999987
Q ss_pred ccCCCc-ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccccCCCCCc
Q 014722 210 FRPGEQ-FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 210 ~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~ 283 (419)
...... .....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.. ...+...+......++ .
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~ 414 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----D 414 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----T
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----c
Confidence 765443 344689999999999874 69999999999999999999999998753 3455555655544332 4
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
.+++++.+||.+||+.||++||+ +.++++||||+..
T Consensus 415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 68999999999999999999995 5899999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=396.66 Aligned_cols=263 Identities=29% Similarity=0.529 Sum_probs=212.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+.++|++.+.||+|+||.||+|++..+|+.||||++... .......+.+.+|+.+++++ +||||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCC
Confidence 4567899999999999999999999999999999999754 23455667889999999999 899999999999766
Q ss_pred --CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 130 --SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 101 ~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~---~~~~kL~DFGla 176 (432)
T 3n9x_A 101 KFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCSVKVCDFGLA 176 (432)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT---TCCEEECCCTTC
T ss_pred cCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC---CCCEEEccCCCc
Confidence 57999999996 599999988888999999999999999999999999999999999999964 455999999999
Q ss_pred eeccCCC-----------------------cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHh---------
Q 014722 208 VFFRPGE-----------------------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLC--------- 253 (419)
Q Consensus 208 ~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~--------- 253 (419)
+...... .....+||++|+|||++. ..|+.++|||||||++|+|++
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 8765332 235678999999999863 469999999999999999998
Q ss_pred --CCCCCCCCC-----------------HHHHHHHHHhcc-----------------------cccCC----CCCccCCH
Q 014722 254 --GVPPFWAET-----------------EQGVAQAIIRSV-----------------------IDFKR----DPWPKVSE 287 (419)
Q Consensus 254 --g~~pf~~~~-----------------~~~~~~~i~~~~-----------------------~~~~~----~~~~~~~~ 287 (419)
|.++|.+.+ .......+.... ..... ..++.+++
T Consensus 257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 336 (432)
T 3n9x_A 257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD 336 (432)
T ss_dssp GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence 445554433 112222221110 00000 01246899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+||.+||+.||++|||+.|+|+||||+....
T Consensus 337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 337 DGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 9999999999999999999999999999997644
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=379.83 Aligned_cols=256 Identities=30% Similarity=0.530 Sum_probs=221.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence 358888899999999999999999999999999975432 2456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC---CcEEEeeeeeeeecccCcc
Confidence 999999999998754 569999999999999999999999999999999999999644 459999999998765432
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... .......+++.+.+||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCccccCCHHHHHHH
Confidence 335568999999999987 46899999999999999999999999988877776666554322 1222346899999999
Q ss_pred HHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 294 KKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+||+.||++|||+.++++||||....
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999999998643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=379.12 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=221.2
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
|..+.++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCC
Confidence 567888999999999999999999999999999999999766555566677899999999999 8999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.+|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN---KTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCSSSTTC
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CCEEEEeCCCcccc
Confidence 999999999999999999988899999999999999999999999999999999999999654 45999999999865
Q ss_pred cCCC--cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-CCCCCccCC
Q 014722 211 RPGE--QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF-KRDPWPKVS 286 (419)
Q Consensus 211 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~ 286 (419)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+............... .....+.+|
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIP 241 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCC
Confidence 4332 2344679999999998874 68899999999999999999999999888776655555443221 122345689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
+.+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 242 ~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 242 QSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 9999999999999999999666666666654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=384.40 Aligned_cols=258 Identities=29% Similarity=0.473 Sum_probs=222.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++++.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeE
Confidence 4556799999999999999999999999999999999765444444567889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+. |+|.+.+. ....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMA 205 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSS
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC---CCEEEeeccCceecC
Confidence 99999997 57877775 45679999999999999999999999999999999999999754 459999999997654
Q ss_pred CCCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
. .....||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.+.......+....... .....+++
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 280 (348)
T 1u5q_A 206 P---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSE 280 (348)
T ss_dssp S---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CCCTTSCH
T ss_pred C---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--CCCCCCCH
Confidence 3 24567999999999873 468999999999999999999999999888777666665543221 12245789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.+||.+||+.||++|||+.++++||||....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=391.23 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=213.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCCeeeeeeEEEeCCeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~~~~~ 133 (419)
..+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++++.. ||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3469999999999999999999754 99999999976543 34456789999999999943 699999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||| +.+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++. +.+||+|||++......
T Consensus 133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC---
T ss_pred EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccCC
Confidence 9999 568899999998888999999999999999999999999999999999999942 45999999999876543
Q ss_pred Cc---ccccccCcccCchhhhcc------------cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccccc
Q 014722 214 EQ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDF 277 (419)
Q Consensus 214 ~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~ 277 (419)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ......+.......
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence 22 345679999999999863 588899999999999999999999977543 33444444433322
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
..+ ...++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 288 ~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 288 EFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 222 23578999999999999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=373.26 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=217.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----CCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~ 131 (419)
..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence 358999999999999999999999999999999976544 344567889999999999 89999999999875 456
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+++||||+++++|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||+++. .++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~--~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC--CCCCEEEeeCCCccc
Confidence 8999999999999999998888999999999999999999999999 999999999999962 334699999999975
Q ss_pred ccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccccCCCCCccCCHH
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV-AQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
... .......||+.|+|||++.+.++.++||||||+++|+|++|..||........ ...+...... .......+++
T Consensus 182 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 258 (290)
T 1t4h_A 182 KRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPE 258 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHH
T ss_pred ccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc--cccCCCCCHH
Confidence 443 23345679999999999988899999999999999999999999987554433 3333332211 1112346789
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+.+||.+||+.||++|||+.++++||||++
T Consensus 259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 999999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=376.57 Aligned_cols=257 Identities=33% Similarity=0.591 Sum_probs=196.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 4799999999999999999999999999999999754332223356789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN---MNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT---CCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC---CCEEEEeecceeeccCCC
Confidence 9999999999998875 569999999999999999999999999999999999999654 45999999999876532
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... .....++.++.+|
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l 242 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY----EMPSFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCC----CCCTTSCHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhccc----CCccccCHHHHHH
Confidence 2234567999999999887 4688999999999999999999999987665444433322211 2223578999999
Q ss_pred HHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 293 VKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
|.+||+.||++|||+.++++||||....
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=385.04 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=214.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh--hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA--VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
...+|++++.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc
Confidence 34579999999999999999999999999999999975432211 1124678899999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC---CCEEEEecccceec
Confidence 9999999986 888888764 358999999999999999999999999999999999999654 45999999999876
Q ss_pred cCC-CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC-----
Q 014722 211 RPG-EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW----- 282 (419)
Q Consensus 211 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 282 (419)
... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+...........|
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 433 33455679999999999863 4888999999999999999999999999888877777654332222221
Q ss_pred -------------------ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 283 -------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 283 -------------------~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
..+++++.+||.+||..||++|||+.|+|+||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 34578999999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=383.28 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=206.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC---
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--- 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--- 130 (419)
+..+|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccch
Confidence 4568999999999999999999999999999999997554 233567899999999999 8999999999986543
Q ss_pred ------------------------------------------------------eEEEEEEecCCcchHHHHHhcCC---
Q 014722 131 ------------------------------------------------------AVHIVMELCEGGELFDRIVARGH--- 153 (419)
Q Consensus 131 ------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--- 153 (419)
.+++|||||+|++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987543
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-------------cccccc
Q 014722 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-------------QFNEIV 220 (419)
Q Consensus 154 ~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~ 220 (419)
.++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....... ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD---DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC---CCEEEeecCcccccccchhhccccccccccccccccC
Confidence 4666789999999999999999999999999999999644 459999999998765432 123457
Q ss_pred cCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 221 gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
||+.|+|||++. ..++.++|||||||++|+|++|..|+.. .......+.... ....+...++++.+||.+||+.
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~ 312 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLK---FPLLFTQKYPQEHMMVQDMLSP 312 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC---CCHHHHHHCHHHHHHHHHHHCS
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC---CCcccccCChhHHHHHHHHccC
Confidence 999999999987 4789999999999999999999877521 111222222211 1112234678899999999999
Q ss_pred CCCCCCCHHHHhcCCcccc
Q 014722 300 DPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 300 dp~~R~s~~~~l~~~~~~~ 318 (419)
||++|||+.|+++||||++
T Consensus 313 ~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 313 SPTERPEATDIIENAIFEN 331 (332)
T ss_dssp SGGGSCCHHHHHHSTTCCC
T ss_pred CCCcCCCHHHHhhchhhhc
Confidence 9999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=369.85 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=214.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+..+|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+..+..+.+||||+++++++.+.+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 4667899999999999999999999999999999999765433 334567888999999987899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--------------
Q 014722 133 HIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK-------------- 194 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~-------------- 194 (419)
++||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 6799999999999999999999999999999999999997544
Q ss_pred --CCCCeEEeecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014722 195 --ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270 (419)
Q Consensus 195 --~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 270 (419)
....+||+|||.+...... ....||+.|+|||++.+ .++.++||||||+++|+|++|.+|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 4457999999999876533 23458999999999875 35579999999999999999998875443 23334
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...... .....+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 241 ~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 433321 2224689999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=377.12 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=214.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSA 131 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~ 131 (419)
..++|++++.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++++.+||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 346899999999999999999999999999999998643 246788999999999559999999999987 678
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.++||||+.+++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC--CEEEEEeCCCceEcC
Confidence 999999999999988774 489999999999999999999999999999999999997543 259999999999877
Q ss_pred CCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHh-------------ccc
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIR-------------SVI 275 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~-------------~~~ 275 (419)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||... ........+.. ...
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6666677789999999999864 5899999999999999999999999543 33222222211 110
Q ss_pred cc--------------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 DF--------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 ~~--------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. .......+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 00 0111223799999999999999999999999999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=382.30 Aligned_cols=259 Identities=27% Similarity=0.469 Sum_probs=216.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEE
Confidence 47999999999999999999999999999999986553 2344456788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...... .
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS---GVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC---CcEEEEeCCCceeecCCcc
Confidence 9999999998887777789999999999999999999999999999999999999644 45999999999765432 3
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc--------------C
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF--------------K 278 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------------~ 278 (419)
......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.........+....... .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 3455679999999999875 58999999999999999999999999888776665554321110 0
Q ss_pred ---C----------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 279 ---R----------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 279 ---~----------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
. ..++.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 0123578999999999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=370.26 Aligned_cols=259 Identities=31% Similarity=0.532 Sum_probs=220.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+.+..|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence 45689999999999999999999999999999999975543 23457889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC---CCEEEeeCCCccccCCC
Confidence 999999999999999877789999999999999999999999999999999999999644 45999999999865432
Q ss_pred C---cccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccccCCCCCccCCH
Q 014722 214 E---QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 214 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
. ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||....... ....+.... .....+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TTSTTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--cccCchhhcCH
Confidence 2 2345679999999999874 3 4678999999999999999999997765432 222222221 12234567899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+.+||.+||+.||++|||+.|+++||||+...
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=387.83 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=213.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----- 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----- 128 (419)
...+|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence 34579999999999999999999999999999999865432 123699999999 99999999999843
Q ss_pred ---------------------------------CCeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 014722 129 ---------------------------------DSAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQ 171 (419)
Q Consensus 129 ---------------------------------~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~ 171 (419)
...+++||||+++ +|.+.+. ....+++..+..++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3458999999984 7766554 3567999999999999999999
Q ss_pred HHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHH
Q 014722 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILY 249 (419)
Q Consensus 172 ~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~ 249 (419)
|||++||+||||||+|||++.. ++.+||+|||++.............||+.|+|||++.+ .++.++||||+||++|
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999999732 34599999999998776666677789999999998764 5899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhccccc-----------------C---CCC-----CccCCHHHHHHHHHhcCCCCCCC
Q 014722 250 ILLCGVPPFWAETEQGVAQAIIRSVIDF-----------------K---RDP-----WPKVSENAKDLVKKMLNPDPKQR 304 (419)
Q Consensus 250 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~-----------------~---~~~-----~~~~~~~~~~li~~~L~~dp~~R 304 (419)
+|++|.+||.+.+..+....+....... + ... ....++++.+||.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999988887777765421110 0 011 12478899999999999999999
Q ss_pred CCHHHHhcCCccccCc
Q 014722 305 LTAEEVLEHPWLQNAK 320 (419)
Q Consensus 305 ~s~~~~l~~~~~~~~~ 320 (419)
||+.|+|+||||+...
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCHHHHHTSGGGHHHH
T ss_pred CCHHHHhcCHHHHHHH
Confidence 9999999999998643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=387.99 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=205.6
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC---
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--- 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--- 130 (419)
+..+|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccc
Confidence 4568999999999999999999999999999999997543 2344567788999999999 8999999999997665
Q ss_pred ---eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 131 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~---~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCCCC-
T ss_pred cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC---CCEEEEEeecc
Confidence 78999999975 7888775 458999999999999999999999999999999999999654 45999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC--------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-------- 278 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------- 278 (419)
.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 87665544556789999999999874 689999999999999999999999999888777766654321110
Q ss_pred ---------CCCC--------------c-------cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 279 ---------RDPW--------------P-------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 279 ---------~~~~--------------~-------~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.+.+ + ..++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 0000 0 11567899999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=386.91 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=202.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC---
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--- 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--- 129 (419)
.+..+|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcc
Confidence 35568999999999999999999999999999999987543 3444567888999999999 899999999998654
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..+|+|+|++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~---~~~~kL~DFG~ 178 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DCELKILDFGL 178 (367)
T ss_dssp GGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT---TCCEEECC---
T ss_pred ccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC---CCCEEEeeccc
Confidence 5689999999 7899888765 57999999999999999999999999999999999999964 44599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------- 277 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------- 277 (419)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 179 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 179 ARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 986542 2445689999999998864 68999999999999999999999999988877776665422111
Q ss_pred ----------------CCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 278 ----------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 278 ----------------~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.. .++..++.+.+||.+||..||++|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 111 1235688999999999999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=390.38 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=213.7
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-- 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-- 129 (419)
.....+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+++++.+ +||||+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l-~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEEEEET
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHc-CCCCccceeeEEeccCC
Confidence 4556689999999999999999999999999999999865421 223699999999 899999999988532
Q ss_pred ----CeEEEEEEecCCcchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 130 ----SAVHIVMELCEGGELFDRIV----ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 130 ----~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
.++++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~--~~~kl 198 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKL 198 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT--TEEEE
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC--CeEEe
Confidence 247799999975 6665554 246799999999999999999999999999999999999997432 34899
Q ss_pred eecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc----
Q 014722 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI---- 275 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---- 275 (419)
+|||+++............||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+.+...
T Consensus 199 ~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 199 CDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999998766655566789999999999864 689999999999999999999999999887776666654211
Q ss_pred -------------ccC---CCCC-----ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 -------------DFK---RDPW-----PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 -------------~~~---~~~~-----~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.++ ...| +.+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 010 1111 24689999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=382.38 Aligned_cols=265 Identities=38% Similarity=0.704 Sum_probs=196.0
Q ss_pred CCccccceeecc-ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHH-HHhCCCCCCeeeeeeEEEe
Q 014722 51 GQDISIDYDLGR-ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI-MKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 51 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~-l~~l~~hpnIv~l~~~~~~ 128 (419)
...+.++|++.+ .||+|+||.||+|.+..+|+.||+|++.... ...+|+.. ++.+ +||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~-~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQAS-GGPHIVCILDVYEN 93 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHT-TSTTBCCEEEEEEE
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhc-CCCChHHHHHHHhh
Confidence 356778999965 5999999999999999999999999986421 22334333 4555 89999999999976
Q ss_pred ----CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 129 ----DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 129 ----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
...+++||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 556899999999999999998754 69999999999999999999999999999999999999876667789999
Q ss_pred ecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccccc
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV----AQAIIRSVIDF 277 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~ 277 (419)
|||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+.......
T Consensus 174 Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 174 DFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp CCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 9999986543 2334567899999999986 5688899999999999999999999977655443 22333334445
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCC
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~ 325 (419)
+...|..+++++.+||.+||+.||++|||+.|+++||||+.....+..
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~ 300 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQT 300 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCC
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCC
Confidence 555667899999999999999999999999999999999976554443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=383.18 Aligned_cols=259 Identities=28% Similarity=0.474 Sum_probs=217.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD---- 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~---- 129 (419)
+..+|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccc
Confidence 4468999999999999999999999999999999997432 344557888999999999 899999999999755
Q ss_pred -CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 -SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~---~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLAR 176 (364)
T ss_dssp CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCE
T ss_pred cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC---CCEEEEeCcceE
Confidence 46899999997 599888865 469999999999999999999999999999999999999654 459999999998
Q ss_pred eccCCCc----ccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC----
Q 014722 209 FFRPGEQ----FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---- 278 (419)
Q Consensus 209 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 278 (419)
....... .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 7653322 24568999999999865 3489999999999999999999999998887776666543211110
Q ss_pred -------------------CC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 279 -------------------RD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 279 -------------------~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. .++.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00 1245789999999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=381.00 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=215.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS- 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 130 (419)
..+..+|++.+.||+|+||.||+|.+..+|+.||+|++...... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC
Confidence 35667899999999999999999999999999999999765432 2356778999999999 8999999999998765
Q ss_pred -eEEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeec-CCCCCCeEEeecc
Q 014722 131 -AVHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN-KKESSPLKAIDFG 205 (419)
Q Consensus 131 -~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~-~~~~~~~kl~Dfg 205 (419)
..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||+.. ++....+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999976433 999999999999999999999999999999999999832 2334569999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc---------ccCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHh
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIR 272 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~ 272 (419)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 999887666666778999999999875 468899999999999999999999996433 2334444444
Q ss_pred ccccc-------------------C--CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 273 SVIDF-------------------K--RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 273 ~~~~~-------------------~--~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
..... + ......+++.+.+||.+||+.||++|||+.|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 32210 0 0111234567899999999999999999999999973
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=390.93 Aligned_cols=264 Identities=26% Similarity=0.444 Sum_probs=216.7
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC-----CCCCeeeeeeE
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-----KHPNIVSLKDT 125 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hpnIv~l~~~ 125 (419)
+..+..+|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+. +||||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 356777899999999999999999999999999999999643 233456778888888762 57799999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
+.....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~D 245 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVID 245 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEee
Confidence 999999999999996 69999888754 4999999999999999999999999999999999999975432 3499999
Q ss_pred cccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC----
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK---- 278 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---- 278 (419)
||++.... .......||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 246 FG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 246 FGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99997643 3344578999999999987 4699999999999999999999999999888777766653211000
Q ss_pred ----------------------------------------------CCCC-----ccCCHHHHHHHHHhcCCCCCCCCCH
Q 014722 279 ----------------------------------------------RDPW-----PKVSENAKDLVKKMLNPDPKQRLTA 307 (419)
Q Consensus 279 ----------------------------------------------~~~~-----~~~~~~~~~li~~~L~~dp~~R~s~ 307 (419)
...| ...++++.+||.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 0000 1237889999999999999999999
Q ss_pred HHHhcCCccccCccC
Q 014722 308 EEVLEHPWLQNAKKA 322 (419)
Q Consensus 308 ~~~l~~~~~~~~~~~ 322 (419)
.|+|+||||++....
T Consensus 404 ~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 404 GQALRHPWLRRRLPK 418 (429)
T ss_dssp HHHHTSTTTC-----
T ss_pred HHHhCChhhccCCCC
Confidence 999999999975443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=389.57 Aligned_cols=262 Identities=26% Similarity=0.496 Sum_probs=200.0
Q ss_pred Cccccceee-ccccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDL-GRELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+.+.|++ .++||+|+||.||+|++. .+++.||+|++..... ...+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLREL-KHPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHC-CCTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhc-CCCCeeeEeeEEec
Confidence 456677888 458999999999999965 5789999999975432 24678899999999 89999999999954
Q ss_pred --CCeEEEEEEecCCcchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-CCC
Q 014722 129 --DSAVHIVMELCEGGELFDRIVAR---------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK-KES 196 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~-~~~ 196 (419)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ...
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 678999999996 5888877532 248999999999999999999999999999999999999643 345
Q ss_pred CCeEEeecccceeccCC----CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-------
Q 014722 197 SPLKAIDFGLSVFFRPG----EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE------- 263 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~------- 263 (419)
+.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+...
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 67999999999876432 22345689999999999874 489999999999999999999999976654
Q ss_pred --HHHHHHHHhcccccCCCCCcc----------------------------------CCHHHHHHHHHhcCCCCCCCCCH
Q 014722 264 --QGVAQAIIRSVIDFKRDPWPK----------------------------------VSENAKDLVKKMLNPDPKQRLTA 307 (419)
Q Consensus 264 --~~~~~~i~~~~~~~~~~~~~~----------------------------------~~~~~~~li~~~L~~dp~~R~s~ 307 (419)
......+...........|.. .++.+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 234444443322222222322 26789999999999999999999
Q ss_pred HHHhcCCccccCc
Q 014722 308 EEVLEHPWLQNAK 320 (419)
Q Consensus 308 ~~~l~~~~~~~~~ 320 (419)
.|+|+||||+...
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=387.22 Aligned_cols=257 Identities=31% Similarity=0.585 Sum_probs=214.8
Q ss_pred cceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.+|++.+.||+|+||.||+|++. .+|+.||+|++...... .....+.+.+|+.+++++.+||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 68999999999999999999984 58999999998754321 111234567799999999669999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC---CcEEEeeCCCCeecc
Confidence 99999999999999999988889999999999999999999999999999999999999644 459999999998654
Q ss_pred CCC--cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhcccccCCCCC
Q 014722 212 PGE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 282 (419)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+.... ....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 286 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----PPYP 286 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----CCCC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC----CCCC
Confidence 322 2344679999999999873 47889999999999999999999997543 233333333332 2233
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
..++..+.+||.+||..||++|| |+.++++||||+..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 46899999999999999999999 99999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=368.02 Aligned_cols=258 Identities=27% Similarity=0.459 Sum_probs=223.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.....|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++.+...+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeE
Confidence 344579999999999999999999999999999999976543 23467899999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC---CCEEEeecccceecCc
Confidence 999999999999998764 579999999999999999999999999999999999999644 4599999999987654
Q ss_pred CC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..... ......++..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---PTLEGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---CCCCSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC---CCCccccCHHHH
Confidence 33 234567999999999987 4688999999999999999999999988877766665554432 122346799999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+||.+||..||++|||+.++++||||....
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=382.99 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=221.0
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS 102 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE
Confidence 345566789999999999999999999999999999999997652 344567889999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+.+++||||++|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||++
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~ 179 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVS 179 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC---CCEEEEECCCC
Confidence 999999999999999999999888899999999999999999999996 99999999999999654 45999999998
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI---------------- 270 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---------------- 270 (419)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.......+
T Consensus 180 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 180 GQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred cccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 754322 2345679999999999874 6899999999999999999999999877655432221
Q ss_pred --------------------------HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 271 --------------------------IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 271 --------------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.... ....+...++.++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 1111 11112234789999999999999999999999999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=377.57 Aligned_cols=257 Identities=28% Similarity=0.485 Sum_probs=209.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CCeeeeeeEEEeCCe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSA 131 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~ 131 (419)
...+|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.+ .| |||+++++++.+...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECSSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeCCE
Confidence 345799999999999999999997 5689999999976543 344567889999999999 55 999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+||| +.+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++. +.+||+|||++....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~----~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCCC-
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC----CcEEEeecccccccC
Confidence 999999 557899999999889999999999999999999999999999999999999962 349999999998765
Q ss_pred CCCc---ccccccCcccCchhhhc------------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccc
Q 014722 212 PGEQ---FNEIVGSPYYMAPEVLK------------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVI 275 (419)
Q Consensus 212 ~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~ 275 (419)
.... .....||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4332 23567999999999875 45788999999999999999999999765432 23333332222
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. ......++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 239 ~~--~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 EI--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CC--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cc--CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 11 12234678999999999999999999999999999998643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=395.62 Aligned_cols=250 Identities=16% Similarity=0.213 Sum_probs=203.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeee-------e
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLK-------D 124 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~-------~ 124 (419)
...+|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+. +||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3568999999999999999999998999999999998665445556788999995444442 799999998 7
Q ss_pred EEEeCCe-----------------EEEEEEecCCcchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCEe
Q 014722 125 TYEDDSA-----------------VHIVMELCEGGELFDRIVARGHYTE-------RAAAAVMKTIVEVVQVCHEQGVMH 180 (419)
Q Consensus 125 ~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~ivH 180 (419)
++.+.+. .|+||||+ +|+|.+++...+.+++ ..+..|+.||+.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7766543 89999999 6899999987655555 788889999999999999999999
Q ss_pred eCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhcc------------cCCCcccHHHHHHHH
Q 014722 181 RDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVIL 248 (419)
Q Consensus 181 rDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il 248 (419)
|||||+|||++.+ +.+||+|||++.... .......| +.|+|||++.+ .++.++|||||||++
T Consensus 230 rDikp~NIll~~~---~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQR---GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTT---CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCC---CCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999754 459999999998643 34456678 99999999874 599999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 249 YILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 249 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|+|++|..||.+......... ....++.+++++.+||.+||+.||++|||+.|+++||||+.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEW--------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGG--------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCCcccccccchhh--------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999976543322111 11223578999999999999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=384.97 Aligned_cols=263 Identities=25% Similarity=0.463 Sum_probs=222.6
Q ss_pred CCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChh--------------hHHHHHHHHHHHHhCCC
Q 014722 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV--------------DIEDVRREVQIMKHLPK 115 (419)
Q Consensus 50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--------------~~~~~~~Ei~~l~~l~~ 115 (419)
.+.....+|++.+.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++++ +
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 101 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-K 101 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-C
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-C
Confidence 3455667899999999999999999998 8999999999765432211 127889999999999 8
Q ss_pred CCCeeeeeeEEEeCCeEEEEEEecCCcchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCC
Q 014722 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDR------IVA--RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPE 186 (419)
Q Consensus 116 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~ 186 (419)
||||+++++++.+.+..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999988 655 5679999999999999999999999 99999999999
Q ss_pred cEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhcc--cCCC-cccHHHHHHHHHHHHhCCCCCCCCCH
Q 014722 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGP-EVDVWSAGVILYILLCGVPPFWAETE 263 (419)
Q Consensus 187 NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~~DiwslG~il~~ll~g~~pf~~~~~ 263 (419)
||+++.+ +.+||+|||++...... ......||+.|+|||++.+ .++. ++||||||+++|+|++|..||.....
T Consensus 182 Nil~~~~---~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKN---GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTT---SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCC---CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999654 45999999999876543 4456679999999999874 3555 89999999999999999999988776
Q ss_pred -HHHHHHHHhcccccCCCC---------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 264 -QGVAQAIIRSVIDFKRDP---------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 264 -~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
......+......++... ...+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 666666665544433210 14678999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=367.45 Aligned_cols=259 Identities=25% Similarity=0.327 Sum_probs=199.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+...++.+ +||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEE
Confidence 45689999999999999999999999999999999975432 222233344444556667 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
+||||++| +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+||+++.+ +.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL---GQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT---CCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC---CCEEEeecCCcc
Confidence 99999974 87776643 46799999999999999999999998 99999999999999654 459999999998
Q ss_pred eccCCCcccccccCcccCchhhhc-----ccCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCC
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 282 (419)
............||+.|+|||++. ..++.++||||||+++|+|++|..||... .............. .....
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPA 236 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCccc
Confidence 776555555567999999999962 35888999999999999999999999763 33333333333322 22223
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
..+++++.+|+.+||+.||++|||+.|+++||||+...
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 46899999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=369.17 Aligned_cols=261 Identities=29% Similarity=0.473 Sum_probs=217.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCe
Confidence 456778999999999999999999999999999999987543 23457888999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE---GDIRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---SCEEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC---CCEEEEECCCCccc
Confidence 9999999999999998876 4569999999999999999999999999999999999999644 45999999987543
Q ss_pred cCC-CcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 211 RPG-EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 211 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...+.......+....... .....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCcc
Confidence 211 1223457899999999873 458889999999999999999999999888777666665543221 11224
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.++..+.+||.+||..||++|||+.++++||||+...
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 6789999999999999999999999999999998654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=368.69 Aligned_cols=259 Identities=26% Similarity=0.468 Sum_probs=214.7
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
....++|++++.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.+++++.+||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4566789999999999999999999999999999999875432 246788999999998779999999999986
Q ss_pred ---CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 129 ---DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 129 ---~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~---~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE---NAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT---TCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC---CCCEEEee
Confidence 56899999999999999999764 46999999999999999999999999999999999999964 44599999
Q ss_pred cccceeccCCC-cccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 204 FGLSVFFRPGE-QFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 204 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 252 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence 99988654322 234567999999999985 35889999999999999999999999888776666555544321
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
......+++.+.+||.+||..||.+|||+.++++||||+..
T Consensus 253 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 --RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp --CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred --cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 22234679999999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=375.42 Aligned_cols=264 Identities=30% Similarity=0.484 Sum_probs=218.8
Q ss_pred CCCCccccceeeccccccccceEEEEEEE-cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC------Ceee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTD-VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP------NIVS 121 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp------nIv~ 121 (419)
..|..+..+|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.+ +|+ +|++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~ 81 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCVQ 81 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBCC
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeEe
Confidence 45677888999999999999999999998 568899999998643 23456788899999988 555 5999
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC----
Q 014722 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE---- 195 (419)
Q Consensus 122 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~---- 195 (419)
+++++.+.+.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++..+.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 889999998765 6899999999999999999999999999999999999975331
Q ss_pred ------------CCCeEEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC
Q 014722 196 ------------SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET 262 (419)
Q Consensus 196 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 262 (419)
+..+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 45699999999986543 3345679999999999874 78999999999999999999999999888
Q ss_pred HHHHHHHHHhcccccCC----------------CCC------------------------ccCCHHHHHHHHHhcCCCCC
Q 014722 263 EQGVAQAIIRSVIDFKR----------------DPW------------------------PKVSENAKDLVKKMLNPDPK 302 (419)
Q Consensus 263 ~~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~L~~dp~ 302 (419)
..+....+.......+. ..| ...++++.+||.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 76655544332111100 001 12356789999999999999
Q ss_pred CCCCHHHHhcCCccccCc
Q 014722 303 QRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 303 ~R~s~~~~l~~~~~~~~~ 320 (419)
+|||+.|+++||||+..+
T Consensus 319 ~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 319 KRITLREALKHPFFDLLK 336 (339)
T ss_dssp TSCCHHHHTTSGGGGGGG
T ss_pred cccCHHHHhcCHHHHHHh
Confidence 999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=380.90 Aligned_cols=263 Identities=27% Similarity=0.422 Sum_probs=217.2
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-----Ceeeee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-----NIVSLK 123 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-----nIv~l~ 123 (419)
..+..+..+|++.+.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+..|+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 34566778999999999999999999999999999999999643 234567788999988884455 499999
Q ss_pred eEEEeCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 124 DTYEDDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCH--EQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
+++...+.+|+||||+. ++|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++.+ ..+.+
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~-~~~~~ 200 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP-KRSAI 200 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-TSCCE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-CCCcE
Confidence 99999999999999996 5999998875 45999999999999999999999 5799999999999999642 24569
Q ss_pred EEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC
Q 014722 200 KAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278 (419)
Q Consensus 200 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 278 (419)
||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.......+
T Consensus 201 kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 278 (382)
T 2vx3_A 201 KIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278 (382)
T ss_dssp EECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999987643 3456789999999999874 699999999999999999999999999888877776654321100
Q ss_pred ------------------CCCC-----------------cc-------------------------CCHHHHHHHHHhcC
Q 014722 279 ------------------RDPW-----------------PK-------------------------VSENAKDLVKKMLN 298 (419)
Q Consensus 279 ------------------~~~~-----------------~~-------------------------~~~~~~~li~~~L~ 298 (419)
...| .. .++++.+||.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 358 (382)
T 2vx3_A 279 AHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358 (382)
T ss_dssp HHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence 0000 00 01478999999999
Q ss_pred CCCCCCCCHHHHhcCCccccC
Q 014722 299 PDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 299 ~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.||++|||+.|+|+||||+..
T Consensus 359 ~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SCTTTSCCHHHHTTSGGGCC-
T ss_pred CChhhCCCHHHHhcCcccccC
Confidence 999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=366.97 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=215.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence 345668999999999999999999999999999999997542 246788999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+++||||+++++|.+++. ....+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE---GHAKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC---CCEEEeecccchhh
Confidence 999999999999999987 35679999999999999999999999999999999999999654 45999999999876
Q ss_pred cCCC-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...... .......+++.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 254 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDN 254 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHH
Confidence 5432 2345679999999999874 6899999999999999999999999887766555544433221 11122357899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+.+||.+||..||.+|||+.++++||||+...
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=371.08 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=217.2
Q ss_pred ccccceeeccccccccceEEEEEEEc-CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEE--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYE-- 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~-- 127 (419)
....+|++.+.||+|+||.||+|++. .+|+.||+|++........ ....+.+|+.+++.+. +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45578999999999999999999985 6789999999975543211 1224556666665542 7999999999987
Q ss_pred ---eCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 128 ---DDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 128 ---~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
....+++||||+. |+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~---~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC---CCEEEe
Confidence 5677999999997 59999988753 48999999999999999999999999999999999999654 459999
Q ss_pred ecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC---
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK--- 278 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 278 (419)
|||++.............||+.|+|||++. ..++.++||||||+++|+|++|.+||.+.........+........
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998765544555678999999999986 5689999999999999999999999999888777777664321110
Q ss_pred --------------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 279 --------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 279 --------------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
...++.+++.+.+||.+||..||++|||+.++++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 0112457899999999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=372.50 Aligned_cols=262 Identities=33% Similarity=0.497 Sum_probs=217.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-- 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-- 129 (419)
..+..+|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeeccccc
Confidence 45677899999999999999999999999999999999643 2344556788999999999 899999999987654
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
...|+||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~---~~~kl~Dfg~ 158 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN---CDLKVCDFGL 158 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTT
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC---CcEEEEeccc
Confidence 67999999997 589888876 479999999999999999999999999999999999999644 4599999999
Q ss_pred ceeccCCCc-----------ccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Q 014722 207 SVFFRPGEQ-----------FNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 207 a~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 273 (419)
+........ .....||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 987643211 22357899999999875 46889999999999999999999999988876655544332
Q ss_pred cccc------------------------CCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 274 VIDF------------------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 274 ~~~~------------------------~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.... ... .++.+++++.+||.+||+.||++|||+.++++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 1110 000 12467899999999999999999999999999999987544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=378.47 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=214.5
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence 346678999999999999999999999999999999997543 2344567888999999999 89999999999987765
Q ss_pred E------EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 132 V------HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 132 ~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
. |+||||+. ++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kL~Dfg 189 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFG 189 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECSTT
T ss_pred cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC---CCEEEEecC
Confidence 4 99999997 58877763 459999999999999999999999999999999999999644 459999999
Q ss_pred cceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc------
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF------ 277 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~------ 277 (419)
++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9986542 3345678999999998864 68999999999999999999999999988777666664421110
Q ss_pred -----------------CCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 278 -----------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 278 -----------------~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
... .++.+++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 011 1235789999999999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=377.93 Aligned_cols=260 Identities=22% Similarity=0.258 Sum_probs=221.3
Q ss_pred CccccceeeccccccccceEEEEEE-----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
.....+|++++.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 143 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVS 143 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhC-CCCCCCeEEEEE
Confidence 3455789999999999999999999 45578899999986432 344556788999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
.+....++||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++....+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999998653 48999999999999999999999999999999999999876666779
Q ss_pred EEeecccceeccCC---CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014722 200 KAIDFGLSVFFRPG---EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 274 (419)
Q Consensus 200 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 274 (419)
||+|||+++..... .......||+.|+|||++. +.++.++|||||||++|+|++ |.+||.+.........+....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999754322 2233456899999999886 578999999999999999998 999999998888877776654
Q ss_pred cccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 275 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
.. .....+++.+.+|+.+||+.||++|||+.+++++.|+-
T Consensus 304 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 22346789999999999999999999999999987664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=367.26 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=209.9
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|++ +|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+...
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCc
Confidence 34456899999999999999999985 688999999976543 344567889999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 132 VHIVMELCEGGELFDRIVARGH---YTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
+++||||+++|+|.+++...+. +++..+..++.|++.||.|||++| |+||||||+|||++.+ +.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~---~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK---YTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT---CCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC---CcEEECCCCC
Confidence 9999999999999999987553 999999999999999999999999 9999999999999644 4599999999
Q ss_pred ceeccCCC-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 207 SVFFRPGE-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 207 a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+....... .....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~ 263 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL--EIPRN 263 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--CCCcc
Confidence 97654332 2345679999999999874 68999999999999999999999999888877766664433222 22346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCcccc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE--HPWLQN 318 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~--~~~~~~ 318 (419)
+++++.+||.+||+.||.+|||+.++++ .++++.
T Consensus 264 ~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 8999999999999999999999999987 455554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=372.03 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=214.2
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE---
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--- 127 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--- 127 (419)
|..+..+|++++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSG 81 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTS
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccc
Confidence 456778999999999999999999999999999999998643 344567889999999999 8999999999873
Q ss_pred -----------eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC
Q 014722 128 -----------DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES 196 (419)
Q Consensus 128 -----------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~ 196 (419)
+....|+||||+. |+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.+ +
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~--~ 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE--D 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT--T
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC--C
Confidence 4468999999997 599888754 579999999999999999999999999999999999999743 3
Q ss_pred CCeEEeecccceeccCC----CcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014722 197 SPLKAIDFGLSVFFRPG----EQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 270 (419)
Q Consensus 197 ~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 270 (419)
..+||+|||++...... .......+|+.|+|||++. ..++.++||||||+++|+|++|..||.+.........+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 45999999999876432 1234456799999999875 46889999999999999999999999998877766666
Q ss_pred Hhccccc----------------------CCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 271 IRSVIDF----------------------KRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 271 ~~~~~~~----------------------~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
....... ... .++.+++++.+||.+||+.||++|||+.++|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 5432110 000 12357999999999999999999999999999999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=371.22 Aligned_cols=262 Identities=29% Similarity=0.497 Sum_probs=197.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESSSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCc
Confidence 345689999999999999999999988999999999865432 22356788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 133 HIVMELCEGGELFDRIVA--------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~---~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED---GSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT---CCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC---CCEEEEec
Confidence 999999999999998874 3568999999999999999999999999999999999999654 45999999
Q ss_pred ccceeccCCC------cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 205 GLSVFFRPGE------QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 205 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
|++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654322 123457999999999986 36899999999999999999999999887766555444433221
Q ss_pred cC------CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 FK------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ~~------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. ...+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 11 122346789999999999999999999999999999998754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=383.54 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=210.8
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC-------CCCCeee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-------KHPNIVS 121 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-------~hpnIv~ 121 (419)
..|..+.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.+. +||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 33566778999999999999999999999999999999999643 334567889999999883 2788999
Q ss_pred eeeEEE----eCCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCC
Q 014722 122 LKDTYE----DDSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKK 194 (419)
Q Consensus 122 l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~ 194 (419)
+++++. +...+++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 566899999999 56777777654 4699999999999999999999998 999999999999997543
Q ss_pred ----------------------------------------------CCCCeEEeecccceeccCCCcccccccCcccCch
Q 014722 195 ----------------------------------------------ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228 (419)
Q Consensus 195 ----------------------------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 228 (419)
....+||+|||++..... ......||+.|+||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aP 262 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSL 262 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCC
Confidence 113699999999987643 24556799999999
Q ss_pred hhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcccccC-----------------------
Q 014722 229 EVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQGVAQAIIRSVIDFK----------------------- 278 (419)
Q Consensus 229 E~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~----------------------- 278 (419)
|++.+ .++.++|||||||++|+|++|..||...+ .......+.......+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99874 69999999999999999999999997654 2222222222110000
Q ss_pred --C-------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 279 --R-------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 279 --~-------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
. ......++.+.+||.+||+.||++|||+.|+|+||||+.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 001123467889999999999999999999999999973
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=366.64 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=217.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE--EeCC
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTY--EDDS 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~--~~~~ 130 (419)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.+ +||||+++++++ .+..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 346799999999999999999999999999999999765321 123457889999999999 899999999998 4556
Q ss_pred eEEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 131 AVHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
..++||||+.++ |.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG---GTLKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC---CcEEeecccccc
Confidence 899999999876 7677665 4569999999999999999999999999999999999999654 459999999998
Q ss_pred eccCC---CcccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 209 FFRPG---EQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 209 ~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---- 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP---- 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----
Confidence 76432 22345679999999999874 247799999999999999999999999888887777776644332
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..+++.+.+||.+||..||.+|||+.++++||||+....
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 367899999999999999999999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=378.41 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe---
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA--- 131 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~--- 131 (419)
.++|++.+.||+|+||.||+|++..+|+.||+|++...... .....++++.++.+ +||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhc-CCCCcccHHHhhhccccccc
Confidence 35799999999999999999999999999999998654322 23456788888889 89999999999875443
Q ss_pred ----EEEEEEecCCcchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 132 ----VHIVMELCEGGELFDRI----VARGHYTERAAAAVMKTIVEVVQVCH--EQGVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 132 ----~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
+++||||+++ +|...+ .....+++..+..++.|++.||.||| ++||+||||||+|||++.. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA--DGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETT--TTEEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCC--CCcEEE
Confidence 8899999986 444433 34567899999999999999999999 9999999999999999742 345999
Q ss_pred eecccceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccC-
Q 014722 202 IDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK- 278 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~- 278 (419)
+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.+......
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence 99999988776666667789999999998853 489999999999999999999999999888877777654221110
Q ss_pred -------------------C--------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 279 -------------------R--------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 279 -------------------~--------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
. ......++++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 011125688999999999999999999999999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=384.97 Aligned_cols=259 Identities=17% Similarity=0.221 Sum_probs=197.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC-CCCCeeeee-------eEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP-KHPNIVSLK-------DTY 126 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-~hpnIv~l~-------~~~ 126 (419)
..+|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.|. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999998765544556677888876666663 499988755 555
Q ss_pred EeC-----------------CeEEEEEEecCCcchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHcCCEeeC
Q 014722 127 EDD-----------------SAVHIVMELCEGGELFDRIVAR-GHYTERAA------AAVMKTIVEVVQVCHEQGVMHRD 182 (419)
Q Consensus 127 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~~l~~LH~~~ivHrD 182 (419)
... ..+|+||||++ |+|.+++... ..+++... ..++.||+.||.|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33899999998 8999999863 33454555 67779999999999999999999
Q ss_pred CCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCC
Q 014722 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFW 259 (419)
Q Consensus 183 lkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~ 259 (419)
|||+|||++.+ +.+||+|||++..... ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 220 ikp~NIll~~~---~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPD---GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTT---SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCC---CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999654 4599999999986542 2225567799999999863 68999999999999999999999997
Q ss_pred CCCHHHHH--HH---HHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 260 AETEQGVA--QA---IIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 260 ~~~~~~~~--~~---i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+....... .. ..........+.++.+++.+.+||.+||+.||++|||+.++|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 76432100 00 00011122223345789999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=361.89 Aligned_cols=257 Identities=31% Similarity=0.544 Sum_probs=219.2
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE--eCCeE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DDSAV 132 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~~~~ 132 (419)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++++ +||||+++++++. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence 3579999999999999999999999999999999976543 344567899999999999 8999999999875 46789
Q ss_pred EEEEEecCCcchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 133 HIVMELCEGGELFDRIVAR----GHYTERAAAAVMKTIVEVVQVCHEQG-----VMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+||+++.+ +.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~---~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS---SCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC---CCEEEec
Confidence 9999999999999998753 34999999999999999999999999 9999999999999644 4599999
Q ss_pred cccceeccCCCc-ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 204 FGLSVFFRPGEQ-FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 204 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+....... .
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~ 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---I 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---C
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---C
Confidence 999876654322 234578999999999874 68999999999999999999999999988877777776654321 2
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...+++++.++|.+||+.||++|||+.|+++|+|+...
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 23678999999999999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=367.61 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=214.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
.....+|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 4456789999999999999999999876555 59999997542 344567899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+..|+||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS---NLVCKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC---CCCEEECCCCcc
Confidence 99999999999999999999654 57999999999999999999999999999999999999964 455999999999
Q ss_pred eeccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 208 VFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 208 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..... .+.
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR---LPA 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---CCC
Confidence 87654322 22334678899999987 578999999999999999999 9999999988888777765532 222
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...+++.+.+||.+||..||++|||+.++++.
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34689999999999999999999999999764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=375.18 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=207.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC--------ChhhHHHHHHHHHHHHhCCCCCCeeeeee
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR--------TAVDIEDVRREVQIMKHLPKHPNIVSLKD 124 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~ 124 (419)
.+..+|++.+.||+|+||.||+|.+. +|+.||+|++...... .....+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceee
Confidence 45678999999999999999999975 4999999998654321 222347889999999999 8999999999
Q ss_pred EEEe-----CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 125 TYED-----DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 125 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
++.. ...+|+||||+. |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~---~~ 172 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN---ND 172 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CC
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC---CC
Confidence 9843 346899999997 5888877654 369999999999999999999999999999999999999644 45
Q ss_pred eEEeecccceeccCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc
Q 014722 199 LKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID 276 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 276 (419)
+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999999998665555556678999999999876 46899999999999999999999999998877776666532111
Q ss_pred c------------------------CCCC----CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 F------------------------KRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ~------------------------~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
. .... .+..++.+.+||.+||+.||++|||+.|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0 1111 134688999999999999999999999999999998753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=369.86 Aligned_cols=258 Identities=28% Similarity=0.487 Sum_probs=213.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe-
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA- 131 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~- 131 (419)
.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++.....
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccc
Confidence 45568999999999999999999999999999999997543 2344567788999999999 89999999999987654
Q ss_pred -----EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 132 -----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 132 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
+|+||||+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED---CELKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT---CCEEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC---CcEEEeeccc
Confidence 599999997 58887764 359999999999999999999999999999999999999644 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI--------- 275 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~--------- 275 (419)
+..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 876542 2345678999999998864 689999999999999999999999998887766655543210
Q ss_pred --------------cc----CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 276 --------------DF----KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 276 --------------~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.. ....++.+++++.+||.+||+.||++|||+.++++||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 1122346799999999999999999999999999999998643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=363.06 Aligned_cols=255 Identities=25% Similarity=0.484 Sum_probs=207.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-----
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----- 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----- 128 (419)
+..+|++++.||+|+||.||+|++..+|+.||+|++... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence 456899999999999999999999999999999998643 33567889999999999 89999999998865
Q ss_pred --------CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 129 --------DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 129 --------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
....|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~---~~~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES---RNV 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC---CCE
Confidence 457899999999999999998644 57889999999999999999999999999999999999644 459
Q ss_pred EEeecccceeccCC---------------CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCC-
Q 014722 200 KAIDFGLSVFFRPG---------------EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE- 261 (419)
Q Consensus 200 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~- 261 (419)
||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999998765422 12344578999999999873 58999999999999999998 55432
Q ss_pred CHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 262 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
........+......++.......++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2333444444444444444445678899999999999999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=359.57 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=207.8
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
|.....||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence 333448999999999999999999999999987543 23456788999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 138 LCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.. ++.+||+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence 999999999987652 46789999999999999999999999999999999999752 3459999999998765432
Q ss_pred -cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 -QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
......||+.|+|||++.+ .++.++||||||+++|+|++|..||............ .............+++++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHHH
Confidence 2345679999999999864 3889999999999999999999999765433221111 1111122223356899999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+||.+||+.||++|||+.++++||||+...
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999999999998654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=371.37 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=215.2
Q ss_pred ccccceeeccccccccceEEEEEEEc-------CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~ 125 (419)
...++|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+++++.+||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34578999999999999999999874 345689999997542 344567899999999999779999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
+.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998753 4789999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 264 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 264 (419)
++.+ +.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....
T Consensus 236 l~~~---~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 236 VTEN---NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp ECTT---CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ECCC---CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9644 4599999999987654322 23345788999999886 468999999999999999999 99999988877
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+....+..... ......+++++.+||.+||+.||++|||+.|++++
T Consensus 313 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 313 ELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GHHHHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 77766655432 12234689999999999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=368.84 Aligned_cols=263 Identities=27% Similarity=0.444 Sum_probs=215.4
Q ss_pred CCCccccceeeccccccccceEEEEEEEcCCC-cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC------eeee
Q 014722 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNG-EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN------IVSL 122 (419)
Q Consensus 50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn------Iv~l 122 (419)
.|..+.++|++.+.||+|+||.||+|.+..++ +.||+|++... ....+.+.+|+.+++.+ .|++ ++.+
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCVLM 87 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEEEe
Confidence 35667789999999999999999999998776 78999998643 23456788899999988 6655 9999
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC-------
Q 014722 123 KDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK------- 193 (419)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~------- 193 (419)
++++...+.+++||||+ +++|.+.+.... .+++..+..++.||+.||.|||++||+||||||+|||+...
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 567777777653 69999999999999999999999999999999999999543
Q ss_pred ---------CCCCCeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCH
Q 014722 194 ---------KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE 263 (419)
Q Consensus 194 ---------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 263 (419)
.....+||+|||++..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 2356699999999986543 334567999999999986 5789999999999999999999999998887
Q ss_pred HHHHHHHHhcccccCC----------------CCC------------------------ccCCHHHHHHHHHhcCCCCCC
Q 014722 264 QGVAQAIIRSVIDFKR----------------DPW------------------------PKVSENAKDLVKKMLNPDPKQ 303 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~----------------~~~------------------------~~~~~~~~~li~~~L~~dp~~ 303 (419)
......+.......+. ..| ...+.++.+||.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 6655544332211100 001 112457889999999999999
Q ss_pred CCCHHHHhcCCccccCc
Q 014722 304 RLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 304 R~s~~~~l~~~~~~~~~ 320 (419)
|||+.|+|+||||+...
T Consensus 325 Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 325 RITLAEALLHPFFAGLT 341 (355)
T ss_dssp SCCHHHHTTSGGGGGCC
T ss_pred CcCHHHHhcChhhcCCC
Confidence 99999999999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=365.31 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=197.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
....+|++.+.||+|+||.||+|.+..++. .||+|++...... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEF-DHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHC-CCCceehhhceeecc
Confidence 445689999999999999999999877765 8999999765432 33567899999999999 999999999999877
Q ss_pred CeE------EEEEEecCCcchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 130 SAV------HIVMELCEGGELFDRIVARG------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 130 ~~~------~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
... ++||||+.+|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~---~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---M 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---S
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC---C
Confidence 665 99999999999999986543 58999999999999999999999999999999999999644 4
Q ss_pred CeEEeecccceeccCCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 014722 198 PLKAIDFGLSVFFRPGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 272 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~ 272 (419)
.+||+|||++......... ....+|+.|+|||++. ..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 5999999999876543322 2345678899999987 468999999999999999999 9999998888777777665
Q ss_pred cccccCCCCCccCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcCCccccCccC
Q 014722 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLT-------AEEVLEHPWLQNAKKA 322 (419)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s-------~~~~l~~~~~~~~~~~ 322 (419)
.... ...+.+++++.+|+.+||+.||++||| +.++++|||+......
T Consensus 255 ~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 255 GNRL---KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp TCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCC---CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 4422 223468899999999999999999999 7888899999875443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=372.00 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=210.8
Q ss_pred cccceeeccccccccceEEEEEE-----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++|++.+.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++.+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45689999999999999999998 55677999999997543 344567899999999999789999999999987
Q ss_pred CC-eEEEEEEecCCcchHHHHHhcCC------------------------------------------------------
Q 014722 129 DS-AVHIVMELCEGGELFDRIVARGH------------------------------------------------------ 153 (419)
Q Consensus 129 ~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 153 (419)
.+ .+++||||++||+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 55 48999999999999999976533
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC---cccc
Q 014722 154 ------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNE 218 (419)
Q Consensus 154 ------------~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 218 (419)
+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC---CcEEEEeccceeeecccccchhccc
Confidence 8999999999999999999999999999999999999754 459999999998664332 2334
Q ss_pred cccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHh
Q 014722 219 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKM 296 (419)
Q Consensus 219 ~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 296 (419)
..||+.|+|||++. ..++.++||||||+++|+|++ |..||.+................. .....+++++.+++.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--RAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHH
Confidence 56899999999886 578999999999999999998 999998876544444443332222 22245789999999999
Q ss_pred cCCCCCCCCCHHHHhcC
Q 014722 297 LNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 297 L~~dp~~R~s~~~~l~~ 313 (419)
|+.||.+|||+.|+++|
T Consensus 333 l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEH 349 (359)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCCCHHHHHHH
Confidence 99999999999999887
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=362.09 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=219.2
Q ss_pred eeecCCCCCccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC
Q 014722 44 CVLKEPSGQDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN 118 (419)
Q Consensus 44 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn 118 (419)
.....+.......+|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +|||
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~ 87 (314)
T 2ivs_A 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPH 87 (314)
T ss_dssp ---CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTT
T ss_pred eccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCc
Confidence 33444555566778999999999999999999973 456899999997542 445567899999999999 8999
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHH
Q 014722 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH------------------------YTERAAAAVMKTIVEVVQVCH 174 (419)
Q Consensus 119 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~LH 174 (419)
|+++++++.+.+..++||||+++++|.+++..... +++..+..++.||+.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987543 899999999999999999999
Q ss_pred HcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHH
Q 014722 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYI 250 (419)
Q Consensus 175 ~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ 250 (419)
++||+||||||+||+++.+ +.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+
T Consensus 168 ~~~ivH~dikp~NIli~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVAEG---RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp HTTEECCCCSGGGEEEETT---TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HCCCcccccchheEEEcCC---CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 9999999999999999754 4599999999987654332 23345788999999887 468999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 251 LLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 251 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
|++ |..||.+.........+..... ......+++.+.+++.+||+.||++|||+.+++++
T Consensus 245 l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 245 IVTLGGNPYPGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHhhcCCc---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999 9999998887776666655432 22234689999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=364.84 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=205.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEE
Confidence 5799999999999999999999999999999998543 445667899999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++++|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE---NKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT---TSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC---CCCEEEeecccceeccccc
Confidence 999999999999987 567999999999999999999999999999999999999964 4459999999998764332
Q ss_pred cc---------------cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhc
Q 014722 215 QF---------------NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----VAQAIIRS 273 (419)
Q Consensus 215 ~~---------------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~ 273 (419)
.. ....||+.|+|||++. ..++.++||||||+++|+|++|..||....... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 21 1467999999999987 468999999999999999999999986532211 01111111
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...+.+++.+.+++.+||+.||++|||+.++++
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112457889999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=359.55 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=207.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.-++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++++ +||||+++++++...+..|
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence 345799999999999999999999999999999999866554555567899999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD---DFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC---CCEEEecCccCcccccc
Confidence 999999999999999988889999999999999999999999999999999999999654 45999999998765433
Q ss_pred C--cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 214 E--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 214 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+........ .............+.+|+++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH-HHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH-HhccCCCCccccCCCCCHHHH
Confidence 2 234567999999999986 468999999999999999999999998776554333 333333333334457899999
Q ss_pred HHHHHhcCCCCCCCC-CHHHHhcC
Q 014722 291 DLVKKMLNPDPKQRL-TAEEVLEH 313 (419)
Q Consensus 291 ~li~~~L~~dp~~R~-s~~~~l~~ 313 (419)
++|.+||+.||++|| |+.++++.
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHHH
Confidence 999999999999999 78887653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=365.59 Aligned_cols=258 Identities=31% Similarity=0.556 Sum_probs=215.3
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHhCC-CCCCeeeeee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP-KHPNIVSLKD 124 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~-~hpnIv~l~~ 124 (419)
..+..+..+|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. .||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4456788899999999999999999999999999999999976543321 11235667999999994 2699999999
Q ss_pred EEEeCCeEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 125 TYEDDSAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 125 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
++...+..++|+|++.+ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++. .++.+||+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--~~~~~kL~D 193 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--NRGELKLID 193 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC--CCCCEEEee
Confidence 99999999999999976 899999998889999999999999999999999999999999999999973 234599999
Q ss_pred cccceeccCCCcccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
||++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||.... .+......+
T Consensus 194 fg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~---- 262 (320)
T 3a99_A 194 FGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFF---- 262 (320)
T ss_dssp CTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCC----
T ss_pred Cccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccc----
Confidence 9999876533 3345679999999998864 3 4678999999999999999999996532 222332222
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 263 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 24679999999999999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=359.79 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=195.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
-.+|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+..+..+++.+ +||||+++++++.+.+.+++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEE
Confidence 3579999999999999999999999999999999975532 122223344445567777 99999999999999999999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||+ ++.+..+... ...+++..+..++.|++.||.|||++ ||+||||||+||+++.+ +.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~---~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER---GQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT---SCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC---CCEEEEECCCchhccC
Confidence 99999 5555554443 56799999999999999999999995 99999999999999644 4599999999987665
Q ss_pred CCcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCccC
Q 014722 213 GEQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
........||+.|+|||++. ..++.++||||||+++|+|++|..||... ........+....... .+....+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL-LPGHMGF 256 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-CCSSSCC
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-CCccCCC
Confidence 55555667999999999984 35889999999999999999999999763 4445555555543221 2223468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 99999999999999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=357.32 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=213.5
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
+..+..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+.+||||+++++++.+..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 45677789999999999999999999999999999999865432 2357789999999988999999999999999
Q ss_pred eEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccc
Q 014722 131 AVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLS 207 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a 207 (419)
..++||||+ +++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++ ....+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 999999998754 599999999999999999999999999999999999997543 2345999999999
Q ss_pred eeccCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccc
Q 014722 208 VFFRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVI 275 (419)
Q Consensus 208 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~ 275 (419)
........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.. .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 87654322 245679999999999874 68999999999999999999999997743 3333333333222
Q ss_pred ccC-CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFK-RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
... ....+.+++++.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 111 11123679999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=349.94 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=213.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceE
Confidence 3467999999999999999999864 677899999975432 246788999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD---LCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT---CCEEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC---CCEEEccCccceecch
Confidence 9999999999999997754 49999999999999999999999999999999999999644 4599999999987654
Q ss_pred CCcc--cccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQF--NEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
.... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+........ ....++.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 233 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDT 233 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHH
Confidence 4322 23456778999999874 78999999999999999999 9999998888877777665543222 2356899
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.+++.+||+.||++|||+.+++++
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=351.91 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=212.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
..+|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEE
Confidence 357999999999999999999975 577899999975432 236788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG---GCEEECCTTGGGGBCCH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC---CCEEecccccccccccc
Confidence 99999999999999654 458999999999999999999999999999999999999654 45999999999865433
Q ss_pred C--cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 214 E--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 214 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
. ......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+...... ......++.+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---CCCCcCCHHH
Confidence 2 123445778899999987 578999999999999999999 99999998888877777665322 2223578999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+||+.||++|||+.++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=367.59 Aligned_cols=257 Identities=24% Similarity=0.357 Sum_probs=219.1
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcCC-------CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeee
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNN-------GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS 121 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~ 121 (419)
+......++|++.+.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+++++.+||||++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 34455667899999999999999999997543 3579999997542 44456788999999999978999999
Q ss_pred eeeEEEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCC
Q 014722 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185 (419)
Q Consensus 122 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 185 (419)
+++++.+.+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998754 489999999999999999999999999999999
Q ss_pred CcEEeecCCCCCCeEEeecccceeccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 014722 186 ENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWA 260 (419)
Q Consensus 186 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~ 260 (419)
+|||++.+ +.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+
T Consensus 220 ~NIll~~~---~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 220 RNVLVTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGEEECTT---CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceEEEcCC---CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999644 459999999998765432 233456788999999887 468999999999999999999 9999999
Q ss_pred CCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....+....+...... .....+++++.+||.+||+.||++|||+.+++++
T Consensus 297 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 VPVEELFKLLKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8888777766654322 2234689999999999999999999999999886
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=364.94 Aligned_cols=253 Identities=18% Similarity=0.221 Sum_probs=208.4
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+..+|++.+.||+|+||.||+|++..+|+.||+|++..... .+.+.+|+.+++.+.+||||+++++++.+.+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 345689999999999999999999999999999999875432 235788999999998899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC--CCCeEEeeccccee
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE--SSPLKAIDFGLSVF 209 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~--~~~~kl~Dfg~a~~ 209 (419)
++||||+ +++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++. ...+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8999999986 467999999999999999999999999999999999999975432 22399999999987
Q ss_pred ccCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccccc
Q 014722 210 FRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVIDF 277 (419)
Q Consensus 210 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~ 277 (419)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 644322 245679999999999874 68999999999999999999999998743 333344443332222
Q ss_pred CCCC-CccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 278 KRDP-WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 278 ~~~~-~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+... ....| ++.+++..||..||.+||++.++++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2111 11234 9999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=370.75 Aligned_cols=260 Identities=24% Similarity=0.432 Sum_probs=208.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-----------CCCeeeee
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-----------HPNIVSLK 123 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----------hpnIv~l~ 123 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++++ . ||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRV-NDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHTCCSHHHHHHHTTBCCCC
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHh-hcccccchhccccchHHHHH
Confidence 35799999999999999999999999999999998643 33456788899999988 4 89999999
Q ss_pred eEEEeCC----eEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCC--
Q 014722 124 DTYEDDS----AVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKK-- 194 (419)
Q Consensus 124 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~-- 194 (419)
+++...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998654 789999999 88999999863 4599999999999999999999998 999999999999996432
Q ss_pred -CCCCeEEeecccceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCC------HHHH
Q 014722 195 -ESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQGV 266 (419)
Q Consensus 195 -~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~ 266 (419)
....+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 234699999999987643 2345679999999999874 68999999999999999999999997654 2222
Q ss_pred HHHHHhcccccC--------------------------------------CCCCccCCHHHHHHHHHhcCCCCCCCCCHH
Q 014722 267 AQAIIRSVIDFK--------------------------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAE 308 (419)
Q Consensus 267 ~~~i~~~~~~~~--------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~R~s~~ 308 (419)
...+.......+ .......++++.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 222222111000 001123467889999999999999999999
Q ss_pred HHhcCCccccCccC
Q 014722 309 EVLEHPWLQNAKKA 322 (419)
Q Consensus 309 ~~l~~~~~~~~~~~ 322 (419)
|+|+||||+.....
T Consensus 330 ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 330 GLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHTCGGGTTCTTC
T ss_pred HHhhChhhhcccCc
Confidence 99999999976443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=351.23 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=201.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC-hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEE
Confidence 4799999999999999999996 48999999987543322 23356788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CEeeCCCCCcEEeecCCC-----CCCeEEeeccc
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG---VMHRDLKPENFLFANKKE-----SSPLKAIDFGL 206 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIl~~~~~~-----~~~~kl~Dfg~ 206 (419)
||||+++++|.+++. ...+++..+..++.|++.||.|||++| |+||||||+||+++.... ++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999988775 457999999999999999999999999 899999999999975322 56699999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
+....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........ ....+
T Consensus 163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 239 (271)
T 3dtc_A 163 AREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPSTC 239 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred cccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCccc
Confidence 98655333 234579999999999874 689999999999999999999999998887777666655543322 22467
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=362.03 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=217.6
Q ss_pred CccccceeeccccccccceEEEEEE-----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
.....+|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKF-NHQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence 4456789999999999999999999 55678899999996432 344566888999999999 999999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARG-------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
.+....|+||||++|++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++....+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998753 48999999999999999999999999999999999999876666779
Q ss_pred EEeecccceeccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014722 200 KAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 274 (419)
Q Consensus 200 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 274 (419)
||+|||++....... ......||+.|+|||++. +.++.++||||||+++|+|++ |..||...........+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987553322 223456889999999886 578999999999999999998 999999888877777666543
Q ss_pred cccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 275 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
.. .....+++.+.++|.+||+.||.+|||+.+++++.|+-
T Consensus 263 ~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RM---DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22 22346899999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=370.44 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=213.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.-..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSC
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCc
Confidence 34568999999999999999999999899999999987432 333455788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~---~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK---NVLKISDFGMSREEA 264 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCGGGCEECT
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC---CcEEECcCCCceecC
Confidence 99999999999999997654 59999999999999999999999999999999999999644 459999999998654
Q ss_pred CCCcc---cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PGEQF---NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
..... ....+++.|+|||++. +.++.++|||||||++|||++ |..||.+.........+..... .+....++
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 341 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR---LPCPELCP 341 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC---CCCCTTCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 33211 1223577899999987 578999999999999999998 9999998888777666654432 12224578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+.+||.+||+.||++|||+.++++
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999975
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=363.71 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=215.8
Q ss_pred CccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
....++|++++.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 344568999999999999999999986 355899999997543 344567889999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeC
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVAR------------------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRD 182 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrD 182 (419)
.+.+..++||||+++|+|.+++... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 5689999999999999999999999999999
Q ss_pred CCCCcEEeecCCCCCCeEEeecccceeccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCC
Q 014722 183 LKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPP 257 (419)
Q Consensus 183 lkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~p 257 (419)
|||+|||++.+ +.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus 200 lkp~NIl~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 200 LATRNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSGGGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCcceEEECCC---CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999754 459999999987654322 223456889999999887 578999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 258 FWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
|.+....+....+....... ....+++.+.+|+.+||+.||++|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99988888777776654322 224678999999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=362.98 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=190.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHH-HHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ-IMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..+|++++.||+|+||.||+|.+..+|+.||+|++.... .......+..|+. +++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceE
Confidence 457999999999999999999999999999999997543 2334456666776 55556 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 134 IVMELCEGGELFDRIVA-----RGHYTERAAAAVMKTIVEVVQVCHEQ-GVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS---GNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT---TEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC---CCEEEccCCCc
Confidence 99999975 78777653 56799999999999999999999999 99999999999999754 45999999999
Q ss_pred eeccCCCcccccccCcccCchhhhc-----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcc-cccCCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-IDFKRD 280 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~-~~~~~~ 280 (419)
.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+.... ......
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence 8765554445557999999999973 45899999999999999999999999764321 1111111111 111222
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.+..+++.+.+||.+||+.||++|||+.++++||||....
T Consensus 254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 2346899999999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=356.37 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=209.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC-CCCeeeeeeEEEeCCeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~~~~ 132 (419)
...+|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++++.. ||||+++++++.+.+..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4457999999999999999999974 589999999976543 34456788999999999943 69999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++. +.+||+|||++.....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECCCSSSCC---
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEeeccccccccC
Confidence 99999 568899999998888999999999999999999999999999999999999953 4599999999987643
Q ss_pred CCc---ccccccCcccCchhhhcc------------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcccc
Q 014722 213 GEQ---FNEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVID 276 (419)
Q Consensus 213 ~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~ 276 (419)
... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence 322 234579999999999863 5788999999999999999999999765432 233333332221
Q ss_pred cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
. ......++++.+||.+||+.||++|||+.++++||||+...
T Consensus 259 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 I--EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp C--CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred c--CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 1 11234688999999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=351.92 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=202.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
.....+|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-
Confidence 34556899999999999999999998654 4579999986532 344567889999999999 8999999999985
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC---CEEECccccc
Confidence 567899999999999999998654 699999999999999999999999999999999999997654 4999999999
Q ss_pred eeccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 208 VFFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 208 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+....+....+..... ....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~ 240 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---CCCCC
Confidence 87654332 23345678999999987 578999999999999999997 9999998887777776665432 12335
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+.+++.+||..||++|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 689999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=351.65 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=209.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhh----HHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD----IEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
...++|++.+.||+|+||.||+|++..+++.||+|++.......... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence 44568999999999999999999999999999999997654332222 16788999999999 89999999999976
Q ss_pred CCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCC--CCCeEEee
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKE--SSPLKAID 203 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~--~~~~kl~D 203 (419)
.. ++||||+++++|.+.+... ..+++..+..++.|++.||.|||++| |+||||||+||+++.++. ...+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 6999999999999888654 46999999999999999999999999 999999999999975432 23489999
Q ss_pred cccceeccCCCcccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcccccC
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVIDFK 278 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~~~ 278 (419)
||++.... .......||+.|+|||++. ..++.++||||||+++|+|++|..||........ ...+..... .
T Consensus 173 fg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 248 (287)
T 4f0f_A 173 FGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--R 248 (287)
T ss_dssp CTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC--C
T ss_pred CCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC--C
Confidence 99997543 2345577999999999984 3578899999999999999999999977654433 333333222 2
Q ss_pred CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 279 ~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......+++.+.+||.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 22335689999999999999999999999999863
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=360.98 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=209.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEE--EEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKF--ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
.+|++.+.||+|+||.||+|++..++..+ |+|.+.... .....+.+.+|+.+++++.+||||+++++++.+.+..|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 57999999999999999999998888866 899886432 23345678899999999978999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 134 IVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ +
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~---~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---Y 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---G
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC---C
Confidence 9999999999999997654 69999999999999999999999999999999999999654 4
Q ss_pred CeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccc
Q 014722 198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
.+||+|||++.............+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+.....
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 59999999987543333334456788999999987 468999999999999999998 9999998888777666554421
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 260 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 ---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22234689999999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=351.03 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=211.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.-..+|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+.+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCe
Confidence 34568999999999999999999864 678899999975532 236788999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~---~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TSCEEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC---CCCEEEcccccccccc
Confidence 999999999999999976 457999999999999999999999999999999999999964 4459999999998654
Q ss_pred CCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+........ ....++
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 248 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASE 248 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCH
Confidence 3321 22345678899999987 578999999999999999998 9999999888887777766533222 235689
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+.+++.+||+.||++|||+.++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=353.92 Aligned_cols=256 Identities=28% Similarity=0.520 Sum_probs=203.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++++ +||||+++++++...+.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCc
Confidence 34456899999999999999999999999999999999876555566677899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 132 VHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~---~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT---GVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC---CCEEEEeccce
Confidence 9999999999999998864 4568999999999999999999999999999999999999644 45999999998
Q ss_pred eeccCCC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcccccCCCCCc
Q 014722 208 VFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 208 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~ 283 (419)
....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.. .......+.... +......
T Consensus 184 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 261 (310)
T 2wqm_A 184 RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSD 261 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC--SCCCCTT
T ss_pred eeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc--CCCCccc
Confidence 7654332 234567899999999887 468899999999999999999999997643 233334443332 2222335
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++++.+||.+||..||++|||+.+++++
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 689999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=357.21 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=214.5
Q ss_pred ccccceeeccccccccceEEEEEEE-----cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
....+|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3446899999999999999999985 4578899999997543 33456788999999999978999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARG------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
+.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 9999999999999999999998754 4899999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 264 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 264 (419)
++.+ +.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+....
T Consensus 178 ~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 178 LTHG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp EETT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred EcCC---CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 9754 4599999999987654432 23345788999999876 578999999999999999999 99999887665
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.............. ....+++.+.+++.+||..||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 255 SKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 55544444433222 234689999999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=373.20 Aligned_cols=259 Identities=24% Similarity=0.378 Sum_probs=212.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS- 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 130 (419)
..+..+|++.+.||+|+||.||+|++..+|+.||+|++...... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCC
Confidence 45667899999999999999999999999999999999765432 2356778999999999 8999999999998765
Q ss_pred -eEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeec-CCCCCCeEEeecc
Q 014722 131 -AVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN-KKESSPLKAIDFG 205 (419)
Q Consensus 131 -~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~-~~~~~~~kl~Dfg 205 (419)
..++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.. ++....+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 7899999999999999987643 2999999999999999999999999999999999999832 2334569999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc---------ccCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIR 272 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~ 272 (419)
++.............||+.|+|||++. ..++.++|||||||++|+|++|..||... ...+....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 999877666666778999999999875 35778999999999999999999999642 23444455544
Q ss_pred ccccc---------------------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 273 SVIDF---------------------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 273 ~~~~~---------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.... .......+++.+.++|.+||+.||++|||+.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 33210 000112345678999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=362.92 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=211.6
Q ss_pred ccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
....+|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34568999999999999999999973 466789999997543 22345688999999999977999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCC
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARG-----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLK 184 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 184 (419)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 27899999999999999999999999999999
Q ss_pred CCcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCC
Q 014722 185 PENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFW 259 (419)
Q Consensus 185 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~ 259 (419)
|+|||++.+ +.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|+| |..||.
T Consensus 200 p~NIll~~~---~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 200 ARNVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGGEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhhEEEcCC---CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 999999754 4599999999986644332 23456788999999886 578999999999999999998 999998
Q ss_pred CCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014722 260 AETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314 (419)
Q Consensus 260 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~ 314 (419)
+.........+........ ....+++++.+||.+||..||.+|||+.++++|.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCcHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 8776555555554433322 2245799999999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=353.15 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=202.9
Q ss_pred CccccceeeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.....+|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 4456789999999999999999998 5678999999998743 344567889999999999 8999999999985
Q ss_pred e--CCeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 128 D--DSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 128 ~--~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
. ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~---~~kl~Df 158 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDF 158 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC---eEEEccC
Confidence 4 456899999999999999998754 499999999999999999999999999999999999997654 4999999
Q ss_pred ccceeccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------------
Q 014722 205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--------------- 264 (419)
Q Consensus 205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------------- 264 (419)
|++........ .....+|+.|+|||++. ..++.++||||||+++|+|+||..||......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99987654322 22345778899999987 57899999999999999999999998543221
Q ss_pred -HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 265 -GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 265 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.....+... ...+....+++++.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 239 FHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcc---CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111111111 1222234689999999999999999999999999753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=350.87 Aligned_cols=246 Identities=38% Similarity=0.690 Sum_probs=198.7
Q ss_pred ccccceeec-cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 53 DISIDYDLG-RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 53 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
.+..+|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++.++.+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 355678887 7899999999999999999999999998632 3567889888555599999999999987
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 -DSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
...+++||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++..+.+..+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 778999999999999999998754 69999999999999999999999999999999999999875556779999999
Q ss_pred cceeccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----cccCCCC
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----IDFKRDP 281 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~ 281 (419)
++..... ..++.++|||||||++|+|++|..||.+.........+.... ...+...
T Consensus 166 ~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (299)
T 3m2w_A 166 FAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225 (299)
T ss_dssp TCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHH
T ss_pred ccccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchh
Confidence 9875431 346778999999999999999999997765443221111111 1111111
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCC
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~ 326 (419)
+..+++++.+||.+||+.||++|||+.|+++||||+.....+...
T Consensus 226 ~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred cccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 246799999999999999999999999999999999876655443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=356.34 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=215.3
Q ss_pred CccccceeeccccccccceEEEEEEEc-------CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeee
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKD 124 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~ 124 (419)
....++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++.+||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 444578999999999999999999975 467889999987543 34456788999999999978999999999
Q ss_pred EEEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 125 TYEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 125 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
++.+.+.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999998654 389999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCH
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE 263 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~ 263 (419)
+++. ++.+||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+...
T Consensus 189 ll~~---~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 189 LVTE---NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EECT---TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEcC---CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 9964 34599999999987654332 23345788999999886 568999999999999999999 9999998888
Q ss_pred HHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 264 QGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+....+...... .....+++.+.+++.+||..||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7777766655322 2234679999999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=359.37 Aligned_cols=257 Identities=30% Similarity=0.566 Sum_probs=203.8
Q ss_pred CCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---hhHHHHHHHHHHHHhCC---CCCCeeeeee
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---VDIEDVRREVQIMKHLP---KHPNIVSLKD 124 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~~Ei~~l~~l~---~hpnIv~l~~ 124 (419)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++++. +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 45677899999999999999999999999999999999976543221 12234557888888873 6999999999
Q ss_pred EEEeCCeEEEEEEe-cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 125 TYEDDSAVHIVMEL-CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 125 ~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
++.+.+..++|+|+ +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++. .++.+||+|
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--~~~~~kl~d 183 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL--RRGCAKLID 183 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET--TTTEEEECC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC--CCCeEEEEE
Confidence 99999999999999 789999999998888999999999999999999999999999999999999972 234599999
Q ss_pred cccceeccCCCcccccccCcccCchhhhcc-cC-CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-NY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP 281 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (419)
||++...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.... .+......+
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~---- 252 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHF---- 252 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCC----
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCC----
Confidence 9999876543 3455679999999998864 33 458999999999999999999996532 222322222
Q ss_pred CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 282 WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
...++..+.+||.+||+.||++|||+.|+++||||+...
T Consensus 253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 246799999999999999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=353.63 Aligned_cols=248 Identities=17% Similarity=0.240 Sum_probs=205.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCC-------cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNG-------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKL-SHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTS-CCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhC-CCCCEeEEEEEE
Confidence 4568999999999999999999988777 479999986543 33457889999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCcchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC-----CCeE
Q 014722 127 EDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES-----SPLK 200 (419)
Q Consensus 127 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~-----~~~k 200 (419)
.+.+..++||||++|++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.. ..+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 9999999999999999999999999999999999999765432 2299
Q ss_pred EeecccceeccCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccccc
Q 014722 201 AIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDF 277 (419)
Q Consensus 201 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~ 277 (419)
|+|||++..... .....||+.|+|||++. ..++.++||||||+++|+|++| .+||......... .........
T Consensus 162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~~~ 237 (289)
T 4fvq_A 162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRHQL 237 (289)
T ss_dssp ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCC
T ss_pred eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccCCC
Confidence 999999865432 23456889999999887 4589999999999999999995 5555554444333 333322222
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....++++.+|+.+||+.||++|||+.+++++
T Consensus 238 ----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 238 ----PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 23457789999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=357.63 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=202.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEE----EEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
..+|++.+.||+|+||.||+|++..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC
Confidence 457999999999999999999988887765 667665332 233457889999999999 8999999999998764
Q ss_pred eEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++|+||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL 166 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTHHHH
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC---CEEEccCcceeE
Confidence 7889999999999999987 45699999999999999999999999999999999999997654 499999999987
Q ss_pred ccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
...... .....||+.|+|||++. +.++.++|||||||++|+|++ |..||.+.........+..... ....+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 243 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI 243 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---CCCCcc
Confidence 654332 22345688999999887 568999999999999999999 9999988887776665554432 122346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.++.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78999999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=363.22 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=202.7
Q ss_pred ccccceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
....+|++.+.||+|+||.||+|++. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKS 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC
Confidence 34458999999999999999999976 467889999987542 344567899999999999 899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
+.+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS---NLVCKVSDFGLGR 195 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC----
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC---CCCEEECcCcccc
Confidence 99999999999999999997654 6999999999999999999999999999999999999964 4459999999998
Q ss_pred eccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 209 FFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 209 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
....... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||...........+..... .+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~ 272 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPP 272 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence 7654321 12234577899999987 578999999999999999998 9999999888877776655432 2223
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
..++..+.+++.+||+.||++|||+.++++
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 467899999999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=370.76 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=201.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++++.+||||+++++++.+.+.
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 4566678888999999999998754 4689999999986432 34678899999876589999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC----------
Q 014722 132 VHIVMELCEGGELFDRIVARGHYT-------ERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK---------- 194 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~---------- 194 (419)
+|+|||||. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999996 69999997654332 334578999999999999999999999999999997542
Q ss_pred CCCCeEEeecccceeccCCCc-----ccccccCcccCchhhhc--------ccCCCcccHHHHHHHHHHHHh-CCCCCCC
Q 014722 195 ESSPLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWA 260 (419)
Q Consensus 195 ~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~--------~~~~~~~DiwslG~il~~ll~-g~~pf~~ 260 (419)
....+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|+| |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 345799999999987754322 23467999999999985 358889999999999999999 9999976
Q ss_pred CCHHHHHHHHHhcccccCCCC---CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 261 ETEQGVAQAIIRSVIDFKRDP---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 261 ~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
..... ..+........... ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 55443 34444443332221 1235688999999999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=348.54 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=215.8
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++++ +||||+++++++.+...
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC
Confidence 345668999999999999999999999999999999986432 2457889999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG---GCEEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC---CCEEEccCcccee
Confidence 99999999999999999874 348999999999999999999999999999999999999654 4599999999987
Q ss_pred ccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |.+||.+.+.......+..... ......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 237 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGC 237 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---CCCCCCC
Confidence 654332 23345788999999987 578999999999999999999 9999988887776666554322 2223468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+.+|+.+||..||.+|||+.++++.
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999663
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=354.58 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=216.2
Q ss_pred CCccccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE
Q 014722 51 GQDISIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125 (419)
Q Consensus 51 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~ 125 (419)
......+|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~ 96 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGV 96 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeEEE
Confidence 3456678999999999999999999876 467899999987542 334556788999999999 89999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE 195 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~ 195 (419)
+.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-- 174 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-- 174 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT--
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC--
Confidence 99999999999999999999988753 357999999999999999999999999999999999999654
Q ss_pred CCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 014722 196 SSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 270 (419)
Q Consensus 196 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i 270 (419)
+.+||+|||++........ .....||+.|+|||++. +.++.++||||||+++|+|++ |..||.+.........+
T Consensus 175 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 175 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp -CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred -CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 4599999999986543322 23345788999999987 468999999999999999999 89999988888777776
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
...... .....+++.+.+||.+||+.||++|||+.+++++
T Consensus 254 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 254 MEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 655432 2224689999999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=359.87 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=205.6
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||.||+|.+ .+|+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeE
Confidence 4556899999999999999999995 578999999886542 23467889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 133 HIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE---NFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT---TCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC---CCCEEEeeccccc
Confidence 99999999999999886543 4899999999999999999999999999999999999964 4569999999998
Q ss_pred eccCCC---cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcccc-
Q 014722 209 FFRPGE---QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-------AIIRSVID- 276 (419)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~i~~~~~~- 276 (419)
...... ......||+.|+|||++. +.++.++||||||+++|+|++|..||.+........ ........
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 654322 223456899999999886 579999999999999999999999997654322111 11111110
Q ss_pred c-----CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 277 F-----KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 277 ~-----~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
. .....+..+..+.+++.+||+.||++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 011112345678999999999999999999999976
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=349.28 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=203.7
Q ss_pred ccccceeeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
....+|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEec
Confidence 344579999999999999999998 67789999999997553 233457889999999999 89999999999987
Q ss_pred C--CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 D--SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 ~--~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
. ..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH---QVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC---CEEECccc
Confidence 6 679999999999999999954 45699999999999999999999999999999999999997654 49999999
Q ss_pred cceeccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCC--------------HHHH
Q 014722 206 LSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--------------EQGV 266 (419)
Q Consensus 206 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~ 266 (419)
++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..|+.... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987755432 23456888899999886 468899999999999999999998763221 1111
Q ss_pred HHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
........ ......+.+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEG--KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTT--CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcc--CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11111111 122233568999999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=350.94 Aligned_cols=248 Identities=25% Similarity=0.442 Sum_probs=210.7
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
..+..+|++++.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEecccc
Confidence 456778999999999999999999999899999999997542 2466899999999 89999999999864
Q ss_pred -------------CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC
Q 014722 129 -------------DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193 (419)
Q Consensus 129 -------------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~ 193 (419)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 45689999999999999999754 579999999999999999999999999999999999999765
Q ss_pred CCCCCeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 014722 194 KESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272 (419)
Q Consensus 194 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 272 (419)
+ .+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||... ......+..
T Consensus 159 ~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~ 233 (284)
T 2a19_B 159 K---QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD 233 (284)
T ss_dssp T---EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT
T ss_pred C---CEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc
Confidence 4 49999999998876655556677999999999987 46899999999999999999999987432 222222222
Q ss_pred cccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 273 SVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.. ....+++.+.++|.+||..||.+|||+.++++|.|.-.
T Consensus 234 ~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 GI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 21 12357899999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=356.33 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=213.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCc-----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGE-----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
....+|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344679999999999999999999877664 79999987543 34456788999999999977999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecC
Q 014722 128 DDSAVHIVMELCEGGELFDRIVAR--------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANK 193 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~ 193 (419)
+.+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999998753 357999999999999999999999999999999999999754
Q ss_pred CCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 014722 194 KESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 268 (419)
Q Consensus 194 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 268 (419)
+ .+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|+| |..||.+........
T Consensus 201 ~---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 H---VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp G---EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred C---eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 4 499999999986643322 23345788999999876 578999999999999999998 999998876655555
Q ss_pred HHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+......... ....++.+.+++.+||+.||.+|||+.+++++
T Consensus 278 ~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 55544333222 23578999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=359.83 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=205.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcE----EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
..+|++++.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++++ +||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CC
Confidence 45799999999999999999999888876 66776643321 12234567899999999 8999999999986 56
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP---SQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS---SCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC---CeEEECCCCcccc
Confidence 789999999999999999764 579999999999999999999999999999999999999654 4599999999987
Q ss_pred ccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
...... .....||+.|+|||++. +.++.++||||||+++|+|++ |..||.+.........+....... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA---QPQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC---CCTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC---CCCc
Confidence 654332 24456788999999987 578999999999999999999 999999888777766665543221 1234
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.++.+++.+||..||.+|||+.+++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 67889999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=345.97 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=209.2
Q ss_pred ccceeecc-ccccccceEEEEEE--EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 55 SIDYDLGR-ELGRGEFGVTYLCT--DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 55 ~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+|.+.+ .||+|+||.||+|. +..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence 45799998 99999999999995 456789999999976532 233467899999999999 899999999999 5677
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC---cEEEccCCcceeec
Confidence 899999999999999999888899999999999999999999999999999999999997654 49999999998765
Q ss_pred CCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.........+..... ......+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 44321 2234678899999987 468899999999999999999 9999998888777666655432 1222468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+.++|.+||+.||++|||+.++++
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=354.14 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=209.3
Q ss_pred cccceeeccccccccceEEEEEEE-----cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTD-----VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 456899999999999999999985 4577899999997543 344556789999999999779999999999876
Q ss_pred CC-eEEEEEEecCCcchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEee
Q 014722 129 DS-AVHIVMELCEGGELFDRIVARGH----------------YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA 191 (419)
Q Consensus 129 ~~-~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~ 191 (419)
.+ .+++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+||+++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 59999999999999999987543 89999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014722 192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 266 (419)
Q Consensus 192 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 266 (419)
.+ +.+||+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++ |..||.+......
T Consensus 183 ~~---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 EK---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp GG---GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CC---CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 54 4599999999987644322 23456789999999886 568999999999999999998 9999987664433
Q ss_pred HHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
........... .....+++.+.+++.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33333222211 1223578999999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=361.96 Aligned_cols=256 Identities=15% Similarity=0.175 Sum_probs=196.7
Q ss_pred cccceeeccccccccceEEEEEEEcCC-----CcEEEEEEecccccCChh--------hHHHHHHHHHHHHhCCCCCCee
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNN-----GEKFACKSISKKKLRTAV--------DIEDVRREVQIMKHLPKHPNIV 120 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~--------~~~~~~~Ei~~l~~l~~hpnIv 120 (419)
...+|++.+.||+|+||.||+|.+..+ ++.||+|++......... .......|+..++.+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 344899999999999999999998664 588999998654210000 011233455566677 799999
Q ss_pred eeeeEEEeC----CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC
Q 014722 121 SLKDTYEDD----SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE 195 (419)
Q Consensus 121 ~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~ 195 (419)
++++++... ...|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 999998764 5589999999 99999999875 579999999999999999999999999999999999999732 3
Q ss_pred CCCeEEeecccceeccCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014722 196 SSPLKAIDFGLSVFFRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 266 (419)
Q Consensus 196 ~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 266 (419)
++.+||+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 45699999999987643321 133459999999999875 589999999999999999999999975432222
Q ss_pred HHHHHhcc-----cccC--CCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 267 AQAIIRSV-----IDFK--RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 267 ~~~i~~~~-----~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
........ .... .-....+++++.+++..||..||++|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11111100 0000 0011357899999999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=345.31 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=211.5
Q ss_pred ccceeecc-ccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 55 SIDYDLGR-ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 55 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++++ +||||+++++++ ..+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCC
Confidence 45688877 9999999999999854 468889999997642 445677899999999999 899999999999 4567
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~---~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC---CEEECcccceeee
Confidence 99999999999999998654 4599999999999999999999999999999999999997544 5999999999876
Q ss_pred cCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 211 RPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..... .....||+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc---CCCCCC
Confidence 54332 12345688999999987 578999999999999999998 9999998887777766665432 122346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~~ 314 (419)
+++++.++|.+||..||++|||+.+++++.
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=352.08 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=207.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCC----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.....+|.+.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEe
Confidence 344567999999999999999999976553 459999987543 344566789999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~---~~~~kl~Dfg~ 193 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGL 193 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC---CCcEEECCCCc
Confidence 999999999999999999999764 56999999999999999999999999999999999999964 44699999999
Q ss_pred ceeccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 207 SVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 207 a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
+........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..... .+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~---~~ 270 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LP 270 (333)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CC
T ss_pred chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc---CC
Confidence 987643321 12234678899999987 578999999999999999999 9999998888777776665422 12
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....+++.+.+++.+||+.||++|||+.+++++
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234678999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=342.36 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=211.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEE
Confidence 57999999999999999999975 678999999976532 236788999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~---~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG---GCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC---CCEEEccccccccccccc
Confidence 9999999999999775 468999999999999999999999999999999999999654 459999999987654321
Q ss_pred --cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 --QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
......+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+...... ......++.+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~ 235 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHVY 235 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---CCCccCcHHHH
Confidence 123345788899999987 578999999999999999999 89999988888777777655322 12235789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+||+.||++|||+.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=348.02 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=205.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCee-eeeeEEEeCCe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV-SLKDTYEDDSA 131 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv-~l~~~~~~~~~ 131 (419)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++...... +.+.+|+.+++.+ .|++++ .+..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHh-hcCCCCCccccccCCCCc
Confidence 4567899999999999999999999999999999998754322 3578899999999 666654 44445577888
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++..+.++.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99999999 8999999874 457999999999999999999999999999999999999964334566999999999876
Q ss_pred cCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccccC
Q 014722 211 RPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFK 278 (419)
Q Consensus 211 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~ 278 (419)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 54332 245679999999999874 689999999999999999999999976432 223333333222221
Q ss_pred C-CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 279 R-DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 279 ~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
. .....+|+++.+++.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 1 1124578999999999999999999999999763
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=370.36 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+++.+.+||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3699999999999999764 3357899999999865432 23457999999987799999999999999999999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccceeccC
Q 014722 136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a~~~~~ 212 (419)
||||. |+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999987654 466667889999999999999999999999999999996433 234588999999987654
Q ss_pred CC----cccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 213 GE----QFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 213 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
.. ......||+.|+|||++. ..++.++|||||||++|+|++ |..||......... .+.............
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDCLHPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTTSCTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccccCccc
Confidence 32 234567999999999986 357789999999999999999 99999665444332 222211111111122
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
..+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 346678999999999999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.20 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=199.4
Q ss_pred CCCccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 50 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++....+|++.+.||+|+||.||+|++. ..||+|++..... .....+.+.+|+.+++++ +||||++++++. ..
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TA 91 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cC
Confidence 34566778999999999999999999853 3599999876542 445567899999999999 899999999965 56
Q ss_pred CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~---~~~kl~Dfg~~~ 168 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED---NTVKIGDFGLAT 168 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---TEEEECCCC---
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC---CCEEEccceecc
Confidence 678999999999999999864 3469999999999999999999999999999999999999754 459999999987
Q ss_pred eccC---CCcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcccccC-C
Q 014722 209 FFRP---GEQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA-IIRSVIDFK-R 279 (419)
Q Consensus 209 ~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-i~~~~~~~~-~ 279 (419)
.... ........||+.|+|||++. ..++.++||||||+++|+|++|..||........... +........ .
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS 248 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence 6543 22234567999999999885 3578899999999999999999999987655444433 333333222 2
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.....+++.+.+|+.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 2234688999999999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.41 Aligned_cols=251 Identities=25% Similarity=0.305 Sum_probs=207.9
Q ss_pred ccccceeeccccccccceEEEEEEEcC---CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
....+|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC
Confidence 345689999999999999999998654 34569999987543 344567899999999999 899999999998754
Q ss_pred CeEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~---~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE---CVKLGDFGLSR 161 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT---EEEECCCCGGG
T ss_pred -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC---cEEeCccCCCc
Confidence 568999999999999999765 4599999999999999999999999999999999999997654 49999999998
Q ss_pred eccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 209 FFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 209 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+...... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 238 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL---PKPDL 238 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC---CCCTT
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC---CCCCC
Confidence 7654322 23345788999999987 578999999999999999998 99999887777666666554321 22245
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+.+++.+||..||++|||+.+++++
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 78999999999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=342.72 Aligned_cols=246 Identities=15% Similarity=0.229 Sum_probs=209.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC--CeE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD--SAV 132 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~ 132 (419)
..+|++.+.||+|+||.||+|++ +++.||+|++..... .....+.+.+|+.+++++ +||||+++++++.+. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 45799999999999999999997 489999999976543 344567899999999999 899999999999877 789
Q ss_pred EEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 133 HIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++| |+||||||+||+++.+ +.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~---~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED---MTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT---SCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC---cceeEEecccee
Confidence 99999999999999998765 4899999999999999999999999 9999999999999644 458999998875
Q ss_pred eccCCCcccccccCcccCchhhhcc-cC---CCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR-NY---GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~---~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
... .....||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+.......+....... .....
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (271)
T 3kmu_A 162 SFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPG 235 (271)
T ss_dssp TTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTT
T ss_pred eec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCC
Confidence 432 234578999999999874 23 337999999999999999999999888877766666554332 22346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=354.68 Aligned_cols=247 Identities=22% Similarity=0.314 Sum_probs=196.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC----e
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS----A 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----~ 131 (419)
.+|++.+.||+|+||.||+|++. ++.||+|++.... ........|+.+++++ +||||+++++++.+.. .
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCce
Confidence 47999999999999999999864 8999999986542 2334566799999999 8999999999998754 4
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCEeeCCCCCcEEeecCCCCCCeEE
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ----------GVMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
+++||||+++|+|.+++... .+++..+..++.|++.||.|||+. ||+||||||+|||++. ++.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~---~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN---NLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT---TCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC---CCeEEE
Confidence 79999999999999998764 599999999999999999999999 9999999999999964 445999
Q ss_pred eecccceeccCCCc---ccccccCcccCchhhhcc------cCCCcccHHHHHHHHHHHHhCCCCCCCCCH---------
Q 014722 202 IDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETE--------- 263 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------- 263 (419)
+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|+||..||.+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987654332 334679999999999874 456688999999999999999999965421
Q ss_pred -------HHHHHHHHhcccccCCC-CCc--cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 264 -------QGVAQAIIRSVIDFKRD-PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 264 -------~~~~~~i~~~~~~~~~~-~~~--~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......+.......... .|. ..++++.+||.+||+.||++|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12222222221111111 011 124569999999999999999999999763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=365.46 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=206.6
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-eE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-AV 132 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~~ 132 (419)
-..+|++.+.||+|+||.||+|.. +|+.||||++.... ..+.+.+|+.+++++ +||||+++++++.... .+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCce
Confidence 446899999999999999999986 47899999997543 346789999999999 8999999999987665 79
Q ss_pred EEEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+||||+++|+|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE---DNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TSCEEECCCTTCEEC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC---CCCEEEeeCCCcccc
Confidence 999999999999999987554 799999999999999999999999999999999999964 445999999999865
Q ss_pred cCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 211 RPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+.+..+....+..+.. ......+++.
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~ 414 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPA 414 (450)
T ss_dssp C--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHH
T ss_pred ccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHH
Confidence 432 22346788999999987 578999999999999999998 9999998887777766665432 2223468999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+.+||.+||+.||++|||+.++++
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=351.90 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=202.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEE----EEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKF----ACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
..+|++++.||+|+||.||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC
Confidence 457999999999999999999998888766 555554322 233467889999999999 8999999999998765
Q ss_pred eEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++|+||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~---~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC---CEEEccCcceeE
Confidence 7889999999999999987 45699999999999999999999999999999999999997654 499999999987
Q ss_pred ccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 210 FRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 210 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
...... .....||+.|+|||++. ..++.++|||||||++|+|++ |..||.+.........+..... ....+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 643322 22345688999999887 468999999999999999999 9999998887776666554432 122346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.++.++|.+||..||.+|||+.++++.
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 79999999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=360.73 Aligned_cols=257 Identities=18% Similarity=0.230 Sum_probs=199.1
Q ss_pred cccceeeccccccccceEEEEEEEcC---CCcEEEEEEecccccCCh--------hhHHHHHHHHHHHHhCCCCCCeeee
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTA--------VDIEDVRREVQIMKHLPKHPNIVSL 122 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~--------~~~~~~~~Ei~~l~~l~~hpnIv~l 122 (419)
...+|++.+.||+|+||.||+|.+.. ++..+|+|++........ .....+.+|+..++.+ +||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence 34589999999999999999999987 889999999875431100 0122466788899999 99999999
Q ss_pred eeEEEe----CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 123 KDTYED----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 123 ~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
++++.. ....|+||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS-TTS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC-CCc
Confidence 999987 78899999999 999999998877899999999999999999999999999999999999998654 236
Q ss_pred eEEeecccceeccCCC--------cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Q 014722 199 LKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQ 268 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~ 268 (419)
+||+|||++..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... ....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998764322 1244579999999999875 5899999999999999999999999653221 1111
Q ss_pred HHHhccc-ccCC-----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 269 AIIRSVI-DFKR-----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 269 ~i~~~~~-~~~~-----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
....... ..+. .....+++++.++|.+||..||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111 1110 0112678999999999999999999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=371.13 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=214.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.-..+|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+...+
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcE
Confidence 345679999999999999999999998999999999975432 357889999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN---HLVKVADFGLSRLM 368 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG---GCEEECCTTCEECC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC---CcEEEeecccceec
Confidence 9999999999999999864 458999999999999999999999999999999999999654 45999999999876
Q ss_pred cCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
..... .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+.......+.... .......++
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 445 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCP 445 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 54322 22344678899999987 578999999999999999999 999999888777666555432 122234689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.+.+||.+||+.||++|||+.++++.
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999999999999999999999999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=353.43 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=202.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE----eCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE----DDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~----~~~ 130 (419)
..+|++.+.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.+++.+ +||||+++++++. ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence 35799999999999999999999999999999998653 344567889999999999 9999999999987 345
Q ss_pred eEEEEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 131 AVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
..++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~---~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE---GQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC---CCEEEEecCc
Confidence 78999999999999998876 4679999999999999999999999999999999999999644 4599999999
Q ss_pred ceeccCCCc----------ccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Q 014722 207 SVFFRPGEQ----------FNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAI 270 (419)
Q Consensus 207 a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i 270 (419)
+........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ..... .
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~ 259 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-A 259 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-H
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-H
Confidence 876532111 123457999999999863 378999999999999999999999943111 01111 1
Q ss_pred HhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 271 IRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..... ..+..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 VQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 22222 222335689999999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=345.73 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=199.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeee-eeeEEEeCCe
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS-LKDTYEDDSA 131 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~-l~~~~~~~~~ 131 (419)
.+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.+++.+ .|++++. +..++.....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc
Confidence 4567899999999999999999999999999999987654322 3577899999999 5665554 4455578888
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++..+..+.+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 8999999875 457999999999999999999999999999999999999954344566999999999876
Q ss_pred cCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccccC
Q 014722 211 RPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVIDFK 278 (419)
Q Consensus 211 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~ 278 (419)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.... .....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 54322 235679999999999874 6899999999999999999999999764322 22222222222211
Q ss_pred C-CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 279 R-DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 279 ~-~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
. .....+|+++.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 112357899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=348.62 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=202.1
Q ss_pred cccceeeccccccccceEEEEEEEcC---CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN---NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
...+|.+.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++++ +||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence 34579999999999999999998765 556899999876532 344567889999999999 8999999999998655
Q ss_pred -----eEEEEEEecCCcchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCe
Q 014722 131 -----AVHIVMELCEGGELFDRIVA------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPL 199 (419)
Q Consensus 131 -----~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~ 199 (419)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.+ +.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~---~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT---SCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcE
Confidence 35999999999999999843 3469999999999999999999999999999999999999654 459
Q ss_pred EEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcc
Q 014722 200 KAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 274 (419)
Q Consensus 200 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~ 274 (419)
||+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |.+||.+.........+....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999987644322 23345788999999987 468999999999999999999 999998888877777666543
Q ss_pred cccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 275 IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 275 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
. ......+++.+.++|.+||..||.+|||+.+++++
T Consensus 267 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 R---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 22234688999999999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=386.18 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=213.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe------
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------ 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------ 128 (419)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccC
Confidence 367999999999999999999999999999999986542 445567899999999999 89999999998765
Q ss_pred CCeEEEEEEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
.+..++||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++....+||+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999998644 58999999999999999999999999999999999999876666679999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------------- 270 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-------------- 270 (419)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||............
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 999877666666778999999999987 57899999999999999999999999765433211000
Q ss_pred Hhccccc------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 271 IRSVIDF------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 271 ~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
..+...+ +......+++.+.+||.+||..||++|||+.++++||||+.
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0011111 11122346789999999999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=346.18 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=203.4
Q ss_pred cccceeeccccccccceEEEEEEEcC-CCc--EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN-NGE--KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 130 (419)
...+|++.+.||+|+||.||+|++.. ++. .||+|++...........+.+.+|+.+++++ +||||+++++++.+..
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC
Confidence 34589999999999999999998643 333 6899998766544445677899999999999 8999999999998765
Q ss_pred eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~---~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC---CEEEcccccccc
Confidence 88999999999999998764 5699999999999999999999999999999999999997654 499999999987
Q ss_pred ccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 210 FRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 210 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||.+.+.......+........ ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 248 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPE 248 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCT
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCc
Confidence 654332 22345788999999987 468899999999999999999 9999999888887777766543332 234
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++++.+++.+||..||++|||+.+++++
T Consensus 249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 689999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=364.62 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=211.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|+.+++++ +||||+++++++. .+.
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCc
Confidence 345568999999999999999999974 57889999997543 2457899999999999 8999999999986 667
Q ss_pred EEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA---SLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT---TCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC---CCcEEEeeCCCceE
Confidence 89999999999999999753 36899999999999999999999999999999999999964 45699999999987
Q ss_pred ccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... .....+|+.|+|||++. +.++.++|||||||++|+|+| |..||.+.+..+....+..... .+....+
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~ 410 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR---MPRPENC 410 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC---CCCCTTS
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 643221 12344678899999987 579999999999999999999 9999999888888777765432 2223468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++++.+||.+||..||++|||+.++++
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999999999999999999975
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=350.05 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=206.0
Q ss_pred cceeeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE--eC
Q 014722 56 IDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE--DD 129 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~ 129 (419)
.+|++++.||+|+||.||+|+ +..+++.||+|++... .....+.+.+|+.+++++ +||||+++++++. +.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence 579999999999999999998 5678999999998754 344567789999999999 9999999999886 55
Q ss_pred CeEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~---~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA---HVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC---CEEEcccccce
Confidence 679999999999999999976 45699999999999999999999999999999999999997654 49999999998
Q ss_pred eccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHH
Q 014722 209 FFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------------GVAQ 268 (419)
Q Consensus 209 ~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------------~~~~ 268 (419)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||...... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654332 23356888899999887 46889999999999999999999998554322 1111
Q ss_pred HHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+... . .......+++.+.+||.+||+.||++|||+.+++++
T Consensus 256 ~~~~~-~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 256 LLEEG-Q--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHTT-C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Hhhcc-c--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111 1 122234689999999999999999999999999765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.90 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=210.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+ +.
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CC
Confidence 445578999999999999999999964 677899999875432 346789999999999 89999999999874 56
Q ss_pred EEEEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC---CCCEEECCCccccc
Confidence 899999999999999886543 6999999999999999999999999999999999999964 44599999999987
Q ss_pred ccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---MVRPDNC 235 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---CCCcccc
Confidence 654332 22345788999999987 568999999999999999999 9999998888777776655432 1222467
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+.+++.+||..||++|||+.++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999999999976
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=348.22 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=196.0
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHh--CCCCCCeeeeeeEEEe-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH--LPKHPNIVSLKDTYED- 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hpnIv~l~~~~~~- 128 (419)
..+.++|++.+.||+|+||.||+|++ +|+.||+|++... ....+..|.+++.. + +||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence 45677999999999999999999986 6899999998643 23455667777776 6 89999999998654
Q ss_pred ---CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEeeCCCCCcEEeecCCCCC
Q 014722 129 ---DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH--------EQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 129 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
...+++||||+++|+|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+|||++.+ +
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~---~ 150 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN---G 150 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT---S
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC---C
Confidence 3568999999999999998854 57999999999999999999999 9999999999999999644 4
Q ss_pred CeEEeecccceeccCCCc-----ccccccCcccCchhhhcc-------cCCCcccHHHHHHHHHHHHhC----------C
Q 014722 198 PLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCG----------V 255 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g----------~ 255 (419)
.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 599999999987654332 233479999999999874 344689999999999999999 8
Q ss_pred CCCCCCCH----HHHHHHHHhcccccCCCC----CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 256 PPFWAETE----QGVAQAIIRSVIDFKRDP----WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 256 ~pf~~~~~----~~~~~~i~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.||..... ..............+..+ ....++.+.+|+.+||+.||++|||+.++++.
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 88855322 222222221111111111 01245789999999999999999999999763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=355.69 Aligned_cols=248 Identities=16% Similarity=0.214 Sum_probs=200.7
Q ss_pred ccceeeccccccccceEEEEEEEcC--------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeee-----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVN--------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVS----- 121 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~----- 121 (419)
.++|++.+.||+|+||.||+|++.. .++.||+|++... +.+.+|+.+++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence 4689999999999999999999987 4899999998643 3577899999999 8999887
Q ss_pred ----------eeeEEEe-CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcE
Q 014722 122 ----------LKDTYED-DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENF 188 (419)
Q Consensus 122 ----------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 188 (419)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 5667765 78899999999 99999999875 6799999999999999999999999999999999999
Q ss_pred EeecCCCCCCeEEeecccceeccCCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCC
Q 014722 189 LFANKKESSPLKAIDFGLSVFFRPGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW 259 (419)
Q Consensus 189 l~~~~~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 259 (419)
|++.++ ...+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 191 l~~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPED-QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTE-EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCC-CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 997543 12599999999986643221 134579999999999875 78999999999999999999999997
Q ss_pred CCC--HHHHHHHHH---hccccc--CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 260 AET--EQGVAQAII---RSVIDF--KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 260 ~~~--~~~~~~~i~---~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
... ......... .....+ ....|..+++++.+||.+||..||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 753 222222221 111111 112234679999999999999999999999999763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.69 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=205.9
Q ss_pred ccceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE-EeCC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY-EDDS 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~-~~~~ 130 (419)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+... ......+.+.+|+.+++++ +||||+++++++ ..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence 45799999999999999999996543 346899988653 2445567889999999999 899999999985 4566
Q ss_pred eEEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 131 AVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC---CCCEEECccccccc
Confidence 88999999999999999976 345899999999999999999999999999999999999964 44599999999986
Q ss_pred ccCCCc-----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 210 FRPGEQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 210 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
...... .....||+.|+|||++. ..++.++||||||+++|+|++ |.+||...........+........ .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---P 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---C
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---C
Confidence 643321 23456788999999987 468999999999999999999 7788877777666666665443222 2
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+++.+.+++.+||+.||++|||+.++++.
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3578999999999999999999999999763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.00 Aligned_cols=257 Identities=19% Similarity=0.245 Sum_probs=203.6
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
....++|++.+.||+|+||.||+|.+ .+|+.||+|++....... ....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhc-cCCCccceEEEEecCCc
Confidence 44567899999999999999999984 579999999997653221 223688999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 132 VHIVMELCEGGELFDRIVARG----HYTERAAAAVMKTIVEVVQVCHEQ---GVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+ +.+||+||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~---~~~kl~Df 178 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE---FEAVVGDF 178 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT---CCEEECCC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC---CCEEeccC
Confidence 999999999999999997643 389999999999999999999999 99999999999999644 45999999
Q ss_pred ccceeccCCC--cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHhccccc
Q 014722 205 GLSVFFRPGE--QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVIDF 277 (419)
Q Consensus 205 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~~i~~~~~~~ 277 (419)
|++....... ......||+.|+|||++. +.++.++||||||+++|+|++|..||... ................
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 9998765332 234456999999999986 57899999999999999999999999421 0000111111111110
Q ss_pred -----------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCc
Q 014722 278 -----------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPW 315 (419)
Q Consensus 278 -----------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~ 315 (419)
........++.+.+++.+||+.||.+|||+.++++|-+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00111223467999999999999999999999999854
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=346.54 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=203.1
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEeccccc-CChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL-RTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
|...+.||+|+||.||+|.+ +++.||+|++..... ......+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence 55568999999999999984 689999999875432 2233467889999999999 8999999999999999999999
Q ss_pred EecCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 137 ELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 137 e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~---~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE---AFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT---TCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC---CCcEEEeecccccccccc
Confidence 99999999998874 346999999999999999999999999999999999999964 446999999999876543
Q ss_pred Cc---ccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccc------c-cCC
Q 014722 214 EQ---FNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA----QAIIRSVI------D-FKR 279 (419)
Q Consensus 214 ~~---~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~------~-~~~ 279 (419)
.. .....||+.|+|||++.+.++.++||||||+++|+|++|.+||......... ..+..... . ...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 22 2345799999999999888999999999999999999999999765433222 22211110 0 011
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......++.+.+++.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1122345778999999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=339.86 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=205.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
..|++.+.||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCC
Confidence 357888999999999999999765544 7999998653 2445567889999999999 899999999999876655
Q ss_pred -EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 -HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 -~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++...
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~---~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLARDI 174 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---CCEEECCTTSSCTT
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC---CcEEeCcCCCcccc
Confidence 999999999999999976 4568999999999999999999999999999999999999644 45999999999765
Q ss_pred cCCC-----cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 211 RPGE-----QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 211 ~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
.... ......+|+.|+|||.+.+ .++.++||||||+++|+|++ |.+||...+.......+..... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 251 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---LPQPE 251 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---CCCCT
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---CCCCc
Confidence 4322 2234567899999999874 68999999999999999999 5566666666665555554432 12224
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+.+++.+||+.||.+|||+.++++.
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 578999999999999999999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.59 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=203.7
Q ss_pred Cccccce-eeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEE
Q 014722 52 QDISIDY-DLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTY 126 (419)
Q Consensus 52 ~~~~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 126 (419)
..+..+| ++++.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTL-YHEHIIKYKGCC 102 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence 3466666 999999999999998775 44588999999997542 344567899999999999 899999999999
Q ss_pred Ee--CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 127 ED--DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 127 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
.+ ...+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~---~~~kl~Df 178 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND---RLVKIGDF 178 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---CCEEECCG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC---CCEEECCc
Confidence 87 46799999999999999988665 59999999999999999999999999999999999999644 45999999
Q ss_pred ccceeccCCCc----ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHH--------------
Q 014722 205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-------------- 265 (419)
Q Consensus 205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------------- 265 (419)
|++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99988765432 234568889999999874 68899999999999999999999996532210
Q ss_pred HHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 266 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.......... .......+++++.+||.+||+.||++|||+.++++
T Consensus 259 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RLTELLERGE--RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccc--CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0111111111 12223468999999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.01 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=198.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC-CeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD-SAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-~~~~ 133 (419)
..+|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++++ +||||+++++++... +.++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceE
Confidence 45799999999999999999986 48899999986432 346788999999999 899999999987544 5789
Q ss_pred EEEEecCCcchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||||+++++|.+++...+. +++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC---CcEEEeecccccccc
Confidence 99999999999999976543 8999999999999999999999999999999999999643 459999999987654
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.. .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.... .......+++.+
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 243 (278)
T 1byg_A 169 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAV 243 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHHH
T ss_pred cc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHHH
Confidence 32 23346788999999987 568999999999999999998 999998887777666655432 122334689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhc
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.++|.+||..||++|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=360.94 Aligned_cols=254 Identities=20% Similarity=0.272 Sum_probs=208.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.|.+|++|+.+..++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 3567899999999999999999999999999999988754422 34778999999995557777777788888999
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8999999975 5579999999999999999999999999999999999999644445679999999998765
Q ss_pred CCCc--------ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcccccCC
Q 014722 212 PGEQ--------FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDFKR 279 (419)
Q Consensus 212 ~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 279 (419)
.... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4332 125679999999999874 689999999999999999999999977543 3333333322221111
Q ss_pred -CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 280 -DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 280 -~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.....+++++.+||.+||..||++||++.++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111357899999999999999999999998875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=349.75 Aligned_cols=247 Identities=27% Similarity=0.470 Sum_probs=186.5
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE-------
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE------- 127 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~------- 127 (419)
..+|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|+.+++++.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 34799999999999999999999999999999998543 34456778899999999956999999999984
Q ss_pred -eCCeEEEEEEecCCcchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEE
Q 014722 128 -DDSAVHIVMELCEGGELFDRIVA---RGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKA 201 (419)
Q Consensus 128 -~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl 201 (419)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~---~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ---GTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT---SCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC---CCEEE
Confidence 3455899999996 689888765 456999999999999999999999999 9999999999999654 45999
Q ss_pred eecccceeccCCCcc-------------cccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH
Q 014722 202 IDFGLSVFFRPGEQF-------------NEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 264 (419)
Q Consensus 202 ~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 264 (419)
+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543221 1456899999999873 35788999999999999999999999765443
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~ 314 (419)
... ..... .......+..+.+||.+||+.||++|||+.|++++-
T Consensus 260 ~~~----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 260 RIV----NGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ----------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred Hhh----cCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 322 22222 222345678899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=359.56 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=207.5
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.+++++ +||||+++++++.+ +..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cce
Confidence 445689999999999999999999754 56799999975432 346789999999999 89999999999876 678
Q ss_pred EEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 133 HIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~---~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC---CCEEECCCccceec
Confidence 999999999999999974 3469999999999999999999999999999999999999654 45999999999876
Q ss_pred cCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
..... .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||.+....+....+..+.. .+..+.++
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~ 407 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECP 407 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSC
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 53321 22345678899999886 578999999999999999999 9999999888887777665432 12234689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC--Cccc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH--PWLQ 317 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~--~~~~ 317 (419)
+.+.+||.+||+.||++|||+.++++. .++.
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 999999999999999999999999863 4444
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=354.13 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=197.8
Q ss_pred cceeeccccccccceEEEEEEEcCCC---cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE-eCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE-DDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-~~~~ 131 (419)
..|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 46889999999999999999875433 46899988643 2344567899999999999 8999999999864 4568
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC---CCCEEEeeccccccc
Confidence 89999999999999999764 35899999999999999999999999999999999999964 445999999999865
Q ss_pred cCCCc-----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCc
Q 014722 211 RPGEQ-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283 (419)
Q Consensus 211 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (419)
..... .....+|+.|+|||++. ..++.++||||||+++|+|+| |.+||...+..+....+..+.... ...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~---~p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL---QPE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC---CCT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence 43221 22345788999999987 578999999999999999999 788898777666666555543221 224
Q ss_pred cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 284 ~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+++.+.+++.+||..||++|||+.+++++
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=370.96 Aligned_cols=242 Identities=22% Similarity=0.302 Sum_probs=204.2
Q ss_pred cccccccceEEEEEEE--cCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRGEFGVTYLCTD--VNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
+.||+|+||.||+|.+ ..+++.||||+++.... .....+.+.+|+.+++++ +||||+++++++.. +.+++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence 4799999999999954 45778999999976532 334567899999999999 89999999999975 5688999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc----
Q 014722 140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---- 215 (419)
Q Consensus 140 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---- 215 (419)
++|+|.+++.....+++..+..|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC---CEEEEEcCCccccccCcccccc
Confidence 9999999999888899999999999999999999999999999999999997654 499999999987654332
Q ss_pred ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....+|+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+....+...... .....+++++.+||
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence 22345678899999987 479999999999999999998 99999999888877777665422 22246899999999
Q ss_pred HHhcCCCCCCCCCHHHHhc
Q 014722 294 KKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~l~ 312 (419)
.+||+.||++|||+.++++
T Consensus 606 ~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.50 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=196.6
Q ss_pred cccceeeccccccccceEEEEE-----EEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCC---CCCeeeeeeE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLC-----TDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK---HPNIVSLKDT 125 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~---hpnIv~l~~~ 125 (419)
...+|.+.+.||+|+||.||+| .+..+++.||+|++... ....+..|+.+++.+ . ||||++++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERL-KPSMQHMFMKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHS-CGGGGGGBCCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHh-hhhhhhhhhhhhee
Confidence 3457999999999999999999 46778999999998643 235677888888888 5 8999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeec--------
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVA-----RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN-------- 192 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~-------- 192 (419)
+...+..|+||||++||+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 456999999999999999999999999999999999999976
Q ss_pred CCCCCCeEEeecccceecc---CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 014722 193 KKESSPLKAIDFGLSVFFR---PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 268 (419)
Q Consensus 193 ~~~~~~~kl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 268 (419)
+...+.+||+|||+|.... .........||+.|+|||++.+ .|+.++|||||||++|+|+||..||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 2225679999999997653 2334456789999999999874 58999999999999999999999995443210
Q ss_pred HHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 269 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
......... ...++.+.+++..||+.+|.+|++..+.+.+
T Consensus 293 ----~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 ----CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ----EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ----eeechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 000001111 1246788999999999999999765555444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=340.66 Aligned_cols=241 Identities=28% Similarity=0.434 Sum_probs=193.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++.+.||+|+||.||+|.+ .++.||+|++... ...+.+.+|+.+++++ +||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEE
Confidence 4799999999999999999986 4789999998632 2456789999999999 89999999998763 47899
Q ss_pred EEecCCcchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 136 MELCEGGELFDRIVARG---HYTERAAAAVMKTIVEVVQVCHE---QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
|||++|++|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+||+++.++ ..+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG--TVLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT--TEEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC--CEEEEcccccccc
Confidence 99999999999998654 37899999999999999999999 8999999999999997543 2379999999876
Q ss_pred ccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccccCCCCCccCC
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .....+.... .......++
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---RPPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC---CCCCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC---CCCcccccC
Confidence 5422 234569999999999874 6899999999999999999999999754332 2222222221 222335689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=357.66 Aligned_cols=251 Identities=17% Similarity=0.242 Sum_probs=196.2
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-----ChhhHHHHHHHHHHHHhCC--------CCCCeee
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----TAVDIEDVRREVQIMKHLP--------KHPNIVS 121 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~Ei~~l~~l~--------~hpnIv~ 121 (419)
..+|++++.||+|+||+||+|++ +|+.||+|++...... .....+.+.+|+.+++.+. .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999997 7899999999865432 2234577889999999883 3666666
Q ss_pred eeeEE-----------------Ee-------------CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 014722 122 LKDTY-----------------ED-------------DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171 (419)
Q Consensus 122 l~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~ 171 (419)
+.+++ .+ ...+|+|||||++|++.+.+.+ ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 65553 32 7889999999999987777654 56899999999999999999
Q ss_pred HHH-HcCCEeeCCCCCcEEeecCCC-----------------CCCeEEeecccceeccCCCcccccccCcccCchhhhcc
Q 014722 172 VCH-EQGVMHRDLKPENFLFANKKE-----------------SSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR 233 (419)
Q Consensus 172 ~LH-~~~ivHrDlkp~NIl~~~~~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 233 (419)
||| ++||+||||||+|||++.++. ...+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999987641 126999999999876532 4579999999999987
Q ss_pred cCCCcccHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhcccccCC---CCCccCCHHHHHHHHHhcCCCCCCCCCHH
Q 014722 234 NYGPEVDVWSAGVI-LYILLCGVPPFWAETE-QGVAQAIIRSVIDFKR---DPWPKVSENAKDLVKKMLNPDPKQRLTAE 308 (419)
Q Consensus 234 ~~~~~~DiwslG~i-l~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~R~s~~ 308 (419)
..+.++||||+|++ .+++++|..||..... ......+......... ..++.+++++.+||.+||++| |+.
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998777 7789999999843211 1122233322111111 113357889999999999976 999
Q ss_pred HHh-cCCccc
Q 014722 309 EVL-EHPWLQ 317 (419)
Q Consensus 309 ~~l-~~~~~~ 317 (419)
|+| +||||+
T Consensus 327 e~l~~Hp~f~ 336 (336)
T 2vuw_A 327 DLLCQHSLFK 336 (336)
T ss_dssp HHHHHCGGGC
T ss_pred HHHhcCCCcC
Confidence 999 999995
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=340.35 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=204.2
Q ss_pred CccccceeeccccccccceEEEEEE----EcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCT----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
.....+|++++.||+|+||.||+|+ +..+|+.||+|++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEE
Confidence 3455679999999999999999998 4678999999998753 334567899999999999 8999999999986
Q ss_pred eCC--eEEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 128 DDS--AVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 128 ~~~--~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
..+ .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+||
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~---~~kL~Df 189 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN---RVKIGDF 189 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC---cEEEecC
Confidence 544 789999999999999999875 4599999999999999999999999999999999999997654 4999999
Q ss_pred ccceeccCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH------------HHH
Q 014722 205 GLSVFFRPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ------------GVA 267 (419)
Q Consensus 205 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------~~~ 267 (419)
|++........ .....+|+.|+|||++. ..++.++||||||+++|+|+||..||...... ...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 99987754432 12345778899999987 46889999999999999999999998543111 001
Q ss_pred ---HHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 268 ---QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 268 ---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
........ ..+....+++++.+||.+||+.||++|||+.++++
T Consensus 270 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 11223468999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.58 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=204.0
Q ss_pred cceeecc-ccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGR-ELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.++.+.+ .||+|+||.||+|... .++..||||++.... .....+.+.+|+.+++++ +||||+++++++.. +.+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence 3556665 7999999999999865 356789999997653 233567899999999999 99999999999976 569
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH---YAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC---cEEEeeccCccccc
Confidence 9999999999999998754 4599999999999999999999999999999999999997644 59999999998764
Q ss_pred CCCcc----cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQF----NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
..... ....+|+.|+|||++. +.++.++|||||||++|||++ |..||.+.+..+....+..+.. ......+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC 564 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC---CCCCTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence 33221 1234568899999987 579999999999999999998 9999999888887777766532 1222468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++++.+||.+||..||++|||+.++++
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.50 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=210.4
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.....+|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+++ +||||+++++++.+ +.
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SS
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhC-CCCCEeeEEEEEee-cc
Confidence 3445689999999999999999999754 56799999975432 346789999999999 89999999999876 67
Q ss_pred EEEEEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 132 VHIVMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
+||||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~---~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARL 412 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCTTSTTT
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC---CcEEEccccccee
Confidence 8999999999999999975 3469999999999999999999999999999999999999654 4599999999986
Q ss_pred ccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 210 FRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 210 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
...... .....+|..|+|||++. +.++.++|||||||++|+|++ |..||.+....+....+..+.. ......+
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~ 489 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPEC 489 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTC
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCC
Confidence 543211 12345678899999886 578999999999999999999 9999999888887777765432 1223468
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+.+||.+||+.||++|||+.++++.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=338.34 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=193.2
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhC-CCCCCeeeeeeEEEeC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL-PKHPNIVSLKDTYEDD- 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~~hpnIv~l~~~~~~~- 129 (419)
..+.++|++.+.||+|+||.||+|++. |+.||+|++.... ......|.+++..+ .+||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 456779999999999999999999864 8999999985432 23344455555443 2899999999999887
Q ss_pred ---CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCEeeCCCCCcEEeecCCCCCC
Q 014722 130 ---SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ--------GVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 130 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
..+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+ +.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~---~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN---GT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT---SC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC---CC
Confidence 7899999999999999998664 699999999999999999999999 99999999999999644 45
Q ss_pred eEEeecccceeccCCCc-----ccccccCcccCchhhhccc-CCCc------ccHHHHHHHHHHHHhC----------CC
Q 014722 199 LKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKRN-YGPE------VDVWSAGVILYILLCG----------VP 256 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~------~DiwslG~il~~ll~g----------~~ 256 (419)
+||+|||++........ .....||+.|+|||++.+. ++.. +|||||||++|+|+|| ..
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 99999999976643322 1345799999999998753 4443 8999999999999999 77
Q ss_pred CCCCCC----HHHHHHHHHh-cccccCCCC---CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 257 PFWAET----EQGVAQAIIR-SVIDFKRDP---WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 257 pf~~~~----~~~~~~~i~~-~~~~~~~~~---~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
||.... .......... .......+. ...+++++.+|+.+||+.||.+|||+.++++|
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 775432 1122222221 111111110 01356789999999999999999999999886
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.77 Aligned_cols=250 Identities=19% Similarity=0.313 Sum_probs=206.2
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
....+|++.+.||+|+||.||+|.+.. .+|+|++...... ....+.+.+|+.+++++ +||||+++++++.+...+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCce
Confidence 345679999999999999999999743 4999998765322 22334567899999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++||||++|++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCccccc
Confidence 99999999999999987654 699999999999999999999999999999999999996 2359999999987543
Q ss_pred C------CCcccccccCcccCchhhhcc----------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Q 014722 212 P------GEQFNEIVGSPYYMAPEVLKR----------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 212 ~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 275 (419)
. ........||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 1 122334568999999999863 368899999999999999999999998888777766655433
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.. .....++.++.+++.+||..||++|||+.++++.
T Consensus 261 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 261 PN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 22 1223578899999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=341.51 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=201.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHh--CCCCCCeeeeeeEEEeC
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH--LPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~--l~~hpnIv~l~~~~~~~ 129 (419)
..+..+|++.+.||+|+||.||+|++ +|+.||+|++... ....+.+|+++++. + +||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVML-RHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCC-CCTTBCCEEEEEECC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhc-CCCcEEEEEeeeccc
Confidence 34567899999999999999999996 5899999998643 24567789999888 6 899999999999877
Q ss_pred C----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCEeeCCCCCcEEeecCCCCC
Q 014722 130 S----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH--------EQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 130 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
. ..++||||+++|+|.+++.+. .+++..+..++.|++.||.||| ++||+||||||+|||++.+ +
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~---~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN---G 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT---S
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC---C
Confidence 6 899999999999999999764 6999999999999999999999 8999999999999999654 4
Q ss_pred CeEEeecccceeccCCCc-----ccccccCcccCchhhhccc-------CCCcccHHHHHHHHHHHHhC----------C
Q 014722 198 PLKAIDFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG----------V 255 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~ll~g----------~ 255 (419)
.+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 599999999987654432 2455799999999998753 23689999999999999999 7
Q ss_pred CCCCCCC-----HHHHHHHHHhcccccCCCC-C--ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 256 PPFWAET-----EQGVAQAIIRSVIDFKRDP-W--PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 256 ~pf~~~~-----~~~~~~~i~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.||.... .......+.........+. | ...++.+.+|+.+||+.||++|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 8886642 2333333322222111110 1 1234678999999999999999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=376.04 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=205.8
Q ss_pred CCCCccccceeeccccccccceEEEEEEEcC-CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVN-NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 49 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
..|..+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++++ +||||+++++++.
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE 149 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence 3456778899999999999999999999976 78999999986432 344556788999999999 8999999999998
Q ss_pred eCCe-----EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 128 DDSA-----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 128 ~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
..+. .||||||++|++|.+.+.. .+++.++..++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~ 223 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLI 223 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEEC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEE
Confidence 7665 7999999999999887654 79999999999999999999999999999999999999752 59999
Q ss_pred ecccceeccCCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
|||++...... ....||+.|+|||++.+.++.++|||||||++|+|++|.+||.+..... . ......
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------~-~~~~~~ 290 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG---------L-PEDDPV 290 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------C-CTTCHH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccccc---------c-cccccc
Confidence 99999876543 4567999999999998778899999999999999999999986532110 0 011111
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
...++.+.+||.+||+.||++||+..+.+.|+|+.
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 23467899999999999999999999999888874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=344.98 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=188.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHH--HHhCCCCCCeeeeeeEEEe----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI--MKHLPKHPNIVSLKDTYED---- 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~--l~~l~~hpnIv~l~~~~~~---- 128 (419)
.++|++.+.||+|+||.||+|++ +++.||+|++.... ...+..|..+ +..+ +||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence 35799999999999999999975 78999999986432 2333444444 4457 89999999986542
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCEeeCCCCCcEEeecCCCCCC
Q 014722 129 -DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---------GVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
...+++||||+++|+|.+++... ..++..+..++.||+.||.|||+. ||+||||||+|||++.+ +.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~---~~ 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND---GT 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT---SC
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC---Cc
Confidence 33678999999999999998765 459999999999999999999999 99999999999999644 45
Q ss_pred eEEeecccceeccCCC---------cccccccCcccCchhhhcc--------cCCCcccHHHHHHHHHHHHhCCCCCCCC
Q 014722 199 LKAIDFGLSVFFRPGE---------QFNEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLCGVPPFWAE 261 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwslG~il~~ll~g~~pf~~~ 261 (419)
+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998764322 1234579999999999864 4667899999999999999997665332
Q ss_pred CH-----------------HHHHHHHHh-ccccc-CCCCC---ccCCHHHHHHHHHhcCCCCCCCCCHHHHh------cC
Q 014722 262 TE-----------------QGVAQAIIR-SVIDF-KRDPW---PKVSENAKDLVKKMLNPDPKQRLTAEEVL------EH 313 (419)
Q Consensus 262 ~~-----------------~~~~~~i~~-~~~~~-~~~~~---~~~~~~~~~li~~~L~~dp~~R~s~~~~l------~~ 313 (419)
.. ......... ..... ....| ...++.+.+||.+||+.||++|||+.|++ -+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 11 111111111 11110 01111 12456899999999999999999999995 46
Q ss_pred CccccCcc
Q 014722 314 PWLQNAKK 321 (419)
Q Consensus 314 ~~~~~~~~ 321 (419)
+|-++...
T Consensus 319 ~~~~~~~~ 326 (336)
T 3g2f_A 319 IWERNKSV 326 (336)
T ss_dssp CCCC----
T ss_pred HHHhcccC
Confidence 77665443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=353.17 Aligned_cols=247 Identities=16% Similarity=0.202 Sum_probs=192.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CCeee-------------
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVS------------- 121 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~------------- 121 (419)
.+|...+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 4588999999999999999999999999999998754433444567899999999999 55 32211
Q ss_pred --------eeeEEEe-----CCeEEEEEEecCCcchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCEee
Q 014722 122 --------LKDTYED-----DSAVHIVMELCEGGELFDRIVA-------RGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181 (419)
Q Consensus 122 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 181 (419)
+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111121 23467788876 5799888741 2347788999999999999999999999999
Q ss_pred CCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhh----------c-ccCCCcccHHHHHHHHHH
Q 014722 182 DLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL----------K-RNYGPEVDVWSAGVILYI 250 (419)
Q Consensus 182 Dlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~-~~~~~~~DiwslG~il~~ 250 (419)
||||+|||++.++ .+||+|||+++.... ......| +.|+|||++ . ..++.++|||||||++|+
T Consensus 236 DiKp~NILl~~~~---~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRG---GVFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTC---CEEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCC---eEEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999997544 499999999886542 2455678 999999988 3 247789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 251 LLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 251 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
|++|..||...+.......+ ...+..+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus 310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999776543322211 2223468999999999999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.08 Aligned_cols=251 Identities=25% Similarity=0.330 Sum_probs=209.1
Q ss_pred ccccceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
....+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++++ +||||+++++++. .
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-c
Confidence 3456899999999999999999998653 4679999886432 344567889999999999 8999999999985 4
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~---~vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC---CEEEEecCCCe
Confidence 56899999999999999998654 689999999999999999999999999999999999997654 49999999998
Q ss_pred eccCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 209 FFRPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 209 ~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
....... .....+|+.|+|||++. ..++.++||||||+++|+|++ |.+||.+....+....+...... ...+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~ 616 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPN 616 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---CCCTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---CCCcc
Confidence 7654332 22345678999999987 578999999999999999997 99999998888877777665322 22346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+.+||.+||..||++|||+.++++.
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=331.48 Aligned_cols=229 Identities=14% Similarity=0.082 Sum_probs=189.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcE
Confidence 5677899999999999999999999999999999999876655555667899999999999 999999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+||||++|++|.+++... ....++..++.|++.||.|||++||+||||||+|||++.++ .+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g---~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG---DVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS---CEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC---CEEEEecc-------
Confidence 9999999999999998543 46678899999999999999999999999999999997544 48887443
Q ss_pred CCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccccCCCCCccCCHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~ 289 (419)
|++| ++.++|||||||++|+|+||..||.+.+...... ..............+.+++++
T Consensus 175 ------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 175 ------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred ------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence 4443 6889999999999999999999998765432110 000111111111234689999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+||.+||+.||++| |+.++++.
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHH
Confidence 999999999999999 99999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=313.49 Aligned_cols=231 Identities=16% Similarity=0.143 Sum_probs=157.4
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCC-------hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT-------AVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
..+.|++|.+..++....|+.+|+|++.+..... ....+++.+|+++|+++..||||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4678888888888888899999999997653221 234567999999999998899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-C
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG-E 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~ 214 (419)
|||++|++|.++|...+++++. .|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d---g~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR---QHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT---SCEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC---CCEEEeecccCeeCCCCCc
Confidence 9999999999999998888765 588999999999999999999999999999654 45999999999876543 3
Q ss_pred cccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
...+.+||+.|||||++.+.+..++|+||+|++++++.++..|+ ...+.. .+... ..+..+..
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~----~~~~~-----~~~~~l~~ 457 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ----EPVER-----WNFVLLLA 457 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHT----SCGGG-----CSHHHHHH
T ss_pred cccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhc----CCCCC-----CcHHHHHH
Confidence 44567899999999999998899999999999998887665443 111111 01110 11345555
Q ss_pred HhcCCCCCCCCCHHHHhcCCcc
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
.++..+|..||.......++|.
T Consensus 458 ~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 458 LFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHHTGGGSCCGGGSSCCHHHHH
T ss_pred HHhCCCCCCCCChhhhccchhH
Confidence 6666666666665555555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=259.69 Aligned_cols=184 Identities=21% Similarity=0.185 Sum_probs=146.0
Q ss_pred eeccccccccceEEEEEEEcCCCcEEEEEEecccccCChh-----hHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 59 DLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV-----DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 59 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-----~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+.||+|+||.||+|. ..+..+++|........... ..+.+.+|+++++++ +||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 345689999999999995 56889999987654433221 245578999999999 9999996666666777889
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCc
Confidence 99999999999998865 6789999999999999999999999999999964 5999999999987653
Q ss_pred Cc--------ccccccCcccCchhhhc---ccCCCcccHHHHHHHHHHHHhCCCCC
Q 014722 214 EQ--------FNEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 214 ~~--------~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf 258 (419)
.. .....||+.|||||++. ..|+..+|+||..+-..+-+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32 13568999999999987 35888899999999888887777666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=213.65 Aligned_cols=158 Identities=24% Similarity=0.336 Sum_probs=123.0
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh---------------hhHHHHHHHHHHHHhCCCCCCeeee
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA---------------VDIEDVRREVQIMKHLPKHPNIVSL 122 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~~hpnIv~l 122 (419)
|.+.+.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+++++ + | +++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v 166 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAV 166 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSS
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCc
Confidence 55559999999999999998 8899999999964321110 1356788999999999 4 4 666
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
.+++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ + +.+||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~---~~vkl~ 234 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E---EGIWII 234 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T---TEEEEC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C---CcEEEE
Confidence 666654 45699999999999987 41 134557999999999999999999999999999997 3 459999
Q ss_pred ecccceeccCCCcccccccCcccCchhhhcc-----------cCCCcccHHHH
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMAPEVLKR-----------NYGPEVDVWSA 244 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~Diwsl 244 (419)
|||+|.. +..++|||.+.+ .|+..+|+|.+
T Consensus 235 DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~~ 275 (282)
T 1zar_A 235 DFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINSA 275 (282)
T ss_dssp CCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHH
T ss_pred ECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHHH
Confidence 9999864 345899998752 35666777654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=184.36 Aligned_cols=140 Identities=17% Similarity=0.208 Sum_probs=107.9
Q ss_pred eeeccccccccceEEEEEEEcCCCcE--EEEEEecccccCC---------------------hhhHHHHHHHHHHHHhCC
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRT---------------------AVDIEDVRREVQIMKHLP 114 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~---------------------~~~~~~~~~Ei~~l~~l~ 114 (419)
|++.+.||+|+||.||+|.+..+|+. ||||++....... ......+.+|+.+++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 78899999999999999998778999 9999975432110 01123678899999999
Q ss_pred CCCCe--eeeeeEEEeCCeEEEEEEecCC-c----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCEeeCCCCC
Q 014722 115 KHPNI--VSLKDTYEDDSAVHIVMELCEG-G----ELFDRIVARGHYTERAAAAVMKTIVEVVQVCH-EQGVMHRDLKPE 186 (419)
Q Consensus 115 ~hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~ 186 (419)
.|+++ +.++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 77754 344432 356899999942 3 56554322 345678899999999999999 999999999999
Q ss_pred cEEeecCCCCCCeEEeecccceec
Q 014722 187 NFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 187 NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
|||++. .++|+|||+|...
T Consensus 201 NILl~~-----~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID-----KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS-----SEEECCCTTCEET
T ss_pred HEEEcC-----cEEEEECcccccC
Confidence 999964 5999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-20 Score=173.61 Aligned_cols=142 Identities=18% Similarity=0.258 Sum_probs=100.7
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-----------ChhhH--------HHHHHHHHHHHhCCCCCC
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----------TAVDI--------EDVRREVQIMKHLPKHPN 118 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~--------~~~~~Ei~~l~~l~~hpn 118 (419)
|++...||+|++|.||+|.+ .+|+.||||+++..... ..... -....|...|.++ .+++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 99999999999999999997 47999999997643211 00001 1123567777777 4444
Q ss_pred eeeeeeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCC--
Q 014722 119 IVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKES-- 196 (419)
Q Consensus 119 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~-- 196 (419)
+. ....+.... .+|||||++|++|.... ....+..++.|++.+|.+||+.|||||||||.|||++.++..
T Consensus 175 v~-vp~p~~~~~-~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FP-VPEPIAQSR-HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CS-CCCEEEEET-TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CC-CCeeeeccC-ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 32 222222222 36999999998886532 223456789999999999999999999999999999865421
Q ss_pred -----CCeEEeeccccee
Q 014722 197 -----SPLKAIDFGLSVF 209 (419)
Q Consensus 197 -----~~~kl~Dfg~a~~ 209 (419)
..+.|+||+.+..
T Consensus 247 ~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECCCTTCEE
T ss_pred ccccccceEEEEeCCccc
Confidence 1278999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-13 Score=123.17 Aligned_cols=140 Identities=18% Similarity=0.175 Sum_probs=111.3
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|++...++.|+.+.||++.. .+..+++|+........ ...+.+|+.+++.+..+..++++++++.+.+..|+||
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 588888899999999999873 47899999986532111 2357889999999966788999999999999999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE----------------------------------------- 175 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~----------------------------------------- 175 (419)
||++|.+|.+.+. +......++.++..+|..||+
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999876521 223345788999999999998
Q ss_pred ------------------cCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 176 ------------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 176 ------------------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
..++|||++|.|||++.. ..+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence 458999999999999642 2356999997754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=4.3e-12 Score=114.28 Aligned_cols=135 Identities=14% Similarity=0.163 Sum_probs=98.2
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-CeeeeeeEEEeCCeEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~~~~~~~~~~~lv 135 (419)
.|.+....+.|..+.||++. ..+|..+++|+..... ...+.+|+.+++.+..+. .+++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 45654444566779999986 3567889999975431 235678999999884442 266788888888889999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG-------------------------------------- 177 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------------------------------------- 177 (419)
|||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998883 2 1122 2356777778888888643
Q ss_pred --------------------CEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 178 --------------------VMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 178 --------------------ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
++|||++|.||+++.+ ..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENG---RFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC---cEEEEEcchhccc
Confidence 9999999999999642 3356999998754
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.1e-12 Score=111.38 Aligned_cols=107 Identities=24% Similarity=0.285 Sum_probs=83.8
Q ss_pred cCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
.|||.+... .....+...+..++++|...+++++..+..++..++.++...++++|..+|.|++|.|+.+|++.+|..+
T Consensus 8 ~~~~~~~~~-~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~ 86 (197)
T 3pm8_A 8 SSGRENLYF-QGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILDGLKKI 86 (197)
T ss_dssp ----------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred cchHhhhcc-CCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHh
Confidence 489988653 4566777889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 392 GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 392 g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
|..+++.++..++..+|.+ |.|+|+||+
T Consensus 87 g~~~~~~~~~~l~~~~D~d~~g~I~~~EF~ 116 (197)
T 3pm8_A 87 GYQKIPPDIHQVLRDIDSNASGQIHYTDFL 116 (197)
T ss_dssp C----CHHHHHHHHC-------CEEHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 9999999999999999887 789999994
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=99.26 E-value=5.8e-12 Score=108.04 Aligned_cols=106 Identities=23% Similarity=0.371 Sum_probs=88.7
Q ss_pred cCCccccCccCCCCCcchHHHHHHhhhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
.|||+... ..+...+...+..++++|...+++++.++..++..++.++...++++|..+|.|++|.|+.+|+..+++.+
T Consensus 3 ~~~~~~~~-~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~ 81 (191)
T 3k21_A 3 HHHHHSSG-RENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKKGLEKD 81 (191)
T ss_dssp ------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHT
T ss_pred CCccccCC-ccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHc
Confidence 47777654 33455666788999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 392 GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 392 g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
|..++ .++..++..+|.| |.|+|+||+
T Consensus 82 g~~~~-~~~~~l~~~~D~d~~g~i~~~EF~ 110 (191)
T 3k21_A 82 GLKLP-YNFDLLLDQIDSDGSGKIDYTEFI 110 (191)
T ss_dssp TCCCC-TTHHHHHHHHCTTCSSSEEHHHHH
T ss_pred CCCcH-HHHHHHHHHhCCCCCCeEeHHHHH
Confidence 99988 8999999999887 689999984
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=115.44 Aligned_cols=143 Identities=20% Similarity=0.347 Sum_probs=105.4
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEec--ccccCChhhHHHHHHHHHHHHhCCC-CCCeeeeeeEEEeC---CeEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSIS--KKKLRTAVDIEDVRREVQIMKHLPK-HPNIVSLKDTYEDD---SAVHI 134 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~--~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~---~~~~l 134 (419)
++.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|..+++.|.. +..+++++.++.+. +..|+
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 56789999999999884 35688888775 33211 123467889999999843 34688888888766 45899
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE--------------------------------------- 175 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------- 175 (419)
||||++|..+.+.. ...+++.+...++.+++.+|..||+
T Consensus 119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99999998875422 2346788899999999999999997
Q ss_pred -------------------cCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 176 -------------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 176 -------------------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
..++|||++|.|||++.++. ..+.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence 35899999999999975432 33689999988653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.22 E-value=3.4e-11 Score=111.21 Aligned_cols=185 Identities=18% Similarity=0.238 Sum_probs=125.3
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCC--eeeeeeEEEeCC---eEEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPN--IVSLKDTYEDDS---AVHIV 135 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn--Iv~l~~~~~~~~---~~~lv 135 (419)
++.++.|....||++. ..+++|+.... .....+.+|..+++.+..+.. +++++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999853 56888886422 235678899999988844433 445544433333 35889
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE---------------------------------------- 175 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---------------------------------------- 175 (419)
|++++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998876443 347888888999999999999996
Q ss_pred ------------------cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcccccccCcccCchhhhc---cc
Q 014722 176 ------------------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK---RN 234 (419)
Q Consensus 176 ------------------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 234 (419)
..++|+|++|.||+++.+. ...+.|+||+.+....+............-.+|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1369999999999997531 3347899999887654332221111100002333221 12
Q ss_pred CCC------------cccHHHHHHHHHHHHhCCCCC
Q 014722 235 YGP------------EVDVWSAGVILYILLCGVPPF 258 (419)
Q Consensus 235 ~~~------------~~DiwslG~il~~ll~g~~pf 258 (419)
|.. ..+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222 258999999999999998886
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=6.4e-12 Score=95.26 Aligned_cols=65 Identities=18% Similarity=0.318 Sum_probs=60.3
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++..+++++|+.+|+|++|.|+.+||+.+|+.+|..++++|++.++..+|.| |.|+|+||+
T Consensus 29 ~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~EF~ 95 (100)
T 2lv7_A 29 DIPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFEEFV 95 (100)
T ss_dssp CCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHHHHH
Confidence 34567788899999999999999999999999999999999999999999999987 789999995
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=98.97 E-value=7.9e-10 Score=82.06 Aligned_cols=69 Identities=29% Similarity=0.361 Sum_probs=62.7
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++..++.++...++.+|..+|.|++|.|+.+|++.+|+.+|..++++++..++..+|.+ |.|+|+||+
T Consensus 9 ~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~D~~~dg~i~~~eF~ 79 (90)
T 1avs_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFL 79 (90)
T ss_dssp SHHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHH
T ss_pred HHHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 345566778888999999999999999999999999999999999999999999999876 789999994
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=98.96 E-value=5.8e-10 Score=81.97 Aligned_cols=66 Identities=23% Similarity=0.285 Sum_probs=58.4
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..+++++...++.+|..+|.|++|.|+.+|++.+|+.+| .++++++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 69 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFT 69 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcC-CCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4556777888999999999999999999999999999999 99999999999999887 689999984
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.94 E-value=2.1e-09 Score=90.91 Aligned_cols=90 Identities=20% Similarity=0.298 Sum_probs=82.3
Q ss_pred chHHHHHHhhhhhhhhhhhhhHhhhhhhhh--hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHH
Q 014722 328 GETVKARLKQFSVMNKLKKRALQVVAEFLS--VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405 (419)
Q Consensus 328 ~~~~~~~~~~~~~~~~l~~~~l~~~~~~~~--~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~ 405 (419)
...+..++++|...+++++..+..++..++ .++...++++|..+|.|++|.|+.+|+..+|..+|.. +.++..++.
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~g~~--~~~~~~~~~ 80 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYTVLASVGIK--KWDINRILQ 80 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCC--HHHHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCC--HHHHHHHHH
Confidence 456888999999999999999999999887 7888999999999999999999999999999999864 689999999
Q ss_pred HcCCC--CCcCccccC
Q 014722 406 AVSII--CLLSYFLVC 419 (419)
Q Consensus 406 ~~d~~--g~i~~~~f~ 419 (419)
.+|.+ |.|+|+||+
T Consensus 81 ~~D~d~~g~i~~~Ef~ 96 (180)
T 3mse_B 81 ALDINDRGNITYTEFM 96 (180)
T ss_dssp HHCTTCCSEECHHHHH
T ss_pred HhCCCCCCcCcHHHHH
Confidence 99887 689999984
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=98.93 E-value=6.1e-10 Score=84.02 Aligned_cols=61 Identities=20% Similarity=0.222 Sum_probs=54.4
Q ss_pred HHHhhHHHHHhhhC-CCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+.++|+.|| +|++ |+|+.+||+.+|+. +|..+++++++++|+.+|.| |.|+|+||+
T Consensus 7 ~~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~EF~ 76 (101)
T 3nso_A 7 QAVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYV 76 (101)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 34578999999997 8887 99999999999997 57889999999999999886 799999994
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.91 E-value=5.2e-10 Score=92.06 Aligned_cols=60 Identities=20% Similarity=0.292 Sum_probs=56.1
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC-CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII-CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-g~i~~~~f~ 419 (419)
..+.++++|+.||.|++|+|+.+||+.+|..+|.++|++|++.|+..+|.+ |.|+|+||+
T Consensus 83 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~ei~~~~~~~D~~dG~I~y~EF~ 143 (153)
T 3i5g_B 83 PEDALRNAFSMFDEDGQGFIPEDYLKDLLENMGDNFSKEEIKNVWKDAPLKNKQFNYNKMV 143 (153)
T ss_dssp CHHHHHHHHHTTCSSCSSCCCHHHHHHHHHSSSSCCCHHHHHHHHTTCCEETTEECHHHHH
T ss_pred cHHHHHHHHhccccCCCCeEeHHHHHHHHHHcCCcCCHHHHHHHHHHhCCCcCEEcHHHHH
Confidence 346799999999999999999999999999999999999999999999875 899999995
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-09 Score=83.88 Aligned_cols=62 Identities=21% Similarity=0.245 Sum_probs=55.7
Q ss_pred hHHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|+.|| .|++| +|+.+||+.+|+. +|..+++++++.+|..+|.| |.|+|+||+
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~EF~ 88 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYC 88 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 455678999999999 89997 9999999999987 77888999999999999987 789999994
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.3e-09 Score=80.14 Aligned_cols=65 Identities=15% Similarity=0.023 Sum_probs=59.3
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHH---HHHHHHHcCCC--CCcCccccC
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD---LQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e---~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.++...++++|..+|.|++|.|+.+|++.+|+.+|..+++.+ +..++..+|.+ |.|+| +|+
T Consensus 6 ~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~ 75 (86)
T 1j7q_A 6 RALGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWL 75 (86)
T ss_dssp CCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHH
T ss_pred ccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHH
Confidence 3456677888999999999999999999999999999999999999 99999999876 78999 984
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1.6e-09 Score=81.17 Aligned_cols=61 Identities=26% Similarity=0.187 Sum_probs=55.7
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|..+|+|++|+|+.+|++.+|+.+| ++++++..++..+|.| |.|+|+||+
T Consensus 5 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~ 67 (95)
T 1c07_A 5 SPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFA 67 (95)
T ss_dssp CSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHH
Confidence 456778899999999999999999999999999987 6899999999999876 789999994
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=98.88 E-value=9.4e-10 Score=78.90 Aligned_cols=63 Identities=27% Similarity=0.403 Sum_probs=58.1
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|..+|.|++|.|+.+|++.+++.+|..++++++..++..+|.+ |.|+|+||+
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 66 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKVAMRALGFDVKKPEILELMNEYDREGNGYIGFDDFL 66 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCHHHHHHHHHHHHCCSSSSEEEHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHH
Confidence 456678899999999999999999999999999999999999999999999876 789999984
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.8e-09 Score=80.82 Aligned_cols=61 Identities=20% Similarity=0.342 Sum_probs=56.4
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..+.++++|..+|.|++|.|+.+|++.+|+.+|..+++++++.++..+|.| |.|+|+||+
T Consensus 26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~ 88 (94)
T 2kz2_A 26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 88 (94)
T ss_dssp SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 4456789999999999999999999999999999999999999999999876 789999994
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.3e-09 Score=81.24 Aligned_cols=61 Identities=16% Similarity=0.143 Sum_probs=55.5
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|+.+|+|++|+|+.+|++.+|+.+| ++++++..++..+|.| |.|+|+||+
T Consensus 4 s~~~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g--~~~~~~~~i~~~~D~d~dG~i~~~EF~ 66 (92)
T 1fi6_A 4 TDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFC 66 (92)
T ss_dssp CHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 456778899999999999999999999999999987 6889999999999876 789999994
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.9e-09 Score=87.76 Aligned_cols=83 Identities=48% Similarity=0.691 Sum_probs=74.3
Q ss_pred hhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcC
Q 014722 337 QFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLS 414 (419)
Q Consensus 337 ~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~ 414 (419)
+|...+.+++..+..++..++.++...++++|..+|.|++|.|+.+|+..++..+|..+++.++..++..+|.+ |.|+
T Consensus 2 ~f~~~~~~~~~~~~~~~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~ 81 (166)
T 2aao_A 2 QFSAMNKFKKMALRVIAESLSEEEIAGLKEMFNMIDADKSGQITFEELKAGLKRVGANLKESEILDLMQAADVDNSGTID 81 (166)
T ss_dssp ----CHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHHGGGGTCCCCHHHHHHHHHHHCTTCCSSBC
T ss_pred chhhHHHHHHHHHHHHHHhCCHHHHHHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEc
Confidence 56777888999999999999999999999999999999999999999999999999999999999999999887 6899
Q ss_pred ccccC
Q 014722 415 YFLVC 419 (419)
Q Consensus 415 ~~~f~ 419 (419)
|.||+
T Consensus 82 ~~ef~ 86 (166)
T 2aao_A 82 YKEFI 86 (166)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99983
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.2e-09 Score=78.26 Aligned_cols=65 Identities=20% Similarity=0.245 Sum_probs=58.3
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.++...++++|..+|.|++|.|+.+|++.+|+.+| ++.+++..++..+|.| |.|+|+||+
T Consensus 18 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dg~I~~~EF~ 84 (91)
T 2pmy_A 18 GADGDGEELARLRSVFAACDANRSGRLEREEFRALCTELR--VRPADAEAVFQRLDADRDGAITFQEFA 84 (91)
T ss_dssp -CHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEECHHHHT
T ss_pred hccCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcC--cCHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence 3455677788999999999999999999999999999999 7899999999999876 789999995
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-09 Score=80.46 Aligned_cols=67 Identities=40% Similarity=0.589 Sum_probs=59.4
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..++.++...++++|..+|.|++|.|+.+|++.+|+.+|..++++++..++..+|.+ |.|+|++|+
T Consensus 14 ~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~ 82 (87)
T 1s6j_A 14 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFI 82 (87)
T ss_dssp SSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHT
T ss_pred HHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3344555567789999999999999999999999999999999999999999999876 789999995
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.82 E-value=3.4e-09 Score=73.60 Aligned_cols=57 Identities=26% Similarity=0.309 Sum_probs=53.5
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++++|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~ 60 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFT 60 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCcCcHHHHH
Confidence 578999999999999999999999999999999999999999999876 789999984
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=5e-09 Score=79.55 Aligned_cols=61 Identities=20% Similarity=0.193 Sum_probs=52.8
Q ss_pred HHHhhHHHHHhhhC-CCCC-CcccHHHHHHHHHh-CC----CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-GG----QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++++|+.|| .|++ |+|+.+||+.+|+. +| ..+++++++.+|+.+|.| |.|+|+||+
T Consensus 10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~EF~ 79 (104)
T 3zwh_A 10 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYC 79 (104)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHHHHH
Confidence 44578999999997 6775 89999999999996 54 567899999999999987 799999994
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.82 E-value=3.2e-09 Score=87.87 Aligned_cols=59 Identities=24% Similarity=0.242 Sum_probs=54.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC--C--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI--I--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~--~--g~i~~~~f~ 419 (419)
...++++|+.||+|++|+|+.+||+.+|..+|..++++|+..|+..+|. | |.|+|+||+
T Consensus 84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~D~~~d~dG~I~~~EF~ 146 (159)
T 3i5g_C 84 ADEFMEAFKTFDREGQGLISSAEIRNVLKMLGERITEDQCNDIFTFCDIREDIDGNIKYEDLM 146 (159)
T ss_dssp HHHHHHHHHHHCTTSSSEECHHHHHHHHHHSSSCCCHHHHHHHHHHTTCCCCSSCCEEHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCCCeEeHHHHH
Confidence 4578999999999999999999999999999999999999999999874 3 799999994
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=98.82 E-value=3.7e-09 Score=78.63 Aligned_cols=63 Identities=21% Similarity=0.408 Sum_probs=57.9
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+....++++|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.+ |.|+|++|+
T Consensus 4 ~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~dg~i~~~eF~ 68 (92)
T 2kn2_A 4 DTDAEEELKEAFKVFDKDQNGYISASELRHVMINLGEKLTDEEVEQMIKEADLDGDGQVNYEEFV 68 (92)
T ss_dssp CCHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCCSSEEHHHHH
T ss_pred CccHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 345667899999999999999999999999999999999999999999999876 789999984
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=9.7e-08 Score=87.93 Aligned_cols=138 Identities=18% Similarity=0.245 Sum_probs=97.0
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-C-CeeeeeeEEE-eCCeEEEEEEe
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-P-NIVSLKDTYE-DDSAVHIVMEL 138 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p-nIv~l~~~~~-~~~~~~lv~e~ 138 (419)
+.++.|....||+. |..+++|+.. .......+.+|..+|+.|..| + .+++++.+.. ..+..++|||+
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788888899987 5778888753 223456788999999999443 2 3566666664 45567899999
Q ss_pred cCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 014722 139 CEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ------------------------------------------ 176 (419)
Q Consensus 139 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------ 176 (419)
++|.++.+... ..++..+...++.++...|..||+.
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 99988876432 2345666666666666666666642
Q ss_pred ------------------CCEeeCCCCCcEEeecCCCCCC-eEEeecccceecc
Q 014722 177 ------------------GVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFR 211 (419)
Q Consensus 177 ------------------~ivHrDlkp~NIl~~~~~~~~~-~kl~Dfg~a~~~~ 211 (419)
.++|+|++|.||+++.++.++. +.|+||+.+....
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3499999999999975222233 4799999887644
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=98.80 E-value=5.2e-09 Score=79.81 Aligned_cols=60 Identities=18% Similarity=0.182 Sum_probs=55.0
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|+.+|+ ++|+|+.+|++.+|+++| ++++++.+++..+|.| |.|+|+||+
T Consensus 10 s~~e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~id~~EF~ 71 (106)
T 1eh2_A 10 KPEDKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFA 71 (106)
T ss_dssp CHHHHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTT--CCHHHHHHHHHHHCSSCSSBCCHHHHH
T ss_pred CHHHHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 46677889999999999 999999999999999987 7899999999999986 799999994
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=98.80 E-value=4.1e-09 Score=79.56 Aligned_cols=61 Identities=11% Similarity=0.029 Sum_probs=54.7
Q ss_pred HHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|+.|| .|++| +|+.+||+.+|+. +|..++++++..++..+|.| |.|+|+||+
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~ 76 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKELLNAELTDFLMSQKDPMLVEKIMNDLDSNKDNEVDFNEFV 76 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSGGGGTTSCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHCCCCCCcCcHHHHH
Confidence 44678999999997 89988 9999999999987 67889999999999999987 789999994
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=2.8e-09 Score=74.99 Aligned_cols=59 Identities=24% Similarity=0.440 Sum_probs=55.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 65 (71)
T 2b1u_A 5 LEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYEEFA 65 (71)
T ss_dssp HHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETTHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45789999999999999999999999999999999999999999999876 789999984
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.79 E-value=4.2e-09 Score=79.49 Aligned_cols=59 Identities=14% Similarity=0.133 Sum_probs=53.7
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|+.+|+|++|+|+.+|++.+|+.+| ++++++.+++..+|.| |.|+|+||+
T Consensus 8 ~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~--l~~~~l~~i~~~~D~d~dG~i~~~EF~ 68 (99)
T 1qjt_A 8 SGNPVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFF 68 (99)
T ss_dssp TTCTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHH
T ss_pred hhHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcCCHHHHH
Confidence 4456799999999999999999999999999987 6899999999999876 799999994
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=6.3e-09 Score=77.45 Aligned_cols=61 Identities=20% Similarity=0.193 Sum_probs=51.4
Q ss_pred HHHhhHHHHHhhhC-CCCC-CcccHHHHHHHHHh-CC----CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-GG----QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-lg----~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++++|+.|| .|++ |+|+.+||+.+|+. +| ...++++++++++.+|.| |.|+|+||+
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~ 76 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYC 76 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 34578999999998 6774 89999999999986 65 456899999999999987 799999994
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4e-09 Score=79.01 Aligned_cols=61 Identities=8% Similarity=0.106 Sum_probs=48.9
Q ss_pred HHHhhHHHHHhhhC-CCC-CCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNK-RGKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~-~g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|+.|| .|+ +|+|+.+||+.+|+. +|..+++++++.++..+|.| |.|+|+||+
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~EF~ 75 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFI 75 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 44678999999999 788 589999999999987 67788999999999999887 789999994
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.6e-09 Score=92.34 Aligned_cols=93 Identities=23% Similarity=0.313 Sum_probs=84.7
Q ss_pred cchHHHHHHhhhhhhhhhhhhhHhhhhhhh-hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-----------CCC
Q 014722 327 LGETVKARLKQFSVMNKLKKRALQVVAEFL-SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----------GQN 394 (419)
Q Consensus 327 ~~~~~~~~~~~~~~~~~l~~~~l~~~~~~~-~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----------g~~ 394 (419)
+...+..++++|...+++++.++..++..+ +.++...++++|..+|.|++|.|+.+|+..++..+ |..
T Consensus 4 ~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~ 83 (191)
T 3khe_A 4 ALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIEGYRKLMQWKGDTVSDLDSS 83 (191)
T ss_dssp HHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHC-----CCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHHHhhcccccccccch
Confidence 345678899999999999999999999988 78888999999999999999999999999999987 777
Q ss_pred CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 395 IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 395 ~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+++++..++..+|.| |.|+|+||+
T Consensus 84 ~~~~~~~~~~~~~D~d~~g~i~~~ef~ 110 (191)
T 3khe_A 84 QIEAEVDHILQSVDFDRNGYIEYSEFV 110 (191)
T ss_dssp HHHHHHHHHHHHTCTTCSSSEEHHHHH
T ss_pred hhHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 8889999999999877 789999983
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.78 E-value=4.5e-09 Score=85.83 Aligned_cols=59 Identities=19% Similarity=0.415 Sum_probs=55.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++++|+.+|.|++|+|+.+||+.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 82 ~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~EF~ 142 (148)
T 2lmt_A 82 EEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYEEFV 142 (148)
T ss_dssp HHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHHHHH
T ss_pred HHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 35689999999999999999999999999999999999999999999987 799999995
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=98.77 E-value=8.7e-09 Score=76.67 Aligned_cols=60 Identities=15% Similarity=0.151 Sum_probs=54.2
Q ss_pred HHHhhHHHHHhhhCCCCCC---cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRG---KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g---~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++++|+.+| +++| .|+.+||+.+|+. +|..+++++++.++..+|.| |.|+|+||+
T Consensus 6 ~~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~ 75 (92)
T 3rm1_A 6 KAVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQEFM 75 (92)
T ss_dssp HHHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHHHHH
Confidence 34567899999999 7766 9999999999999 99999999999999999987 799999994
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.77 E-value=8.2e-09 Score=86.95 Aligned_cols=59 Identities=25% Similarity=0.321 Sum_probs=54.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++++|+.||.|++|+|+.+||+.+|..+|..++++|++.|++.+| | |.|+|+||+
T Consensus 82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~EF~ 142 (176)
T 2lhi_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFA 142 (176)
T ss_dssp HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTTHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHHHHH
Confidence 4467899999999999999999999999999999999999999999987 5 799999994
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.76 E-value=2e-08 Score=81.42 Aligned_cols=60 Identities=20% Similarity=0.292 Sum_probs=55.8
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 77 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~eF~ 138 (143)
T 2obh_A 77 TKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFL 138 (143)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 346789999999999999999999999999999999999999999999887 799999994
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=98.76 E-value=4.1e-10 Score=104.52 Aligned_cols=133 Identities=24% Similarity=0.241 Sum_probs=91.1
Q ss_pred CccCCHHHHHHHHHhc---CCCCCCCCCHHHHhcC------CccccCccCC----------------CCCc-------ch
Q 014722 282 WPKVSENAKDLVKKML---NPDPKQRLTAEEVLEH------PWLQNAKKAP----------------NVSL-------GE 329 (419)
Q Consensus 282 ~~~~~~~~~~li~~~L---~~dp~~R~s~~~~l~~------~~~~~~~~~~----------------~~~~-------~~ 329 (419)
|.+.+.++.+|.++++ ..+|+.|...++.+.| +|+....... .... ..
T Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~ 93 (323)
T 1ij5_A 14 VKKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLA 93 (323)
T ss_dssp HHHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhH
Confidence 4456788999999998 8899999999999888 8876541110 0000 01
Q ss_pred HHHHHHh-hhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcC
Q 014722 330 TVKARLK-QFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS 408 (419)
Q Consensus 330 ~~~~~~~-~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d 408 (419)
.++.+++ +|...+.+++ ++..++.++...++.+|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|
T Consensus 94 ~vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~~L~~lg~~~~~~~i~~l~~~~D 168 (323)
T 1ij5_A 94 SLLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVE 168 (323)
T ss_dssp HHHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhc
Confidence 2333343 4444444443 334567788899999999999999999999999999999999999999999999998
Q ss_pred CC--CCcCccccC
Q 014722 409 II--CLLSYFLVC 419 (419)
Q Consensus 409 ~~--g~i~~~~f~ 419 (419)
.+ |.|+|.+|+
T Consensus 169 ~d~~G~I~f~ef~ 181 (323)
T 1ij5_A 169 NDTKGRMSYITLV 181 (323)
T ss_dssp HCCSSTHHHHHHT
T ss_pred CCCCCcCcHHHHH
Confidence 76 689998884
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.74 E-value=7.5e-09 Score=79.90 Aligned_cols=61 Identities=16% Similarity=0.161 Sum_probs=55.3
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|..+|+|++|+|+.+|++.+|+ |..++++++..++..+|.| |.|+|+||+
T Consensus 9 s~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~--~~~~~~~~~~~i~~~~D~d~dG~I~~~EF~ 71 (111)
T 2kgr_A 9 PQSSRLKYRQLFNSHDKTMSGHLTGPQARTILM--QSSLPQAQLASIWNLSDIDQDGKLTAEEFI 71 (111)
T ss_dssp CHHHHHHHHHHHHTTSCSSCCEEEHHHHHHHHH--TTCCCHHHHHHHHHHHCSSCCSEEEHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHH--hCCCCHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 456678899999999999999999999999999 6778999999999999876 789999994
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.74 E-value=4.3e-09 Score=81.96 Aligned_cols=59 Identities=12% Similarity=0.161 Sum_probs=54.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.+..+|+.+|.| +|+|+.+||+.+|++ +|...++++++.||+.+|.| |.|+|+||+
T Consensus 13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~EF~ 78 (121)
T 4drw_A 13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFF 78 (121)
T ss_dssp HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHHHHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 457899999999988 899999999999987 78899999999999999998 799999994
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-07 Score=85.24 Aligned_cols=133 Identities=16% Similarity=0.201 Sum_probs=97.0
Q ss_pred cccccce-EEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEecCCc
Q 014722 64 LGRGEFG-VTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGG 142 (419)
Q Consensus 64 lg~G~~g-~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~~~g 142 (419)
+..|..| .||+......+..+++|+-... ....+.+|...|+.|..+--+.+++.++.+.+..++|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 3445444 6899887677888999986532 34568889999999865555788999999999999999999998
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 014722 143 ELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---------------------------------------------- 176 (419)
Q Consensus 143 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------------- 176 (419)
++.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887655432 223345666666677777632
Q ss_pred ------------CCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 177 ------------GVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 177 ------------~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++|+|+.|.|||++.. ..+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~---~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEG---KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECC---eEEEEEECccccc
Confidence 14899999999999743 2356999998764
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.72 E-value=8.1e-09 Score=96.61 Aligned_cols=70 Identities=29% Similarity=0.361 Sum_probs=64.7
Q ss_pred hhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 350 ~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+.++.++..+++++|+.+|.|++|.|+.+||+.+|+.+|..++++|+..++..+|.| |.|+|+||+
T Consensus 290 ePs~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~aLrsLG~~~TeeEI~~Lf~~~D~DgDG~IdFeEFl 361 (440)
T 3u0k_A 290 EPTRDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGDGTIDFPEFL 361 (440)
T ss_dssp CCBCBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCSSSEEHHHHH
T ss_pred HhhHhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3445677899999999999999999999999999999999999999999999999999987 689999994
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=98.72 E-value=3e-09 Score=79.68 Aligned_cols=62 Identities=13% Similarity=0.095 Sum_probs=54.9
Q ss_pred hHHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|+.|| +|++| +|+.+||+.+|+. +|..++++++..++..+|.| |.|+|+||+
T Consensus 8 e~~~~~l~~~F~~fD~~dg~gg~I~~~El~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~EF~ 78 (95)
T 2wcb_A 8 EEHLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFI 78 (95)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEEEHHHHHHHHHHHTHHHHHHCCCHHHHHHHHTTSSSSTTSEEEHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCccCHHHHHHHHHHHhhhhccccccHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 344678999999999 89998 9999999999987 67788999999999999987 689999994
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=98.72 E-value=1.4e-09 Score=83.77 Aligned_cols=61 Identities=13% Similarity=0.084 Sum_probs=54.9
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|..+|+|++|+|+.+|++.+|+.+| ++++++.+++..+|.| |.|+|+||+
T Consensus 17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~g--l~~~el~~i~~~~D~d~dG~I~~~EF~ 79 (110)
T 1iq3_A 17 TEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFC 79 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 456678899999999999999999999999999887 6778999999999876 789999994
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.72 E-value=1.3e-08 Score=78.03 Aligned_cols=62 Identities=27% Similarity=0.280 Sum_probs=57.8
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++.+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.+ |.|+|++|+
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~i~~~eF~ 91 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKKLIGEVSSGSGETFSYPDFL 91 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSEECHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 56678899999999999999999999999999999999999999999999877 789999984
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.70 E-value=7.6e-09 Score=87.17 Aligned_cols=66 Identities=26% Similarity=0.361 Sum_probs=61.1
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.++..+++++|..+|+|++|.|+.+||+.+|+.+|..+++.++..++..+|.+ |.|+|.+|+
T Consensus 3 ~~Lt~eqi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~d~d~~~~i~~~ef~ 70 (176)
T 2lhi_A 3 SNLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFL 70 (176)
T ss_dssp CCCCTTGGGHHHHHHHTTCSSCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTTCSSCSSSBCTTHHH
T ss_pred CcCCHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCChhHHHHHHHHHHhCcCCCccchHHHHH
Confidence 356788889999999999999999999999999999999999999999999999987 689999983
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=98.69 E-value=3.2e-08 Score=74.63 Aligned_cols=61 Identities=18% Similarity=0.113 Sum_probs=51.5
Q ss_pred HHHhhHHHHHhhhCCCC---CCcccHHHHHHHHHh-CCCCCC----HHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNK---RGKINLEELRLGLLK-GGQNIP----EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~---~g~i~~~el~~~l~~-lg~~~~----~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++++|+.||.++ +|+|+.+||+.+|+. +|..++ +++++.+|+.+|.| |.|+|+||+
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~EF~ 78 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFDEYW 78 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 34567999999999964 799999999999987 444444 78999999999987 799999994
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.69 E-value=2.2e-08 Score=76.40 Aligned_cols=60 Identities=22% Similarity=0.216 Sum_probs=55.6
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++++|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~e~~~l~~~~d~~~~g~i~~~eF~ 83 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFL 83 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 356789999999999999999999999999999999999999999999876 789999994
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=98.68 E-value=3.5e-09 Score=77.12 Aligned_cols=61 Identities=18% Similarity=0.171 Sum_probs=55.6
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC--CCCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG--QNIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg--~~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
+....++.+|..+|.|++|.|+.+|++.++..+| ..++++++.. ++..+|.+ |.|+|+||+
T Consensus 4 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~eF~ 72 (83)
T 1yx7_A 4 KVKAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKEEFL 72 (83)
T ss_dssp CSCTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHHHHH
T ss_pred cHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 4456789999999999999999999999999999 8899999999 99999876 789999994
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=98.67 E-value=1e-08 Score=73.64 Aligned_cols=57 Identities=25% Similarity=0.358 Sum_probs=53.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++.+|..+|.|++|.|+.+|++.+++.+| .++++++..++..+|.+ |.|+|+||+
T Consensus 3 ~~l~~~F~~~D~~~~G~i~~~el~~~l~~~g-~~~~~~~~~~~~~~D~~~dg~i~~~ef~ 61 (78)
T 1k9u_A 3 DDMERIFKRFDTNGDGKISLSELTDALRTLG-STSADEVQRMMAEIDTDGDGFIDFNEFI 61 (78)
T ss_dssp CHHHHHHHHHCTTCSSEECHHHHHHHHHHHH-TCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHHHHHHhC-CCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 4688999999999999999999999999999 99999999999999876 789999984
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=98.67 E-value=6.8e-09 Score=75.18 Aligned_cols=60 Identities=22% Similarity=0.352 Sum_probs=54.8
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+....++ +|..+|.|++|.|+.+|++.++..+| ..++++++..++..+|.+ |.|+|+||+
T Consensus 6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 68 (81)
T 1c7v_A 6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFM 68 (81)
T ss_dssp -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHH
T ss_pred cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3456788 99999999999999999999999999 999999999999999987 789999984
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=98.67 E-value=3.5e-08 Score=80.37 Aligned_cols=62 Identities=24% Similarity=0.228 Sum_probs=57.8
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++.+|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~~~eF~ 107 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKRMLEKLGVPKTHLELKRLIREVSSGSEETFSYSDFL 107 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSCTTEECHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 46677899999999999999999999999999999999999999999999876 789999994
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.3e-08 Score=80.19 Aligned_cols=60 Identities=22% Similarity=0.223 Sum_probs=55.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|+|++|.|+.+|++.++..+| ..++++++..++..+|.| |.|+|+||+
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~e~~~~~~~~D~d~dG~I~~~EF~ 100 (135)
T 3h4s_E 38 FVSELCKGFSLLADPERHLITAESLRRNSGILGIEGMSKEDAQGMVREGDLDGDGALNQTEFC 100 (135)
T ss_dssp HHHHHHHHHHHHSBTTTTBBCHHHHHHHGGGGTCCCCCHHHHHHHHHHHCSSCSSSBCHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 456789999999999999999999999999999 599999999999999876 799999994
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=98.66 E-value=1e-08 Score=78.21 Aligned_cols=62 Identities=11% Similarity=0.130 Sum_probs=52.8
Q ss_pred hHHHhhHHHHHhhhC-CCCC-CcccHHHHHHHHHh-CCCCCC-HHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-GGQNIP-EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-lg~~~~-~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|+.|| .|++ |+|+.+||+.+|+. +|...+ +++++.+|..+|.| |.|+|+||+
T Consensus 18 e~~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~EF~ 85 (106)
T 2h2k_A 18 EESIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYW 85 (106)
T ss_dssp HHHHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 344678999999999 7986 79999999999986 786553 57899999999987 799999994
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=98.65 E-value=6.6e-08 Score=78.64 Aligned_cols=60 Identities=22% Similarity=0.338 Sum_probs=55.6
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 81 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~ 142 (148)
T 1exr_A 81 SEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFV 142 (148)
T ss_dssp HHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 346788999999999999999999999999999999999999999999876 799999994
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=98.64 E-value=2.3e-08 Score=93.61 Aligned_cols=60 Identities=20% Similarity=0.353 Sum_probs=55.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++++|+.+|.|++|+|+.+||+.+|..+|..++++|++.+|+.+|.| |.|+|+||+
T Consensus 373 ~eeeLreAFk~fDkDgdG~IS~eELr~vL~~lGe~LSdeEIdeLfke~D~DgDGkIsyeEFv 434 (440)
T 3u0k_A 373 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 434 (440)
T ss_dssp -CHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred hHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 346789999999999999999999999999999999999999999999987 799999994
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-08 Score=80.16 Aligned_cols=59 Identities=17% Similarity=0.182 Sum_probs=53.6
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|+.+| |++|+|+.+|++.+|+++| ++++++.+|+..+|.| |.|+|+||+
T Consensus 47 ~~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~g--l~~~el~~I~~~~D~d~dG~Ld~~EF~ 107 (139)
T 2jq6_A 47 GKDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSK--LPNTVLGKIWKLADVDKDGLLDDEEFA 107 (139)
T ss_dssp GGTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCSSCCSEEEHHHHH
T ss_pred hHHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 345678999999999 9999999999999999987 7899999999999986 789999994
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.2e-08 Score=75.83 Aligned_cols=60 Identities=13% Similarity=0.188 Sum_probs=53.1
Q ss_pred HHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh---CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK---GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|..+| +|++| .|+.+||+.+|+. +|. +++.++..++..+|.| |.|+|+||+
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~-~~~~~i~~~~~~~D~d~dG~I~f~EF~ 73 (92)
T 2kax_A 7 KALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGE-MKESSIDDLMKSLDKNSDQEIDFKEYS 73 (92)
T ss_dssp HHHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTT-TCCTTHHHHHHHHTTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCC-CCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 44678999999999 99999 9999999999997 345 8889999999999987 689999994
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=98.62 E-value=1.9e-08 Score=74.91 Aligned_cols=61 Identities=11% Similarity=0.071 Sum_probs=55.6
Q ss_pred HHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+....++++|..+| .|++| .|+.+|++.++.. +|..++++++..++..+|.| |.|+|+||+
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~~l~~~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 75 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFV 75 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHHHHHHHTHHHHHCCCCHHHHHHHHHHHHHCTTSCCCHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 44568999999999 79999 9999999999998 99999999999999999876 789999994
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=98.62 E-value=2.1e-08 Score=81.27 Aligned_cols=62 Identities=16% Similarity=0.340 Sum_probs=57.4
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|..+|.|++|.|+.+|+..+|+.+|..+++.++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 65 (143)
T 2obh_A 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFL 65 (143)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeeeHHHHH
Confidence 45677899999999999999999999999999999999999999999999987 689999984
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=98.61 E-value=4.6e-09 Score=72.71 Aligned_cols=56 Identities=18% Similarity=0.186 Sum_probs=51.8
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++++|..+|.|++|.|+.+|++.+++.+|..++++++..++..+|.+ |.|+|+||+
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef~ 59 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFA 59 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSCCHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHccCCCcHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 45789999999999999999999999999999999999999999887 789999984
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=98.60 E-value=4.6e-08 Score=75.75 Aligned_cols=61 Identities=13% Similarity=0.073 Sum_probs=53.8
Q ss_pred HHHhhHHHHHhhhCC-CCCC-cccHHHHHHHHH-hCCCC-----CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDT-NKRG-KINLEELRLGLL-KGGQN-----IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l~-~lg~~-----~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|..+|. |++| .|+.+||+.+|+ .+|.. ++++++..+|..+|.| |.|+|+||+
T Consensus 9 ~~~~~l~~~F~~fD~~dgdG~~Is~~El~~~l~~~lg~~~~~~~~~~~~v~~l~~~~D~d~dG~I~f~EF~ 79 (113)
T 1xk4_C 9 RNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFI 79 (113)
T ss_dssp HHHHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhhcccccCHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence 345789999999995 9999 999999999999 78853 6899999999999987 789999994
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=98.59 E-value=5.4e-08 Score=79.58 Aligned_cols=62 Identities=23% Similarity=0.272 Sum_probs=57.4
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+....++++|..+|.|++|.|+.+|++.+|+.+|..++++++..++..+|.| |.|+|+||+
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~D~d~dg~I~~~eF~ 109 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKRMMEKLGVPKTHLEMKKMISEVTGGVSDTISYRDFV 109 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSCSSBCHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 45667899999999999999999999999999999999999999999999876 789999994
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=98.58 E-value=9.4e-09 Score=73.31 Aligned_cols=59 Identities=24% Similarity=0.274 Sum_probs=54.5
Q ss_pred HhhHHHHHhhh-CCCCC-CcccHHHHHHHHHhCCCCC--CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMM-DTNKR-GKINLEELRLGLLKGGQNI--PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~lg~~~--~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|..+ |.|++ |.|+.+|++.+|..+|..+ +++++..++..+|.+ |.|+|+||+
T Consensus 4 ~~~l~~~F~~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~ 68 (76)
T 1qx2_A 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFL 68 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHHcccCCCcCeECHHHHHHHHHHhCCCcCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 45788999999 99999 9999999999999999999 999999999999876 789999984
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=98.58 E-value=3.3e-08 Score=75.81 Aligned_cols=60 Identities=20% Similarity=0.267 Sum_probs=55.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 103 (108)
T 2pvb_A 39 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFA 103 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 35678999999999999999999999999999 8899999999999999876 789999984
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=98.57 E-value=4e-08 Score=75.45 Aligned_cols=60 Identities=22% Similarity=0.204 Sum_probs=55.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.| |.|+|+||+
T Consensus 40 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~EF~ 104 (109)
T 3fs7_A 40 TPDQIKKVFGILDQDKSGFIEEEELQLFLKNFSSSARVLTSAETKAFLAAGDTDGDGKIGVEEFQ 104 (109)
T ss_dssp CHHHHHHHHHHHSTTCSSSBCHHHHHTTGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCeEeHHHHHHHHHHHhcccccCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34568899999999999999999999999999 8999999999999999887 789999994
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.57 E-value=4e-08 Score=75.50 Aligned_cols=60 Identities=25% Similarity=0.263 Sum_probs=55.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.+|..+ |..++++++..++..+|.| |.|+|+||+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 103 (109)
T 5pal_A 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFA 103 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34568899999999999999999999999998 9999999999999999887 789999984
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=98.56 E-value=3.4e-08 Score=75.90 Aligned_cols=60 Identities=22% Similarity=0.228 Sum_probs=55.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 104 (109)
T 1bu3_A 40 SADDIKKAFFVIDQDKSGFIEEDELKLFLQVFSAGARALTDAETKAFLKAGDSDGDGAIGVDEWA 104 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSSEEHHHHHTHHHHHSTTCCCCCHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 35678899999999999999999999999999 8899999999999999887 689999984
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=98.56 E-value=3.7e-08 Score=75.79 Aligned_cols=60 Identities=20% Similarity=0.278 Sum_probs=55.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 40 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 104 (110)
T 1pva_A 40 SANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFE 104 (110)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 45678999999999999999999999999999 8899999999999999876 789999984
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.4e-08 Score=75.66 Aligned_cols=61 Identities=8% Similarity=0.130 Sum_probs=54.5
Q ss_pred HHHhhHHHHHhhhCC-CCCC-cccHHHHHHHH-HhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDT-NKRG-KINLEELRLGL-LKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l-~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+....++.+|..+|. |++| .|+.+||+.+| +.+|..++..++..++..+|.| |.|+|+||+
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~ 72 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFL 72 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHHHHHHHHCcccCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 345679999999999 9999 99999999999 7899877778899999999887 789999994
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1e-08 Score=77.52 Aligned_cols=61 Identities=11% Similarity=0.049 Sum_probs=53.1
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHh-----CCC--CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQ--NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----lg~--~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++...++++|+.||.+ +|+|+.+||+.+|+. +|. .+++++++.+|+.+|.| |.|+|+||+
T Consensus 6 ~~~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~EF~ 75 (100)
T 1psr_A 6 ERSIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFL 75 (100)
T ss_dssp HHHHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHH
T ss_pred HHHHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34567899999999976 799999999999987 565 67888999999999987 799999994
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=98.55 E-value=4.4e-08 Score=75.22 Aligned_cols=61 Identities=20% Similarity=0.203 Sum_probs=55.6
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 38 ~~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 103 (109)
T 1rwy_A 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFS 103 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred chHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHhccCCCCCHHHHHHHHHHHCCCCCCcCCHHHHH
Confidence 345678999999999999999999999999998 8899999999999999876 789999984
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=98.55 E-value=4.9e-08 Score=79.46 Aligned_cols=64 Identities=31% Similarity=0.397 Sum_probs=59.1
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|+..+|+.+|..++..++..++..+|.+ |.|+|+||+
T Consensus 4 l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~g~i~~~eF~ 69 (148)
T 1exr_A 4 LTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 69 (148)
T ss_dssp CCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcCcHHHHH
Confidence 4567778899999999999999999999999999999999999999999999887 689999984
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.54 E-value=6.7e-08 Score=77.94 Aligned_cols=59 Identities=19% Similarity=0.262 Sum_probs=55.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 75 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 135 (143)
T 3j04_B 75 EDVIRNAFACFDEEASGFIHEDHLRELLTTMGDRFTDEEVDEMYREAPIDKKGNFNYVEFT 135 (143)
T ss_dssp HHHHHHHHTTSCSSSCCCCCTTTHHHHHHTSSSCCCHHHHHHHHHHTTCCSSSCCCSTHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 45788999999999999999999999999999999999999999999876 799999994
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=98.54 E-value=4.2e-08 Score=85.78 Aligned_cols=83 Identities=12% Similarity=0.263 Sum_probs=74.4
Q ss_pred hhhhhhhhhhhhHhhhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcC
Q 014722 337 QFSVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLS 414 (419)
Q Consensus 337 ~~~~~~~l~~~~l~~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~ 414 (419)
.+...+.+++.....++..++.++...++++|..+|.|++|.|+.+|+..+|..+|..++++++..++..+|.| |.|+
T Consensus 26 ~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~D~d~dg~I~ 105 (220)
T 3sjs_A 26 IYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMGQFPGGIRLSPQTALRMMRIFDTDFNGHIS 105 (220)
T ss_dssp HHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHCCBGGGBCCCHHHHHHHHHHHCTTCSSCBC
T ss_pred ccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCC
Confidence 44455567777777888889999999999999999999999999999999999999999999999999999876 7899
Q ss_pred ccccC
Q 014722 415 YFLVC 419 (419)
Q Consensus 415 ~~~f~ 419 (419)
|+||+
T Consensus 106 ~~EF~ 110 (220)
T 3sjs_A 106 FYEFM 110 (220)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99984
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=98.54 E-value=2.2e-08 Score=75.07 Aligned_cols=60 Identities=12% Similarity=0.151 Sum_probs=52.2
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++...++++|+.||. ++|.|+.+||+.+|+. +|..++++++..++..+|.| |.|+|+||+
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~~l~~~~~~~lg~~~~~~ev~~l~~~~D~d~dG~I~f~EF~ 72 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFF 72 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHH
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHHHHHHHcccccccccCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 446789999999994 5679999999999987 56778999999999999887 789999994
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=98.53 E-value=1.1e-07 Score=78.06 Aligned_cols=63 Identities=27% Similarity=0.412 Sum_probs=57.0
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
.++.++..+++++|..+|+|++|.|+.+||+.+|+.+|..+++.++..++... ++.|+|.+|+
T Consensus 9 ~Lt~~qi~elk~~F~~~D~d~dG~I~~~El~~~l~~lg~~~~~~~~~~~~~~~--~~~i~f~ef~ 71 (153)
T 3i5g_B 9 KLSQRQMQELKEAFTMIDQDRDGFIGMEDLKDMFSSLGRVPPDDELNAMLKEC--PGQLNFTAFL 71 (153)
T ss_dssp TCCHHHHHHHHHHHHHHCCSTTSCCCHHHHHHHHHHTTSCCCHHHHHHHHHTS--SSCCCSHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCccHHHHHHHHHhc--cCCccHHHHH
Confidence 46788899999999999999999999999999999999999999999998754 4779998883
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.52 E-value=1e-07 Score=78.50 Aligned_cols=68 Identities=24% Similarity=0.243 Sum_probs=62.1
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+...++.++...++++|..+|.|+ +|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 8 ~~~~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~eF~ 78 (161)
T 1dtl_A 8 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFL 78 (161)
T ss_dssp GGGGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHhhCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 445567788899999999999999 99999999999999999999999999999999986 789999984
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=98.52 E-value=2.6e-08 Score=73.57 Aligned_cols=61 Identities=16% Similarity=0.198 Sum_probs=54.9
Q ss_pred HHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHHh---CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLLK---GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+....++.+|..+| +|++| .|+.+|++.+++. +|..+++.++..++..+|.| |.|+|+||+
T Consensus 7 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 74 (90)
T 1k8u_A 7 QAIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYV 74 (90)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHhcccCCCCCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 34567899999999 59999 9999999999998 99999999999999999876 789999984
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=98.51 E-value=1.3e-08 Score=84.12 Aligned_cols=65 Identities=17% Similarity=0.183 Sum_probs=56.0
Q ss_pred hhhhHHHhhHHHHHhhhCC--CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC-CCCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI-ICLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-~g~i~~~~f~ 419 (419)
.++.++..+++++|..||. |++|.|+..||+.+|+.+|..+|++|+..++...+. +|.|+|++|+
T Consensus 2 qLt~eqi~elre~F~~fD~~~d~dG~I~~~El~~~lr~lG~~~t~~el~~~~~~d~~~~g~i~f~eFl 69 (159)
T 3i5g_C 2 QLTKDEIEEVREVFDLFDFWDGRDGDVDAAKVGDLLRCLGMNPTEAQVHQHGGTKKMGEKAYKLEEIL 69 (159)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTTSSSCEEGGGHHHHHHHTTCCCCHHHHHTTTCCSSTTSCEECHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHcccccCCCcccHHHHH
Confidence 3577888999999999995 899999999999999999999999999988754322 2789999984
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.51 E-value=8.2e-08 Score=77.68 Aligned_cols=68 Identities=25% Similarity=0.370 Sum_probs=60.7
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
|+..++.++...++++|..+|.|++|.|+.+|+..++..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 1 m~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~ef~ 70 (147)
T 4ds7_A 1 MSQNLTEEQIAEFKEAFALFDKDNSGSISASELATVMRSLGLSPSEAEVADLMNEIDVDGNHAIEFSEFL 70 (147)
T ss_dssp ---CCCHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSEEEHHHHH
T ss_pred CCCcCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcCcHHHHH
Confidence 34566788889999999999999999999999999999999999999999999999887 689999984
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.51 E-value=1.1e-07 Score=79.88 Aligned_cols=67 Identities=31% Similarity=0.393 Sum_probs=59.2
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..++.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~EF~ 70 (179)
T 2f2o_A 2 ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 70 (179)
T ss_dssp ----CCSHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCcHHHHH
Confidence 3456677888999999999999999999999999999999999999999999999887 689999983
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=98.50 E-value=4.9e-08 Score=74.85 Aligned_cols=60 Identities=20% Similarity=0.263 Sum_probs=54.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 103 (108)
T 1rro_A 39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQ 103 (108)
T ss_dssp CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34568899999999999999999999999999 6889999999999999876 789999984
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.49 E-value=7.7e-08 Score=78.10 Aligned_cols=59 Identities=22% Similarity=0.411 Sum_probs=55.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 82 ~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~d~dg~i~~~eF~ 142 (148)
T 1m45_A 82 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 142 (148)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 46788999999999999999999999999999999999999999999876 789999994
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.48 E-value=1.7e-07 Score=77.79 Aligned_cols=60 Identities=20% Similarity=0.295 Sum_probs=55.6
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 93 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~I~~~eF~ 154 (166)
T 2mys_B 93 PEDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNIC 154 (166)
T ss_pred cHHHHHHHHHHhCCCCCcceeHHHHHHHHHHcCCCCCHHHHHHHHHhcCCCCCCeEeHHHHH
Confidence 346788999999999999999999999999999999999999999999876 799999994
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=3.9e-07 Score=87.11 Aligned_cols=81 Identities=17% Similarity=0.192 Sum_probs=50.4
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEeccccc--CC--hhhHHHHHHHHHHHHhCCCC-C-CeeeeeeEEEeCCeEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RT--AVDIEDVRREVQIMKHLPKH-P-NIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~--~~~~~~~~~Ei~~l~~l~~h-p-nIv~l~~~~~~~~~~~l 134 (419)
.+.||.|..+.||++....+++.+++|....... .. ......+..|.++++.+..+ | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4578999999999997656678999998653211 00 01234567788888877332 3 34455543 4455689
Q ss_pred EEEecCCcc
Q 014722 135 VMELCEGGE 143 (419)
Q Consensus 135 v~e~~~~g~ 143 (419)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=98.47 E-value=2.2e-08 Score=71.79 Aligned_cols=60 Identities=18% Similarity=0.098 Sum_probs=54.0
Q ss_pred HHhhHHHHHhhhCC-CCCC-cccHHHHHHHHHh-CCCCC-CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDT-NKRG-KINLEELRLGLLK-GGQNI-PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~-~~~g-~i~~~el~~~l~~-lg~~~-~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|..+|. |++| .|+.+|++.+++. +|..+ +++++..++..+|.+ |.|+|+||+
T Consensus 5 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 70 (78)
T 1cb1_A 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQ 70 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHH
T ss_pred HHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHHHHH
Confidence 35678999999999 9999 9999999999986 88877 888999999999877 789999984
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.47 E-value=1.2e-07 Score=76.72 Aligned_cols=59 Identities=22% Similarity=0.290 Sum_probs=54.8
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++..+|..++++++..++..++.+|.|+|+||+
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~ 141 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKNILTTWGDALTDQEAIDALNAFSSEDNIDYKLFC 141 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSEEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCcCcHHHHH
Confidence 46789999999999999999999999999999999999999999998666999999994
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.47 E-value=3.6e-07 Score=75.90 Aligned_cols=60 Identities=20% Similarity=0.276 Sum_probs=55.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 99 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 160 (169)
T 3qrx_A 99 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFI 160 (169)
T ss_dssp HHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCCSSSSCBCHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence 345788999999999999999999999999999999999999999999887 799999994
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.46 E-value=6.3e-08 Score=78.88 Aligned_cols=67 Identities=25% Similarity=0.278 Sum_probs=61.2
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..++.++...++++|..+|.|++|.|+.+|+..++..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~ 70 (153)
T 3ox6_A 2 DRSLRPEEIEELREAFREFDKDKDGYINCRDLGNCMRTMGYMPTEMELIELSQQINMNLGGHVDFDDFV 70 (153)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHCSSSCCHHHHHHHHHHTTCCCCHHHHHHHHHHHHTTSTTCCCHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCccCcHHHHH
Confidence 3456778889999999999999999999999999999999999999999999999876 789999983
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=98.46 E-value=4.5e-08 Score=79.77 Aligned_cols=64 Identities=34% Similarity=0.419 Sum_probs=59.5
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++..+++++|..+|+|++|.|+.+|++.+++.+|..+++.++..++..+|.+ |.|+|.+|+
T Consensus 4 lt~eqi~el~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 69 (148)
T 2lmt_A 4 LTEEQIAEFKDAFVQFDKEGTGKIATRELGTLMRTLGQNPTEAELQDLIAEAENNNNGQLNFTEFC 69 (148)
T ss_dssp CCSHHHHHHHHHHHHHHCSSCCEEEGGGHHHHHHHHTCCCCHHHHHHHHHHHHTTSTTEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCchHHHHHHHHHhcccCCCCcccHHHHH
Confidence 5678889999999999999999999999999999999999999999999999887 689999883
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-07 Score=76.97 Aligned_cols=60 Identities=23% Similarity=0.267 Sum_probs=55.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHH--cCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA--VSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~--~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|++.++..+|..++++++..++.. +|.| |.|+|+||+
T Consensus 82 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 145 (156)
T 1wdc_C 82 TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFV 145 (156)
T ss_dssp CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCCCcEeHHHHH
Confidence 34678899999999999999999999999999999999999999999 8876 789999994
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.45 E-value=2.3e-07 Score=76.25 Aligned_cols=61 Identities=20% Similarity=0.373 Sum_probs=56.2
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+..+|+.+|.|++|.|+.+|++.+|..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 93 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 155 (161)
T 3fwb_A 93 DPLDEIKRAFQLFDDDHTGKISIKNLRRVAKELGETLTDEELRAMIEEFDLDGDGEINENEFI 155 (161)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCSSSSSSEEHHHHH
T ss_pred CcHHHHHHHHHHHcCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3356789999999999999999999999999999999999999999999876 799999994
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.44 E-value=1.2e-07 Score=76.28 Aligned_cols=62 Identities=23% Similarity=0.317 Sum_probs=57.1
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~ 65 (142)
T 2bl0_C 2 DDQVSEFKEAFELFDSERTGFITKEGLQTVLKQFGVRVEPAAFNEMFNEADATGNGKIQFPEFL 65 (142)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCcCCCCeeeHHHHH
Confidence 45677899999999999999999999999999999999999999999999887 689999984
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.43 E-value=3.1e-07 Score=74.35 Aligned_cols=60 Identities=20% Similarity=0.271 Sum_probs=55.2
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++.. |.+ |.|+|++|+
T Consensus 82 ~~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~-d~~~dg~i~~~eF~ 143 (149)
T 2mys_C 82 GTFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKG-QEDSNGCINYEAFV 143 (149)
T ss_pred chHHHHHHHHHHhCCCCCceEcHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCcEeHHHHH
Confidence 345678999999999999999999999999999999999999999999 887 789999994
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=98.43 E-value=2.4e-07 Score=76.86 Aligned_cols=63 Identities=22% Similarity=0.447 Sum_probs=58.2
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
.++.++...++++|..+|.|++|.|+.+|+..+|..+|. .++..++..++... +|.|+|+||+
T Consensus 18 ~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~l~~~~--dg~i~~~eF~ 81 (166)
T 2mys_B 18 MFDETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIKEA--SGPINFTVFL 81 (166)
T ss_pred hCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHC--CCCcCHHHHH
Confidence 557788889999999999999999999999999999999 99999999999875 7999999984
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-07 Score=80.33 Aligned_cols=61 Identities=18% Similarity=0.257 Sum_probs=54.9
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHH-hCCCC-C------CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLL-KGGQN-I------PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~-~lg~~-~------~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++.+|+.+|.|++|.|+.+||+.+|. .+|.. + +++++..++..+|.| |.|+|+||+
T Consensus 95 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 165 (179)
T 3a8r_A 95 GFDNRLRTFFDMVDKNADGRLTAEEVKEIIALSASANKLSKIKERADEYTALIMEELDPTNLGYIEMEDLE 165 (179)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHTTHHHHHHHHHHHHHHHHHHHHSTTCCSEECHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHHhccccccccccchHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4456899999999999999999999999999 88877 6 889999999999887 789999994
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.42 E-value=2.1e-07 Score=76.44 Aligned_cols=65 Identities=15% Similarity=0.208 Sum_probs=59.8
Q ss_pred hhhhHHHhhHHHHHhhhC-CCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMD-TNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D-~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++++|..+| .|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 6 ~l~~~~~~~l~~~F~~~D~~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~ 73 (158)
T 2jnf_A 6 KLSSNQVKLLETAFRDFETPEGSGRVSTDQIGIILEVLGIQQTKSTIRQLIDEFDPFGNGDIDFDSFK 73 (158)
T ss_dssp TSCHHHHHHHHHHHHHSBCSSSCSSEEHHHHHHHHHHTTCSCSHHHHHHHHHHHCTTCCSEECHHHHH
T ss_pred hCCHHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 346677889999999999 99999999999999999999999999999999999987 689999984
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.42 E-value=2.9e-07 Score=73.99 Aligned_cols=59 Identities=19% Similarity=0.231 Sum_probs=54.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+| + |.|+|+||+
T Consensus 77 ~~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~ 137 (142)
T 2bl0_C 77 SEDILRQAFRTFDPEGTGYIPKAALQDALLNLGDRLKPHEFAEFLGITE-TEKGQIRYDNFI 137 (142)
T ss_dssp CHHHHHHHHHHTCCSSCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHHC-CSSSEECSHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCcEeHHHHH
Confidence 3457889999999999999999999999999999999999999999998 7 789999994
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=98.42 E-value=3.3e-07 Score=76.94 Aligned_cols=60 Identities=20% Similarity=0.353 Sum_probs=53.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 82 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 143 (179)
T 2f2o_A 82 SEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 143 (179)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHC--CCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 446789999999999999999999999999999999999999999999876 789999994
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=98.42 E-value=2.3e-07 Score=76.35 Aligned_cols=67 Identities=22% Similarity=0.335 Sum_probs=61.3
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 14 ~~~l~~~~~~~l~~~F~~~D~~~~G~i~~~e~~~~l~~~~~~~~~~~~~~l~~~~d~~~~g~i~~~eF~ 82 (161)
T 3fwb_A 14 NSELLEEQKQEIYEAFSLFDMNNDGFLDYHELKVAMKALGFELPKREILDLIDEYDSEGRHLMKYDDFY 82 (161)
T ss_dssp TTTSCHHHHHHHHHHHHHHCTTSSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSCEEHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCCCeEeHHHHH
Confidence 3456778889999999999999999999999999999999999999999999999886 689999983
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.41 E-value=1.9e-07 Score=75.36 Aligned_cols=61 Identities=28% Similarity=0.418 Sum_probs=56.0
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+..+|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 73 ~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 135 (145)
T 2bl0_B 73 EQSKEMLDAFRALDKEGNGTIQEAELRQLLLNLGDALTSSEVEELMKEVSVSGDGAINYESFV 135 (145)
T ss_dssp GGHHHHHHHHHHHCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCCCCTTSEEEHHHHH
T ss_pred ccHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHHH
Confidence 3456789999999999999999999999999999999999999999999876 789999984
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=98.41 E-value=4.7e-07 Score=73.08 Aligned_cols=59 Identities=25% Similarity=0.323 Sum_probs=54.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+| + |.|+|+||+
T Consensus 82 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d-~~dg~i~~~eF~ 142 (147)
T 4ds7_A 82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDEMLREVS-DGSGEINIKQFA 142 (147)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHS-SSCSSEEHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHH
Confidence 3467889999999999999999999999999999999999999999998 6 799999994
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.41 E-value=2.4e-07 Score=74.33 Aligned_cols=59 Identities=20% Similarity=0.405 Sum_probs=54.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC-CCCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI-ICLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-~g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|. +|.|+|+||+
T Consensus 75 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~dg~i~~~eF~ 134 (140)
T 1ggw_A 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVKDGMVNYHDFV 134 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCSSCCSTTTHHH
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCCCHHHHHHHHHhccCCCCcEeHHHHH
Confidence 4678899999999999999999999999999999999999999999985 4799999994
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=98.40 E-value=3.6e-07 Score=74.33 Aligned_cols=59 Identities=25% Similarity=0.398 Sum_probs=55.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHh-CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++.. +|..++++++..++..+|.+ |.|+|+||+
T Consensus 87 ~~~~~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 148 (153)
T 3ox6_A 87 VKELRDAFREFDTNGDGEISTSELREAMRALLGHQVGHRDIEEIIRDVDLNGDGRVDFEEFV 148 (153)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHHSSCCCHHHHHHHHHHHCSSSSSSBCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhcCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 467889999999999999999999999999 89999999999999999876 799999994
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=98.40 E-value=2.7e-07 Score=76.62 Aligned_cols=64 Identities=19% Similarity=0.362 Sum_probs=59.3
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 22 l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~eF~ 87 (169)
T 3qrx_A 22 LTEEQKQEIREAFDLFDTDGSGTIDAKELKVAMRALGFEPKKEEIKKMISEIDKDGSGTIDFEEFL 87 (169)
T ss_dssp CCHHHHHHHHHHHHHHCTTCCSEECHHHHHHHHHHTSCCCCHHHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 4567788999999999999999999999999999999999999999999999886 789999984
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=98.40 E-value=1.3e-07 Score=71.15 Aligned_cols=61 Identities=13% Similarity=0.111 Sum_probs=53.6
Q ss_pred HHHhhHHHHHhhhC-CCCCC-cccHHHHHHHHH-hCC----CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMD-TNKRG-KINLEELRLGLL-KGG----QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D-~~~~g-~i~~~el~~~l~-~lg----~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+....+..+|..+| .|++| .|+.+|++.++. .+| ..+++.++..++..+|.| |.|+|+||+
T Consensus 10 ~~~~~l~~~F~~~Dd~d~~G~~I~~~el~~~l~~~~~~~~~~~~~~~~~~~l~~~~D~~~dg~I~~~EF~ 79 (99)
T 1qls_A 10 RCIESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFL 79 (99)
T ss_dssp HHHHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCcCeeCHHHHHHHHHHHcchhccccCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34567999999998 99999 999999999998 454 778999999999999877 789999994
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=98.39 E-value=2.1e-07 Score=76.36 Aligned_cols=60 Identities=18% Similarity=0.279 Sum_probs=55.6
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 89 ~~~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 150 (158)
T 2jnf_A 89 MQQELREAFRLYDKEGNGYISTDVMREILAELDETLSSEDLDAMIDEIDADGSGTVDFEEFM 150 (158)
T ss_dssp TSSTHHHHHHHHCSSSSSSEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCSSCCSEECSHHHH
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCcCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 345789999999999999999999999999999999999999999999876 789999994
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.39 E-value=2.7e-07 Score=75.97 Aligned_cols=69 Identities=29% Similarity=0.361 Sum_probs=63.0
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++..++.++...++++|..+|.|++|.|+.+|+..++..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 9 ~~~~~ls~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 79 (162)
T 1top_A 9 EARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFL 79 (162)
T ss_dssp HHHHHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHHH
T ss_pred HhhhhcCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCcEeHHHHH
Confidence 345567888899999999999999999999999999999999999999999999999886 789999983
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.39 E-value=2.5e-07 Score=75.79 Aligned_cols=59 Identities=19% Similarity=0.336 Sum_probs=54.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC-CCCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI-ICLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-~g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|. +|.|+|+||+
T Consensus 86 ~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~dg~i~~~eF~ 145 (156)
T 1wdc_B 86 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVEGGKFDYVKFT 145 (156)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEETTEECHHHHH
T ss_pred HHHHHHHHHHHCcCCCCccCHHHHHHHHHHhCCCCCHHHHHHHHHhcCCCCCEEeHHHHH
Confidence 4578899999999999999999999999999999999999999999866 5899999994
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=98.38 E-value=1e-06 Score=72.49 Aligned_cols=60 Identities=25% Similarity=0.326 Sum_probs=55.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 94 ~~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 155 (162)
T 1top_A 94 SEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFL 155 (162)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 456789999999999999999999999999999999999999999999887 789999984
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.38 E-value=1.2e-07 Score=80.70 Aligned_cols=65 Identities=38% Similarity=0.576 Sum_probs=59.4
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++++|..+|.|++|.|+.+|+..+|..+|..+++.++..++..+|.+ |.|+|+||+
T Consensus 3 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~E~~~~l~~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~ 69 (188)
T 1s6i_A 3 RLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFI 69 (188)
T ss_dssp SSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHH
Confidence 34566778899999999999999999999999999999999999999999999987 689999984
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=98.37 E-value=4.3e-07 Score=73.53 Aligned_cols=64 Identities=19% Similarity=0.210 Sum_probs=58.7
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHc---CCC-CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV---SII-CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~---d~~-g~i~~~~f~ 419 (419)
+++++...++++|..+|.|++|.|+.+|+..+|..+|..++.+++..++..+ |.+ |.|+|++|+
T Consensus 2 l~~~~~~~l~~~F~~~D~~~~G~i~~~el~~~l~~~~~~~~~~~~~~l~~~~~~~d~~~g~i~~~eF~ 69 (149)
T 2mys_C 2 FSKAAADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFL 69 (149)
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhhhccccCCcCcHHHHH
Confidence 3567788899999999999999999999999999999999999999999999 776 799999984
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=98.37 E-value=8e-07 Score=72.46 Aligned_cols=61 Identities=26% Similarity=0.338 Sum_probs=55.3
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHh-CCCCCCHHHHHHHHHH----cCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEA----VSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-lg~~~~~~e~~~~~~~----~d~~--g~i~~~~f~ 419 (419)
.....++.+|..+|.|++|.|+.+|++.++.. +|..++++++..++.. +|.| |.|+|+||+
T Consensus 72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 139 (155)
T 3ll8_B 72 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFC 139 (155)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred CHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 44567899999999999999999999999999 6999999999999998 8876 789999994
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=98.35 E-value=3.6e-07 Score=74.89 Aligned_cols=66 Identities=20% Similarity=0.338 Sum_probs=56.9
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
+...++.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++. +.+|.|+|++|+
T Consensus 8 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~--~~~g~i~~~eF~ 73 (156)
T 1wdc_B 8 VLTKLPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK--EAPGPLNFTMFL 73 (156)
T ss_dssp ----CCHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT--TSSSCCCHHHHH
T ss_pred hhccCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHH--hCCCcCcHHHHH
Confidence 344567778889999999999999999999999999999999999999999997 356999999984
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.34 E-value=1.6e-07 Score=76.52 Aligned_cols=59 Identities=20% Similarity=0.285 Sum_probs=53.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+| + |.|+|+||+
T Consensus 85 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-~~dg~i~~~eF~ 145 (151)
T 1w7j_B 85 TYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAGHE-DSNGCINYEAFL 145 (151)
T ss_dssp ---CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTTCC-CTTSEEEHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHhcc-CCCCeEeHHHHH
Confidence 3457788999999999999999999999999999999999999999998 7 789999994
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=98.34 E-value=2.4e-07 Score=74.65 Aligned_cols=61 Identities=26% Similarity=0.373 Sum_probs=55.9
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
+.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++.. .+|.|+|+||+
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~--~~g~i~~~eF~ 62 (143)
T 3j04_B 2 DQSQIQEFKEAFNMIDQNRDGFIDKEDLHDMLASMGKNPTDEYLEGMMSE--APGPINFTMFL 62 (143)
T ss_dssp CHHHHHHHHHHHTTTCSSCTTCCCHHHHHHHHHHTSCCCCHHHHHTTTTT--SSSCCCHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCcCHHHHHHHHHHhCCCCCHHHHHHHHHh--CCCCcCHHHHH
Confidence 46678899999999999999999999999999999999999999999887 67899999984
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.33 E-value=6.6e-07 Score=76.83 Aligned_cols=61 Identities=21% Similarity=0.257 Sum_probs=55.6
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-CCCCCHHHHHHHHHH----cCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIPEADLQILMEA----VSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-g~~~~~~e~~~~~~~----~d~~--g~i~~~~f~ 419 (419)
.....++.+|..+|.|++|.|+.+|++.++..+ |..++++++..++.. +|.| |.|+|+||+
T Consensus 111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~ 178 (202)
T 2bec_A 111 SRRNKLHYAFQLYDLDRDGKISRHEMLQVLRLMVGVQVTEEQLENIADRTVQEADEDGDGAVSFVEFT 178 (202)
T ss_dssp SHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHSCCSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 445678999999999999999999999999999 999999999999998 8876 799999994
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=98.33 E-value=7.5e-07 Score=77.74 Aligned_cols=57 Identities=14% Similarity=0.067 Sum_probs=53.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+..+|+.+|.|++|.|+.+|++.++..+|..+++++++.++..+| | |.|+|+||+
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~l~~~~d-d~dg~I~~~eF~ 175 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILPALQQLGFYINQRTSLLLHRLFA-RGMAFCDLNCWI 175 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHHHHHHHTCCCCHHHHHHHHHHHC---CCSEEHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhCCCCCHHHHHHHHHHhc-CCCCcCcHHHHH
Confidence 56899999999999999999999999999999999999999999998 6 799999994
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.32 E-value=3.2e-07 Score=76.91 Aligned_cols=56 Identities=14% Similarity=0.136 Sum_probs=52.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++++|+.+| |++|.|+.+||+.+|+.+ |..+++++++.++..+| | |.|+|+||+
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~~l~~l~~~~G~~~~~~~~~~l~~~~d-d~dG~I~~~EF~ 137 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWKAIENTDFLRGIFISRELLHLVTLRYS-DSVGRVSFPSLV 137 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHHHHHTCGGGTTCCCCHHHHHHHHHHHS-CTTSEECHHHHH
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHHHHHHhHhccCCCCCHHHHHHHHHHHc-CCCCeEcHHHHH
Confidence 46889999999 999999999999999999 99999999999999998 5 789999994
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.30 E-value=2.4e-07 Score=79.28 Aligned_cols=58 Identities=12% Similarity=0.080 Sum_probs=54.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+||+.+| .+|..++++++..++..+|.| |.|+|++|+
T Consensus 125 ~~~l~~~F~~~D~d~~G~Is~~El~~~l-~~g~~~~~~~~~~l~~~~D~d~dG~I~~~EF~ 184 (196)
T 3dtp_E 125 EDVIVNAFNLFDEGDGKCKEETLKRSLT-TWGEKFSQDEVDQALSEAPIDGNGLIDIKKFA 184 (196)
T ss_dssp HHHHHHHHHTTCSSSSCCBHHHHHHHHH-HSSSCCCHHHHHHHHHSSCEETTEECHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHH-HcCCCCCHHHHHHHHHHcCCCCCCEEeHHHHH
Confidence 4578899999999999999999999999 999999999999999999875 789999994
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=98.29 E-value=8.2e-07 Score=73.52 Aligned_cols=58 Identities=19% Similarity=0.200 Sum_probs=54.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++.+|+.+|.|++|.|+.+|++.++..+|..++++++..++..++.+|.|+|+||+
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~ 127 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKNGRIFFDDYV 127 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBTTBCBHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCeEcHHHHH
Confidence 5688999999999999999999999999999999999999999999777999999984
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.3e-07 Score=85.42 Aligned_cols=86 Identities=8% Similarity=0.062 Sum_probs=55.8
Q ss_pred ecccc-ccccceEEEEEEEc--C----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CCeeeeeeEEEeC-
Q 014722 60 LGREL-GRGEFGVTYLCTDV--N----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDD- 129 (419)
Q Consensus 60 ~~~~l-g~G~~g~V~~~~~~--~----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~- 129 (419)
..+.| +.|....+|++... . ++..+++|+..............+.+|..+++.|..+ ..+++++.+..+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34567 88989999988642 0 2678889986543200000013567788888887444 3577788777655
Q ss_pred --CeEEEEEEecCCcchH
Q 014722 130 --SAVHIVMELCEGGELF 145 (419)
Q Consensus 130 --~~~~lv~e~~~~g~L~ 145 (419)
+..++||||++|.++.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=98.29 E-value=5.1e-08 Score=74.73 Aligned_cols=60 Identities=18% Similarity=0.222 Sum_probs=54.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.+ |.|+|+||+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~~~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 103 (108)
T 2kyc_A 39 SSSQLKEIFRILDNDQSGFIEEDELKYFLQRFESGARVLTASETKTFLAAADHDGDGKIGAEEFQ 103 (108)
T ss_dssp CSSSHHHHCSSSCSCCSSCCCGGGTTTSHHHHSSSCCCCCTTTTHHHHTTTCCSSSSCCCSSHHH
T ss_pred cHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHhhccCCCCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 34678899999999999999999999999998 8899999999999999876 789999994
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=3.5e-07 Score=77.88 Aligned_cols=69 Identities=16% Similarity=0.186 Sum_probs=60.3
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHH-----HHHHhCCCCCCHH-----HHHHHHHHcCCC--CCcCcccc
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELR-----LGLLKGGQNIPEA-----DLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~~--g~i~~~~f 418 (419)
.++..++.++...++++|..+|.|++|.|+.+|+. .+++.+|..++.. ++..++..+|.| |.|+|+||
T Consensus 9 ~~~~~~s~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF 88 (195)
T 1qv0_A 9 LKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQF 88 (195)
T ss_dssp CSCCTTCHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHH
T ss_pred cCcccCCHHHHHHHHHHHhHcCCCCCCcCcHHHHHHHHHHHHHHHcCCCccHHHHHHHHHHHHHHHcCCCCCceEcHHHH
Confidence 34445578888999999999999999999999999 7889999988877 688999999887 78999998
Q ss_pred C
Q 014722 419 C 419 (419)
Q Consensus 419 ~ 419 (419)
+
T Consensus 89 ~ 89 (195)
T 1qv0_A 89 L 89 (195)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.26 E-value=2.2e-06 Score=72.73 Aligned_cols=57 Identities=18% Similarity=0.220 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 108 ~~~~~~~F~~~D~d~dG~I~~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~Ef~ 166 (191)
T 2ccm_A 108 TKYMNFMFDVNDTSGDNIIDKHEYSTVYMSYG--IPKSDCDAAFDTLSDGGKTMVTREIFA 166 (191)
T ss_dssp HHHHHHHHHHHCTTCSSBCCHHHHHHHHHTTT--CCHHHHHHHHHHHTTTTTSCCBHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCcCHHHHH
Confidence 45689999999999999999999999999998 8999999999999876 799999984
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=98.26 E-value=6.1e-07 Score=76.75 Aligned_cols=64 Identities=20% Similarity=0.369 Sum_probs=58.7
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++.++...++++|..+|.|++|.|+.+||..+|..+|..++..++..++..+ +|.|+|.+|+
T Consensus 49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~l~~~~--~g~i~~~eF~ 112 (196)
T 3dtp_E 49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRATFDSLGRLCTEQELDSMVAEA--PGPINFTMFL 112 (196)
T ss_dssp CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHHHHHTTSCCCCHHHHHHHHTTS--SSCCBHHHHH
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHc--cCCCcHHHHH
Confidence 345677788999999999999999999999999999999999999999999988 8999999984
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=98.26 E-value=4.4e-07 Score=74.63 Aligned_cols=60 Identities=32% Similarity=0.421 Sum_probs=53.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 93 ~~~~~~~~F~~~D~d~~G~i~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 154 (161)
T 1dtl_A 93 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 154 (161)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 345689999999999999999999999999999999999999999999876 789999984
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=98.26 E-value=7.1e-07 Score=68.80 Aligned_cols=61 Identities=18% Similarity=0.243 Sum_probs=55.1
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...+.++|+.+|. ++|+|+.+|++.+|.+.| ++.+++.+|+..+|.| |.|+|+||+
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~~~~~sg--Lp~~~L~~Iw~laD~d~dG~Ld~~EF~ 89 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARNFFFQSG--LPQPVLAQIWALADMNNDGRMDQVEFS 89 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHHHHGGGC--CCHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHHHHHHcC--CCHHHHHHHHHHHcCCCCCcCCHHHHH
Confidence 357788899999999998 899999999999999876 5789999999999987 799999994
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.25 E-value=2.8e-07 Score=78.96 Aligned_cols=59 Identities=17% Similarity=0.258 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC--CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG--GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++..+ |..++++++..++..+|.| |.|+|+||+
T Consensus 128 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~ 190 (197)
T 3pm8_A 128 KEVCLIPFKFFDIDGNGKISVEELKRIFGRDDIENPLIDKAIDSLLQEVDLNGDGEIDFHEFM 190 (197)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHC----CCHHHHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 4578999999999999999999999999998 7888999999999999876 799999994
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.25 E-value=1.1e-06 Score=74.72 Aligned_cols=58 Identities=24% Similarity=0.384 Sum_probs=54.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|+.+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 93 ~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 152 (191)
T 1y1x_A 93 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYV 152 (191)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4678999999999999999999999999999999999999999999876 799999984
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.24 E-value=9.5e-07 Score=73.31 Aligned_cols=58 Identities=16% Similarity=0.260 Sum_probs=54.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++.+|..+|.|++|.|+.+|++.+|..+|..++++++..++..++.+|.|+|+||+
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~dg~i~~~eF~ 129 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQKALTTMGFRLNPQTVNSIAKRYSTSGKITFDDYI 129 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHHHHHTTTCCCCHHHHHHHHHHTCBTTBEEHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCCcCcHHHHH
Confidence 5688999999999999999999999999999999999999999999777999999984
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=98.24 E-value=8e-07 Score=76.71 Aligned_cols=60 Identities=25% Similarity=0.278 Sum_probs=54.6
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-CCCCCHHHHHHH----HHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIPEADLQIL----MEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-g~~~~~~e~~~~----~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |..++++++..+ +..+|.| |.|+|+||+
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~ 177 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQVLRMMVGVNISDEQLGSIADRTIQEADQDGDSAISFTEFV 177 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHSCTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45678999999999999999999999999996 999999999888 9999876 799999994
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=9.7e-07 Score=75.11 Aligned_cols=54 Identities=17% Similarity=0.184 Sum_probs=47.6
Q ss_pred HHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 366 EAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 366 ~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+|+.+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 117 ~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dg~i~~~eF~ 172 (195)
T 1qv0_A 117 AVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMT 172 (195)
T ss_dssp HHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 899999999999999999999999999999999999999999876 799999984
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=98.22 E-value=9e-07 Score=77.75 Aligned_cols=59 Identities=19% Similarity=0.188 Sum_probs=50.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC------------CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG------------GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------------g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.|++|.|+.+|+..++..+ +...++++++.++..+|.| |.|+|+||+
T Consensus 137 ~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~ 209 (229)
T 3dd4_A 137 QEKLNWAFNLYDINKDGYITKEEMLDIMKAIYDMMGKCTYPVLKEDAPRQHVETFFQKMDKNKDGVVTIDEFI 209 (229)
T ss_dssp HHHHHHHHHHHCTTCSSCCBHHHHHHHHHHHHHHCC-----------CCTHHHHHHHHHCSSCSSBCCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeECHHHHHHHHHHHHHHhccccCCCcchhhHHHHHHHHHHHhcCCCCCcEeHHHHH
Confidence 4678899999999999999999999999876 6677889999999999887 799999994
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.22 E-value=7.9e-07 Score=75.36 Aligned_cols=55 Identities=18% Similarity=0.210 Sum_probs=51.9
Q ss_pred HHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 365 ~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 112 ~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~eF~ 168 (191)
T 1uhk_A 112 DALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 168 (191)
T ss_dssp HHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHHHHhcCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3899999999999999999999999999999999999999999876 799999984
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.9e-07 Score=71.95 Aligned_cols=55 Identities=24% Similarity=0.342 Sum_probs=52.4
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
++++|..+|.|++|.|+.+|+..+|..+|..++..++..++.. +.+|.|+|+||+
T Consensus 7 l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~-~~~g~i~~~eF~ 61 (145)
T 2bl0_B 7 IQECFQIFDKDNDGKVSIEELGSALRSLGKNPTNAELNTIKGQ-LNAKEFDLATFK 61 (145)
T ss_dssp HHHHHHHHCTTCSSCEEGGGHHHHHHHTTCCCCHHHHHHHHHH-HTSSEECHHHHH
T ss_pred HHHHHHHhCCCCcCccCHHHHHHHHHHhCCCCCHHHHHHHHHh-cCCCeEcHHHHH
Confidence 8999999999999999999999999999999999999999998 778999999984
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.20 E-value=1.1e-06 Score=75.30 Aligned_cols=62 Identities=19% Similarity=0.229 Sum_probs=52.5
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+...++++|..+|.|++|.|+.+|+..+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 33 ~~~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~d~dg~i~~~ef~ 96 (204)
T 3e3r_A 33 ASGIQGLARFFRQLDRDGSRSLDADEFRQGLAKLGLVLDQAEAEGVCRKWDRNGSGTLDLEEFL 96 (204)
T ss_dssp -------CHHHHHHCTTCCSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred chhHHHHHHHHHHHccCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCcCcHHHHH
Confidence 45567899999999999999999999999999999999999999999999876 789999983
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=98.20 E-value=3.3e-07 Score=74.54 Aligned_cols=64 Identities=20% Similarity=0.209 Sum_probs=53.5
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC----CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII----CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|+..+|..+|..++..++..++..+|.+ |.|+|+||+
T Consensus 4 ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~~~~~g~i~~~eF~ 71 (151)
T 1w7j_B 4 FNKDQLEEFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETFL 71 (151)
T ss_dssp -------CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCcCcCCCCcCcHHHHH
Confidence 4567788999999999999999999999999999999999999999999998754 789999984
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.6e-06 Score=72.18 Aligned_cols=57 Identities=21% Similarity=0.153 Sum_probs=52.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 93 ~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~ 151 (174)
T 1q80_A 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLG--LDKTMAPASFDAIDTNNDGLLSLEEFV 151 (174)
T ss_dssp HTHHHHHHHHHCTTSSSSBCHHHHHHHHHHHT--CCGGGHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCceEeHHHHH
Confidence 46789999999999999999999999999997 7889999999999876 799999984
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.3e-06 Score=74.67 Aligned_cols=58 Identities=17% Similarity=0.266 Sum_probs=54.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++++|+.+|.|++|.|+.+|++.+|..+|..+++++++.++..+|.+|.|+|+||+
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~l~~~~d~dg~i~~~eF~ 160 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYI 160 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSSSSEEHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCeEcHHHHH
Confidence 5688999999999999999999999999999999999999999999777999999984
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.19 E-value=6.8e-07 Score=71.67 Aligned_cols=57 Identities=19% Similarity=0.187 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
...++++|..+|.|++|.|+.+|+..+|+.+|..++.+++..++. +.+|.|+|+||+
T Consensus 4 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~--~~~g~i~~~eF~ 60 (140)
T 1ggw_A 4 DSPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES--TLPAEVDMEQFL 60 (140)
T ss_dssp CTTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT--TSCSSEEHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHh--CCCCcCcHHHHH
Confidence 356889999999999999999999999999999999999999998 777999999983
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.19 E-value=1.4e-06 Score=72.58 Aligned_cols=58 Identities=17% Similarity=0.229 Sum_probs=54.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|..+|.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 74 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d~~~dg~i~~~eF~ 133 (172)
T 2znd_A 74 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFI 133 (172)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHCCCCCCccCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 5688999999999999999999999999999999999999999999876 789999984
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.18 E-value=1.5e-06 Score=72.41 Aligned_cols=63 Identities=16% Similarity=0.132 Sum_probs=55.9
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHH----HHHhCCCCCCHHHHH-----------HHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRL----GLLKGGQNIPEADLQ-----------ILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~----~l~~lg~~~~~~e~~-----------~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++...++++|..+|.|++|.|+.+|+.. +++.+|..++..++. .++..+|.+ |.|+|+||+
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~~~~~~l~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~ 81 (176)
T 1nya_A 2 TAIASDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFI 81 (176)
T ss_dssp CSHHHHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHH
T ss_pred cHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 356678899999999999999999999999 788899999999887 788888877 789999983
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=98.18 E-value=2.2e-07 Score=75.29 Aligned_cols=59 Identities=22% Similarity=0.193 Sum_probs=52.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHc-CCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV-SII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~-d~~--g~i~~~~f~ 419 (419)
...++++|..+|.|++|.|+.+|+..+|+.+|..++..++..++..+ |.+ |.|+|+||+
T Consensus 3 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~~D~~~~g~i~~~eF~ 64 (148)
T 1m45_A 3 TRANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQIT 64 (148)
T ss_dssp CCCCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCCCHHHHHHHHHHhhCCCCCCeEcHHHHH
Confidence 35678899999999999999999999999999999999999999999 876 789999984
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=98.18 E-value=4e-07 Score=74.54 Aligned_cols=63 Identities=22% Similarity=0.234 Sum_probs=57.3
Q ss_pred hhhHHHhhHHHHHhhhCC--CCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|. |++|.|+.+|++.+|..+|..++..++..+ ..+|.+ |.|+|+||+
T Consensus 3 ls~~~~~~l~~~F~~~D~~~d~~G~i~~~el~~~l~~~g~~~~~~~~~~l-~~~D~~~~g~i~~~eF~ 69 (156)
T 1wdc_C 3 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAV-GGTHKMGEKSLPFEEFL 69 (156)
T ss_dssp CCHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHT-TCCSSTTSCEECHHHHH
T ss_pred CCHHHHHHHHHHHHHHccCCCCCCCCcHHHHHHHHHHcCCCCCHHHHHHH-HhhCCCCCCeeeHHHHH
Confidence 456778889999999999 999999999999999999999999999999 888876 689999984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=2.7e-05 Score=72.45 Aligned_cols=74 Identities=14% Similarity=0.201 Sum_probs=41.5
Q ss_pred cccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC----CCCCeeeee-e--EEEeCCeEEE
Q 014722 62 RELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----KHPNIVSLK-D--TYEDDSAVHI 134 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hpnIv~l~-~--~~~~~~~~~l 134 (419)
+.|+.|..+.||++.. . +..+++|+.... . ..+..|..+++.|. ..|.++... + +....+..++
T Consensus 38 ~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHT-D-SGAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEE-T-TEEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEe-C-CCCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 4566678899999874 3 345889988642 1 23334555555442 234444311 1 2245678899
Q ss_pred EEEecCCcch
Q 014722 135 VMELCEGGEL 144 (419)
Q Consensus 135 v~e~~~~g~L 144 (419)
|++|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998654
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.17 E-value=5.2e-07 Score=78.66 Aligned_cols=59 Identities=14% Similarity=0.108 Sum_probs=54.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.+|..+|. .++++++..++..+|.| |.|+|+||+
T Consensus 129 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~e~~~l~~~~D~d~dG~I~~~EF~ 190 (219)
T 3cs1_A 129 FFELTVMFDEIDASGNMLVDEEEFKRAVPKLEAWGAKVEDPAALFKELDKNGTGSVTFDEFA 190 (219)
T ss_dssp HHHHHHHHHTTCSSSSSEEEHHHHHHHHHHHHHHTCCCSCHHHHHHHHCTTSSSEEEHHHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhcccCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 467899999999999999999999999999987 88999999999999876 789999994
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=98.16 E-value=4.8e-06 Score=68.57 Aligned_cols=57 Identities=18% Similarity=0.148 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 97 ~~~~~~~F~~~D~d~~G~i~~~E~~~~l~~~~--~~~~~~~~~~~~~D~d~dg~i~~~ef~ 155 (166)
T 3akb_A 97 RPFLHAALGVADTDGDGAVTVADTARALTAFG--VPEDLARQAAAALDTDGDGKVGETEIV 155 (166)
T ss_dssp HHHHHHHHHHHCSSSSSCCBHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSBCCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 34689999999999999999999999999999 8999999999999876 799999984
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=98.15 E-value=8e-07 Score=71.85 Aligned_cols=59 Identities=14% Similarity=0.069 Sum_probs=47.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC--------CCCCHHHHHHHH----HHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGG--------QNIPEADLQILM----EAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg--------~~~~~~e~~~~~----~~~d~~--g~i~~~~f~ 419 (419)
.+.++.+|+.+|.|++|+|+.+|++.++..++ ..++++++..++ ..+|.| |.|+|+||+
T Consensus 67 ~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~g~~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~ 139 (143)
T 3a4u_B 67 QELQLHYFKMHDYDGNNLLDGLELSTAITHVHKEEGSEQAPLMSEDELINIIDGVLRDDDKNNDGYIDYAEFA 139 (143)
T ss_dssp HHHHHHHHHHTCTTCSSCEEHHHHHHTCC-------------CCHHHHHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHhhhccccCCCCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHH
Confidence 35678899999999999999999999998884 578999997776 888876 789999984
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.15 E-value=7.5e-07 Score=76.86 Aligned_cols=66 Identities=17% Similarity=0.110 Sum_probs=54.6
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC--CCCHHHHHHHH-------HHcCCC--CCcCccccC
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--NIPEADLQILM-------EAVSII--CLLSYFLVC 419 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~--~~~~~e~~~~~-------~~~d~~--g~i~~~~f~ 419 (419)
..++.++...++++|..+|.|++|.|+.+|+..++..+|. .++++++..++ ..+|.| |.|+|+||+
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~~~~~~~~~~l~~~~~~lf~~~D~d~dg~i~~~EF~ 104 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLYWPDRMRQLVNATDEQVEKMRDAVRVFFLHKGVEPVNGLLREDWV 104 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTHHHHHHHHHSCCCHHHHHHHHHHHHHHHHHTTCBTTTBEEGGGHH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHhhcCCCHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 4556777889999999999999999999999999999998 89999999999 999876 789999984
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=98.14 E-value=1.3e-06 Score=66.13 Aligned_cols=57 Identities=21% Similarity=0.135 Sum_probs=48.8
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHh-----CCCCCCH-----------HHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLK-----GGQNIPE-----------ADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~-----lg~~~~~-----------~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.+|..+|.|++|.|+.+|++.++.. +|...+. ..+..++..+|.| |.|+|+||+
T Consensus 21 ~~~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~g~~~~~~~~~~~~e~~~~~~~~~~~~~D~d~dG~Is~~EF~ 95 (103)
T 1snl_A 21 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFL 95 (103)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHH
T ss_pred CHHHHHHHHcCCCCCcccHHHHHHHHHHHHHHHhccCCCCccHHHHHHHHHHHHHHHHHHcCCCCCCcCCHHHHH
Confidence 5789999999999999999999999996 5776653 2488899999887 789999984
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-06 Score=73.89 Aligned_cols=64 Identities=17% Similarity=0.240 Sum_probs=57.5
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHH-----HHHHhCCCCCCHH-----HHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELR-----LGLLKGGQNIPEA-----DLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~-----~~l~~lg~~~~~~-----e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++...++++|..+|.|++|.|+.+|+. .+++.+|..++.. ++..++..+|.+ |.|+|+||+
T Consensus 10 ~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~~~~~~~l~~~g~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EF~ 85 (191)
T 1uhk_A 10 DNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEAFFGGAGMKYGVETDWPAYI 85 (191)
T ss_dssp TCHHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHTTCCTTCEEEHHHHH
T ss_pred CCHHHHHHHHHHHhhccCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHHHhCcCCCCcCcHHHHH
Confidence 356778899999999999999999999999 8999999998887 689999999887 789999984
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.7e-06 Score=74.52 Aligned_cols=54 Identities=13% Similarity=0.238 Sum_probs=50.8
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~I~~~EF~ 185 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELKTMMKAFD--VPQEAAYTFFEKADTDKSGKLERTELV 185 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHHHHHHTT--SCTTHHHHHHHHHCTTCCSSBCHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHHHHHHHhC--cCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 78999999999999999999999999999 8899999999999876 799999994
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.4e-06 Score=75.96 Aligned_cols=68 Identities=15% Similarity=0.124 Sum_probs=57.3
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHh-CCCCCCHHHHHHHHHH-----------cCCCCCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEA-----------VSIICLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~-lg~~~~~~e~~~~~~~-----------~d~~g~i~~~~f~ 419 (419)
+...++.++...++++|..+|.|++|.|+.+|+..+|.. +|..++.+++..++.. .+.+|.|+|.||+
T Consensus 38 ~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~d~~g~I~~~EF~ 117 (219)
T 3cs1_A 38 IPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYSGCLEVLKLDEFTSRVRDITKRAFDKSRTLGSKLENKGSEDFVEFL 117 (219)
T ss_dssp SCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTTCGGGTCSCHHHHHHHHHHHHHHHHHHHHTSCCCSSBCHH
T ss_pred hcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHhhhhccCCCCcCCHHHHH
Confidence 334456788899999999999999999999999999988 7988888888776653 3677999999994
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.12 E-value=9.1e-07 Score=73.16 Aligned_cols=58 Identities=22% Similarity=0.256 Sum_probs=45.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 97 ~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~--~~~~~~~~~~~~~d~~~dg~i~~~eF~ 156 (166)
T 2aao_A 97 REDHLFAAFTYFDKDGSGYITPDELQQACEEFG--VEDVRIEELMRDVDQDNDGRIDYNEFV 156 (166)
T ss_dssp TTHHHHHHHHHHCTTCSSSBCHHHHHHHTCC----------CCHHHHHCTTCSSSBCHHHHH
T ss_pred cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 345789999999999999999999999999887 5688899999999876 799999984
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=98.12 E-value=1.7e-06 Score=73.31 Aligned_cols=57 Identities=18% Similarity=0.174 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++. |..++++++..++..+|.| |.|+|+||+
T Consensus 122 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~--~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~ 180 (191)
T 3khe_A 122 RERLLAAFQQFDSDGSGKITNEELGRLFG--VTEVDDETWHQVLQECDKNNDGEVDFEEFV 180 (191)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHTT--SSCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHCCCCcCcCCHHHHHHHHc--cCCCCHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 35689999999999999999999999998 8899999999999999976 789999994
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=98.12 E-value=8.8e-07 Score=71.59 Aligned_cols=61 Identities=18% Similarity=0.143 Sum_probs=56.2
Q ss_pred hhHHHhhHHHHHhhhCCCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++...++++|..+|.|+ +|.|+.+|+..+|+.+|..++..++..++..+|.+ |+|++|+
T Consensus 9 ~~~~~~~l~~~F~~~D~d~~~G~i~~~el~~~l~~~g~~~~~~~~~~l~~~~d~~--i~~~eF~ 70 (146)
T 2qac_A 9 QLEEKVDESDVRIYFNEKSSGGKISIDNASYNARKLGLAPSSIDEKKIKELYGDN--LTYEQYL 70 (146)
T ss_dssp HHHHHSCHHHHHHHHHHHCBTTBEEHHHHHHHHHHTTCCCCHHHHHHHHHHHCSE--ECHHHHH
T ss_pred HHHHHHHHHHHHHHhCccCCCCcccHHHHHHHHHHhCCCCCHHHHHHHHHHhCCC--CCHHHHH
Confidence 4566778999999999999 99999999999999999999999999999999987 9999883
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-06 Score=72.40 Aligned_cols=59 Identities=15% Similarity=0.143 Sum_probs=52.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-----CCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.|++|.|+.+|++.++..+|. .++++++.. ++..+|.| |.|+|+||+
T Consensus 97 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 166 (183)
T 1dgu_A 97 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQ 166 (183)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHSSSCCCHHHHHHHHHHHHHHHHHHCTTSSSEEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhcccccCCCCHHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 457899999999999999999999999999876 788888886 99999876 789999994
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.10 E-value=3.9e-06 Score=71.37 Aligned_cols=59 Identities=19% Similarity=0.230 Sum_probs=51.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHh--CCCCCCHH---HHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK--GGQNIPEA---DLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~--lg~~~~~~---e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.++.. .|..++++ ++..++..+|.| |.|+|+||+
T Consensus 121 ~~~l~~~F~~~D~d~~G~Is~~El~~~l~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~ 186 (191)
T 3k21_A 121 KKLIYCAFRVFDVDNDGEITTAELAHILYNGNKKGNITQRDVNRVKRMIRDVDKNNDGKIDFHEFS 186 (191)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHHHHHHSSSCSCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHhcCCCCCCCHhHHHHHHHHHHHhcCCCCCeECHHHHH
Confidence 457889999999999999999999999998 56778863 689999999876 799999994
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=98.09 E-value=1.7e-06 Score=75.10 Aligned_cols=59 Identities=15% Similarity=0.143 Sum_probs=52.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-----CCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-----~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.|++|.|+.+|++.++..+|. .++++++.. ++..+|.| |.|+|+||+
T Consensus 128 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~~~~~~~s~~e~~~~~~~~~~~~D~d~dG~Is~~EF~ 197 (214)
T 2l4h_A 128 DIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQ 197 (214)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHHHSSSCTTCSCTHHHHHHHHHHHHHCCSCCSSBCSHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhccccCCCCCHHHHHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 457899999999999999999999999999875 788888875 89999876 799999994
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.4e-06 Score=74.72 Aligned_cols=62 Identities=15% Similarity=0.180 Sum_probs=54.4
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHH-------hCCCCCCHHHHHHHHHHcCC-C--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLL-------KGGQNIPEADLQILMEAVSI-I--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~-------~lg~~~~~~e~~~~~~~~d~-~--g~i~~~~f~ 419 (419)
......+..+|..+|.|++|.|+.+|+..++. ..|...+++++..++..+|. | |.|+|+||+
T Consensus 105 ~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~D~~d~dg~Is~~EF~ 176 (204)
T 3e3r_A 105 QAREAVIAAAFAKLDRSGDGVVTVDDLRGVYSGRAHPKVRSGEWTEDEVLRRFLDNFDSSEKDGQVTLAEFQ 176 (204)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEECHHHHHHHCCCTTCHHHHTTSSCHHHHHHHHHHHHSCSSCCSCEEHHHHH
T ss_pred chHHHHHHHHHHHhCcCCCCeEeHHHHHHHHccccCCccccCCCChHHHHHHHHHHhhccCCCCcCcHHHHH
Confidence 34556789999999999999999999999998 45777888999999999987 6 799999984
|
| >2kld_A Polycystin-2; PC2, PKD2, calcium binding domain, EF hand, cytosolic, calcium, coiled coil, disease mutation, glycoprotein, ION transport; NMR {Homo sapiens} PDB: 2kle_A 2kq6_A 2y4q_A | Back alignment and structure |
|---|
Probab=98.09 E-value=4.2e-07 Score=71.37 Aligned_cols=56 Identities=21% Similarity=0.280 Sum_probs=47.5
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+....++++|+.+| |+|+.+|++.+|+.+|. +++++..++..+|.| |.|+|+||+
T Consensus 46 ~~~~~~l~~aF~~fD----G~I~~~El~~~l~~lG~--t~~ei~~~~~~~D~d~dG~I~~~EF~ 103 (123)
T 2kld_A 46 KNTVDDISESLRQGG----GKLNFDELRQDLKGKGH--TDAEIEAIFTKYDQDGDQELTEHEHQ 103 (123)
T ss_dssp -----CCSCSSTTTT----TCEEHHHHHHHTTTCCS--SHHHHHHHHHHHSSSSCCEECSHHHH
T ss_pred hhHHHHHHHHHHHhC----CCCCHHHHHHHHHHhCC--CHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 344567889999999 99999999999999998 999999999999887 789999994
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.09 E-value=5.6e-07 Score=76.45 Aligned_cols=57 Identities=18% Similarity=0.278 Sum_probs=51.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 81 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~g--~~~~~~~~~~~~~D~d~dG~Is~~EF~ 139 (188)
T 1s6i_A 81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFA 139 (188)
T ss_dssp CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHH
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcC--CCHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 35689999999999999999999999999988 6788999999999877 789999994
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=98.08 E-value=3e-06 Score=70.57 Aligned_cols=57 Identities=25% Similarity=0.180 Sum_probs=52.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 101 ~~~~~~~F~~~D~d~~G~I~~~e~~~~l~~~g--~~~~~~~~~~~~~D~d~dg~i~~~ef~ 159 (176)
T 1nya_A 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELL 159 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHhC--CCHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 35688999999999999999999999999999 8999999999999887 789999984
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.9e-06 Score=73.07 Aligned_cols=65 Identities=14% Similarity=0.014 Sum_probs=58.2
Q ss_pred hhhhHHHhhHHHHHhhh-CCCCCCcccHHHHHHHHHhC----CCCCCHHHHHHHH-----------HHcCCC--CCcCcc
Q 014722 355 FLSVEEVAGLKEAFEMM-DTNKRGKINLEELRLGLLKG----GQNIPEADLQILM-----------EAVSII--CLLSYF 416 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~-D~~~~g~i~~~el~~~l~~l----g~~~~~~e~~~~~-----------~~~d~~--g~i~~~ 416 (419)
.++.++...++++|..+ |.|++|.|+.+|+..++..+ |..++..++..++ ..+|.| |.|+|+
T Consensus 5 ~ls~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~~~~~D~d~dG~i~~~ 84 (191)
T 2ccm_A 5 QLSDFQRNKILRVFNTFYDCNHDGVIEWDDFELAIKKICNLHSWPTDGKKHNEARATLKLIWDGLRKYADENEDEQVTKE 84 (191)
T ss_dssp CCCHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHH
T ss_pred hccHHHHHHHHHhccccccCCCCCeeeHHHHHHHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCeECHH
Confidence 34567778899999999 99999999999999999998 9999999999998 888876 789999
Q ss_pred ccC
Q 014722 417 LVC 419 (419)
Q Consensus 417 ~f~ 419 (419)
||+
T Consensus 85 Ef~ 87 (191)
T 2ccm_A 85 EWL 87 (191)
T ss_dssp HHH
T ss_pred HHH
Confidence 983
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.08 E-value=2e-06 Score=71.71 Aligned_cols=57 Identities=14% Similarity=0.189 Sum_probs=53.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|..+|.|++|.|+.+|++.++..+|..++++++..++..+| + |.|+|+||+
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dg~i~~~eF~ 135 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYS-DEGGNMDFDNFI 135 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHT-CSSSCBCHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHHHcCCCCCHHHHHHHHHHhc-CCCCcCcHHHHH
Confidence 56889999999999999999999999999999999999999999997 5 799999984
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=98.08 E-value=2.4e-06 Score=72.63 Aligned_cols=59 Identities=22% Similarity=0.211 Sum_probs=54.1
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|..+|.|++|.|+.+|+..+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 26 ~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~ 86 (191)
T 1y1x_A 26 NQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEFK 86 (191)
T ss_dssp TSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 46789999999999999999999999998888899999999999999887 689999983
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=98.06 E-value=2.7e-06 Score=67.24 Aligned_cols=55 Identities=18% Similarity=0.187 Sum_probs=46.2
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++++|..+|.|++|.|+.+|+..++..+|..++.+++..++..+|.+ |.|+|+||
T Consensus 2 l~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~ef 58 (134)
T 1jfj_A 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEF 58 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHHcCCCCCeEcHHHH
Confidence 56788888888888888888888888888888888888888888776 67888887
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=98.06 E-value=1.6e-06 Score=72.29 Aligned_cols=59 Identities=14% Similarity=0.058 Sum_probs=53.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-C-------CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-G-------QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-g-------~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+...++++|..+| |++|.|+.+|+..+|+.+ | ..++.+++..++..+|.+ |.|+|+||+
T Consensus 2 ~~~~l~~~F~~~D-d~~G~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~ 70 (173)
T 1alv_A 2 EVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFK 70 (173)
T ss_dssp HHHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred chhHHHHHHHHHh-CCCCCcCHHHHHHHHHHhhhcccccccCCCCHHHHHHHHHHHcCCCCCccCHHHHH
Confidence 4678999999999 999999999999999997 7 788999999999999987 689999983
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=98.04 E-value=3.4e-06 Score=80.67 Aligned_cols=59 Identities=20% Similarity=0.357 Sum_probs=55.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++.+|+.+|.|++|.|+.+||+.+|..+|..+++++++.++..+|.| |.|+|+||+
T Consensus 384 ~e~l~~aFk~fD~D~dG~Is~eELr~~L~~lG~~ls~eei~~Lf~~~D~D~DG~IsfdEFv 444 (450)
T 3sg6_A 384 EEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 444 (450)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTSSSSEEHHHHH
T ss_pred hhHHHHHHHHhCCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 45688999999999999999999999999999999999999999999875 799999994
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-06 Score=71.23 Aligned_cols=60 Identities=15% Similarity=0.208 Sum_probs=54.5
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC-CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg-~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++++|..+|.|++|.|+.+|+..+|..+| ..++++++..++..+|.+ |.|+|+||+
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~ef~ 67 (172)
T 2znd_A 5 DQSFLWNVFQRVDKDRSGVISDTELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFT 67 (172)
T ss_dssp -CHHHHHHHHHHCTTCSSCEEHHHHHHHCCCSSSSCCCHHHHHHHHHHHCSSSSSEECHHHHH
T ss_pred chhHHHHHHHHhCCCCCCcCcHHHHHHHHHhcCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 456789999999999999999999999999998 789999999999999887 689999983
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.8e-06 Score=71.47 Aligned_cols=56 Identities=20% Similarity=0.236 Sum_probs=51.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC----------CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII----------CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----------g~i~~~~f~ 419 (419)
..+..+|..+|.|++|.|+.+|++.++. +..++++++..++..+|.| |.|+|+||+
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~~l~--~~~~~~~~~~~~~~~~d~~~d~~~~~~~~G~i~~~eF~ 173 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVSLVH--DKVLDNNDIDNFFLSVHSIKKGIPREHIINKISFQEFK 173 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHHHTT--TSSCCHHHHHHHHHHHHTC---------CCCBCHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHc--CCCCCHHHHHHHHHHhhhccCcccccccCCeeeHHHHH
Confidence 5788999999999999999999999998 6789999999999999876 789999994
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=98.03 E-value=2e-06 Score=71.67 Aligned_cols=62 Identities=18% Similarity=0.033 Sum_probs=54.1
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC----CCCCHHH-HH--------HHHHHcCCCCCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG----QNIPEAD-LQ--------ILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg----~~~~~~e-~~--------~~~~~~d~~g~i~~~~f~ 419 (419)
.++...++++|..+|.|++|.|+.+|+..++..+| ..++..+ +. .++..+|.+|.|+|+||+
T Consensus 2 ~~~~~~l~~~F~~~D~d~~G~i~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~l~~~~D~~g~i~~~EF~ 76 (174)
T 1q80_A 2 DLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKVLMDSLTGVWDNFLTAVAGGKGIDETTFI 76 (174)
T ss_dssp HHHHHHHHHHHHHHCTTCSSEESHHHHHHHHHHHHHHSSCCTTHHHHHHHHHHHHHHHTGGGTTTTSCEEHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHhcCCCCeEcHHHHH
Confidence 45677899999999999999999999999999988 8999888 64 577888866899999983
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=98.00 E-value=1.8e-06 Score=75.70 Aligned_cols=68 Identities=15% Similarity=0.040 Sum_probs=57.6
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHH-HHHhCCCCCCHHHHHHHHHHc---------CCC--CCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRL-GLLKGGQNIPEADLQILMEAV---------SII--CLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~-~l~~lg~~~~~~e~~~~~~~~---------d~~--g~i~~~~f~ 419 (419)
+...++.++...++++|..+|.|++|.|+.+|+.. +++.+|..++..++..++..+ |.+ |.|+|+||+
T Consensus 41 l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~lg~~~~~~~~~~~~~~~f~~~~~~~~D~d~~G~I~~~EF~ 120 (226)
T 2lvv_A 41 IPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLDGCYGILKLDEFTTHLPDIVQRAFDKAKDLGNKVKGVGEEDLVEFL 120 (226)
T ss_dssp SCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHHHHHHTTCCTTTSSSCHHHHHHHHHHHHHHHHHHSCCCCCSCBCHH
T ss_pred hchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHhCCCCCHHHHHHHHHHHHHHhcccCCCCCCCCcCCHHHHH
Confidence 34455778889999999999999999999999999 556679988888888888876 665 789999994
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=97.99 E-value=4.9e-06 Score=79.55 Aligned_cols=65 Identities=31% Similarity=0.379 Sum_probs=59.6
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++++|..+|.|++|.|+.+||+.+|..+|..++.+++..++..+|.| |.|+|+||+
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~~L~~lg~~~s~eel~~Lf~~~D~DgdG~IsfeEFl 371 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 371 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTSSSSEEHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhccCCCCcccHHHHH
Confidence 44566778999999999999999999999999999999999999999999999887 789999993
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=97.98 E-value=4.9e-06 Score=70.11 Aligned_cols=59 Identities=17% Similarity=0.216 Sum_probs=52.7
Q ss_pred HhhHHHHH--hhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAF--EMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F--~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+| ..||.|++|.|+.+|++.++..+|..++++++..++..+|.| |.|+|+||+
T Consensus 99 ~~~~~~~f~~~~fD~d~~G~I~~~E~~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~i~~~ef~ 161 (186)
T 2hps_A 99 MAVIQSLIMYDCIDTDKDGYVSLPEFKAFLQAVGPDLTDDKAITCFNTLDFNKNGQISRDEFL 161 (186)
T ss_dssp HTTHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHCTTCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHHHccCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 34566666 788999999999999999999999999999999999999976 789999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.6e-05 Score=73.98 Aligned_cols=77 Identities=8% Similarity=0.020 Sum_probs=44.8
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEeccccc--CCh----hhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL--RTA----VDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
++.||.|..+.||++. .++..+++|....... ... .....+..|+..+..-.....+++++.+. ....++
T Consensus 39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 3568999999999986 3567899994322110 000 02223333433332210234566776654 566789
Q ss_pred EEEec-CC
Q 014722 135 VMELC-EG 141 (419)
Q Consensus 135 v~e~~-~~ 141 (419)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.96 E-value=1e-05 Score=69.85 Aligned_cols=59 Identities=19% Similarity=0.232 Sum_probs=51.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC-----CCCCHHH-HHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-----QNIPEAD-LQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg-----~~~~~~e-~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.|++|.|+.+|++.++..++ ..++.++ +..++..+|.| |.|+|+||+
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 158 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLDMFMAVQALNGQQTLSPEEFINLVFHKIDINNDGELTLEEFI 158 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHTTSSCCCSCTHHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCccccHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 45688999999999999999999999999886 6667654 89999999876 799999983
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=97.94 E-value=1.9e-06 Score=73.63 Aligned_cols=62 Identities=11% Similarity=0.116 Sum_probs=55.2
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++..++++ |..+|.|++|.|+.+|++.+|+.+|. .++++++..++..+|.| |.|+|+||+
T Consensus 28 ~~~~~~~l~~-F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~eF~ 96 (198)
T 1juo_A 28 PGQTQDPLYG-YFAAVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFK 96 (198)
T ss_dssp TTCCCCTTHH-HHHHHHTTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHH
T ss_pred CccccHHHHH-HHHHhCCCCCcCCHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHhCCCCCCeECHHHHH
Confidence 3456677888 99999999999999999999999986 68999999999999887 689999984
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.94 E-value=5.5e-06 Score=69.56 Aligned_cols=63 Identities=16% Similarity=0.179 Sum_probs=55.8
Q ss_pred hhHHHhhHHHHHhhh-CCCCCCcccHHHHHHHHHhCC----CCCCHHHHHHH-----------HHHcCCC--CCcCcccc
Q 014722 357 SVEEVAGLKEAFEMM-DTNKRGKINLEELRLGLLKGG----QNIPEADLQIL-----------MEAVSII--CLLSYFLV 418 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~-D~~~~g~i~~~el~~~l~~lg----~~~~~~e~~~~-----------~~~~d~~--g~i~~~~f 418 (419)
+.++...++++|..+ |.|++|.|+.+|+..++..++ ..++..++..+ +..+|.| |.|+|+||
T Consensus 3 s~~~~~~l~~~F~~~~D~d~dG~i~~~E~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef 82 (185)
T 2sas_A 3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEY 82 (185)
T ss_dssp CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CHHHHHHHHHHHHHheeCCCCCeEcHHHHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHH
Confidence 456678899999999 999999999999999999998 88999888866 8898886 78999998
Q ss_pred C
Q 014722 419 C 419 (419)
Q Consensus 419 ~ 419 (419)
+
T Consensus 83 ~ 83 (185)
T 2sas_A 83 L 83 (185)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=97.93 E-value=6.8e-06 Score=68.05 Aligned_cols=54 Identities=11% Similarity=0.137 Sum_probs=49.6
Q ss_pred HHHhhhCCCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 366 EAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 366 ~~F~~~D~~~~g~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.|..+|.|++|.|+.+|++.++..+|. .++.+++..++..+|.+ |.|+|+||+
T Consensus 5 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~ 65 (167)
T 1gjy_A 5 YGYFASVAGQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFK 65 (167)
T ss_dssp HHHHHHHCCTTSCBCHHHHHHHHHHHTCSTTSCCCCHHHHHHHHHHHCTTCCSCBCHHHHH
T ss_pred HHHHHHHcCCCCcCCHHHHHHHHHhhcccCCCCCcCHHHHHHHHHHHCCCCCCcCCHHHHH
Confidence 4699999999999999999999999987 68999999999999887 689999984
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=97.91 E-value=7.6e-06 Score=71.57 Aligned_cols=57 Identities=19% Similarity=0.293 Sum_probs=50.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+|.|++|.|+.+|++.+|..+ |...+ ++..+|..+|.| |.|+|+||+
T Consensus 132 ~~~l~~~F~~~D~d~dG~Is~~El~~~l~~~~~~g~~~~--e~~~~~~~~D~d~dG~Is~~EF~ 193 (226)
T 2lvv_A 132 IFELTVMFDTMDKDGSLLLELQEFKEALPKLKEWGVDIT--DATTVFNEIDTNGSGVVTFDEFS 193 (226)
T ss_dssp HHHHHHHHHHHSCSSCCEECHHHHHHHHHHHHHHTCCCC--SCHHHHHHHCCSCSSCEEHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHHhhcCCCHH--HHHHHHHHhCCCCCCcEeHHHHH
Confidence 3578999999999999999999999999987 66555 599999999887 789999994
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=97.90 E-value=1e-05 Score=67.95 Aligned_cols=60 Identities=20% Similarity=0.225 Sum_probs=49.1
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCC----CCH----HHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQN----IPE----ADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~----~~~----~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|+..++..+ |.. +++ +++..++..+|.| |.|+|+||+
T Consensus 90 ~~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~Ef~ 163 (183)
T 1s6c_A 90 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFL 163 (183)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCeEcHHHHHHHHHHHHHHhccccCcCccHHHHHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 34578899999999999999999999999886 643 443 8899999999886 789999983
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.90 E-value=3.7e-06 Score=70.62 Aligned_cols=57 Identities=16% Similarity=0.086 Sum_probs=51.8
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++..+| ++++++..++..+|.| |.|+|+||+
T Consensus 104 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~g--~~~~~~~~~~~~~D~d~dG~i~~~ef~ 162 (185)
T 2sas_A 104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYK 162 (185)
T ss_dssp HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHH
T ss_pred HHHHHHHHHHHcCCCCCeEcHHHHHHHHHHhC--CCHHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 35688999999999999999999999999988 6788999999999887 799999984
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.89 E-value=8.7e-06 Score=69.83 Aligned_cols=56 Identities=16% Similarity=0.055 Sum_probs=31.1
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.+..+|..+|.|++|.|+.+|+..++..++...+.+++..++..+|.| |.|+++||
T Consensus 60 ~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~E~ 117 (204)
T 1jba_A 60 YVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQEL 117 (204)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHH
T ss_pred HHHHHHHHHcCCCCCeEeHHHHHHHHHHHccCCHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence 444555555555555555555555555555555555555555555544 45555554
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.88 E-value=1.6e-05 Score=67.86 Aligned_cols=59 Identities=17% Similarity=0.147 Sum_probs=51.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC------CCCCHHH-HHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGG------QNIPEAD-LQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg------~~~~~~e-~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|+..++..++ ..++.++ +..++..+|.| |.|+|+||+
T Consensus 87 ~~~~~~~F~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 154 (198)
T 2r2i_A 87 DQKLRWYFKLYDVDGNGCIDRGELLNIIKAIRAINRCNEAMTAEEFTNMVFDKIDINGDGELSLEEFM 154 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHTTGGGGSSSCCCHHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45678899999999999999999999999886 5667655 89999999876 789999983
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=9.2e-05 Score=67.88 Aligned_cols=76 Identities=16% Similarity=0.137 Sum_probs=59.7
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC--CCeeeeeeEEEeCCeEEEEEEe
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSAVHIVMEL 138 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~lv~e~ 138 (419)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|..+ ..+++++.+....+..++||||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 45689999999999873 5778889987532 245678898888887433 5688888888888899999999
Q ss_pred cCCcch
Q 014722 139 CEGGEL 144 (419)
Q Consensus 139 ~~~g~L 144 (419)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=1.6e-05 Score=78.01 Aligned_cols=59 Identities=19% Similarity=0.200 Sum_probs=52.9
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.+..+|+.+|.|++|.|+.+|++.++.. ..+++++++.++..+|.| |.|+|+||+
T Consensus 415 ~~~~~~~~~F~~~D~d~dG~I~~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~i~~~Ef~ 475 (484)
T 3nyv_A 415 LSRERLERAFRMFDSDNSGKISSTELATIFGV--SDVDSETWKSVLSEVDKNNDGEVDFDEFQ 475 (484)
T ss_dssp HHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHH--TTCCHHHHHHHHHHHCTTCCSEEEHHHHH
T ss_pred CcHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 34467899999999999999999999999987 568999999999999976 789999994
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=97.85 E-value=1.8e-05 Score=69.10 Aligned_cols=60 Identities=12% Similarity=0.181 Sum_probs=51.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHH----hCCCCCCHHHHHHHHH----HcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLL----KGGQNIPEADLQILME----AVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~----~lg~~~~~~e~~~~~~----~~d~~--g~i~~~~f~ 419 (419)
....++.+|..+|.|++|.|+.+|++.++. .+|..+++++++.++. .+|.| |.|+|+||+
T Consensus 120 ~~~~l~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~ 189 (226)
T 2zfd_A 120 IDDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWR 189 (226)
T ss_dssp HHHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 345789999999999999999999999995 6799999999877665 78776 789999983
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=97.85 E-value=5.6e-06 Score=68.35 Aligned_cols=54 Identities=13% Similarity=0.160 Sum_probs=49.6
Q ss_pred HHHhhhCCCCCCcccHHHHHHHHHhCCC-----CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 366 EAFEMMDTNKRGKINLEELRLGLLKGGQ-----NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 366 ~~F~~~D~~~~g~i~~~el~~~l~~lg~-----~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+|..+|.|++|.|+.+|++.+|+.+|. .++.+++..++..+|.+ |.|+|+||+
T Consensus 3 ~~F~~~D~d~~G~i~~~el~~~l~~lg~~~~~~~~~~~~~~~l~~~~D~~~~g~i~~~eF~ 63 (165)
T 1k94_A 3 YTYFSAVAGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFK 63 (165)
T ss_dssp HHHHHHHHGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHH
T ss_pred HHHHHHhCCCCCcCCHHHHHHHHHHhccccCCCCCCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 4699999999999999999999999987 78999999999999887 689999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.6e-06 Score=85.16 Aligned_cols=59 Identities=22% Similarity=0.292 Sum_probs=35.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+..+|+.+|.|++|.|+.+|++.++..+|..+++++++.++..+|.| |.|+|+||+
T Consensus 416 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 476 (486)
T 3mwu_A 416 RERMERAFKMFDKDGSGKISTKELFKLFSQADSSIQMEELESIIEQVDNNKDGEVDFNEFV 476 (486)
T ss_dssp HHHHHHHHHHHCSSCSSSBCSSCC--------------------CCCCSSCSSSBCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 45789999999999999999999999999999999999999999999887 799999994
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=97.83 E-value=1.5e-05 Score=65.58 Aligned_cols=59 Identities=12% Similarity=0.034 Sum_probs=50.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHH----HhCCCCCCHHHHHHH-----------HHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGL----LKGGQNIPEADLQIL-----------MEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l----~~lg~~~~~~e~~~~-----------~~~~d~~--g~i~~~~f~ 419 (419)
...++++|..+|.|++|.|+.+|+..++ ..+|..++..++..+ +..+|.+ |.|+|+||+
T Consensus 3 ~~~l~~~F~~~D~d~dG~i~~~E~~~~l~~~~~~~g~~~~~~~~~~l~~~~~~~~~~~f~~~D~d~~g~i~~~ef~ 78 (166)
T 3akb_A 3 ERRIAARFTTFDQDGNGHIDRSDFSGAAKAMLAEFGVAARSDRGQALYGGAEALWQGLAGIADRDGDQRITREEFV 78 (166)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHHTCCTTSHHHHHHHHHHHHHHHHHHHHHCTTSSSCEEHHHHH
T ss_pred HHHHHHHHhHHcCCCCCCcCHHHHHHHHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4678999999999999999999999975 556999999888866 5888876 789999983
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.81 E-value=1.6e-05 Score=69.44 Aligned_cols=60 Identities=18% Similarity=0.207 Sum_probs=50.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCC----CC----HHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQN----IP----EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~----~~----~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|++.++..+ |.. ++ .+++..++..+|.| |.|+|+||+
T Consensus 123 ~~~~l~~~F~~~D~d~dG~Is~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~EF~ 196 (224)
T 1s1e_A 123 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFL 196 (224)
T ss_dssp HHHHHHHHHHHHCTTCCSEECHHHHHHHHHHHHHHHTTCCCGGGCSSSHHHHHHHHHHHHCTTCSSCEEHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCeECHHHHHHHHHHHHHHhcccCCCCCCHhHHHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 34578899999999999999999999999886 643 33 48899999999887 799999984
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=97.80 E-value=7.2e-06 Score=73.20 Aligned_cols=59 Identities=17% Similarity=0.169 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC----CCCHHHHHHHHHH-cCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ----NIPEADLQILMEA-VSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~----~~~~~e~~~~~~~-~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|+|++|.|+.+|++.++..+|. .++++++..++.. +|.| |.|+|+||+
T Consensus 190 ~~~~~~~F~~~D~d~~G~is~~El~~~l~~~~~~~~~~~~~~e~~~~~~~~~D~d~dG~i~~~EF~ 255 (263)
T 2f33_A 190 GKEFNKAFELYDQDGNGYIDENELDALLKDLCEKNKQELDINNISTYKKNIMALSDGGKLYRTDLA 255 (263)
T ss_dssp HHHHHHHHHHHCCSSSSCEEHHHHHHHHHHHHHHCTTTCCTTTHHHHHHHHHTTSBTTEECGGGTH
T ss_pred HHHHHHHHHHhCCCCCCcccHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHhhccCCCCeEcHHHHH
Confidence 456889999999999999999999999998877 8999999999887 5665 799999994
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=97.79 E-value=6.8e-06 Score=76.00 Aligned_cols=57 Identities=19% Similarity=0.179 Sum_probs=53.6
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHH-HhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGL-LKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l-~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+..+|..+|.|++|.|+.+|++.++ ..+|..++++++..++..+|.| |.|+|+||+
T Consensus 254 ~l~~~F~~~D~d~dG~Is~~El~~~l~~~~g~~ls~~e~~~l~~~~D~d~dG~Is~~EF~ 313 (323)
T 1ij5_A 254 VLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFV 313 (323)
T ss_dssp HHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHH
T ss_pred HHHHHHHHhCCCCCCCccHHHHHHHHHHHcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 68899999999999999999999999 9999999999999999999876 789999994
|
| >2jul_A Calsenilin; EF-hand, calcium, LXXLL, DNA binding protein, dimer, alternative splicing, apoptosis, cytoplasm, endoplasmic reticulum, golgi apparatus; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=97.76 E-value=3.5e-05 Score=68.65 Aligned_cols=60 Identities=22% Similarity=0.211 Sum_probs=52.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----C--------CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG----G--------QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|+..++..+ | ...+++++..+|..+|.| |.|+|+||+
T Consensus 163 ~~~~l~~~F~~~D~d~dG~I~~~Ef~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~ 236 (256)
T 2jul_A 163 VHEKLKWAFNLYDINKDGCITKEEMLAIMKSIYDMMGRHTYPILREDAPLEHVERFFQKMDRNQDGVVTIDEFL 236 (256)
T ss_dssp HHHHHHHHHHHTCCSSSSCBCHHHHHHHHHHHHHHCCCCCSCCSCCCCHHHHHHHHHHHSCCSTTCSBCHHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCCcccchhhHHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 34578899999999999999999999999876 5 455788999999999887 799999983
|
| >1g8i_A Frequenin, neuronal calcium sensor 1; calcium binding-protein, EF-hand, calcium ION, metal binding protein; HET: 1PE P6G; 1.90A {Homo sapiens} SCOP: a.39.1.5 PDB: 2lcp_A | Back alignment and structure |
|---|
Probab=97.76 E-value=2.2e-05 Score=66.30 Aligned_cols=60 Identities=20% Similarity=0.165 Sum_probs=51.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHh----CC--------CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLK----GG--------QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~----lg--------~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.|++|.|+.+|+..++.. +| ...+++++..++..+|.| |.|+|+||+
T Consensus 97 ~~~~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~i~~~ef~ 170 (190)
T 1g8i_A 97 LDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQ 170 (190)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHH
T ss_pred HHHHHHHHHHhhcCCCCCeECHHHHHHHHHHHHHHhCCccCCccccccHHHHHHHHHHHhcCCCCCcEeHHHHH
Confidence 3456888999999999999999999999988 34 357788999999999887 789999983
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=97.76 E-value=2.8e-05 Score=66.70 Aligned_cols=60 Identities=17% Similarity=0.134 Sum_probs=51.3
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHH----hCCCCCCHHHHHHHH----HHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLL----KGGQNIPEADLQILM----EAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~----~lg~~~~~~e~~~~~----~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+|.|++|.|+.+|++.++. .+|..++++++..++ ..+|.| |.|+|+||+
T Consensus 109 ~~~~l~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 178 (207)
T 2ehb_A 109 VHEKVKFAFKLYDLRQTGFIEREELKEMVVALLHESELVLSEDMIEVMVDKAFVQADRKNDGKIDIDEWK 178 (207)
T ss_dssp HHHHHHHHHHHHCTTCCSSEEHHHHHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHcccccCHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 345688999999999999999999999996 569999999887666 478876 789999983
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=97.75 E-value=1.5e-05 Score=78.67 Aligned_cols=57 Identities=25% Similarity=0.281 Sum_probs=51.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+..+|+.+|.|++|.|+.+|++.++... .++++++++++..+|.| |.|+|+||+
T Consensus 434 ~~~~~~~F~~~D~d~dG~Is~~El~~~l~~~--~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 492 (504)
T 3q5i_A 434 EERLRRAFNLFDTDKSGKITKEELANLFGLT--SISEKTWNDVLGEADQNKDNMIDFDEFV 492 (504)
T ss_dssp HHHHHHHHHHHCTTCCSEECHHHHHHHTTCS--CCCHHHHHHHHHTTCSSCSSSEEHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHHHHhhC--CCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 4578999999999999999999999998874 58999999999999876 799999994
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=97.74 E-value=1.4e-05 Score=68.62 Aligned_cols=59 Identities=15% Similarity=0.097 Sum_probs=51.1
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----C----CCCCH------HHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----G----QNIPE------ADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g----~~~~~------~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|+..++..+ | ..+++ +++..++..+|.| |.|+|+||+
T Consensus 106 ~~~~~~~f~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~l~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 180 (207)
T 2d8n_A 106 NQKLEWAFSLYDVDGNGTISKNEVLEIVMAIFKMITPEDVKLLPDDENTPEKRAEKIWKYFGKNDDDKLTEKEFI 180 (207)
T ss_dssp STTHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHSCHHHHHTSCTTTSSHHHHHHHHHHHTTCCTTCCEEHHHHH
T ss_pred HHHHHHHHHHhcCCCCCeEcHHHHHHHHHHHHHHhccccCCCcccccccHHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 3568889999999999999999999999986 7 55554 6799999999876 799999984
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0003 Score=59.90 Aligned_cols=122 Identities=16% Similarity=0.064 Sum_probs=77.4
Q ss_pred cchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCccccc
Q 014722 142 GELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEI 219 (419)
Q Consensus 142 g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 219 (419)
-+|.+.|.. ..+++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|. |-+.+ +.+ .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~---V~f~~-~~s------~----- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA---VTLAP-AAD------D----- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC---EEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc---eeccc-ccc------c-----
Confidence 478888875 5679999999999999999877622 22223344568888865543 54432 110 0
Q ss_pred ccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCC
Q 014722 220 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNP 299 (419)
Q Consensus 220 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 299 (419)
.....+.|||......+.+.=|||||+++|..+--..|- ..-..+|+.+.+||..|...
T Consensus 98 ~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHhc
Confidence 112347788876555567788999999999888643331 11136899999999999866
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=1.3e-05 Score=78.81 Aligned_cols=58 Identities=17% Similarity=0.288 Sum_probs=51.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.+..+|+.+|+|++|.|+.+|++.++.. ..++++++++++..+|.| |.|+|+||+
T Consensus 424 ~~~~~~~~F~~~D~d~~G~Is~~El~~~l~~--~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 483 (494)
T 3lij_A 424 SKDKLESAFQKFDQDGNGKISVDELASVFGL--DHLESKTWKEMISGIDSNNDGDVDFEEFC 483 (494)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHHHC-C--CSCCCHHHHHHHHTTCSSSSSSEEHHHHH
T ss_pred cHHHHHHHHHHHCCCCCCcCCHHHHHHHHHh--cCCCHHHHHHHHHHhCCCCCCcCCHHHHH
Confidence 3457899999999999999999999999976 668889999999999877 799999994
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.73 E-value=9e-06 Score=69.61 Aligned_cols=61 Identities=16% Similarity=0.056 Sum_probs=53.6
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++++|..+|.|++|.|+.+|+..+ ..+|...+ +..++..+|.| |.|+|+||+
T Consensus 22 ~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~~-~~lg~~~~---~~~l~~~~D~d~dg~i~~~EF~ 84 (202)
T 2bec_A 22 GFSQASLLRLHHRFRALDRNKKGYLSRMDLQQI-GALAVNPL---GDRIIESFFPDGSQRVDFPGFV 84 (202)
T ss_dssp CCCHHHHHHHHHHHHHHCSSCSSCCCHHHHHTC-HHHHHSTT---HHHHHHTTSCSSCCCCCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-HhcCCCcc---HHHHHHHhCCCCCCcCcHHHHH
Confidence 346777889999999999999999999999999 88887666 88999999877 789999984
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=97.73 E-value=1.3e-05 Score=65.18 Aligned_cols=56 Identities=14% Similarity=0.206 Sum_probs=30.7
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.+...|..+|.|++|.|+.+|+..++...... ...+++..++..+|.| |.|+.+||
T Consensus 39 ~~~~~~~~~D~~~~g~i~~~ef~~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~i~~~e~ 97 (155)
T 3ll8_B 39 LVQRVIDIFDTDGNGEVDFKEFIEGVSQFSVKGDKEQKLRFAFRIYDMDKDGYISNGEL 97 (155)
T ss_dssp THHHHHHHHCTTCSSSBCHHHHHHHHGGGCSSCCHHHHHHHHHHHHCTTCSSCBCHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHHHHHHHcccCCHHHHHHHHHHHhCCCCCCcCcHHHH
Confidence 45555666666666666666666665554322 3334555566665554 45555554
|
| >2f33_A Calbindin; EF-hand, Ca2+-binding, metal binding protein; NMR {Rattus norvegicus} PDB: 2g9b_A | Back alignment and structure |
|---|
Probab=97.72 E-value=3.1e-05 Score=69.03 Aligned_cols=59 Identities=17% Similarity=0.188 Sum_probs=53.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCCCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQNIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.|++|.|+.+|++.+|..+ |..++++++.. ++..+|.+ |.|+|+||+
T Consensus 102 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~d~~~dg~i~~~ef~ 170 (263)
T 2f33_A 102 CEEFMKTWRKYDTDHSGFIETEELKNFLKDLLEKANKTVDDTKLAEYTDLMLKLFDSNNDGKLELTEMA 170 (263)
T ss_dssp HHHHHHHHTTSSTTTCSSBCHHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHHHTCSSSSSCBCHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcCHHHHHHHHHHHHhhcCCCCCHHHHHHHHHHHHHhcCCCCCCeEcHHHHH
Confidence 4568999999999999999999999999988 99999999887 99999876 789999984
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.71 E-value=4.3e-05 Score=64.48 Aligned_cols=59 Identities=19% Similarity=0.227 Sum_probs=51.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC------------CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG------------GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------------g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|+..++..+ +...+++++..++..+|.| |.|+|+||+
T Consensus 98 ~~~~~~~f~~~D~d~~G~i~~~e~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 170 (190)
T 2l2e_A 98 NDKLIWAFQLYDLDNNGLISYDEMLRIVDAIYKMVGSMVKLPEDEDTPEKRVNKIFNMMDKNKDGQLTLEEFC 170 (190)
T ss_dssp HHHHHHHHHHHCTTSCSCBCHHHHHHHHHHHHHHHHHHSCCCSSCCCTHHHHHHHHHHHTCCSSCCBCHHHHH
T ss_pred HHHHHHHHhHccCCCCCcCcHHHHHHHHHHHHHHhccccCcccccccHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4567889999999999999999999999872 3467889999999999887 799999983
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=97.70 E-value=1.5e-05 Score=71.51 Aligned_cols=59 Identities=14% Similarity=0.129 Sum_probs=52.8
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC----CCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ----NIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~----~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.++..+|. .++++++.. ++..+|.| |.|+|+||+
T Consensus 195 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~~D~d~dG~is~~EF~ 263 (272)
T 2be4_A 195 KRDFEKIFAHYDVSRTGALEGPEVDGFVKDMMELVRPSISGGDLDKFRECLLTHCDMNKDGKIQKSELA 263 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEETHHHHHHHHHHHHHHSSSCCHHHHHHHHHHHHHHHCCSTTCEEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeecHHHHHHHHHHHHHHcCCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 456889999999999999999999999998876 899999887 99999876 789999984
|
| >1djx_A PLC-D1, phosphoinositide-specific phospholipase C, isozyme delta1; phosphoric diester hydrolase, hydrolase, lipid degradation, transducer; HET: I3P; 2.30A {Rattus norvegicus} SCOP: a.39.1.7 b.7.1.1 c.1.18.1 PDB: 1djg_A 1dji_A 1djh_A* 1djw_A* 1djy_A* 1djz_A* 2isd_A 1qas_A 1qat_A | Back alignment and structure |
|---|
Probab=97.69 E-value=5.5e-06 Score=83.14 Aligned_cols=58 Identities=16% Similarity=0.088 Sum_probs=2.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++++|..+|.|++|.|+.+||+.+|+.+|..++++++..+|..+|.| |.|+|+||+
T Consensus 11 ~~l~~~F~~fD~d~dG~Is~~El~~~l~~lg~~~s~~el~~lf~~~D~d~~G~I~f~EF~ 70 (624)
T 1djx_A 11 HWIHSCLRKADKNKDNKMNFKELKDFLKELNIQVDDGYARKIFRECDHSQTDSLEDEEIE 70 (624)
T ss_dssp ---------------------------------------------------------CTT
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4689999999999999999999999999999999999999999999987 789999995
|
| >1sjj_A Actinin; 3-helix bundle, calponin homology domain, calmodulin-like domain, actin binding protein, contractIle protein; 20.00A {Gallus gallus} SCOP: i.15.1.1 | Back alignment and structure |
|---|
Probab=97.69 E-value=1.3e-05 Score=84.45 Aligned_cols=64 Identities=23% Similarity=0.414 Sum_probs=58.4
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 719 l~~~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~~~D~d~dG~I~~~EF~ 784 (863)
T 1sjj_A 719 ISQEQMNEFRASFNHFDRKKTGMMDCEDFRACLISMGYNMGEAEFARIMSIVDPNRMGVVTFQAFI 784 (863)
T ss_dssp SSHHHHHHHHHHHTTTCSSSSSEEESTTHHHHHHHHTCCCCTHHHHHHHHHHCTTSCSEEETTHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 3455678899999999999999999999999999999999999999999999876 789999994
|
| >1jba_A GCAP-2, protein (guanylate cyclase activating protein 2); EF-hand, calcium-binding protein, guanylyl cyclase regulation, lyase; NMR {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.69 E-value=3.1e-05 Score=66.31 Aligned_cols=59 Identities=22% Similarity=0.128 Sum_probs=50.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----C------------C-CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----G------------Q-NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g------------~-~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|+..++..+ | . ..+++++..++..+|.| |.|+|+||+
T Consensus 94 ~~~~~~~F~~~D~d~~G~I~~~E~~~~l~~~~~~~g~~~~~~~~~~~g~~~~~~~~~~~~f~~~D~d~dG~Is~~Ef~ 171 (204)
T 1jba_A 94 EHKLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFV 171 (204)
T ss_dssp THHHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHHHHHhCCCCccccccccCchhhHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 3468899999999999999999999999887 3 1 15667899999999876 799999983
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=97.63 E-value=1.8e-05 Score=62.32 Aligned_cols=53 Identities=21% Similarity=0.222 Sum_probs=47.3
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+..+|+.+|.|++|.|+.+|++.++..+|..+ +..++..+|.+ |.|+|+||+
T Consensus 76 ~~~~~f~~~D~d~~G~i~~~e~~~~l~~~~~~~----~~~~~~~~D~~~dg~i~~~ef~ 130 (134)
T 1jfj_A 76 GLKVLYKLMDVDGDGKLTKEEVTSFFKKHGIEK----VAEQVMKADANGDGYITLEEFL 130 (134)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHHHHTTTTCHH----HHHHHHHHHCSSSSEEEHHHHH
T ss_pred HHHHHHHHHCCCCCCccCHHHHHHHHHHhCHHH----HHHHHHHhCCCCCCcEeHHHHH
Confidence 388999999999999999999999999988654 88999999876 789999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.62 E-value=9.2e-05 Score=67.63 Aligned_cols=72 Identities=10% Similarity=0.001 Sum_probs=44.1
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec-
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC- 139 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~- 139 (419)
++.|+.|....+|++ ..+++|+....... .....+|..+++.+..+.-.++++.+ +.+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 567888999999998 56888887643110 11224577777766333222455544 343456899999
Q ss_pred CCcch
Q 014722 140 EGGEL 144 (419)
Q Consensus 140 ~~g~L 144 (419)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 76555
|
| >2hps_A Coelenterazine-binding protein with bound coelent; bioluminescence, southeast collabora structural genomics, secsg, structural genomics, PSI; HET: CTZ; 1.72A {Renilla muelleri} PDB: 2hq8_A | Back alignment and structure |
|---|
Probab=97.61 E-value=6.6e-06 Score=69.29 Aligned_cols=65 Identities=17% Similarity=0.100 Sum_probs=55.5
Q ss_pred hhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC------CCCCCHHHHHHHH---------HHcCCC--CCcCc
Q 014722 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG------GQNIPEADLQILM---------EAVSII--CLLSY 415 (419)
Q Consensus 353 ~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------g~~~~~~e~~~~~---------~~~d~~--g~i~~ 415 (419)
+..++.++...++++|..+|.|++|.|+.+|+..++..+ |..++.+++..++ ..+|.| |.|+|
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~dG~i~~~El~~~l~~~~~~~~~g~~~~~~~~~~l~~~~~~~~~f~~~D~d~dg~I~~ 84 (186)
T 2hps_A 5 TESERAYHLRKMKTRMQRVDVTGDGFISREDYELIAVRIAKIAKLSAEKAEETRQEFLRVADQLGLAPGVRISVEEAAVN 84 (186)
T ss_dssp CHHHHHHHHHHHHHHHHTTCTTCSSEEEHHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHTCCTTCEEEHHHHHHH
T ss_pred cccccHHHHHHHHHHhhhcCCCCCCccCHHHHHHHHHHHHHHHHcCCCCCcHHHHHHHHHHHHHHHHHhcCCCCCCcccH
Confidence 445667788899999999999999999999999999876 8888999999885 778776 67887
Q ss_pred cc
Q 014722 416 FL 417 (419)
Q Consensus 416 ~~ 417 (419)
+|
T Consensus 85 ~E 86 (186)
T 2hps_A 85 AT 86 (186)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=97.59 E-value=5.2e-05 Score=63.92 Aligned_cols=58 Identities=21% Similarity=0.248 Sum_probs=50.5
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh----CCC--------CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK----GGQ--------NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~----lg~--------~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+..+|..+|.|++|.|+.+|+..++.. +|. ..+++++..++..+|.| |.|+|+||+
T Consensus 99 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 170 (190)
T 1fpw_A 99 EKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFR 170 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHHHHHhccccCcccccchHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 46778999999999999999999999987 453 47788999999999876 789999983
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00063 Score=61.55 Aligned_cols=79 Identities=15% Similarity=0.083 Sum_probs=54.0
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC--CeeeeeeEEEeCCeEEEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP--NIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp--nIv~l~~~~~~~~~~~lv 135 (419)
..-++.+|.|..+.||+++ ..+|+.|++|+....... ....+..|...|+.|.... .+++++.+ +. .++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEE
T ss_pred eEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEE
Confidence 4456789999999999988 467899999987543221 1235678999998884332 34555543 22 3688
Q ss_pred EEecCCcch
Q 014722 136 MELCEGGEL 144 (419)
Q Consensus 136 ~e~~~~g~L 144 (419)
|||+.++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00019 Score=67.66 Aligned_cols=140 Identities=12% Similarity=0.154 Sum_probs=81.9
Q ss_pred cccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 62 RELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+.|..|-...+|++.... +++.+++|+.... . .....+.+|..+++.|..+.-.+++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 467778888999988532 3578999986331 1 1245666899999888555445677766543 28
Q ss_pred EEEecCCcchHH--------------HH---Hhc----C-CC--CHHHHHHHHHHHHH-------------------HHH
Q 014722 135 VMELCEGGELFD--------------RI---VAR----G-HY--TERAAAAVMKTIVE-------------------VVQ 171 (419)
Q Consensus 135 v~e~~~~g~L~~--------------~l---~~~----~-~~--~~~~~~~i~~qi~~-------------------~l~ 171 (419)
|+||++|.+|.. .+ ... + .. -..++..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865531 11 111 0 11 13455555544422 233
Q ss_pred HHH----H----cCCEeeCCCCCcEEeecC-CCCCCeEEeeccccee
Q 014722 172 VCH----E----QGVMHRDLKPENFLFANK-KESSPLKAIDFGLSVF 209 (419)
Q Consensus 172 ~LH----~----~~ivHrDlkp~NIl~~~~-~~~~~~kl~Dfg~a~~ 209 (419)
.|. . ..++|+|+.+.|||++.+ +....+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 2 258999999999999754 1224589999997753
|
| >1bjf_A Neurocalcin delta; calcium-binding, myristoylation, neuronal specific guanylate cyclase activator; 2.40A {Bos taurus} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=97.56 E-value=9.2e-05 Score=62.53 Aligned_cols=59 Identities=22% Similarity=0.154 Sum_probs=49.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----C--CCCCH------HHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----G--QNIPE------ADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g--~~~~~------~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|+..++..+ | ..++. +++..++..+|.| |.|+|+||+
T Consensus 98 ~~~~~~~f~~~D~d~~G~I~~~E~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~ 170 (193)
T 1bjf_A 98 EQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLEEFI 170 (193)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHHHHH
T ss_pred HHHHHHHHhhcCCCCCCeECHHHHHHHHHHHHHHhccccCCCcccccHHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4568889999999999999999999999873 5 34443 4589999999887 789999983
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=97.54 E-value=6.8e-05 Score=65.39 Aligned_cols=62 Identities=24% Similarity=0.330 Sum_probs=40.6
Q ss_pred hhhHHHhhHHHHHhhhCCC--CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 356 LSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~--~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.++...++++|..+|.| ++|.|+.+|+..+|.. +....+..+..++..+|.| |.|+|+||
T Consensus 42 ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~~l~~-~~~~~~~~~~~~f~~~D~d~dG~I~~~Ef 107 (226)
T 2zfd_A 42 FSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFK-TNKKESLFADRVFDLFDTKHNGILGFEEF 107 (226)
T ss_dssp CCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHHHHHS-CSSCCCHHHHHHHHHHCSSCSSSBCHHHH
T ss_pred CCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHHHHhc-cCcccHHHHHHHHHHHcCCCCCcCcHHHH
Confidence 3556666777777777777 7777777777777765 2222334456677777665 56777776
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=97.52 E-value=4.9e-05 Score=77.90 Aligned_cols=57 Identities=16% Similarity=0.306 Sum_probs=53.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|+.+|.|++|.|+.+|++.+|..+|..+++++++.++..+| | |.|+|+||+
T Consensus 605 ~~l~~~F~~~D~d~dG~Is~~El~~~L~~~G~~ls~~~~~~l~~~~D-d~dG~Isf~EF~ 663 (714)
T 3bow_A 605 QKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLHQVIVARFA-DDELIIDFDNFV 663 (714)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHHTTEECCHHHHHHHHHHHS-CTTCEECHHHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhC-CCCCeEcHHHHH
Confidence 67899999999999999999999999999999999999999999998 6 789999994
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=97.52 E-value=7.8e-05 Score=63.88 Aligned_cols=62 Identities=23% Similarity=0.379 Sum_probs=37.4
Q ss_pred hhhHHHhhHHHHHhhhCCC--CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 356 LSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~--~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.++...++++|..+|.| ++|.|+.+|+..+|.. .....+..+..++..+|.+ |.|+|.||
T Consensus 31 ~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~~l~~-~~~~~~~~~~~~f~~~D~d~~g~i~~~Ef 96 (207)
T 2ehb_A 31 FTVEEVEALYELFKKLSSSIIDDGLIHKEEFQLALFR-NRNRRNLFADRIFDVFDVKRNGVIEFGEF 96 (207)
T ss_dssp CCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHHHHHS-CTTCCCHHHHHHHHHHCTTCSSEECHHHH
T ss_pred CCHHHHHHHHHHHHHhccccCCCCccCHHHHHHHHhc-cccccHHHHHHHHHHhcCCCCCeEeHHHH
Confidence 3455566666667777766 6677777777666665 2222333455566666655 45666666
|
| >2be4_A Hypothetical protein LOC449832; DR.36843, BC083168, calicium binding, EF-hand superfamily, S genomics, protein structure initiative, PSI; 2.10A {Danio rerio} PDB: 2q4u_A | Back alignment and structure |
|---|
Probab=97.51 E-value=5.3e-05 Score=67.80 Aligned_cols=59 Identities=19% Similarity=0.176 Sum_probs=52.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCCCCHHHHHH----HHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQNIPEADLQI----LMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~~~~~e~~~----~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.|++|.|+.+|+..++..+ |..++++++.. ++..+|.+ |.|+|+||+
T Consensus 103 ~~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~ef~ 171 (272)
T 2be4_A 103 SVEFMKIWRKYDADSSGYISAAELKNFLKDLFLQHKKKIPPNKLDEYTDAMMKIFDKNKDGRLDLNDLA 171 (272)
T ss_dssp HHHHHHHHHHHCTTCCSEEEGGGHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEEEHHHHG
T ss_pred HHHHHHHHHHhCCCCCCccCHHHHHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHhccCCCCcCcHHHHH
Confidence 4568999999999999999999999999988 99999988865 88888876 789999984
|
| >2l2e_A Calcium-binding protein NCS-1; NCS1P, myristoylated, metal binding protein; HET: MYR; NMR {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00012 Score=61.66 Aligned_cols=57 Identities=21% Similarity=0.230 Sum_probs=53.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
..+..+|..+|.|++|.|+.+|+..++..++...+.+++..++..+|.| |.|+++||
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~ 121 (190)
T 2l2e_A 63 AFAEYVFNVFDADKNGYIDFKEFICALSVTSRGELNDKLIWAFQLYDLDNNGLISYDEM 121 (190)
T ss_dssp HHHHHHHHHHCSSSTTCEEHHHHHHHHTTSSCSCSHHHHHHHHHHHCTTSCSCBCHHHH
T ss_pred HHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHhHccCCCCCcCcHHHH
Confidence 4678899999999999999999999999999999999999999999976 78999998
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00016 Score=66.67 Aligned_cols=139 Identities=16% Similarity=0.152 Sum_probs=75.7
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-Ceeeeee------EEEeCCeEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKD------TYEDDSAVH 133 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~~------~~~~~~~~~ 133 (419)
++.|+.|....+|++.. .+| .+++|+..... ..+.+..|+.+++.|..+. .+++++. +....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 45677888899999874 333 68899886421 1134556777777663221 1333332 123346788
Q ss_pred EEEEecCCcchHH--------------HHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH
Q 014722 134 IVMELCEGGELFD--------------RIVAR-GHY--------TERAAAA---------------VMKTIVEVVQVCHE 175 (419)
Q Consensus 134 lv~e~~~~g~L~~--------------~l~~~-~~~--------~~~~~~~---------------i~~qi~~~l~~LH~ 175 (419)
++++|++|..+.. .+... ..+ ....... +...+...+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865311 11110 011 1000000 00113344555553
Q ss_pred -------cCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 176 -------QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 176 -------~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.+++|+|+.|.|||++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~---~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD---ELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT---EEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC---ceEEEecchhccC
Confidence 369999999999999743 2247999997653
|
| >1fpw_A Yeast frequenin, calcium-binding protein NCS-1; EF-hand, metal binding protein; NMR {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2ju0_A | Back alignment and structure |
|---|
Probab=97.42 E-value=9.4e-05 Score=62.31 Aligned_cols=57 Identities=18% Similarity=0.206 Sum_probs=52.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
..+..+|..+|.|++|.|+.+|+..++..++...+++++..++..+|.| |.|+++||
T Consensus 63 ~~~~~~f~~~D~d~~G~i~~~ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~ef 121 (190)
T 1fpw_A 63 DFANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEM 121 (190)
T ss_dssp HHHHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHH
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHHHccCCcHHHHHHHHHHhcCCCCCcCcHHHH
Confidence 3478899999999999999999999999999888999999999999987 78999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00034 Score=67.27 Aligned_cols=75 Identities=15% Similarity=0.104 Sum_probs=50.0
Q ss_pred ccccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 61 GRELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++.|+.|....||++.... ++..+++|+.... .. .+.+.+|..+++.|..+.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4567888889999998542 3578999988431 11 13455798888888544334667765542 2
Q ss_pred EEEEecCCcch
Q 014722 134 IVMELCEGGEL 144 (419)
Q Consensus 134 lv~e~~~~g~L 144 (419)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987444
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00012 Score=61.37 Aligned_cols=59 Identities=14% Similarity=0.099 Sum_probs=50.5
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
....+..+|..+|.|++|.|+.+|+..++..++...+.+++..+++.+|.| |.|+++||
T Consensus 54 ~~~~~~~~f~~~D~d~~g~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~i~~~e~ 114 (183)
T 1s6c_A 54 ASTYAHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEM 114 (183)
T ss_dssp CHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred hHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHHcCCCHHHHHHHHHHHhCCCCCCeEcHHHH
Confidence 345678889999999999999999999998887777888899999999876 68998887
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.36 E-value=9e-05 Score=61.79 Aligned_cols=50 Identities=12% Similarity=0.014 Sum_probs=42.9
Q ss_pred hhCCCCCCcccHHHHHHHHHhC------CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 370 MMDTNKRGKINLEELRLGLLKG------GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 370 ~~D~~~~g~i~~~el~~~l~~l------g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.-++|++|.|+.+||+.+|+.+ |..++++++..++..+|.| |.|+|+||+
T Consensus 12 ~~~~~~dG~I~~~EL~~~l~~l~~~~~~g~~~~~~~~~~l~~~~D~d~~G~I~f~EF~ 69 (174)
T 2i7a_A 12 SGLVPRGSDIDATQLQGLLNQELLTGPPGDMFSLDECRSLVALMELKVNGRLDQEEFA 69 (174)
T ss_dssp CCSCC-CCCEEHHHHHHHHHHHHC-----CCCCHHHHHHHHHHHCSSCSSEECHHHHH
T ss_pred cccCCCCCcCCHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHHHCCCCCCcCCHHHHH
Confidence 3578999999999999999998 6788999999999999987 689999983
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00017 Score=61.33 Aligned_cols=58 Identities=17% Similarity=0.110 Sum_probs=53.1
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...+..+|..+|.|++|.|+.+|+..++..++...+.+++..++..+|.| |.|+++||
T Consensus 51 ~~~~~~~f~~~D~d~~G~I~~~Ef~~~~~~~~~~~~~~~~~~~F~~~D~d~~G~I~~~Ef 110 (198)
T 2r2i_A 51 NKYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVDQKLRWYFKLYDVDGNGCIDRGEL 110 (198)
T ss_dssp HHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHSSCCHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHHHHHHHccCchHHHHHHHHHHhcCCCCCcCcHHHH
Confidence 44588999999999999999999999999998888899999999999987 78999988
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00082 Score=61.95 Aligned_cols=76 Identities=13% Similarity=0.166 Sum_probs=48.2
Q ss_pred ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-CeeeeeeE-----EEeCCeEEEEE
Q 014722 63 ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLKDT-----YEDDSAVHIVM 136 (419)
Q Consensus 63 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~~~-----~~~~~~~~lv~ 136 (419)
.++ |....||++.. .+|+.+++|+...... ....+..|..+++.|..+. .+++++.. ....+..++|+
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 456 77889998763 4567899999863321 2346667888887773221 24444432 23356678999
Q ss_pred EecCCcch
Q 014722 137 ELCEGGEL 144 (419)
Q Consensus 137 e~~~~g~L 144 (419)
++++|.++
T Consensus 107 ~~i~G~~~ 114 (328)
T 1zyl_A 107 PSVGGRQF 114 (328)
T ss_dssp ECCCCEEC
T ss_pred EecCCCCC
Confidence 99988543
|
| >2d8n_A Recoverin; structural genomics, NPPSFA, national project on protein STR and functional analyses, riken structural genomics/proteomi initiative; 2.20A {Homo sapiens} PDB: 2i94_A 1iku_A* 1jsa_A* 1omr_A 1rec_A 1la3_A* 1omv_A 2het_A | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00013 Score=62.39 Aligned_cols=58 Identities=17% Similarity=0.172 Sum_probs=53.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...+..+|..+|.|++|.|+.+|+..++..++...+++++..++..+|.| |.|+++||
T Consensus 70 ~~~~~~~f~~~D~d~~G~i~~~Ef~~~~~~~~~~~~~~~~~~~f~~~D~d~~G~I~~~E~ 129 (207)
T 2d8n_A 70 KAYAQHVFRSFDSNLDGTLDFKEYVIALHMTTAGKTNQKLEWAFSLYDVDGNGTISKNEV 129 (207)
T ss_dssp HHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHSCSSSSTTHHHHHHHHCTTCSSEECHHHH
T ss_pred HHHHHHHHHHhcCCCCCeEeHHHHHHHHHHHcCCCHHHHHHHHHHHhcCCCCCeEcHHHH
Confidence 35688999999999999999999999999998888899999999999987 78999998
|
| >3bow_A Calpain-2 catalytic subunit; cysteine protease, inhibitor, cell membrane, hydrolase, MEMB protease, thiol protease, phosphoprotein; 2.40A {Rattus norvegicus} PDB: 3df0_A 1df0_A 1u5i_A 1kfu_L 1kfx_L | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00012 Score=75.05 Aligned_cols=63 Identities=14% Similarity=0.146 Sum_probs=56.9
Q ss_pred hhhHH-HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC--------CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEE-VAGLKEAFEMMDTNKRGKINLEELRLGLLKG--------GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~-~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l--------g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++ ...++++|..+| |++|.|+.+||+.+|..+ |..++.+++..++..+|.| |.|+|+||+
T Consensus 525 ls~~e~~~~l~~~F~~~D-d~dG~Is~~El~~~L~~l~~~~~~~~g~~~s~~~~~~l~~~~D~d~~G~I~f~EF~ 598 (714)
T 3bow_A 525 ANEEDIGDGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFY 598 (714)
T ss_dssp CSGGGCCHHHHHHHHHHH-GGGTSBCHHHHHHHHHHHHTTCTTSCCSCCCHHHHHHHHHHHCCSSCSSBCHHHHH
T ss_pred CChhhHHHHHHHHHHHHc-CCCCcCCHHHHHHHHHHHhhhcccccCCCCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 44555 778999999999 999999999999999997 8899999999999999987 789999994
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00036 Score=64.64 Aligned_cols=35 Identities=26% Similarity=0.401 Sum_probs=26.5
Q ss_pred cCCEeeCCCCCcEEeecCCC-CCCeEEeecccceec
Q 014722 176 QGVMHRDLKPENFLFANKKE-SSPLKAIDFGLSVFF 210 (419)
Q Consensus 176 ~~ivHrDlkp~NIl~~~~~~-~~~~kl~Dfg~a~~~ 210 (419)
..++|||+.+.|||++.+.. ...+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 46999999999999964311 135899999987653
|
| >1qxp_A MU-like calpain; M-calpain, MU-calpain, catalytic triad, Ca(2+) requirement, hydrolase chimera; 2.80A {Rattus norvegicus} SCOP: a.39.1.8 a.39.1.8 b.14.1.1 d.3.1.3 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00016 Score=76.26 Aligned_cols=57 Identities=16% Similarity=0.289 Sum_probs=53.8
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|+.+|.|++|.|+.+|++.+|..+|..+++++++.++..+| + |.|+|+||+
T Consensus 607 ~~l~~~F~~~D~d~~G~Is~~El~~~l~~~g~~l~~~~~~~l~~~~d-d~dg~I~~~eF~ 665 (900)
T 1qxp_A 607 RNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFA-DDELIIDFDNFV 665 (900)
T ss_dssp HHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTS-CSSSBCCHHHHH
T ss_pred HHHHHHHHhhCCCCCCeECHHHHHHHHHHhCCCCCHHHHHHHHHHhC-CCCCeEcHHHHH
Confidence 67899999999999999999999999999999999999999999998 5 789999994
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00018 Score=60.27 Aligned_cols=59 Identities=15% Similarity=0.059 Sum_probs=37.6
Q ss_pred hhhHHHhhHHHHHhhhCC-----CC-C--CcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CC-cCcccc
Q 014722 356 LSVEEVAGLKEAFEMMDT-----NK-R--GKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CL-LSYFLV 418 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~-----~~-~--g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~-i~~~~f 418 (419)
++.++...+++.|..+|. |+ + |.|+.+|+.. |..+|..++.++ ++..+|.+ |. |+|.||
T Consensus 14 ls~~~~~~l~~~F~~~D~~~~~~~~~~~~G~i~~~el~~-l~~~g~~~~~~~---l~~~~D~d~~G~~I~~~EF 83 (183)
T 1dgu_A 14 LTKQEILLAHRRFCELLPQEQRSVESSLRAQVPFEQILS-LPELKANPFKER---ICRVFSTSPAKDSLSFEDF 83 (183)
T ss_dssp CCHHHHHHHHHHHHHHSCSTTCSSCCCTTTCSCHHHHHT-STTSSSCTTHHH---HHHHHSCSSSSCCCCHHHH
T ss_pred CCHHHHHHHHHHHHHhCccccccccccccCcCcHHHHHH-HHhhhcCcHHHH---HHHHhCCCCCCCEecHHHH
Confidence 345556667777777777 56 6 7777777777 666776666543 34444544 56 777776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 419 | ||||
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-96 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-94 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-91 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-91 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-89 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-88 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-88 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-85 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-85 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-85 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-85 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-83 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-78 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-78 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-78 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-78 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-76 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-76 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-74 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-72 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-70 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-69 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-69 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-69 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-68 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-67 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-66 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-66 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-64 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-63 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-58 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-57 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-46 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-22 | |
| d1ij5a_ | 321 | a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-bind | 2e-10 | |
| d1s6ja_ | 87 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 1e-09 | |
| d1s6ia_ | 182 | a.39.1.5 (A:) Calcium-dependent protein kinase sk5 | 2e-08 | |
| d2pq3a1 | 73 | a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [T | 1e-07 | |
| d1f54a_ | 77 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 4e-07 | |
| d1lkja_ | 146 | a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharom | 6e-07 | |
| d1avsa_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 6e-07 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 2e-06 | |
| d1topa_ | 162 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 5e-06 | |
| d1qv0a_ | 189 | a.39.1.5 (A:) Calcium-regulated photoprotein {Hydr | 7e-06 | |
| d1wrka1 | 82 | a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens) | 8e-06 | |
| d1uhka1 | 187 | a.39.1.5 (A:3-189) Calcium-regulated photoprotein | 1e-05 | |
| d1c7va_ | 68 | a.39.1.5 (A:) Calcium vector protein {Amphioxus (B | 2e-05 | |
| d1m45a_ | 146 | a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's ye | 2e-05 | |
| d1exra_ | 146 | a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetr | 3e-05 | |
| d1w7jb1 | 139 | a.39.1.5 (B:11-149) Myosin Essential Chain {Human | 4e-05 | |
| d1wdcb_ | 142 | a.39.1.5 (B:) Myosin Essential Chain {Bay scallop | 7e-05 | |
| d1oqpa_ | 77 | a.39.1.5 (A:) Caltractin (centrin 2) {Green algae | 8e-05 | |
| d1y1xa_ | 182 | a.39.1.8 (A:) Programmed cell death 6 protein-like | 1e-04 | |
| d1wdcc_ | 152 | a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop | 1e-04 | |
| d1tiza_ | 67 | a.39.1.5 (A:) Calmodulin-related protein T21P5.17 | 2e-04 | |
| d1alva_ | 173 | a.39.1.8 (A:) Calpain small (regulatory) subunit ( | 3e-04 | |
| d1dtla_ | 156 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 4e-04 | |
| d2opoa1 | 81 | a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Che | 5e-04 | |
| d1auib_ | 165 | a.39.1.5 (B:) Calcineurin regulatory subunit (B-ch | 5e-04 | |
| d2zfda1 | 183 | a.39.1.5 (A:32-214) Calcineurin B-like protein 2 { | 5e-04 | |
| d1fi5a_ | 81 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), | 6e-04 | |
| d1jc2a_ | 75 | a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) | 7e-04 | |
| d1jfja_ | 134 | a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histoly | 0.001 | |
| d1rroa_ | 108 | a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) | 0.001 | |
| d2fcea1 | 61 | a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [ | 0.002 | |
| d2obha1 | 141 | a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapien | 0.002 | |
| d2sasa_ | 185 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 0.002 | |
| d1pvaa_ | 109 | a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [Tax | 0.002 | |
| d1nyaa_ | 176 | a.39.1.5 (A:) Calerythrin {Saccharopolyspora eryth | 0.003 | |
| d1jbaa_ | 189 | a.39.1.5 (A:) Guanylate cyclase activating protein | 0.003 | |
| d1hqva_ | 181 | a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mous | 0.004 | |
| d1rwya_ | 109 | a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [Ta | 0.004 | |
| d2scpa_ | 174 | a.39.1.5 (A:) Sarcoplasmic calcium-binding protein | 0.004 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 289 bits (740), Expect = 2e-96
Identities = 112/297 (37%), Positives = 174/297 (58%), Gaps = 5/297 (1%)
Query: 51 GQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
+DI YD LG G F L D + A K I+KK L + E+ ++
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVL 61
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
+ KHPNIV+L D YE ++++M+L GGELFDRIV +G YTER A+ ++ +++ V
Sbjct: 62 HKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAV 120
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
+ H+ G++HRDLKPEN L+ + E S + DFGLS PG + G+P Y+APEV
Sbjct: 121 KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
Query: 231 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
L + Y VD WS GVI YILLCG PPF+ E + + + I+++ +F W +S++A
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346
KD ++ ++ DP++R T E+ L+HPW+ A + ++ ++V ++K+ +K K+
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 286 bits (733), Expect = 1e-94
Identities = 104/336 (30%), Positives = 161/336 (47%), Gaps = 28/336 (8%)
Query: 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
E + YD+ ELG G FGV + C + G F K I+ +D V+ E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEI 77
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTI 166
IM L HP +++L D +ED + +++E GGELFDRI A + +E M+
Sbjct: 78 SIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
E ++ HE ++H D+KPEN + KK SS +K IDFGL+ P E + +
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 227 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
APE++ R G D+W+ GV+ Y+LL G+ PF E + Q + R +F D + V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN---------------------AKKAPN 324
S AKD +K +L +P++RLT + LEHPWL+ +K +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
Query: 325 VSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEE 360
+ R+ FS + K + + Q+ + +E
Sbjct: 316 WPAPQPAIGRIANFSSLRKHRPQEYQIYDSYFDRKE 351
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 277 bits (710), Expect = 2e-91
Identities = 95/272 (34%), Positives = 142/272 (52%), Gaps = 7/272 (2%)
Query: 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
E + YD+ ELG G FGV + T+ G FA K + D E VR+E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEI 74
Query: 108 QIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTI 166
Q M L +HP +V+L D +EDD+ + ++ E GGELF+++ +E A M+ +
Sbjct: 75 QTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
+ + HE +H DLKPEN +F K S+ LK IDFGL+ P + G+ +
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192
Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285
APEV + + G D+WS GV+ YILL G+ PF E + + + + + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
SE+ KD ++K+L DP R+T + LEHPWL
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 276 bits (706), Expect = 4e-91
Identities = 87/305 (28%), Positives = 160/305 (52%), Gaps = 12/305 (3%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+++ Y + +LGRGEFG+ + C + ++ + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVV 170
+H NI+ L +++E + ++ E G ++F+RI ER + + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
Q H + H D++PEN ++ ++ S +K I+FG + +PG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 231 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRAL 349
D V ++L + K R+TA E L+HPWL+ + + + T LK + L K+ L
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT----LKHRRYYHTLIKKDL 290
Query: 350 QVVAE 354
+V
Sbjct: 291 NMVVS 295
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 268 bits (687), Expect = 6e-89
Identities = 97/274 (35%), Positives = 144/274 (52%), Gaps = 16/274 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD------IEDVRREVQIM 110
+Y+ LGRG V C +++A K I + E +EV I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 111 KHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
+ + HPNI+ LKDTYE ++ +V +L + GELFD + + +E+ +M+ ++EV+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
H+ ++HRDLKPEN L + +K DFG S PGE+ E+ G+P Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 231 L-------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
+ YG EVD+WS GVI+Y LL G PPFW + + + I+ F W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
S+ KDLV + L P++R TAEE L HP+ Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (682), Expect = 2e-88
Identities = 92/262 (35%), Positives = 142/262 (54%), Gaps = 10/262 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+++GR LG+G+FG YL + + A K + K +L A +RREV+I HL +H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 65
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
PNI+ L + D + V++++E G ++ + + E+ A + + + CH +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
V+HRD+KPEN L + E LK DFG SV P + + G+ Y+ PE+++ R +
Sbjct: 126 RVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 181
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
+VD+WS GV+ Y L G PPF A T Q + I R F V+E A+DL+ +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISR 237
Query: 296 MLNPDPKQRLTAEEVLEHPWLQ 317
+L +P QR EVLEHPW+
Sbjct: 238 LLKHNPSQRPMLREVLEHPWIT 259
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 267 bits (683), Expect = 5e-88
Identities = 100/272 (36%), Positives = 158/272 (58%), Gaps = 6/272 (2%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKL---RTAVDIEDVRREVQ 108
+++ YD G ELG G+F V C + + G ++A K I K++ R V ED+ REV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
I+K + +HPN+++L + YE+ + V +++EL GGELFD + + TE A +K I+
Sbjct: 66 ILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSP-LKAIDFGLSVFFRPGEQFNEIVGSPYYMA 227
V H + H DLKPEN + ++ P +K IDFGL+ G +F I G+P ++A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
PE++ G E D+WS GVI YILL G PF +T+Q + +F+ + + S
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
AKD ++++L DPK+R+T ++ L+HPW++
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 261 bits (668), Expect = 1e-85
Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 15/303 (4%)
Query: 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
D + RE+G G FG Y DV N E A K +S ++ +D+ +EV+ ++
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
L +HPN + + Y + +VME C G V + E AAV ++ +
Sbjct: 71 KL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
H ++HRD+K N L + +K DFG + P F VG+PY+MAPEV+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVI 183
Query: 232 ----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
+ Y +VDVWS G+ L PP + I ++ + SE
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSE 241
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKR 347
++ V L P+ R T+E +L+H ++ + P + + ++ ++ L+ R
Sbjct: 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER--PPTVIMDLIQRTKDAVRELDNLQYR 299
Query: 348 ALQ 350
++
Sbjct: 300 KMK 302
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (664), Expect = 3e-85
Identities = 85/287 (29%), Positives = 136/287 (47%), Gaps = 25/287 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ G+ LG G F L ++ ++A K + K+ + + V RE +M L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P V L T++DD ++ + + GEL I G + E IV ++ H +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK- 232
G++HRDLKPEN L E ++ DFG + P + N VG+ Y++PE+L
Sbjct: 128 GIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
++ D+W+ G I+Y L+ G+PPF A E + Q II+ DF K A+DL
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARDL 240
Query: 293 VKKMLNPDPKQRLTAEE------VLEHPWLQN-------AKKAPNVS 326
V+K+L D +RL EE + HP+ ++ + P ++
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 4e-85
Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 12/270 (4%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+DL + LG G +G L + E A K + K+ E++++E+ I K L H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-NH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
N+V + + ++ +E C GGELFDRI E A ++ V H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLKR 233
G+ HRD+KPEN L + LK DFGL+ FR + N++ G+ Y+APE+LKR
Sbjct: 123 GITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 234 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
+ VDVWS G++L +L G P+ ++ + + + +PW K+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LNPWKKIDSAPLA 238
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
L+ K+L +P R+T ++ + W K
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (664), Expect = 4e-85
Identities = 82/279 (29%), Positives = 143/279 (51%), Gaps = 11/279 (3%)
Query: 50 SGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
S D Y ++G+G G Y DV G++ A + ++ ++ E + E+ +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILV 70
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
M+ K+PNIV+ D+Y + +VME GG L D +V E AAV + ++
Sbjct: 71 MREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQA 128
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAP 228
++ H V+HRD+K +N L +K DFG + + +VG+PY+MAP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
EV+ R YGP+VD+WS G++ ++ G PP+ E I + ++P K+S
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSA 244
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
+D + + L+ D ++R +A+E+L+H +L+ AK +++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT 283
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (652), Expect = 7e-83
Identities = 105/316 (33%), Positives = 154/316 (48%), Gaps = 21/316 (6%)
Query: 57 DYD-LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPK 115
DY + LG G G + EKFA K + RREV++ +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQ 63
Query: 116 HPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEV 169
P+IV + D YE+ + IVME +GGELF RI RG +TER A+ +MK+I E
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE 229
+Q H + HRD+KPEN L+ +K+ ++ LK DFG + +PYY+APE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183
Query: 230 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV----IDFKRDPWPK 284
VL Y D+WS GVI+YILLCG PPF++ ++ + + +F W +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKL 344
VSE K L++ +L +P QR+T E + HPW+ + K P L T + + +
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL-HTSRVLKEDKERWEDV 302
Query: 345 KKRALQVVAEFLSVEE 360
K+ +A E
Sbjct: 303 KEEMTSALATMRVDYE 318
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 8e-83
Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 16/279 (5%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ +++ ELG G FG Y + A K I K ++ED E+ I+
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILAS 65
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQ 171
HPNIV L D + ++ + I++E C GG + ++ TE V K ++ +
Sbjct: 66 C-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN 124
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEV 230
H+ ++HRDLK N LF + +K DFG+S R ++ + +G+PY+MAPEV
Sbjct: 125 YLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181
Query: 231 L------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
+ R Y + DVWS G+ L + PP V I +S P +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SR 240
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAP 323
S N KD +KK L + R T ++L+HP++ P
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP 279
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 1e-78
Identities = 60/273 (21%), Positives = 116/273 (42%), Gaps = 15/273 (5%)
Query: 54 ISID---YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIM 110
+S D E+GRG F Y D + A + +KL T + + + E +++
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEML 62
Query: 111 KHLPKHPNIVSLKDTYED----DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
K L +HPNIV D++E + +V EL G L + + + + I
Sbjct: 63 KGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 121
Query: 167 VEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
++ +Q H + ++HRDLK +N + +K D GL+ R ++G+P
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR-ASFAKAVIGTPE 178
Query: 225 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
+MAPE+ + Y VDV++ G+ + + P+ + S +
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKV 237
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
K++++ + + +R + +++L H + Q
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 4e-78
Identities = 74/265 (27%), Positives = 129/265 (48%), Gaps = 10/265 (3%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ L + LG+G FG +L + FA K++ K + D+E E +++ +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P + + T++ + VME GG+L I + + A I+ +Q H +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RN 234
G+++RDLK +N L + +K DFG+ G+ + N G+P Y+APE+L +
Sbjct: 123 GIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294
Y VD WS GV+LY +L G PF + E+ + +I + + + AKDL+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLV 235
Query: 295 KMLNPDPKQRLTAE-EVLEHPWLQN 318
K+ +P++RL ++ +HP +
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 6e-78
Identities = 69/322 (21%), Positives = 120/322 (37%), Gaps = 50/322 (15%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D++ ELG G GV + + +G A K I + + RE+Q++
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NS 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P IV + D + I ME +GG L + G E+ V +++ + E+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 177 -GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RN 234
+MHRD+KP N L ++ E +K DFG+S N VG+ YM+PE L+ +
Sbjct: 124 HKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTH 179
Query: 235 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI------------------- 275
Y + D+WS G+ L + G P + + V
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 276 ---------------------DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHP 314
+ P S +D V K L +P +R ++++ H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 315 WLQNAKKAPNVSLGETVKARLK 336
+++ + V + + +
Sbjct: 300 FIKRSDAEE-VDFAGWLCSTIG 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 7e-78
Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 21/273 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY++ +G G +G ++G+ K + + T + + + EV +++ L KH
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KH 62
Query: 117 PNIVSLKDTYED--DSAVHIVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVV 170
PNIV D D ++ ++IVME CEGG+L I R + E VM + +
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 171 QVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF-NEIVGSPY 224
+ CH + V+HRDLKP N K+ +K DFGL+ F VG+PY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTPY 179
Query: 225 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
YM+PE + R Y + D+WS G +LY L +PPF A +++ +A I R
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPY 236
Query: 284 KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316
+ S+ +++ +MLN R + EE+LE+P +
Sbjct: 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 238 bits (609), Expect = 5e-76
Identities = 71/275 (25%), Positives = 126/275 (45%), Gaps = 15/275 (5%)
Query: 54 ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK- 111
+++ D+ + R +GRG FG Y C + G+ +A K + KK+++ E ++
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 112 -HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
P IV + + + +++L GG+L + G ++E I+ +
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEV 230
+ H + V++RDLKP N L E ++ D GL+ F + + VG+ YMAPEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEV 176
Query: 231 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
L++ Y D +S G +L+ LL G PF + + I R + + S
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPE 235
Query: 289 AKDLVKKMLNPDPKQRLT-----AEEVLEHPWLQN 318
+ L++ +L D +RL A+EV E P+ ++
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 235 bits (599), Expect = 9e-76
Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 7/270 (2%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
+S Y+LG LG G +L D+ A K + R RRE Q L
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 114 PKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEV 169
HP IV++ DT E ++ +IVME +G L D + G T + A V+ +
Sbjct: 65 -NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 170 VQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG-LSVFFRPGEQFNEIVGSPYYMAP 228
+ H+ G++HRD+KP N + + + ++ Q ++G+ Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 229 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287
E + + DV+S G +LY +L G PPF ++ VA +R +S
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 288 NAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ +V K L +P+ R + ++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 235 bits (601), Expect = 2e-75
Identities = 74/268 (27%), Positives = 132/268 (49%), Gaps = 16/268 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D+ + R LG G FG +L +NG +A K + K+ + +E E ++ + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-TH 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
P I+ + T++D + ++M+ EGGELF + + A + ++ H +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNY 235
+++RDLKPEN L ++ +K DFG + + + + G+P Y+APEV+ + Y
Sbjct: 124 DIIYRDLKPENILLD---KNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPY 178
Query: 236 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKK 295
+D WS G+++Y +L G PF+ + I+ + + F P +E+ KDL+ +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSR 234
Query: 296 MLNPDPKQRL-----TAEEVLEHPWLQN 318
++ D QRL E+V HPW +
Sbjct: 235 LITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 3e-74
Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 20/269 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIED---VRREVQIMKHL 113
Y +G LG G FG Y V++ A K + K ++ ++ + V EV ++K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 114 -PKHPNIVSLKDTYEDDSAVHIVMELCEGG-ELFDRIVARGHYTERAAAAVMKTIVEVVQ 171
++ L D +E + +++E E +LFD I RG E A + ++E V+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVL 231
CH GV+HRD+K EN L + LK IDFG + + G+ Y PE +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWI 181
Query: 232 --KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289
R +G VWS G++LY ++CG PF + E IIR + F+ +VS
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVSSEC 231
Query: 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ L++ L P R T EE+ HPW+Q+
Sbjct: 232 QHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-72
Identities = 83/273 (30%), Positives = 138/273 (50%), Gaps = 16/273 (5%)
Query: 54 ISI-DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
+++ D+D + LG+G FG L + G +A K + K+ + ++ E +++++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQV 172
+HP + +LK ++ + VME GGELF + +TE A IV ++
Sbjct: 62 T-RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL 231
H + V++RD+K EN + + +K DFGL G G+P Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 232 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
+ N YG VD W GV++Y ++CG PF+ + + + + I+ I F +S AK
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAK 233
Query: 291 DLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
L+ +L DPKQRL A+EV+EH + +
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 222 bits (566), Expect = 4e-70
Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 49/303 (16%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
DY L R+LGRG++ + ++ N EK K + K + ++RE++I+++L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 117 PNIVSLKDTYEDDSA--VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCH 174
PNI++L D +D + +V E + T+ M I++ + CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-- 232
G+MHRD+KP N + + E L+ ID+GL+ F+ PG+++N V S Y+ PE+L
Sbjct: 147 SMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 233 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVI----------------- 275
+ Y +D+WS G +L ++ PF+ + I V+
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 276 -----------------DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
+ VS A D + K+L D + RLTA E +EHP+
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
Query: 319 AKK 321
K
Sbjct: 325 VVK 327
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 2e-69
Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)
Query: 64 LGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD--IEDVRREVQIMKHLPKHPNIVS 121
LG G+F Y D N + A K I A D RE+++++ L HPNI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIG 64
Query: 122 LKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHR 181
L D + S + +V + E T A M ++ ++ H+ ++HR
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 124
Query: 182 DLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVLK--RNYGPE 238
DLKP N L E+ LK DFGL+ F P + V + +Y APE+L R YG
Sbjct: 125 DLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 239 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP--------------- 283
VD+W+ G IL LL VP +++ I ++ + WP
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 284 ---------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
++ DL++ + +P R+TA + L+ + N
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-69
Identities = 78/316 (24%), Positives = 125/316 (39%), Gaps = 47/316 (14%)
Query: 48 EPSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREV 107
+ + + Y + +G G FGV Y ++GE A K + + K RE+
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNREL 64
Query: 108 QIMKHLPKHPNIVSLKDTY------EDDSAVHIVMELCEGG---ELFDRIVARGHYTERA 158
QIM+ L H NIV L+ + +D+ +++V++ A+
Sbjct: 65 QIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 159 AAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
M + + H G+ HRD+KP+N L +++ LK DFG + GE
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 219 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-- 274
+ S YY APE++ +Y +DVWSAG +L LL G P F ++ II+ +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 275 -----------------------IDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
+ + P+ A L ++L P RLT E
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 312 EHPWLQNAKKAPNVSL 327
H + + PNV L
Sbjct: 302 AHSFFDELRD-PNVKL 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 2e-69
Identities = 82/283 (28%), Positives = 150/283 (53%), Gaps = 18/283 (6%)
Query: 51 GQDISID-YDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKL-RTAVDIEDVRR 105
+ + I+ ++L + LG G +G +L ++ G+ +A K + K + + A E R
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 106 EVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKT 165
E Q+++H+ + P +V+L ++ ++ +H++++ GGELF + R +TE +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 166 IVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP--GEQFNEIVGSP 223
IV ++ H+ G+++RD+K EN L + + DFGLS F E+ + G+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 224 YYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280
YMAP++++ + VD WS GV++Y LL G PF + E+ I R ++ +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254
Query: 281 PWPKVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
++S AKDL++++L DPK+RL A+E+ EH + Q
Sbjct: 255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-68
Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 49/313 (15%)
Query: 49 PSGQDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
P ++S Y+ ++G+G FG + G+K A K + + + I RE++
Sbjct: 4 PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIK 61
Query: 109 IMKHLPKHPNIVSLKDTYEDDSA--------VHIVMELCEGGELFDRIVARGHYTERAAA 160
I++ L KH N+V+L + ++ +++V + CE +T
Sbjct: 62 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----Q 215
VM+ ++ + H ++HRD+K N L LK DFGL+ F + +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 216 FNEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 273
+ V + +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 274 VIDFKRDPWPKV----------------------------SENAKDLVKKMLNPDPKQRL 305
+ WP V A DL+ K+L DP QR+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 306 TAEEVLEHPWLQN 318
+++ L H + +
Sbjct: 298 DSDDALNHDFFWS 310
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 7e-68
Identities = 83/357 (23%), Positives = 138/357 (38%), Gaps = 53/357 (14%)
Query: 51 GQ--DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQ 108
GQ D+ Y +G G +G+ D N + A K IS + +T + RE++
Sbjct: 1 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIK 58
Query: 109 IMKHLPKHPNIVSLKDTYEDDSAVH----IVMELCEGGELFDRIVARGHYTERAAAAVMK 164
I+ +H NI+ + D + ++ G +L+ + H + +
Sbjct: 59 ILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLY 116
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE----QFNEIV 220
I+ ++ H V+HRDLKP N L + LK DFGL+ P E V
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYV 173
Query: 221 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK 278
+ +Y APE++ + Y +D+WS G IL +L P F + I+ +
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 279 RDPW---------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVL 311
++ P A DL+ KML +P +R+ E+ L
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 312 EHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKKRALQVVAEFLSVEEVAGLKEAF 368
HP+L+ + + E A K ++ L K L+ L EE A + +
Sbjct: 294 AHPYLEQYYDPSDEPIAE---APFKFDMELDDLPKEKLKE----LIFEETARFQPGY 343
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-67
Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 19/267 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+G+ +G G FG Y A K ++ T ++ + EV +++ +H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RH 63
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
NI+ Y + IV + CEG L+ + + + + + + + H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE---QFNEIVGSPYYMAPEVLK 232
+ ++HRDLK N +K DFGL+ QF ++ GS +MAPEV++
Sbjct: 123 KSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 233 RN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP--WPKVS 286
Y + DV++ G++LY L+ G P+ + ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ K L+ + L +R ++L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 8e-67
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 35/297 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL--P 114
Y+ E+G G +G + D+ NG +F + + REV +++HL
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 115 KHPNIVSLKD-----TYEDDSAVHIVMELCEGGEL-FDRIVARGHYTERAAAAVMKTIVE 168
+HPN+V L D + ++ + +V E + + V +M ++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
+ H V+HRDLKP+N L + + K DFGL+ + +V + +Y AP
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 229 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK--- 284
EVL ++ Y VD+WS G I + P F ++ I+ + + WP+
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 285 --------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321
+ E KDL+ K L +P +R++A L HP+ Q+ ++
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 2e-66
Identities = 76/280 (27%), Positives = 135/280 (48%), Gaps = 17/280 (6%)
Query: 46 LKEPSGQDISID-YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR 104
+ PS +D +D + LG G FG L +G +A K + K+K+ IE
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 105 REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMK 164
E +I++ + P +V L+ +++D+S +++VME GGE+F + G ++E A
Sbjct: 90 NEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 165 TIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPY 224
IV + H +++RDLKPEN L + ++ DFG + + + + G+P
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVK--GRTWTLCGTPE 203
Query: 225 YMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP 283
+APE++ + Y VD W+ GV++Y + G PPF+A+ + + I+ + F
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PS 259
Query: 284 KVSENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQN 318
S + KDL++ +L D +R ++ H W
Sbjct: 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 210 bits (535), Expect = 5e-66
Identities = 85/289 (29%), Positives = 128/289 (44%), Gaps = 34/289 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y ++G G +GV Y + N GE FA K I +K + RE+ I+K L KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGI-PSTTIREISILKEL-KH 59
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
NIV L D + +V E + V G A + + ++ + CH++
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR-PGEQFNEIVGSPYYMAPEVL--KR 233
V+HRDLKP+N L + E LK DFGL+ F P ++ + + +Y AP+VL +
Sbjct: 120 RVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 234 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWP---------- 283
Y +D+WS G I ++ G P F +E I R + WP
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 284 ---------------KVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
+ E+ DL+ KML DP QR+TA++ LEH + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-66
Identities = 74/291 (25%), Positives = 121/291 (41%), Gaps = 34/291 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y+ ++G G +G + + E A K + V RE+ ++K L KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-KH 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ 176
NIV L D D + +V E C+ G + + +++ + CH +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 177 GVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVL--KR 233
V+HRDLKP+N L E K +FGL+ F P ++ V + +Y P+VL +
Sbjct: 121 NVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 234 NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPW---------- 282
Y +D+WSAG I L P F + I R + + W
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 283 ---------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318
PK++ +DL++ +L +P QR++AEE L+HP+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 8e-66
Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 35/301 (11%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
++ ++G G +GV Y + GE A K I + T RE+ ++K L H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-NH 60
Query: 117 PNIVSLKDTYEDDSAVHIVMELCE-GGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE 175
PNIV L D ++ +++V E + F A + + +++ + CH
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF-RPGEQFNEIVGSPYYMAPEVLKRN 234
V+HRDLKP+N L + +K DFGL+ F P + V + +Y APE+L
Sbjct: 121 HRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 235 --YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW---------- 282
Y VD+WS G I ++ F ++E I R++ W
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 283 ---------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA-KKAPNVS 326
P + E+ + L+ +ML+ DP +R++A+ L HP+ Q+ K P++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
Query: 327 L 327
L
Sbjct: 298 L 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-64
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 44/301 (14%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
++ Y + +G G +G D G K A K + + ++ + + RE++++KH
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKH 73
Query: 113 LPKHPNIVSLKDTYEDDSA------VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTI 166
+ +H N++ L D + D ++VM G +++ E ++ +
Sbjct: 74 M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 167 VEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYM 226
++ ++ H G++HRDLKP N E LK +DFGL+ + V + +Y
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTRWYR 185
Query: 227 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW-- 282
APEV+ Y VD+WS G I+ ++ G F + I++ +
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245
Query: 283 -------------------------PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317
S A +L++KML D +QR+TA E L HP+ +
Sbjct: 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 318 N 318
+
Sbjct: 306 S 306
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 6e-63
Identities = 52/277 (18%), Positives = 95/277 (34%), Gaps = 21/277 (7%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y LGR++G G FG YL TD+ GE+ A K K + E +I K +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGV 63
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
I +++ + +VMEL ++ + + ++ ++ H +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMAPE 229
+HRD+KP+NFL K+ + + IDFGL+ +R + + G+ Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 230 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----WPK 284
D+ S G +L G P+ Q R P
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243
Query: 285 VSENAKDLVKKMLNPDPKQRLTAEEV---LEHPWLQN 318
+ + + + + + +
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 9e-63
Identities = 59/262 (22%), Positives = 101/262 (38%), Gaps = 21/262 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ L + +G+GEFG L G K A K I + E +M L +H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RH 59
Query: 117 PNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGH--YTERAAAAVMKTIVEVVQVC 173
N+V L E+ ++IV E G L D + +RG + E ++
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK- 232
+HRDL N L + K DFGL+ + + + APE L+
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE 174
Query: 233 RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
+ + + DVWS G++L+ + G P+ + V + + +K D +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYE 231
Query: 292 LVKKMLNPDPKQRLTAEEVLEH 313
++K + D R + ++ E
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 59/293 (20%), Positives = 108/293 (36%), Gaps = 26/293 (8%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D +G G FG +G + K+ + D D E++++ L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI----------------VARGHYTERAAA 160
PNI++L E +++ +E G L D + + +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 161 AVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
+ + ++ +HRDL N L E+ K DFGLS +
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGR 187
Query: 221 GSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVIDFK 278
+MA E L + Y DVWS GV+L+ ++ G P+ T + + + + ++
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYR 244
Query: 279 RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH--PWLQNAKKAPNVSLGE 329
+ + DL+++ P +R + ++L L+ K N +L E
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-62
Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 36/288 (12%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHL 113
+ + G+ LG G FG T + ++ K L+ D E + E+++M L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-------------------- 153
H NIV+L ++++ E C G+L + + ++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 154 ---YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210
T + + ++ + +HRDL N L + K +K DFGL+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARDI 214
Query: 211 RPGEQF---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 265
+ +MAPE L Y + DVWS G++L+ I GV P+
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 266 VAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+I++ FK D +E +++ D ++R + +
Sbjct: 275 NFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-61
Identities = 71/337 (21%), Positives = 133/337 (39%), Gaps = 41/337 (12%)
Query: 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKH 112
++ Y +G G +G D G + A K + + ++ + + RE++++KH
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 113 LPKHPNIVSLKDTYEDDSAV----HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVE 168
+ KH N++ L D + ++ + + G + IV T+ ++ I+
Sbjct: 74 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 169 VVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAP 228
++ H ++HRDLKP N E LK +DFGL+ ++ V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 229 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFK-------- 278
E++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 279 -------------------RDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319
+ + + A DL++KML D +R+TA + L H +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
Query: 320 KKAPNVSLGETVKARLKQFSV-MNKLKKRALQVVAEF 355
+ + + + + +++ K V F
Sbjct: 308 HDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISF 344
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 62/274 (22%), Positives = 98/274 (35%), Gaps = 19/274 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCT---DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
D L +LG G FGV A K + L ++D REV M L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQV 172
H N++ L + +V EL G L DR+ GH+ + + E +
Sbjct: 69 -DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 173 CHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF----NEIVGSPYYMAP 228
+ +HRDL N L A + +K DFGL + + AP
Sbjct: 127 LESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 229 EVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
E LK R + D W GV L+ + G P+ + I + R
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCP 241
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320
++ +++ + P+ R T + + +L A+
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 20/271 (7%)
Query: 62 RELGRGEFGVTYLCTDVNN--GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
+ELG G FG + A K + K + +++ E +M+ L +P I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVM 179
V + E +S +VME+ E G L + H ++ ++ + ++ E +
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 180 HRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE----IVGSPYYMAPEVLKRN- 234
HRDL N L + K DFGLS R E + + + APE +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 235 YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293
+ + DVWS GV+++ G P+ V + + + DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLM 243
Query: 294 KKMLNPDPKQRLTAEEV---LEHPWLQNAKK 321
D + R V L + + +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-60
Identities = 58/263 (22%), Positives = 103/263 (39%), Gaps = 19/263 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D +ELG G+FGV A K I + + ++ E ++M +L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SH 58
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRI-VARGHYTERAAAAVMKTIVEVVQVCHE 175
+V L + I+ E G L + + R + + + K + E ++
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR 233
+ +HRDL N L ++ +K DFGLS + E + PEVL
Sbjct: 119 KQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 234 N-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-VSENAK 290
+ + + D+W+ GV+++ I G P+ T A+ I + R P SE
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----LRLYRPHLASEKVY 231
Query: 291 DLVKKMLNPDPKQRLTAEEVLEH 313
++ + +R T + +L +
Sbjct: 232 TIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-59
Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 17/262 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
+ +E+G G+FG+ +L +N +K A K+I + + ED E ++M L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SH 59
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQVCHE 175
P +V L + + + +V E E G L D + + + + + E + E
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLKR 233
V+HRDL N L + +K DFG++ F + + +PEV
Sbjct: 120 ACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 234 N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
+ Y + DVWS GV+++ + G P+ + V + I F+ S +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVYQ 233
Query: 292 LVKKMLNPDPKQRLTAEEVLEH 313
++ P+ R +L
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (490), Expect = 4e-59
Identities = 64/278 (23%), Positives = 104/278 (37%), Gaps = 19/278 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISK-KKLRTAVDIEDVRREVQIMKHLPK 115
+ + +G GEFG G++ +I K T D E IM
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-D 85
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
HPN++ L+ + V I+ E E G L + G +T +++ I ++
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE------IVGSPYYMAP 228
+ +HRDL N L + K DFGLS F + AP
Sbjct: 146 DMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 229 EVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286
E ++ R + DVWS G++++ ++ G P+W T Q V AI + D++ P
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCP 259
Query: 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
L+ D R +++ L + PN
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNT--LDKMIRNPN 295
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 8e-59
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 22/272 (8%)
Query: 62 RELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNI 119
ELG G FG ++ A K + + + D E++ RE QIM L +P I
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQL-DNPYI 71
Query: 120 VSLKDTYEDDSAVHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGV 178
V L + ++ + +VME+ GG L +V R A ++ + ++ E+
Sbjct: 72 VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 179 MHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE----IVGSPYYMAPEVLK-R 233
+HRDL N L N+ K DFGLS + + + APE + R
Sbjct: 131 VHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 234 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292
+ DVWS GV ++ L G P+ V I + + + P+ L
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPECPPELYAL 244
Query: 293 VKKMLNPDPKQRLTAEEV---LEHPWLQNAKK 321
+ + R V + + A K
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 2e-58
Identities = 54/275 (19%), Positives = 106/275 (38%), Gaps = 17/275 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
D + +LG G++G Y A K++ + + ++E+ +E +MK + KH
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEI-KH 72
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY--TERAAAAVMKTIVEVVQVCH 174
PN+V L + +I+ E G L D + + + I ++
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ--FNEIVGSPYYMAPEVLK 232
++ +HRDL N L +K DFGLS + APE L
Sbjct: 133 KKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 233 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291
N + + DVW+ GV+L+ + + + ++ D++ + E +
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCPEKVYE 247
Query: 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVS 326
L++ +P R + E+ + + + ++S
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQ--AFETMFQESSIS 280
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-58
Identities = 60/262 (22%), Positives = 100/262 (38%), Gaps = 19/262 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
L LG G+FG ++ N K A KS+ + + + E +MK L +H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QH 67
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCH 174
+V L + ++I+ E E G L D + T + I E +
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE--IVGSPYYMAPEVLK 232
E+ +HRDL+ N L ++ K DFGL+ E + APE +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 233 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
+ + DVWS G++L ++ G P+ T V Q + R ++ E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPEELY 240
Query: 291 DLVKKMLNPDPKQRLTAEEVLE 312
L++ P+ R T + +
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRS 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-58
Identities = 60/270 (22%), Positives = 103/270 (38%), Gaps = 21/270 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
L +LG+G FG ++ T N + A K++ + E +E Q+MK L +H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RH 71
Query: 117 PNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCH 174
+V L ++ ++IV E G L D + + + I +
Sbjct: 72 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE--QFNEIVGSPYYMAPEVLK 232
+HRDL+ N L K DFGL+ E + APE
Sbjct: 131 RMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187
Query: 233 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
+ + DVWS G++L L G P+ + V + R ++ P+ E+
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLH 244
Query: 291 DLVKKMLNPDPKQRLTAEEVLE--HPWLQN 318
DL+ + +P++R T E + + +
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 2e-57
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 53/307 (17%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH 116
Y + +G G G+ D A K + + + + RE+ +MK + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCV-NH 75
Query: 117 PNIVSLKDTY------EDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVV 170
NI+SL + + E+ V++VMEL + + + ++ ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 171 QVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPE- 229
+ H G++HRDLKP N + + K +DFGL+ V + YY APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 230 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------------- 272
+L Y VD+WS G I+ ++ F +I
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 273 -----SVIDFKRDPWPK----------------VSENAKDLVKKMLNPDPKQRLTAEEVL 311
+ + +PK + A+DL+ KML DP +R++ ++ L
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 312 EHPWLQN 318
+HP++
Sbjct: 310 QHPYINV 316
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-57
Identities = 63/263 (23%), Positives = 102/263 (38%), Gaps = 14/263 (5%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSI-SKKKLRTAVDIEDVRREVQIMKHLPK 115
+LGR +G G+FG + ++ +I + K + E +E M+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 116 HPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCH 174
HP+IV L ++ V I+MELC GEL + R + + +
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 175 EQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--NEIVGSPYYMAPEVLK 232
+ +HRD+ N L ++ +K DFGLS + + ++ +MAPE +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 233 -RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290
R + DVW GV ++ IL+ GV PF V I + P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLY 239
Query: 291 DLVKKMLNPDPKQRLTAEEVLEH 313
L+ K DP +R E+
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (471), Expect = 2e-56
Identities = 53/270 (19%), Positives = 101/270 (37%), Gaps = 20/270 (7%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
Y +GR +G G FGV + T++ N ++ A K ++ D +R E + K L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCT 61
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
I ++ ++ +V++L + ++ + A K ++ VQ HE+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 178 VMHRDLKPENFLFANK--KESSPLKAIDFGLSVFFRPGE--------QFNEIVGSPYYMA 227
+++RD+KP+NFL K ++ + +DFG+ F+R + + G+ YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP----W 282
R D+ + G + L G P+ Q R + P
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
E + N + +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-55
Identities = 55/284 (19%), Positives = 101/284 (35%), Gaps = 35/284 (12%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
G+ LG G FG T + A K + T + E + E++++
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLS 81
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH------------------ 153
+L H NIV+L ++ E C G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
+ + + + + +HRDL N L + + + K DFGL+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDIKND 198
Query: 214 EQF---NEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 268
+ +MAPE + E DVWS G+ L+ L G P+
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 269 AIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
+I+ F+ D++K + DP +R T +++++
Sbjct: 259 KMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-55
Identities = 52/265 (19%), Positives = 100/265 (37%), Gaps = 16/265 (6%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVD---IEDVRREVQIMKHL 113
++ + LG G FG Y + GEK ++ K+LR A +++ E +M +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASV 68
Query: 114 PKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVC 173
+P++ L + I + G L + + + I + +
Sbjct: 69 -DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 174 HEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEV 230
++ ++HRDL N L + +K DFGL+ E+ +MA E
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 231 LK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288
+ R Y + DVWS GV ++ L+ G P+ ++ + + + P + +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTID 241
Query: 289 AKDLVKKMLNPDPKQRLTAEEVLEH 313
++ K D R E++
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-54
Identities = 55/282 (19%), Positives = 102/282 (36%), Gaps = 30/282 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDV-------NNGEKFACKSISKKKLRTAVDIEDVRREVQI 109
LG+ LG G FG L + N K A K + D+ D+ E+++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEM 71
Query: 110 MKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRI----------------VARGH 153
MK + KH NI++L D +++++E G L + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 154 YTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213
+ + + + ++ + +HRDL N L
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 271
++ +MAPE L R Y + DVWS GV+L+ I G P+ + + + +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 272 RSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ D + +++ + P QR T ++++E
Sbjct: 252 E---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-50
Identities = 57/279 (20%), Positives = 103/279 (36%), Gaps = 22/279 (7%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEK----FACKSISKKKLRTAVDIEDVRREVQIMKH 112
+ +G GEFG Y + K A K++ K T D E IM
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQ 65
Query: 113 LPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQ 171
H NI+ L+ + I+ E E G L + + G ++ +++ I ++
Sbjct: 66 F-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ----FNEIVGSPYYMA 227
+HRDL N L + K DFGLS + + + A
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 228 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPK-V 285
PE + R + DVWS G++++ ++ + E +++++ D R P P
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRLPTPMDC 238
Query: 286 SENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPN 324
L+ + + +R +++ L +AP+
Sbjct: 239 PSAIYQLMMQCWQQERARRPKFADIVSI--LDKLIRAPD 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-50
Identities = 61/270 (22%), Positives = 113/270 (41%), Gaps = 19/270 (7%)
Query: 55 SIDYDLGRELGRGEFGVTYLCTDV-NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
S+ +GRG FG Y T + N+G+K C S ++ ++ E IMK
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 114 PKHPNIVSLKDT-YEDDSAVHIVMELCEGGELFDRIVARGH-YTERAAAAVMKTIVEVVQ 171
HPN++SL + + +V+ + G+L + I H T + + + ++
Sbjct: 86 -SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 172 VCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-----QFNEIVGSPYYM 226
+ +HRDL N + E +K DFGL+ E +M
Sbjct: 145 FLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 227 APEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284
A E L+ + + + DVWS GV+L+ L+ G PP+ + +++ +R P+
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQPE 257
Query: 285 -VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ +++ K +P + R + E++
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 3e-50
Identities = 54/291 (18%), Positives = 102/291 (35%), Gaps = 45/291 (15%)
Query: 57 DYDLGRELGRGEFGVTYLCT-----DVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+ + R++G G FG + A K + ++ +A D +RE +M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHY----------------- 154
+PNIV L + ++ E G+L + + + +
Sbjct: 72 EF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 155 -------TERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207
+ + + + + E+ +HRDL N L +K DFGLS
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 187
Query: 208 VFFRPGEQF---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAET 262
+ + +M PE + N Y E DVW+ GV+L+ + G+ P++
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 263 EQGVAQAIIRSVIDFKRDPWPK-VSENAKDLVKKMLNPDPKQRLTAEEVLE 312
+ +I V D P+ +L++ + P R + +
Sbjct: 248 H----EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-48
Identities = 58/300 (19%), Positives = 104/300 (34%), Gaps = 51/300 (17%)
Query: 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL 113
I+ L +G+G FG + GE+ A K S ++ R+ E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVML 54
Query: 114 PKHPNIVSLKDTYEDDSA----VHIVMELCEGGELFDRIVARGHYTERA-------AAAV 162
+H NI+ D+ + +V + E G LFD + E A+ +
Sbjct: 55 -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ-----FN 217
+E+V + + HRDLK +N L D GL+V N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPN 170
Query: 218 EIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQG----- 265
VG+ YMAPEVL + D+++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 266 ------VAQAIIRSVIDFKRDP-------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312
+ + + V + K P + ++++ + RLTA + +
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-48
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 30/282 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHL 113
LG+ LGRG FG + C++++ K L+ + R E++I+ H+
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 114 PKHPNIVSLKD-TYEDDSAVHIVMELCEGGELFDRIVARGHY----------------TE 156
H N+V+L + + +++E C+ G L + ++ + T
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 157 RAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF 216
+ + ++ + +HRDL N L + K +K DFGL+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDY 190
Query: 217 ---NEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 272
+ +MAPE + Y + DVWS GV+L+ + + + + + R
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--IDEEFCR 248
Query: 273 SVIDFKRDPWP-KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
+ + R P + + + +P QR T E++EH
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-47
Identities = 52/277 (18%), Positives = 104/277 (37%), Gaps = 29/277 (10%)
Query: 57 DYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMK 111
+ RELG+G FG+ Y + A K++++ + + E +MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMK 78
Query: 112 HLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGH----------YTERAAAA 161
++V L ++MEL G+L + + +
Sbjct: 79 EF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 162 VMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF---NE 218
+ I + + + +HRDL N + A +K DFG++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYRKGGK 194
Query: 219 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVID 276
+ +M+PE LK + DVWS GV+L+ I P+ + + V + ++ +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253
Query: 277 FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313
D + +L++ +PK R + E++
Sbjct: 254 --LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (404), Expect = 5e-46
Identities = 62/332 (18%), Positives = 118/332 (35%), Gaps = 66/332 (19%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHL---- 113
Y L R+LG G F +L D+ N A K + K+ T E E+++++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDAD 70
Query: 114 ------PKHPNIVSLKDTYED--DSAVHIVMELCEGG---ELFDRIVARGHYTERAAAAV 162
+I+ L D + + VH+VM G + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 163 MKTIVEVVQ-VCHEQGVMHRDLKPENFLF-ANKKESSPLKAIDFGLSVFFRPGEQFNEIV 220
K ++ + + G++H D+KPEN L + ++ L E + +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 221 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV------------- 266
+ Y +PEVL +G D+WS +++ L+ G F +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 267 --------------------AQAIIRSVIDFKRDPWPKV-----------SENAKDLVKK 295
++ ++R++ K P V ++ D +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 296 MLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSL 327
ML DP++R A ++ HPWL++ + +
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 342
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.2 bits (223), Expect = 7e-22
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 35/209 (16%)
Query: 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACK-----SISKKKLRTAVDIEDVR-------- 104
+G+ +G G+ + C + K S KK++ D D+
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 105 --REVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAV 162
E + ++ L + + + + ++MEL + E V
Sbjct: 61 ARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAKE-------LYRVRVENPDEV 108
Query: 163 MKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNEIVGS 222
+ I+E V + +G++H DL N L + + + IDF SV E + EI+
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILER 163
Query: 223 PYYMAPEVLKRNYGPEVDVWSAGVILYIL 251
R Y E D+ S I IL
Sbjct: 164 DVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} Length = 321 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Score = 59.6 bits (143), Expect = 2e-10
Identities = 24/130 (18%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 289 AKDLVKKMLN---PDPKQRLTAEEVLEHPWLQNAK---KAPNVSLGETVKARLKQFSVMN 342
+D ++ + + K +L + + + + G+ + + S++
Sbjct: 38 DRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLASLLK 97
Query: 343 KLKKRA-----LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE 397
L+ A L+ LS E+ L++ F + GK + ++L+ L K IPE
Sbjct: 98 DLEDDASGYNRLRPSKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPE 157
Query: 398 ADLQILMEAV 407
L+ L V
Sbjct: 158 GPLKKLFVMV 167
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 87 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 52.3 bits (125), Expect = 1e-09
Identities = 25/58 (43%), Positives = 40/58 (68%)
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ +AE LS EE+ GLKE F+M+DT+ G I +EL+ GL + G + E++++ LM+A
Sbjct: 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAA 68
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Score = 51.6 bits (122), Expect = 2e-08
Identities = 22/45 (48%), Positives = 30/45 (66%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE 397
AE LS EE+ GLKE F+M+DT+ G I +EL+ GL + G + E
Sbjct: 1 AERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELME 45
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} Length = 73 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Score = 46.5 bits (110), Expect = 1e-07
Identities = 20/52 (38%), Positives = 30/52 (57%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++ V
Sbjct: 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 53
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 45.0 bits (106), Expect = 4e-07
Identities = 17/52 (32%), Positives = 28/52 (53%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L+ E++A KEAF + D + G I+ EL + G + EA++ LM +
Sbjct: 4 LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.4 bits (109), Expect = 6e-07
Identities = 17/52 (32%), Positives = 28/52 (53%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L+ E++A KEAF + D + G I+ EL + G + EA++ LM +
Sbjct: 4 LTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEI 55
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 44.6 bits (105), Expect = 6e-07
Identities = 20/54 (37%), Positives = 30/54 (55%)
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
FLS E +A K AF+M D + G I+ +EL + GQN + +L ++E V
Sbjct: 6 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEV 59
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 47.1 bits (111), Expect = 2e-06
Identities = 23/161 (14%), Positives = 49/161 (30%), Gaps = 4/161 (2%)
Query: 62 RELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP 117
+E+G G + D + K A + I+ R E + +H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 118 NIVSLKDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG 177
+ + Y D VME ++ + + G + + + + + + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 178 VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQFNE 218
+ + K F N + + + F F F E
Sbjct: 152 LEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDTNDFEE 192
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 162 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 44.2 bits (103), Expect = 5e-06
Identities = 22/69 (31%), Positives = 34/69 (49%), Gaps = 4/69 (5%)
Query: 339 SVMNKLKKRALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA 398
+ M + A FLS E +A K AF+M D + G I+ +EL + GQN +
Sbjct: 1 ASMTDQQAEARA----FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKE 56
Query: 399 DLQILMEAV 407
+L ++E V
Sbjct: 57 ELDAIIEEV 65
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Score = 44.2 bits (103), Expect = 7e-06
Identities = 10/42 (23%), Positives = 20/42 (47%)
Query: 349 LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK 390
+++ +F + + K F+ +D N GKI L+E+
Sbjct: 1 VKLKTDFDNPRWIKRHKHMFDFLDINGNGKITLDEIVSKASD 42
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} Length = 82 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Score = 41.5 bits (97), Expect = 8e-06
Identities = 16/59 (27%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ E L+ E+ K AF++ + G I+ +EL + GQN +LQ +++ V
Sbjct: 3 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEV 61
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} Length = 187 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Score = 43.8 bits (102), Expect = 1e-05
Identities = 11/58 (18%), Positives = 20/58 (34%), Gaps = 5/58 (8%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG-----QNIPEADLQILME 405
++F + + K F +D N GKI+L+E+ +A
Sbjct: 3 SDFDNPRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAV 60
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 68 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 40.2 bits (94), Expect = 2e-05
Identities = 11/45 (24%), Positives = 25/45 (55%), Gaps = 1/45 (2%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLK-GGQNIPEADLQILMEAV 407
+ AF++ D N G I+ +E + + K G + + +A+++ M+
Sbjct: 4 ILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEA 48
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.0 bits (97), Expect = 2e-05
Identities = 9/36 (25%), Positives = 13/36 (36%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEAD 399
K+ F + D +G I + L L G N
Sbjct: 4 NKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQL 39
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} Length = 146 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Score = 41.8 bits (97), Expect = 3e-05
Identities = 21/54 (38%), Positives = 31/54 (57%)
Query: 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
E L+ E++A KEAF + D + G I +EL + GQN EA+LQ ++ V
Sbjct: 1 EQLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEV 54
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} Length = 139 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 4e-05
Identities = 13/41 (31%), Positives = 20/41 (48%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
KEAFE+ D GKI + + GQN A++ ++
Sbjct: 2 FKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVL 42
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 142 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 40.4 bits (93), Expect = 7e-05
Identities = 11/49 (22%), Positives = 29/49 (59%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
L +++ +KEAF M+D ++ G ++ E+++ + G+ + +L ++
Sbjct: 1 LPQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAML 49
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 77 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.7 bits (90), Expect = 8e-05
Identities = 12/44 (27%), Positives = 25/44 (56%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ +AF + D + G I +++LR + G+N+ E +LQ ++
Sbjct: 11 ILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEA 54
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} Length = 182 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Score = 40.8 bits (94), Expect = 1e-04
Identities = 11/41 (26%), Positives = 17/41 (41%)
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPE 397
+ + L E F +DT+ G I++ EL L G
Sbjct: 13 HMNDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSL 53
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} Length = 152 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Score = 40.0 bits (92), Expect = 1e-04
Identities = 13/51 (25%), Positives = 23/51 (45%), Gaps = 2/51 (3%)
Query: 356 LSVEEVAGLKEAFEMMDT--NKRGKINLEELRLGLLKGGQNIPEADLQILM 404
LS +E+ LK+ FE+ D + G ++ +L G N D+ +
Sbjct: 1 LSQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVG 51
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 67 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 37.2 bits (86), Expect = 2e-04
Identities = 14/44 (31%), Positives = 20/44 (45%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
K FE D NK GK++L+E R L + D+ E +
Sbjct: 3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEI 46
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} Length = 173 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 39.1 bits (90), Expect = 3e-04
Identities = 9/47 (19%), Positives = 15/47 (31%), Gaps = 1/47 (2%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILME 405
EEV + F + +++ EL L K P+
Sbjct: 1 EEVRQFRRLFAQLA-GDDMEVSATELMNILNKVVTRHPDLKTDGFGI 46
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 156 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 38.4 bits (88), Expect = 4e-04
Identities = 15/53 (28%), Positives = 24/53 (45%), Gaps = 1/53 (1%)
Query: 350 QVVAEFLSVEEVAGLKEAFEMMDTNKR-GKINLEELRLGLLKGGQNIPEADLQ 401
+ E L+ E+ K AF++ G I+ +EL + GQN +LQ
Sbjct: 2 KAAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQ 54
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Score = 36.4 bits (84), Expect = 5e-04
Identities = 13/49 (26%), Positives = 26/49 (53%), Gaps = 1/49 (2%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+++A + F+ DTN GKI+ EL LK ++ +++ +M +
Sbjct: 3 QDIADRERIFKRFDTNGDGKISSSELGD-ALKTLGSVTPDEVRRMMAEI 50
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} Length = 165 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 5e-04
Identities = 7/40 (17%), Positives = 16/40 (40%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG 392
+E+ L + F+ +D + G +++EE
Sbjct: 7 CSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQ 46
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 183 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 38.8 bits (89), Expect = 5e-04
Identities = 14/53 (26%), Positives = 22/53 (41%), Gaps = 2/53 (3%)
Query: 355 FLSVEEVAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIPEADLQILME 405
SV E+ L E F+ + + G IN EE +L L K + ++
Sbjct: 10 VFSVSEIEALYELFKKISSAVIDDGLINKEEFQLALFKTNKKESLFADRVFDL 62
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} Length = 81 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Score = 36.5 bits (84), Expect = 6e-04
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 347 RALQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEA 406
R ++ ++ + EE L + F M D N G I+LEEL++ L G+ I E D++ LM+
Sbjct: 3 RCMKDDSKGKTEEE---LSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKD 59
Query: 407 V 407
Sbjct: 60 G 60
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} Length = 75 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 36.1 bits (83), Expect = 7e-04
Identities = 15/44 (34%), Positives = 24/44 (54%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
L F + D N G I++EEL L G+++ E D++ LM+
Sbjct: 11 LANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDS 54
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} Length = 134 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Score = 36.6 bits (83), Expect = 0.001
Identities = 12/39 (30%), Positives = 20/39 (51%), Gaps = 1/39 (2%)
Query: 364 LKEA-FEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQ 401
+ EA F+ +D N G ++ EE++ + K E LQ
Sbjct: 1 MAEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQ 39
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 108 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.1 bits (83), Expect = 0.001
Identities = 14/55 (25%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLK---GGQNIPEADLQILMEAV 407
LS + +K+ F +D ++ G ++ +EL+ L K + + E++ + LM+A
Sbjct: 35 LSKMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAA 89
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} Length = 61 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Score = 34.6 bits (79), Expect = 0.002
Identities = 12/44 (27%), Positives = 26/44 (59%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+AF++ D GK+++ +LR L G+ + +A++ L++ V
Sbjct: 3 FVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGV 46
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} Length = 141 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (82), Expect = 0.002
Identities = 10/49 (20%), Positives = 29/49 (59%)
Query: 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
E+ ++EAF++ D + G I+++EL++ + G + +++ ++ +
Sbjct: 3 EQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEI 51
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} Length = 185 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Score = 36.9 bits (84), Expect = 0.002
Identities = 7/40 (17%), Positives = 16/40 (40%), Gaps = 1/40 (2%)
Query: 356 LSVEEVAGLKEAFE-MMDTNKRGKINLEELRLGLLKGGQN 394
L+ + +K F+ +D N G I + + + +
Sbjct: 2 LNDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEV 41
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Score = 35.3 bits (81), Expect = 0.002
Identities = 12/47 (25%), Positives = 26/47 (55%), Gaps = 3/47 (6%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGL---LKGGQNIPEADLQILMEAV 407
+K+ F+ +D + G I EEL+ L G+++ +A+ + ++A
Sbjct: 43 VKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAA 89
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} Length = 176 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Score = 36.2 bits (82), Expect = 0.003
Identities = 5/33 (15%), Positives = 11/33 (33%)
Query: 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP 396
LK+ F+ D + G + + +
Sbjct: 9 LKKRFDRWDFDGNGALERADFEKEAQHIAEAFG 41
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} Length = 189 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 36.4 bits (83), Expect = 0.003
Identities = 6/53 (11%), Positives = 17/53 (32%), Gaps = 1/53 (1%)
Query: 356 LSVEEVAGLKEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAV 407
+ + A L+E ++ G + + E + ++ + A
Sbjct: 15 VGAADAAQLQEWYKKFLEECPSGTLFMHEFKRFFKVPDNEEATQYVEAMFRAF 67
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 181 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 35.8 bits (81), Expect = 0.004
Identities = 10/42 (23%), Positives = 20/42 (47%)
Query: 353 AEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN 394
A ++ + + L F+ +D ++ G I+ EL+ L G
Sbjct: 10 AAGAALPDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWT 51
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} Length = 109 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Score = 34.6 bits (79), Expect = 0.004
Identities = 18/83 (21%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 329 ETVKARLKQFSVMNKLKKRA-LQVVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLG 387
E +K + F+ + + Q+V L + +K+ F ++D +K G I +EL
Sbjct: 9 EDIKKAIGAFTAADSFDHKKFFQMVG--LKKKSADDVKKVFHILDKDKSGFIEEDELGSI 66
Query: 388 LLK---GGQNIPEADLQILMEAV 407
L +++ + + LM A
Sbjct: 67 LKGFSSDARDLSAKETKTLMAAG 89
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} Length = 174 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Score = 35.8 bits (81), Expect = 0.004
Identities = 8/48 (16%), Positives = 15/48 (31%)
Query: 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILM 404
S V +K F +D +K G I + + + +
Sbjct: 1 SDLWVQKMKTYFNRIDFDKDGAITRMDFESMAERFAKESEMKAEHAKV 48
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 99.32 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.28 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 99.27 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 99.27 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.23 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 99.22 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 99.22 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 99.2 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 99.18 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 99.12 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 99.1 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 99.09 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 99.08 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 98.99 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 98.93 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.87 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.87 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 98.83 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.76 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 98.76 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 98.76 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.75 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 98.73 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 98.72 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.68 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.64 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 98.64 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.6 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.59 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.55 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.53 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 98.52 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.52 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 98.51 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 98.51 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.51 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.5 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 98.5 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 98.47 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 98.45 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 98.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.41 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 98.4 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.4 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 98.39 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 98.38 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 98.37 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 98.36 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 98.35 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 98.34 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 98.34 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 98.3 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 98.29 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 98.28 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.28 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.28 | |
| d1y1xa_ | 182 | Programmed cell death 6 protein-like protein {Leis | 98.26 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 98.26 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.23 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 98.23 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 98.2 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 98.14 | |
| d2mysb_ | 145 | Myosin Essential Chain {Chicken (Gallus gallus) [T | 98.14 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.13 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 98.13 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 98.11 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 98.11 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 98.1 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.09 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 98.09 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 98.08 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.06 | |
| d1hqva_ | 181 | Apoptosis-linked protein alg-2 {Mouse (Mus musculu | 98.05 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 98.02 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 98.02 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 98.0 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 97.98 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 97.96 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 97.93 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 97.93 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 97.92 | |
| d1s6ia_ | 182 | Calcium-dependent protein kinase sk5 CLD {Soybean | 97.91 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 97.9 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 97.86 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 97.79 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 97.77 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 97.62 | |
| d1juoa_ | 172 | Sorcin {Human (Homo sapiens) [TaxId: 9606]} | 97.62 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 97.61 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 97.6 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 97.57 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 97.55 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 97.5 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 97.46 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 97.44 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.37 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 97.24 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 97.22 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 97.2 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 97.11 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 97.07 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 97.06 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 97.06 | |
| d1j7qa_ | 86 | Calcium vector protein {Amphioxus (Branchiostoma l | 97.02 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 96.81 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 96.73 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 96.62 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 96.32 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 96.11 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 96.1 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 95.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.74 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 95.68 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 95.64 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 95.54 | |
| d2zkmx1 | 170 | Phospholipase C-beta-2 {Human (Homo sapiens) [TaxI | 94.93 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 94.65 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 94.49 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 93.86 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 93.8 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 92.33 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 91.4 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 91.23 | |
| d1tuza_ | 118 | Diacylglycerol kinase alpha, N-terminal domain {Hu | 91.21 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 90.95 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 90.64 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 90.45 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 89.71 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 89.56 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 89.46 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 89.4 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 88.37 | |
| d1sraa_ | 151 | C-terminal (EC) domain of BM-40/SPARC/osteonectin | 88.24 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 88.09 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 87.7 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 87.6 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 87.58 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 87.56 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 87.39 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 86.69 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 86.42 | |
| d1h8ba_ | 73 | alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | 85.75 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 84.91 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 84.84 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 84.7 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 84.61 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 84.59 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 84.09 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 83.69 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 83.58 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 83.38 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 83.12 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 82.94 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 81.85 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 80.98 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 80.98 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 80.78 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-67 Score=483.23 Aligned_cols=291 Identities=38% Similarity=0.726 Sum_probs=236.1
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+.++|++++.||+|+||+||+|+++.+|+.||+|++.+..... ....+.+|+.+|+++ +|||||++++++.+++.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 467888999999999999999999999999999999998665432 245678999999999 99999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|+|||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999998899999999999999999999999999999999999999876667789999999999877
Q ss_pred CCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
......+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+....+....+.+....+..+.++.+|+++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6666677889999999999874 699999999999999999999999999999999999998888887777888999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHHhhhhhhhhhhh
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARLKQFSVMNKLKK 346 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 346 (419)
+||.+||++||++|||+.|+++||||+..... ...+...+...+++....+++++
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 296 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL-DKNIHQSVSEQIKKNFAKSKWKQ 296 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCC-CCCCHHHHHHHHHHHSCCCTTTS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCCcc-ccccchhHHHHHHHHHHHhhhhh
Confidence 99999999999999999999999999864322 23344444455555444444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=462.71 Aligned_cols=254 Identities=35% Similarity=0.633 Sum_probs=229.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+++.+|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 4799999999999999999999999999999999765543344567889999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|...... .
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA---GELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEECCCCSCSCCCCC-C
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC---CCEeecccceeeecCCC-c
Confidence 9999999999999988899999999999999999999999999999999999999654 45999999999876543 3
Q ss_pred ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+....+.+....++ +.+|+++++||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHH
Confidence 456789999999999985 689999999999999999999999999998888888877655433 358999999999
Q ss_pred HhcCCCCCCCCCHHHHhcCCcccc
Q 014722 295 KMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 295 ~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+||++||++|||+.|+|+||||+.
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-65 Score=464.42 Aligned_cols=259 Identities=31% Similarity=0.533 Sum_probs=220.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+.++|++++.||+|+||+||+|+++.+|+.||+|++...... ...+.+.+|+.+++++ +||||+++++++.+++.+|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeE
Confidence 556899999999999999999999999999999999765432 2345788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
||||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~---~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER---DNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT---CCEEECCCTTCEECEET
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC---CCEEEccchhheeeccC
Confidence 999999999999999888889999999999999999999999999999999999999654 45999999999876543
Q ss_pred C---cccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 214 E---QFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 214 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
. .....+||+.|||||++.+ . ++.++||||+||++|+|+||.+||................. .....++.+|++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~ 235 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSA 235 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHH
Confidence 2 2355789999999999874 4 46789999999999999999999977654433333332222 233456789999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+.+||.+||+.||++|||++|+|+||||++.
T Consensus 236 ~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 236 PLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-64 Score=464.72 Aligned_cols=267 Identities=37% Similarity=0.708 Sum_probs=241.3
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCC---hhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRT---AVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
..+.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+++ +|||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence 357788999999999999999999999999999999997654432 22467899999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCC-CCCeEEeecccc
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKE-SSPLKAIDFGLS 207 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~-~~~~kl~Dfg~a 207 (419)
.+.+|||||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ...+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999999998889999999999999999999999999999999999999976542 346999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.....+.......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+......+....++.+|
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 98877766777889999999999884 69999999999999999999999999999999988888877766655566789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+++++||.+||+.||++|||++|+|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-63 Score=456.47 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=226.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
...+|++++.||+|+||+||+|++..+|+.||+|++...... ..+.+.+|+.+++++ +|||||++++++.+.+.+|
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEE
Confidence 345799999999999999999999999999999999765433 356789999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+|||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 94 ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCST
T ss_pred EEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC---CcEeeccchhheeeccc
Confidence 99999999999987765 479999999999999999999999999999999999999654 45999999999987544
Q ss_pred C-cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 214 E-QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
. .....+||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.+.......+...... ....++.+|+++++
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ 248 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHH
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHH
Confidence 3 3456789999999999875 6899999999999999999999999998887776666554321 22334578999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
||.+||++||++|||+.|+|+||||+..
T Consensus 249 li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 249 FLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-63 Score=467.54 Aligned_cols=262 Identities=36% Similarity=0.669 Sum_probs=239.3
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+.++|++++.||+|+||+||+|++..+|+.||+|++.... ......+.+|+.+|+++ +|||||+++++|.+++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 5568999999999999999999999999999999997543 33456788999999999 9999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
||||||+||+|.+.+...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~-~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TCCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-CCCeEEEeecccceecCC
Confidence 9999999999998876644 69999999999999999999999999999999999999743 345799999999999887
Q ss_pred CCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
........||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.+.......+.+....++...++.+|+++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777889999999999874 6999999999999999999999999999999999999998888888788899999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
||.+||++||++|||+.|+|+||||+...
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999999999998643
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-64 Score=458.72 Aligned_cols=257 Identities=32% Similarity=0.581 Sum_probs=227.5
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++++++ +||||+++++++.+++.+|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999865543344567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
||||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~---~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED---MHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT---SCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC---ceEEecccccceecccCCc
Confidence 9999999999999998999999999999999999999999999999999999999644 459999999998775332
Q ss_pred --cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 215 --QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 215 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
.....+||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+...+...+.+..+.++ ..+++++++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHH
Confidence 2345689999999999874 689999999999999999999999999999888888887765443 368999999
Q ss_pred HHHHhcCCCCCCCCCHHH------HhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEE------VLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~------~l~~~~~~~~~ 320 (419)
||.+||+.||++|||++| +++||||+...
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 999999999999999988 57899998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-63 Score=467.02 Aligned_cols=262 Identities=36% Similarity=0.663 Sum_probs=238.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+-++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|+++ +|||||++++++.+.+.+|
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4468999999999999999999999999999999997543 34567889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~-~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-TSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-CCCeEEEeecchheeccc
Confidence 99999999999999854 4579999999999999999999999999999999999999753 245799999999998877
Q ss_pred CCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKD 291 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 291 (419)
........||+.|||||++.+ .|+.++|||||||++|+|++|..||.+.+..+....+......+....++.+|+++++
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 776777899999999999874 6899999999999999999999999999999999999888877777777789999999
Q ss_pred HHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 292 LVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 292 li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
||.+||++||++|||+.|+|+||||+...
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999998654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-63 Score=450.72 Aligned_cols=263 Identities=37% Similarity=0.683 Sum_probs=238.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCCh------hhHHHHHHHHHHHHhCCCCCCeeeeeeEEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTA------VDIEDVRREVQIMKHLPKHPNIVSLKDTYE 127 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 127 (419)
|.++|++.+.||+|+||+||+|++..+|+.||||++.+...... ...+.+.+|+.+++++..||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 45789999999999999999999999999999999987654321 123468899999999955999999999999
Q ss_pred eCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 128 DDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 128 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
+++.+|||||||+||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~---~~~~kl~DFG~a 157 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD---DMNIKLTDFGFS 157 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TCCEEECCCTTC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC---CCCeEEccchhe
Confidence 99999999999999999999999999999999999999999999999999999999999999964 455999999999
Q ss_pred eeccCCCcccccccCcccCchhhhcc-------cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 208 VFFRPGEQFNEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
.............||+.|+|||.+.+ .++.++||||+||++|+|++|..||.+.+.......+..+...+..+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 98876666667889999999998752 36889999999999999999999999999999888899888777777
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.++.+|+++++||.+||++||++|||+.|+|+||||++.
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 778899999999999999999999999999999999853
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-63 Score=449.49 Aligned_cols=253 Identities=23% Similarity=0.415 Sum_probs=217.6
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----CCeEE
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED----DSAVH 133 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~~~ 133 (419)
|++.++||+|+||+||+|++..+++.||+|++..... .....+.+.+|+++|+++ +|||||++++++.+ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEE
Confidence 4777889999999999999999999999999976654 344567899999999999 89999999999875 45689
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQG--VMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|||||+||+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~--~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS--TTSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC--CCCCEEEeecCcceecc
Confidence 99999999999999998889999999999999999999999998 999999999999963 23469999999998644
Q ss_pred CCCcccccccCcccCchhhhcccCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.......+||+.|||||++.+.|+.++|||||||++|+|++|..||.+... ......+...... .......++++.
T Consensus 167 -~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 -ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVK 243 (270)
T ss_dssp -TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC--GGGGGCCCHHHH
T ss_pred -CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC--cccCccCCHHHH
Confidence 333456789999999999998999999999999999999999999976554 3444444433221 112245789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
+||.+||++||++|||+.|+|+||||+
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999999999999999996
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-63 Score=454.51 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=224.7
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.+.|++++.||+|+||+||+|++..+|+.||+|++.... ....+.+.+|+++|+++ +|||||++++++.+.+.+|+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEE
Confidence 356999999999999999999999999999999997643 23456788999999999 89999999999999999999
Q ss_pred EEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|......
T Consensus 87 vmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~---~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD---GDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECHHH
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC---CCEEEEechhhhccCCC
Confidence 9999999999998765 4569999999999999999999999999999999999999654 45999999999765432
Q ss_pred -CcccccccCcccCchhhhc------ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 214 -EQFNEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.......||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+..+....+....... ...++.+|
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s 242 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWS 242 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSC
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCC
Confidence 2334678999999999873 358899999999999999999999999988888888877765322 22235789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
+++++||.+||++||++|||+.|+|+||||+.
T Consensus 243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-63 Score=456.46 Aligned_cols=257 Identities=29% Similarity=0.454 Sum_probs=228.3
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
....|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|+++ +|||||++++++.+++.+|
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 91 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEE
Confidence 445699999999999999999999999999999999876655555667899999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
+|||||.||+|..++..++++++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~---~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP---GLVKLGDFGSASIMAP- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT---TEEEECCCTTCBSSSS-
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC---CCEEEeecccccccCC-
Confidence 999999999998888888889999999999999999999999999999999999999754 4599999999986543
Q ss_pred CcccccccCcccCchhhhc----ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.....||+.|||||++. +.|+.++|||||||++|+|++|..||.+.+..+....+........ ....+|+++
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~ 243 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF 243 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHH
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHH
Confidence 34568999999999985 3589999999999999999999999999888887777776544322 234679999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
++||.+||+.||++|||+.|+|+||||.+.
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-62 Score=459.61 Aligned_cols=256 Identities=32% Similarity=0.581 Sum_probs=232.1
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+|+++ +||||+++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence 4799999999999999999999999999999999876543344567889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC-CC
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP-GE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~-~~ 214 (419)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~---g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD---GHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC---CCEEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999654 4599999999987643 34
Q ss_pred cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 215 QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||.+.+..++...+....+.++ ..+|+++++||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence 456688999999999987 5799999999999999999999999999999988888888765543 46899999999
Q ss_pred HHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 294 KKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 294 ~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
.+||++||.+||+ +.|+++||||+..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HhhccCCchhhcccccccHHHHHcCcccccC
Confidence 9999999999994 9999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-63 Score=459.31 Aligned_cols=262 Identities=31% Similarity=0.637 Sum_probs=238.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+-++|++++.||+|+||+||+|+++.+|+.||+|++.... .+...+.+|+++|+.+ +||||++++++|++.+.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 35678999999999999999999999999999999997643 2345688999999999 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+|||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ....+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~-~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-CceEEEEcccchhhccc
Confidence 99999999999999998765 69999999999999999999999999999999999999754 34569999999999887
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
.........||+.|+|||.+. ..|+.++||||+||++|+|++|.+||.+.+..+....+.+....++...|+.+|++++
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 666667788999999999887 4689999999999999999999999999999999999998887777777778999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+||.+||.+||++|||+.|+|+||||++..
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence 999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-62 Score=445.66 Aligned_cols=253 Identities=32% Similarity=0.555 Sum_probs=212.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~ 133 (419)
++|++++.||+|+||+||+|+++.+|+.||+|++..... +....+.+.+|+++++++ +|||||++++++.+ .+.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 589999999999999999999999999999999987654 344567899999999999 99999999999864 46689
Q ss_pred EEEEecCCcchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CEeeCCCCCcEEeecCCCCCCeEEeec
Q 014722 134 IVMELCEGGELFDRIVA----RGHYTERAAAAVMKTIVEVVQVCHEQG-----VMHRDLKPENFLFANKKESSPLKAIDF 204 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~-----ivHrDlkp~NIl~~~~~~~~~~kl~Df 204 (419)
+|||||+||+|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~---~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK---QNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT---SCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC---CcEEEeec
Confidence 99999999999998864 457999999999999999999999976 9999999999999654 45999999
Q ss_pred ccceeccCCC-cccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 205 GLSVFFRPGE-QFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 205 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
|+|+...... ......||+.|||||++. ..|+.++|||||||++|+|+||.+||.+.+..++...+....... .+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IP 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CC
Confidence 9998775443 345678999999999987 469999999999999999999999999999888888887765432 23
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWL 316 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~ 316 (419)
..+|+++.+||.+||+.||++|||+.|+|+|||+
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 4689999999999999999999999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-62 Score=459.27 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=217.0
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
..++|++++.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|+.+|+++ +|||||+++++|.+.+.+|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4578999999999999999999999999999999997653 233457889999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~---~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT---CCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC---CCEEEeeCCCccccCC
Confidence 999999999999999988899999999999999999999997 599999999999999654 4599999999987643
Q ss_pred CCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------------
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------------- 272 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------------------- 272 (419)
. ...+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+.+..........
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 2356789999999999874 799999999999999999999999977654322110000
Q ss_pred -------------------cccc--cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 273 -------------------SVID--FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 273 -------------------~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.... .+..+...+|+++++||.+||+.||++|||++|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000 00011123688999999999999999999999999999998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.6e-62 Score=450.65 Aligned_cols=254 Identities=29% Similarity=0.585 Sum_probs=229.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++++ +||||+++++++.+.+.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 4799999999999999999999999999999999765443334567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~---g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN---GHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---SCEEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC---CCEEEecCccceEeccc--
Confidence 9999999999999999999999999999999999999999999999999999999654 45999999999876533
Q ss_pred ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
..+..||+.|||||++.+ .|+.++|||||||++|+|+||..||.+.+..+....+......++ +.+|+++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHH
Confidence 346789999999999885 699999999999999999999999999999998888887765433 468999999999
Q ss_pred HhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 295 KMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+||++||.+|+ |++++++||||+..
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 99999999996 99999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-62 Score=456.21 Aligned_cols=265 Identities=38% Similarity=0.677 Sum_probs=224.3
Q ss_pred ccccceeecc-ccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe---
Q 014722 53 DISIDYDLGR-ELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--- 128 (419)
Q Consensus 53 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--- 128 (419)
.+-++|+++. .||+|+||+||+|++..+|+.||||++... ..+.+|+.++.++.+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4556899875 599999999999999999999999998642 4567899987766589999999999976
Q ss_pred -CCeEEEEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 -DSAVHIVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
...+|+|||||+||+|.+++.+. ..+++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999874 369999999999999999999999999999999999999877677889999999
Q ss_pred cceeccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cccccCCC
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVIDFKRD 280 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~ 280 (419)
+|+............||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+.......+.. ....++..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 9998877776777889999999999875 699999999999999999999999987765554444333 33334444
Q ss_pred CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCC
Q 014722 281 PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNV 325 (419)
Q Consensus 281 ~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~ 325 (419)
.+..+|+++.+||.+||+.||++|||+.|+|+||||++....+..
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~ 284 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCC
Confidence 456789999999999999999999999999999999876554444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-61 Score=452.23 Aligned_cols=254 Identities=29% Similarity=0.550 Sum_probs=229.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.+ +||||+++++++.+...+++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 5899999999999999999999999999999999765543444567889999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCc
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQ 215 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 215 (419)
|||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~---g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---SCEEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC---CCEEeeeceeeeecccc--
Confidence 9999999999999998899999999999999999999999999999999999999654 46999999999987533
Q ss_pred ccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHHH
Q 014722 216 FNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVK 294 (419)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 294 (419)
.....||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+.+.......+......+ +..+|+++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHHH
Confidence 346789999999999875 68999999999999999999999999999888888888775543 3468999999999
Q ss_pred HhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 295 KMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 295 ~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+||++||.+|+ |++++++||||+..
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999995 99999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-61 Score=444.81 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=226.4
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHH-hCCCCCCeeeeeeEEEeCCeEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMK-HLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++. .+ +||||+++++++.+++.+|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 47999999999999999999999999999999997654333334566777877766 57 99999999999999999999
Q ss_pred EEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC-
Q 014722 135 VMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG- 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~- 213 (419)
|||||+||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~---~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD---GHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT---SCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC---Cceeccccchhhhccccc
Confidence 99999999999999998899999999999999999999999999999999999999644 45999999999866543
Q ss_pred CcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHH
Q 014722 214 EQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDL 292 (419)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 292 (419)
.......||+.|+|||++. +.|+.++||||+||++|+|+||..||.+.+...+...+......++ +.+|+++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHH
Confidence 3345578999999999987 4799999999999999999999999999999988888877654332 3689999999
Q ss_pred HHHhcCCCCCCCCCHH-HHhcCCccccC
Q 014722 293 VKKMLNPDPKQRLTAE-EVLEHPWLQNA 319 (419)
Q Consensus 293 i~~~L~~dp~~R~s~~-~~l~~~~~~~~ 319 (419)
|.+||++||++|||+. ++++||||+..
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999999995 89999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-60 Score=450.98 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=219.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHH---HHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVR---REVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~---~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
++|++++.||+|+||.||+|++..+|+.||+|++.+...........+. +++.+++.+ +|||||++++++.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 4799999999999999999999999999999999765433222223333 446777777 899999999999999999
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|+|||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~---g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH---GHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---SCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC---CcEEEeeeceeeecCC
Confidence 9999999999999999998899999999999999999999999999999999999999644 4599999999987654
Q ss_pred CCcccccccCcccCchhhhc-c-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 213 GEQFNEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. ......||+.|+|||++. + .|+.++|||||||++|+|+||..||.+.+..... .+.+.........+..+|++++
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence 3 345668999999999986 3 5899999999999999999999999876543332 2333334444444567999999
Q ss_pred HHHHHhcCCCCCCCCC-----HHHHhcCCccccC
Q 014722 291 DLVKKMLNPDPKQRLT-----AEEVLEHPWLQNA 319 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s-----~~~~l~~~~~~~~ 319 (419)
+||.+||++||++||| ++|+++||||+..
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999999 7999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=438.29 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=215.0
Q ss_pred eccccccccceEEEEEEEcCCCcEEEEEEecccccCChh--hHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEE
Q 014722 60 LGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV--DIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVME 137 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e 137 (419)
.++.||+|+||+||+|++..+|+.||||++......... ..+.+.+|+.+++++ +|||||++++++.+++.+|+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 457899999999999999999999999999765432211 134688999999999 89999999999999999999999
Q ss_pred ecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-cc
Q 014722 138 LCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE-QF 216 (419)
Q Consensus 138 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 216 (419)
||.|+++..+......+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~---~~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN---GVLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC---CccccccCccccccCCCcccc
Confidence 99988887766667789999999999999999999999999999999999999644 459999999998765433 34
Q ss_pred cccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC-------------
Q 014722 217 NEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP------------- 281 (419)
Q Consensus 217 ~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------- 281 (419)
...+||+.|+|||++. ..|+.++||||+||++|+|+||.+||.+.+..+....+.+.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 5678999999999886 3589999999999999999999999999998888877765432221111
Q ss_pred -----------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 282 -----------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 282 -----------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
++.+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 135688999999999999999999999999999998654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=428.06 Aligned_cols=253 Identities=32% Similarity=0.573 Sum_probs=216.1
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChh---hHHHHHHHHHHHHhCC-CCCCeeeeeeEEEeC
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAV---DIEDVRREVQIMKHLP-KHPNIVSLKDTYEDD 129 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~~Ei~~l~~l~-~hpnIv~l~~~~~~~ 129 (419)
+.++|++.+.||+|+||+||+|++..+|+.||||++.+....... ....+.+|+.+++++. .||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 567899999999999999999999999999999999865543321 1234668999999983 389999999999999
Q ss_pred CeEEEEEEecCC-cchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 130 SAVHIVMELCEG-GELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 130 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
+.+|+||||+.+ +++.+++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~--~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN--RGELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--TTEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC--CCeEEECccccce
Confidence 999999999976 6888888888899999999999999999999999999999999999999743 3459999999998
Q ss_pred eccCCCcccccccCcccCchhhhcc-c-CCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.... ....+..||+.|+|||++.+ . ++.++||||+||++|+|+||..||.+.. .+.+....++ +.+|
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s 228 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS 228 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCC
Confidence 7543 33456789999999999874 3 4678999999999999999999996532 3444443332 4689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
+++++||.+||+.||++|||++|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-59 Score=427.46 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=222.5
Q ss_pred CccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC-
Q 014722 52 QDISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS- 130 (419)
Q Consensus 52 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 130 (419)
..+.++|++.+.||+|+||+||+|++..+|+.||||++......+......+.+|+++++.+ +||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 35677899999999999999999999999999999999877666666677899999999999 9999999999987654
Q ss_pred ---eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 131 ---AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 131 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
.+|+|||||+|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||.+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~---~~~l~d~~~~ 158 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN---AVKVMDFGIA 158 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS---CEEECCCTTC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc---cceeehhhhh
Confidence 4899999999999999999988999999999999999999999999999999999999997544 4899999998
Q ss_pred eeccCCC----cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 208 VFFRPGE----QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 208 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
....... ......||+.|+|||++.+ .|+.++|||||||++|+|+||.+||.+.+..+....+.......+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 7654332 2345689999999999875 6899999999999999999999999999988888888877666655666
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccc
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQ 317 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~ 317 (419)
+.+|+++.+||.+||++||++||+..+.+.|+|.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 78999999999999999999999544455566654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-59 Score=428.52 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=216.6
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|++..+|+.||+|++..... .....+.+.+|+++++++ +|||||++++++.+++.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999976543 223356888999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 136 MELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||+.++ +.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||+|+.....
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~---~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE---GAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECSTTHHHHHCCC
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc---CcceeccCCcceeccCC
Confidence 9999765 4444433 4569999999999999999999999999999999999999644 45999999999876543
Q ss_pred -CcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCC---------
Q 014722 214 -EQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDP--------- 281 (419)
Q Consensus 214 -~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 281 (419)
.......||+.|+|||++.. .++.++||||+||++|+|++|+.||.+.+.......+...........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 34456689999999998763 468899999999999999999999999888877777654332221111
Q ss_pred ----------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 282 ----------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 282 ----------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
++.+++++++||.+||++||++|||+.|+|+||||++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 2346789999999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-58 Score=426.79 Aligned_cols=263 Identities=26% Similarity=0.419 Sum_probs=215.6
Q ss_pred ccceeeccccccccceEEEEEEEcCC-CcEEEEEEecccccCChhhHHHHHHHHHHHHhCC--CCCCeeeeeeEEEe---
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNN-GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP--KHPNIVSLKDTYED--- 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~--- 128 (419)
.++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.|. +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 67799999976543221 2234556777766552 79999999999853
Q ss_pred --CCeEEEEEEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecc
Q 014722 129 --DSAVHIVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFG 205 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg 205 (419)
...++++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.. +.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~---~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC---CCeeecchh
Confidence 357899999999877654433 34568999999999999999999999999999999999999654 459999999
Q ss_pred cceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC-----
Q 014722 206 LSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR----- 279 (419)
Q Consensus 206 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 279 (419)
++.............||+.|+|||++. ..|+.++||||+||++|+|++|.+||.+.+..+....+.........
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 998776666667788999999999886 57999999999999999999999999999888887777643211110
Q ss_pred ------------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 280 ------------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 280 ------------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
..+..+++.+.+||.+||++||++|||+.|+|+||||++..+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 113457899999999999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-57 Score=418.33 Aligned_cols=257 Identities=31% Similarity=0.483 Sum_probs=215.8
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|++. +|+.||||++..... .....+.+.+|+.+|+++ +||||+++++++.+.+..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence 47999999999999999999985 789999999976543 223356889999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
+||+.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+|||++.+ +.+||+|||.|.......
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~---~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE---GELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---SCEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC---CCEEecccccceecccCcc
Confidence 9999888777777767889999999999999999999999999999999999999654 459999999998765332
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD------------ 280 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 280 (419)
......||+.|+|||.+.+ .++.++||||+||++|+|++|++||.+.+..+....+..........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 3345679999999999863 57999999999999999999999999988877777665432211111
Q ss_pred -------------CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 281 -------------PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 281 -------------~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
..+.+++++.+||.+||++||++|||+.|+|+||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 12346889999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=410.23 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=204.9
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++.+.||+|+||+||+|+. +..||||++..... +....+.+.+|+.+++++ +|||||++++++. .+.+++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEE
Confidence 45799999999999999999984 34699999976543 334577899999999999 9999999999875 456899
Q ss_pred EEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCC
Q 014722 135 VMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPG 213 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 213 (419)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~---~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED---LTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT---SSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC---CCEEEccccceeecccc
Confidence 99999999999999764 569999999999999999999999999999999999999754 45999999999876432
Q ss_pred ---CcccccccCcccCchhhhcc----cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cccC-CCCCcc
Q 014722 214 ---EQFNEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-IDFK-RDPWPK 284 (419)
Q Consensus 214 ---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~-~~~~~~ 284 (419)
.......||+.|||||++.+ .|+.++|||||||++|||+||..||.+.+............ .... ......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 23355789999999999852 47889999999999999999999998876655444444332 2211 223456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+|+++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 89999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-57 Score=420.91 Aligned_cols=252 Identities=21% Similarity=0.318 Sum_probs=212.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCc-----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGE-----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+++++.+|||||++++++.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 3689999999999999999999866544 68999886543 2234567889999999987899999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCC
Q 014722 130 SAVHIVMELCEGGELFDRIVARG-----------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPE 186 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~ 186 (419)
+.+|+|||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 99999999999999999997542 4889999999999999999999999999999999
Q ss_pred cEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCC
Q 014722 187 NFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAE 261 (419)
Q Consensus 187 NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~ 261 (419)
|||++.+ +.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+.
T Consensus 194 Nill~~~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHG---KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETT---TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccC---CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999754 4599999999987654432 23456899999999886 679999999999999999998 89999887
Q ss_pred CHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 262 TEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 262 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+.......+......+. .+..+|+++.+||.+||+.||++|||++|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 77666666666544332 234689999999999999999999999999876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-56 Score=411.15 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=210.5
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++|++.+.||+|+||+||+|++..+|+.||||++.... ...+++.+|+.+|+++ +|||||++++++.+++.+|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeE
Confidence 3457999999999999999999999999999999987543 2356799999999999 8999999999999999999
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~---~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN---HLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC---CcEEEccccceeecC
Confidence 999999999999998764 468999999999999999999999999999999999999754 459999999998765
Q ss_pred CCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....||+.|+|||++. +.|+.++|||||||++|||++|..| |.+.+.......+... .. .+.+..+|+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~--~~~~~~~~~ 243 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR--MERPEGCPE 243 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC--CCCCTTCCH
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-CC--CCCCccchH
Confidence 4432 23345899999999877 5799999999999999999996555 5555555544444333 22 223356899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
++.+||.+||+.||++|||+.|+++
T Consensus 244 ~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 244 KVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9999999999999999999999965
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-56 Score=419.89 Aligned_cols=258 Identities=29% Similarity=0.435 Sum_probs=215.0
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe----
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED---- 128 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~---- 128 (419)
....+|+.+++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+++ +||||++++++|..
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHC-CCTTBCCEEEEEEEC--C
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhc-CCCCCCcEEEEEEecCcc
Confidence 334579999999999999999999999999999999976532 224699999999 99999999999853
Q ss_pred --CCeEEEEEEecCCcchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEee
Q 014722 129 --DSAVHIVMELCEGGELFDR---IVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAID 203 (419)
Q Consensus 129 --~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~D 203 (419)
..++|+|||||+++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~--~~~kl~D 166 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT--AVLKLCD 166 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT--CCEEECC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC--CceeEec
Confidence 3458999999987643332 23456799999999999999999999999999999999999997543 3599999
Q ss_pred cccceeccCCCcccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc-----
Q 014722 204 FGLSVFFRPGEQFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID----- 276 (419)
Q Consensus 204 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~----- 276 (419)
||++..........+..||+.|+|||.+. ..|+.++||||+||++|||++|.+||...+..+....+.+....
T Consensus 167 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 99999887777777789999999999875 36899999999999999999999999998887776666532110
Q ss_pred ------------c--------CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 ------------F--------KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ------------~--------~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
+ .....+.+++++.+||.+||++||++|||+.|+|+||||+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0 0111245789999999999999999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=415.34 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=215.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-------
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------- 128 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------- 128 (419)
++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|+++ +||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 5899999999999999999999999999999998765433 23456788999999999 89999999998754
Q ss_pred -CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccc
Q 014722 129 -DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLS 207 (419)
Q Consensus 129 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a 207 (419)
+..+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~---~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD---GVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---SCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC---CcEEeeeccee
Confidence 45689999999887776655566779999999999999999999999999999999999999654 45999999999
Q ss_pred eeccCCC-----cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCC
Q 014722 208 VFFRPGE-----QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRD 280 (419)
Q Consensus 208 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (419)
....... .....+||+.|+|||++.+ .|+.++||||+||++|+|++|++||.+.+.......+.+....+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 8665322 2234679999999999863 68999999999999999999999999988888877776654443332
Q ss_pred CCcc----------------------------CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 281 PWPK----------------------------VSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 281 ~~~~----------------------------~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
.+.. .++++++||.+||++||++|||+.|+|+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 2211 26788999999999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-56 Score=411.92 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=203.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCc---EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGE---KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..+|++.+.||+|+||+||+|++..+|+ .||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 3579999999999999999999877665 58888876443 344567899999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS---NLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC---CCcEEECCcccceEc
Confidence 99999999999999988764 46999999999999999999999999999999999999964 456999999999876
Q ss_pred cCCCcc------cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCC
Q 014722 211 RPGEQF------NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPW 282 (419)
Q Consensus 211 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (419)
...... ....||+.|||||++. +.|+.++|||||||++|||+| |.+||.+.+..+....+..+.. .+..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR---LPPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Confidence 543321 1245789999999987 579999999999999999998 8999999988888777765432 2233
Q ss_pred ccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 283 PKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 283 ~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+++++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 5689999999999999999999999999765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=408.95 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=206.2
Q ss_pred cccccccceEEEEEEEc--CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEEEec
Q 014722 62 RELGRGEFGVTYLCTDV--NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVMELC 139 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~e~~ 139 (419)
++||+|+||+||+|... .+++.||||++..... +....+.+.+|+.+|+++ +|||||++++++.++ ..+||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcC
Confidence 46999999999999754 4567899999975543 334567899999999999 999999999999754 578999999
Q ss_pred CCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCCcc---
Q 014722 140 EGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGEQF--- 216 (419)
Q Consensus 140 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~--- 216 (419)
++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~---~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH---YAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT---EEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC---cccccchhhhhhcccccccccc
Confidence 9999999999988999999999999999999999999999999999999997654 4999999999876544322
Q ss_pred -cccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHHHHH
Q 014722 217 -NEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLV 293 (419)
Q Consensus 217 -~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 293 (419)
....||+.|||||++. +.++.++|||||||++|||+| |.+||.+.+..++...+.++.. .+....+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHHHHHH
Confidence 2356899999999987 578999999999999999998 8999999888887777766432 122346899999999
Q ss_pred HHhcCCCCCCCCCHHHH---hcCCcc
Q 014722 294 KKMLNPDPKQRLTAEEV---LEHPWL 316 (419)
Q Consensus 294 ~~~L~~dp~~R~s~~~~---l~~~~~ 316 (419)
.+||+.||++|||+.++ |+|+|+
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 99999999999999998 456554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-56 Score=417.14 Aligned_cols=255 Identities=30% Similarity=0.560 Sum_probs=213.4
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe--CCeE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED--DSAV 132 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~ 132 (419)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+.+||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 35899999999999999999999999999999998643 245788999999999669999999999984 4569
Q ss_pred EEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 133 HIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
++|||||.+++|.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+|....+
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~--~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--RKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT--TEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC--CeeeecccccceeccC
Confidence 9999999999997653 4699999999999999999999999999999999999997543 3489999999998877
Q ss_pred CCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhc-------------ccc
Q 014722 213 GEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRS-------------VID 276 (419)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~-------------~~~ 276 (419)
........||+.|+|||.+.+ .++.++||||+||++|+|++|..||..... ......+... ...
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 777778889999999998764 589999999999999999999999966543 2222222110 000
Q ss_pred --------------------cCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 --------------------FKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 --------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.....+..+++++.+||.+||.+||++|||++|+|+||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01112234789999999999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-56 Score=407.03 Aligned_cols=252 Identities=25% Similarity=0.323 Sum_probs=213.4
Q ss_pred cceeeccc-cccccceEEEEEEEcC--CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRE-LGRGEFGVTYLCTDVN--NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
++|.+.+. ||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+++|+++ +|||||++++++.+ +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence 46888884 9999999999998654 45689999997543 445677899999999999 89999999999875 468
Q ss_pred EEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
|+|||||+||+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~---~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH---YAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT---EEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC---ceeeccchhhhccc
Confidence 999999999999998765 45799999999999999999999999999999999999997654 49999999998775
Q ss_pred CCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+.+..++...+..+.. .+..+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR---MECPPEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC---CCCCTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcC
Confidence 4432 22456899999999987 579999999999999999998 9999998888877777765432 1223578
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHH---hcCCccc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEV---LEHPWLQ 317 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~---l~~~~~~ 317 (419)
|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999888 5677764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=419.57 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=212.7
Q ss_pred ccccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC--
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS-- 130 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 130 (419)
.+..+|++++.||+|+||+||+|++..+|+.||||++.+.. ......+.+.+|+++|+++ +|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 36789999999999999999999999999999999997653 3445567889999999999 8999999999997654
Q ss_pred ----eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccc
Q 014722 131 ----AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGL 206 (419)
Q Consensus 131 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~ 206 (419)
.+|+||||| +.+|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~---~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED---CELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc---cccccccccc
Confidence 579999999 56676655 45679999999999999999999999999999999999999654 4599999999
Q ss_pred ceeccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccc--------
Q 014722 207 SVFFRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVID-------- 276 (419)
Q Consensus 207 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-------- 276 (419)
|..... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+......
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987643 3456789999999998863 5789999999999999999999999988876665554432111
Q ss_pred ---------------cCCC----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCc
Q 014722 277 ---------------FKRD----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAK 320 (419)
Q Consensus 277 ---------------~~~~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~ 320 (419)
.... ..+.+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 1111 2245789999999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=405.77 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=212.7
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
-.++|++.+.||+|+||+||+|++ .+++.||||++..... ..+.+.+|+.+++++ +|||||++++++.+ +.+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM----SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcC----CHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeE
Confidence 446899999999999999999996 4678999999975432 346799999999999 99999999998764 5678
Q ss_pred EEEEecCCcchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVAR--GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+|||||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~---~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD---TLSCKIADFGLARLIE 160 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT---TSCEEECCCTTCEECS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec---ccceeeccccceEEcc
Confidence 999999999999876543 35999999999999999999999999999999999999964 4559999999999876
Q ss_pred CCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCH
Q 014722 212 PGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
.... .....||+.|||||++. +.++.++|||||||++|||+| |.+||...+..+....+..+... .....+++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~ 237 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM---VRPDNCPE 237 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCcccChH
Confidence 5432 23467899999999987 579999999999999999999 56677777777777776654321 22346899
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhc--CCcccc
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLE--HPWLQN 318 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~--~~~~~~ 318 (419)
++.+|+.+||+.||++|||+.++++ |+||..
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999999999998 788753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=403.52 Aligned_cols=246 Identities=24% Similarity=0.388 Sum_probs=202.7
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
.+|++++.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence 36999999999999999999975 577899999875432 346789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~---~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN---QVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG---GCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC---CCeEecccchheeccCCC
Confidence 9999999999988754 568999999999999999999999999999999999999754 459999999998765433
Q ss_pred c--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 Q--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||...+..+....+..+... .....+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---YKPRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---CCCTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHH
Confidence 2 23467899999999987 579999999999999999999 67788777877777777665322 22245789999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+|+.+||+.||++|||++|+++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999886
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=416.28 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=212.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC---
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS--- 130 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--- 130 (419)
++.+|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|+++ +||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccc
Confidence 4468999999999999999999999999999999997543 344567889999999999 9999999999987543
Q ss_pred --eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 131 --AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 131 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
.+|++ +|+.||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|.
T Consensus 83 ~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~---~~~kl~DfG~a~ 157 (345)
T d1pmea_ 83 MKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT---CDLKICDFGLAR 157 (345)
T ss_dssp CCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT---CCEEECCCTTCE
T ss_pred cceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC---CCEEEcccCcee
Confidence 34554 566689999998654 79999999999999999999999999999999999999644 459999999998
Q ss_pred eccCCC----cccccccCcccCchhhhc--ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc-----
Q 014722 209 FFRPGE----QFNEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF----- 277 (419)
Q Consensus 209 ~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~----- 277 (419)
...... .....+||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+...............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 764432 234567999999999875 357899999999999999999999998887766555443221110
Q ss_pred ------------------CC----CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 278 ------------------KR----DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 278 ------------------~~----~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
.. ..++.+++++++||.+||++||++|||+.|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 01 113467889999999999999999999999999999986544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=397.52 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=214.9
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|+. .+++.||||++..... ..+++.+|+.+++++ +||||+++++++.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence 3799999999999999999997 5788999999976543 346789999999999 899999999999999999999
Q ss_pred EEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
|||+++|+|.+++.. ...+++..+..++.|+++||.|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~---~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND---QGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT---TCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC---CCcEEECcchhheeccCCC
Confidence 999999999988664 456899999999999999999999999999999999999964 4569999999998765443
Q ss_pred c--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHHH
Q 014722 215 Q--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAK 290 (419)
Q Consensus 215 ~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 290 (419)
. .....||+.|+|||++. ..++.++|||||||++|||+| |+.||.+.+..++...+..... ...+...++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---LYRPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---CCCCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC---CCCcccccHHHH
Confidence 2 23456899999999987 579999999999999999998 8999999998888877766432 223346889999
Q ss_pred HHHHHhcCCCCCCCCCHHHHhcC
Q 014722 291 DLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 291 ~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+||.+||+.||++|||+.++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=403.61 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=220.3
Q ss_pred cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIV 135 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 135 (419)
++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence 479999999999999999999999999999999976543 334567899999999999 999999999999999999999
Q ss_pred EEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC-
Q 014722 136 MELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE- 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~- 214 (419)
++++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+ ..+||+|||.|.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~---~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN---GELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT---CCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC---CceeeeecchhhcccCCCc
Confidence 9999999998888888889999999999999999999999999999999999999754 459999999998875443
Q ss_pred cccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcccccCC------------
Q 014722 215 QFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF-WAETEQGVAQAIIRSVIDFKR------------ 279 (419)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~------------ 279 (419)
......+++.|+|||++.+ .++.++||||+||++|+|++|..|| .+.+..+....+.........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344567889999998764 4789999999999999999999885 555555555555432221110
Q ss_pred -------------CCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccC
Q 014722 280 -------------DPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNA 319 (419)
Q Consensus 280 -------------~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~ 319 (419)
...+.+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 1123568899999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=416.70 Aligned_cols=261 Identities=31% Similarity=0.576 Sum_probs=221.7
Q ss_pred cceeeccccccccceEEEEEEEc---CCCcEEEEEEecccccC-ChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDV---NNGEKFACKSISKKKLR-TAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~~aiK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
++|++++.||+|+||+||+|++. .+|+.||+|++.+.... +....+.+.+|+.+++++.+||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999974 47899999999765432 122345678899999999444899999999999999
Q ss_pred EEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 132 VHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+++||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~---~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN---GHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---SCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC---CCEEEeeccchhhhc
Confidence 99999999999999999999899999999999999999999999999999999999999754 459999999998764
Q ss_pred CCC--cccccccCcccCchhhhcc---cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PGE--QFNEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
... ......||+.|+|||.+.+ .++.++|||||||+||+|++|..||.+.........+.+............+|
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 3456779999999998863 47889999999999999999999998876655555555554444444445789
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHHHHhcCCccccC
Q 014722 287 ENAKDLVKKMLNPDPKQRL-----TAEEVLEHPWLQNA 319 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~-----s~~~~l~~~~~~~~ 319 (419)
+++.+||.+||++||++|| |++|+++||||+..
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 9999999999999999999 58999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-55 Score=396.47 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=203.3
Q ss_pred ccceeeccccccccceEEEEEEEcCC---CcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNN---GEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
.++|++++.||+|+||+||+|++..+ +..||||.+.... .....+.+.+|+.+++++ +||||+++++++. .+.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence 46899999999999999999997654 3568888875432 444567899999999999 9999999999996 467
Q ss_pred EEEEEEecCCcchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVA-RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
+|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~---~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND---CVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT---EEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC---cEEEccchhheec
Confidence 8999999999999998765 44699999999999999999999999999999999999997654 4999999999876
Q ss_pred cCCCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 211 RPGEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 211 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
..... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..+....+..+.. .+.++.+|
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCC
Confidence 54332 33456899999999987 579999999999999999998 8999999888888887776542 23446789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+||.+||+.||++|||+.|+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=411.00 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=203.1
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe------
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED------ 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------ 128 (419)
.++|++++.||+|+||+||+|+++.+|+.||||++..... +......+.+|+.+++++ +||||++++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEeccccccc
Confidence 3679999999999999999999999999999999976543 445567889999999999 89999999999953
Q ss_pred CCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccce
Q 014722 129 DSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSV 208 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~ 208 (419)
...+|+|||||.++ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+|++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~---~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD---CTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT---CCEEECCCCC--
T ss_pred CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc---cceeeechhhhh
Confidence 46899999999765 44544 3568999999999999999999999999999999999999654 459999999998
Q ss_pred eccCCCcccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccccc----------
Q 014722 209 FFRPGEQFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDF---------- 277 (419)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------- 277 (419)
............||+.|+|||++.+ .+++++||||+||++|+|++|++||.+.+.......+.......
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7776666677789999999999874 68999999999999999999999999888777666654322110
Q ss_pred ------------CCCC----------------CccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCcccc
Q 014722 278 ------------KRDP----------------WPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQN 318 (419)
Q Consensus 278 ------------~~~~----------------~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~ 318 (419)
.... ....++++.+||.+||..||++||||+|+|+||||+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 0123568899999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=411.67 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=214.6
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC-----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD----- 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~----- 129 (419)
.++|++++.||+|+||+||+|++..+|+.||||++.+.. .+....+.+.+|+++|+++ +||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeecccccc
Confidence 468999999999999999999999999999999998654 3444567788999999999 899999999998633
Q ss_pred CeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 130 SAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
...+++++|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~---~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED---CELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT---CCEEECCC----C
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc---ccccccccchhcc
Confidence 334566777889999998754 579999999999999999999999999999999999999654 4599999999875
Q ss_pred ccCCCcccccccCcccCchhhhcc--cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccccCC--------
Q 014722 210 FRPGEQFNEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKR-------- 279 (419)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 279 (419)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+.........
T Consensus 171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 43 33456779999999998663 4689999999999999999999999999888777776554322110
Q ss_pred ---------------C----CCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCcc
Q 014722 280 ---------------D----PWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKK 321 (419)
Q Consensus 280 ---------------~----~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~ 321 (419)
. .+..+++++++||.+||+.||++|||+.|+|+||||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0 12457899999999999999999999999999999987543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=393.50 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=207.8
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
.++|++.+.||+|+||+||+|++..+ +.||||++..... ..+.+.+|+.+++++ +|||||++++++.+ +.+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEE
Confidence 45899999999999999999998654 6799999975432 346799999999999 99999999999864 56789
Q ss_pred EEEecCCcchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 135 VMELCEGGELFDRIVA--RGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 135 v~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
|||||++|+|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~---~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN---LVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG---GCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC---CcEEEcccchhhhccC
Confidence 9999999999988764 3569999999999999999999999999999999999999754 4599999999987654
Q ss_pred CCc--ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccccCCCCCccCCHH
Q 014722 213 GEQ--FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSEN 288 (419)
Q Consensus 213 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (419)
+.. .....||+.|+|||++. +.++.++|||||||++|||+|| .+|+.+....+....+.+... .+..+.+|++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---~~~~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---MPCPPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---CCCCcccCHH
Confidence 432 23467899999999987 5799999999999999999995 566667777777776665432 2234578999
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHhc--CCccccCc
Q 014722 289 AKDLVKKMLNPDPKQRLTAEEVLE--HPWLQNAK 320 (419)
Q Consensus 289 ~~~li~~~L~~dp~~R~s~~~~l~--~~~~~~~~ 320 (419)
+.+||.+||+.||++|||+.++++ ++||....
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 999999999999999999999988 88987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=401.79 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=210.0
Q ss_pred cceeeccccccccceEEEEEEEcCCCcE--EEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNGEK--FACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
++|++.+.||+|+||+||+|++..+|.. ||||.+.... .....+.+.+|+++|+++.+|||||++++++.+++.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 4799999999999999999999888875 5667664332 33345678999999999867999999999999999999
Q ss_pred EEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCC
Q 014722 134 IVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESS 197 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~ 197 (419)
+||||++||+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~--- 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--- 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG---
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC---
Confidence 999999999999998654 4689999999999999999999999999999999999997554
Q ss_pred CeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhccc
Q 014722 198 PLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVI 275 (419)
Q Consensus 198 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~ 275 (419)
.+||+|||+|+............||+.|+|||.+. +.|+.++|||||||++|||++| .+||.+.+..++...+.++.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~- 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-
Confidence 59999999998765544445667999999999987 5799999999999999999996 46888888888777766542
Q ss_pred ccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 276 DFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 276 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+.+..+++++.+||.+||+.||++|||+.+++++
T Consensus 244 --~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 223345789999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=391.60 Aligned_cols=248 Identities=21% Similarity=0.309 Sum_probs=201.4
Q ss_pred cceeeccccccccceEEEEEEEcCCC----cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCe
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVNNG----EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSA 131 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 131 (419)
..|++.+.||+|+||+||+|....++ ..||||++.... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence 35999999999999999999876554 479999986543 344556789999999999 89999999999999999
Q ss_pred EEEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceec
Q 014722 132 VHIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFF 210 (419)
Q Consensus 132 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~ 210 (419)
.++|||||.++++.+.+... ..+++.++..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~---~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS---NLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT---TCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC---CCeEEEcccchhhcc
Confidence 99999999999999887764 56999999999999999999999999999999999999965 456999999999876
Q ss_pred cCCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccccCCCCCcc
Q 014722 211 RPGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVIDFKRDPWPK 284 (419)
Q Consensus 211 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (419)
..... .....||+.|||||++. +.++.++|||||||++|||++| .+|+...+..+....+..+.. .+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR---LPTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC---CCCchh
Confidence 54322 22356899999999887 5799999999999999999995 566666666666666655432 222346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 285 VSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 285 ~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
+++.+.+||.+||+.||++|||+.|+++
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 8899999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=392.32 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=203.0
Q ss_pred cceeeccccccccceEEEEEEEcC-CC--cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 56 IDYDLGRELGRGEFGVTYLCTDVN-NG--EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 56 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
.+|++.+.||+|+||.||+|+... ++ ..||||++.+.........+.+.+|+.+|+++ +||||+++++++.+ ...
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 579999999999999999998543 33 47899999876655555677899999999999 99999999999976 467
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++|||||++|++.+++..+ +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~---~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD---LVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT---EEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc---ceeeccchhhhhcc
Confidence 8999999999999877654 5699999999999999999999999999999999999998654 49999999999875
Q ss_pred CCCc----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccC
Q 014722 212 PGEQ----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKV 285 (419)
Q Consensus 212 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 285 (419)
.... .....||+.|+|||++. ..++.++|||||||++|||+| |.+||.+.+..+....+.+....++ .++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--Ccccc
Confidence 4432 22346788999999987 468999999999999999998 8999999999998888877654332 33578
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 286 SENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 286 ~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
|+.+.+||.+||..||++|||+.++++
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999999963
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=398.38 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=204.4
Q ss_pred ceeeccccccccceEEEEEEEcCCCc----EEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGE----KFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAV 132 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 132 (419)
+|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.+++++ +|||||++++++.++ ..
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-Ce
Confidence 69999999999999999999988876 57777775432 233467899999999999 899999999999865 56
Q ss_pred EEEEEecCCcchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 133 HIVMELCEGGELFDRIVAR-GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 133 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
++++||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~---~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT---EEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC---CeEeeccccceecc
Confidence 7888999999999887764 5699999999999999999999999999999999999997654 49999999998765
Q ss_pred CCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCC
Q 014722 212 PGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVS 286 (419)
Q Consensus 212 ~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (419)
.... .....||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+.+..++...+..+... +..+.++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~p~~~~ 239 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---PQPPICT 239 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---CCCTTBC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccC
Confidence 4332 23456899999999876 579999999999999999998 89999988887777666654321 2234689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
+++.+|+.+||+.||++|||+.|+++|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=394.89 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=199.7
Q ss_pred ccceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED- 128 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~- 128 (419)
.++|++++.||+|+||.||+|++.. +++.||||++.... .....+.+.+|..++.++.+||||+.+++++..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3579999999999999999999654 45789999986543 344566788899989888789999999998765
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeec
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR----------------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFAN 192 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~ 192 (419)
+..+++|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 45689999999999999998753 24889999999999999999999999999999999999975
Q ss_pred CCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Q 014722 193 KKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVA 267 (419)
Q Consensus 193 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~ 267 (419)
+ +.+||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||+|| .+||.+.......
T Consensus 170 ~---~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 K---NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp G---GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred C---CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4 4599999999986644322 34567999999999987 5689999999999999999986 5788776655444
Q ss_pred HHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 268 QAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 268 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
..+......+ .....+++++.+|+.+||+.||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 247 CRRLKEGTRM--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444332222 2234689999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-53 Score=392.39 Aligned_cols=249 Identities=20% Similarity=0.283 Sum_probs=213.0
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++|++++.||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence 457999999999999999999864 356889999987543 344567899999999999 999999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCC
Q 014722 130 SAVHIVMELCEGGELFDRIVARG------------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKP 185 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 185 (419)
+..++||||+++|+|.+++.... .+++..+..|+.|++.||+|||+++|+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999986532 378999999999999999999999999999999
Q ss_pred CcEEeecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCC-CCCCC
Q 014722 186 ENFLFANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWA 260 (419)
Q Consensus 186 ~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~-~pf~~ 260 (419)
+|||++.+ +.+||+|||+|+...+... .....||+.|+|||.+. ..|+.++|||||||++|||++|. +||.+
T Consensus 169 ~NILld~~---~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLVGEN---MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEECGG---GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEECCC---CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999754 4599999999986644322 23467899999999987 47999999999999999999985 78999
Q ss_pred CCHHHHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 261 ETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 261 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.+..+....+..+... +.+..+++++.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9988888887765432 223468999999999999999999999999954
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=390.45 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=210.3
Q ss_pred ccccceeeccccccccceEEEEEEEcCCC-------cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeE
Q 014722 53 DISIDYDLGRELGRGEFGVTYLCTDVNNG-------EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDT 125 (419)
Q Consensus 53 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~ 125 (419)
.-.++|++++.||+|+||.||+|++..++ ..||||++.... .......+.+|...+.++.+|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34568999999999999999999976554 479999987543 344567888999999998789999999999
Q ss_pred EEeCCeEEEEEEecCCcchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEE
Q 014722 126 YEDDSAVHIVMELCEGGELFDRIVARG----------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFL 189 (419)
Q Consensus 126 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 189 (419)
+.+++..++|||||++|+|.+++.... .+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 999999999999999999999997543 4899999999999999999999999999999999999
Q ss_pred eecCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHH
Q 014722 190 FANKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 264 (419)
Q Consensus 190 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~ 264 (419)
++.+ +.+||+|||+++....... .....||+.|+|||.+. +.|+.++|||||||++|||++ |.+||.+.+..
T Consensus 168 l~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 168 VTED---NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp ECTT---CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ecCC---CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 9654 4599999999987754432 33467899999999886 689999999999999999998 79999988888
Q ss_pred HHHHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 265 GVAQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 265 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.....+..+.. + +....+++++.+||.+||+.||++|||+.|+++
T Consensus 245 ~~~~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 245 ELFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHTTCC-C--CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCC-C--CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77766655422 2 223468999999999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=385.30 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=200.3
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-CCeEE
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVH 133 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~ 133 (419)
.++|++++.||+|+||.||+|+. +|..||||+++... ..+.+.+|+.+++++ +||||+++++++.+ .+.+|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEE
Confidence 35799999999999999999996 57899999996542 346789999999999 99999999998854 56789
Q ss_pred EEEEecCCcchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceecc
Q 014722 134 IVMELCEGGELFDRIVARG--HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFR 211 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 211 (419)
+||||+++|+|.+++..++ .+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~---~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED---NVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT---SCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC---CCEeecccccceecC
Confidence 9999999999999987643 48999999999999999999999999999999999999654 459999999998654
Q ss_pred CCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccccCCCCCccCCHHH
Q 014722 212 PGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENA 289 (419)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 289 (419)
.. .....+|+.|+|||++. +.++.++|||||||++|||+| |.+||...+..+....+.++.. .+..+.+++++
T Consensus 155 ~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~ 229 (262)
T d1byga_ 155 ST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAV 229 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHH
T ss_pred CC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCccCCHHH
Confidence 32 34456899999999886 579999999999999999998 7999988888887777765432 12234678999
Q ss_pred HHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 290 KDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 290 ~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.+||.+||+.||++|||+.+++++
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999999774
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=386.49 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=213.2
Q ss_pred ccceeeccccccccceEEEEEEEc-----CCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeC
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDV-----NNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDD 129 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 129 (419)
.++|++++.||+|+||.||+|+.. .+++.||||++.... .......+.+|+.+++++.+|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 468999999999999999999853 467899999997543 3445678899999999997799999999999999
Q ss_pred CeEEEEEEecCCcchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEee
Q 014722 130 SAVHIVMELCEGGELFDRIVARG------------------HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFA 191 (419)
Q Consensus 130 ~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~ 191 (419)
..+++|||||++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987643 589999999999999999999999999999999999997
Q ss_pred cCCCCCCeEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 014722 192 NKKESSPLKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 266 (419)
Q Consensus 192 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~ 266 (419)
.+ +.+|++|||.++....... .....||+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..+.
T Consensus 180 ~~---~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 HG---RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp TT---TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cc---CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 54 4599999999987654332 23457899999999987 578999999999999999998 7777877776666
Q ss_pred HHHHHhcccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 267 AQAIIRSVIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 267 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
...+......... ...+|+++.+||.+||+.||++|||+.|+++
T Consensus 257 ~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666554433222 2457899999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-52 Score=385.18 Aligned_cols=259 Identities=20% Similarity=0.279 Sum_probs=205.4
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+.++|++++.||+|+||+||+|++..+|+.||||++...... +.+..|+++++.+.+|++|+.+.+++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 456799999999999999999999999999999998754322 347789999999944555666777778889999
Q ss_pred EEEEecCCcchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccC
Q 014722 134 IVMELCEGGELFDRIV-ARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRP 212 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 212 (419)
+||||+. ++|.+.+. ....+++..+..++.|++.||+|||++||+||||||+|||++..+.+..+||+|||+|+....
T Consensus 80 ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9999995 56655554 456799999999999999999999999999999999999997666667899999999998754
Q ss_pred CC--------cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccccc-CC
Q 014722 213 GE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVIDF-KR 279 (419)
Q Consensus 213 ~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~-~~ 279 (419)
.. ......||+.|||||++.+ .++.++|||||||++|||+||..||...........+.. ..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 32 2245679999999999875 699999999999999999999999987655443332221 11111 11
Q ss_pred CCCccCCHHHHHHHHHhcCCCCCCCCCHHH---HhcCCcccc
Q 014722 280 DPWPKVSENAKDLVKKMLNPDPKQRLTAEE---VLEHPWLQN 318 (419)
Q Consensus 280 ~~~~~~~~~~~~li~~~L~~dp~~R~s~~~---~l~~~~~~~ 318 (419)
..++.+|+++.+|+.+||+.||++||++.+ +|+|+|.+.
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 123468999999999999999999999874 467776543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=382.92 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=213.9
Q ss_pred cccceeeccccccccceEEEEEEEcC-----CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVN-----NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED 128 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 128 (419)
-.++|++++.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 94 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec
Confidence 34689999999999999999998742 46789999987442 444556789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCcchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCC
Q 014722 129 DSAVHIVMELCEGGELFDRIVAR----------GHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSP 198 (419)
Q Consensus 129 ~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~ 198 (419)
+...++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++. +.+
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~---~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT---TCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC---Cce
Confidence 99999999999999999988643 24689999999999999999999999999999999999964 456
Q ss_pred eEEeecccceeccCCCc---ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhc
Q 014722 199 LKAIDFGLSVFFRPGEQ---FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRS 273 (419)
Q Consensus 199 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~ 273 (419)
+||+|||+|+....... .....||+.|+|||.+. +.++.++||||||+++|||+|| .+||.+.+..+....+.++
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC
Confidence 99999999987654332 23446899999999987 5688899999999999999998 5889898888888877765
Q ss_pred ccccCCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 274 VIDFKRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.. .+..+.+++.+.+||.+||+.||++|||+.++++
T Consensus 252 ~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 252 GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 43 2223468999999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=375.54 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=198.6
Q ss_pred eccccccccceEEEEEEEcCCC---cEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEe-CCeEEEE
Q 014722 60 LGRELGRGEFGVTYLCTDVNNG---EKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYED-DSAVHIV 135 (419)
Q Consensus 60 ~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~lv 135 (419)
+.++||+|+||+||+|++..++ ..||||++... ......+.+.+|+++|+++ +||||+++++++.+ ++.+++|
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEE
Confidence 3578999999999999976543 36899998643 3555678899999999999 89999999999765 5689999
Q ss_pred EEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEeecccceeccCCC
Q 014722 136 MELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAIDFGLSVFFRPGE 214 (419)
Q Consensus 136 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 214 (419)
||||++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++. +..+||+|||+++......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~---~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE---KFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT---TCCEEECSSGGGCCTTTTT
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC---CCCEEEecccchhhccccc
Confidence 99999999999887543 5788899999999999999999999999999999999964 4569999999998765432
Q ss_pred c-----ccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccccCCCCCccCCH
Q 014722 215 Q-----FNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVIDFKRDPWPKVSE 287 (419)
Q Consensus 215 ~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (419)
. .....||+.|+|||.+. +.++.++||||||+++|||+||..||... +..+....+..+.. .. ..+.+++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-~~--~p~~~~~ 261 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LL--QPEYCPD 261 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-CC--CCTTCCH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-CC--CcccCcH
Confidence 2 22356899999999877 67999999999999999999977666543 33444455544432 11 2246789
Q ss_pred HHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 288 NAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 288 ~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
++.+||.+||+.||++|||+.|+++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-50 Score=369.76 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=207.2
Q ss_pred cccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEE
Q 014722 54 ISIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVH 133 (419)
Q Consensus 54 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 133 (419)
+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.|.+||||+.+++++......+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 45689999999999999999999999999999999865432 2356789999999966799999999999999999
Q ss_pred EEEEecCCcchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCC--CCCCeEEeecccceec
Q 014722 134 IVMELCEGGELFDRIVARG-HYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKK--ESSPLKAIDFGLSVFF 210 (419)
Q Consensus 134 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~--~~~~~kl~Dfg~a~~~ 210 (419)
+||||+ +++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++... ..+.+||+|||+|+..
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 689998887654 699999999999999999999999999999999999997532 2456999999999876
Q ss_pred cCCC--------cccccccCcccCchhhhcc-cCCCcccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccccc-
Q 014722 211 RPGE--------QFNEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVIDF- 277 (419)
Q Consensus 211 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~- 277 (419)
.... ......||+.|||||++.+ .++.++|||||||++|+|+||..||.+... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 4321 2345679999999999875 699999999999999999999999975433 22233332221111
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014722 278 KRDPWPKVSENAKDLVKKMLNPDPKQRLTAEEVLE 312 (419)
Q Consensus 278 ~~~~~~~~~~~~~~li~~~L~~dp~~R~s~~~~l~ 312 (419)
.....+.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11123468899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=366.77 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=189.5
Q ss_pred ccceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCC----
Q 014722 55 SIDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDS---- 130 (419)
Q Consensus 55 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~---- 130 (419)
..+|.+.+.||+|+||.||+|+. +|+.||||++..... .......|+..+..+ +||||+++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVML-RHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcce
Confidence 45799999999999999999984 689999999864321 112233455556677 8999999999987654
Q ss_pred eEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 131 AVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHE--------QGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 131 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
.+|+|||||++|+|.+++.+. .+++..+..++.|++.||.|||+ +||+||||||+|||++. ++.+||+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~---~~~~Kl~ 150 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK---NGTCCIA 150 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT---TSCEEEC
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC---CCCeEEE
Confidence 689999999999999999765 68999999999999999999996 59999999999999964 4569999
Q ss_pred ecccceeccCCCc-----ccccccCcccCchhhhccc-------CCCcccHHHHHHHHHHHHhCCCCCCCCC--------
Q 014722 203 DFGLSVFFRPGEQ-----FNEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAET-------- 262 (419)
Q Consensus 203 Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~DiwslG~il~~ll~g~~pf~~~~-------- 262 (419)
|||++........ .....||+.|+|||++.+. ++.++|||||||++|||+||.+||....
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 9999987754432 2356799999999998642 5668999999999999999988763211
Q ss_pred -------HHHHHHHHHhcccccCCC-CCc--cCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014722 263 -------EQGVAQAIIRSVIDFKRD-PWP--KVSENAKDLVKKMLNPDPKQRLTAEEVLEH 313 (419)
Q Consensus 263 -------~~~~~~~i~~~~~~~~~~-~~~--~~~~~~~~li~~~L~~dp~~R~s~~~~l~~ 313 (419)
.......+.........+ .+. ..+..+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 122222222222211110 111 123468899999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-47 Score=363.19 Aligned_cols=264 Identities=25% Similarity=0.428 Sum_probs=199.6
Q ss_pred CCccc-cceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCC----------CCCCe
Q 014722 51 GQDIS-IDYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLP----------KHPNI 119 (419)
Q Consensus 51 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~----------~hpnI 119 (419)
|+.+. .+|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+++.+. .||||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 45554 46999999999999999999999999999999997542 23456788999888872 25789
Q ss_pred eeeeeEEEe--CCeEEEEEEecCCcchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCEeeCCCCCcEEeecC
Q 014722 120 VSLKDTYED--DSAVHIVMELCEGGELFDRI---VARGHYTERAAAAVMKTIVEVVQVCHE-QGVMHRDLKPENFLFANK 193 (419)
Q Consensus 120 v~l~~~~~~--~~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIl~~~~ 193 (419)
+++++++.. ....+++++++..+...... .....+++..+..++.||+.||.|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999998754 45677777777655433322 234568999999999999999999998 899999999999999765
Q ss_pred CCC---CCeEEeecccceeccCCCcccccccCcccCchhhhc-ccCCCcccHHHHHHHHHHHHhCCCCCCCCCHH-----
Q 014722 194 KES---SPLKAIDFGLSVFFRPGEQFNEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----- 264 (419)
Q Consensus 194 ~~~---~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----- 264 (419)
+.. ..++++|||.|..... ......||+.|+|||++. ..|+.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 432 2389999999886543 335678999999999876 57999999999999999999999999654321
Q ss_pred -HHHHHHHhccc------------------------cc--------------CCCCCccCCHHHHHHHHHhcCCCCCCCC
Q 014722 265 -GVAQAIIRSVI------------------------DF--------------KRDPWPKVSENAKDLVKKMLNPDPKQRL 305 (419)
Q Consensus 265 -~~~~~i~~~~~------------------------~~--------------~~~~~~~~~~~~~~li~~~L~~dp~~R~ 305 (419)
........... .. ....+...++++.+||.+||.+||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111111000 00 0011123467899999999999999999
Q ss_pred CHHHHhcCCccccCc
Q 014722 306 TAEEVLEHPWLQNAK 320 (419)
Q Consensus 306 s~~~~l~~~~~~~~~ 320 (419)
|+.|+|+||||++..
T Consensus 321 ta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 321 DAGGLVNHPWLKDTL 335 (362)
T ss_dssp CHHHHHTCGGGTTCT
T ss_pred CHHHHhcCcccCCCC
Confidence 999999999999653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=6.3e-28 Score=206.41 Aligned_cols=166 Identities=21% Similarity=0.252 Sum_probs=123.7
Q ss_pred eeeccccccccceEEEEEEEcCCCcEEEEEEecccccC-----C----------hhhHHHHHHHHHHHHhCCCCCCeeee
Q 014722 58 YDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLR-----T----------AVDIEDVRREVQIMKHLPKHPNIVSL 122 (419)
Q Consensus 58 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~----------~~~~~~~~~Ei~~l~~l~~hpnIv~l 122 (419)
|.+.+.||+|+||+||+|++ .+|+.||||++...... . .........|...+.++ .|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 45788999999999999997 47899999987532110 0 11123456789999999 89999988
Q ss_pred eeEEEeCCeEEEEEEecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCEeeCCCCCcEEeecCCCCCCeEEe
Q 014722 123 KDTYEDDSAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQGVMHRDLKPENFLFANKKESSPLKAI 202 (419)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl~~~~~~~~~~kl~ 202 (419)
+++.. .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||++.++ ++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC----EEEE
Confidence 76532 269999999876532 45566788999999999999999999999999999997432 8999
Q ss_pred ecccceeccCCCcccccccCcccCc------hhhhcccCCCcccHHHHHHH
Q 014722 203 DFGLSVFFRPGEQFNEIVGSPYYMA------PEVLKRNYGPEVDVWSAGVI 247 (419)
Q Consensus 203 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwslG~i 247 (419)
|||.|.....+... .|.. .+.+.+.|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99999765432211 1222 23345678999999998643
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=99.32 E-value=1.3e-12 Score=93.12 Aligned_cols=69 Identities=23% Similarity=0.240 Sum_probs=63.6
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.+++++...++++|..||+++ +|.|+..||+.+|+.+|..+++++++.++..+|.| |.|+|+||+
T Consensus 4 ~~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~eFl 75 (82)
T d1wrka1 4 AAVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEFL 75 (82)
T ss_dssp HHHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4456778899999999999999995 79999999999999999999999999999999987 689999994
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.28 E-value=2e-12 Score=92.10 Aligned_cols=65 Identities=31% Similarity=0.395 Sum_probs=61.0
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++..+++++|..+|.|++|.|+.+|++.+|+.+|..+++.++..++..+|.| |.|+|++|+
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~eF~ 73 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEFL 73 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 45788888999999999999999999999999999999999999999999999987 689999994
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=99.27 E-value=5.4e-13 Score=96.42 Aligned_cols=69 Identities=39% Similarity=0.570 Sum_probs=64.4
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.|++.++.++...++++|..+|+|++|.|+.+||+.+|+.+|..++++|+..++..+|.| |.|+|+||+
T Consensus 12 ~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~EFl 82 (87)
T d1s6ja_ 12 HMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEFI 82 (87)
T ss_dssp HSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHHHHT
T ss_pred HHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHHHHH
Confidence 566777888888899999999999999999999999999999999999999999999987 689999995
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.27 E-value=9.4e-13 Score=93.04 Aligned_cols=65 Identities=26% Similarity=0.365 Sum_probs=61.3
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++..+++++|..+|.|++|+|+.+||+.+|+.+|..++++++..++..+|.+ |.|+|+||+
T Consensus 3 ~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~eF~ 69 (77)
T d1f54a_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEFL 69 (77)
T ss_dssp CCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 46778889999999999999999999999999999999999999999999999987 789999994
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.23 E-value=3.5e-12 Score=85.44 Aligned_cols=58 Identities=22% Similarity=0.418 Sum_probs=55.0
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++++++|..+|++++|+|+..||+.+|+.+|..+++.++..|+..+|.| |.|+|+||+
T Consensus 1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHHHHH
T ss_pred ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHHHhc
Confidence 3688999999999999999999999999999999999999999999987 789999995
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.22 E-value=4.9e-12 Score=85.91 Aligned_cols=58 Identities=21% Similarity=0.374 Sum_probs=55.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++++++|+.+|+|++|+|+.+|++.+++.+|..++++++..++..+|.| |.|+|+||+
T Consensus 3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~eF~ 62 (65)
T d1fw4a_ 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFV 62 (65)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHHHHH
Confidence 4689999999999999999999999999999999999999999999987 799999994
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=99.22 E-value=3.1e-12 Score=89.20 Aligned_cols=64 Identities=31% Similarity=0.398 Sum_probs=60.4
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++..+++++|..+|.|++|.|+..|++.+|..+|..++++++..++..+|.+ |.|+|+||+
T Consensus 2 Ls~eei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~eF~ 67 (73)
T d2pq3a1 2 LTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 67 (73)
T ss_dssp CCHHHHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred cCHHHHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 4678889999999999999999999999999999999999999999999999987 789999995
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=99.20 E-value=7.3e-12 Score=89.11 Aligned_cols=62 Identities=23% Similarity=0.333 Sum_probs=57.6
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++++..+++++|+.+|+|++|.|+..||+.+|+.+| .++++++..++..+|.| |.|+|+||+
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg-~~~~~ei~~~~~~~D~d~~G~I~~~EF~ 64 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGDALKTLG-SVTPDEVRRMMAEIDTDGDGFISFDEFT 64 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTT-TCCHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhh-cCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 357788999999999999999999999999999999 68999999999999988 689999994
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.18 E-value=1e-11 Score=86.91 Aligned_cols=59 Identities=25% Similarity=0.315 Sum_probs=55.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++++|+.||+|++|+|+..|++.+|+.+|..++++++..++..+|.+ |.|+|+||+
T Consensus 8 eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~EF~ 68 (75)
T d1jc2a_ 8 EEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFDEFL 68 (75)
T ss_dssp HHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHHHHH
T ss_pred HHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 35789999999999999999999999999999999999999999999987 799999995
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=99.12 E-value=2.7e-11 Score=86.08 Aligned_cols=59 Identities=32% Similarity=0.427 Sum_probs=55.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++++|..+|.|++|+|+.+||+.+|+.+|..+++++++.++..+|.| |.|+|+||+
T Consensus 14 ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~EF~ 74 (81)
T d1fi5a_ 14 EEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 74 (81)
T ss_dssp HHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 35689999999999999999999999999999999999999999999987 799999994
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.10 E-value=2.8e-11 Score=85.24 Aligned_cols=61 Identities=20% Similarity=0.286 Sum_probs=56.7
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+..++++++|..+|.|++|.|+.+|++.+|+.+|..++..++..++..+|.| |.|+|+||+
T Consensus 6 d~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~EF~ 68 (77)
T d1oqpa_ 6 DSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFI 68 (77)
T ss_dssp SHHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHHHHH
T ss_pred cHHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 3456799999999999999999999999999999999999999999999887 789999994
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=99.09 E-value=1.5e-11 Score=84.16 Aligned_cols=58 Identities=19% Similarity=0.338 Sum_probs=54.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++++++|+.+|.+++|+|+.+||+.+|+.+|.. +|+++++.++..+|.| |.|+|+||+
T Consensus 2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~ 62 (68)
T d1c7va_ 2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFM 62 (68)
T ss_dssp HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHH
T ss_pred HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 468899999999999999999999999999985 7999999999999998 799999995
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.08 E-value=5.9e-11 Score=80.99 Aligned_cols=57 Identities=26% Similarity=0.309 Sum_probs=54.0
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++++|+.+|.|++|.|+..|++.+++.+|..++++++..++..+|.| |.|+|+||+
T Consensus 2 ~~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~EF~ 60 (67)
T d1tiza_ 2 SAKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNADEFT 60 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHHHHH
T ss_pred hHHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 468999999999999999999999999999999999999999999987 789999993
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=98.99 E-value=1.3e-10 Score=87.37 Aligned_cols=60 Identities=25% Similarity=0.263 Sum_probs=54.7
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++++|+.+|+|++|+|+.+||+.+|+.+ |..+++++++.+++.+|.| |.|+|+||+
T Consensus 39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~EF~ 103 (109)
T d5pala_ 39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGADEFA 103 (109)
T ss_dssp CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence 34579999999999999999999999999875 7899999999999999987 799999994
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=6.3e-10 Score=79.38 Aligned_cols=59 Identities=22% Similarity=0.217 Sum_probs=55.8
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++|..+|.+++|.|+.+|++.+|..+|..++++|+..++..+|.+ |.|+|.||+
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~eFl 79 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYPDFL 79 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHHHHH
Confidence 56789999999999999999999999999999999999999999999887 799999994
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.87 E-value=7e-10 Score=88.10 Aligned_cols=59 Identities=19% Similarity=0.346 Sum_probs=55.7
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC-CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII-CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-g~i~~~~f~ 419 (419)
.+.+.++|+.+|.|++|+|+.+||+.+|..+|..+|++|+..+++.+|.+ |.|+|.||+
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~~G~I~y~eF~ 134 (142)
T d1wdcb_ 75 EETIRNAFAMFDEQETKKLNIEYIKDLLENMGDNFNKDEMRMTFKEAPVEGGKFDYVKFT 134 (142)
T ss_dssp HHHHHHHHHTTCTTCCSCEEHHHHHHHHHHSSSCCCHHHHHHHHHHCCEETTEECHHHHH
T ss_pred hhhHHHhhhhhcccCCCcccHHHHHHHHHHccccCCHHHHHHHHHHhCCCCCEEcHHHHH
Confidence 46789999999999999999999999999999999999999999999886 799999995
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.87 E-value=6.3e-10 Score=83.51 Aligned_cols=59 Identities=20% Similarity=0.282 Sum_probs=54.0
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++++|+.+|.|++|+|+.+||+.+|..+ |..+++++++.+++.+|.| |.|+|+||+
T Consensus 40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~EF~ 103 (109)
T d1pvaa_ 40 ANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGIDEFE 103 (109)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHHHHH
Confidence 4568899999999999999999999999887 7789999999999999987 799999994
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=98.83 E-value=1.4e-09 Score=81.39 Aligned_cols=60 Identities=20% Similarity=0.267 Sum_probs=54.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++++|+.+|+|++|+|+.+|++.+++.+ |..++++++..+++.+|.| |.|+|+||+
T Consensus 38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~EF~ 102 (107)
T d2pvba_ 38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVDEFA 102 (107)
T ss_dssp CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 44578999999999999999999999999998 4578999999999999887 799999994
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.76 E-value=2.8e-09 Score=84.26 Aligned_cols=59 Identities=20% Similarity=0.415 Sum_probs=55.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC-CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII-CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~-g~i~~~~f~ 419 (419)
...+.++|+.+|.+++|.|+.+||+.+|..+|.+++++|++.+++.+|.+ |.|+|+||+
T Consensus 75 ~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~lt~~e~~~l~~~~d~~dG~I~y~eF~ 134 (140)
T d1ggwa_ 75 PEEFVKGFQVFDKDATGMIGVGELRYVLTSLGEKLSNEEMDELLKGVPVKDGMVNYHDFV 134 (140)
T ss_dssp HHHHHHHHHTTCSSCSSCCCHHHHHHHHHHHHSCSCHHHHHHHHHHTTCSSCCSTTTHHH
T ss_pred HHHHHHHHHHHhccCCCcchHHHHHHHHHHcCCCCCHHHHHHHHHhhCCCCCEEeHHHHH
Confidence 45689999999999999999999999999999999999999999999876 899999995
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.76 E-value=1.5e-09 Score=81.40 Aligned_cols=62 Identities=19% Similarity=0.235 Sum_probs=55.2
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
......++++|+.+|.|++|+|+.+|++.+|..+ |..+++++++.++..+|.| |.|+|+||+
T Consensus 37 ~~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~EF~ 103 (108)
T d1rroa_ 37 KMSASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGADEFQ 103 (108)
T ss_dssp GSCHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHHHHH
T ss_pred cCCHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 3345678999999999999999999999999987 5678999999999999987 799999994
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=98.76 E-value=4e-09 Score=79.17 Aligned_cols=61 Identities=20% Similarity=0.203 Sum_probs=54.5
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC---CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG---GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l---g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++.+|+.+|+|++|+|+.+|++.+|..+ +..++++++..+++.+|.| |.|+|+||+
T Consensus 38 ~~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~EF~ 103 (109)
T d1rwya_ 38 KSADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVEEFS 103 (109)
T ss_dssp SCHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred CCHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 345678899999999999999999999999987 4578999999999999987 799999994
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=5e-09 Score=76.45 Aligned_cols=62 Identities=26% Similarity=0.194 Sum_probs=56.5
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...+.++|+.+|+|++|.|+.+|++.+|.+.| ++.+++..++..+|.| |.|+|+||+
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~ 67 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTG--LPSTLLAHIWSLCDTKDCGKLSKDQFA 67 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTT--CCHHHHHHHHHHHCTTCSSSEETTTHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcC--CCHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 4567788899999999999999999999999999987 5889999999999987 799999994
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=2.8e-08 Score=80.42 Aligned_cols=58 Identities=19% Similarity=0.200 Sum_probs=55.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++.+|+.+|+|++|.|+.+|++.+|..+|..+++++++.++..+|.+|.|+|++|+
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~~l~~~G~~l~~~~~~~l~~~~d~~g~i~~~eFi 127 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQAIGLMGYRLSPQTLTTIVKRYSKNGRIFFDDYV 127 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHHHHHHTTCCCCHHHHHHHHHHHCBTTBCBHHHHH
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHHHHHHhhhcCCHHHHHHHHHHcCCCCcCcHHHHH
Confidence 4578899999999999999999999999999999999999999999999999999993
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.72 E-value=1.6e-09 Score=75.72 Aligned_cols=59 Identities=24% Similarity=0.278 Sum_probs=50.4
Q ss_pred HhhHHHHHhhhCCC--CCCcccHHHHHHHHHhCCCCCC--HHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTN--KRGKINLEELRLGLLKGGQNIP--EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~--~~g~i~~~el~~~l~~lg~~~~--~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++++++|+.||.+ ++|+|+.+||+.+|+.+|..++ +.++..++..+|.| |.|+|+||+
T Consensus 4 ~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~EF~ 68 (76)
T d1qx2a_ 4 PEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFEEFL 68 (76)
T ss_dssp HHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHHHHH
Confidence 35688999998653 5799999999999999998775 45799999999988 689999994
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=5.7e-08 Score=85.07 Aligned_cols=140 Identities=17% Similarity=0.166 Sum_probs=94.5
Q ss_pred ceeeccccccccceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEEEE
Q 014722 57 DYDLGRELGRGEFGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHIVM 136 (419)
Q Consensus 57 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 136 (419)
.|+..+..+.++.+.||++. .++..+++|+........ ...+.+|...++.+..+--+++++.+..+++..++||
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 46766665556667999876 567778889876543222 2346778888888855655788888888899999999
Q ss_pred EecCCcchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 014722 137 ELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQVCHEQ---------------------------------------- 176 (419)
Q Consensus 137 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------------------------------------- 176 (419)
++++|.++.+..... .....++.++...+..||+.
T Consensus 90 ~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999998875543211 11222334444444444421
Q ss_pred -------------------CCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 177 -------------------GVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 177 -------------------~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.++|+|+.|.|||++.+ ..+-|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~---~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC---ceEEEeechhccc
Confidence 25899999999999643 2245999997764
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.68 E-value=1.2e-08 Score=80.97 Aligned_cols=61 Identities=21% Similarity=0.347 Sum_probs=56.6
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++.+|+.+|.|++|.|+..|++.++..+|..++++++..+++.+|.| |.|+|+||+
T Consensus 79 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l~~~~~~~~~~~~~~i~~~~D~d~dG~i~~~eF~ 141 (146)
T d1exra_ 79 DSEEELIEAFKVFDRDGNGLISAAELRHVMTNLGEKLTDDEVDEMIREADIDGDGHINYEEFV 141 (146)
T ss_dssp HHHHHHHHHHHHHSTTCSSCBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCSSSSSSBCHHHHH
T ss_pred ChHHHHHHHHHHhCCCCCCcCCHHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 3456789999999999999999999999999999999999999999999887 799999994
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.64 E-value=1e-08 Score=82.16 Aligned_cols=60 Identities=23% Similarity=0.300 Sum_probs=54.8
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC----CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII----CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----g~i~~~~f~ 419 (419)
....+.++|+.+|.+++|.|+.+||+.+|..+|..+|++|++.+++.+|.+ |.|+|++|+
T Consensus 80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l~~~g~~ls~~e~~~l~~~~d~~~d~~G~I~y~eF~ 143 (152)
T d1wdcc_ 80 TFADYMEAFKTFDREGQGFISGAELRHVLTALGERLSDEDVDEIIKLTDLQEDLEGNVKYEDFV 143 (152)
T ss_dssp CHHHHHHHHHTTCSSSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHHHHTCCCCTTSEEEHHHHH
T ss_pred HHHhhhhhhhccccccCccchHHHHHHHHHHcCCCCCHHHHHHHHHHhccCCCCCCEEEHHHHH
Confidence 345789999999999999999999999999999999999999999998753 689999994
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.64 E-value=7.8e-09 Score=74.93 Aligned_cols=62 Identities=16% Similarity=0.156 Sum_probs=56.7
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|++.+|.+.| ++.+++..|++.+|.| |.|+|+||+
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~~~l~~~~--l~~~~l~~i~~~~D~d~dG~l~~~EF~ 66 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSK--LPILELSHIWELSDFDKDGALTLDEFC 66 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHS--SCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHHcc--CCHHHHHHHHHHhCCCCCCeecHHHHH
Confidence 4677888999999999999999999999999999976 6889999999999998 799999994
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.60 E-value=1e-08 Score=81.47 Aligned_cols=59 Identities=22% Similarity=0.411 Sum_probs=55.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+.++|..+|.+++|.|+.+||+.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 80 ~~~l~~~F~~~D~~~~G~I~~~el~~~l~~~g~~l~~~ei~~l~~~~D~d~dG~I~y~eF~ 140 (146)
T d1m45a_ 80 TEDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYKKFI 140 (146)
T ss_dssp THHHHHHHHTTCSSSSSEEEHHHHHHHHHHSTTCCCHHHHHHHHTTCCCCTTSEEEHHHHH
T ss_pred HHHHHHHHHhhccccccccchhhhhhhhcccCCcchHHHHHHHHHHhCCCCCCcEEHHHHH
Confidence 35689999999999999999999999999999999999999999999887 799999994
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.59 E-value=1.7e-08 Score=80.08 Aligned_cols=59 Identities=20% Similarity=0.303 Sum_probs=55.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++|+.+|.+++|.|+.++++.+|+.+|.+++++|+..++..+|.| |.|+|.+|+
T Consensus 76 ~~~l~~aF~~fD~~~~g~I~~~el~~~l~~~g~~ls~~e~~~~~~~~d~d~dg~I~y~eF~ 136 (145)
T d2mysb_ 76 EDVIMGAFKVLDPDGKGSIKKSFLEELLTTGGGRFTPEEIKNMWAAFPPDVAGNVDYKNIC 136 (145)
T ss_pred HHHHHHHHHhhhhcccchhhHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 45688999999999999999999999999999999999999999999887 799999995
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.55 E-value=1.7e-08 Score=80.13 Aligned_cols=58 Identities=26% Similarity=0.325 Sum_probs=54.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+..+|+.+|++++|.|+.+|++.+|..+|..++++++..++..+| | |.|+|+||+
T Consensus 82 ~~~~~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~~~~~~~~~~d-d~dG~I~~~eF~ 141 (146)
T d1lkja_ 82 EQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQQFA 141 (146)
T ss_dssp HHHHHHHHHHHCSSSSCEEEHHHHHHHHHHHTCSCCHHHHHHHHHHHC-CSSSEEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCCcccHHHHHHHHHhcc-CCCCeEeHHHHH
Confidence 457889999999999999999999999999999999999999999998 5 799999995
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.53 E-value=1.7e-08 Score=81.14 Aligned_cols=60 Identities=32% Similarity=0.421 Sum_probs=53.9
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.+..+|+.+|.+++|+|+.+|++.++..+|..++++++..+++.+|.| |.|+|+||+
T Consensus 89 ~~~~l~~~F~~~D~d~~G~I~~~e~~~~~~~~~~~ls~~e~~~i~~~~D~d~dG~I~~~eF~ 150 (156)
T d1dtla_ 89 SEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYDEFL 150 (156)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHGGGGTTC--CCCHHHHHHHHHHHCTTSSSEEEHHHHH
T ss_pred HHHHHHHHHHHhCcCCCCcCcHHHHHHHHhhcCCCCCHHHHHHHHHHhCCCCCCeEeHHHHH
Confidence 346788999999999999999999999999999999999999999999887 799999994
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=98.52 E-value=3e-08 Score=55.35 Aligned_cols=31 Identities=32% Similarity=0.509 Sum_probs=29.3
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGG 392 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg 392 (419)
++++++|+.||+|++|+|+..||+.+|+.+|
T Consensus 3 eel~eAF~~FDkDg~G~Is~~EL~~vm~~lG 33 (33)
T d2hf5a1 3 EEIREAFRVFDKDGNGYISAAELRHVMTNLG 33 (33)
T ss_dssp HHHHHHHHHHSSSCCSCBCHHHHHHHTTSCC
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHcC
Confidence 5789999999999999999999999999887
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.52 E-value=4e-08 Score=77.85 Aligned_cols=60 Identities=20% Similarity=0.278 Sum_probs=53.2
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcC-CCCCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS-IICLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d-~~g~i~~~~f~ 419 (419)
....+.++|+.+|.+++|.|+.+|++.+|..+|..++++|++.+++..+ .+|.|+|+||+
T Consensus 79 ~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~~~d~dG~I~y~eF~ 139 (145)
T d2mysc_ 79 TFEDFVEGLRVFDKEGNGTVMGAELRHVLATLGEKMTEEEVEELMKGQEDSNGCINYEAFV 139 (145)
T ss_pred hHHHHHHHHHHhhcCCCCEEcHHHHHHHHHHhCCCCCHHHHHHHHhhcCCCCCeEEHHHHH
Confidence 4456899999999999999999999999999999999999999998632 23799999994
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.51 E-value=3.9e-08 Score=77.67 Aligned_cols=61 Identities=18% Similarity=0.351 Sum_probs=55.9
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
++++.++++++|..+|.|++|.|+.+|+..+|+.+|..+++.++..++. +.+|.|+|.+|+
T Consensus 2 ~~~qi~e~~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~el~~~~~--~~~~~i~~~eF~ 62 (142)
T d1wdcb_ 2 PQKQIQEMKEAFSMIDVDRDGFVSKEDIKAISEQLGRAPDDKELTAMLK--EAPGPLNFTMFL 62 (142)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSSCCHHHHHHHHHHHSSCCCHHHHHHHHT--TSSSCCCHHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCChHHHHHHHHHhhcCCCHHHHHHHHH--hccCcccccccc
Confidence 5678899999999999999999999999999999999999999999986 445899999984
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=98.51 E-value=4.3e-08 Score=71.00 Aligned_cols=59 Identities=12% Similarity=0.050 Sum_probs=51.2
Q ss_pred HhhHHHHHhhh-CCCCC-CcccHHHHHHHHHhCC-----CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMM-DTNKR-GKINLEELRLGLLKGG-----QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~lg-----~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+.++|..+ |++++ |+|+.+||+.+|..++ ...+++++..+|..+|.| |.|+|+||+
T Consensus 8 i~~l~~~F~~y~d~dg~~G~is~~El~~~L~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~Idf~EF~ 75 (93)
T d1zfsa1 8 METLINVFHAHSGKEGDKYKLSKKELKDLLQTELSSFLDVQKDADAVDKIMKELDENGDGEVDFQEFV 75 (93)
T ss_dssp HHHHHHHHHHHGGGSSCCSSEEHHHHHHHHHHHSTTTSCCSSCHHHHHHHHHHHTTTCCSEECSHHHH
T ss_pred HHHHHHHHHHHcccCCCCCEecHHHHHHHHHHhcccccccCCCHHHHHHHHHHHcCCCCCCCcHHHHH
Confidence 46788999988 78874 9999999999998865 356899999999999998 799999994
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.51 E-value=1.4e-07 Score=76.08 Aligned_cols=61 Identities=25% Similarity=0.327 Sum_probs=56.1
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++++|+.+|.|++|.|+..|++.+|...|...+++++..+++.+|.| |.|+|+||+
T Consensus 93 ~~~~~~~~aF~~~D~d~~G~Is~~e~~~~l~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~ 155 (162)
T d1topa_ 93 KSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVTEEDIEDLMKDSDKNNDGRIDFDEFL 155 (162)
T ss_dssp HHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHTTTCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred CcHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhhCCCCCHHHHHHHHHHhCCCCCCcEEHHHHH
Confidence 3445778899999999999999999999999999999999999999999887 899999994
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.5e-07 Score=73.87 Aligned_cols=61 Identities=20% Similarity=0.302 Sum_probs=56.8
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....++.+|..+|.+++|.|+..+++.++..+|..++++++..+++.+|.| |.|+|+||+
T Consensus 76 ~~~~~l~~~f~~~d~~~~G~i~~~el~~~l~~~g~~l~~~e~~~l~~~~D~d~dG~i~~~EF~ 138 (141)
T d2obha1 76 DTKEEILKAFKLFDDDETGKISFKNLKRVAKELGENLTDEELQEMIDEADRDGDGEVSEQEFL 138 (141)
T ss_dssp HHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred ccHHHHHHHHHHhcccCCCCccHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCCEeHHHHH
Confidence 3456789999999999999999999999999999999999999999999987 799999994
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=3.4e-08 Score=71.79 Aligned_cols=61 Identities=18% Similarity=0.183 Sum_probs=55.1
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...+.++|..+| +++|.|+.+|++.+|.+.| ++.+++..|+..+|.| |.|+|+||+
T Consensus 4 ls~ee~~~y~~~F~~~D-~~~G~i~~~el~~~l~~~g--l~~~~L~~Iw~~~D~~~dG~l~~~EF~ 66 (95)
T d2jxca1 4 VKPEDKAKYDAIFDSLS-PVNGFLSGDKVKPVLLNSK--LPVDILGRVWELSDIDHDGMLDRDEFA 66 (95)
T ss_dssp SCHHHHHHHHHHHHHTC-CBTTEEEHHHHHHHHTTSS--CCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHhC-CCCCceeHHHHHHHHHHcC--CCHHHHHHHHHHhcCCCCCeEcHHHHH
Confidence 45677888999999999 8999999999999999887 5788999999999987 789999994
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=98.47 E-value=4.6e-08 Score=71.39 Aligned_cols=60 Identities=10% Similarity=0.093 Sum_probs=50.7
Q ss_pred HHhhHHHHHhhh-CCCCC-CcccHHHHHHHHHhCCC--CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMM-DTNKR-GKINLEELRLGLLKGGQ--NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~lg~--~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+.++|+.| |.+++ |.|+..||+.+|+.++. ..++++++.+|..+|.| |.|+|.||+
T Consensus 12 ~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~EF~ 77 (98)
T d1yuta1 12 SIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFNEYW 77 (98)
T ss_dssp HHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 356888999987 77775 99999999999998643 45677899999999987 799999994
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=98.45 E-value=9.8e-09 Score=71.72 Aligned_cols=60 Identities=18% Similarity=0.110 Sum_probs=51.1
Q ss_pred HHhhHHHHHhhhCC--CCCCcccHHHHHHHHHhC--CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDT--NKRGKINLEELRLGLLKG--GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~--~~~g~i~~~el~~~l~~l--g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.+..+|..||. ++.|+|+.+||+.+|+.+ +...++++++.+|..+|.| |.|+|+||+
T Consensus 5 ~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~EF~ 70 (78)
T d1cb1a_ 5 SPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFEEFQ 70 (78)
T ss_dssp CHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHHHHH
T ss_pred hHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHHHHH
Confidence 45678999999975 346899999999999987 5566777899999999998 789999994
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=98.43 E-value=7.2e-08 Score=76.39 Aligned_cols=65 Identities=31% Similarity=0.378 Sum_probs=60.0
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.++...++++|..+|+|++|.|+.+|+..++...|..+++.++..++..+|.+ |.|+|++|+
T Consensus 2 ~lt~~e~~~l~~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 68 (146)
T d1exra_ 2 QLTEEQIAEFKEAFALFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFL 68 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCeECHHHHHHHHHhcCCCCCHHHHHHHHHhcCCCCCCcccHHHHH
Confidence 35677888999999999999999999999999999999999999999999999876 789999983
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.41 E-value=3.6e-07 Score=84.79 Aligned_cols=82 Identities=16% Similarity=0.168 Sum_probs=51.2
Q ss_pred ccccccccceEEEEEEEcCCCcEEEEEEecccc-c-C--ChhhHHHHHHHHHHHHhCCCC--CCeeeeeeEEEeCCeEEE
Q 014722 61 GRELGRGEFGVTYLCTDVNNGEKFACKSISKKK-L-R--TAVDIEDVRREVQIMKHLPKH--PNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 61 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~-~--~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~l 134 (419)
.+.||.|....||++.+..+++.+++|.-.... . . -+........|...|+.+..+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999987778899999754211 0 0 011234456688888776433 245666544 4556678
Q ss_pred EEEecCCcch
Q 014722 135 VMELCEGGEL 144 (419)
Q Consensus 135 v~e~~~~g~L 144 (419)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=98.40 E-value=2.1e-07 Score=76.90 Aligned_cols=59 Identities=17% Similarity=0.133 Sum_probs=54.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|+|++|.|+.+|++.+|..+|..++++++..++..+|.| |.|+|+||+
T Consensus 104 ~~~~~~~F~~~D~d~~G~Is~~El~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~ 164 (187)
T d1uhka1 104 RIWGDALFDIVDKDQNGAITLDEWKAYTKAAGIIQSSEDCEETFRVCDIDESGQLDVDEMT 164 (187)
T ss_dssp HHHHHHHHHHHCTTCSSEECHHHHHHHHHHHTSCCSHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHHHHHHHHHccCCCcccchHHHHHHHHHhCCCccHHHHHHHHHHhCCCCCCCEeHHHHH
Confidence 34578999999999999999999999999999999999999999999987 799999983
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=5.6e-08 Score=76.35 Aligned_cols=60 Identities=20% Similarity=0.269 Sum_probs=51.6
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+.++|+.+|.+++|+|+.+|++.+|..+|..+++++++.|+.. +.| |.|+|.||+
T Consensus 74 ~~~~~l~~aF~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~l~~~-~~d~dg~I~~~eF~ 135 (139)
T d1w7jb1 74 GTYEDYLEGFRVFDKEGNGKVMGAELRHVLTTLGEKMTEEEVETVLAG-HEDSNGCINYEAFL 135 (139)
T ss_dssp ----CCHHHHHTTCTTSSSEEEHHHHHHHHHHSSSCCCHHHHHHHHTT-CCCTTSEEEHHHHH
T ss_pred cHHHHHHHhhhhccCCCCCeEeHHHHHHHHHHhCCCCCHHHHHHHHhh-CCCCCCeEeHHHHH
Confidence 345678999999999999999999999999999999999999998875 555 799999994
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.39 E-value=9.3e-08 Score=75.67 Aligned_cols=59 Identities=20% Similarity=0.200 Sum_probs=53.6
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC----CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII----CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~----g~i~~~~f~ 419 (419)
.++++++|..+|.|++|.|+.+|+..+|+.+|..++..++..++...+.+ |.|+|.+|+
T Consensus 3 ~eelke~F~~~D~d~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~~~d~~~~g~i~~~eF~ 65 (145)
T d2mysc_ 3 ADDFKEAFLLFDRTGDAKITASQVGDIARALGQNPTNAEINKILGNPSKEEMNAAAITFEEFL 65 (145)
T ss_pred HHHHHHHHHHHcCCCCCeECHHHHHHHHHHhhhcchhhhhHHHHHHHhhcccccCccchhHHH
Confidence 46789999999999999999999999999999999999999999987654 689999984
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=98.38 E-value=4.4e-08 Score=70.57 Aligned_cols=59 Identities=12% Similarity=0.181 Sum_probs=51.0
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-----CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|..+|.+ +|+|+.+||+.+|..+ +...++..++.+|..+|.| |.|+|+||+
T Consensus 7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~ 72 (92)
T d1a4pa_ 7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQSFF 72 (92)
T ss_dssp HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHHHHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHHHHH
Confidence 356789999999987 8999999999999873 4456778899999999998 799999993
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=98.37 E-value=1.9e-07 Score=67.33 Aligned_cols=60 Identities=22% Similarity=0.255 Sum_probs=51.0
Q ss_pred HHhhHHHHHhhh-CCCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMM-DTNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.+.++|..+ |.+++| .|+.+||+++|.. ++...+++++..+|+.+|.| |.|+|.||+
T Consensus 7 ~i~~l~~~F~~ya~~dg~~~~L~~~Elk~~l~~~~~~~~~~~~~~~~~~~i~~~~D~n~DG~I~F~EF~ 75 (93)
T d3c1va1 7 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQEYC 75 (93)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCHHHHTTCCSHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHHccCCCCCCeeCHHHHHHHHHHhchhccccCCCHHHHHHHHHHHcCCCCCCCCHHHHH
Confidence 356788999998 666554 7999999999987 46678999999999999987 799999994
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=98.36 E-value=1.8e-07 Score=67.17 Aligned_cols=60 Identities=20% Similarity=0.236 Sum_probs=51.4
Q ss_pred HHhhHHHHHhhh-CCCCCC-cccHHHHHHHHHhC-----CCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMM-DTNKRG-KINLEELRLGLLKG-----GQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~l-----g~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+..+|+.+ |++++| .|+.+||+.+|++. +...++.++..+|+.+|.| |.|+|+||+
T Consensus 7 ~i~~i~~vF~kya~~dGd~~~ls~~Elk~ll~~~~~~~~~~~~~~~~~~~~~~~lD~n~Dg~IdF~EF~ 75 (93)
T d1ksoa_ 7 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFVEYV 75 (93)
T ss_dssp HHHHHHHHHHHHHTSSSCTTCEEHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHTTTCEECHHHHH
T ss_pred HHHHHHHHHHHHcCcCCCCCeECHHHHHHHHHHhhhcccccCCCHHHHHHHHHHHcCCCCCCCcHHHHH
Confidence 346788999987 999999 59999999999874 4456789999999999987 799999994
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=98.35 E-value=2.2e-07 Score=76.92 Aligned_cols=58 Identities=16% Similarity=0.126 Sum_probs=50.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+..+|..+|.|++|.|+.+|++.++..+|..++++++..+|..+|.| |.|+|+||+
T Consensus 107 ~~~~~~F~~~D~d~~G~is~~E~~~~l~~~g~~~~~~~~~~lf~~~D~d~dG~Is~~EF~ 166 (189)
T d1qv0a_ 107 EWGDAVFDIFDKDGSGTITLDEWKAYGKISGISPSQEDCEATFRHCDLDNAGDLDVDEMT 166 (189)
T ss_dssp HHHHHHHHHTC----CEECHHHHHHHHHHHSSCCCHHHHHHHHHHSCCCTTSCEEHHHHH
T ss_pred HHHHHHHHHHccCCCCcccchhhHHHHHhcCCCCCHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 4567899999999999999999999999999999999999999999987 799999994
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=98.34 E-value=9.5e-08 Score=78.80 Aligned_cols=65 Identities=40% Similarity=0.600 Sum_probs=60.2
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
..++.++...|+++|+.+|.|++|.|+.+|++.+|..+|..+++.++..++...|.+ |.|+|++|
T Consensus 2 ~~Lt~~ei~~l~~~F~~~D~d~dG~Is~~e~~~~l~~l~~~~~~~~~~~~~~~~d~~~~g~i~~~ef 68 (182)
T d1s6ia_ 2 ERLSEEEIGGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYGEF 68 (182)
T ss_dssp CSSSCTTTCSHHHHHHTTSSSSSSCEEHHHHHHHHTTTTCCCCHHHHHHHHHHTCTTCSSEECHHHH
T ss_pred CCCCHHHHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCccccccchhhhhhhhccccccchHHHH
Confidence 456777888999999999999999999999999999999999999999999999987 68999987
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=98.34 E-value=5.2e-08 Score=77.86 Aligned_cols=62 Identities=21% Similarity=0.206 Sum_probs=53.6
Q ss_pred hhHHHhhHHHHHhhhC--CCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMD--TNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D--~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++..+++++|..|| .|++|.|+.+|++.+|+++|..+|++|+..++. .+.+ |.|+|++|+
T Consensus 2 s~eqi~~l~~~F~~fD~~~~~dG~I~~~el~~~l~~lG~~~t~~e~~~~~~-~~~~~~~~i~~~eFl 67 (152)
T d1wdcc_ 2 SQDEIDDLKDVFELFDFWDGRDGAVDAFKLGDVCRCLGINPRNEDVFAVGG-THKMGEKSLPFEEFL 67 (152)
T ss_dssp CHHHHHHHHHHHHHHHHHTCSSSCEEGGGHHHHHHHTTCCCCHHHHHHTTC-CSSTTSCEECHHHHH
T ss_pred CHHHHHHHHHHHHHHCcCCCCCCeECHHHHHHHHHHhccCccHhhhhhhhh-hhccccccccccccc
Confidence 5678889999999999 489999999999999999999999999988754 3444 689999984
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=98.30 E-value=1.2e-07 Score=67.55 Aligned_cols=60 Identities=17% Similarity=0.189 Sum_probs=52.8
Q ss_pred HHhhHHHHHhhh-CCCCCC-cccHHHHHHHHHh---CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMM-DTNKRG-KINLEELRLGLLK---GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~---lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+.++|..+ |++++| .|+..|++.+++. +|...++++++.+|+.+|.| |.|+|.||+
T Consensus 7 ai~~ii~vF~kya~~dg~~~~ls~~Elk~Ll~~e~~~~~~~~~~~~~~~~~~lD~d~Dg~IdF~EF~ 73 (89)
T d1k8ua_ 7 AIGLLVAIFHKYSGREGDKHTLSKKELKELIQKELTIGSKLQDAEIARLMEDLDRNKDQEVNFQEYV 73 (89)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHHHHHHHSCCGGGTTSHHHHHHHHHHHHTTTCEEEHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeecHHHHHHHHHHHHHhhccCCHHHHHHHHHHhcCCCCCCCcHHHHH
Confidence 356788999888 999999 5999999999997 67778889999999999987 799999994
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.29 E-value=2.1e-07 Score=73.06 Aligned_cols=62 Identities=16% Similarity=0.340 Sum_probs=57.4
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++..+++++|..+|+|++|.|+..|+..++...|..+++.++..++..+|.+ |.|+|.+|+
T Consensus 2 ~~~~~elk~~F~~~D~~~~G~Is~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 65 (141)
T d2obha1 2 EEQKQEIREAFDLFDADGTGTIDVKELKVAMRALGFEPKKEEIKKMISEIDKEGTGKMNFGDFL 65 (141)
T ss_dssp HHHHHHHHHHHHTTCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHTTTCCSEEEHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeHHHHHHHHHhcCCchhHHHHHHHHHhhccCCCCeechHHHH
Confidence 56778999999999999999999999999999999999999999999999876 689999883
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=4.4e-08 Score=73.22 Aligned_cols=62 Identities=13% Similarity=0.097 Sum_probs=55.1
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...+.++|+.+|+|++|.|+.+|++.+|.+.| ++.+++..|++.+|.| |.|+++||+
T Consensus 16 lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~--L~~~~L~~Iw~l~D~d~dG~l~~~EF~ 79 (110)
T d1iq3a_ 16 ITEEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSK--LSIPELSYIWELSDADCDGALTLPEFC 79 (110)
T ss_dssp CSSSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSS--CSSCCHHHHHHHHCSSSCSEEEHHHHH
T ss_pred cCHHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhc--cchHHHHHHHHHhccCCCCeECHHHHH
Confidence 4567778899999999999999999999999998876 5667899999999887 799999994
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=98.28 E-value=1.1e-07 Score=67.59 Aligned_cols=59 Identities=8% Similarity=0.097 Sum_probs=51.4
Q ss_pred HhhHHHHHhhh-CCCCCCc-ccHHHHHHHHHh-CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMM-DTNKRGK-INLEELRLGLLK-GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~-D~~~~g~-i~~~el~~~l~~-lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|+.+ |++++|. ++.+|++.++.. +|..+++++++++|+++|.| |.|+|+||+
T Consensus 9 i~~ii~~F~kya~~dG~~~~l~~~Elk~ll~~e~~~~~~~~~v~~i~~~~D~n~DG~IdF~EF~ 72 (87)
T d1xk4a1 9 LNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETESPQYIRKKGADVWFKELDINTDGAVNFQEFL 72 (87)
T ss_dssp HHHHHHHHHHHHTSSSCTTCBCHHHHHHHHHHHSCHHHHTTCHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHcccCCCCCccCHHHHHHHHHHhcCCccchHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45678888887 8999986 589999999986 78888888999999999988 799999994
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.28 E-value=2.5e-07 Score=76.17 Aligned_cols=60 Identities=22% Similarity=0.243 Sum_probs=55.7
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.++++++|..+|.|++|.|+.+|+..+|+++|..+++.++..++..+|.+ |.|+|.+|
T Consensus 15 ~~~~~l~~~F~~~D~d~dG~Is~~El~~~l~~l~~~~s~~~~~~l~~~~d~d~~~~i~~~ef 76 (182)
T d1y1xa_ 15 NDNQELMEWFRAVDTDGSGAISVPELNAALSSAGVPFSLATTEKLLHMYDKNHSGEITFDEF 76 (182)
T ss_dssp CTTSCHHHHHHHHCTTCSSSBCHHHHHHHHCBTTBCCCHHHHHHHHHHHCTTCSSSBCHHHH
T ss_pred CcHHHHHHHHHHHcCCCcCCCCHHHHHHHHHHhcccCchhhhhhhhcccccccccccccccc
Confidence 3446899999999999999999999999999999999999999999999887 68999988
|
| >d1y1xa_ a.39.1.8 (A:) Programmed cell death 6 protein-like protein {Leishmania major [TaxId: 5664]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Programmed cell death 6 protein-like protein species: Leishmania major [TaxId: 5664]
Probab=98.26 E-value=5.8e-07 Score=73.90 Aligned_cols=58 Identities=24% Similarity=0.384 Sum_probs=54.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++|..+|.+++|.|+.+|++.+|..+|..+++++++.+++.+|.| |.|+|+||+
T Consensus 84 ~~~~~~F~~~D~~~~g~I~~~el~~~l~~~g~~ls~~e~~~i~~~~d~~~dg~I~~~eF~ 143 (182)
T d1y1xa_ 84 LSMREGFRKRDSSGDGRLDSNEVRAALLSSGYQVSEQTFQALMRKFDRQRRGSLGFDDYV 143 (182)
T ss_dssp HHHHHHHHHHCTTSSSCBCHHHHHHHHHTTSCCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred cccccchhccccccchhhhhHHHHHHHHHhCCchhHHHHHHHHhhcccCCCCCcCHHHHH
Confidence 4577889999999999999999999999999999999999999999987 799999994
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.26 E-value=5e-07 Score=65.94 Aligned_cols=56 Identities=14% Similarity=0.156 Sum_probs=50.9
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++|+.+|.|++|.|+.+|++.++++.| ++.+++..++..+|.| |.|+++||+
T Consensus 11 ~~y~~~F~~~D~d~~G~i~~~e~~~~l~~s~--L~~~~L~~i~~~~D~d~dG~L~~~EF~ 68 (99)
T d1qjta_ 11 PVYEKYYRQVEAGNTGRVLALDAAAFLKKSG--LPDLILGKIWDLADTDGKGVLSKQEFF 68 (99)
T ss_dssp THHHHHHHHHCCTTSSCCCSHHHHHHHHTSS--SCHHHHHHHHHHHCCSSSSSCCSHHHH
T ss_pred HHHHHHHHHHCCCCCCcccHHHHHHHHHHcC--CcHHHHHHHHHHHcCCCCCccCHHHHH
Confidence 3466889999999999999999999999877 6899999999999987 799999994
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.23 E-value=3.5e-07 Score=73.69 Aligned_cols=65 Identities=31% Similarity=0.403 Sum_probs=59.4
Q ss_pred hhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
..++.++..+++++|..+|+|++|.|+.+|++.++...+..+++.++..++..+|.+ |.++|.+|
T Consensus 12 ~~ls~~~i~el~~~F~~~D~d~~G~Is~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~e~ 78 (162)
T d1topa_ 12 AFLSEEMIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFEEF 78 (162)
T ss_dssp HHSCHHHHHHHHHHHHTTTCSCSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTSCCEEEHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHhccCCchhHHHHHhhhheeccCCCCCeeeehh
Confidence 345778888999999999999999999999999999999999999999999999877 67888887
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.23 E-value=2.3e-07 Score=72.81 Aligned_cols=56 Identities=20% Similarity=0.208 Sum_probs=50.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..++++|..+|.|++|.|+.+|++.+|+.+|..++++++..+.. +.+|.|+|++|+
T Consensus 5 ~~fke~F~~~D~d~dG~I~~~el~~~l~~lg~~~t~~ei~~~~~--~~~~~i~~~eF~ 60 (140)
T d1ggwa_ 5 SPYKQAFSLFDRHGTGRIPKTSIGDLLRACGQNPTLAEITEIES--TLPAEVDMEQFL 60 (140)
T ss_dssp TTTHHHHHHTCSSSSSEECHHHHHHHHHHTSCCCCHHHHHHHHT--TSCSSEEHHHHH
T ss_pred HHHHHHHHHHCCCCCCeECHHHHHHHHHHHHhhhHHHhhhhhhc--cccccccchhhh
Confidence 57899999999999999999999999999999999999988754 445899999883
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=98.20 E-value=4.7e-07 Score=70.23 Aligned_cols=56 Identities=18% Similarity=0.186 Sum_probs=52.0
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+|+.+|.|++|.|+.+|++.++..+|...+++++..++..+|.+ |.|+|+||+
T Consensus 2 ae~~F~~~D~d~dG~is~~E~~~~l~~~~~~~~~~~~~~~~~~~D~~~~g~i~~~Ef~ 59 (134)
T d1jfja_ 2 AEALFKEIDVNGDGAVSYEEVKAFVSKKRAIKNEQLLQLIFKSIDADGNGEIDQNEFA 59 (134)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHTTCCSSHHHHHHHHHHHHCSSCCSEEEHHHHH
T ss_pred HHHHHHHHcCCCcCCCcHHHHHHHHHHcCCCCCHHHHHHHHHHhhhcccccccccccc
Confidence 35789999999999999999999999999999999999999999987 689999983
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=98.14 E-value=1.1e-06 Score=72.32 Aligned_cols=59 Identities=15% Similarity=0.281 Sum_probs=50.4
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcC-CCCCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS-IICLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d-~~g~i~~~~f~ 419 (419)
...++.+|+.+|+|++|.|+..|++.+|..+|..++++.++.++.... .+|.|+|++|+
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~l~~~g~~~~~~~~~~l~~~~~~~dg~i~f~eFi 151 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMAIEAAGFKLPCQLHQVIVARFADDELIIDFDNFV 151 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHHHHHTTEECCHHHHHHHHHHTSCSSSBCCHHHHH
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHHHHHhhhcCCHHHHHHHHHHhcCCCCcCCHHHHH
Confidence 356788999999999999999999999999999999877777776643 23799999993
|
| >d2mysb_ a.39.1.5 (B:) Myosin Essential Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.14 E-value=1.6e-06 Score=68.30 Aligned_cols=61 Identities=21% Similarity=0.362 Sum_probs=49.4
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHH-HHHHHHHHcCCCCCcCccccC
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEA-DLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~-e~~~~~~~~d~~g~i~~~~f~ 419 (419)
++++..+++++|..+|.+++|.|+.+|++.+|+.+|...+.. .+..++. +.+|.|+|.+|+
T Consensus 2 ~~~qi~el~e~F~~~D~~~~G~I~~~e~~~~l~~lg~~~~~~~~~~~~~~--~~~g~i~~~eF~ 63 (145)
T d2mysb_ 2 DETEIEDFKEAFTVIDQNADGIIDKDDLRETFAAMGRLNVKNEELDAMIK--EASGPINFTVFL 63 (145)
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhCCCcchHHHHHHHHH--hccCceeechhh
Confidence 567788999999999999999999999999999999765544 4444443 345899999984
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.13 E-value=1.7e-06 Score=68.93 Aligned_cols=65 Identities=25% Similarity=0.261 Sum_probs=58.6
Q ss_pred hhhhhHHHhhHHHHHhhhCCCC-CCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 354 EFLSVEEVAGLKEAFEMMDTNK-RGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 354 ~~~~~~~~~~l~~~F~~~D~~~-~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
+.++.++..+++++|..+|.++ +|.|+..|++.+|+.+|..+++.++..++..++.+ |.+++++|
T Consensus 6 ~~Lt~~~~~~l~~~F~~~D~d~~dG~I~~~e~~~~l~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 73 (156)
T d1dtla_ 6 EQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFDEF 73 (156)
T ss_dssp GGSCHHHHHHHHHHHHHHTTTCGGGSBCHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTSSSSBCHHHH
T ss_pred HHCCHHHHHHHHHHHHHHcCCCCCCeECHHHHHHHHHHcCCCCCHHHHHHHHHHhhccCCCccchhhh
Confidence 4667888899999999999995 89999999999999999999999999999999887 57887766
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=4.3e-07 Score=66.46 Aligned_cols=57 Identities=19% Similarity=0.133 Sum_probs=46.4
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCC----------------CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNI----------------PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~----------------~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.+|..+|.|++|.|+.+|+..++++++..+ .+..+..++..+|.| |.|+|+||+
T Consensus 17 ~~r~~F~~~D~DgdG~i~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~DG~Is~~EF~ 91 (99)
T d1snla_ 17 NPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFL 91 (99)
T ss_dssp CHHHHHHHHCSSCCSEEEHHHHHHHHHHHHHTTSCCSSCSSHHHHTTHHHHHHHHHHHHHTCSSCSSEEEHHHHH
T ss_pred CHHHHHHHHCCCCCCcCCHHHHHHHHHHHHHhcchhhhhhhhhhhhHHHHHHHHHHHHHHcCCCCCCcCcHHHHH
Confidence 368899999999999999999999998653211 123567899999988 799999994
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.11 E-value=9e-07 Score=69.82 Aligned_cols=64 Identities=27% Similarity=0.379 Sum_probs=57.9
Q ss_pred hhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 355 FLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.++.++..+++++|+.+|.|++|.|+.+|++.++...|..+++.++..++...+.+ +.++|++|
T Consensus 3 ~ls~~~i~~l~~~F~~~D~d~~G~i~~~e~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 68 (146)
T d1lkja_ 3 NLTEEQIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFSEF 68 (146)
T ss_dssp CCCHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCSSSCCEEEHHHH
T ss_pred CCCHHHHHHHHHHHHHHCCCCCCcEeHHHHHHHHHhcCCCCCHHHHHHHHHHhccCCcccccHHHH
Confidence 46788899999999999999999999999999999999999999999999988876 46777766
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=98.11 E-value=2.1e-06 Score=60.45 Aligned_cols=60 Identities=12% Similarity=0.070 Sum_probs=49.0
Q ss_pred HHhhHHHHHhhh-CCCCCC-cccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMM-DTNKRG-KINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~-D~~~~g-~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....+.++|..+ +.++++ +|+.+||+.+|++ ++...+++.++++|+.+|.| |.|+|.||+
T Consensus 6 ai~~li~vF~kya~~~g~~~~Lsk~Elk~ll~~e~~~~~~~~~~~~~v~~~~~~lD~n~Dg~idF~EF~ 74 (87)
T d1e8aa_ 6 HLEGIVNIFHQYSVRKGHFDTLSKGELKQLLTKELANTIKNIKDKAVIDEIFQGLDANQDEQVDFQEFI 74 (87)
T ss_dssp HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHSTTTSTTTTSHHHHHHHHHHHCTTCSSCEEHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCeEcHHHHHHHHHHHccccccCCCCHHHHHHHHHHHcCCCCCcCCHHHHH
Confidence 346788999988 555554 6999999999987 34456788999999999998 799999994
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=98.10 E-value=2.8e-07 Score=67.45 Aligned_cols=61 Identities=11% Similarity=0.061 Sum_probs=49.7
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-------CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-------NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-------~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
......+.+.|..++ +++|.|+..||+.+|+..+. ..++++++.+|..+|.| |.|+|+||+
T Consensus 6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ll~~~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~EF~ 75 (100)
T d1psra_ 6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFSEFL 75 (100)
T ss_dssp HHHHHHHHHHHHHTC-CTTSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHHHHH
T ss_pred HHHHHHHHHHHHHHc-CCCCcccHHHHHHHHHHHccccccccccCCHHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 344567778888887 78899999999999998653 23556789999999987 799999994
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.09 E-value=6e-06 Score=67.52 Aligned_cols=58 Identities=17% Similarity=0.229 Sum_probs=53.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..++.+|+.+|.+++|.|+.+|++.++...|..++++++..++..+|.+ |.|+|++|+
T Consensus 86 ~~~~~~f~~~D~~~~G~i~~~el~~~l~~~~~~l~~e~~~~~~~~~d~~~dg~Is~~eF~ 145 (181)
T d1hqva_ 86 TDWQNVFRTYDRDNSGMIDKNELKQALSGFGYRLSDQFHDILIRKFDRQGRGQIAFDDFI 145 (181)
T ss_dssp HHHHHHHHHHCTTCCSSBCHHHHHHHHHHHTBCCCHHHHHHHHHHHCSSCSSCBCHHHHH
T ss_pred cccccccccccccccchhhhHHHHHHHHHcCCcchhHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 4567899999999999999999999999999999999999999999876 799999984
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=98.09 E-value=1.7e-06 Score=70.21 Aligned_cols=57 Identities=25% Similarity=0.180 Sum_probs=51.8
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|.|++|.|+.+|++.++..+| +++++++.++..+|.| |.|+|+||+
T Consensus 101 ~~~~~~~F~~~D~d~dG~Is~~E~~~~~~~~~--~~~~~~~~~f~~~D~d~dG~i~~~Ef~ 159 (176)
T d1nyaa_ 101 GPVVKGIVGMCDKNADGQINADEFAAWLTALG--MSKAEAAEAFNQVDTNGNGELSLDELL 159 (176)
T ss_dssp HHHHHHHHHHTCSSCCSEEEHHHHHHHHHHTT--CCHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHHccCCChhhhHHHHHHHHHhcC--CcHHHHHHHHHHHCCCCCCcEeHHHHH
Confidence 45678999999999999999999999999987 5889999999999987 799999984
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.08 E-value=2.3e-06 Score=69.50 Aligned_cols=58 Identities=17% Similarity=0.266 Sum_probs=53.8
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSIICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~g~i~~~~f~ 419 (419)
..+..+|+.+|.+++|.|+.+|++.+|..+|..+++++++.+++++|.+|.++|++|+
T Consensus 77 ~~~~~~f~~~D~d~sG~i~~~El~~~l~~~g~~ls~~~~~~l~~~~d~~g~i~~~eF~ 134 (172)
T d1juoa_ 77 NGWRQHFISFDTDRSGTVDPQELQKALTTMGFRLSPQAVNSIAKRYSTNGKITFDDYI 134 (172)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHHHHHHTTCCCCHHHHHHHHHHTCSSSSEEHHHHH
T ss_pred hhhhHHHHHhCcCCCCcCCHHHHHHHHHHHHHhhhHHHHHHHHHHHHhcCCcCHHHHH
Confidence 3466789999999999999999999999999999999999999999999999999983
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=3.4e-07 Score=71.69 Aligned_cols=56 Identities=23% Similarity=0.215 Sum_probs=51.1
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC----CCCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI----ICLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~----~g~i~~~~f 418 (419)
+++++|..+|.+++|.|+.+|++.+|+.+|..+++.++..++...+. +|.|+|.+|
T Consensus 1 e~ke~F~~~D~d~~G~I~~~el~~~l~~lg~~~t~~e~~~~~~~~~~~~~~~~~i~~~ef 60 (139)
T d1w7jb1 1 EFKEAFELFDRVGDGKILYSQCGDVMRALGQNPTNAEVLKVLGNPKSDELKSRRVDFETF 60 (139)
T ss_dssp CHHHHHHHHCCSSSSEEESTTHHHHHHHTTCCCCHHHHHHHTTCCCHHHHTTCEEEHHHH
T ss_pred CHHHHHHHHhCCCCCeECHHHHHHHHHHhccCCCHHHHHHHHHHHhcccccCCceeeecc
Confidence 47899999999999999999999999999999999999999987753 468999887
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.06 E-value=9.1e-06 Score=70.13 Aligned_cols=74 Identities=11% Similarity=0.130 Sum_probs=51.2
Q ss_pred cccc-ceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCC-CCeeeeeeEEEeCCeEEEEEEecCCc
Q 014722 65 GRGE-FGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKH-PNIVSLKDTYEDDSAVHIVMELCEGG 142 (419)
Q Consensus 65 g~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~lv~e~~~~g 142 (419)
..|. -+.||+... .++..+++|....... ..+..|...++.|..+ -.+++++.+..+.+..++||++++|.
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3444 367898873 5677788898654432 2456677777766332 23677888888888999999999987
Q ss_pred chH
Q 014722 143 ELF 145 (419)
Q Consensus 143 ~L~ 145 (419)
++.
T Consensus 92 ~~~ 94 (255)
T d1nd4a_ 92 DLL 94 (255)
T ss_dssp ETT
T ss_pred ccc
Confidence 653
|
| >d1hqva_ a.39.1.8 (A:) Apoptosis-linked protein alg-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Apoptosis-linked protein alg-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.05 E-value=1.1e-06 Score=72.00 Aligned_cols=61 Identities=15% Similarity=0.193 Sum_probs=54.3
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+.|.++|..+|+|++|.|+.+|++.+|+.++. ..+.+++..++..+|.+ |.|+|+||+
T Consensus 16 ~~~~~L~~iF~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~~g~i~~~EFl 79 (181)
T d1hqva_ 16 PDQSFLWNVFQRVDKDRSGVISDNELQQALSNGTWTPFNPVTVRSIISMFDRENKAGVNFSEFT 79 (181)
T ss_dssp SCHHHHHHHHHHHCTTCCSSBCHHHHHHHCCCSSSSCCCHHHHHHHHHHHCCSSSSSBCHHHHH
T ss_pred ccHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCcccHHHHHHHhhccccccccchhhhHHH
Confidence 44567999999999999999999999999999875 47899999999999886 799999984
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.02 E-value=5.1e-07 Score=71.31 Aligned_cols=56 Identities=23% Similarity=0.192 Sum_probs=49.0
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC---CCCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI---ICLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~---~g~i~~~~f 418 (419)
.++++|..+|.|++|.|+.+|+..+|+.+|..++.+|+..++..... +|.|+|.+|
T Consensus 3 ~~k~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~ei~~l~~~~~~~~~~~~i~~~ef 61 (146)
T d1m45a_ 3 ANKDIFTLFDKKGQGAIAKDSLGDYLRAIGYNPTNQLVQDIINADSSLRDASSLTLDQI 61 (146)
T ss_dssp CCTTCHHHHCTTCCSEEEGGGHHHHHHHTTCCCCHHHHHHHHHC--CC--CCEEEHHHH
T ss_pred HHHHHHHHHcCCCcCCCCHHHHHHHHHHcCCchhHHHHhhhhccccccccccccccchh
Confidence 46889999999999999999999999999999999999999976543 267999887
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.02 E-value=1.3e-06 Score=71.61 Aligned_cols=69 Identities=19% Similarity=0.089 Sum_probs=55.0
Q ss_pred hhhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC------------CCCCCHHHHHHHHHHcCCC--CCcCcc
Q 014722 351 VVAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG------------GQNIPEADLQILMEAVSII--CLLSYF 416 (419)
Q Consensus 351 ~~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l------------g~~~~~~e~~~~~~~~d~~--g~i~~~ 416 (419)
.+...........++.+|+.+|.|++|.|+.+|+..++... +...+++.++.+++.+|.| |.|+|+
T Consensus 84 ~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~ 163 (181)
T d1bjfa_ 84 ALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEMLEIVQAIYKMVSSVMKMPEDESTPEKRTEKIFRQMDTNRDGKLSLE 163 (181)
T ss_dssp HHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHTTCCCTTTSCGGGSSHHHHHHHHHHHSCTTCSSEECHH
T ss_pred HHHHHhhhchHHHHHHHHHHhccCCCCeecHHHHHHHHHHHhhhccccccCCcccccHHHHHHHHHHHhCCCCCCcEeHH
Confidence 33333334445678899999999999999999999999864 2255667899999999987 789999
Q ss_pred ccC
Q 014722 417 LVC 419 (419)
Q Consensus 417 ~f~ 419 (419)
||+
T Consensus 164 EF~ 166 (181)
T d1bjfa_ 164 EFI 166 (181)
T ss_dssp HHH
T ss_pred HHH
Confidence 994
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.00 E-value=2.9e-06 Score=44.97 Aligned_cols=32 Identities=38% Similarity=0.489 Sum_probs=28.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGG 392 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg 392 (419)
.++|.+.|+.||+|.+|+|+.+|+..+++.-|
T Consensus 3 EeELae~FRifDkNaDGyiD~eEl~~ilr~tG 34 (34)
T d1ctda_ 3 EEELANAFRIFDKNADGYIDIEELGEILRATG 34 (34)
T ss_dssp HHHHHHHHHTTCCSSSSCBCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHccCCcccccHHHHHHHHHhcC
Confidence 45788999999999999999999999998643
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.98 E-value=1.4e-06 Score=71.57 Aligned_cols=56 Identities=16% Similarity=0.097 Sum_probs=50.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+..+|..+|.|++|.|+.+|++.+++.+| ++++++..++..+|.| |.|+|+||+
T Consensus 105 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~--l~~~~~~~~f~~~D~d~dG~i~~~EF~ 162 (185)
T d2sasa_ 105 NRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQ--LQCADVPAVYNVITDGGKVTFDLNRYK 162 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHHHHTTSSC--CCCSSHHHHHHHHHTTTTSCCSHHHHH
T ss_pred HHHHHHHHHHccCCCccCCHHHHHHHHHHcC--CCHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 4578899999999999999999999999887 5778999999999987 799999983
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.96 E-value=3.6e-06 Score=68.82 Aligned_cols=61 Identities=15% Similarity=0.139 Sum_probs=48.7
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-----CCCCCHHHH----HHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-----GQNIPEADL----QILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-----g~~~~~~e~----~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+.++.+|+.+|.|++|.|+.+|+..++..+ +..++++++ ..+++.+|.| |.|+|+||+
T Consensus 92 ~~~~kl~~~F~~~D~d~~G~I~~~el~~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~ 163 (180)
T d1xo5a_ 92 TPDIKSHYAFRIFDFDDDGTLNREDLSRLVNCLTGEGEDTRLSASEMKQLIDNILEESDIDRDGTINLSEFQ 163 (180)
T ss_dssp CHHHHHHHHHHHHCTTCSSSBCHHHHHHHHHHHC------CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred CHHHHHHHhhccccCCCCCeeeHHHHHHHHHHHHhccccccccHHHHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 334678899999999999999999999999876 455666554 4577888877 799999993
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=97.93 E-value=3.4e-06 Score=68.41 Aligned_cols=57 Identities=21% Similarity=0.127 Sum_probs=51.1
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+|.|++|.|+.+|++.+++.+|. +.+++..++..+|.| |.|+|+||+
T Consensus 93 ~~~~~~~F~~~D~d~dG~Is~~E~~~~l~~~~~--~~~~~~~~f~~~D~d~dG~Is~~Ef~ 151 (174)
T d2scpa_ 93 EGPLPLFFRAVDTNEDNNISRDEYGIFFGMLGL--DKTMAPASFDAIDTNNDGLLSLEEFV 151 (174)
T ss_dssp HTHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTC--CGGGHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHHHCCCccccCCHHHHHHHHHHHhh--hhHHHHHHHhhcCCCCCCcEeHHHHH
Confidence 446789999999999999999999999998874 677899999999988 799999984
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.93 E-value=2.5e-05 Score=63.15 Aligned_cols=58 Identities=14% Similarity=0.166 Sum_probs=47.9
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcC-CCCCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVS-IICLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d-~~g~i~~~~f~ 419 (419)
..++.+|+.+|.|++|.|+..|++.+|...|..+++++++.++...+ .+|.|+|+||+
T Consensus 77 ~~~~~~f~~~D~d~~G~I~~~el~~~L~~~g~~~~~~~~~~~~~~d~d~~G~i~~~EF~ 135 (173)
T d1alva_ 77 KKWQAIYKQFDVDRSGTIGSSELPGAFEAAGFHLNEHLYSMIIRRYSDEGGNMDFDNFI 135 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHHHHHHHTCCCCHHHHHHHHHHHTCSSSCBCHHHHH
T ss_pred hHHHHHHHHhccCCCCeecHHHHHHHHHHHHHhhHHHHHHHhhccccCCCCeEeHHHHH
Confidence 34678899999999999999999999999999999888777665443 23789999984
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.92 E-value=5.1e-06 Score=68.47 Aligned_cols=127 Identities=17% Similarity=0.123 Sum_probs=75.0
Q ss_pred HHHHHHHHHhcCCCCCCCCCHHHHhcCCccccCccCCCCCcchHHHHHH-hhhhhhh--hh-hhhhHhhhhhhhhhHHHh
Q 014722 287 ENAKDLVKKMLNPDPKQRLTAEEVLEHPWLQNAKKAPNVSLGETVKARL-KQFSVMN--KL-KKRALQVVAEFLSVEEVA 362 (419)
Q Consensus 287 ~~~~~li~~~L~~dp~~R~s~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~l-~~~~l~~~~~~~~~~~~~ 362 (419)
.+++++.++....+|+-++|..|.-+. |.... ..........+ +.+..-+ .+ -..++..+..........
T Consensus 21 ~ei~~~~~~F~~~~~~G~i~~~Ef~~~--l~~~~----~~~~~~~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~ 94 (189)
T d1jbaa_ 21 AQLQEWYKKFLEECPSGTLFMHEFKRF--FKVPD----NEEATQYVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEH 94 (189)
T ss_dssp HHHHHHHHHHHSSSTTCCEEHHHHHHH--HHCCS----SSTTHHHHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTH
T ss_pred HHHHHHHHHhcccCCCCeeeHHHHHHH--HHHcC----CCccHHHHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHH
Confidence 456777777777788888988886432 22111 11112222222 2221100 01 111222222222223345
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhC----------------CCCCC-HHHHHHHHHHcCCC--CCcCccccC
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKG----------------GQNIP-EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~l----------------g~~~~-~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.++.+|+.+|.|++|.|+..|+..++..+ +...+ ++.++.++..+|.| |.|+|+||+
T Consensus 95 ~~~~~F~~~D~d~~g~i~~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~if~~~D~d~dG~Is~~EF~ 170 (189)
T d1jbaa_ 95 KLKWTFKIYDKDRNGCIDRQELLDIVESIYKLKKACSVEVEAEQQGKLLTPEEVVDRIFLLVDENGDGQLSLNEFV 170 (189)
T ss_dssp HHHHHHHHHCSSCSSCBCHHHHHHHHHHHHHHHHHSSCCTTSSTTTCCCCHHHHHHHHHHHHCCSCCSCBCHHHHH
T ss_pred HHHHHHhhhccCCCCcccHhHHHHHHHHHHHhhccccccchhhhhccccchHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 67889999999999999999999887543 12223 45567899999987 799999993
|
| >d1s6ia_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=97.91 E-value=7.5e-07 Score=73.18 Aligned_cols=57 Identities=18% Similarity=0.278 Sum_probs=51.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.+..+|..+|.+++|.|+..+++.++..+| ++++++..+++.+|.| |.|+|+||+
T Consensus 81 ~e~l~~aF~~~D~d~~G~i~~~el~~~l~~~g--l~~~ev~~~f~~~D~d~DG~Is~~EF~ 139 (182)
T d1s6ia_ 81 EENLVSAFSYFDKDGSGYITLDEIQQACKDFG--LDDIHIDDMIKEIDQDNDGQIDYGEFA 139 (182)
T ss_dssp CCSTHHHHHHTTTTCSSEEEHHHHHHTTTTTT--CCTTHHHHHHHHHCSSSSSEEETTHHH
T ss_pred HHHHHHHHHHHhhcCCCccchhhhhhhhhhcC--ccHHHHHHHHHHhhcCCCCeEeHHHHH
Confidence 35688999999999999999999999999887 6889999999999987 799999994
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=97.90 E-value=1.6e-06 Score=77.76 Aligned_cols=64 Identities=28% Similarity=0.345 Sum_probs=58.4
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.++...++++|..+|.|++|.|+.+|++.+|.++|..++++++..++..+|.| |.|+|.+|+
T Consensus 116 l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~ef~ 181 (321)
T d1ij5a_ 116 LSEEDTNILRQLFLSSAVSGSGKFSFQDLKQVLAKYADTIPEGPLKKLFVMVENDTKGRMSYITLV 181 (321)
T ss_dssp CCHHHHHHHHHHHTSSSSTTSSCCCHHHHHHHHHHHHTTSCSSHHHHHHHHHHHCCSSTHHHHHHT
T ss_pred CCHHHHHHHHHHHHHHcCCCCCeEcHHHHHHHHHHcCCcccHHHHHHHHHHHhhcCCccccchhhh
Confidence 3456677899999999999999999999999999999999999999999999877 789999984
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=97.86 E-value=3e-06 Score=69.76 Aligned_cols=58 Identities=16% Similarity=0.241 Sum_probs=49.3
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|..+|+|++|.|+.+|++.+|+.+|..++++.+ .++...|.| |.|+|++|+
T Consensus 90 ~~~~~~~F~~~D~d~sG~I~~~El~~~l~~~g~~~~~~~~-~~~~~~d~d~dg~I~f~eFi 149 (186)
T d1df0a1 90 IQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKLPCQLH-QVIVARFADDELIIDFDNFV 149 (186)
T ss_dssp HHHHHHHHHHHCTTCCSCEEGGGHHHHHHHTTEECCHHHH-HHHHHHHCCSTTEECHHHHH
T ss_pred HHHHHHHHHhhCCCCCCcccHHHHHHHHHHHHhcccHHHH-HHHHHHHcCCCCeEeHHHHH
Confidence 3567899999999999999999999999999999997655 455556665 799999994
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=6.1e-06 Score=67.86 Aligned_cols=60 Identities=18% Similarity=0.099 Sum_probs=48.5
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCC------------CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGG------------QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg------------~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+.++.+|+.+|.|++|.|+.+|+..++..+. ....++.++.+|+.+|.| |.|+|+||+
T Consensus 94 ~~e~l~~~F~~~D~d~dG~i~~~El~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~ 167 (187)
T d1g8ia_ 94 LDEKLRWAFKLYDLDNDGYITRNEMLDIVDAIYQMVGNTVELPEEENTPEKRVDRIFAMMDKNADGKLTLQEFQ 167 (187)
T ss_dssp HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHHHHHHC-----CCGGGSSHHHHHHHHHHHHCSSCSSEEEHHHHH
T ss_pred hhhhHHHHHHHHhcCCCCeEcHHHHHHHHHHHhhhhcccccCchhhccHHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 345688899999999999999999999986431 123346788999999887 789999994
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=3.2e-06 Score=68.08 Aligned_cols=64 Identities=13% Similarity=0.168 Sum_probs=48.3
Q ss_pred hhhhhhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 352 VAEFLSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 352 ~~~~~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
|+..++.++...++++|..+|+|++|.|+.+|++.++...+.. .++.++..+|.+ |.|+|+||+
T Consensus 6 ~~t~ft~eei~~l~~~F~~~D~d~~G~I~~~E~~~~~~~~~~~----~~~~l~~~~d~~~~g~i~~~EFl 71 (165)
T d1auib_ 6 MCSHFDADEIKRLGKRFKKLDLDNSGSLSVEEFMSLPELQQNP----LVQRVIDIFDTDGNGEVDFKEFI 71 (165)
T ss_dssp CCCSCCHHHHHHHHHHHHHHCTTCCSEECHHHHTTSHHHHTCT----THHHHHHHHCTTCSSSEEHHHHH
T ss_pred HcCCCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHHhhhccCCH----HHHHHHHHHccccchhhhhhhhh
Confidence 4456778888889999999999999999999988766543332 355677777776 678888883
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=9.8e-05 Score=58.92 Aligned_cols=61 Identities=23% Similarity=0.232 Sum_probs=50.7
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC-CCCCC----HHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG-GQNIP----EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l-g~~~~----~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.....+..+|..+|.|++|.|+.+|+..+++.. |..++ +..+..++..+|.| |.|+|+||+
T Consensus 82 ~~~~~~~~~f~~~d~d~~g~Is~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~ 149 (165)
T d1auib_ 82 DKEQKLRFAFRIYDMDKDGYISNGELFQVLKMMVGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFC 149 (165)
T ss_dssp CHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHTTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHH
T ss_pred hhHHHHHHHHHHhcccccccccHHHHHHHHHHhccccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHH
Confidence 345678999999999999999999999999774 66666 44567788888887 799999983
|
| >d1juoa_ a.39.1.8 (A:) Sorcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Sorcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=7.6e-06 Score=66.25 Aligned_cols=60 Identities=13% Similarity=0.183 Sum_probs=51.5
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC-----CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN-----IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~-----~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++.+.++..|..++ +++|.|+..||+.+|.++|.. ++.+++..++..+|.| |.|+|.||+
T Consensus 4 ~~~~~~~~~F~~~~-~~dG~Is~~EL~~~L~~~g~~~~~~~~~~~~v~~l~~~~D~d~~G~I~f~EF~ 70 (172)
T d1juoa_ 4 QTQDPLYGYFAAVA-GQDGQIDADELQRCLTQSGIAGGYKPFNLETCRLMVSMLDRDMSGTMGFNEFK 70 (172)
T ss_dssp CCCCTTHHHHHHHH-TTTTEECHHHHHHHHHHHTTTCSSCCCCHHHHHHHHHHHCTTCSSCEEHHHHH
T ss_pred chHHHHHHHHHHhC-CCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHHCCCCCCceehHHHH
Confidence 34567889999996 789999999999999998765 4678899999999988 689999984
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.61 E-value=3e-05 Score=64.28 Aligned_cols=60 Identities=17% Similarity=0.018 Sum_probs=49.0
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCC--------------HHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP--------------EADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~--------------~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|+..++..++...+ ++.++.+|..+|.| |.|+|+||+
T Consensus 97 ~~~~l~~~F~~~D~d~~G~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~ 172 (201)
T d1omra_ 97 TNQKLEWAFSLYDVDGNGTISKNEVLEIVTAIFKMISPEDTKHLPEDENTPEKRAEKIWGFFGKKDDDKLTEKEFI 172 (201)
T ss_dssp GGGSHHHHHHHHCTTCSSSBCHHHHHHHHHHHHTTSCHHHHTTSCGGGSSHHHHHHHHHHHTTCCTTCCBCHHHHH
T ss_pred hHHHHHHHHHHHccCCCCccCHHHHHHHHHHHHhhcChhhhhhhhhhhccHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 3456889999999999999999999999987644333 33567899999987 799999993
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=97.60 E-value=1.7e-05 Score=60.95 Aligned_cols=55 Identities=20% Similarity=0.209 Sum_probs=47.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.+++|.|+.+|++.++..+|. +++..+|..+|.| |.|+|+||+
T Consensus 74 ~~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~----~~~~~~~~~~D~d~dG~is~~EF~ 130 (134)
T d1jfja_ 74 KIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI----EKVAEQVMKADANGDGYITLEEFL 130 (134)
T ss_dssp HHHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC----HHHHHHHHHHHCSSSSEEEHHHHH
T ss_pred cccccccccccccccCCcccHHHHHHHHHhcCc----HHHHHHHHHHCCCCCCCCCHHHHH
Confidence 345678999999999999999999999987764 5788899999887 799999994
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=97.57 E-value=1.4e-05 Score=71.31 Aligned_cols=58 Identities=19% Similarity=0.200 Sum_probs=52.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC-CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ-NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~-~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
..+..+|..+|.|++|+|+..|++.++..+|. .++++++..+|..+|.| |.|+|+||+
T Consensus 253 ~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~~~~~~~~~~~~l~~~~D~d~dG~Is~~EF~ 313 (321)
T d1ij5a_ 253 LVLRILYAFADFDKSGQLSKEEVQKVLEDAHIPESARKKFEHQFSVVDVDDSKSLSYQEFV 313 (321)
T ss_dssp HHHHHHHHHTCSSSCSSEEHHHHHHHHHHTTCCGGGCSTHHHHHHHHTTTTCSEECHHHHH
T ss_pred hHHHHHHHHHhcCCCCCCcHHHHHHHHHHcCCCcCcHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45677899999999999999999999999997 48889999999999887 799999994
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.55 E-value=1.8e-05 Score=65.10 Aligned_cols=59 Identities=19% Similarity=0.182 Sum_probs=48.5
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC------------CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ------------NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~------------~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
.+.++.+|+.+|.|++|.|+.+|+..++...+. ...++.++.+++.+|.| |.|+|+||+
T Consensus 98 ~e~~~~~F~~~D~d~dG~is~~E~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~if~~~D~d~dG~Is~~EF~ 170 (190)
T d1fpwa_ 98 EEKLSWAFELYDLNHDGYITFDEMLTIVASVYKMMGSMVTLNEDEATPEMRVKKIFKLMDKNEDGYITLDEFR 170 (190)
T ss_dssp THHHHHHHHHHCSSCSSEEEHHHHHHHHHHHHTTSCSTTSSSCCCCCHHHHHHHHHHHHTTTCSSEEEHHHHH
T ss_pred HHHHHHHHHHhccCCCCcCcHHHHHHHHHHHHHhcccccCCCchhhhHHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 456889999999999999999999999976521 11246788999999987 799999993
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=97.50 E-value=0.00012 Score=51.47 Aligned_cols=59 Identities=14% Similarity=0.071 Sum_probs=47.2
Q ss_pred HhhHHHHHhhh-CCCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMM-DTNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~-D~~~~-g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+ ..+++ +.+++.||+.++.+ ++..-++..++.+|+.+|.| |.|+|.||+
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~~d~~m~~LD~n~Dg~vdF~EF~ 75 (90)
T d3cr5x1 8 VVALIDVFHQYSGREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSDGDGECDFQEFM 75 (90)
T ss_dssp HHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHHHHHHHHHHhccCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 45678889887 34444 57999999999987 34455677899999999987 799999994
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.46 E-value=2.5e-05 Score=63.17 Aligned_cols=60 Identities=15% Similarity=0.051 Sum_probs=51.0
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC--------CCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN--------IPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
++..+++++|..+|. .+|.|+..||+.+|.++|.. ++.+.+..++..+|.+ |.|+|+||+
T Consensus 1 ee~~~~r~~F~~~d~-~dg~I~~~EL~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~~d~d~~g~i~~~ef~ 70 (173)
T d1alva_ 1 EEVRQFRRLFAQLAG-DDMEVSATELMNILNKVVTRHPDLKTDGFGIDTCRSMVAVMDSDTTGKLGFEEFK 70 (173)
T ss_dssp CHHHHHHHHHHHHHG-GGTSBCHHHHHHHHHHHHHTCSTTCCSCCCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred ChHHHHHHHHHHHcC-CCCcCCHHHHHHHHHHhCCCcchhhhccCCHHHHHHHHHHhccCCCCcccchhhh
Confidence 356789999999994 58999999999999987643 5678899999999987 689999983
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.44 E-value=4.8e-05 Score=62.33 Aligned_cols=56 Identities=16% Similarity=0.055 Sum_probs=32.2
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.+..+|..+|.|++|.|+..|+..++..+.....++.+..+++.+|.| |.|++.||
T Consensus 59 ~~~~lf~~~D~d~dG~I~f~Ef~~~l~~~~~~~~~~~~~~~F~~~D~d~~g~i~~~E~ 116 (189)
T d1jbaa_ 59 YVEAMFRAFDTNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDRNGCIDRQEL 116 (189)
T ss_dssp HHHHHHHHHCCSSSSEECHHHHHHHHHHHSSCCCTHHHHHHHHHHCSSCSSCBCHHHH
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHhhhccCCCCcccHhHH
Confidence 345556666666666666666666665554444455555566665555 45555554
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.43 E-value=9.3e-05 Score=60.18 Aligned_cols=59 Identities=14% Similarity=0.177 Sum_probs=48.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHh----CCCCCCHHHHH----HHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK----GGQNIPEADLQ----ILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~----lg~~~~~~e~~----~~~~~~d~~--g~i~~~~f~ 419 (419)
...++.+|+.+|.|++|.|+.+|++.++.. .|..+++.+++ .++..+|.| |.|+|+||+
T Consensus 90 ~~~~~~~F~~~D~d~~G~Is~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~ 158 (183)
T d2zfda1 90 DDKIHFSFQLYDLKQQGFIERQEVKQMVVATLAESGMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWR 158 (183)
T ss_dssp HHHHHHHHHHHCTTSSSSEEHHHHHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHH
T ss_pred HHHHHHhhcccccCCCCCccHHHHHHHHHHHHhhhhcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHH
Confidence 456888999999999999999999998754 47778876654 567788886 799999993
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.37 E-value=0.00022 Score=65.52 Aligned_cols=74 Identities=15% Similarity=0.126 Sum_probs=51.5
Q ss_pred cccccccceEEEEEEEcC-------CCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCCCeeeeeeEEEeCCeEEE
Q 014722 62 RELGRGEFGVTYLCTDVN-------NGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIVSLKDTYEDDSAVHI 134 (419)
Q Consensus 62 ~~lg~G~~g~V~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 134 (419)
+.|+.|-.-.+|++.... .++.|.+++.... .. .....+|..+++.++.+.-.+++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 578888889999988643 3466777776521 11 23456799999988666545678777653 57
Q ss_pred EEEecCCcch
Q 014722 135 VMELCEGGEL 144 (419)
Q Consensus 135 v~e~~~~g~L 144 (419)
|+||++|.+|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987554
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=9.5e-05 Score=58.98 Aligned_cols=55 Identities=16% Similarity=0.221 Sum_probs=45.1
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCC-----CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNI-----PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~-----~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.+.|+.+ .+.+|.|+.+||+.+|..+|... +.+.+..|+..+|.+ |.|+|.||+
T Consensus 2 ~~~~F~~~-a~~dG~I~~~EL~~~L~~~g~~~~~~~~s~~~~~~li~~~D~~~~G~i~~~EF~ 63 (165)
T d1k94a_ 2 VYTYFSAV-AGQDGEVDAEELQRCLTQSGINGTYSPFSLETCRIMIAMLDRDHTGKMGFNAFK 63 (165)
T ss_dssp HHHHHHHH-HGGGTSBCHHHHHHHHHHHTTTTTSCCCCHHHHHHHHHHHCTTCSSCBCHHHHH
T ss_pred hHHHHHHh-cCCCCCCCHHHHHHHHHHcCCCCCcccCCHHHHHHHHHHhCCCCCCcCcHHHHH
Confidence 45667766 67899999999999999988654 567889999999877 789999983
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00063 Score=60.58 Aligned_cols=70 Identities=13% Similarity=0.169 Sum_probs=45.7
Q ss_pred ceEEEEEEEcCCCcEEEEEEecccccCChhhHHHHHHHHHHHHhCCCCC-Ceeeee-----eEEEeCCeEEEEEEecCCc
Q 014722 69 FGVTYLCTDVNNGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHP-NIVSLK-----DTYEDDSAVHIVMELCEGG 142 (419)
Q Consensus 69 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~-----~~~~~~~~~~lv~e~~~~g 142 (419)
--.||++.. .+|+.|++|+...... ..+++..|...+..|..+. -++..+ ..+...+..+.++++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999884 6789999999864421 2466778888888773221 111111 2345677889999999874
Q ss_pred c
Q 014722 143 E 143 (419)
Q Consensus 143 ~ 143 (419)
.
T Consensus 110 ~ 110 (325)
T d1zyla1 110 Q 110 (325)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=97.22 E-value=5e-05 Score=62.09 Aligned_cols=57 Identities=14% Similarity=0.122 Sum_probs=49.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCC--------CCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQ--------NIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~--------~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
+.++++|..+| |++|.|+.+||+.+|..+|. .++.+++..++..+|.| |.|+|.||+
T Consensus 18 ~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~~~~~~l~~~~D~d~~G~I~~~EF~ 84 (186)
T d1df0a1 18 DGFRRLFAQLA-GEDAEISAFELQTILRRVLAKREDIKSDGFSIETCKIMVDMLDEDGSGKLGLKEFY 84 (186)
T ss_dssp HHHHHHHHHHH-GGGTCEEHHHHHHHHHHHHHC----CCCCCCHHHHHHHHHHHCCSSSSEECHHHHH
T ss_pred HHHHHHHHHHc-CCCCeEcHHHHHHHHHHhcccccccccccCCHHHHHHHHHHHcCCCCCcccHHHHH
Confidence 45889999998 89999999999999987653 46788999999999987 689999983
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.20 E-value=0.00026 Score=57.06 Aligned_cols=60 Identities=20% Similarity=0.254 Sum_probs=46.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----C--------CCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG----G--------QNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g--------~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
....++.+|+.+|.|++|.|+.+|+...+..+ + ....+..++.+++.+|.| |.|+|+||+
T Consensus 85 ~~~~~~~~f~~~D~~~~g~i~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~if~~~D~d~DG~Is~~EF~ 158 (178)
T d1s6ca_ 85 VHEKLRWTFNLYDINKDGYINKEEMMDIVKAIYDMMGKYTYPVLKEDTPRQHVDVFFQKMDKNKDGIVTLDEFL 158 (178)
T ss_dssp HHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHHHHHTC-----------CHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred hHHHHHHHHHhhccCCCCeecHHHHHHHHHHHHhhcccccccCCcHHHHHHHHHHHHHHhCCCCCCcEeHHHHH
Confidence 34568889999999999999999998876543 1 122355677899999876 799999983
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=97.11 E-value=0.00026 Score=57.42 Aligned_cols=55 Identities=18% Similarity=0.308 Sum_probs=34.4
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCC-HHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIP-EADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~-~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...+|+.+|.|++|.|+.+|+..++..+....+ ++.+..+++.+|.| |.|+.+||
T Consensus 56 ~~~lf~~~d~~~dg~I~f~EFl~~l~~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~e~ 113 (183)
T d2zfda1 56 ADRVFDLFDTKHNGILGFEEFARALSVFHPNAPIDDKIHFSFQLYDLKQQGFIERQEV 113 (183)
T ss_dssp HHHHHHHHCSSCSSSBCHHHHHHHHHHTSTTSCHHHHHHHHHHHHCTTSSSSEEHHHH
T ss_pred HHHHHHHHccCCCCcCcHHHHHHHHHhhhccCcHHHHHHHhhcccccCCCCCccHHHH
Confidence 456677777777777777777766666543333 34466666777665 56666654
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=97.07 E-value=0.00018 Score=50.94 Aligned_cols=59 Identities=14% Similarity=0.125 Sum_probs=46.5
Q ss_pred HhhHHHHHhhhC-CCCC-CcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMD-TNKR-GKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D-~~~~-g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+. .+++ +.++..||+.+|.+ ++..-+++.++.+|+.+|.| |.|+|.||+
T Consensus 8 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~im~~LD~n~Dg~vdF~EF~ 75 (95)
T d1qlsa_ 8 IESLIAIFQKHAGRDGNNTKISKTEFLIFMNTELAAFTQNQKDPGVLDRMMKKLDLDSDGQLDFQEFL 75 (95)
T ss_dssp HHHHHHHHHHHHTTSSCTTCBCHHHHHHHHTTTSHHHHHHCCCTHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcCcCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 456778888764 4454 67999999999976 44455677899999999987 799999994
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=97.06 E-value=3.1e-05 Score=63.43 Aligned_cols=61 Identities=16% Similarity=0.128 Sum_probs=39.3
Q ss_pred hhHHH-hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC--------CCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 357 SVEEV-AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN--------IPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 357 ~~~~~-~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~--------~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
+.++. +.++++|+.+| +++|.|+..||+.+|...|.. ++.+.+..++..+|.| |.|+|.||
T Consensus 14 s~~~~~~~~r~~F~~~d-~~dG~Is~~EL~~~L~~~~~~~~~~~~~~~s~e~~~~li~~~D~d~~G~i~~~EF 85 (188)
T d1qxpa2 14 SEEEIDDNFKTLFSKLA-GDDMEISVKELQTILNRIISKHKDLRTNGFSLESCRSMVNLMDRDGNGKLGLVEF 85 (188)
T ss_dssp -------------CCCC-CSSSSCCCSCTTTTTCC---------CCCCCHHHHHHHHHHHCC--CCCCCSSSH
T ss_pred CHHHHHHHHHHHHHHHc-CCCCEECHHHHHHHHHHhCccccccccccCCHHHHHHHHHHhcCCCCCcccHHHH
Confidence 34444 45899999999 558999999999998776543 4667899999999987 78999998
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=97.06 E-value=0.00027 Score=49.93 Aligned_cols=59 Identities=8% Similarity=0.110 Sum_probs=43.0
Q ss_pred HhhHHHHHhhhC-CCC-CCcccHHHHHHHHHh-----CCCCCCHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMD-TNK-RGKINLEELRLGLLK-----GGQNIPEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D-~~~-~g~i~~~el~~~l~~-----lg~~~~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+. .++ .+.+++.||+.++.+ ++..-+++.++++|+.+|.| |.|+|.||+
T Consensus 8 i~~ii~vFhkYa~~~g~~~tLsk~Elk~Ll~~El~~~l~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~ 75 (94)
T d1j55a_ 8 MGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFSEFI 75 (94)
T ss_dssp HHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHHHHHcccCCCcccCCHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 456778888874 333 357999999999987 33344567799999999987 799999994
|
| >d1j7qa_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=97.02 E-value=0.00072 Score=42.48 Aligned_cols=55 Identities=20% Similarity=0.196 Sum_probs=50.1
Q ss_pred hhhHHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC
Q 014722 356 LSVEEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII 410 (419)
Q Consensus 356 ~~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~ 410 (419)
+..++.++..++|..||.|....-...+...+|.++|+..+..|.+.+|+++...
T Consensus 8 lgpeekdecmkifdifdrnaeniapvsdtmdmltklgqtytkreteaimkeargp 62 (86)
T d1j7qa_ 8 LGPEEKDECMKIFDIFDRNAENIAPVSDTMDMLTKLGQTYTKRETEAIMKEARGP 62 (86)
T ss_dssp CSSTHHHHHHHHHHHHSTTTTSCBCHHHHHHHHHHTSCCCSHHHHHHHHHHHHCS
T ss_pred cCchhHHHHHHHHHHHhccccccCCcchHHHHHHHhhhHHhHHHHHHHHHHhcCC
Confidence 4567888999999999999999999999999999999999999999999998543
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.81 E-value=0.00027 Score=58.30 Aligned_cols=56 Identities=16% Similarity=0.190 Sum_probs=43.3
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
....+|+.+|.|++|.|+..|+..++..+.....++.+..+++.+|.| |.|+++||
T Consensus 64 ~~~~if~~~D~~~~G~I~f~EF~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~is~~E~ 121 (201)
T d1omra_ 64 YAQHVFRSFDANSDGTLDFKEYVIALHMTSAGKTNQKLEWAFSLYDVDGNGTISKNEV 121 (201)
T ss_dssp HHHHHHHTTTSCSSSEEEHHHHHHHHHHHHSSCGGGSHHHHHHHHCTTCSSSBCHHHH
T ss_pred HHHHHHHHhccCCCCeEeehhHHHHHHhhcccchHHHHHHHHHHHccCCCCccCHHHH
Confidence 346778888888888888888888887776666677788888888776 57887776
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.73 E-value=0.00048 Score=56.15 Aligned_cols=55 Identities=18% Similarity=0.247 Sum_probs=50.2
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...+|+.+|.+++|.|+..|+..++..++....++.+..+++.+|.| |.|+++||
T Consensus 65 ~~~if~~~D~~~~G~I~~~Ef~~~~~~~~~~~~~e~~~~~F~~~D~d~dG~is~~E~ 121 (190)
T d1fpwa_ 65 ANHLFTVFDKDNNGFIHFEEFITVLSTTSRGTLEEKLSWAFELYDLNHDGYITFDEM 121 (190)
T ss_dssp HHHHHHTCCSSCSSEECHHHHHHHHHHHSCCCSTHHHHHHHHHHCSSCSSEEEHHHH
T ss_pred HHHHHHHhCcCCCCcccHHHHHHHHHHHccCchHHHHHHHHHHhccCCCCcCcHHHH
Confidence 46789999999999999999999999998888889999999999887 78998886
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.62 E-value=0.00039 Score=56.16 Aligned_cols=54 Identities=19% Similarity=0.248 Sum_probs=28.1
Q ss_pred HHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 365 ~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.+.|+.+|.+++|.|+.+|+..++...-....++.+..++..+|.| |.|+.+||
T Consensus 62 ~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~~~~f~~~D~d~dg~i~~~E~ 117 (181)
T d1bjfa_ 62 EHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISKAEM 117 (181)
T ss_dssp HHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred HHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHHHHHHHHhccCCCCeecHHHH
Confidence 4455555555555555555555555443333444455555555544 45555444
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.32 E-value=0.0012 Score=52.93 Aligned_cols=55 Identities=15% Similarity=0.133 Sum_probs=43.1
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
....|+.+|.|++|.|+.+|+..++..+.....++.+..+++.+|.+ |.|+++||
T Consensus 53 ~~~lf~~~D~~~~g~I~~~EFl~~~~~~~~~~~~~~~~~~f~~~D~~~~g~i~~~e~ 109 (178)
T d1s6ca_ 53 AHYLFNAFDTTQTGSVKFEDFVTALSILLRGTVHEKLRWTFNLYDINKDGYINKEEM 109 (178)
T ss_dssp HHHHHHHHCTTCSSCEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHHHHHHHHhccchHHHHHHHHHhhccCCCCeecHHHH
Confidence 46788888888888888888888887765556677788888888776 67877765
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=96.11 E-value=0.0044 Score=42.30 Aligned_cols=59 Identities=15% Similarity=0.121 Sum_probs=44.2
Q ss_pred HhhHHHHHhhhCC-C-CCCcccHHHHHHHHHh-CCCCC-----CHHHHHHHHHHcCCC--CCcCccccC
Q 014722 361 VAGLKEAFEMMDT-N-KRGKINLEELRLGLLK-GGQNI-----PEADLQILMEAVSII--CLLSYFLVC 419 (419)
Q Consensus 361 ~~~l~~~F~~~D~-~-~~g~i~~~el~~~l~~-lg~~~-----~~~e~~~~~~~~d~~--g~i~~~~f~ 419 (419)
...+..+|..+-. + ..+.++..|++.++.+ ++.-+ ++.-++.+|+.+|.| |.|+|.||+
T Consensus 9 i~~ii~vFhkYa~~~G~~~tLsk~Elk~Ll~~El~~~l~~~~~d~~~vd~~m~~LD~n~Dg~vdF~EF~ 77 (83)
T d1xk4c1 9 IETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFI 77 (83)
T ss_dssp HHHHHHHHHHHHTTSSSTTSBCHHHHHHHHHHHTTTTTTTGGGCHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcccCCHHHHHHHHHHHhHHHhcCCCCCHHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 3466788887743 3 3468999999999987 33222 345589999999987 799999994
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=96.10 E-value=0.0019 Score=52.14 Aligned_cols=62 Identities=16% Similarity=0.144 Sum_probs=47.2
Q ss_pred hhHHHhhHHHHHhhhCCCCCCcccHHHHHHH-----HHhCCCCCCHHHHHHHHHHcCC-----C--CCcCcccc
Q 014722 357 SVEEVAGLKEAFEMMDTNKRGKINLEELRLG-----LLKGGQNIPEADLQILMEAVSI-----I--CLLSYFLV 418 (419)
Q Consensus 357 ~~~~~~~l~~~F~~~D~~~~g~i~~~el~~~-----l~~lg~~~~~~e~~~~~~~~d~-----~--g~i~~~~f 418 (419)
+++....++++|..+|.|++|.|+.+|+... ++.+|...+..+...++...+. . +.+++++|
T Consensus 9 ~~~~i~r~k~~F~~~D~d~dG~I~~~E~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~e~ 82 (189)
T d1qv0a_ 9 NPRWIKRHKHMFDFLDINGNGKITLDEIVSKASDDICAKLEATPEQTKRHQVCVEAFFRGCGMEYGKEIAFPQF 82 (189)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSCBCHHHHHHHHHHTHHHHTTCCHHHHHHHHHHHHHHHHHTTCCTTCCBCHHHH
T ss_pred CHHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHcCCCchhHHHHHHHHHHHhhhccccCCCceehHHH
Confidence 3456678999999999999999999999874 4567888888777766655532 1 46777665
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.0031 Score=50.89 Aligned_cols=55 Identities=16% Similarity=0.222 Sum_probs=46.2
Q ss_pred HHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...+|+.+|.+++|.|+.+|+..++..+.....++.+..+++.+|.| |.|+.+||
T Consensus 62 ~~~if~~~d~~~dg~I~~~EF~~~l~~~~~~~~~e~l~~~F~~~D~d~dG~i~~~El 118 (187)
T d1g8ia_ 62 ATFVFNVFDENKDGRIEFSEFIQALSVTSRGTLDEKLRWAFKLYDLDNDGYITRNEM 118 (187)
T ss_dssp HHHHHHHHCTTCSSEEEHHHHHHHHHHHHHCCHHHHHHHHHHHHCTTCSSEEEHHHH
T ss_pred HHHHHHHhCcCCCCCCcHHHHHHHHHHhccCchhhhHHHHHHHHhcCCCCeEcHHHH
Confidence 45689999999999999999999998875555677788899999887 68988876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.74 E-value=0.024 Score=49.40 Aligned_cols=31 Identities=32% Similarity=0.478 Sum_probs=24.7
Q ss_pred cCCEeeCCCCCcEEeecCCCCCCeEEeeccccee
Q 014722 176 QGVMHRDLKPENFLFANKKESSPLKAIDFGLSVF 209 (419)
Q Consensus 176 ~~ivHrDlkp~NIl~~~~~~~~~~kl~Dfg~a~~ 209 (419)
.|+||+|+.++||+++.+. ..-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~---v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDE---LSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred cccccCCcchhhhhccccc---ceeEeccccccc
Confidence 4799999999999997432 357899997753
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.68 E-value=0.0021 Score=51.17 Aligned_cols=58 Identities=14% Similarity=0.062 Sum_probs=35.9
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCC----------CCHHHHHHHHHHcCCC------CCcCccccC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGGQN----------IPEADLQILMEAVSII------CLLSYFLVC 419 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~----------~~~~e~~~~~~~~d~~------g~i~~~~f~ 419 (419)
.++..+|..+|.|++|.|+.+||...|...+.. ++.+.+..++...+.+ |.|++++|+
T Consensus 78 ~ei~~~F~~~d~d~~~~it~~el~~fL~~~Q~~~~~~e~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ls~d~F~ 151 (170)
T d2zkmx1 78 PEIDEIFTSYHAKAKPYMTKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMV 151 (170)
T ss_dssp HHHHTTCC--------CCCHHHHHHHHHHTCC---------------CHHHHHHHHCCC--------CCHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccHHHHHHHHHHHhcchhhhhhccccCCHHHHHHHHHHHccccccccCCeECHHHHH
Confidence 457789999999999999999999999876543 5777889999987654 579999883
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=95.64 E-value=0.0033 Score=49.89 Aligned_cols=33 Identities=21% Similarity=0.149 Sum_probs=29.3
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
-....++++|..+|.|++|.|+.+|+..++..+
T Consensus 3 ~~~~~l~~~F~~~D~d~dG~Is~~Ef~~~~~~~ 35 (174)
T d2scpa_ 3 LWVQKMKTYFNRIDFDKDGAITRMDFESMAERF 35 (174)
T ss_dssp HHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHccCCCCcEeHHHHHHHHHHH
Confidence 346789999999999999999999999998765
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=95.54 E-value=0.0021 Score=51.56 Aligned_cols=62 Identities=18% Similarity=0.202 Sum_probs=43.2
Q ss_pred hhHHHhhHHHHHhh-hCCCCCCcccHHHHHHHHHhCCC----CCCHHH-----------HHHHHHHcCCC--CCcCcccc
Q 014722 357 SVEEVAGLKEAFEM-MDTNKRGKINLEELRLGLLKGGQ----NIPEAD-----------LQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 357 ~~~~~~~l~~~F~~-~D~~~~g~i~~~el~~~l~~lg~----~~~~~e-----------~~~~~~~~d~~--g~i~~~~f 418 (419)
+..+...++++|+. +|.|++|.|+.+|+..++.+++. ...... ...+....+.+ |.|++++|
T Consensus 3 t~~q~~~i~~~F~~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~i~~~~~ 82 (185)
T d2sasa_ 3 NDFQKQKIKFTFDFFLDMNHDGSIQDNDFEDMMTRYKEVNKGSLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEY 82 (185)
T ss_dssp CHHHHHHHHHHHHHHTCTTCSSEECHHHHHHHHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHH
T ss_pred CHHHHHHHHHHHHHhhcCCCCCcCCHHHHHHHHHHhccccCCCcccHHHHHHHHHHHHHHHHHHHHhCcCCCCcEeeeHh
Confidence 45567789999997 59999999999999999976531 222211 12334445555 67888876
|
| >d2zkmx1 a.39.1.7 (X:142-311) Phospholipase C-beta-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Phospholipase C-beta-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.93 E-value=0.00038 Score=55.67 Aligned_cols=51 Identities=4% Similarity=-0.103 Sum_probs=21.3
Q ss_pred HHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 365 KEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 365 ~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
...|...|.+++|.|+.+|+...+..+.. ..++..++...|.| |.|+.++|
T Consensus 48 ~~~~~~~D~~~~~~i~F~eF~~~~~~l~~---r~ei~~~F~~~d~d~~~~it~~el 100 (170)
T d2zkmx1 48 HLPKGKNDAINPEDFPEPVYKSFLMSLCP---RPEIDEIFTSYHAKAKPYMTKEHL 100 (170)
T ss_dssp TCCCCTTCEECGGGCCHHHHHHHHHHHSC---CHHHHTTCC--------CCCHHHH
T ss_pred hhhhccccccCCCccCHHHHHHHHhccCC---HHHHHHHHHHHcCCCCCcccHHHH
Confidence 33444445555555555555555554432 23445555555443 34444443
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=94.65 E-value=0.014 Score=46.57 Aligned_cols=50 Identities=22% Similarity=0.243 Sum_probs=39.3
Q ss_pred hHHHhhHHHHHhhhCCCCCCcccHHHHHHHHH-----hCCCCCCHHHHHHHHHHc
Q 014722 358 VEEVAGLKEAFEMMDTNKRGKINLEELRLGLL-----KGGQNIPEADLQILMEAV 407 (419)
Q Consensus 358 ~~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~-----~lg~~~~~~e~~~~~~~~ 407 (419)
+.+..+++++|+.+|.|++|.|+.+|+..++. .+|...+..++...+...
T Consensus 8 p~~~~~~k~~F~~~D~d~dG~Is~~Ef~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 62 (187)
T d1uhka1 8 PRWIGRHKHMFNFLDVNHNGKISLDEMVYKASDIVINNLGATPEQAKRHKDAVEA 62 (187)
T ss_dssp HHHHHHHHHHHHHHCTTCCSEEEHHHHHHHHHHHHHHTSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHHhccCccHHHHHHHHHHh
Confidence 45567899999999999999999999977654 467777777666655544
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=94.49 E-value=0.021 Score=44.83 Aligned_cols=42 Identities=19% Similarity=0.291 Sum_probs=32.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC----CCCCCHHHHHH
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG----GQNIPEADLQI 402 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l----g~~~~~~e~~~ 402 (419)
.+.++++|+.+|.|++|.|+.+|++.++.++ +...+..++..
T Consensus 6 ~~~l~~~F~~~D~d~dG~Is~~Ef~~~l~~~~~~~~~~~~~~~~~~ 51 (176)
T d1nyaa_ 6 SDRLKKRFDRWDFDGNGALERADFEKEAQHIAEAFGKDAGAAEVQT 51 (176)
T ss_dssp HHHHHHHHHHCCSSCCSSBCSHHHHHHHHHHHHHTSSCSSSHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcCcHHHHHHHHHHHHHHcCCcccHHHHHH
Confidence 4568999999999999999999999998764 44555444433
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.86 E-value=0.034 Score=36.03 Aligned_cols=30 Identities=23% Similarity=0.381 Sum_probs=26.7
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
.++.+.|..+|.|++|.|+.+|+..++.++
T Consensus 37 ~~i~~~~~~~D~d~dg~I~~~EF~~~m~~~ 66 (67)
T d1tiza_ 37 EDIVKFFEEIDVDGNGELNADEFTSCIEKM 66 (67)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHh
Confidence 457888999999999999999999998764
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.80 E-value=0.039 Score=43.78 Aligned_cols=55 Identities=9% Similarity=0.047 Sum_probs=45.1
Q ss_pred HHHHHhhhCCC-CCCcccHHHHHHHHHhCCCC-CCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 364 LKEAFEMMDTN-KRGKINLEELRLGLLKGGQN-IPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 364 l~~~F~~~D~~-~~g~i~~~el~~~l~~lg~~-~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
..++|+.+|.+ ++|.|+.+|+..+|..+... -.++.+..+++.+|.| |.|+.+|+
T Consensus 59 ~~rif~~fd~~~~~g~I~f~EFv~~l~~~~~~~~~~~kl~~~F~~~D~d~~G~I~~~el 117 (180)
T d1xo5a_ 59 KERICRVFSTSPAKDSLSFEDFLDLLSVFSDTATPDIKSHYAFRIFDFDDDGTLNREDL 117 (180)
T ss_dssp HHHHHHHHCCSTTCCEECHHHHHHHHHHHSTTSCHHHHHHHHHHHHCTTCSSSBCHHHH
T ss_pred HHHHHHhccCCCCCCcCcHHHHHHHHHHHhhcCCHHHHHHHhhccccCCCCCeeeHHHH
Confidence 45789999987 68999999999999887544 4466788899999887 78988876
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=92.33 E-value=0.062 Score=37.34 Aligned_cols=32 Identities=16% Similarity=0.264 Sum_probs=28.0
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
....+.+.|..+|.|++|.|+.+|+..++.++
T Consensus 50 ~~~~~~~i~~~~D~n~DG~I~F~EF~~lm~~l 81 (93)
T d3c1va1 50 DEAAFQKLMSNLDSNRDNEVDFQEYCVFLSCI 81 (93)
T ss_dssp SHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCCHHHHHHHHHHH
Confidence 34568899999999999999999999988765
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=91.40 E-value=0.13 Score=36.81 Aligned_cols=52 Identities=8% Similarity=0.084 Sum_probs=39.1
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.+++..+|. +|.|+..|+..++.. ..-+++++..+++.+|.| |.|+.+|+
T Consensus 10 di~~~~~~~~~--~G~idf~eF~~~~~~--~~~~~~~l~~~F~~~D~d~~G~I~~~El 63 (109)
T d5pala_ 10 DINKAISAFKD--PGTFDYKRFFHLVGL--KGKTDAQVKEVFEILDKDQSGFIEEEEL 63 (109)
T ss_dssp HHHHHHHHTCS--TTCCCHHHHHHHHTC--TTCCHHHHHHHHHHHCTTCSSEECHHHH
T ss_pred HHHHHHHhcCC--CCcCcHHHHHHHHHh--cCCCHHHHHHHHhhhcCCCCCeEcHHHH
Confidence 35566666664 588999999876642 234678999999999987 78998876
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=91.23 E-value=0.094 Score=36.30 Aligned_cols=31 Identities=10% Similarity=0.149 Sum_probs=26.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
...+.+.|..+|.|++|.|+.+|+..++..+
T Consensus 48 ~~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 78 (92)
T d1a4pa_ 48 PLAVDKIMKDLDQCRDGKVGFQSFFSLIAGL 78 (92)
T ss_dssp TTHHHHHHHHHCTTSSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcHHHHHHHHHHH
Confidence 3467888999999999999999999888654
|
| >d1tuza_ a.39.1.7 (A:) Diacylglycerol kinase alpha, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Diacylglycerol kinase alpha, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.21 E-value=0.067 Score=39.04 Aligned_cols=65 Identities=17% Similarity=0.047 Sum_probs=48.7
Q ss_pred hhhhHHHhhHHHHHhhh---CCCCCCcccHHHHHHHHHhCCC--CCCHHHHHHHHHHcCCC----------CCcCccccC
Q 014722 355 FLSVEEVAGLKEAFEMM---DTNKRGKINLEELRLGLLKGGQ--NIPEADLQILMEAVSII----------CLLSYFLVC 419 (419)
Q Consensus 355 ~~~~~~~~~l~~~F~~~---D~~~~g~i~~~el~~~l~~lg~--~~~~~e~~~~~~~~d~~----------g~i~~~~f~ 419 (419)
.++..+...+.+.|... ....+|.|+.++++.++..+.. ..+..-++.++..+|.+ |.|+|.||+
T Consensus 21 ~fs~~ei~~l~~~Fk~~~~~~~~p~g~i~~~~F~~~~~~~f~~~~~~~~l~~rlF~~FD~~~d~~~~~~~~g~I~f~efv 100 (118)
T d1tuza_ 21 EYSTKKVSDVLKLFEDGEMAKYVQGDAIGYEGFQQFLKIYLEVDNVPRHLSLALFQSFETGHCLNETNVTKDVVCLNDVS 100 (118)
T ss_dssp HHCCCCHHHHHHHHHTSGGGGGEETTEECHHHHHHHHHHHTTCSSCCHHHHHHHHHHSCCCCCTTCCCCCSCCEEHHHHH
T ss_pred CCCHHHHHHHHHHHhccccccCCcccccCHHHHHHHHHHhCCCCCchHHHHHHHHHHHccccccccccCCCceeeHHHHH
Confidence 35667777888888643 2356899999999999987643 23456678899999877 569999984
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=90.95 E-value=0.14 Score=33.90 Aligned_cols=31 Identities=23% Similarity=0.236 Sum_probs=26.9
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGG 392 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg 392 (419)
.++.+.|..+|.|++|.|+.+|+..++++..
T Consensus 45 ~e~~~~~~~~D~d~~G~I~~~EF~~~m~k~~ 75 (77)
T d1oqpa_ 45 EELQEMIAEADRNDDNEIDEDEFIRIMKKTS 75 (77)
T ss_dssp HHHHHHHHHHCCSSSSEECHHHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHccC
Confidence 4567889999999999999999999988653
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.64 E-value=0.11 Score=36.54 Aligned_cols=29 Identities=21% Similarity=0.235 Sum_probs=26.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..+..+|..+|.|++|.|+.+|+..++++
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~~~~~ 96 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLASTQR 96 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHHHHhc
Confidence 45788999999999999999999998875
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=90.45 E-value=0.22 Score=35.56 Aligned_cols=52 Identities=12% Similarity=0.161 Sum_probs=38.6
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.+++..+| .+|.|+.+|+..++... ..+++++..+++.+|.| |.|+.+|+
T Consensus 10 eI~~~~~~~d--~dG~idf~EF~~~~~~~--~~~~~~~~~~F~~~D~d~~G~I~~~El 63 (109)
T d1pvaa_ 10 DIKKALDAVK--AEGSFNHKKFFALVGLK--AMSANDVKKVFKAIDADASGFIEEEEL 63 (109)
T ss_dssp HHHHHHHHTC--STTCCCHHHHHHHHTCT--TSCHHHHHHHHHHHCTTCSSSBCHHHH
T ss_pred HHHHHHHhcC--CCCCCcHHHHHHHHHHc--cCCHHHHHHHhhCccCCCcCeEcHHHH
Confidence 3444555454 56889999998776432 34678899999999987 78998876
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.71 E-value=0.12 Score=34.24 Aligned_cols=30 Identities=30% Similarity=0.416 Sum_probs=26.8
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.|..+|.|++|.|+.+|+..++.++
T Consensus 45 ~ei~~~~~~~D~d~dG~I~f~EF~~~m~~~ 74 (76)
T d1qx2a_ 45 STLDEMIEEVDKNGDGEVSFEEFLVMMKKI 74 (76)
T ss_dssp CSHHHHHHHHCTTCSSEECHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCcCcHHHHHHHHHHH
Confidence 358889999999999999999999988764
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=89.56 E-value=0.095 Score=33.88 Aligned_cols=30 Identities=27% Similarity=0.297 Sum_probs=25.9
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
...+...|+.+|.|++|.|+.+|+..++++
T Consensus 38 ~~e~~~~~~~~D~d~dG~i~~~EF~~~m~r 67 (68)
T d1c7va_ 38 DAEVEEAMKEADEDGNGVIDIPEFMDLIKK 67 (68)
T ss_dssp HHHHHHHHHHHCSSGGGSEEHHHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCCcEeHHHHHHHHHh
Confidence 346778899999999999999999998864
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=89.46 E-value=0.16 Score=34.61 Aligned_cols=32 Identities=19% Similarity=0.313 Sum_probs=27.5
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
....+.+.++..|.|+||.|+.+|+..++..+
T Consensus 49 ~~~~v~~~~~~lD~n~Dg~idF~EF~~li~~l 80 (87)
T d1e8aa_ 49 DKAVIDEIFQGLDANQDEQVDFQEFISLVAIA 80 (87)
T ss_dssp SHHHHHHHHHHHCTTCSSCEEHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHH
Confidence 34568899999999999999999998887654
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=89.40 E-value=0.11 Score=36.03 Aligned_cols=31 Identities=13% Similarity=0.294 Sum_probs=27.2
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
...+.+.|+.+|.|++|.|+.+|+..++..+
T Consensus 51 ~~~~~~~~~~~D~d~dG~Idf~EF~~lm~~l 81 (93)
T d1zfsa1 51 ADAVDKIMKELDENGDGEVDFQEFVVLVAAL 81 (93)
T ss_dssp HHHHHHHHHHHTTTCCSEECSHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 4567889999999999999999999988764
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=88.37 E-value=0.1 Score=36.16 Aligned_cols=32 Identities=19% Similarity=0.199 Sum_probs=27.8
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
....+.+.++.+|.|++|.|+.+|+..++..+
T Consensus 50 ~~~~~~~~~~~lD~n~Dg~IdF~EF~~l~~~l 81 (93)
T d1ksoa_ 50 RECDYNKFMSVLDTNKDCEVDFVEYVRSLACL 81 (93)
T ss_dssp CHHHHHHHHHHHHHTTTCEECHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHcCCCCCCCcHHHHHHHHHHH
Confidence 34568889999999999999999999988765
|
| >d1sraa_ a.39.1.3 (A:) C-terminal (EC) domain of BM-40/SPARC/osteonectin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Osteonectin domain: C-terminal (EC) domain of BM-40/SPARC/osteonectin species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.24 E-value=0.027 Score=42.75 Aligned_cols=52 Identities=13% Similarity=-0.047 Sum_probs=42.1
Q ss_pred HHHHhhhCCC-CCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 365 KEAFEMMDTN-KRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 365 ~~~F~~~D~~-~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
.=-|..+|.| ++|.++..||..+...+ ...+..+..++...|.| |.|++.|+
T Consensus 80 ~W~F~~LD~n~~D~~L~~~EL~~l~~~L--~~~e~C~~~F~~~CD~n~D~~Is~~EW 134 (151)
T d1sraa_ 80 HWQFGQLDQHPIDGYLSHTELAPLRAPL--IPMEHCTTRFFETCDLDNDKYIALDEW 134 (151)
T ss_dssp HHHHHHHCCTTCSSEECTTTTGGGGSTT--STTGGGHHHHHHHHCTTCSSSEEHHHH
T ss_pred eeehhhcCCCCCCCccCHHHHHHHHHhh--cCCchHHHHHHHHhcCCCCCcCCHHHH
Confidence 3449999999 69999999999865433 45677899999999887 68998886
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=88.09 E-value=0.24 Score=33.11 Aligned_cols=30 Identities=17% Similarity=0.212 Sum_probs=26.7
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.|..+|.|++|.|+.+|+..+++..
T Consensus 41 ~ei~~~~~~~D~d~~G~I~~~EF~~~~~~~ 70 (81)
T d2opoa1 41 DEVRRMMAEIDTDGDGFISFDEFTDFARAN 70 (81)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHHC
Confidence 357889999999999999999999988764
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=87.70 E-value=0.17 Score=35.47 Aligned_cols=30 Identities=30% Similarity=0.251 Sum_probs=26.8
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.|+.+|.|++|.|+.+|+..++..+
T Consensus 52 ~~v~~~~~~~D~n~DG~I~F~EF~~li~~l 81 (100)
T d1psra_ 52 NYLADVFEKKDKNEDKKIDFSEFLSLLGDI 81 (100)
T ss_dssp CGGGTHHHHHCTTCSSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 467888999999999999999999988765
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=87.60 E-value=0.24 Score=32.50 Aligned_cols=30 Identities=17% Similarity=0.298 Sum_probs=25.8
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.|..+|.|++|.|+.+|+..+|+.+
T Consensus 45 ~e~~~~~~~~D~d~dg~I~~~EF~~~m~~~ 74 (75)
T d1jc2a_ 45 EDIEDLMKDSDKNNDGRIDFDEFLKMMEGV 74 (75)
T ss_dssp HHHHHHHHHHCSSSCSEECHHHHHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHHhC
Confidence 356778999999999999999999988753
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=87.58 E-value=0.16 Score=36.25 Aligned_cols=28 Identities=21% Similarity=0.317 Sum_probs=24.9
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLL 389 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 389 (419)
+.+...|..+|.|++|.|+.+|+..+++
T Consensus 80 ~~~~~~~~~~D~d~dG~I~~~EF~~~m~ 107 (108)
T d1rroa_ 80 SETKSLMDAADNDGDGKIGADEFQEMVH 107 (108)
T ss_dssp HHHHHHHHHHCCSSSSSEEHHHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHc
Confidence 4577889999999999999999999875
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=87.56 E-value=0.24 Score=35.21 Aligned_cols=29 Identities=21% Similarity=0.197 Sum_probs=25.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
+.+++.|+.+|.|++|.|+.+|+..++++
T Consensus 79 ~~~~~l~~~~D~d~dG~I~~~EF~~~m~a 107 (107)
T d2pvba_ 79 AETKAFLADGDKDGDGMIGVDEFAAMIKA 107 (107)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHHHHHC
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHHHHcC
Confidence 46778899999999999999999988763
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=87.39 E-value=0.39 Score=32.53 Aligned_cols=30 Identities=27% Similarity=0.441 Sum_probs=26.5
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.++..|.|++|.|+.+|+..++.++
T Consensus 49 ~~v~~i~~~~D~n~DG~IdF~EF~~l~~~l 78 (87)
T d1xk4a1 49 KGADVWFKELDINTDGAVNFQEFLILVIKM 78 (87)
T ss_dssp TCHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHHHHHHH
Confidence 457888999999999999999999988764
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=86.69 E-value=0.2 Score=33.50 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=25.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..+...|..+|.|++|.|+.+|+..+++.
T Consensus 51 ~ev~~~~~~~D~d~dg~I~~~EF~~~m~~ 79 (81)
T d1fi5a_ 51 DDIEELMKDGDKNNDGRIDYDEFLEFMKG 79 (81)
T ss_dssp HHHHHHHHHHCSSSSSSEEHHHHHHHHSC
T ss_pred HHHHHHHHHHCCCCCCcEeHHHHHHHHHh
Confidence 35677899999999999999999988764
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=86.42 E-value=0.41 Score=34.00 Aligned_cols=52 Identities=6% Similarity=-0.000 Sum_probs=38.4
Q ss_pred hHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCCC--CCcCcccc
Q 014722 363 GLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 363 ~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
++.+++..++. +|.|+.+|+..++...+ -+++++..+++.+|.| |.|+.+||
T Consensus 10 ~i~~~~~~~~~--~~~i~f~eF~~~~~~~~--~~~~~~~~~F~~~D~d~~G~I~~~El 63 (109)
T d1rwya_ 10 DIKKAIGAFTA--ADSFDHKKFFQMVGLKK--KSADDVKKVFHILDKDKSGFIEEDEL 63 (109)
T ss_dssp HHHHHHHTTCS--TTCCCHHHHHHHHTGGG--SCHHHHHHHHHHHSTTCSSEECHHHH
T ss_pred HHHHHHHhccc--CCCcCHHHHHHHHcccc--CCHHHHHHHhhcccCCCCCcCcHHHH
Confidence 34455555544 47899999988774332 3678899999999987 78998886
|
| >d1h8ba_ a.39.1.7 (A:) alpha-Actinin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: alpha-Actinin species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.75 E-value=0.63 Score=29.99 Aligned_cols=52 Identities=21% Similarity=0.305 Sum_probs=40.3
Q ss_pred HHHhhHHHHHhhhCCCCCCcccHHHHHHHHHhCCCCCCHHHHHHHHHHcCC-------CCCcCcccc
Q 014722 359 EEVAGLKEAFEMMDTNKRGKINLEELRLGLLKGGQNIPEADLQILMEAVSI-------ICLLSYFLV 418 (419)
Q Consensus 359 ~~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg~~~~~~e~~~~~~~~d~-------~g~i~~~~f 418 (419)
+..+++.++|+.+ .++..+|+.+||++.| +.++++-++..+.. .|-.+|..|
T Consensus 5 ~TaEqv~~aFr~l-A~~KpyVT~~dL~~~L-------~peqaeyc~~~M~~y~~~~~~~~ayDY~sF 63 (73)
T d1h8ba_ 5 DTAEQVIASFRIL-ASDKPYILAEELRREL-------PPDQAQYCIKRMPAYSGPGSVPGALDYAAF 63 (73)
T ss_dssp STHHHHHHHHHHH-TTSCSSBCHHHHHHHS-------CHHHHHHHHHHSCSCCCSSCCTTCBCHHHH
T ss_pred ccHHHHHHHHHHH-hCCCCeeCHHHHHhhc-------CHHHHHHHHHHCcccCCCCCCCCcccHHHH
Confidence 3456788999998 5779999999999765 67789889988853 256777766
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=84.91 E-value=0.16 Score=26.49 Aligned_cols=23 Identities=9% Similarity=-0.010 Sum_probs=19.5
Q ss_pred CHHHHHHHHHHcCCC--CCcCcccc
Q 014722 396 PEADLQILMEAVSII--CLLSYFLV 418 (419)
Q Consensus 396 ~~~e~~~~~~~~d~~--g~i~~~~f 418 (419)
+++|+.+.++.+|.| |.|+-+||
T Consensus 2 sEeELae~FRifDkNaDGyiD~eEl 26 (34)
T d1ctda_ 2 SEEELANAFRIFDKNADGYIDIEEL 26 (34)
T ss_dssp HHHHHHHHHHTTCCSSSSCBCHHHH
T ss_pred CHHHHHHHHHHHccCCcccccHHHH
Confidence 467899999999987 78998886
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=84.84 E-value=0.45 Score=31.76 Aligned_cols=30 Identities=17% Similarity=0.449 Sum_probs=26.1
Q ss_pred HhhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 361 VAGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 361 ~~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..++++.+..+|.|++|.|+.+|+..++.+
T Consensus 51 ~~el~~~i~~~D~d~~G~I~f~eFl~im~~ 80 (82)
T d1wrka1 51 PEELQEMIDEVDEDGSGTVDFDEFLVMMVR 80 (82)
T ss_dssp HHHHHHHHHTTCTTCCSSBCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCeEeHHHHHHHHHh
Confidence 356788899999999999999999988864
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=84.70 E-value=0.32 Score=30.79 Aligned_cols=27 Identities=22% Similarity=0.346 Sum_probs=23.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGL 388 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l 388 (419)
..+...|..+|.|++|.|+.+|+..+|
T Consensus 39 ~e~~~l~~~~D~d~~g~I~~~eF~~~m 65 (65)
T d1fw4a_ 39 EEVDEMIREADIDGDGQVNYEEFVQMM 65 (65)
T ss_dssp HHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred HHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence 457788999999999999999998753
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=84.61 E-value=0.17 Score=33.63 Aligned_cols=31 Identities=26% Similarity=0.449 Sum_probs=26.7
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhCC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKGG 392 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~lg 392 (419)
..+.+.+..+|.|++|.|+.+|+..++.++.
T Consensus 47 ~~v~~~~~~~D~d~dG~Idf~EF~~l~~~la 77 (78)
T d1cb1a_ 47 RTLDDLFQELDKNGDGEVSFEEFQVLVKKIS 77 (78)
T ss_dssp CCSSHHHHHTCCCSSSSEEHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCCCCcCcHHHHHHHHHHHh
Confidence 3467889999999999999999999887653
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=84.59 E-value=0.38 Score=33.16 Aligned_cols=32 Identities=13% Similarity=0.185 Sum_probs=27.4
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
....+.+.|+.+|.|+||.|+-+|+..++..+
T Consensus 50 d~~~vd~im~~LD~n~Dg~vdF~EF~~li~~l 81 (95)
T d1qlsa_ 50 DPGVLDRMMKKLDLDSDGQLDFQEFLNLIGGL 81 (95)
T ss_dssp CTHHHHHHHHHHCTTCSSSBCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCcHHHHHHHHHHH
Confidence 34568899999999999999999998887654
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=84.09 E-value=0.44 Score=31.67 Aligned_cols=29 Identities=24% Similarity=0.462 Sum_probs=25.1
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..+.+.|..+|.|++|.|+.+|+..++.+
T Consensus 50 ~e~~~~~~~~D~d~~g~I~~~eF~~~m~~ 78 (81)
T d1avsa_ 50 EELDAIIEEVDEDGSGTIDFEEFLVMMVR 78 (81)
T ss_dssp HHHHHHHHHHCTTCCSSEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 34678899999999999999999988864
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=83.69 E-value=0.44 Score=30.93 Aligned_cols=29 Identities=21% Similarity=0.399 Sum_probs=25.3
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..+.++|..+|.|++|.|+.+|+..++.+
T Consensus 44 ~~~~~~~~~~D~d~~g~I~f~eF~~~m~~ 72 (73)
T d2pq3a1 44 AELQDMINEVDADGNGTIDFPEFLTMMAR 72 (73)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHhc
Confidence 45778899999999999999999988753
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.58 E-value=0.44 Score=33.18 Aligned_cols=28 Identities=21% Similarity=0.379 Sum_probs=25.2
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLL 389 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 389 (419)
..+.++++..|.|++|.|+.+|+..+|+
T Consensus 45 ~~L~~i~~~~D~d~dG~L~~~EF~~am~ 72 (99)
T d1qjta_ 45 LILGKIWDLADTDGKGVLSKQEFFVALR 72 (99)
T ss_dssp HHHHHHHHHHCCSSSSSCCSHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCccCHHHHHHHHH
Confidence 4578999999999999999999998885
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=83.38 E-value=0.42 Score=32.70 Aligned_cols=28 Identities=25% Similarity=0.440 Sum_probs=24.4
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLL 389 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 389 (419)
..+.++++.+|.|++|.|+.+|+..++.
T Consensus 43 ~~l~~i~~~~D~d~dG~l~~~EF~~a~~ 70 (92)
T d1fi6a_ 43 LELSHIWELSDFDKDGALTLDEFCAAFH 70 (92)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeecHHHHHHHHH
Confidence 4678889999999999999999987664
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=83.12 E-value=0.51 Score=32.15 Aligned_cols=32 Identities=16% Similarity=0.227 Sum_probs=27.0
Q ss_pred HHhhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 360 EVAGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 360 ~~~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
....+.+.|+.+|.|+||.|+-+|+-.++..+
T Consensus 50 d~~~~d~~m~~LD~n~Dg~vdF~EF~~li~~l 81 (90)
T d3cr5x1 50 EQEVVDKVMETLDSDGDGECDFQEFMAFVAMI 81 (90)
T ss_dssp SHHHHHHHHHHHCTTSSSSBCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 34568889999999999999999998887654
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.94 E-value=0.27 Score=33.98 Aligned_cols=28 Identities=21% Similarity=0.396 Sum_probs=24.3
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLL 389 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~ 389 (419)
..+.++|+.+|.|++|.|+.+|+..+|.
T Consensus 44 ~~l~~i~~~~D~d~dG~l~~~EF~~am~ 71 (95)
T d1c07a_ 44 TLLAHIWSLCDTKDCGKLSKDQFALAFH 71 (95)
T ss_dssp HHHHHHHHHHCTTCSSSEETTTHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHHHH
Confidence 4577889999999999999999987763
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=81.85 E-value=0.51 Score=32.75 Aligned_cols=30 Identities=17% Similarity=0.237 Sum_probs=26.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHhC
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLKG 391 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~l 391 (419)
..+.+.|..+|.|++|.|+.+|+..++..+
T Consensus 54 ~~v~~l~~~~D~d~DG~IdF~EF~~l~~~l 83 (98)
T d1yuta1 54 GSLDEKMKSLDVNQDSELKFNEYWRLIGEL 83 (98)
T ss_dssp SCHHHHHHHHCTTCCSCBCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHHHHHHHH
Confidence 357899999999999999999999988754
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=80.98 E-value=0.63 Score=28.86 Aligned_cols=24 Identities=17% Similarity=0.403 Sum_probs=21.0
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELR 385 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~ 385 (419)
..+...|+.+|.|++|.|+.+|+.
T Consensus 37 ~ei~~l~~~~D~d~dg~I~~~eFl 60 (61)
T d2fcea1 37 AEVDELLKGVEVDSNGEIDYKKFI 60 (61)
T ss_dssp HHHHHHHTTCCCCTTSEECHHHHH
T ss_pred HHHHHHHHHcCCCCCCcEeHHHhc
Confidence 456788999999999999999975
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=80.98 E-value=0.62 Score=30.50 Aligned_cols=29 Identities=14% Similarity=0.268 Sum_probs=25.3
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHHHh
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGLLK 390 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l~~ 390 (419)
..+.+.|..+|.+++|.|+.+|+..++.+
T Consensus 46 ~e~~~~~~~~D~~~~g~I~~~eF~~~m~~ 74 (77)
T d1f54a_ 46 AEVNDLMNEIDVDGNHQIEFSEFLALMSR 74 (77)
T ss_dssp HHHHHHHHTTCCSSCCEEEHHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCeEeHHHHHHHHHH
Confidence 45788899999999999999999988753
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.78 E-value=0.75 Score=30.54 Aligned_cols=27 Identities=11% Similarity=0.331 Sum_probs=23.6
Q ss_pred hhHHHHHhhhCCCCCCcccHHHHHHHH
Q 014722 362 AGLKEAFEMMDTNKRGKINLEELRLGL 388 (419)
Q Consensus 362 ~~l~~~F~~~D~~~~g~i~~~el~~~l 388 (419)
.++...|..+|.|++|.|+..|+...+
T Consensus 56 ~e~~~l~~~~d~~~~g~I~y~eFl~~f 82 (83)
T d1wlza1 56 EQFDRLWNEMPVNAKGRLKYPDFLSRF 82 (83)
T ss_dssp HHHHHHHTTSCBCTTSCBCHHHHHHHH
T ss_pred hHHHHHhhccccCCCCcEeHHHHHHHh
Confidence 456788999999999999999998775
|